Structure Search

List Search MOL Search Structure Search

 EN

English - EN Chinese - ZH

 Cart 0
Chemistry
Life Science
Catalysts Ligands
Materials Science
Catalysts Ligands
Achiral Nitrogen Ligands
Pyridine and Phenanthroline Ligands (162)
Other Achiral Nitrogen Ligands (53)
Achiral Oxygen Ligands
Achiral Oxygen Ligand (54)
Achiral Phosphine Ligands
Alkyl-phosphine Ligands (17)
Aryl-phosphine Ligands (86)
2-(Diphenylphosphaneyl)Benzaldehyde (5)[1,1'-Biphenyl]-2-Yldi-Tert-Butylphosphane (4)Triphenylphosphine Oxide (7)
Bis-phosphine Ligands (90)
Mono-phosphine Ligands (256)
Multi-phosphine Ligands (5)
Chiral Nitrogen Ligands
Chiral Bis-nitrogen Ligands (133)
Salen Ligands (7)
Other Chiral Nitrogen Ligands (69)
Chiral Oxazoline Ligands
BOX Ligands (510)
Chiral Mono Oxazoline Ligands (363)
Ferrocenyl-oxazoline Ligands (10)
PHOX Ligands (218)
SOX Ligands (34)
TOX Ligands (6)
Other Oxazoline Ligands (14)
Chiral Oxygen Ligands
BINOLs (46)
BIPHENs (2)
Chiral Diphenols (112)
Other Chiral Oxygen Ligands (24)
Chiral Phosphine Ligands
Atropisomeric Bisphosphine Ligands (137)
BIDIME and BIBOP Ligands (78)
BIDIME-BIBOP (7)
2,2',3,3'-Tetrahydro-4,4'-Bibenzo[D][1,3]Oxaphosphole (7)
Chiral Aminophosphine Ligands (50)
Chiral Ferrocenyl Phosphine Ligands (96)
Chiral Phosphoramidite Ligands (98)
Duphos and BPE Ligands (28)
PHOX Ligands (218)
Sadphos Ligands (110)
Other C-Chiral Ligands (76)
Other P-Chiral Ligands (10)
Main-Group Metals
Aluminum (11)
Tin (3)
Metalloids
Metalloid (5)
Organocatalysts
Chiral Hydrogen-Bonding Organocatalysts (79)
Chiral Phosphoric Acids (161)
4-Hydroxy-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepine 4-Oxide (20)
Cinchona Alkaloids (32)
MacMillan Imidazolidinone Organocatalysts (15)
NHTf (59)
Proline-Based Organocatalysts (51)
Other Organocatalysts (45)
Phase-Transfer Catalysts
Achiral Phase-Transfer Catalysts (61)
Chiral Phase-Transfer Catalysts (25)
Photoredox Catalysts
Organic-dye Photoredox Catalysts (86)
Photoredox Acridinium Catalysts (22)
Photoredox Carbazole Catalysts (10)
Photoredox Iridiums Catalysts (104)
Photoredox Rutheniums Catalysts (37)
Other Photoredox Catalysts (13)
Transition Metals
Cadmium (1)
Cobalt (92)
Copper (108)
Gold (70)
Iridium (60)
Iron (101)
Manganese (45)
Molybdenum (11)
Nickel (95)
Osmium (2)
Palladium (240)
Platinum (75)
Rhenium (6)
Rhodium (166)
Ruthenium (199)
Silver (33)
Tantalum (1)
Titanium (10)
Tungsten (6)
Vanadium (6)
Zinc (48)
Other Cheap Metals (6)
Chemistry
Asymmetric Synthesis
Chiral Building Blocks (18939)
Boronic Acids/Esters
1,3,2-Dioxaborinane (394)
Bcat (11)
Boronic Acids (13202)
MIDA Boronates (363)
Pinacol Boronates (16140)
Pinane Boronates (96)
Potassium Organotrifluoroborate Salts (1076)
Other Boronates (132)
Heterocyclic Building Blocks
Acridines (640)
1,2,3,4-Tetrahydroacridine (9)9,10-Diphenylacridin-10-Ium (6)Acridine (18)
Aliphatic Heterocycles (103)
(1R,5S)-3-Azabicyclo[3.1.0]Hexane (11)1,2-Dithiolane (6)1,4-Diazepan-2-One (5)1,4-Diazepan-5-One (9)1,4-Dioxane (17)1,4-Oxazepane (8)10,11-Dihydro-5H-Dibenzo[B,F]Azepine (9)11,12-Didehydro-5,6-Dihydrodibenz[B,F]Azocine (14)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Glycyl)-2,2-Dimethyloxazolidine-4-Carboxylic Acid (8)3H-Diazirine (11)4-Benzyl-1,4-Oxazepane (5)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)
Aromatic Heterocycles (30)
1,2,4,5-Tetrazine (7)3,4-Dihydronaphthalen-2(1H)-One (23)
Azetidines (2997)
1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Phenylsulfonyl)Azetidine (7)1-Benzhydrylazetidine (13)1-Benzylazetidine (6)1-Methylazetidine (6)1-Phenylazetidine (8)2,7-Diazaspiro[3.5]Nonane (7)2-Azaspiro[3.3]Heptane (11)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)3-Bromoazetidine (3)3-Methylazetidin-3-Ol (3)3-Methyleneazetidine (8)3-Phenylazetidine (5)4-(Azetidin-1-Yl)Piperidine (6)Azetidin-2-One (11)Azetidin-2-Ylmethanol (7)Azetidin-3-Amine (4)Azetidin-3-Ol (11)Azetidin-3-Yl Acetate (3)Azetidin-3-Ylmethanamine (3)Azetidine-2-Carboxylic Acid (6)Azetidine-3-Carboxylic Acid (5)Benzyl Azetidine-1-Carboxylate (9)Methyl Azetidine-2-Carboxylate (3)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)Tert-Butyl Azetidine-1-Carboxylate (64)
Benzimidazoles (4428)
Benzimidazole-Carboxylic Acid (43)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)1,2-Diphenyl-1H-Benzo[D]Imidazole (7)1-Benzyl-1H-Benzo[D]Imidazole (6)1-Ethyl-1H-Benzo[D]Imidazole (4)1-Methyl-1H-Benzo[D]Imidazole (47)1-Phenyl-1H-Benzo[D]Imidazole (4)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-2-Thiol (10)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-Benzyl-1H-Benzo[D]Imidazole (7)2-Bromo-1H-Benzo[D]Imidazole (4)2-Chloro-1H-Benzo[D]Imidazole (17)2-Methyl-1H-Benzo[D]Imidazole (20)4-Bromo-1H-Benzo[D]Imidazole (14)4-Methyl-1H-Benzo[D]Imidazole (7)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5-Bromo-1H-Benzo[D]Imidazole (13)5-Chloro-1H-Benzo[D]Imidazole (14)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methyl-1H-Benzo[D]Imidazole (10)6-Chloro-1H-Benzo[D]Imidazole (25)Methyl (1H-Benzo[D]Imidazol-2-Yl)Carbamate (5)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (5)
Benzisoxazoles (508)
3-Chlorobenzo[D]Isoxazole (7)3-Methylbenzo[D]Isoxazole (8)6-Bromobenzo[D]Isoxazole (5)Benzo[C]Isoxazole (5)Benzo[D]Isoxazol-3-Amine (8)
Benzodioxans (697)
(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)6-Bromo-2,3-Dihydrobenzo[B][1,4]Dioxine (6)
Benzofurans (3713)
Benzofuran-Carboxylic Acid (67)Dimethoxyisobenzofuran (4)Epoxyisobenzofuran (1)Fluorobenzofuran (19)Fluoroisobenzofuran (5)Methoxyisobenzofuran (4)Methylbenzofuran (25)1-(Benzofuran-2-Yl)Ethan-1-One (3)2,2-Dimethyl-2,3-Dihydrobenzofuran (7)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,3-Dihydrobenzofuran-7-Amine (5)2-(Benzofuran-3-Yl)Acetic Acid (3)2-Bromodibenzo[B,D]Furan (6)2-Ethylbenzofuran (3)2-Methylbenzofuran (5)3-Methylbenzofuran (4)4-Bromobenzofuran (3)4-Phenyldibenzo[B,D]Furan (8)5,7,8-Trimethylchromane (3)5-Bromo-2,3-Dihydrobenzofuran (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Methoxyisobenzofuran-1(3H)-One (5)6-Bromo-2,3-Dihydrobenzofuran (6)6-Fluoro-2,3-Dihydrobenzofuran (6)6-Methoxybenzofuran (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromobenzofuran (6)7-Fluoro-2,3-Dihydrobenzofuran (6)Benzofuran-2(3H)-One (7)Benzofuran-2-Carbaldehyde (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-2-Ylboronic Acid (8)Benzofuran-3(2H)-One (15)Benzofuran-3-Carboxylic Acid (6)Benzofuran-3-Yl(Phenyl)Methanone (11)Methyl Benzofuran-2-Carboxylate (6)
Benzothiazoles (2422)
Benzothiazole-Carboxylic Acid (27)Bromobenzothiazole (7)Dichlorobenzothiazole (10)Methoxybenzothiazole (4)Methylbenzothiazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-Bromobenzo[D]Thiazole (28)2-Chlorobenzo[D]Thiazole (21)2-Methylbenzo[D]Thiazole (26)4-Bromobenzo[D]Thiazole (9)4-Chlorobenzo[D]Thiazole (7)4-Fluorobenzo[D]Thiazole (6)4-Methylbenzo[D]Thiazole (10)5-Chlorobenzo[D]Thiazole (5)5-Nitrobenzo[D]Thiazole (3)6-Bromobenzo[D]Thiazole (7)6-Chlorobenzo[D]Thiazole (6)6-Fluorobenzo[D]Thiazole (5)6-Methoxybenzo[D]Thiazole (6)6-Methylbenzo[D]Thiazole (6)6-Nitrobenzo[D]Thiazole (3)7-Bromobenzo[D]Thiazole (8)7-Chlorobenzo[D]Thiazole (6)7-Fluorobenzo[D]Thiazole (9)Benzo[D]Thiazol-2-Amine (29)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzo[D]Thiazol-6-Ol (2)Benzo[D]Thiazole-2-Carbonitrile (11)Benzo[D]Thiazole-2-Thiol (11)Benzo[D]Thiazole-6-Carboxylic Acid (5)Methyl Benzo[D]Thiazole-6-Carboxylate (5)
Benzothiophenes (1116)
Benzothiophene-Carboxylic Acid (58)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-Methylbenzo[B]Thiophene (4)3-Bromobenzo[B]Thiophene (5)3-Chlorobenzo[B]Thiophene (6)3-Methylbenzo[B]Thiophene (4)4,5,6,7-Tetrahydrobenzo[B]Thiophene (21)5-Bromobenzo[B]Thiophene (3)5-Chlorobenzo[B]Thiophene (4)6-Bromobenzo[B]Thiophene (4)7-Bromobenzo[B]Thiophene (5)Benzo[B]Thiophen-2-Amine (5)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[B]Thiophene-3-Carbaldehyde (6)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Methyl Benzo[B]Thiophene-2-Carboxylate (27)
Benzoxazoles (2804)
Benzoxazole-Carboxylic Acid (25)2-Chlorobenzo[D]Oxazole (11)2-Methylbenzo[D]Oxazole (26)2-Phenylbenzo[D]Oxazole (22)3-Phenylbenzo[D]Oxazol-3-Ium (8)5-Bromobenzo[D]Oxazole (3)5-Chlorobenzo[D]Oxazole (5)5-Methylbenzo[D]Oxazole (3)6-Chlorobenzo[D]Oxazole (4)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Oxazole-2-Thiol (6)Methyl Benzo[D]Oxazole-2-Carboxylate (3)
Carbazole Series (482)
Carbazolyl-Phenyl-Boronic Acid/Ester (14)1-Methyl-9H-Carbazole (7)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2-Bromo-9H-Carbazole (4)3,9-Diphenyl-9H-Carbazole (7)3-(Tert-Butyl)-9H-Carbazole (3)3-Bromo-9-Phenyl-9H-Carbazole (16)3-Bromo-9H-Carbazole (4)3-Chloro-9H-Carbazole (3)3-Methyl-9H-Carbazole (3)7H-Benzo[C]Carbazole (5)9-([1,1'-Biphenyl]-4-Yl)-9H-Carbazole (9)9-(P-Tolyl)-9H-Carbazole (5)9-Benzyl-9H-Carbazole (7)9-Ethyl-9H-Carbazole (10)
Cinnolines (355)
Cinnoline (11)
Dioxolanes (1580)
(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)1,3-Dioxolan-2-One (11)2,2-Difluorobenzo[D][1,3]Dioxole (24)2,2-Dimethyl-1,3-Dioxolane (29)2,2-Dimethylbenzo[D][1,3]Dioxole (7)2-Phenyl-1,3-Dioxolane (18)4-Bromobenzo[D][1,3]Dioxole (6)4-Methyl-1,3-Dioxolane (5)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromobenzo[D][1,3]Dioxole (12)5-Chlorobenzo[D][1,3]Dioxole (5)5-Nitrobenzo[D][1,3]Dioxole (4)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)Benzo[D][1,3]Dioxol-5-Amine (3)
Dioxoles (13)
Epoxides (407)
Epoxy (7)Oxirane (64)7-Oxabicyclo[4.1.0]Heptane (7)Ethyl Oxirane-2-Carboxylate (4)Oxiran-2-Ylmethanol (3)
Furans (7000)
Aminodihydrofuran (7)Bromofuran (32)Chlorofuran (2)Chlorofuro (11)Cyanofuran (53)Dibromofuran (5)Dihydrofuran (31)Dihydrofuro (15)Dihydroxydihydrofuran (8)Dimethylfuran (10)Formylfuran (10)Hexahydrofuro (6)Hydroxydihydrofuran (31)Methyldihydrofuran (11)Methylfuran (58)Nitrofuran (10)2,3-Dihydrofuran-3-One (9)2-(Bromomethyl)Furan (3)2-(Chloromethyl)Furan (3)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-Bromofuran (21)2-Chlorofuran (3)2-Methylfuran (37)2-Nitrofuran (9)3-Bromofuran (13)4-Methylisobenzofuran-1(3H)-One (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Phenylfuran-2-Carbaldehyde (9)5-Phenylfuran-2-Carboxylic Acid (6)6-Chloro-2,3-Dihydrobenzofuran (3)6-Fluoroisobenzofuran-1(3H)-One (3)7-Chloro-2,3-Dihydrobenzofuran (3)Ethyl Furan-2-Carboxylate (6)Furan-2,5-Dione (8)Furan-2-Carbaldehyde (22)Furan-2-Carbonitrile (8)Furan-2-Carboxylic Acid (31)Furan-2-Ylmethanol (5)Furan-3-Carboxylic Acid (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Methyl Furan-2-Carboxylate (20)N-(Furan-2-Ylmethyl)Aniline (5)
Imidazoles (833)
Biimidazole (5)Bromoimidazo (102)Dibromoimidazo (8)Dichloroimidazo (9)Dihydroimidazo (25)Imidazol-Amine (1)Methoxyimidazo (13)Methylimidazo (121)Tetrahydroimidazo (40)1,1'-Diphenyl-4,4',5,5'-Tetrahydro-1H,1'H-2,2'-Biimidazole (11)1,2-Dimethyl-1H-Imidazole (6)1,3-Diphenyl-1H-Imidazol-3-Ium (14)1,3-Diphenyl-4,5-Dihydro-1H-Imidazol-3-Ium (5)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(Phenylsulfonyl)-1H-Imidazole (5)1-Benzyl-1H-Imidazole (19)1-Decyl-3-Methyl-1H-Imidazol-3-Ium (14)1-Ethyl-1H-Imidazole (3)1-Isopropyl-1H-Imidazole (5)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Trityl-1H-Imidazole (15)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Imidazol-2-Amine (6)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carbonitrile (2)1H-Imidazole-4-Carboxylic Acid (4)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-Bromo-1H-Imidazole (13)2-Bromoimidazo[1,2-A]Pyridine (5)2-Ethyl-1H-Imidazole (3)2-Methyl-1-Phenyl-1H-Imidazole (11)2-Methylimidazo[1,2-A]Pyridine (8)2-Phenyl-1H-Benzo[D]Imidazole (26)2-Phenyl-1H-Imidazole (26)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propyl-1H-Imidazole (5)3-Bromoimidazo[1,2-A]Pyrazine (6)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Iodoimidazo[1,2-A]Pyridine (10)3-Methylimidazo[1,2-A]Pyridine (3)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Methyl-1-Phenyl-1H-Imidazole (7)4-Methyl-1H-Imidazole (6)4-Phenyl-1H-Imidazole (8)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Benzyl-1H-Imidazole (1)5-Bromoimidazo[1,2-A]Pyridine (6)5-Chloro-1H-Imidazole (2)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Iodo-1H-Imidazole (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Phenyl-1H-Imidazole (6)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6-Bromoimidazo[1,2-A]Pyrazine (11)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloroimidazo[1,2-B]Pyridazine (30)7-Methylimidazo[1,2-A]Pyridine (3)8-Bromoimidazo[1,2-A]Pyrazine (7)8-Bromoimidazo[1,2-A]Pyridine (15)8-Chloroimidazo[1,2-A]Pyrazine (8)8-Chloroimidazo[1,2-A]Pyridine (7)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Methylimidazo[1,2-A]Pyridine (9)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Imidazo[1,2-A]Pyridin-8-Ol (3)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Imidazo[1,2-C]Pyrimidine (6)Imidazo[1,5-A]Pyrazine (9)Imidazo[2,1-B]Thiazole (14)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)
Imidazolidines (1145)
Methylimidazolidine (3)Oxoimidazolidine (8)Thioxoimidazolidin (9)(3Ar,6As)-Tetrahydro-1H-Thieno[3,4-D]Imidazol-2(3H)-One (18)1-Phenylimidazolidin-2-One (8)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylimidazolidine-2,4-Dione (4)Imidazolidin-2-One (16)Imidazolidine-2,4-Dione (17)
Imidazolines (695)
Indazoles (3081)
Indazol-Amide (3)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)1-Benzyl-1H-Indazole (7)1-Ethyl-1H-Indazole (7)1H-Indazol-3-Amine (23)1H-Indazol-3-Ol (10)1H-Indazol-4-Amine (12)1H-Indazol-4-Ol (4)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-6-Ol (6)1H-Indazol-7-Amine (6)1H-Indazole-3-Carbaldehyde (19)1H-Indazole-3-Carbonitrile (9)1H-Indazole-3-Carboxylic Acid (27)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)2,3-Dimethyl-2H-Indazole (4)2-Methyl-2H-Indazole (34)3-(Piperidin-4-Yl)-1H-Indazole (5)3-Chloro-1H-Indazole (13)4,5,6,7-Tetrahydro-1H-Indazole (12)4-Chloro-1H-Indazole (18)4-Fluoro-1H-Indazole (22)4-Methoxy-1H-Indazole (7)4-Methyl-1H-Indazole (12)4-Nitro-1H-Indazole (10)5-Bromo-1H-Indazole (14)5-Chloro-1H-Indazole (9)5-Methoxy-1H-Indazole (5)5-Nitro-1H-Indazole (5)6-(Trifluoromethyl)-1H-Indazole (6)6-Bromo-1H-Indazole (23)6-Chloro-1H-Indazole (14)6-Fluoro-1H-Indazole (15)6-Methoxy-1H-Indazole (14)6-Methyl-1H-Indazole (9)6-Nitro-1H-Indazole (9)7-Bromo-1H-Indazole (18)7-Chloro-1H-Indazole (7)7-Fluoro-1H-Indazole (12)7-Methoxy-1H-Indazole (5)7-Nitro-1H-Indazole (11)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Tert-Butyl 1H-Indazole-1-Carboxylate (29)
Indoles (7683)
Azaindole (44)Benzyloxyindole (1)Biindolinylidene (1)Bromo-Indole-Carboxylic Acid (28)Cyanoindole (5)Dihydroindolo (14)Fluoroindole (5)Formylindole (44)Hydroxyindole (7)Hydroxyisoindoline (2)Indolecarboxylic (2)Isoindole (26)Methoxyindole (9)Nitroindole (6)(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1H-Indol-2-Yl)Boronic Acid (3)(1H-Indol-2-Yl)Methanol (8)(3As,7As)-Octahydro-1H-Indole (5)(9H-Fluoren-9-Yl)Methyl (2-(1H-Indol-3-Yl)Ethyl)Carbamate (12)1,2,3,4-Tetrahydrocyclopenta[B]Indole (5)1,2-Dimethyl-1H-Indole (4)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(Phenylsulfonyl)-1H-Indole (26)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)1-Benzyl-1H-Indole (10)1-Ethyl-1H-Indole (7)1-Methyl-1H-Indole (85)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Methyl-1H-Pyrrolo[2,3-B]Pyridine (14)1-Phenyl-1H-Indole (5)1H-Indol-3-Ol (5)1H-Indol-3-Yl Acetate (4)1H-Indol-4-Amine (10)1H-Indol-4-Ol (7)1H-Indol-5-Ol (4)1H-Indol-6-Amine (21)1H-Indol-6-Ol (6)1H-Indol-7-Amine (10)1H-Indole-2-Carbaldehyde (20)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-3-Carboxylic Acid (32)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carbonitrile (5)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carbonitrile (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carbonitrile (6)1H-Indole-7-Carboxylic Acid (7)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (12)2,3-Dimethyl-1H-Indole (9)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(4-Fluorophenyl)-1H-Indole (4)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Methyl-1H-Pyrrolo[2,3-B]Pyridine (12)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(Piperidin-4-Yl)-1H-Indole (8)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Methyl-1H-Indole (41)3H-Indole (8)4-Bromo-1H-Indole (25)4-Chloro-1H-Indole (21)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoroindoline-2,3-Dione (3)4-Methoxy-1H-Indole (11)4-Methyl-1H-Indole (23)4-Nitro-1H-Indole (6)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(Benzyloxy)-1H-Indole (8)5-Bromo-1-Methyl-1H-Indole (4)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoroindolin-2-One (4)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methyl-1H-Indole (33)5-Nitro-1H-Indole (6)6-(Trifluoromethyl)-1H-Indole (5)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Fluoro-1H-Indole (17)6-Methoxy-1H-Indole (12)6-Methyl-1H-Indole (29)6-Methyl-1H-Pyrrolo[2,3-B]Pyridine (8)6-Nitro-1H-Indole (8)7-Bromo-1H-Indole (28)7-Bromoindoline-2,3-Dione (3)7-Chloro-1H-Indole (29)7-Fluoro-1H-Indole (24)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)7-Methoxy-1H-Indole (8)7-Methyl-1H-Indole (34)7-Nitro-1H-Indole (11)9H-Pyrido[3,4-B]Indole (5)Benzo[Cd]Indol-2(1H)-One (5)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 2-(1H-Indol-3-Yl)Acetate (3)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)Tryptophan (21)
Indolines (4489)
Aminoindoline (10)Bromoindoline (17)Bromoisoindolin (5)Bromoisoindoline (6)Chloroindolin (4)Chloroisoindoline (3)Dibromoindoline (12)Dichloroindoline (16)Difluoroindoline (1)Dimethylindoline (21)Dioxoindoline (8)Dioxoisoindolin (72)Fluoroindolin (9)Fluoroindoline (9)Fluoroisoindoline (10)Hydroxyindolin (5)Indoline-Carboxylate (1)Isoindoline (20)Methoxyindoline (12)Methoxyisoindoline (9)Methylindoline (46)Methylisoindoline (18)Nitroindolin (6)Nitroindoline (11)Nitroisoindoline (8)Oxoindoline (32)Oxoisoindoline (16)Spiro-Indoline-Piperidine (34)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1-(Indolin-1-Yl)Ethan-1-One (9)1-Benzylindoline-2,3-Dione (5)1-Methylindolin-2-One (14)1-Methylindoline (3)1-Methylindoline-2,3-Dione (8)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-Methylindoline (7)2-Methylisoindolin-1-One (7)3,3-Dimethylindolin-2-One (5)3,3-Dimethylindoline (7)4-Bromoindoline (4)4-Chloroindoline-2,3-Dione (6)4-Methylindoline (3)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-Bromoindolin-2-One (5)5-Bromoindoline (8)5-Bromoisoindoline-1,3-Dione (3)5-Chloroindolin-2-One (3)5-Fluoroindoline (3)5-Methoxyindoline (4)5-Methylindolin-2-One (3)5-Methylindoline (3)6-Bromoindolin-2-One (8)6-Bromoindoline-2,3-Dione (4)6-Chloroindolin-2-One (5)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Fluoroindolin-2-One (5)6-Fluoroindoline-2,3-Dione (3)7-Bromoindoline (3)7-Fluoroindolin-2-One (3)7-Fluoroindoline-2,3-Dione (6)7-Methylindoline-2,3-Dione (7)Indoline-2-Carboxylic Acid (3)Methyl Indoline-6-Carboxylate (3)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Tert-Butyl Indoline-1-Carboxylate (24)
Isoquinolines (2729)
Bromoisoquinoline (69)Chloroisoquinoline (101)Dibromoisoquinoline (9)Dichloroisoquinoline (14)Dihydroisoquinoline (107)Fluoroisoquinoline (78)Methoxyisoquinoline (59)Methylisoquinoline (59)Nitroisoquinoline (23)1,3-Dichloroisoquinoline (14)1-Bromoisoquinoline (20)1-Chloroisoquinoline (20)1-Methylisoquinoline (9)1H-Benzo[De]Isoquinoline-1,3(2H)-Dione (14)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)3-Bromoisoquinoline (10)3-Chloroisoquinoline (20)3-Methylisoquinoline (8)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Chloroisoquinoline (11)4-Fluoroisoquinoline (6)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromoisoquinoline (17)5-Chloroisoquinoline (6)5-Methoxyisoquinoline (6)5-Nitroisoquinoline (7)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromoisoquinoline (9)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromoisoquinoline (6)7-Chloroisoquinoline (6)7-Fluoroisoquinoline (3)7-Methoxyisoquinoline (5)8-Bromoisoquinoline (17)8-Chloroisoquinoline (7)8-Fluoroisoquinolin-1(2H)-One (3)8-Fluoroisoquinoline (10)8-Methoxyisoquinoline (7)Isoquinolin-1-Amine (18)Isoquinolin-1-Ol (9)Isoquinolin-3-Amine (13)Isoquinolin-3-Ol (6)Isoquinolin-4-Amine (16)Isoquinolin-4-Ol (9)Isoquinolin-4-Ylboronic Acid (3)Isoquinolin-5-Amine (9)Isoquinolin-5-Ol (7)Isoquinolin-8-Amine (6)Isoquinoline-1-Carbonitrile (7)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-5-Sulfonyl Chloride (3)Isoquinoline-6-Carboxylic Acid (3)Methyl Isoquinoline-3-Carboxylate (3)Methyl Isoquinoline-4-Carboxylate (6)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)
Isothiazoles (343)
Methylisothiazole (5)Benzo[D]Isothiazol-3(2H)-One 1,1-Dioxide (10)Benzo[D]Isothiazole (12)Isothiazole (24)
Isoxazoles (3403)
Aminoisoxazole (7)Bromoisoxazole (5)Dihydroisoxazol (2)Dimethylisoxazole (17)Phenylisoxazole (28)(3-Phenylisoxazol-5-Yl)Methanol (7)3-Bromoisoxazole (7)3-Methyl-5-Phenylisoxazole (6)3-Methylisoxazole (30)3-Phenylisoxazol-5-Amine (8)5-(Thiophen-2-Yl)Isoxazole (5)5-Cyclopropylisoxazole (5)5-Methyl-3-Phenylisoxazole (4)5-Methylisoxazole (16)5-Phenylisoxazole-3-Carboxylic Acid (15)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Isoxazol-3-Amine (7)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Amine (15)Isoxazol-5-Ylmethanol (5)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl 5-Phenylisoxazole-3-Carboxylate (6)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)
Morpholines (4988)
Benzylmorpholine (25)Cyanomorpholine (6)Dimorpholine (3)Ethylmorpholine (9)Isopropylmorpholine (9)Methylmorpholine (68)Morpholinobenzaldehyde (11)Morpholinobenzo (13)Morpholinobenzoic (8)Morpholinoethanone (5)Morpholinoethoxy (1)Morpholinoethyl (5)Morpholinomethyl (16)Morpholinophenyl (14)Morpholinopropoxy (6)Morpholinopyrimidin (6)Morpholinosulfonyl (7)Oxomorpholine (6)(R)-3-Phenylmorpholine (7)(S)-3-Phenylmorpholine (10)2,2-Dimethylmorpholine (5)2,6-Dimethylmorpholine (5)2-(Methoxymethyl)Morpholine (4)2-(Morpholin-2-Yl)Acetic Acid (5)2-Ethylmorpholine (3)2-Isopropylmorpholine (4)2-Methylmorpholine (7)2-Phenylmorpholine (8)3-(4-Morpholinophenyl)Oxazolidin-2-One (4)3-(Methoxymethyl)Morpholine (4)3-Ethylmorpholine (4)3-Isopropylmorpholine (5)3-Methylmorpholine (13)3-Phenylmorpholine (8)4-(2-Fluorophenyl)Morpholine (8)4-(3-Phenoxypropyl)Morpholine (7)4-(O-Tolyl)Morpholine (6)4-(Pyrazin-2-Yl)Morpholine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-Benzylmorpholin-3-One (6)4-Morpholinoaniline (4)4-Morpholinobenzaldehyde (8)4-Morpholinobenzoic Acid (5)4-Phenylmorpholin-3-One (6)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)Benzyl Morpholine-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Morpholin-2-Ylmethanamine (8)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Morpholine-2-Carbonitrile (4)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Morpholino(Phenyl)Methanone (11)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl Morpholine-4-Carboxylate (23)
Naphthyridines (939)
1,5-Naphthyridine-3-Carboxylic Acid (6)1,6-Naphthyridine (22)1,7-Naphthyridine (23)2,7-Naphthyridine (5)3-Bromo-1,5-Naphthyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Chloro-1,5-Naphthyridine (6)5,6,7,8-Tetrahydro-1,6-Naphthyridine (22)5,6,7,8-Tetrahydro-1,7-Naphthyridine (6)
Oxadiazoles (3559)
1,2,4-Oxadiazole (19)1,2,5-Oxadiazole (12)1,3,4-Oxadiazole (25)2,5-Diphenyl-1,3,4-Oxadiazole (6)2-Phenyl-1,3,4-Oxadiazole (26)3-Phenyl-1,2,4-Oxadiazole (23)Benzo[C][1,2,5]Oxadiazole (17)
Oxazines (235)
2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromo-2H-Benzo[B][1,4]Oxazin-3(4H)-One (7)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-2H-Benzo[B][1,4]Oxazin-3(4H)-One (8)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)
Oxazoles (2026)
Bioxazole (12)2-Bromooxazole (7)2-Chlorooxazole (7)2-Methyloxazole (19)2-Phenyloxazole (16)3,4-Diphenylisoxazole (8)4,5-Diphenyloxazole (7)4-(Oxazol-5-Yl)Aniline (3)4-Methyloxazole (9)5-(4-Nitrophenyl)Oxazole (3)5-Methyloxazole (5)6-Bromobenzo[D]Oxazole (3)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Methyl Oxazole-4-Carboxylate (9)Oxazol-2-Amine (8)Oxazole-4-Carboxylic Acid (4)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)
Oxazolidines (1298)
Dimethyloxazolidin (6)Dioxooxazolidin (2)Oxazolidinone (5)Phenyloxazolidin (9)Propionyloxazolidin (5)(R)-4-Benzyloxazolidin-2-One (5)(S)-4-Benzyloxazolidin-2-One (11)3-(4-Morpholinophenyl)Oxazolidin-2-One (4)3-Phenyloxazolidin-2-One (4)4-Isopropyloxazolidine (6)Oxazolidine (21)Oxazolidine-2,5-Dione (9)
Oxazolines (1577)
(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,3-Bis(4,5-Dihydrooxazol-2-Yl)Benzene (8)2,2'-(1,3-Diphenylpropane-2,2-Diyl)Bis(4,5-Dihydrooxazole) (5)2,2'-(2-Phenylethane-1,1-Diyl)Bis(4,5-Dihydrooxazole) (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Phenyl-4,5-Dihydrooxazole (18)4,4',5,5'-Tetrahydro-2,2'-Bioxazole (10)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)Bis((3Ar,8As)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis((3As,8Ar)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis(4,5-Dihydrooxazol-2-Yl)Methane (22)
Oxetanes (772)
Methyloxetane (11)
Phthalazines (423)
Dihydrophthalazine (15)Phthalazine (16)
Piperazines (7427)
Isobutylpiperazine (6)Propylpiperazine (10)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(R)-2-Benzylpiperazine (5)1,4-Diphenylpiperazine (7)1-(2-Chlorophenyl)Piperazine (4)1-(2-Fluorophenyl)Piperazine (8)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-(Methylsulfonyl)Piperazine (5)1-(Phenylsulfonyl)Piperazine (17)1-(Piperidin-4-Yl)Piperazine (6)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-Benzhydryl-4-Benzylpiperazine (1)1-Benzhydrylpiperazine (9)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1-Benzyl-4-Methylpiperazine (10)1-Ethyl-4-Phenylpiperazine (4)1-Ethylpiperazine (5)1-Isopropylpiperazine (4)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methyl-4-Phenylpiperazine (22)1-Methylpiperazin-2-One (6)1-Methylpiperazine (21)10-(3-(Piperazin-1-Yl)Propyl)-10H-Phenothiazine (2)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperazin-1-Yl)Pyrazine (9)2-(Piperazin-1-Yl)Pyrimidine (11)2-Phenylpiperazine (17)3-(Piperazin-1-Yl)Aniline (3)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Piperazin-1-Yl)Pyridazine (7)3-Methylpiperazin-2-One (7)4-(Piperazin-1-Yl)Benzaldehyde (5)4-(Piperazin-1-Yl)Pyrimidine (13)Benzyl 2-Methylpiperazine-1-Carboxylate (7)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl 3-Methylpiperazine-1-Carboxylate (5)Phenyl(Piperazin-1-Yl)Methanone (20)Piperazine-2,5-Dione (9)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl 4-Benzylpiperazine-1-Carboxylate (13)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl Piperazine-1-Carboxylate (30)
Piperidines (21889)
Bipiperidine (12)Chloropiperidine (6)Dimethylpiperidine (46)Ethynylpiperidine (5)Fluoropiperidine (33)Formylpiperidine (9)Isopropylpiperidine (11)Piperidine-Carboxylate (3)Piperidineacetic (5)Piperidinecarboxylic (6)Piperidinyl-Phenyl-Boronic Acid/Ester (32)Propylpiperidine (8)(9H-Fluoren-9-Yl)Methyl Piperidine-1-Carboxylate (16)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(R)-2-Phenylpiperidine (10)(R)-3-Aminopiperidin-2-One (3)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)(S)-2-Phenylpiperidine (11)(S)-N-Phenylpiperidine-2-Carboxamide (1)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4'-Bipiperidine (8)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)Piperidine (23)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Piperidin-4-Yl)Piperazine (6)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-3-One (5)1-Benzylpiperidin-4-Amine (8)1-Benzylpiperidin-4-One (8)1-Isopropylpiperidine (5)1-Methyl-4-Phenylpiperidine (4)1-Methylpiperidin-2-One (3)1-Oxa-8-Azaspiro[4.5]Decane (5)1-Phenylpiperidin-2-One (8)2,2-Dimethylpiperidin-4-One (6)2,2-Dimethylpiperidine (21)2,7-Diazaspiro[3.5]Nonane (7)2,8-Diazaspiro[4.5]Decan-3-One (6)2,8-Diazaspiro[4.5]Decane (5)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-(Piperidin-4-Yl)Pyridine (5)2-Methylpiperidin-4-One (6)2-Methylpiperidine (14)2-Phenylpiperidine (14)3,3-Difluoropiperidin-4-One (3)3,3-Difluoropiperidine (29)3,3-Dimethylpiperidin-4-One (3)3,3-Dimethylpiperidine (5)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)-1H-Indazole (5)3-(Piperidin-4-Yl)-1H-Indole (8)3-(Piperidin-4-Yl)Pyridine (5)3-Fluoropiperidin-4-One (3)3-Fluoropiperidine (26)3-Methoxypiperidine (7)3-Methylpiperidin-4-One (3)3-Methylpiperidine (10)3-Phenylpiperidine (6)4,4-Difluoropiperidine (5)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-(Azetidin-1-Yl)Piperidine (6)4-(Piperidin-1-Yl)Pyrimidine (8)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Benzylpiperidine (18)4-Hydrazineylpiperidine (5)4-Hydroxypiperidin-2-One (3)4-Methyl-1-Phenylpiperidine (6)4-Methylenepiperidine (14)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenylpiperidin-4-Ol (10)5-Hydroxypiperidin-2-One (3)6-Azaspiro[2.5]Octane (10)6-Oxopiperidine-2-Carboxylic Acid (3)7-Azaspiro[3.5]Nonane (7)Azepane (25)Benzyl 3-Hydroxypiperidine-1-Carboxylate (7)Benzyl 4-Oxopiperidine-1-Carboxylate (12)Benzyl Piperidin-4-Ylcarbamate (7)Benzyl Piperidine-1-Carboxylate (50)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Ethyl Piperidine-1-Carboxylate (5)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)N-Benzylpiperidin-4-Amine (3)N-Methylpiperidin-3-Amine (5)N-Phenylpiperidine-2-Carboxamide (2)Phenyl(Piperidin-1-Yl)Methanone (21)Phenyl(Piperidin-4-Yl)Methanone (21)Piperidin-2-Ylmethanamine (6)Piperidin-2-Ylmethanol (11)Piperidin-3-Amine (17)Piperidin-3-Ol (27)Piperidin-3-One (13)Piperidin-3-Ylmethanamine (5)Piperidin-3-Ylmethanol (15)Piperidin-4-Amine (14)Piperidin-4-Ol (44)Piperidin-4-Ylmethanamine (7)Piperidin-4-Ylmethanol (11)Piperidine-2,4-Dione (5)Piperidine-2,6-Dione (13)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxamide (5)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (11)Quinuclidine (5)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Spiro[Indoline-3,4'-Piperidine] (5)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl (Piperidin-3-Ylmethyl)Carbamate (5)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Piperidin-3-Ylcarbamate (9)
Purines (2020)
(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (27)2-Chloro-7H-Purine (3)2-Chloro-9H-Purine (5)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)9H-Purin-6-Amine (3)
Pyrans (1095)
Chromene-Carboxylic Acid (1)Thioglucopyranoside (4)(S)-2-Phenylchroman-4-One (17)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)2,2-Dimethylchromane (5)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2H-Chromene (16)3,4-Dihydro-2H-Pyran (11)3,6-Dihydro-2H-Pyran (8)3-Acetyl-2H-Chromen-2-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (21)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-Hydroxy-2H-Chromen-2-One (10)4-Methyl-2H-Chromen-2-One (27)5-Fluorochroman-4-One (3)5-Fluorochromane (6)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)6-Bromochroman-4-One (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Fluorochroman-4-One (5)6-Fluorochromane (6)6-Methoxychromane (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromochroman-4-One (4)7-Bromochromane (7)7-Chlorochromane (5)7-Fluorochroman-4-One (5)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxychroman-4-One (3)8-Bromochroman-4-One (4)8-Bromochromane (6)8-Chlorochromane (5)8-Fluorochromane (5)8-Methylchroman-4-One (4)8-Methylchromane (10)Chroman-2-One (5)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Chroman-4-Ol (4)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Isochromane (11)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Tetrahydro-2H-Pyran-2-One (15)Tetrahydro-2H-Thiopyran (10)Tetrahydro-4H-Pyran-4-One (12)Thiochroman-4-One (10)
Pyrazines (3359)
Dibromopyrazine (7)Dichloropyrazine (21)Dihydropyrazine (6)Dimethylpyrazine (30)Ethoxypyrazine (5)Ethylpyrazine (7)Fluoropyrazine (6)Hydroxypyrazine (4)Iodopyrazine (17)Methoxypyrazine (36)Phenylpyrazin (5)Pyrazino (5)Pyrazino-Nitrile (50)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1-(Pyrazin-2-Yl)Ethan-1-One (5)1H-Pyrazolo[3,4-B]Pyrazine (5)2,3-Diphenylpyrazine (5)2,5-Dibromopyrazine (4)2,5-Dichloropyrazine (4)2,6-Dibromopyrazine (9)2,6-Dichloropyrazine (14)2-(Piperazin-1-Yl)Pyrazine (9)2-(Trifluoromethyl)Pyrazine (6)2-Bromo-3-Methoxypyrazine (5)2-Bromo-3-Methylpyrazine (5)2-Bromo-5-Chloropyrazine (6)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Methylpyrazine (5)2-Bromopyrazine (15)2-Chloro-3-Methylpyrazine (7)2-Chloro-6-Methylpyrazine (12)2-Chloropyrazine (24)2-Ethoxypyrazine (3)2-Ethylpyrazine (9)2-Fluoropyrazine (7)2-Iodopyrazine (25)2-Methoxypyrazine (45)2-Methylpyrazine (16)2-Phenylpyrazine (12)3-Chloropyrazin-2-Amine (6)3-Chloropyrazine-2-Carbonitrile (6)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4-(Pyrazin-2-Yl)Morpholine (5)5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine (11)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Bromopyrazin-2-Amine (13)5-Bromopyrazin-2-Ol (5)5-Chloropyrazin-2-Amine (9)5H-Pyrrolo[2,3-B]Pyrazine (14)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[4,3-A]Pyrazine (11)Ethyl Pyrazine-2-Carboxylate (10)Imidazo[1,5-A]Pyrazine (9)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl Pyrazine-2-Carboxylate (19)Pyrazin-2-Amine (22)Pyrazin-2-Ol (7)Pyrazin-2-Ylmethanamine (12)Pyrazine-2-Carbaldehyde (17)Pyrazine-2-Carbohydrazide (3)Pyrazine-2-Carbonitrile (15)Pyrazine-2-Carboxamide (10)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrazine (5)Pyrido[2,3-B]Pyrazine (12)Pyrido[3,4-B]Pyrazine (11)Tert-Butyl Pyrazin-2-Ylcarbamate (8)
Pyrazoles (16157)
Bipyrazole (5)Chloropyrazolo (33)Dichloropyrazolo (11)Dihydropyrazolo (28)Dimethylpyrazolo (6)Ethylpyrazole (7)Fluoropyrazolo (9)Hydroxypyrazolo (10)Methoxypyrazolo (16)Methyl-Pyrazole-Carboxylic Acid (147)Methyl-Pyrazolone (87)Methylpyrazolo (32)Pyrazolopyridine-Carboxylic Acid (48)Tetrahydropyrazolo (23)(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)1,3-Dimethyl-1H-Pyrazole (28)1,3-Diphenyl-1H-Pyrazole (6)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1,5-Diphenyl-1H-Pyrazole (13)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Pyrazole (9)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Cyclopentyl-1H-Pyrazole (5)1-Cyclopropyl-1H-Pyrazole (9)1-Methyl-1H-Pyrazol-3-Amine (14)1-Methyl-3-Phenyl-1H-Pyrazole (21)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)1-Methyl-5-Phenyl-1H-Pyrazole (7)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)1-Trityl-1H-Pyrazole (5)1H-Pyrazol-4-Amine (6)1H-Pyrazol-4-Ol (3)1H-Pyrazol-5-Amine (19)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-4-Sulfonyl Chloride (8)1H-Pyrazole-5-Carboxamide (3)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrazolo[3,4-B]Pyrazine (5)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,4-Dihydro-3H-Pyrazol-3-One (10)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-Phenyl-2,4-Dihydro-3H-Pyrazol-3-One (23)3-(Tert-Butyl)-1-Phenyl-1H-Pyrazole (4)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Cyclopropyl-1H-Pyrazole (5)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Methyl-1-Phenyl-1H-Pyrazole (23)3-Phenyl-1H-Pyrazol-5-Amine (11)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyridine (6)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Iodo-1H-Pyrazole (9)4-Methyl-1-Phenyl-1H-Pyrazole (6)4-Methyl-1H-Pyrazole (11)4-Nitro-1H-Pyrazole (8)4-Phenyl-1H-Pyrazole (18)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)5-(Difluoromethyl)-1H-Pyrazole (6)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Cyclopropyl-1H-Pyrazole (6)5-Iodo-1H-Pyrazole (4)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)6,7-Dihydro-5H-Pyrazolo[5,1-B][1,3]Oxazine (13)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)7-Chloropyrazolo[1,5-A]Pyrimidine (8)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)Pyrazolo[1,5-A]Pyrazine (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)
Pyridazines (2753)
Aminopyridazine (12)Dihydropyridazine (26)Dimethylpyridazine (9)Hexahydropyridazines (10)Pyridazinecarboxylic (1)2-Methylpyridazin-3(2H)-One (7)3,6-Dichloropyridazine (20)3-(Piperazin-1-Yl)Pyridazine (7)3-(Trifluoromethyl)Pyridazine (3)3-Bromopyridazine (25)3-Chloro-4-Methylpyridazine (7)3-Chloropyridazine (44)3-Iodopyridazine (5)3-Methoxypyridazine (17)3-Methylpyridazine (6)3-Phenylpyridazine (8)4-Aminopyridazin-3(2H)-One (4)4-Bromopyridazin-3(2H)-One (3)4-Bromopyridazine (5)4-Chloropyridazin-3(2H)-One (4)4-Chloropyridazine (16)4-Methoxypyridazine (8)4-Methylpyridazine (3)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridazin-3-Amine (5)[1,2,4]Triazolo[4,3-B]Pyridazine (10)Ethyl Pyridazine-3-Carboxylate (6)Methyl Pyridazine-3-Carboxylate (7)Pyridazin-3-Amine (18)Pyridazin-3-Ol (3)Pyridazin-4-Amine (10)Pyridazine-3-Carboxylic Acid (7)
Pyridines (70617)
Acetylpyridin (5)Aminopicolinate (8)Benzyloxypyridine (36)Bipyridine (202)Bromopicolinate (19)Bromopicolinic (4)Bromopicolinic Acid (5)Bromopicolinonitrile (6)Bromopyrido (13)Butylpyridine (5)Chloroisonicotinic Acid (5)Chloronicotinaldehyde (23)Chloronicotinamide (11)Chloronicotinate (45)Chloronicotinic (41)Cyanopicolinate (7)Cyanopicolinic (6)Cyanopyridine (34)Cyclopropoxypyridine (6)Cyclopropylpyridine (30)Dibromopicolinate (4)Dibromopicolinic Acid (3)Dibromopyridine (36)Dichloropicolinate (9)Dichloropicolinonitrile (4)Dichloropyridine (120)Difluoropicolinic Acid (3)Difluoropyridine (58)Dihydropyrido (27)Diiodopyridine (13)Dimethoxypicolinic Acid (5)Dimethoxypyridine (33)Dimethylpyridine (143)Diphenylpyridine (6)Dipyridine (28)Ethoxypicolinic Acid (3)Ethoxypyridine (35)Ethylpyridine (36)Ethynylpicolinate (3)Fluoro-Pyridine--Boronate (79)Fluoropicolinaldehyde (8)Fluoropicolinamide (8)Fluoropicolinate (22)Fluoropyridine (288)Fluoropyrido (3)Formylpyridine (23)Hexahydropyrido (7)Hydrazinylpyridine (22)Hydroxymethylpyridine (26)Hydroxypicolinate (13)Hydroxypicolinic (9)Hydroxypicolinonitrile (7)Iodopicolinate (5)Iodopicolinic Acid (4)Iodopyridine (167)Isopropoxypyridine (20)Isopropylpyridine (32)Methoxyisonicotinaldehyde (10)Methoxynicotinaldehyde (18)Methoxypicolinaldehyde (13)Methoxypicolinamide (13)Methoxypicolinate (21)Methoxypicolinic (18)Methoxypicolinic Acid (16)Methoxypicolinimidamide (5)Methoxypicolinonitrile (13)Methoxypyridine (342)Methylisonicotinamide (8)Methylnicotinaldehyde (30)Methylnicotinamide (13)Methylpicolinaldehyde (16)Methylpicolinamide (15)Methylpicolinate (27)Methylpicolinic (23)Methylpicolinonitrile (28)Methylpyrido (13)Nitropyridine (393)Oxopyridin (2)Phenoxypyridin (1)Picolinate (42)Pyridinecarbonitrile (50)Pyridyl-Benzene-Boronic Acid/Ester (16)Pyridyl-Phenyl-Boronate (2)Pyridylmethyl (6)Terpyridine (32)Tetrachloropyridine (5)Tetrafluoropyridine (21)Tetrahydropyridine (49)Tetrahydropyrido (32)Tribromopyridine (9)Trichloropyridine (17)Trifluoropyridine (8)Trimethylpyridine (5)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3-Bromopyridin-2-Yl)Methanol (7)(3-Chloropyridin-2-Yl)Methanamine (6)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanol (10)(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(5-Chloropyridin-2-Yl)Methanamine (5)(6-Methylpyridin-2-Yl)Methanamine (6)(6-Methylpyridin-2-Yl)Methanol (5)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,1'-Diphenyl-[4,4'-Bipyridine]-1,1'-Diium (7)1,10-Phenanthrolin-4-Ol (3)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1,2,3,6-Tetrahydropyridine (22)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4-Di(Pyridin-4-Yl)Benzene (5)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-(Pyridin-4-Yl)Ethan-1-One (14)1-Benzyl-1,2,3,6-Tetrahydropyridine (9)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methylpyridin-1-Ium Iodide (5)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,2':6',2''-Terpyridine (15)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2,3'-Bipyridine (11)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (12)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dibromopyridine (21)2,3-Dichloropyridine (38)2,3-Difluoropyridine (13)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (5)2,3-Dihydro-[1,4]Dioxino[2,3-B]Pyridine (5)2,3-Dihydropyridin-2-One (5)2,3-Dimethoxypyridine (7)2,3-Dimethylpyridine (8)2,4,6-Trichloropyridine (5)2,4,6-Triphenylpyridine (7)2,4-Dibromopyridine (5)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloropyridine (50)2,4-Dimethylpyridine (5)2,5-Dibromopyridine (26)2,5-Dichloropyridine (32)2,5-Difluoropyridine (8)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Iodopyridine (4)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloronicotinonitrile (8)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2,6-Difluoropyridine (29)2,6-Dimethoxypyridine (11)2,6-Dimethylpyridin-4-Ol (4)2,6-Dimethylpyridine (26)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(2-Chlorophenyl)Pyridine (3)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-Fluorophenyl)Pyridine (11)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzyloxy)Pyridine (18)2-(Bromomethyl)Pyridine (27)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Difluoromethyl)Pyridine (21)2-(Methylsulfonyl)Pyridine (11)2-(Methylthio)Pyridine (5)2-(P-Tolyl)Pyridine (6)2-(Phenoxymethyl)Pyridine (5)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-4-Yl)Pyridine (5)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)Pyridine (6)2-Aminonicotinonitrile (6)2-Benzylpyridine (12)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Iodopyridine (6)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitropyridine (5)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Methylpyridine (6)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodopyridine (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Phenylpyridine (4)2-Bromonicotinic Acid (5)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Fluoropyridine (20)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Iodopyridine (19)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methylpyridine (31)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Iodopyridine (18)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodopyridine (9)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylpyridine (49)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Ethoxypyridine (20)2-Ethylpyridine (9)2-Ethynylpyridine (31)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Fluoro-3-Iodopyridine (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methoxypyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoropyridine (15)2-Hydrazineylpyridine (32)2-Iodo-6-Methylpyridine (5)2-Iodopyridine (27)2-Isopropoxypyridine (16)2-Isopropylpyridine (14)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Methoxy-5-Methylpyridine (5)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Methylpyridine (14)2-Methoxyisonicotinic Acid (13)2-Methoxypyridin-3-Amine (6)2-Methoxypyridine (436)2-Methyl-1,10-Phenanthroline (3)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-Nitropyridine (9)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)2-Methylimidazo[1,2-A]Pyridine (8)2-Methylpyridin-3-Ol (8)2-Methylpyridin-4-Amine (7)2-Methylpyridine 1-Oxide (9)2-Nitropyridine (40)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propoxypyridine (9)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,3'-Bipyridine (7)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)3,5-Dibromopyridine (12)3,5-Dichloropyridine (16)3,5-Difluoropyridine (12)3,5-Dimethoxypyridine (4)3,5-Dimethylpyridine (8)3,5-Diphenylpyridine (5)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-(Benzyloxy)Pyridine (19)3-(Bromomethyl)Pyridine (18)3-(Chloromethyl)Pyridine (22)3-(Cyclopropylmethyl)Pyridine (6)3-(Difluoromethyl)Pyridine (5)3-(Methylsulfonyl)Pyridine (5)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)Pyridine (5)3-(Pyrrolidin-2-Yl)Pyridine (6)3-(Tert-Butyl)Pyridine (5)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (52)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Methylpyridine (13)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylpyridine (4)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Cyclopropylpyridine (28)3-Ethoxypyridine (12)3-Ethylpyridine (11)3-Ethynylpyridine (22)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-2-Methylpyridine (15)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Fluoropicolinic Acid (6)3-Fluoropicolinonitrile (5)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Hydrazineylpyridine (8)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Methoxypyridin-2-Amine (5)3-Methoxypyridine (52)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Methyl-2-Phenylpyridine (3)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)3-Methyl-5-Nitropyridine (4)3-Methylimidazo[1,2-A]Pyridine (3)3-Methylpicolinic Acid (13)3-Methylpyridin-2-Amine (7)3-Methylpyridine (50)3-Methylpyridine 1-Oxide (7)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Phenoxypyridine (12)4'-Phenyl-2,2':6',2''-Terpyridine (13)4,4'-Bipyridine (10)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,7-Diphenyl-1,10-Phenanthroline (4)4-(2,4-Diphenyl-1H-Imidazol-5-Yl)Pyridine (5)4-(Benzyloxy)Pyridine (8)4-(Bromomethyl)Pyridine (8)4-(Pyridin-2-Yl)Morpholine (21)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-(Tert-Butyl)Pyridine (5)4-(Trifluoromethyl)Nicotinic Acid (3)4-(Trifluoromethyl)Pyridine (14)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-Methylpyridine (5)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Bromopyridine (31)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-3-Methylpyridine (7)4-Chloronicotinic Acid (4)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Cyclopropylpyridine (7)4-Ethoxypyridine (7)4-Ethynylpyridine (10)4-Iodopyridine (17)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Methoxypyridine (136)4-Methyl-2,2'-Bipyridine (8)4-Methyl-2-Phenylpyridine (3)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)4-Methyl-3-Nitropyridine (8)4-Methylnicotinic Acid (5)4-Methylpyridine (24)4-Nitropyridine (11)4-Phenoxypyridine (7)4-Phenyl-1,2,3,6-Tetrahydropyridine (7)4-Phenyl-1,4-Dihydropyridine (10)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5,6-Dichloropyridin-2-Amine (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Iodopyridine (5)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Fluoro-2-Methoxypyridine (15)5-Fluoro-2-Methylpyridine (8)5-Fluoropicolinonitrile (5)5-Fluoropyridin-2-Amine (15)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5-Methoxypyridin-3-Amine (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)5-Phenylpicolinic Acid (4)6,7-Dihydro-5H-Cyclopenta[B]Pyridine (18)6,7-Dihydro-5H-Cyclopenta[C]Pyridine (7)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromonicotinaldehyde (11)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chloro-5-Iodopyridin-2-Amine (3)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxynicotinaldehyde (4)6-Methoxypicolinic Acid (9)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylnicotinic Acid (6)6-Methylnicotinonitrile (7)6-Methylpicolinic Acid (12)6-Methylpicolinonitrile (10)6-Methylpyridin-2-Amine (46)6-Methylpyridin-2-Ol (23)6-Methylpyridin-3-Amine (5)6-Methylpyridin-3-Ol (7)6-Phenoxypyridin-3-Amine (5)6-Phenylnicotinic Acid (8)6-Phenylpicolinic Acid (3)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methylimidazo[1,2-A]Pyridine (3)9H-Pyrido[3,4-B]Indole (5)Bis(Pyridin-2-Ylmethyl)Amine (6)Dimethyl Pyridine-2,6-Dicarboxylate (7)Dimethyl(Pyridin-2-Yl)Phosphine Oxide (8)Dimethyl(Pyridin-3-Yl)Phosphine Oxide (7)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Methylnicotinate (6)Ethyl 4,6-Dichloronicotinate (4)Ethyl 6-Chloropicolinate (7)Ethyl Isonicotinate (12)Ethyl Nicotinate (25)Ethyl Picolinate (41)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Imidazo[1,2-A]Pyridin-2-Ylmethanol (4)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinaldehyde (68)Isonicotinamide (12)Isonicotinic Acid (23)Isonicotinohydrazide (6)Isonicotinonitrile (16)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Bromopicolinate (9)Methyl 3-Chloropicolinate (9)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)Methyl 5-Hydroxypicolinate (5)Methyl 6-Bromonicotinate (6)Methyl 6-Chloropicolinate (11)Methyl 6-Fluoronicotinate (4)Methyl 6-Methoxynicotinate (4)Methyl Isonicotinate (16)Methyl Nicotinate (52)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N-(Pyridin-2-Yl)Benzamide (9)N-Benzylpyridin-2-Amine (9)N-Methylpicolinamide (10)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpicolinamide (8)N-Phenylpyridin-2-Amine (9)Nicotinaldehyde (153)Nicotinamide (64)Nicotinic Acid (53)Nicotinonitrile (82)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)Phenyl(Pyridin-2-Yl)Methanone (10)Phenyl(Pyridin-3-Yl)Methanone (9)Picolinaldehyde (98)Picolinamide (26)Picolinic Acid (22)Picolinimidamide (11)Picolinohydrazide (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyridin-2-Amine (29)Pyridin-2-Ol (170)Pyridin-2-Ylboronic Acid (9)Pyridin-2-Ylmethanamine (38)Pyridin-2-Ylmethanol (65)Pyridin-3-Amine (21)Pyridin-3-Ol (13)Pyridin-3-Ylboronic Acid (49)Pyridin-3-Ylmethanamine (29)Pyridin-3-Ylmethanol (39)Pyridin-4-Amine (22)Pyridin-4-Ol (16)Pyridin-4-Ylboronic Acid (21)Pyridin-4-Ylmethanamine (12)Pyridin-4-Ylmethanol (16)Pyridine 1-Oxide (33)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyridine-2,6-Dicarboxylic Acid (9)Pyridine-2,6-Diol (6)Pyridine-2-Sulfonamide (6)Pyridine-2-Sulfonyl Chloride (9)Pyridine-2-Thiol (8)Pyridine-3-Sulfonic Acid (6)Pyridine-3-Sulfonyl Chloride (25)Pyrido[2,3-B]Pyrazine (12)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-B]Pyrazine (11)Pyrido[3,4-D]Pyrimidine (10)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl Pyridin-2-Ylcarbamate (37)Tert-Butyl Pyridin-3-Ylcarbamate (16)Tert-Butyl Pyridin-4-Ylcarbamate (6)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[3,2-B]Pyridine (18)Thieno[3,2-C]Pyridine (13)
Pyrimidines (14557)
Bipyrimidine (4)Dibromopyrimidine (15)Methoxypyrimidine (107)Pyrimidinone (3)Tetraoxatetradecan (10)Trichloropyrimidine (11)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)1,4,5,6-Tetrahydropyrimidine (4)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (9)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (30)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (46)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyrimidine (14)2,4,6-Triphenylpyrimidine (9)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichloropyrimidin-5-Amine (6)2,4-Dimethoxypyrimidine (13)2,4-Dimethylpyrimidine (7)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(Chloromethyl)Pyrimidine (5)2-(Methylsulfonyl)Pyrimidine (25)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Piperazin-1-Yl)Pyrimidine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Propylthio)Pyrimidine (5)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Trifluoromethyl)Pyrimidine (27)2-Aminopyrimidin-4(3H)-One (11)2-Bromopyrimidine (22)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloropyrimidin-4-Amine (22)2-Cyclopropylpyrimidine (10)2-Ethoxypyrimidine (7)2-Ethylpyrimidine (6)2-Fluoropyrimidine (9)2-Hydrazineylpyrimidine (6)2-Iodopyrimidine (8)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methylpyrimidin-4-Amine (22)2-Methylpyrimidin-4-Ol (11)2-Phenoxypyrimidine (8)2-Phenylpyrimidin-5-Amine (5)3-Methylpyrimidin-4(3H)-One (6)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyrimidin-2-Amine (9)4,6-Dichloropyrimidine (14)4,6-Diphenylpyrimidine (7)4-(Dimethoxymethyl)Pyrimidine (5)4-(Piperazin-1-Yl)Pyrimidine (13)4-(Piperidin-1-Yl)Pyrimidine (8)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-(Pyrimidin-4-Yl)Morpholine (13)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (19)4-Bromopyrimidine (24)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Chloro-5-Iodopyrimidine (6)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-6-Methoxypyrimidine (5)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Chloropyrimidine-5-Carbonitrile (6)4-Ethoxypyrimidine (6)4-Fluoropyrimidine (8)4-Iodopyrimidine (9)4-Methoxy-2-Methylpyrimidine (8)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Methyl-2-(Methylthio)Pyrimidine (7)4-Methylpyrimidin-2-Amine (9)4-Methylpyrimidine (22)4-Phenoxypyrimidine (5)4-Phenylpyrimidin-2-Amine (15)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(Benzyloxy)Pyrimidine (5)5-Benzylpyrimidine (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Bromo-2-(Methylthio)Pyrimidine (6)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Methylpyrimidine (5)5-Bromo-4-Chloropyrimidine (4)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine (8)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Ethylpyrimidine (5)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (2)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine (11)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyrimidine (5)5-Methylpyrimidine (3)5-Phenylpyrimidine (16)5H-Pyrrolo[3,2-D]Pyrimidine (16)6,7-Dihydro-5H-Cyclopenta[D]Pyrimidine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)6-Chloropyrimidin-4-Amine (8)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)[1,2,4]Triazolo[1,5-A]Pyrimidine (14)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Imidazo[1,2-C]Pyrimidine (6)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)N,N-Dimethylpyrimidin-2-Amine (10)N-(9-((2R,5S)-5-((Trityloxy)Methyl)Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)N-Benzyl-9H-Purin-6-Amine (6)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-D]Pyrimidine (10)Pyrimidin-2-Ol (21)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-2-Ylmethanol (5)Pyrimidin-4-Amine (29)Pyrimidin-4-Ol (25)Pyrimidin-5-Amine (6)Pyrimidin-5-Ol (5)Pyrimidin-5-Ylboronic Acid (9)Pyrimidine-2,4-Diamine (14)Pyrimidine-2-Carbonitrile (14)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-2-Thiol (6)Pyrimidine-4,6(1H,5H)-Dione (3)Pyrimidine-4-Carbonitrile (9)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carbaldehyde (38)Pyrimidine-5-Carbonitrile (6)Pyrimidine-5-Carboxylic Acid (7)Tetrahydropyrimidin-2(1H)-One (6)Thiazolo[5,4-D]Pyrimidine (5)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-D]Pyrimidine (24)
Pyrroles (4953)
Bromopyrrolo (8)Chloropyrrolo (10)Dihydropyrrolo (15)Octahydropyrrolo (6)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(Phenylsulfonyl)-1H-Pyrrole (24)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-Benzylpyrrolidin-2-One (18)1-Methyl-1H-Pyrrole (43)1H-Pyrrol-1-Amine (7)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrole-3-Carbonitrile (9)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (5)2-Bromo-1H-Pyrrole (11)2-Methyl-1H-Pyrrole (49)2-Nitro-1H-Pyrrole (5)2-Phenyl-1H-Pyrrole (24)3,6-Di(Thiophen-2-Yl)-2,5-Dihydropyrrolo[3,4-C]Pyrrole-1,4-Dione (17)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Phenyl-1H-Pyrrole (5)3-Phenylpyrrolidine (26)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4H-Thieno[3,2-B]Pyrrole (6)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5H-Pyrrolo[2,3-B]Pyrazine (14)5H-Pyrrolo[3,2-D]Pyrimidine (16)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Pyrrolo[2,1-F][1,2,4]Triazine (14)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)
Pyrrolidines (14879)
Acetylpyrrolidine (9)Benzylpyrrolidine (33)Bipyrrolidine (9)Bromopyrrolidine (7)Carbamoylpyrrolidine (5)Difluoropyrrolidine (16)Dimethylpyrrolidine (31)Dioxopyrrolidin (131)Ethylpyrrolidine (9)Fluoropyrrolidine (26)Formylpyrrolidine (10)Mercaptopyrrolidine (4)Methoxypyrrolidine (19)Methylenepyrrolidine (2)Methylpyrrolidine (129)Phenoxypyrrolidine (3)Pyrrolidine-Benzene-Boronic Acid/Ester (20)(3Ar,6As)-Octahydrocyclopenta[C]Pyrrole (5)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylpyrrolidine (8)(S)-3-Phenylpyrrolidine (14)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)(S)-N-(4-(Thiazol-5-Yl)Benzyl)Pyrrolidine-2-Carboxamide (7)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Phenylsulfonyl)Pyrrolidine (15)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzylpyrrolidin-2-One (18)1-Benzylpyrrolidine (26)1-Methylpyrrolidin-2-One (13)1-Phenylpyrrolidin-2-One (18)2,2-Dimethylpyrrolidine (4)2,5-Dioxopyrrolidin-1-Yl ((Benzyloxy)Carbonyl)Glycinate (8)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2,8-Diazaspiro[4.5]Decan-3-One (6)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(2-Chlorophenyl)Pyrrolidine (17)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Pyrrolidine (5)2-(Methoxymethyl)Pyrrolidine (6)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-1-Yl)Pyridine (11)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Azabicyclo[2.2.1]Heptane (6)2-Methyl-1-Phenyl-1H-Pyrrole (8)2-Methylpyrrolidine (21)3,3-Difluoropyrrolidine (29)3-(Pyrrolidin-2-Yl)Pyridine (6)3-Aminopyrrolidin-2-One (5)3-Bromopyrrolidine (6)3-Hydroxypyrrolidin-2-One (4)3-Phenoxypyrrolidine (5)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenylpyrrolidine (26)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Hydroxypyrrolidin-2-One (7)4-Phenylpyrrolidin-2-One (7)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Azaspiro[2.4]Heptane (13)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Azaspiro[3.4]Octane (4)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Hydroxypyrrolidine-1-Carboxylate (5)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Hexahydro-1H-Pyrrolizine (12)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl Prolinate (43)Methyl Pyrrolidine-3-Carboxylate (9)N,N-Dimethylpyrrolidin-3-Amine (7)N-Methylpyrrolidin-3-Amine (6)Octahydrocyclopenta[C]Pyrrole (6)Phenyl(Pyrrolidin-1-Yl)Methanone (12)Proline (13)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ol (59)Pyrrolidin-3-Ylmethanamine (6)Pyrrolidin-3-Ylmethanol (13)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-2-Carboxamide (12)Pyrrolidine-3-Carbonitrile (6)Pyrrolidine-3-Carboxylic Acid (14)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Hydroxypyrrolidine-1-Carboxylate (20)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl Pyrrolidin-3-Ylcarbamate (12)Tert-Butyl Pyrrolidine-1-Carboxylate (21)
Pyrrolines (1763)
1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1-Phenyl-1H-Pyrrole-2,5-Dione (12)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,5-Dihydro-1H-Pyrrol-2-One (5)2,5-Dihydro-1H-Pyrrole (13)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)3,4-Dihydro-2H-Pyrrole (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)
Quinazolines (3143)
Dichloroquinazoline (14)Iodoquinazoline (10)Methylquinazoline (46)Nitroquinazoline (20)Trichloroquinazoline (5)2,4-Dichloroquinazoline (19)2-(Trifluoromethyl)Quinazoline (4)2-Bromoquinazoline (4)2-Chloroquinazolin-4(3H)-One (4)2-Cyclopropylquinazoline (5)2-Mercaptoquinazolin-4(3H)-One (3)2-Methylquinazoline (20)4-Chloroquinazoline (39)4-Methylquinazoline (4)5,6,7,8-Tetrahydroquinazoline (8)5-Chloroquinazoline (4)6-Bromoquinazoline (7)7-Bromoquinazolin-4(3H)-One (4)7-Fluoroquinazolin-4(3H)-One (4)7-Methoxy-N-Phenylquinazolin-4-Amine (12)8-Bromoquinazoline (8)8-Chloroquinazoline (5)8-Fluoroquinazoline (4)8-Methoxyquinazoline (3)8-Methylquinazoline (3)Ethyl Quinazoline-2-Carboxylate (4)N-(3-Chlorophenyl)Quinazolin-4-Amine (9)Quinazolin-2-Amine (13)Quinazolin-2-Ol (7)Quinazolin-4-Amine (8)Quinazolin-4-Ol (10)
Quinolines (11910)
Iodoquinoline (32)1,2-Dihydroquinoline (5)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)2,2'-Biquinoline (3)2,3,6,7-Tetrahydro-1H,5H-Pyrido[3,2,1-Ij]Quinoline (7)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Hydroxyquinolin-4(1H)-One (3)2-Phenylquinoline (18)3,4-Dihydroisoquinoline (11)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Phenoxyquinoline (5)4-Phenylquinoline (9)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)7,8-Dihydroquinolin-5(6H)-One (5)7-(Benzyloxy)Quinoline (6)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)N-Phenylquinolin-4-Amine (11)
Quinoxalines (1411)
Dichloroquinoxaline (8)Dihydroquinoxalin (7)1,2,3,4-Tetrahydroquinoxaline (6)2-Chloroquinoxaline (39)2-Methylquinoxaline (5)2-Phenylquinoxaline (5)3,4-Dihydroquinoxalin-2(1H)-One (7)5-Bromoquinoxaline (6)6-Bromoquinoxaline (9)6-Chloroquinoxaline (3)6-Methoxyquinoxaline (6)Quinoxalin-2-Amine (3)Quinoxalin-2-Ol (4)
Quinuclidines (202)
Spiroes (4763)
Aminospiro (4)Azaspiro (246)Bromospiro (11)Diazaspiro (182)Dihydrospiro (18)Dioxaspiro (39)Fluorospiro (4)Oxospiro (22)Triazaspiro (13)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4-Dioxaspiro[4.5]Decane (17)2,8-Diazaspiro[4.5]Decane (5)2-Oxa-8-Azaspiro[4.5]Decane (5)3-Phenyloxetane (11)6-Azaspiro[3.4]Octane (4)7-Azaspiro[3.5]Nonane (7)9,9'-Spirobi[Fluorene] (19)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidine] (5)
Tetrahydrofurans (2265)
Hydroxytetrahydrofuran (16)Iodotetrahydrofuran (3)Methoxytetrahydrofuran (11)Oxotetrahydrofuran (26)(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(3Ar,6Ar)-Hexahydrofuro[3,2-B]Furan (5)(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-2-Yl)Methanol (6)(Tetrahydrofuran-3-Yl)Methanamine (3)1,3-Dihydrobenzo[C][1,2]Oxaborole (20)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (9)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (30)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (46)1-Oxa-8-Azaspiro[4.5]Decane (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (27)2-Oxa-8-Azaspiro[4.5]Decane (5)2-Oxabicyclo[2.1.1]Hexane (6)3-Aminodihydrofuran-2(3H)-One (4)3-Iodotetrahydrofuran (3)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (19)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Hydroxydihydrofuran-2(3H)-One (14)5-(Hydroxymethyl)Dihydrofuran-2(3H)-One (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (2)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)Dihydrofuran-3(2H)-One (7)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Amine (6)Tetrahydrofuran-3-Carboxylic Acid (4)Tetrahydrofuran-3-Ol (7)
Tetrahydroisoquinolines (1291)
Tetrahydroisoquinoline-Carboxylic Acid (48)(9H-Fluoren-9-Yl)Methyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (7)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,4-Dihydroisoquinolin-3(2H)-One (5)1-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)2-Methyl-1,2,3,4-Tetrahydroisoquinoline (13)4,4-Dimethyl-1,2,3,4-Tetrahydroisoquinoline (3)5,6,7,8-Tetrahydroisoquinoline (5)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)Isoquinoline-1,3(2H,4H)-Dione (7)
Tetrahydropyrans (3359)
Chroman-Amine (1)Difluorochroman (16)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)4-Phenoxytetrahydro-2H-Pyran (5)9-Bromoanthracene (5)
Tetrahydroquinolines (1464)
Tetrahydroquinoline-Carboxylic Acid (18)1-Ethyl-1,2,3,4-Tetrahydroquinoline (6)1-Methyl-1,2,3,4-Tetrahydroquinoline (6)2,3-Dihydroquinolin-4(1H)-One (19)2-Methyl-1,2,3,4-Tetrahydroquinoline (3)4,4-Dimethyl-1,2,3,4-Tetrahydroquinoline (3)4-Methyl-1,2,3,4-Tetrahydroquinoline (2)5,6,7,8-Tetrahydroquinoline (17)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)Tert-Butyl 3,4-Dihydroquinoline-1(2H)-Carboxylate (11)
Tetrazoles (82)
1-Phenyl-1H-Tetrazole (6)5-Phenyl-1H-Tetrazole (23)5-Phenyl-2H-Tetrazole (9)
Thiadiazoles (2122)
1,2,3-Thiadiazole (8)1,2,4-Thiadiazole (15)1,2,5-Thiadiazole (6)1,3,4-Thiadiazol-2-Amine (9)2-Bromo-1,3,4-Thiadiazole (11)2-Methyl-1,3,4-Thiadiazole (12)2-Phenyl-1,3,4-Thiadiazole (19)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-Bromobenzo[C][1,2,5]Thiadiazole (14)Benzo[D][1,2,3]Thiadiazole (7)
Thiazines (62)
Thiazoles (6687)
Acetylthiazole (7)Bromothiazolo (9)Chlorothiazole (32)Chlorothiazolo (18)Cyanothiazole (7)Cyclopropylthiazole (11)Dibromothiazole (7)Dichlorothiazole (8)Dihydrothiazole (16)Dihydrothiazolo (14)Dimethylthiazole (22)Ethylthiazole (8)Formylthiazole (7)Methylthiazole (109)Nitrothiazol (8)Tetrahydrothiazolo (8)1-(Thiazol-2-Yl)Ethan-1-One (9)2,4-Dibromothiazole (5)2,4-Dichlorothiazole (4)2,4-Dimethylthiazole (7)2,5-Dibromothiazole (5)2,5-Dimethylthiazole (4)2-(Chloromethyl)Thiazole (5)2-(Methylthio)Thiazole (5)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethyl)Thiazole (11)2-Bromo-4-Methylthiazole (7)2-Bromo-5-Methylthiazole (7)2-Chloro-4-Methylthiazole (5)2-Chloro-5-Methylthiazole (5)2-Chlorothiazole (32)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)2-Isopropylthiazole (11)2-Methyl-4-Phenylthiazole (6)2-Phenoxythiazole (5)2-Phenylbenzo[D]Thiazole (16)2-Phenylthiazole-4-Carbaldehyde (9)4,5,6,7-Tetrahydrobenzo[D]Thiazole (14)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5-Dihydrothiazole (8)4-(4-Fluorophenyl)Thiazole (9)4-(Trifluoromethyl)Thiazole (7)4-Bromothiazole (10)4-Cyclopropylthiazole (6)4-Methyl-2-Phenylthiazole (6)4-Methylthiazol-2-Amine (7)4-Methylthiazole (5)4-Phenylthiazol-2-Amine (37)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)5-Bromothiazol-2-Amine (6)5-Bromothiazole (8)5-Methyl-4-Phenylthiazole (5)5-Methylthiazol-2-Amine (6)5-Phenylthiazole (20)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Phenylthiazole-4-Carboxylate (12)Ethyl 2-Phenylthiazole-5-Carboxylate (9)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)N-(Thiazol-2-Yl)Acetamide (9)N-(Thiazol-2-Yl)Benzamide (9)N-Phenylthiazol-2-Amine (9)Tert-Butyl Thiazol-2-Ylcarbamate (22)Thiazol-2-Ylmethanamine (5)Thiazol-2-Ylmethanol (9)Thiazol-5-Amine (6)Thiazole-2-Carbaldehyde (9)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carbaldehyde (19)Thiazole-5-Carbonitrile (7)Thiazole-5-Carboxylic Acid (10)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thiazolo[5,4-D]Pyrimidine (5)
Thiazolidines (1260)
Thioxothiazolidin (23)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)1,2,3-Oxathiazolidine 2,2-Dioxide (14)2-Thioxothiazolidin-4-One (6)Thiazolidine (16)
Thiomorpholines (454)
Thiomorpholine (10)Thiomorpholine 1,1-Dioxide (6)
Thiophenes (960)
Acetylthiophene (5)Aminothiophene (23)Bromothieno (29)Chlorothieno (41)Chlorothiophene (61)Cyanothiophene (5)Dibromothieno (5)Dibromothiophene (17)Dichlorothieno (10)Dichlorothiophene (13)Dihydrothieno (24)Dihydrothiophene (1)Dihydroxythiophene (7)Dimethylthieno (10)Dimethylthiophene (21)Dithiophene (40)Fluorothiophene (18)Formylthiophene (16)Hydroxythiophene (7)Iodothieno (6)Iodothiophene (13)Methylthieno (27)Nitrothiophene (27)Terthiophene (10)Tetrahydrothieno (17)Thiophenecarboxaldehyde (10)Thiphen-Amine-Hydrochloride (58)Trithiophene (5)(9H-Fluoren-9-Yl)Methyl (2-(Thiophen-2-Yl)Ethyl)Carbamate (5)1-(Thiophen-2-Yl)Ethan-1-One (17)2,2'-Bithiophene (25)2,2':5',2''-Terthiophene (9)2,3-Dihydrothieno[3,4-B][1,4]Dioxine (9)2,5-Dibromothiophene (18)2,5-Diphenylthiophene (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethyl)Thiophene (11)2-Chlorothiophene (20)2-Ethynylthiophene (8)2-Iodothiophene (14)2-Methoxythiophene (7)2-Nitrothiophene (20)3-Bromothiophene (6)3-Chlorothiophene (17)3-Fluorothiophene (6)3-Methoxythiophene (9)3-Methylthiophene (14)3-Nitrothiophene (6)3-Phenylthiophene (13)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,7-Di(Thiophen-2-Yl)Benzo[C][1,2,5]Thiadiazole (9)4,8-Di(Thiophen-2-Yl)Benzo[1,2-B:4,5-B']Dithiophene (8)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-Cyclopenta[2,1-B:3,4-B']Dithiophene (9)4H-Thieno[3,2-B]Pyrrole (6)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5,6-Dihydro-4H-Cyclopenta[B]Thiophene (7)5-(Thiophen-2-Yl)Isoxazole (5)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Phenylthiophen-2-Amine (5)Benzo[1,2-B:4,5-B']Dithiophene (7)Dibenzo[B,D]Thiophene (22)Dihydrothiophen-3(2H)-One (4)Dithieno[3,2-B:2',3'-D]Thiophene (5)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Methyl Thiophene-3-Carboxylate (34)N,N-Diphenyl-4-(Thiophen-2-Yl)Aniline (5)Phenyl(Thiophen-2-Yl)Methanone (6)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-B]Pyridine (18)Thieno[3,2-B]Thiophene (19)Thieno[3,2-C]Pyridine (13)Thieno[3,2-D]Pyrimidine (24)Thieno[3,4-B]Thiophene (5)Thiophen-2-Ylboronic Acid (20)Thiophen-2-Ylmethanol (11)Thiophen-3-Amine (18)Thiophen-3-Ol (6)Thiophene-2-Carbaldehyde (43)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbaldehyde (17)Thiophene-3-Carbonitrile (13)Thiophene-3-Carboxamide (5)Thiophene-3-Carboxylic Acid (8)
Triazines (1387)
1,2,4-Triazine (9)1,3,5-Triazin-2-Amine (3)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4,6-Triphenyl-1,3,5-Triazine (24)2,4-Diphenyl-1,3,5-Triazine (6)2-Chloro-1,3,5-Triazine (10)2-Methoxy-1,3,5-Triazine (10)2-Phenyl-1,3,5-Triazine (6)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)Pyrrolo[2,1-F][1,2,4]Triazine (14)
Triazoles (7749)
(5As,10Br)-2-Phenyl-2,5A,6,10B-Tetrahydro-4H-Indeno[2,1-B][1,2,4]Triazolo[4,3-D][1,4]Oxazin-11-Ium (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-Benzyl-1H-1,2,3-Triazole (8)1-Benzyl-1H-1,2,4-Triazole (6)1-Methyl-1H-1,2,3-Triazole (9)1-Methyl-1H-1,2,4-Triazole (17)1-Methyl-1H-Benzo[D][1,2,3]Triazole (10)1-Phenethyl-1H-1,2,4-Triazole (6)1-Phenyl-1H-1,2,3-Triazole (7)1-Phenyl-1H-1,2,4-Triazole (20)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenyl-2H-Benzo[D][1,2,3]Triazole (8)2H-1,2,3-Triazole (7)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-Phenyl-4H-1,2,4-Triazole (6)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-1,2,4-Triazole (13)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)
Other Aliphatic Heterocycles (6209)
1,3-Dioxane (20)1,4-Diazepane (12)3-Azabicyclo[3.1.0]Hexane (14)
Other Aromatic Heterocycles (37751)
Indolizine (15)Phenazine (8)
NHCs
Achiral NHCs Catalysts (35)
Achiral NHCs Ligands (110)
Chiral NHCs Catalysts (138)
Chiral NHCs Ligands (84)
Organic Building Blocks
Acyl Chlorides (3025)
2-Chlorobenzoyl Chloride (13)2-Phenoxyacetyl Chloride (3)2-Phenylacetyl Chloride (9)
Alcohols (45771)
Amino-Propanol (6)Cyclopropylethanol (6)Diethanol (23)Diethanol (23)Dihydroxybenzylidene (4)Dihydroxynaphthalene (7)Dihydroxypropanoate (7)Dihydroxyterephthalic Acid (3)Hydroxyacetamide (1)Hydroxyacetimidamide (3)Hydroxyadamantan (4)Hydroxyadamantan (4)Hydroxyazetidine (7)Hydroxybenzyl (18)Hydroxybenzylidene (5)Hydroxybicyclo (7)Hydroxybutan (4)Hydroxybutan (4)Hydroxybutanoate (36)Hydroxybutanoic (33)Hydroxycarbamimidoyl (2)Hydroxycinnamic Acid (2)Hydroxycyclobutyl (3)Hydroxycyclohexyl (7)Hydroxycyclopentyl (1)Hydroxydiphenylmethyl (2)Hydroxyethoxy (22)Hydroxyethoxy (22)Hydroxyhexanoate (8)Hydroxyhexanoic (6)Hydroxyimino (11)Hydroxyisonicotinaldehyde (7)Hydroxyisonicotinate (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic Acid (4)Hydroxymethyl-Phenyl-Boronic-Acid (31)Hydroxynaphthalene (29)Hydroxynicotinaldehyde (7)Hydroxynicotinate (13)Hydroxynicotinonitrile (6)Hydroxyoctadec (1)Hydroxyoctadec (1)Hydroxyoctadecanoic (7)Hydroxypentanoate (6)Hydroxypropanoic (35)Pentahydroxyhexanal (9)Phenyl-Methanol (3)Propanediol (9)Propanediol (9)Tetrahydroxy (25)Tetrahydroxy (25)Tetrahydroxyhexanal (9)Tetrahydroxypentanal (5)Trihydroxy (246)Trihydroxy (246)(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenylcyclopropyl)Methanol (3)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)(1H-Indol-2-Yl)Methanol (8)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromophenyl)Methanol (39)(2-Chlorophenyl)Methanol (39)(2-Fluorophenyl)Methanol (60)(2-Iodophenyl)Methanol (12)(2-Nitrophenyl)Methanol (29)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Methanol (21)(3-Chlorophenyl)Methanol (38)(3-Fluorophenyl)Methanol (58)(3-Iodophenyl)Methanol (13)(3-Methylpyridin-2-Yl)Methanol (10)(3-Nitrophenyl)Methanol (31)(3-Phenoxyphenyl)Methanol (3)(3-Phenylisoxazol-5-Yl)Methanol (7)(4-Fluorophenyl)Methanol (29)(4-Nitrophenyl)Methanol (17)(6-Methylpyridin-2-Yl)Methanol (5)(Tetrahydrofuran-2-Yl)Methanol (6)1,2-Diphenylethan-1-Ol (8)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenylethan-1-Ol (102)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Amino-2-Phenylethan-1-Ol (196)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxyethyl Benzoate (3)2-Phenoxyethan-1-Ol (14)2-Phenylethan-1-Ol (77)2-Phenylpropan-2-Ol (21)3-Phenylpropan-1-Ol (24)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Phenylpiperidin-4-Ol (10)Azetidin-2-Ylmethanol (7)Azetidin-3-Ol (11)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Cyclobutanol (46)Cyclobutylmethanol (15)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanol (51)Diphenylmethanol (20)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Ylmethanol (5)M-Tolylmethanol (34)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Naphthalen-1-Ylmethanol (8)O-Tolylmethanol (35)Oxiran-2-Ylmethanol (3)Piperidin-2-Ylmethanol (11)Piperidin-3-Ol (27)Piperidin-3-Ylmethanol (15)Piperidin-4-Ylmethanol (11)Pyridin-2-Ylmethanol (65)Pyridin-3-Ylmethanol (39)Pyridin-4-Ylmethanol (16)Pyrimidin-2-Ylmethanol (5)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ylmethanol (13)Quinazolin-2-Ol (7)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Thiazol-2-Ylmethanol (9)Thiophen-2-Ylmethanol (11)Triphenylmethanol (13)
Aldehydes (18914)
Aminonicotinaldehyde (5)Aminonicotinaldehyde (5)Carboxyaldehyde (1094)Dicarbaldehyde (37)Dicarbaldehyde (37)Formylisonicotinate (7)Tetracarbaldehyde (8)Tetracarbaldehyde (8)Tricarbaldehyde (10)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Naphthaldehyde (23)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Indazole-3-Carbaldehyde (19)1H-Indole-2-Carbaldehyde (20)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3-Dichlorobenzaldehyde (7)2,3-Difluorobenzaldehyde (18)2,4-Dichlorobenzaldehyde (8)2,4-Difluorobenzaldehyde (19)2,6-Dibromobenzaldehyde (4)2,6-Difluorobenzaldehyde (25)2-(Benzyloxy)Benzaldehyde (13)2-(Phenylethynyl)Benzaldehyde (9)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethyl)Benzaldehyde (27)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-6-Fluorobenzaldehyde (15)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-4-Fluorobenzaldehyde (10)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluorobenzaldehyde (175)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodobenzaldehyde (17)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Naphthaldehyde (12)2-Nitrobenzaldehyde (53)2-Oxo-2-Phenylacetaldehyde (12)2-Phenylacetaldehyde (20)3-(Benzyloxy)Benzaldehyde (13)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethyl)Benzaldehyde (31)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Methoxybenzaldehyde (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-4-Methoxybenzaldehyde (7)3-Chlorobenzaldehyde (106)3-Fluorobenzaldehyde (137)3-Iodobenzaldehyde (28)3-Methoxy-2-Nitrobenzaldehyde (3)3-Nitrobenzaldehyde (49)3-Phenoxybenzaldehyde (7)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-(Benzyloxy)Benzaldehyde (23)4-(Piperazin-1-Yl)Benzaldehyde (5)4-Fluorobenzaldehyde (78)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Morpholinobenzaldehyde (8)4-Nitrobenzaldehyde (18)4-Phenoxybenzaldehyde (12)5-Phenylfuran-2-Carbaldehyde (9)6-Methoxynicotinaldehyde (4)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-4-Carbaldehyde (31)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-3-Carbaldehyde (6)Benzo[D][1,3]Dioxole-5-Carbaldehyde (6)Benzofuran-2-Carbaldehyde (5)Furan-2-Carbaldehyde (22)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Isonicotinaldehyde (68)Methyl 3-Formylbenzoate (23)Nicotinaldehyde (153)Picolinaldehyde (98)Pyrazine-2-Carbaldehyde (17)Pyrimidine-5-Carbaldehyde (38)Thiazole-2-Carbaldehyde (9)Thiazole-5-Carbaldehyde (19)Thiophene-2-Carbaldehyde (43)Thiophene-3-Carbaldehyde (17)
Aliphatic Chain Hydrocarbons (12579)
Acetylthio (7)Acetylthio (7)Azanonadecan (7)Azanylylidene (1)Azapentadecan (10)Azapentadecan (10)Azatridecan (4)Butyloctyl (4)Butyloctyl (4)Carbonylbis (2)Carbonylbis (2)Diazirine (13)Diazirine (13)Didodecyl (7)Didodecyl (7)Diethyl (73)Diethyl (73)Dihydroxypropan (6)Diisobutyl (2)Diisopropyl (27)Diisopropyl (27)Dimethoxy (306)Dimethyladamantane (14)Dimethyladamantane (14)Dimethylalkanes (7)Dinonyl (1)Dinonyl (1)Dioctyl (1)Dioxide (451)Dioxide (451)Ethoxy (711)Ethoxyethoxy (5)Ethoxyethoxy (5)Ethoxyethyl (16)Ethoxyethyl (16)Ethoxymethyl (11)Ethoxymethylene (1)Ethoxymethylene (1)Isopropylidenebis (2)Isopropylsulfonyl (10)Isopropylsulfonyl (10)Methoxybut (2)Methoxybut (2)Methoxyethoxy (67)Methoxyethoxy (67)Methoxyethyl (69)Methoxyisonicotinic (11)Methoxyisonicotinic (11)Methoxymethoxy (23)Methoxymethoxy (23)Methoxymethyl (117)Methoxynicotinic (26)Methoxynicotinic (26)Methoxynicotinic Acid (20)Methoxypropan (24)Methoxypropan (24)Methoxypropoxy (8)Methoxypropoxy (8)Methoxypropyl (10)Methoxytetrahydro (14)Methoxytetrahydro (14)Methyladamantan (4)Methylisonicotinic (13)Oxoethoxy (1)Oxopropane (10)Oxopropyl (32)Oxopropyl (32)Pentyloxy (7)Tetramethoxy (6)Trimethoxy (15)Trimethoxy (15)Yldisulfanyl (7)
Aliphatic Cyclic Hydrocarbons (11046)
Aminobicyclo (24)Aminocyclobutanol (5)Aminocyclobutyl (5)Aminocyclohexane (55)Aminocyclohexanol (21)Aminocyclopentanol (17)Aminocyclopentyl (6)Aminocyclopropyl (4)Azabicyclo (292)Azabicyclo (292)Azatricyclo (5)Azatricyclo (5)Azetidine (185)Azetidine (185)Benzylazetidin (9)Bicyclo (61)Bicyclohexyl (6)Bromobicyclo (9)Butylcyclohexyl (9)Butylsulfonyl (6)Chlorocyclopropyl (2)Cyanoazetidine (5)Cyanocyclopropyl (4)Cyclobutanecarbonitrile (2)Cyclobutylacetic (4)Cyclobutylmethyl (4)Cyclobutylmethyl (4)Cyclodextrin (1)Cyclodextrin (1)Cyclohexa (176)Cyclohexa (176)Cyclohexane (127)Cyclohexane (127)Cyclohexanecarboxylic (19)Cyclohexanediamine (8)Cyclohexanone (92)Cyclohexylacetic (2)Cyclohexylamino (9)Cyclohexylbutanoic (4)Cyclohexylcarbamoyl (5)Cyclohexylethanamine (12)Cyclohexylmethoxy (4)Cyclohexylmethoxy (4)Cyclohexylmethyl (7)Cyclohexylmethyl (7)Cyclohexyloxy (10)Cyclohexylpropan (94)Cyclohexylpropanoic (9)Cyclopentadienyl (2)Cyclopentane (169)Cyclopentane (169)Cyclopentanecarboxylic (7)Cyclopentyl (56)Cyclopentyl (56)Cyclopentylacetic (3)Cyclopentylamino (1)Cyclopentylmethyl (4)Cyclopentyloxy (16)Cyclopentyloxy (16)Cyclopentylpropanoic (1)Cyclopropanamine (32)Cyclopropanamine (32)Cyclopropanecarbonitrile (14)Cyclopropanecarbonyl (6)Cyclopropanecarbonyl (6)Cyclopropanecarboxamide (14)Cyclopropanol (4)Cyclopropoxyphenyl (7)Cyclopropyl (355)Cyclopropyl (355)Cyclopropylacetate (6)Cyclopropylacetic (3)Cyclopropylamino (24)Cyclopropylcarbamoyl (5)Cyclopropylethan (5)Cyclopropylethan (5)Cyclopropylethynyl (1)Cyclopropylmethoxy (32)Cyclopropylmethoxy (32)Cyclopropylmethyl (22)Cyclopropylmethyl (22)Cyclopropylpropanoic (5)Cyclopropylsulfonyl (6)Cyclopropylsulfonyl (6)Diazabicyclo (77)Diazabicyclo (77)Dicyclohexyl (6)Dicyclohexyl (6)Dicyclohexylphosphino (18)Dicyclohexylphosphino (18)Difluorocyclobutyl (6)Difluorocyclohexyl (7)Dihydroinden (8)Dihydroindeno (5)Dihydroindeno (5)Dihydropteridin (6)Dimethylbicyclo (5)Dimethylbicyclo (5)Dimethylcyclohex (5)Dimethylcyclohexane (16)Dimethylcyclohexanone (7)Dioxathiolane (1)Dioxathiolane (1)Dioxol (175)Dithiolan (1)Dithiolan (1)Ethylcyclohexyl (4)Ethylcyclohexyl (4)Ethylsulfonyl (42)Fluoroazetidine (1)Fluorobicyclo (4)Hexahydrocyclohepta (6)Hexahydrocyclohepta (6)Hexahydrocyclopenta (4)Hydroxycyclobutanecarboxylic (4)Hydroxycyclohexanecarboxylic (6)Methanesulfonyl (314)Methanesulfonyl (314)Methoxycyclohexanamine (6)Methylazetidine (30)Methylbicyclo (6)Methylbicyclo (6)Methylcyclobutanamine (5)Methylcyclobutanecarboxylic (5)Methylcyclohexanamine (12)Methylcyclohexane (8)Methylcyclohexane (8)Methylcyclohexanecarboxylic (5)Methylcyclohexanecarboxylic Acid (4)Methylcyclohexanol (21)Methylcyclohexanone (5)Methylcyclohexyl (33)Methylcyclopentane (2)Methylcyclopropanamine (4)Methylcyclopropanamine (4)Methylcyclopropane (16)Methylsulfinyl (24)Methylsulfonimidoyl (6)Methylsulfonimidoyl (6)Methylsulphonyl (10)Octahydrocyclopenta (14)Oxabicyclo (40)Oxabicyclo (40)Oxazepane (13)Oxetanes (228)Oxoazetidine (8)Oxoazetidine (8)Oxobicyclo (11)Oxobicyclo (11)Oxocyclobutyl (2)Oxocyclohex (3)Oxocyclohexane (4)Oxocyclohexane (4)Oxocyclohexanecarboxylic (6)Oxocyclohexyl (3)Oxocyclohexyl (3)Oxocyclopentane (2)Oxocyclopentyl (5)Pentamethylcyclopentadienyl (11)Pentylcyclohexyl (10)Pentylcyclohexyl (10)Phenylcyclopropanamine (8)Propylcyclohexyl (15)Propylcyclohexyl (15)Tetraazacyclododecane (13)Tetraazacyclododecane (13)Tetraazacyclotetradecane (7)Tetraazacyclotetradecane (7)Tetramethylcyclohexane (4)Tetraoxatridecan (3)Tetraoxatridecan (3)Thiazepine (2)Tricyclohexylphosphine (9)Trimethylbicyclo (21)Trimethylcyclohex (20)Trimethylcyclohexane (1)Trimethylcyclohexane (1)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1-Phenylcyclopropyl)Methanol (3)(3Ar,E)-4-((Z)-2-(2-Methylenecyclohexylidene)Ethylidene)Octahydro-1H-Indene (7)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Pentylcyclohexyl)Benzene (5)(4-Propylcyclohexyl)Benzene (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Cyclopropylmethoxy)Benzene (18)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,1-Difluorocyclopentane (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-3-Cyclopropylbenzene (6)1-Chloro-2-Cyclopropylbenzene (7)1-Cyclohexyl-2-Fluorobenzene (4)1-Cyclopropyl-3-Methylbenzene (3)1-Methylcyclohex-1-Ene (26)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropan-1-Amine (26)1-Phenylcyclopropane-1-Carbonitrile (19)1-Phenylcyclopropane-1-Carboxylic Acid (23)2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-2-Phenylacetic Acid (5)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Cyclohexylacetic Acid (14)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Cyclopropylpyrimidine (10)2-Iodo-9H-Fluorene (8)2-Methylcyclohexan-1-One (3)2-Phenylcyclopropan-1-Amine (19)3,3-Dimethylcyclohexan-1-One (4)3-Cyclopropylpyridine (28)3-Methylcyclohexan-1-One (9)4-Cyclohexylbenzoic Acid (6)4-Cyclohexylbenzonitrile (10)4-Cyclohexylphenol (7)5-Azaspiro[2.4]Heptane (13)6-Azaspiro[2.5]Octane (10)9,9-Dimethyl-9H-Fluorene (16)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Bicyclo[2.2.1]Hept-2-Ene (18)Bicyclo[2.2.1]Heptane (15)Bromocyclohexane (7)Cyclobutanamine (90)Cyclobutanecarboxylic Acid (23)Cyclobutanol (46)Cyclobutylmethanol (15)Cycloheptane (12)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanamine (59)Cyclohexanecarboxylic Acid (83)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanamine (5)Cyclopentanecarboxylic Acid (26)Cyclopentanol (51)Cyclopropoxybenzene (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Isopropylcyclohexane (19)Methoxycyclohexane (7)Methyl 1-Phenylcyclopropane-1-Carboxylate (10)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)N-Methylcyclohexanamine (7)Naphthalene-1,4-Dione (23)Spiro[3.3]Heptane (11)Tert-Butyl (1-Phenylcyclopropyl)Carbamate (6)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclobutylcarbamate (17)Tert-Butyl Cyclohexylcarbamate (9)Tert-Butyl Cyclopentylcarbamate (28)
Alkenyls (16078)
Acrylaldehyde (11)Acryloyl (9)Acryloyl (9)Annulene (2)Cyclohexene (88)Cyclooctene (9)Cyclopentene (3)Diacrylamide (6)Diallyl (5)Diazene (21)Divinyl (1)Divinyl (1)Enamide (6)Enamide (6)Enecarbaldehyde (2)Enoyl (9)Methacrylamide (3)Methacrylamide (3)Methoxycinnamaldehyde (3)Nitroethylene (37)Tetrahydrocyclopenta (19)(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Nitrovinyl)Benzene (28)(Allyloxy)Benzene (19)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1,2-Diphenylethene (5)1,3,3-Trimethylcyclohex-1-Ene (12)1-Bromo-4-Styrylbenzene (5)1-Methylcyclohex-1-Ene (26)2-Benzalacetophenone (36)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methyleneazetidine (8)3-Phenylacrylaldehyde (29)3-Styrylphenol (11)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Prop-1-En-2-Yl)Cyclohex-1-Ene (5)5H-Dibenzo[B,F]Azepine (4)Allyl Benzoate (5)Cyclohex-1-En-1-Yl Trifluoromethanesulfonate (3)Cyclohex-1-En-1-Ylboronic Acid (4)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohexa-1,3-Diene (5)Cyclopent-2-En-1-Amine (4)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Methyl Cinnamate (36)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methylenecyclobutane (8)Methylenecyclohexane (8)N-Phenylacrylamide (7)Styrene (81)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Vinylcyclopropane (8)
Alkyls (195)
Isopropyl-Phenyl-Boronic Acid/Ester (26)Methylpentan (11)
Alkynyls (2698)
(Bromoethynyl)Benzene (5)(Prop-2-Yn-1-Yloxy)Benzene (13)1,3,5-Tris(Phenylethynyl)Benzene (6)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-Ethynyl-2-Fluorobenzene (10)1-Methyl-4-(Phenylethynyl)Benzene (7)2-(Phenylethynyl)Benzaldehyde (9)2-Ethynylpyridine (31)2-Ethynylthiophene (8)3-Ethynylpyridine (22)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-(Phenylethynyl)Phenol (7)4-Ethynylpyridine (10)9,10-Bis(Phenylethynyl)Anthracene (5)Ethynylbenzene (145)Trimethyl(Phenylethynyl)Silane (23)
Amides (90371)
Acetamide (651)Acetamide (651)Acetamido (156)Carboxamide (929)Carboxamide (929)Diacetamide (3)Dicarboxamide (19)Diethylacetamide (4)Diethylacetamide (4)Dimethylacetamide (9)Dimethylnicotinamide (7)Dimethylnicotinamide (7)Formamidophenylboronic Acid/Ester (11)Isobutyramide (7)Oxobutanamide (10)Oxobutanamide (10)Pentanamide (18)Pentanamide (18)Propanamide (2)Propanamido (5)Propanamido (5)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)(S)-N-Phenylpiperidine-2-Carboxamide (1)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-Methylindoline-2,3-Dione (8)1-Phenylurea (11)1H-Pyrazole-5-Carboxamide (3)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Trifluoromethyl)Benzamide (6)2-Amino-3-Phenylpropanamide (8)2-Amino-N-Phenylbenzamide (21)2-Aminobenzamide (30)2-Bromo-N-Phenylacetamide (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylbenzamide (4)2-Chlorobenzamide (16)2-Fluoro-N-Methylbenzamide (12)2-Fluorobenzamide (32)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Iodobenzamide (4)2-Methoxybenzamide (9)3-Benzamidopropanoic Acid (3)3-Bromo-4-Fluorobenzamide (3)3-Fluorobenzamide (26)3-Nitrobenzamide (17)3-Oxo-N-Phenylbutanamide (10)4-Amino-N-Phenylbenzamide (7)4-Benzamidobenzoic Acid (3)4-Fluorobenzamide (19)4-Oxo-4-(Phenylamino)Butanoic Acid (7)Benzoylglycine (15)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Phenylcarbamate (15)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Isonicotinamide (12)N,N-Diethylbenzamide (17)N,N-Dimethylbenzamide (34)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)N-(2-Chlorophenyl)Acetamide (16)N-(2-Iodophenyl)Acetamide (8)N-(2-Nitrophenyl)Acetamide (11)N-(3-Fluorophenyl)Acetamide (14)N-(4-Aminophenyl)Benzamide (2)N-(4-Chlorophenyl)Acetamide (9)N-(4-Chlorophenyl)Benzamide (6)N-(4-Fluorophenyl)Benzamide (3)N-(4-Phenoxyphenyl)Acetamide (4)N-(O-Tolyl)Benzamide (9)N-(P-Tolyl)Benzamide (6)N-(Thiazol-2-Yl)Acetamide (9)N-Isopropylbenzamide (16)N-Methoxy-N-Methylbenzamide (24)N-Methylbenzamide (58)N-Methylpicolinamide (10)N-Phenylacrylamide (7)N-Phenylpivalamide (11)Nicotinamide (64)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Picolinamide (26)Piperidine-3-Carboxamide (5)Pyrazine-2-Carboxamide (10)Pyrrolidine-2-Carboxamide (12)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Thiophene-3-Carboxamide (5)
Amidines (1564)
Carbamimidoyl (16)Benzimidamide (50)N'-Hydroxybenzimidamide (13)Picolinimidamide (11)
Amines (139951)
Amino-Carboxylate (2)Amino-Propanol (6)Aminoacetamido (4)Aminoacetyl (2)Aminoadamantan (5)Aminoadamantan (5)Aminoazepane (10)Aminobutane (23)Aminobutane (23)Aminobutyl (15)Aminobutyl (15)Aminoethoxy (18)Aminoethoxy (18)Aminoethyl (157)Aminoethyl (157)Aminohexan (6)Aminohexyl (3)Aminohexyl (3)Aminoisonicotinic Acid (12)Aminomethyl (403)Aminomethyl (403)Aminooxy (6)Aminopentyl (10)Aminopentyl (10)Aminopropanamido (1)Aminopropane (20)Aminopropane (20)Aminopropoxy (2)Aminopropoxy (2)Aminotetrahydro (12)Aminotetrahydro (12)Benzylazetidine (4)Bromobenzylamine (6)Bromobenzylcarbamate (28)Butoxycarbonylamino (8)Butylcarbamoyl (5)Carbamothioyl (2)Carbamoyl (114)Chlorobenzylamine (4)Chroman-Amine (1)Diamino (90)Diamino (90)Diaminopteridin (3)Diaminopteridin (3)Dibutylamino (6)Dibutylamino (6)Dichlorobenzylamine (5)Diethylamino (91)Diethylamino (91)Diisopropylamino (1)Dimethyl-Ethylamine (2)Dimethylamino (490)Dimethylamino (490)Dimethylcarbamoyl (14)Dimethylmethanamine (16)Dipropylamino (1)Dipropylamino (1)Ethylamino (37)Ethylamino (37)Fluindamine (32)Hydroxyamino (3)Hydroxyamino (3)Imidazol-Amine (1)Methoxyethanamine (1)Methoxyethanamine (1)Methoxyimino (2)Methylamino (241)Methylamino (241)Methylcarbamoyl (19)Methylcarbamoyl (19)Propanediamine (6)Propylamino (5)Propylamino (5)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)Silanamine (3)Triamine (25)Triamine (25)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)Methanamine (12)(2-Chlorophenyl)Methanamine (28)(2-Fluorophenyl)Methanamine (49)(3-Chlorophenyl)Methanamine (19)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Fluorophenyl)Methanamine (27)(6-Methylpyridin-2-Yl)Methanamine (6)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-3-Yl)Methanamine (3)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2-Diphenylethan-1-Amine (15)1,3,4-Thiadiazol-2-Amine (9)1,3,5-Triazin-2-Amine (3)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-Aminoanthracene-9,10-Dione (8)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-4-Amine (8)1-Methyl-1H-Pyrazol-3-Amine (14)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclopropan-1-Amine (26)1-Phenylethan-1-Amine (436)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Imidazol-2-Amine (6)1H-Indazol-3-Amine (23)1H-Indazol-4-Amine (12)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-7-Amine (6)1H-Indol-4-Amine (10)1H-Indol-6-Amine (21)1H-Indol-7-Amine (10)1H-Pyrazol-4-Amine (6)1H-Pyrazol-5-Amine (19)1H-Pyrrol-1-Amine (7)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,3-Dichloroaniline (18)2,3-Difluoroaniline (34)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,4-Dibromoaniline (18)2,4-Dichloropyrimidin-5-Amine (6)2,4-Difluoroaniline (44)2,5-Difluoroaniline (34)2,6-Dibromoaniline (17)2,6-Dichloroaniline (27)2,6-Difluoroaniline (23)2,6-Diiodoaniline (8)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(Diethylamino)Ethyl Benzoate (3)2-(Methylsulfonyl)Aniline (3)2-(Phenylamino)Benzoic Acid (11)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethyl)Aniline (58)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-Phenylethan-1-Ol (196)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-Chlorophenol (4)2-Amino-3-Fluorobenzoic Acid (11)2-Amino-6-Bromophenol (3)2-Amino-6-Chlorobenzoic Acid (5)2-Amino-6-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Aminobenzamide (30)2-Aminobenzenesulfonic Acid (9)2-Aminophenol (107)2-Aminopyrimidin-4(3H)-One (11)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Methylaniline (6)2-Bromo-4-Methylaniline (14)2-Bromo-6-Methylaniline (11)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Chloro-3-Methylaniline (4)2-Chloro-4-Methylaniline (7)2-Chloro-6-Methylaniline (11)2-Chloro-N-Methylaniline (4)2-Chloro-N-Phenylaniline (7)2-Chloroaniline (214)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,4-Diamine (6)2-Chloropyrimidin-4-Amine (22)2-Fluoro-6-Iodoaniline (7)2-Fluoro-N-Phenylaniline (4)2-Fluoroaniline (262)2-Iodo-4-Methylaniline (5)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Methoxypyridin-3-Amine (6)2-Methyl-6-Nitroaniline (10)2-Methyl-N-Phenylaniline (6)2-Methylpyridin-4-Amine (7)2-Methylpyrimidin-4-Amine (22)2-Nitro-N-Phenylaniline (3)2-Phenoxyaniline (4)2-Phenylcyclopropan-1-Amine (19)2-Phenylpyrimidin-5-Amine (5)3,4-Dibromoaniline (4)3,4-Dichloroaniline (21)3,4-Difluoroaniline (44)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(Benzyloxy)Aniline (12)3-(Methylsulfonyl)Aniline (7)3-(Piperazin-1-Yl)Aniline (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethyl)Aniline (102)3-Aminobenzenesulfonic Acid (6)3-Aminodihydrofuran-2(3H)-One (4)3-Bromo-2-Fluoroaniline (15)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methylaniline (14)3-Bromoaniline (187)3-Bromobenzene-1,2-Diamine (11)3-Chloro-2-Iodoaniline (3)3-Chloro-2-Methylaniline (11)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Iodoaniline (3)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methylaniline (12)3-Chlorobenzene-1,2-Diamine (6)3-Chloropyrazin-2-Amine (6)3-Fluoro-2-Methylaniline (9)3-Fluoroaniline (289)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Methoxypyridin-2-Amine (5)3-Methyl-N-Phenylaniline (4)3-Methylpyridin-2-Amine (7)3-Nitroaniline (98)3-Phenoxyaniline (2)3-Phenyl-1H-Pyrazol-5-Amine (11)3-Phenylisoxazol-5-Amine (8)4,6-Dichloropyrimidin-2-Amine (9)4-(Benzyloxy)Aniline (8)4-(Oxazol-5-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Trifluoromethoxy)Aniline (26)4-Amino-2-Chlorobenzonitrile (8)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorobenzoic Acid (6)4-Amino-3-Chlorophenol (5)4-Amino-N-Phenylbenzenesulfonamide (3)4-Aminopyridazin-3(2H)-One (4)4-Benzylaniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Iodoaniline (3)4-Chloro-3-Methylaniline (11)4-Chloro-N-Phenylaniline (6)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Fluoro-N-Phenylaniline (4)4-Fluoroaniline (225)4-Iodo-N,N-Diphenylaniline (3)4-Methoxy-N-Phenylaniline (5)4-Methyl-3-Nitroaniline (8)4-Methylpyrimidin-2-Amine (9)4-Methylthiazol-2-Amine (7)4-Morpholinoaniline (4)4-Nitroaniline (65)4-Phenoxyaniline (6)4-Phenylpyrimidin-2-Amine (15)4-Phenylthiazol-2-Amine (37)5-Bromopyrazin-2-Amine (13)5-Bromothiazol-2-Amine (6)5-Chloropyrazin-2-Amine (9)5-Methoxypyridin-3-Amine (4)5-Methyl-2-Nitroaniline (6)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Methylthiazol-2-Amine (6)5-Phenylthiophen-2-Amine (5)5H-Dibenzo[B,F]Azepine (4)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)6-Chloropyridazin-3-Amine (5)6-Chloropyrimidin-4-Amine (8)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylpyridin-2-Amine (46)6-Methylpyridin-3-Amine (5)6-Phenoxypyridin-3-Amine (5)7-Methoxy-N-Phenylquinazolin-4-Amine (12)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)9H-Purin-6-Amine (3)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-3-Amine (11)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Azetidin-3-Amine (4)Azetidin-3-Ylmethanamine (3)Aziridine (9)Benzo[B]Thiophen-2-Amine (5)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Thiazol-2-Amine (29)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Bis(Pyridin-2-Ylmethyl)Amine (6)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Cyclobutanamine (90)Cyclohexanamine (59)Cyclopent-2-En-1-Amine (4)Cyclopentanamine (5)Cyclopropyl(Phenyl)Methanamine (22)Diphenylmethanamine (26)Ethyl 2-Aminobenzoate (23)Ethyl 3-Aminobenzoate (19)Ethyl 4-Aminobenzoate (23)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Isoquinolin-1-Amine (18)Isoquinolin-3-Amine (13)Isoquinolin-4-Amine (16)Isoquinolin-5-Amine (9)Isoquinolin-8-Amine (6)Isoxazol-5-Amine (15)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 4-Aminobenzoate (71)Methyl L-Phenylalaninate (20)Morpholin-2-Ylmethanamine (8)N,N-Diethylaniline (17)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N,N-Dimethylaniline (117)N,N-Dimethylnaphthalen-1-Amine (4)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N,N-Dimethylpyrimidin-2-Amine (10)N,N-Dimethylpyrrolidin-3-Amine (7)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-(4-Aminophenyl)Benzamide (2)N-(Furan-2-Ylmethyl)Aniline (5)N-(Prop-2-Yn-1-Yl)-2,3-Dihydro-1H-Inden-1-Amine (3)N-Benzyl-1-Phenylethan-1-Amine (7)N-Benzyl-2-Phenylethan-1-Amine (1)N-Benzylpiperidin-4-Amine (3)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-1,2-Diphenylethan-1-Amine (7)N-Methyl-1-Phenylmethanamine (65)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)N-Methylaniline (140)N-Methylcyclohexanamine (7)N-Methylpiperidin-3-Amine (5)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Methylpyrrolidin-3-Amine (6)N-Phenyl-3-(Trifluoromethyl)Aniline (3)N-Phenyl-4-(Trifluoromethyl)Aniline (3)N-Phenylnaphthalen-1-Amine (5)N-Phenylpyridin-2-Amine (9)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N1,N1-Diphenylbenzene-1,4-Diamine (2)N1-Phenylbenzene-1,4-Diamine (3)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Naphthalen-2-Amine (12)O-Benzylhydroxylamine (16)Oxazol-2-Amine (8)Phenylmethanamine (315)Piperidin-2-Ylmethanamine (6)Piperidin-3-Amine (17)Piperidin-3-Ylmethanamine (5)Piperidin-4-Amine (14)Piperidin-4-Ylmethanamine (7)Pyrazin-2-Amine (22)Pyrazin-2-Ylmethanamine (12)Pyridazin-3-Amine (18)Pyridazin-4-Amine (10)Pyridin-2-Amine (29)Pyridin-2-Ylmethanamine (38)Pyridin-3-Amine (21)Pyridin-3-Ylmethanamine (29)Pyridin-4-Amine (22)Pyridin-4-Ylmethanamine (12)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-4-Amine (29)Pyrimidin-5-Amine (6)Pyrimidine-2,4-Diamine (14)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-3-Ylmethanamine (6)Quinazolin-2-Amine (13)Quinazolin-4-Amine (8)Quinoxalin-2-Amine (3)Tetrahydrofuran-3-Amine (6)Thiazol-2-Ylmethanamine (5)Thiazol-5-Amine (6)Thiophen-3-Amine (18)Tri([1,1'-Biphenyl]-4-Yl)Amine (9)
Anhydrides (659)
Dianhydride (3)1H,3H-Benzo[De]Isochromene-1,3-Dione (8)Furan-2,5-Dione (8)
Aryls (187653)
Acetylbenzonitrile (3)Aminobenzyl (7)Benzylamine (21)Benzylamino (47)Benzylhydroxylamine (25)Benzylidene (16)Benzylidene (16)Benzyloxy (1061)Benzylthio (16)Benzylthio (16)Cyanobenzyl (12)Dibenzyl (15)Dibenzylamino (7)Dichlorobenzylidene (8)Difluorobenzyl (17)Dimethoxybenzyl (20)Dimethoxybenzyl (20)Dimethylbenzonitrile (25)Dimethylbenzyl (6)Dimethylbenzyl (6)Dimethylbenzylamine (6)Ethoxybenzyl (8)Ethoxybenzyl (8)Fluorobenzyl (132)Fluorobenzylidene (2)Formylbenzonitrile (35)Iodobenzyl (9)Isopropylbenzonitrile (4)Methoxybenzyl (176)Methoxybenzylamine (7)Methoxybenzylidene (6)Methylbenzonitrile (104)Methylbenzyl (73)Methylbenzyl (73)Methylbenzylamine (8)Methylbenzylidene (1)Methylbenzylidene (1)Nitrobenzyl (33)Nitrobenzylidene (2)Phenoxybenzonitrile (5)Trifluorobenzyl (2)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(8S,9S,14R)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-Tetradecahydro-3H-Cyclopenta[A]Phenanthren-3-One (1)(9H-Fluoren-9-Yl)Methyl (2-(Tritylthio)Ethyl)Carbamate (10)(9H-Fluoren-9-Yl)Methyl Cyclohexylcarbamate (8)(Benzylsulfonyl)Benzene (11)(Cyclopentyloxy)Benzene (12)1,1-Dimethylcyclopropane (5)1,3,4,5-Tetrahydro-2H-Benzo[B]Azepin-2-One (15)1,3-Diphenylurea (24)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-Benzyl-4-Chlorobenzene (6)1-Benzyl-4-Fluorobenzene (2)1-Bromonaphthalene (4)1-Chloronaphthalene (24)1-Fluoronaphthalene (23)1-Methoxynaphthalene (17)1-Methyl-4-(Phenylethynyl)Benzene (7)1-Methylnaphthalene (10)1-Naphthaldehyde (23)1-Naphthoic Acid (23)1-Nitronaphthalene (3)10H-Phenothiazine (20)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,5-Diphenylthiophene (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-Benzylaniline (5)2-Bromo-1,1'-Biphenyl (12)2-Bromonaphthalene (4)2-Chloro-1,1'-Biphenyl (8)2-Chloronaphthalene (6)2-Ethoxynaphthalene (4)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Iodonaphthalene (5)2-Methoxy-1,1'-Biphenyl (7)2-Methoxynaphthalene (22)2-Methoxytetrahydro-2H-Pyran (9)2-Methyl-1,1'-Biphenyl (26)2-Methylnaphthalene (13)2-Naphthaldehyde (12)2-Naphthoic Acid (14)2-Naphthonitrile (15)2-Nitronaphthalene (4)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)2-Phenylnaphthalene (12)3,3'-Diphenyl-5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (13)3,3-Diphenyl-3H-Benzo[C][1,2]Oxathiole 1,1-Dioxide (19)3-Bromo-1,1'-Biphenyl (12)3-Chloro-1,1'-Biphenyl (12)3-Fluoro-1,1'-Biphenyl (16)3-Methyl-1,1'-Biphenyl (10)3-Methyl-1,1':4',1''-Terphenyl (3)3-Phenethylphenol (5)3-Phenyl-1,2,4,5-Tetrazine (9)3-Styrylphenol (11)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Phenylsulfonyl)Morpholine (14)4-(Tert-Butyl)-1,1'-Biphenyl (5)4-Cyclohexylphenol (7)4-Iodo-1,1'-Biphenyl (9)4-Methoxy-1,1'-Biphenyl (4)9H-Xanthene (7)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-2-Ol (16)[1,1'-Biphenyl]-3-Amine (11)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-3-Carboxylic Acid (39)[1,1'-Biphenyl]-3-Ol (9)[1,1'-Biphenyl]-4-Carbaldehyde (31)[1,1'-Biphenyl]-4-Carbonitrile (27)[1,1'-Biphenyl]-4-Ol (28)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzyltriphenylphosphonium (14)Cyclopentylbenzene (28)Cyclopropanecarboxylic Acid (11)Cyclopropyl(Phenyl)Methanamine (22)Cyclopropyl(Phenyl)Methanone (13)Diphenyl Phosphonate (11)Diphenylphosphane (25)Diphenylphosphine Oxide (27)Ethane-1,1-Diyldibenzene (3)Ethene-1,1,2-Triyltribenzene (13)Ethyl Cyclopropanecarboxylate (8)Methyl 1-Naphthoate (7)Methyl 2-Naphthoate (11)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Cyclopropanecarboxylate (8)N,1-Diphenylmethanimine (15)N,N-Dimethylnaphthalen-1-Amine (4)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-2-Phenylacetamide (5)N-Benzylbenzamide (21)N-Benzylbenzenesulfonamide (17)N-Cyclopropylbenzamide (14)N-Cyclopropylbenzenesulfonamide (10)N-Phenethylbenzamide (9)N-Phenyl-2-Naphthamide (11)Naphthalen-1-Ol (28)Naphthalen-1-Ylboronic Acid (4)Naphthalen-1-Ylmethanol (8)Naphthalen-2-Amine (12)Naphthalen-2-Ol (25)Naphthalen-2-Ylboronic Acid (8)Naphthalene-1,4-Diol (3)Naphthalene-2-Sulfonic Acid (4)Propane-2,2-Diyldibenzene (17)Tert-Butyl Cyclopropylcarbamate (7)Tetrahydro-2H-Pyran-2-Ol (12)Tetrahydro-2H-Pyran-2-Yl Acetate (12)Tetraphenylmethane (16)Triphenylene (12)Vinylcyclopropane (8)
Azides (42)
Azoes (112)
(E)-1-(Naphthalen-1-Yl)-2-Phenyldiazene (7)1,2-Diphenyldiazene (7)3-(Phenyldiazenyl)Benzoic Acid (7)
Benzene Compounds (19035)
Acetamidophenoxy (1)Acetamidophenyl (5)Acetylbenzoate (7)Acetylphenyl (13)Acetylphenyl (13)Acetylphenylboronic (3)Aminobenzoyl (4)Aminobiphenyl (4)Aminonaphthalene (14)Aminophenoxy (19)Aminophenyl (239)Anisole (4)Anthracenes (142)Benzaldehyde (1601)Benzamidophenyl (1)Benzenedimethanol (4)Benzenethiol (8)Benzhydrylazetidine (10)Benzhydrylazetidine (10)Benzhydryloxy (4)Benzhydryloxy (4)Benziodoxol (2)Benzodioxole (5)Benzoquinone (6)Benzoquinone (6)Benzoylbenzoate (4)Benzoylphenyl (4)Binaphthalene (123)Binaphthalene (123)Biphenyl (1393)Boronophenyl (1)Boronophenyl (1)Bromobenzo (104)Bromobenzoyl (6)Bromodibenzo (9)Bromophenoxy (34)Bromophenyl (989)Butoxyphenyl (8)Butylaniline (7)Butylbenzene (16)Butyldiphenylsilyl (7)Butylphenol (20)Butylphenyl (32)Butylphenyl (32)Carbamoylphenoxy (12)Carbamoylphenyl (8)Carboxyphenyl (17)Carboxyphenyl (17)Chlorobenzenesulfonyl (23)Chlorobenzoyl (9)Chlorodibenzo (18)Chloronaphthalene (36)Chlorophenethyl (7)Chlorophenoxy (44)Chlorophenylacetate (4)Chlorophenylacetate Acid (9)Chlorophenylboronic (5)Cyclopropylaniline (6)Cyclopropylbenzoate (5)Cyclopropylnaphthalen (10)Cyclopropylnaphthalen (10)Cyclopropylphenyl (12)Cyclopropylphenyl (12)Diaminobenzene (7)Dibenzaldehyde (19)Dibenzene (7)Dibenzimidamide (5)Dibenzo (108)Dibenzo (108)Dibenzoate (9)Dibenzonitrile (11)Dibromobenzene (45)Dibromobenzo (14)Dibromodibenzo (8)Dibromonaphthalene (15)Dibromophenanthrene (3)Dibromophenoxy (2)Dibromophenylboronic (3)Dichlorobenzene (38)Dichlorobenzoyl (4)Dichlorophenoxy (16)Dichlorophenyl (345)Dichlorophenylboronic (5)Didehydrodibenz (2)Didehydrodibenz (2)Diethoxyphenyl (10)Diethylaniline (6)Diethylbenzamide (7)Diethylbenzene (6)Diethylbenzene (6)Difluorobenzene (57)Difluorobenzo (12)Difluorobenzoyl (9)Difluorophenoxy (9)Difluorophenyl (403)Difluorophenylboronic (11)Dihydroanthracene (1)Dihydroanthracene (1)Dihydrobenzo (189)Dihydrobenzo (189)Dihydrodibenzo (7)Dihydronaphthalene (104)Dihydronaphthalene (104)Diiodobenzene (12)Diisopropylaniline (5)Diisopropylbenzamide (8)Diisopropylphenyl (40)Diisopropylphenyl (40)Dimesityl (12)Dimesityl (12)Dimethoxyacetophenone (5)Dimethoxyaniline (20)Dimethoxybenzaldehyde (40)Dimethoxybenzamide (6)Dimethoxybenzene (47)Dimethoxybenzo (4)Dimethoxybenzo (4)Dimethoxybenzoate (20)Dimethoxybenzohydrazide (3)Dimethoxybenzonitrile (11)Dimethoxybenzoyl (4)Dimethoxybiphenyl (3)Dimethoxybiphenyl (3)Dimethoxynaphthalene (10)Dimethoxynaphthalene (10)Dimethoxyphenol (22)Dimethoxyphenyl (257)Dimethoxyphenylboronic (17)Dimethoxyphenylboronic (17)Dimethoxystyryl (4)Dimethylaminophenyl (4)Dimethylanthracene (4)Dimethylbenzaldehyde (27)Dimethylbenzamide (37)Dimethylbenzene (334)Dimethylbenzene (334)Dimethylbenzenesulfonamide (16)Dimethylbenzo (21)Dimethylbenzo (21)Dimethylbenzoate (27)Dimethylbenzoyl (3)Dimethylbenzoyl (3)Dimethylnaphthalene (6)Dimethylphenol (36)Dimethylphenoxy (13)Dimethylphenoxy (13)Dimethylphenylboronic (6)Dimethylphenylboronic (6)Dimethylphenylhydrazine (3)Dimethylphenylisothiocyanate (4)Dinaphtho (5)Dinitrobenzene (20)Diphenol (32)Diphenylamino (27)Diphenylaniline (9)Diphenylethane (19)Diphenylethanone (5)Diphenylethene (6)Diphenylethyl (7)Diphenylethyl (7)Diphenylmethyl (8)Diphenylmethyl (8)Diphenylmethylene (6)Diphenylphosphine (204)Diphenylphosphine (204)Diphenylpropane (22)Diphenylsilane (2)Diphenylurea (4)Diphenylurea (4)Ethoxyaniline (10)Ethoxybenzaldehyde (9)Ethoxybenzoate (12)Ethoxybenzonitrile (6)Ethoxyphenoxy (7)Ethoxyphenoxy (7)Ethoxyphenyl (46)Ethoxyphenyl (46)Ethoxyphenylboronic (7)Ethylaniline (8)Ethylaniline (8)Ethylbenzenesulfonamide (338)Ethylbenzo (7)Ethylbenzo (7)Ethylbenzoate (9)Ethylphenol (12)Ethylphenyl (39)Ethylphenyl (39)Ethynylaniline (7)Ethynylbenzaldehyde (17)Ethynylphenyl (35)Fluorobenzeneboronic (24)Fluoronaphthalene (34)Fluorophenoxy (46)Formylbenzoate (39)Formylphenoxy (4)Formylphenoxy (4)Formylphenyl (43)Formylphenyl (43)Formylphenylboronic (9)Formylphenylboronic (9)Hexahydrobenzo (3)Hexahydrobenzo (3)Hexylphenyl (3)Hexylphenyl (3)Homophenylalanine (18)Hydroxybenzenesulfonate (5)Hydroxybenzimidamide (11)Hydroxyisophthalaldehyde (6)Hydroxyphenethyl (2)Hydroxyphenethyl (2)Hydroxyphenyl (461)Hydroxyphenyl (461)Iodobenzo (15)Iodobenzoic (54)Iodobenzoyl (7)Iodobiphenyl (24)Iododibenzo (7)Iodonaphthalene (9)Iodophenoxy (6)Isobutoxyphenyl (15)Isobutoxyphenyl (15)Isobutylbenzene (5)Isobutylbenzene (5)Isobutylphenyl (9)Isophthalate (8)Isophthalonitrile (4)Isopropoxyaniline (10)Isopropoxyaniline (10)Isopropoxybenzaldehyde (7)Isopropoxybenzoate (7)Isopropoxyphenyl (41)Isopropoxyphenyl (41)Isopropylaniline (18)Isopropylbenzaldehyde (6)Isopropylbenzamide (9)Isopropylbenzenesulfonamide (19)Isopropylbenzoate (8)Isopropylphenyl (58)Mercaptobenzo (21)Methanobenzo (15)Methanobenzo (15)Methoxyacetophenone (12)Methoxyaniline (74)Methoxybenzaldehyde (104)Methoxybenzene (1749)Methoxybenzene (1749)Methoxybenzenesulfonamide (6)Methoxybenzenesulfonic (3)Methoxybenzenesulfonyl (13)Methoxybenzenesulfonyl (13)Methoxybenzimidamide (5)Methoxybenzo (52)Methoxybenzo (52)Methoxybenzoate (116)Methoxybenzonitrile (67)Methoxybenzoyl (12)Methoxybenzoyl (12)Methoxycarbonylphenylboronic (5)Methoxynaphthalene (56)Methoxynaphthalene (56)Methoxyphenethyl (1)Methoxyphenethyl (1)Methoxyphenol (72)Methoxyphenoxy (41)Methoxyphenoxy (41)Methoxyphenylacetate (4)Methoxyphenylboronic (24)Methoxyphenylboronic (24)Methoxyphenylhydrazine (4)Methoxystyryl (13)Methylacetophenone (6)Methylaniline (183)Methylanisole (3)Methylanthracene (5)Methylbenzaldehyde (101)Methylbenzamide (90)Methylbenzamido (3)Methylbenzenesulfinamide (4)Methylbenzenesulfonamide (81)Methylbenzenesulfonic (9)Methylbenzenesulfonyl (4)Methylbenzenesulfonyl (4)Methylbenzimidamide (6)Methylbenzoate (193)Methylbenzohydrazide (7)Methylbenzothioamide (6)Methylbenzothioamide (6)Methylbenzotrifluoride (5)Methylbenzoyl (24)Methylbenzoyl (24)Methylnaphthalene (34)Methylnaphthalene (34)Methylphenol (107)Methylphenoxy (18)Methylphenoxy (18)Methylphenyl (529)Methylphenylacetonitrile (45)Methylphenylboronic (24)Methylphenylhydrazine (10)Methylpropiophenone (5)Methylpropiophenone (5)Naphthaldehyde (28)Naphthalene (465)Naphthalene (465)Naphthaleneboronic (15)Naphthalenesulfonic (7)Naphthamide (15)Naphthonitrile (18)Nitrobenzenesulfonyl (8)Nitrobenzo (54)Nitrobenzoyl (13)Nitronaphthalene (24)Nitrophenoxy (43)Nitrophenyl (727)Nitrophenylboronic (14)Nitrotoluene (27)Octylbenzene (11)Octylbenzene (11)Paracyclophane (2)Paracyclophane (2)Pentafluorobenzene (13)Pentylbenzene (5)Pentylbenzene (5)Pentylbenzoate (2)Pentylphenol (4)Pentylphenyl (5)Pentylphenyl (5)Perfluorophenoxy (5)Perfluorophenyl (31)Phenoxyacetate (5)Phenoxyaniline (8)Phenoxybenzaldehyde (5)Phenoxybenzoate (5)Phenoxyethyl (6)Phenoxyethyl (6)Phenoxymethyl (7)Phenoxymethyl (7)Phenoxyphenyl (61)Phenoxyphenyl (61)Phenoxypropan (4)Phenylacetamide (34)Phenylacetonitrile (8)Phenylacetyl (2)Phenylacetyl (2)Phenylacrylamide (3)Phenylalaninol (4)Phenylamino (31)Phenylaniline (19)Phenylanthracene (16)Phenylbenzamide (23)Phenylbenzenesulfonamide (3)Phenylbutanoate (12)Phenylbutoxy (2)Phenylbutoxy (2)Phenylcarbamoyl (4)Phenylcyclohexanone (6)Phenylcyclopropanecarboxylic (6)Phenylcyclopropyl (7)Phenylcyclopropyl (7)Phenyldiazenyl (4)Phenylene (169)Phenylene (169)Phenylenediamine (13)Phenylenedimethanamine (5)Phenylethanamine (12)Phenylethane (14)Phenylethane (14)Phenylethanol (10)Phenylethanone (20)Phenylethoxy (2)Phenylethyl (70)Phenylethyl (70)Phenylethylisocyanate (2)Phenylhex (3)Phenylimino (1)Phenylisocyanate (9)Phenylisoserine (4)Phenylmethanesulfonyl (2)Phenylmethanesulfonyl (2)Phenylmethanone (2)Phenylmethoxy (4)Phenylmethoxy (4)Phenylmethyl (8)Phenylmethyl (8)Phenylnaphthalene (6)Phenylpentan (11)Phenylpentan (11)Phenylpropanamide (15)Phenylpropyl (20)Phenylpyrazolo (8)Phenylsulfinyl (3)Phenylsulfinyl (3)Phenylsulfonyl (88)Phenylsulfonyl (88)Phenylthio (24)Phenylthio (24)Phenylthiophene (23)Phenylthiophene (23)Phenylthiourea (6)Phenylurea (3)Phenylurea (3)Phenylvinyl (9)Phthalate (23)Phthalimide (12)Phthalonitrile (9)Propoxybenzaldehyde (4)Propoxyphenyl (29)Propoxyphenyl (29)Propoxyphenylboronic (79)Propylphenyl (26)Propylphenyl (26)Pyrenes (52)Quaternaphthalene (6)Quaterphenyl (15)Quaterphenyl (15)Styryl (12)Sulfamoylphenyl (3)Sulfophenyl (4)Sulfophenyl (4)Terephthalaldehyde (11)Terephthalate (13)Terphenyl (239)Terphenyl (239)Tetraaniline (6)Tetrabenzaldehyde (7)Tetrafluorobenzene (17)Tetrahydrobenzo (70)Tetrahydrobenzo (70)Tetrahydronaphthalene (149)Tetrahydronaphthalene (149)Tetralone (12)Tetramethylbenzene (9)Tetramethylbenzene (9)Tetramethylbiphenyl (57)Tetramethylbiphenyl (57)Tetraphenyl (11)Tetraphenyl (11)Toluenesulfonyl (68)Tolyl (418)Tolyl (418)Tolylamino (3)Tolylazanediyl (4)Tolylazanediyl (4)Tolylethynyl (3)Tolyloxy (19)Tolyloxy (19)Tolylphosphine (8)Tolylphosphine (8)Tolylthio (3)Tolylthio (3)Trianiline (7)Tribenzaldehyde (5)Tribromobenzene (7)Trichlorobenzene (20)Trichlorophenoxy (3)Trichlorophenylboronic (6)Triethylbenzene (5)Trifluorophenyl (56)Trifluorophenylboronic (154)Triiodobenzene (5)Triisopropylbenzene (9)Triisopropylphenyl (6)Triisopropylphenyl (6)Trimethoxybenzene (43)Trimethoxystyryl (5)Trimethylaniline (18)Trimethylbenzene (28)Trimethylphenol (6)Trimethylphenyl (20)Trimethylphenyl (20)Trimethylpropiophenone (4)Triphenylphosphoranylidene (9)Triphenylphosphoranylidene (9)Triphenylvinyl (11)Trityl (19)Trityl (19)Tritylamino (2)Trityloxy (2)Tritylthio (3)Tritylthio (3)(((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Fluorophenyl)Propanoic Acid (3)(10Ar)-1,2,3,4,4A,9,10,10A-Octahydrophenanthrene (3)(1E,1'E)-N,N'-(Ethane-1,2-Diyl)Bis(1-Phenylmethanimine) (5)(1R,4R)-4-Phenyl-1,1'-Bi(Cyclohexane) (24)(9H-Fluoren-9-Yl)Methyl Benzylcarbamate (22)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(Cyclopentylmethyl)Benzene (5)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylmorpholine (7)(R)-4-Benzyloxazolidin-2-One (5)(R)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)(S)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)1,1':2',1''-Terphenyl (4)1,1':3',1''-Terphenyl (28)1,1':4',1'':4'',1'''-Quaterphenyl (7)1,1,2,2-Tetra([1,1'-Biphenyl]-4-Yl)Ethene (10)1,1-Dimethyl-1,2,3,4-Tetrahydronaphthalene (10)1,2,3,4-Tetrahydronaphthalen-1-Amine (36)1,2,3,4-Tetrahydronaphthalen-1-Ol (5)1,2,3,4-Tetrahydronaphthalene-1-Carboxylic Acid (3)1,2,3,5,6,7-Hexahydro-S-Indacene (23)1,2,4-Trimethylbenzene (41)1,2-Dihydroacenaphthylene (6)1,2-Dinitrobenzene (6)1,3,5-Tris(Phenylethynyl)Benzene (6)1,3,6,8-Tetraphenylpyrene (10)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dihydro-2H-Inden-2-One (6)1,3-Diphenoxypropane (6)1,3-Diphenyl-1H-Pyrazole (6)1,3-Diphenylpropane (7)1,3-Diphenylpropane-1,3-Dione (4)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-Benzylazetidine (6)1-Bromopyrene (4)1-Cyclohexyl-4-(Phenylethynyl)Benzene (10)1-Cyclopropylnaphthalene (6)1-Phenyl-1H-Tetrazole (6)1-Phenylnaphthalene (12)1-Trityl-1H-Pyrazole (5)1H-Indene (19)1H-Indene-1,3(2H)-Dione (5)2,2 ', 3,3' - Tetrahydro-1,1 '- Spiro [Indene] (5)2,3,4,5-Tetrahydro-1H-Benzo[C]Azepine (7)2,3-Dihydro-1H-Inden-1-Amine (52)2,3-Dihydro-1H-Inden-1-Ol (13)2,3-Dihydro-1H-Inden-4-Amine (6)2,3-Dihydro-1H-Inden-4-Ol (6)2,3-Dihydro-1H-Indene-1-Carboxylic Acid (5)2,3-Dihydro-1H-Indene-4-Carbonitrile (4)2,4-Diphenyl-1,3,5-Triazine (6)2,5-Diphenyl-1,3,4-Oxadiazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(2-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (24)2-(2-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (21)2-(2-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (29)2-(3-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (14)2-(3-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (19)2-(3-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (30)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (17)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (20)2-(4-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (15)2-(4-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Methyl-2,3-Dihydro-1H-Inden-1-One (9)2-Phenyl-1,3,5-Triazine (6)2-Phenyl-1,3-Dioxane (7)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenylisoindoline-1,3-Dione (7)2H-Benzo[B][1,4]Thiazin-3(4H)-One (6)3,3-Dimethyl-2,3-Dihydro-1H-Inden-1-One (5)3,4-Dihydro-2H-Benzo[B][1,4]Dioxepine (7)3,5,6,7-Tetrahydro-S-Indacen-1(2H)-One (5)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Chlorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-(Trifluoromethyl)Phenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Fluorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Methoxyphenyl)Propanoic Acid (4)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(O-Tolyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(P-Tolyl)Propanoic Acid (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (19)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoic Acid (12)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (13)3-Methyl-2,3-Dihydro-1H-Inden-1-One (4)3-Phenyl-1H-Pyrrole (5)3-Phenylazetidine (5)3-Phenyloxazolidin-2-One (4)3-Phenylpiperidine (6)4',5'-Diphenyl-1,1':2',1''-Terphenyl (7)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(3-Nitrophenyl)-1,3,2-Dioxaborolane (24)4,4,5,5-Tetramethyl-2-(M-Tolyl)-1,3,2-Dioxaborolane (21)4,4,5,5-Tetramethyl-2-(O-Tolyl)-1,3,2-Dioxaborolane (24)4,5-Diphenyloxazole (7)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-Bromo-2,3-Dihydro-1H-Inden-1-One (5)4-Bromo-2,3-Dihydro-1H-Indene (10)4-Chloro-2,3-Dihydro-1H-Inden-1-One (8)4-Chloro-2,3-Dihydro-1H-Indene (5)4-Cyclohexyl-1,1'-Biphenyl (18)4-Fluoro-2,3-Dihydro-1H-Inden-1-One (6)4-Fluoro-2,3-Dihydro-1H-Indene (14)4-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)4-Methyl-2,3-Dihydro-1H-Inden-1-One (8)4-Methyl-2,3-Dihydro-1H-Indene (3)4-Phenyl-1,1'-Bi(Cyclohexane) (8)4-Phenyl-4H-1,2,4-Triazole (6)5''-([1,1'-Biphenyl]-4-Yl)-1,1':4',1'':3'',1''':4''',1''''-Quinquephenyl (5)5',5''-Diphenyl-1,1':3',1'':3'',1'''-Quaterphenyl (8)5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (6)5,6,7,8-Tetrahydronaphthalen-2-Ol (5)5-Bromo-1,2,3,4-Tetrahydronaphthalene (6)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Methoxy-1,2,3,4-Tetrahydronaphthalene (3)5-Methoxy-2,3-Dihydro-1H-Indene (2)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Phenyl-1H-Imidazole (6)5-Phenylcyclohexane-1,3-Dione (6)6,7,8,9-Tetrahydro-5H-Benzo[7]Annulen-5-One (6)6-Bromo-1,2,3,4-Tetrahydronaphthalene (9)6-Bromo-2,3-Dihydro-1H-Inden-1-One (8)6-Bromo-3,4-Dihydronaphthalen-1(2H)-One (3)6-Chloro-1,2,3,4-Tetrahydronaphthalene (3)6-Chloro-2,3-Dihydro-1H-Inden-1-One (5)6-Fluoro-1,2,3,4-Tetrahydronaphthalene (6)6-Fluoro-2,3-Dihydro-1H-Inden-1-One (4)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methyl-1,2,3,4-Tetrahydronaphthalene (5)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)6-Methyl-3,4-Dihydronaphthalen-1(2H)-One (2)7-Bromo-2,3-Dihydro-1H-Inden-1-One (13)7-Chloro-2,3-Dihydro-1H-Inden-1-One (9)7-Fluoro-2,3-Dihydro-1H-Inden-1-One (8)7-Hydroxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methyl-2,3-Dihydro-1H-Inden-1-One (7)9,10-Bis(Phenylethynyl)Anthracene (5)9,10-Diphenylanthracene (16)9-Methylanthracene (4)9-Phenylxanthylium (7)9H-Fluoren-9-One (17)[1,1'-Binaphthalen]-2-Amine (3)[1,1':4',1''-Terphenyl]-4,4''-Dicarbaldehyde (9)Benzenesulfinic Acid (6)Benzil (17)Benzo-18-Crown-6 (7)Benzo[Lmn][3,8]Phenanthroline-1,3,6,8(2H,7H)-Tetraone (10)Benzyl ((Benzyloxy)Carbonyl)Glycinate (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Phenylpropanoate (8)Benzyl Piperidin-4-Ylcarbamate (7)Bicyclo[4.2.0]Octa-1,3,5-Triene (13)Cumene (181)Dibenzyl Phosphonate (6)Diphenylmethanimine (9)Ethane-1,1,2-Triyltribenzene (5)Ethylbenzene (198)Mesitylene (71)Methyl 2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (14)Methyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (11)N,2-Diphenylacetamide (7)N,N,N-Trimethyl-1-Phenylmethanaminium (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-Benzyl-2-Phenylethan-1-Amine (1)N-Benzylcyclopropanamine (6)N-Phenylcinnamamide (16)N1,N1,N4,N4-Tetraphenylbenzene-1,4-Diamine (6)N4,N4,N4',N4'-Tetraphenyl-[1,1'-Biphenyl]-4,4'-Diamine (7)Phenanthrene (23)Phenanthrene-9,10-Dione (8)Phenethyldiphenylphosphane (6)Phenothiazin-5-Ium (6)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl 4-Cyclohexylbenzoate (8)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butylbenzene (251)Triphenyl Phosphate (6)
Benzyl Bromides (1065)
1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Bromomethyl)-3-Methoxybenzene (19)1-Bromo-2-(Bromomethyl)Benzene (34)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-(Bromomethyl)Benzonitrile (15)Methyl 2-(Bromomethyl)Benzoate (33)
Benzyl Chlorides (646)
Dichlorobenzyl (39)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)
Bromides (52859)
Bromoacetyl (14)Bromoaniline (2)Bromoanthracene (5)Bromoanthracene (5)Bromobenzaldehyde (15)Bromobenzamide (7)Bromobenzimidamide (6)Bromobenzyl (36)Bromobut (2)Bromobut (2)Bromobutoxy (4)Bromobutoxy (4)Bromobutyl (6)Bromobutyl (6)Bromochroman (26)Bromochroman (26)Bromocyclopropanecarboxylate (1)Bromoethoxy (22)Bromoethoxy (22)Bromoethyl (86)Bromoethyl (86)Bromoethynyl (6)Bromohexyl (11)Bromohexyl (11)Bromomethyl (760)Bromonicotinaldehyde (5)Bromonicotinamide (5)Bromooctyl (3)Bromopentyl (8)Bromopentyl (8)Bromopropane (10)Bromopropane (10)Bromopropoxy (6)Bromopropoxy (6)Bromopropyl (25)Bromopropyl (25)Bromothiochroman (4)Bromothiochroman (4)Bromovinyl (2)Dibromo (698)Dibromo (698)Dibromoanthracene (3)Dibromoanthracene (3)Dibromobenzaldehyde (8)Dibromobenzonitrile (8)Dibromomethyl (6)Dibromomethyl (6)Dibromopropoxy (1)Dibromopropoxy (1)Tetrabromo (10)Tetrabromo (10)Tribromo (9)Tribromo (9)(1-Bromoethyl)Benzene (11)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromoethyl)Benzene (33)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Bromophenyl)Boronic Acid (39)(2-Bromophenyl)Hydrazine (8)(2-Bromophenyl)Methanamine (12)(2-Bromophenyl)Methanol (39)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Bromopropyl)Benzene (10)(3-Bromopyridin-2-Yl)Methanol (7)(4-Bromophenyl)(Phenyl)Methanone (9)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(Bromoethynyl)Benzene (5)(Dibromomethyl)Benzene (6)1,2,3-Tribromobenzene (5)1,2,4-Tribromobenzene (13)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-3-Methylbenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dibromobenzene (64)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2,4-Dimethylbenzene (3)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dibromo-2-Iodobenzene (4)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dibromo-2-Methylbenzene (14)1,3-Dibromo-2-Nitrobenzene (4)1,4-Dibromo-2-Iodobenzene (3)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Bromophenyl)Ethan-1-One (27)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-4-Bromobenzene (8)1-(Bromomethyl)-2-Iodobenzene (9)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-2-Methylbenzene (14)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Bromomethyl)-3-Methylbenzene (11)1-Benzyl-3-Bromobenzene (7)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2,3-Dimethylbenzene (23)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-(Bromomethyl)Benzene (34)1-Bromo-2-(Difluoromethyl)Benzene (5)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-2-(Tert-Butyl)Benzene (7)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Ethylbenzene (13)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-2-Iodobenzene (65)1-Bromo-2-Isopropylbenzene (10)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-3-Cyclopropylbenzene (6)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-3-Iodobenzene (70)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Bromo-4-Iodobenzene (67)1-Bromo-4-Phenoxybenzene (8)1-Bromo-4-Styrylbenzene (5)1-Bromobicyclo[1.1.1]Pentane (3)1-Bromoisoquinoline (20)1-Bromonaphthalene (4)2,3-Dibromopyridine (21)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dibromoaniline (18)2,4-Dibromophenol (16)2,4-Dibromopyridine (5)2,4-Dibromothiazole (5)2,5-Dibromopyrazine (4)2,5-Dibromopyridine (26)2,5-Dibromothiazole (5)2,5-Dibromothiophene (18)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromoaniline (17)2,6-Dibromobenzaldehyde (4)2,6-Dibromobenzonitrile (4)2,6-Dibromophenol (21)2,6-Dibromopyrazine (9)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Bromophenyl)Acetonitrile (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(Bromomethyl)Furan (3)2-(Bromomethyl)Pyridine (27)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Bromophenol (3)2-Amino-6-Bromophenol (3)2-Bromo-1,1'-Biphenyl (12)2-Bromo-1,3,4-Thiadiazole (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3,4-Trimethylbenzene (4)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,3-Dimethylbenzene (35)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1,4-Dimethylbenzene (22)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-1H-Benzo[D]Imidazole (4)2-Bromo-1H-Imidazole (13)2-Bromo-1H-Pyrrole (11)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylaniline (6)2-Bromo-3-Methylphenol (4)2-Bromo-3-Methylpyrazine (5)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-3-Nitropyridine (5)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-4-Methylaniline (14)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-4-Methylpyridine (6)2-Bromo-4-Methylthiazole (7)2-Bromo-4-Nitroaniline (12)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyrazine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Methylthiazole (7)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorobenzaldehyde (15)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Fluorobenzonitrile (7)2-Bromo-6-Fluorophenol (9)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylaniline (11)2-Bromo-6-Methylbenzoic Acid (5)2-Bromo-6-Methylphenol (7)2-Bromo-6-Methylpyrazine (5)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Bromo-6-Phenylpyridine (4)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Bromo-N-Phenylacetamide (5)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Bromobenzenesulfonyl Chloride (8)2-Bromobenzo[D]Thiazole (28)2-Bromodibenzo[B,D]Furan (6)2-Bromofuran (21)2-Bromoimidazo[1,2-A]Pyridine (5)2-Bromonaphthalene (4)2-Bromonicotinic Acid (5)2-Bromooxazole (7)2-Bromopyrazine (15)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Bromopyrimidine (22)2-Bromoquinazoline (4)3,4-Dibromoaniline (4)3,4-Dibromophenol (3)3,5-Dibromopyridine (12)3-(Bromomethyl)Pyridine (18)3-Bromo-1,1'-Biphenyl (12)3-Bromo-1,5-Naphthyridine (8)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoroaniline (15)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Fluorophenol (5)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Fluorobenzamide (3)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Fluorophenol (11)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methoxybenzaldehyde (9)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylaniline (14)3-Bromo-4-Methylbenzoic Acid (9)3-Bromo-4-Methylpyridine (13)3-Bromo-5'-Phenyl-1,1':3',1''-Terphenyl (4)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromoaniline (187)3-Bromoazetidine (3)3-Bromobenzene-1,2-Diamine (11)3-Bromobenzene-1,2-Diol (8)3-Bromobenzo[B]Thiophene (5)3-Bromobenzoic Acid (159)3-Bromobenzonitrile (110)3-Bromofuran (13)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Bromoisoquinoline (10)3-Bromoisoxazole (7)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Bromopyridazine (25)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Bromopyrrolidine (6)3-Bromothiophene (6)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Bromomethyl)Pyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Benzo[D]Imidazole (14)4-Bromo-1H-Indole (25)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Iodoaniline (8)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-(Trifluoromethyl)Aniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Methylpyridine (5)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Bromobenzo[C][1,2,5]Thiadiazole (14)4-Bromobenzo[D][1,3]Dioxole (6)4-Bromobenzo[D]Thiazole (9)4-Bromobenzofuran (3)4-Bromoindoline (4)4-Bromoisoindolin-1-One (3)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Bromopyridazine (5)4-Bromopyridine (31)4-Bromopyrimidine (24)4-Bromothiazole (10)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Bromo-1-Methyl-1H-Indole (4)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Bromo-1H-Benzo[D]Imidazole (13)5-Bromo-1H-Indazole (14)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Bromo-2,3-Dihydrobenzofuran (6)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Methylpyrimidine (5)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromobenzo[B]Thiophene (3)5-Bromobenzo[D][1,3]Dioxole (12)5-Bromobenzo[D]Oxazole (3)5-Bromoimidazo[1,2-A]Pyridine (6)5-Bromoindoline (8)5-Bromoisoindolin-1-One (8)5-Bromoisoquinoline (17)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyrazin-2-Ol (5)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Bromoquinoxaline (6)5-Bromothiazole (8)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indazole (23)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)6-Bromobenzo[B]Thiophene (4)6-Bromobenzo[D]Oxazole (3)6-Bromobenzo[D]Thiazole (7)6-Bromochroman-4-One (6)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Bromoindoline-2,3-Dione (4)6-Bromoisoindolin-1-One (4)6-Bromoisoquinoline (9)6-Bromonicotinaldehyde (11)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Bromoquinazoline (7)6-Bromoquinoxaline (9)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Bromo-1H-Indazole (18)7-Bromo-1H-Indole (28)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromobenzo[B]Thiophene (5)7-Bromobenzo[D]Thiazole (8)7-Bromobenzofuran (6)7-Bromochromane (7)7-Bromoindoline (3)7-Bromoisoquinoline (6)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)8-Bromochromane (6)8-Bromoimidazo[1,2-A]Pyridine (15)8-Bromoisoquinoline (17)8-Bromoquinazoline (8)9-Bromoanthracene (5)Bromocyclohexane (7)Ethyl 2-Bromo-2-Phenylacetate (6)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopicolinate (9)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 6-Bromonicotinate (6)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)
Carbamates (7957)
Carboxylic Acid Salts (668)
Carboxylic Acids (58191)
Aceticacid (1249)Acetylbenzoic Acid (3)Acrylic (95)Aminobenzoic (7)Aminobutanoic (8)Aminoheptanoic (6)Aminohexanoic (10)Aminonicotinic Acid (4)Aminopentanoic (8)Aminophenylacetic Acid (22)Aminopropanoic (11)Aminoundecanoic Acid (4)Benzenedicarboxylic (6)Benzenedicarboxylic Acid (6)Benzylpropanoic Acid (75)Benzylsuccinic Acid (6)Boronobenzoic (4)Bromobutanoic (5)Bromododecanoate (3)Bromoisonicotinic Acid (4)Bromonicotinic (8)Bromonicotinic Acid (9)Bromophenylacetic Acid (15)Bromovalerate (4)Butanoic (124)Chlorobenzoic (35)Chloromandelic Acid (3)Chromene-Carboxylic Acid (1)Cyanonicotinic (5)Cyanonicotinic Acid (3)Diacetic (19)Diacetic (19)Diaminobenzoic (7)Diaminobutanoic (5)Diaminohexanoic (4)Dibenzoic (40)Dibromobenzoic (10)Dibromobenzoic Acid (10)Dibromonicotinic Acid (7)Dicarboxylic (183)Dicarboxylic (183)Dichlorobenzoic (21)Dichlorobenzoic Acid (22)Dichloroisonicotinic (6)Dichloroisonicotinic Acid (6)Dichlorophenylacetic Acid (4)Dienoate (14)Dienoic (10)Difluorobenzoic (54)Difluorobutanoic (3)Difluoroisonicotinic Acid (7)Difluorophenylacetic (7)Difluorophenylacetic Acid (7)Diiodobenzoic (5)Diisophthalic (17)Diisophthalic Acid (9)Diisopropylbenzoic Acid (4)Dimethoxybenzoic (33)Dimethoxyphenylacetic Acid (3)Dimethylbenzoic (32)Dimethylbutanoic (13)Dimethylbutanoic (13)Dimethylpropanoic (5)Diphenylpropanoic (8)Diyldimethanol (17)Enedioic (8)Enoic (127)Ethoxybenzoic (9)Ethylbenzoic (11)Ethylbenzoic Acid (12)Ethynylbenzoic (6)Ethynylbenzoic Acid (5)Fluoroisophthalic Acid (4)Fluorophenylacetic (10)Fluorophenylacetic Acid (11)Fluorophthalic (5)Fluorophthalic Acid (3)Fluoropicolinic (12)Formylbenzoic (22)Formylbenzoic Acid (19)Guanidinopentanoic (8)Heptanoic (6)Heptanoic (6)Hexacarboxylic Acid (5)Hexanoic (25)Hexanoic (25)Hydrazinylbenzoic (6)Hydrazinylbenzoic Acid (5)Hydroxynicotinic (15)Indolecarboxylic (2)Isophthalic (29)Isophthalic Acid (15)Isopropoxybenzoic (8)Isopropoxybenzoic Acid (7)Isopropylbenzoic (13)Isopropylnicotinic Acid (4)Malonate (39)Mercaptobenzoic (6)Mercaptobenzoic Acid (4)Mercaptopropanoic (11)Methoxybenzoic (142)Methoxybutanoic (4)Methoxybutanoic (4)Methoxyisophthalic Acid (5)Methoxyphenylacetic (10)Methoxyphenylacetic Acid (11)Methoxypropanoic (7)Methoxypropanoic (7)Methylbenzoic (175)Methylbutanoic (32)Methylbutanoic (32)Methylcinnamic Acid (9)Methylhexanoic (8)Methylhexanoic (8)Methylisophthalic Acid (17)Methylnicotinic (46)Methyloctanoic (6)Methylpentanoic (108)Methylpentanoic (108)Methylpropanoic (57)Naphthoic (64)Nitrobenzoic (161)Nitroisonicotinic Acid (5)Nitroisophthalic Acid (3)Nitronicotinic (10)Nitropicolinic (11)Octanoic (6)Octanoic (6)Oxoacetic (22)Oxobutanoic (57)Oxobutanoic (57)Oxodecanoic (5)Oxodecanoic (5)Oxododecanoic (9)Oxododecanoic (9)Oxoheptanoic (5)Oxoheptanoic (5)Oxoheptanoic Acid (4)Oxohexadecanoic (13)Oxohexadecanoic (13)Oxohexanoic (10)Oxohexanoic (10)Oxooctadecanoic (7)Oxooctadecanoic (7)Oxopentanoic (37)Oxopentanoic (37)Oxopropanoic (8)Pentanedioic (18)Pentanedioic (18)Pentanoic (27)Phenoxybenzoic (5)Phenylacetic (35)Phenylbutanoic (47)Phenylpentanoic (11)Phenylpropanoic (45)Propanoic (1167)Propenoic (6)Pyridazinecarboxylic (1)Succinic (13)Sulfamoylbenzoic (15)Sulfobenzoic (5)Terephthalic (7)Tetraacetic (5)Tetrabenzoic (13)Tetrabenzoic Acid (14)Tetracarboxylic (13)Tribenzoic (15)Tribenzoic Acid (14)Tricarboxylic (18)Trichlorobenzoic (5)Trichlorobenzoic Acid (4)Trifluorobenzoic (12)Trifluorobenzoic Acid (11)Trifluorobutanoic (3)Trifluoromethylbenzoic (5)Trifluoromethylbenzoic Acid (4)Trifluoropentanoic (4)Trifluorophenylacetic Acid (16)Trifluoropropanoic (4)Triiodobenzoic (4)Trimethylbenzoic Acid (4)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,5-Naphthyridine-3-Carboxylic Acid (6)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Naphthoic Acid (23)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropane-1-Carboxylic Acid (23)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carboxylic Acid (4)1H-Indazole-3-Carboxylic Acid (27)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)1H-Indole-3-Carboxylic Acid (32)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carboxylic Acid (7)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,3-Difluorobenzoic Acid (35)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)2,4-Difluorobenzoic Acid (29)2,5-Dichlorobenzoic Acid (13)2,5-Difluorobenzoic Acid (32)2,6-Dichlorobenzoic Acid (13)2,6-Difluorobenzoic Acid (33)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(2-Methoxyphenyl)Acetic Acid (16)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Hydroxyphenyl)Acetic Acid (7)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-Chlorophenoxy)Acetic Acid (3)2-(4-Fluorophenyl)Acetic Acid (30)2-(4-Methoxyphenyl)Acetic Acid (19)2-(4-Nitrophenyl)Acetic Acid (9)2-(Benzofuran-3-Yl)Acetic Acid (3)2-(M-Tolyl)Acetic Acid (16)2-(Morpholin-2-Yl)Acetic Acid (5)2-(O-Tolyl)Acetic Acid (17)2-(P-Tolyl)Acetic Acid (9)2-(Phenylamino)Benzoic Acid (11)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethyl)Benzoic Acid (33)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (16)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-6-Chlorobenzoic Acid (5)2-Benzoylbenzoic Acid (10)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Methylbenzoic Acid (5)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-6-Fluorobenzoic Acid (8)2-Chlorobenzoic Acid (130)2-Cyclohexylacetic Acid (14)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluorobenzoic Acid (220)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Iodobenzoic Acid (47)2-Methoxyisonicotinic Acid (13)2-Methyl-2-Phenylpropanoic Acid (20)2-Methyl-3-Nitrobenzoic Acid (7)2-Naphthoic Acid (14)2-Nitrobenzoic Acid (65)2-Oxo-2-Phenylacetic Acid (17)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2-Phenoxypropanoic Acid (13)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-(3-Chlorophenyl)Propanoic Acid (11)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Benzoic Acid (5)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Methylsulfonyl)Benzoic Acid (6)3-(Phenyldiazenyl)Benzoic Acid (7)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethyl)Benzoic Acid (52)3-Benzamidopropanoic Acid (3)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylbenzoic Acid (9)3-Bromobenzoic Acid (159)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Methoxybenzoic Acid (5)3-Chlorobenzoic Acid (144)3-Fluoro-4-Methoxybenzoic Acid (6)3-Fluorobenzoic Acid (206)3-Fluoropicolinic Acid (6)3-Iodobenzoic Acid (55)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methylpicolinic Acid (13)3-Nitrobenzoic Acid (109)3-Phenoxybenzoic Acid (6)3-Phenoxypropanoic Acid (14)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(Benzyloxy)Benzoic Acid (5)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Trifluoromethyl)Nicotinic Acid (3)4-Amino-3-Chlorobenzoic Acid (6)4-Benzamidobenzoic Acid (3)4-Cyclohexylbenzoic Acid (6)4-Fluoro-3-Iodobenzoic Acid (5)4-Fluorobenzoic Acid (114)4-Methylnicotinic Acid (5)4-Morpholinobenzoic Acid (5)4-Nitrobenzoic Acid (35)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Oxo-4-(Phenylamino)Butanoic Acid (7)4-Oxo-4-Phenylbutanoic Acid (16)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenoxybenzoic Acid (4)4-Phenylbutanoic Acid (19)5'-(4-Carboxyphenyl)-[1,1':3',1''-Terphenyl]-4,4''-Dicarboxylic Acid (7)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)5-Phenylfuran-2-Carboxylic Acid (6)5-Phenylisoxazole-3-Carboxylic Acid (15)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)6-Methoxypicolinic Acid (9)6-Methylnicotinic Acid (6)6-Methylpicolinic Acid (12)6-Oxopiperidine-2-Carboxylic Acid (3)6-Phenylpicolinic Acid (3)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-3-Carboxylic Acid (39)Azetidine-2-Carboxylic Acid (6)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[D]Thiazole-6-Carboxylic Acid (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-3-Carboxylic Acid (6)Benzoic Acid (3519)Benzoylglycine (15)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Cyclobutanecarboxylic Acid (23)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanecarboxylic Acid (83)Cyclopentanecarboxylic Acid (26)Cyclopropanecarboxylic Acid (11)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Furan-2-Carboxylic Acid (31)Furan-3-Carboxylic Acid (11)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Indoline-2-Carboxylic Acid (3)Isonicotinic Acid (23)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-6-Carboxylic Acid (3)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl Benzofuran-2-Carboxylate (6)Methyl Isoquinoline-3-Carboxylate (3)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Nicotinic Acid (53)Oxazole-4-Carboxylic Acid (4)Picolinic Acid (22)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (11)Proline (13)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Pyridazine-3-Carboxylic Acid (7)Pyridine-2,6-Dicarboxylic Acid (9)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carboxylic Acid (7)Pyrrolidine-3-Carboxylic Acid (14)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Carboxylic Acid (4)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carboxylic Acid (10)Thiophene-3-Carboxylic Acid (8)Tryptophan (21)
Chlorides (77875)
Chloroacetamide (17)Chloroacetyl (12)Chloroaniline (18)Chlorobenzaldehyde (18)Chlorobenzamide (12)Chlorobutyl (6)Chlorobutyl (6)Chlorocarbonyl (7)Chloroethoxy (10)Chloroethoxy (10)Chloroethyl (89)Chloromethyl (479)Chloropicolinaldehyde (8)Chloropicolinamide (5)Chloropropane (18)Chloropropane (18)Chloropropoxy (2)Chloropropoxy (2)Chloropropyl (23)Dichloride (28)Dichloroaniline (9)Dichloroanthracene (3)Dichlorobenzaldehyde (13)Dichlorobenzamide (8)Dichloroisonicotinaldehyde (4)Dichloromethyl (3)Dichloromethyl (3)Dichloronicotinaldehyde (6)Dichloronicotinic (6)Dichloronicotinic (6)Dichloronicotinic Acid (5)Dichloropalladium (4)Dichloropalladium (4)Tetrachloro (2)Tetrachloro (2)Trichloro (36)Trichloro (36)Trichloroacetimidate (5)Trichloroaniline (6)Trichlorobenzaldehyde (4)Trichloromethyl (11)Trichloromethyl (11)(2,3-Dichlorophenyl)Boronic Acid (11)(2,6-Dichlorophenyl)Boronic Acid (6)(2-Chloroethoxy)Benzene (5)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Chlorophenyl)Hydrazine (16)(2-Chlorophenyl)Methanamine (28)(2-Chlorophenyl)Methanol (39)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3,4-Dichlorophenyl)Boronic Acid (10)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Chlorophenyl)Boronic Acid (121)(3-Chlorophenyl)Hydrazine (12)(3-Chlorophenyl)Methanamine (19)(3-Chlorophenyl)Methanol (38)(3-Chloropyridin-2-Yl)Methanamine (6)(4-Chlorophenyl)(Phenyl)Methanone (10)(5-Chloropyridin-2-Yl)Methanamine (5)(Chloromethanetriyl)Tribenzene (7)(Chloromethylene)Dibenzene (5)1,2,3,4-Tetrachlorobenzene (8)1,2,4-Trichlorobenzene (26)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-3-Methylbenzene (8)1,2-Dichloro-4-Fluorobenzene (15)1,2-Dichloro-4-Methoxybenzene (11)1,2-Dichloro-4-Nitrobenzene (16)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dichloro-2-Fluorobenzene (23)1,3-Dichloro-2-Iodobenzene (5)1,3-Dichloro-2-Methoxybenzene (9)1,3-Dichloro-2-Nitrobenzene (5)1,3-Dichloroisoquinoline (14)1,4-Dichloro-2-Fluorobenzene (11)1,4-Dichloro-2-Methoxybenzene (8)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Chlorophenyl)Piperazine (4)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Chloromethyl)-2-Methylbenzene (7)1-Benzyl-2-Chlorobenzene (9)1-Benzyl-3-Chlorobenzene (3)1-Benzyl-4-Chlorobenzene (6)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-(Chloromethyl)Benzene (12)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-2-Cyclopropylbenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Iodobenzene (65)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3,5-Dimethylbenzene (8)1-Chloro-3-(Chloromethyl)Benzene (7)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Nitrobenzene (161)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Chloro-4-Iodobenzene (49)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Chloroanthracene-9,10-Dione (6)1-Chloroisoquinoline (20)1-Chloronaphthalene (24)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dichloroaniline (18)2,3-Dichlorobenzaldehyde (7)2,3-Dichlorophenol (9)2,3-Dichloropyridine (38)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyridine (5)2,4,6-Trichloropyrimidine (14)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dichloro-1-Fluorobenzene (27)2,4-Dichloro-1-Methoxybenzene (18)2,4-Dichloro-1-Nitrobenzene (19)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichlorobenzaldehyde (8)2,4-Dichlorobenzonitrile (4)2,4-Dichloropyridine (50)2,4-Dichloroquinazoline (19)2,4-Dichlorothiazole (4)2,5-Dichlorophenol (7)2,5-Dichloropyrazine (4)2,5-Dichloropyridine (32)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloroaniline (27)2,6-Dichlorobenzoic Acid (13)2,6-Dichlorobenzonitrile (8)2,6-Dichloronicotinonitrile (8)2,6-Dichlorophenol (16)2,6-Dichloropyrazine (14)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(2-Chlorophenyl)Pyridine (3)2-(2-Chlorophenyl)Pyrrolidine (17)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Chlorophenyl)Acetonitrile (16)2-(4-Chlorophenoxy)Acetic Acid (3)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Furan (3)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Chloromethyl)Pyrimidine (5)2-(Chloromethyl)Thiazole (5)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Chloro-1,1'-Biphenyl (8)2-Chloro-1,3,5-Triazine (10)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-1-Phenylethan-1-One (20)2-Chloro-1H-Benzo[D]Imidazole (17)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylaniline (4)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-3-Methylpyrazine (7)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Methylaniline (7)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-4-Methylpyridine (31)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Methylthiazole (5)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Methoxyaniline (8)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Methylthiazole (5)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorophenol (5)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodophenol (3)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylaniline (11)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylphenol (5)2-Chloro-6-Methylpyrazine (12)2-Chloro-6-Methylpyridine (49)2-Chloro-6-Nitroaniline (11)2-Chloro-7H-Purine (3)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloro-9H-Purine (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylaniline (7)2-Chloroaniline (214)2-Chlorobenzamide (16)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,3-Diol (4)2-Chlorobenzene-1,4-Diamine (6)2-Chlorobenzenesulfonyl Chloride (24)2-Chlorobenzenethiol (7)2-Chlorobenzo[D]Oxazole (11)2-Chlorobenzo[D]Thiazole (21)2-Chlorobenzoic Acid (130)2-Chlorobenzonitrile (99)2-Chlorobenzoyl Chloride (13)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chlorofuran (3)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronaphthalene (6)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chlorooxazole (7)2-Chlorophenol (163)2-Chloropyrazine (24)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Chloroquinoxaline (39)2-Chlorothiazole (32)2-Chlorothiophene (20)3,4-Dichloroaniline (21)3,5-Dichloropyridine (16)3,6-Dichloropyridazine (20)3-(3-Chlorophenyl)Propanoic Acid (11)3-(Chloromethyl)Pyridine (22)3-Chloro-1,1'-Biphenyl (12)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Chloro-1-Phenylpropan-1-One (10)3-Chloro-1H-Indazole (13)3-Chloro-2-Fluoroaniline (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Fluorobenzonitrile (7)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylaniline (11)3-Chloro-2-Methylpyridine (4)3-Chloro-2-Nitroaniline (5)3-Chloro-4-(Trifluoromethyl)Aniline (5)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chloro-4-Methylaniline (12)3-Chloro-4-Methylpyridazine (7)3-Chloro-4-Nitroaniline (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloro-9H-Carbazole (3)3-Chlorobenzaldehyde (106)3-Chlorobenzene-1,2-Diamine (6)3-Chlorobenzene-1,2-Diol (6)3-Chlorobenzenesulfonyl Chloride (21)3-Chlorobenzo[B]Thiophene (6)3-Chlorobenzoic Acid (144)3-Chlorobenzonitrile (100)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloroisoquinoline (20)3-Chlorophenol (112)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridazine (44)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Chlorothiophene (17)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,6-Dichloropyrimidine (14)4-Chloro-1,5-Naphthyridine (6)4-Chloro-1-Phenylbutan-1-One (8)4-Chloro-1H-Indazole (18)4-Chloro-1H-Indole (21)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Methylaniline (11)4-Chloro-3-Methylpyridine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-N-Phenylaniline (6)4-Chlorobenzene-1,3-Diol (6)4-Chlorobenzenesulfonic Acid (4)4-Chlorobenzenesulfonyl Chloride (12)4-Chlorobenzo[D]Thiazole (7)4-Chloroindoline-2,3-Dione (6)4-Chloroisoquinoline (11)4-Chloronicotinic Acid (4)4-Chloropyridazine (16)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Chloroquinazoline (39)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5,6-Dichloropyridin-2-Amine (4)5-Bromo-4-Chloropyrimidine (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Chloro-1H-Imidazole (2)5-Chloro-1H-Indazole (9)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chlorobenzo[B]Thiophene (4)5-Chlorobenzo[D]Oxazole (5)5-Chlorobenzo[D]Thiazole (5)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloroindolin-2-One (3)5-Chloroisoquinoline (6)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Chloropyrimidine (8)5-Chloroquinazoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Chloro-1H-Benzo[D]Imidazole (25)6-Chloro-1H-Indazole (14)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-2,3-Dihydrobenzofuran (3)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chlorobenzo[D]Oxazole (4)6-Chlorobenzo[D]Thiazole (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Chloroquinoxaline (3)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Chloro-1H-Indazole (7)7-Chloro-1H-Indole (29)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Chloro-2,3-Dihydrobenzofuran (3)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Chlorobenzo[D]Thiazole (6)7-Chlorochromane (5)7-Chloroisoquinoline (6)7-Chloropyrazolo[1,5-A]Pyrimidine (8)8-Chlorochromane (5)8-Chloroimidazo[1,2-A]Pyridine (7)8-Chloroisoquinoline (7)8-Chloroquinazoline (5)Ethyl 4,6-Dichloronicotinate (4)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloropicolinate (7)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 2,6-Dichlorobenzoate (7)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Chlorobenzoate (88)Methyl 3-Chloropicolinate (9)Methyl 6-Chloropicolinate (11)N-(2-Chlorophenyl)Acetamide (16)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(3-Chlorophenyl)Quinazolin-4-Amine (9)N-(4-Chlorophenyl)Acetamide (9)Phenyl Carbonochloridate (5)Pyridine-2-Sulfonyl Chloride (9)Pyridine-3-Sulfonyl Chloride (25)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)
Diazoes (3)
Difluoromethyls (32566)
(Difluoromethyl)Benzene (63)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-(Difluoromethyl)-2-Fluorobenzene (13)1-Bromo-2-(Difluoromethyl)Benzene (5)2-(Difluoromethoxy)Phenol (5)2-(Difluoromethyl)Pyridine (21)3-(Difluoromethyl)Pyridine (5)4-(Difluoromethoxy)Aniline (6)5-(Difluoromethyl)-1H-Pyrazole (6)
Esters (51168)
Acetoxymethyl (85)Acetoxyphenyl (1)Acetyloxy (53)Acrylate (118)Acryloyloxy (3)Adipate (17)Adipate (17)Amino-Carboxylate (2)Aminobenzoate (18)Aminobenzylcarbamate (8)Aminobutanoate (14)Aminocyclobutanecarboxylic Acid (4)Aminocyclohexanecarboxylic (16)Aminocyclohexanecarboxylic Acid (10)Aminocyclopentanecarboxylic (13)Aminoheptanoate (9)Aminohexanoate (6)Aminoisonicotinate (4)Aminoisophthalate (5)Aminonicotinate (7)Aminopentanedioate (15)Aminopentanoate (7)Aminopropanoate (16)Benzoyloxy (14)Benzylcarbamate (8)Bromobenzoate (26)Bromobutanoate (9)Bromocyclopropanecarboxylate (1)Bromodecanoate (20)Bromoisonicotinate (8)Bromoisophthalate (3)Bromonicotinate (13)Bromopropanoate (9)Bromoundecanoate (3)Butoxycarbonyl (1675)Butoxycarbonyl (1675)Carbamate (1539)Chlorobenzoate (49)Chloroformate (4)Chloropicolinate (30)Chloropropanoate (5)Cyanoacrylate (6)Decanedioate (9)Decanedioate (9)Decanoate (7)Decanoate (7)Diacetate (56)Diacetoxy (1)Diacrylate (15)Diaminobenzoate (7)Dibromobenzoate (4)Dicarbamate (14)Dichlorobenzoate (24)Dichloroisonicotinate (9)Dimethacrylate (1)Dimethylbutanoate (14)Dimethylcarbamate (3)Dimethylnicotinate (10)Dimethylnicotinate (10)Dipropanoate (6)Dipropanoate (6)Diyldicarbamate (5)Dodecanoate (11)Enecarboxylate (9)Enoate (116)Ethoxycarbonyl (70)Ethylbutanoate (6)Ethynylbenzoate (7)Ethynylbenzylcarbamate (3)Glutarate (3)Glutarate (3)Hexanoate (14)Hexanoate (14)Indoline-Carboxylate (1)Iodoacrylate (6)Iodobutanoate (4)Iodopropanoate (1)Isobutyrate (18)Isobutyrate (18)Methacrylate (87)Methacryloyloxy (7)Methoxycarbonyl (169)Methoxycarbonyl (169)Methoxyisonicotinate (11)Methoxyisonicotinate (11)Methoxynicotinate (24)Methoxynicotinate (24)Methoxypropanoate (5)Methoxypropanoate (5)Methylacrylate (13)Methylbutanoate (38)Methylmalonate (6)Methylnicotinate (57)Methylpentanoate (17)Methylpropanoate (47)Nitropicolinate (13)Nonanedioate (4)Nonanedioate (4)Oxoacetate (21)Oxoacetate (21)Oxobutanoate (56)Oxobutanoate (56)Oxoheptanoate (8)Oxoheptanoate (8)Oxohexanoate (14)Oxohexanoate (14)Oxopentanoate (31)Oxopropanoate (39)Oxopropanoate (39)Pentanoate (13)Pentanoate (13)Phenylacrylate (5)Phenylpropanoate (42)Propanoate (296)Propylpentanoate (5)Propylpentanoate (5)Succinate (23)Succinate (23)Sulfamoylbenzoate (6)Tetraacetate (7)Tetraacetate (7)Tetradecanoate (10)Tetradecanoate (10)Thiophenecarboxylate (2)Tosylcarbamate (4)Tosyloxy (12)Triacetate (12)Triacetate (12)Vinylbenzoate (3)Vinylcyclopropanecarboxylic Acid (3)(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1H-Indol-3-Yl Acetate (4)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Diethylamino)Ethyl Benzoate (3)2-Ethylhexyl Benzoate (13)2-Hydroxyethyl Benzoate (3)2-Phenoxyacetyl Chloride (3)4-Cyanophenyl Benzoate (11)Allyl Benzoate (5)Azetidin-3-Yl Acetate (3)Benzoic Anhydride (6)Benzyl Acetate (11)Benzyl Benzoate (12)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Morpholine-4-Carboxylate (5)Benzyl Phenylcarbamate (15)Benzyl Piperidine-1-Carboxylate (50)Butyl Benzoate (10)Dimethyl Isophthalate (32)Dimethyl Phthalate (14)Dimethyl Pyridine-2,6-Dicarboxylate (7)Ethane-1,2-Diyl Dibenzoate (11)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Aminobenzoate (23)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Bromo-2-Phenylacetate (6)Ethyl 2-Fluorobenzoate (37)Ethyl 2-Hydroxybenzoate (18)Ethyl 2-Iodobenzoate (4)Ethyl 2-Methylbenzoate (26)Ethyl 2-Methylnicotinate (6)Ethyl 2-Nitrobenzoate (9)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Ethyl 2-Phenoxyacetate (10)Ethyl 2-Phenylacetate (60)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Ethyl 3-Aminobenzoate (19)Ethyl 3-Fluorobenzoate (34)Ethyl 3-Hydroxybenzoate (12)Ethyl 3-Iodobenzoate (11)Ethyl 3-Nitrobenzoate (22)Ethyl 3-Oxo-3-Phenylpropanoate (41)Ethyl 3-Phenylpropanoate (17)Ethyl 4-Aminobenzoate (23)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Ethyl Cinnamate (26)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Ethyl Cyclopropanecarboxylate (8)Ethyl Furan-2-Carboxylate (6)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Ethyl Isonicotinate (12)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Ethyl Nicotinate (25)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Ethyl Oxirane-2-Carboxylate (4)Ethyl Picolinate (41)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Ethyl Pyrazine-2-Carboxylate (10)Ethyl Pyridazine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Ethyl Quinazoline-2-Carboxylate (4)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Hexyl Benzoate (5)Isobutyl Benzoate (10)Isopropyl Benzoate (10)Methyl 1-Naphthoate (7)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Methyl 2,6-Dichlorobenzoate (7)Methyl 2,6-Difluorobenzoate (17)Methyl 2-(1H-Indol-3-Yl)Acetate (3)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-(Bromomethyl)Benzoate (33)Methyl 2-(Chlorosulfonyl)Benzoate (7)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Cyanobenzoate (22)Methyl 2-Fluorobenzoate (132)Methyl 2-Hydroxybenzoate (74)Methyl 2-Iodobenzoate (28)Methyl 2-Methoxybenzoate (70)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Methyl 2-Methylbenzoate (101)Methyl 2-Naphthoate (11)Methyl 2-Nitrobenzoate (54)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 2-Phenylacetate (114)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-(Trifluoromethyl)Benzoate (22)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 3-Chlorobenzoate (88)Methyl 3-Cyanobenzoate (29)Methyl 3-Fluorobenzoate (136)Methyl 3-Formylbenzoate (23)Methyl 3-Hydroxybenzoate (58)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 3-Methoxybenzoate (70)Methyl 3-Methylbenzoate (75)Methyl 3-Nitrobenzoate (109)Methyl 3-Oxo-3-Phenylpropanoate (16)Methyl 3-Phenylpropanoate (28)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 4-Amino-3-Iodobenzoate (7)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Aminobenzoate (71)Methyl 4-Fluorobenzoate (75)Methyl 4-Nitrobenzoate (29)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl 4-Phenoxybenzoate (3)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 5-Hydroxypicolinate (5)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl 5-Phenylisoxazole-3-Carboxylate (6)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl 6-Methoxynicotinate (4)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Azetidine-2-Carboxylate (3)Methyl Benzo[B]Thiophene-2-Carboxylate (27)Methyl Benzo[D]Oxazole-2-Carboxylate (3)Methyl Benzo[D]Thiazole-6-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cinnamate (36)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)Methyl Cyclopropanecarboxylate (8)Methyl Furan-2-Carboxylate (20)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Methyl Indoline-6-Carboxylate (3)Methyl Isonicotinate (16)Methyl Isoquinoline-4-Carboxylate (6)Methyl L-Phenylalaninate (20)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Methyl Nicotinate (52)Methyl Oxazole-4-Carboxylate (9)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)Methyl Prolinate (43)Methyl Pyrazine-2-Carboxylate (19)Methyl Pyridazine-3-Carboxylate (7)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)Methyl Pyrrolidine-3-Carboxylate (9)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)Methyl Thiophene-3-Carboxylate (34)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Propyl Benzoate (11)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (5)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)Tert-Butyl 1H-Indazole-1-Carboxylate (29)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Azetidine-1-Carboxylate (64)Tert-Butyl Benzoate (66)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclopentylcarbamate (28)Tert-Butyl Isoindoline-2-Carboxylate (13)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl Morpholine-4-Carboxylate (23)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl Piperazine-1-Carboxylate (30)Tert-Butyl Pyrrolidine-1-Carboxylate (21)
Ethers (82526)
Butoxy-Phenyl-Boronic Acid/Ester (76)Diethoxy (14)Diethoxy (14)Diethoxyethyl (9)Diethoxyethyl (9)Diethoxymethyl (8)Diethoxymethyl (8)Dimethoxyethyl (8)Dimethoxypropane (11)Dimethoxypropane (11)Dioxane (153)Dioxepine (7)Dioxepine (7)Disulfide (38)Methoxyphenylboronic-Acid (32)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Benzyloxy)Phenyl)Boronic Acid (23)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloroethoxy)Benzene (5)(2-Methoxyethoxy)Benzene (32)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Phenoxyphenyl)Methanol (3)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-Methoxyphenyl)(Phenyl)Methanone (7)(9H-Fluoren-9-Yl)Methyl (2-(Benzyloxy)Ethyl)Carbamate (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Allyloxy)Benzene (19)(Ethoxymethyl)Benzene (7)(Hexyloxy)Benzene (7)(Methoxymethyl)Benzene (30)(Prop-2-Yn-1-Yloxy)Benzene (13)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)1,2-Bis(Benzyloxy)Benzene (11)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-4-Methoxybenzene (11)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-4-Methoxybenzene (19)1,2-Dimethoxybenzene (223)1,2-Diphenoxyethane (11)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dichloro-2-Methoxybenzene (9)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Dimethoxybenzene (235)1,3-Diphenoxybenzene (8)1,4-Dichloro-2-Methoxybenzene (8)1,4-Dimethoxybenzene (66)1-(2-Methoxyphenyl)Ethan-1-One (33)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-2-Methoxybenzene (19)1-(Benzyloxy)-2-Methylbenzene (12)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Benzyloxy)-3-Methylbenzene (8)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Benzyloxy)-4-Bromobenzene (8)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-3-Methoxybenzene (19)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-Benzyl-4-Methoxybenzene (8)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-Phenoxybenzene (8)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Phenoxybenzene (8)1-Iodo-2-Methoxybenzene (50)1-Iodo-3-Methoxybenzene (48)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-(Phenoxymethyl)Benzene (3)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methoxy-4-Nitrobenzene (90)1-Methoxynaphthalene (17)1-Methyl-3-Phenoxybenzene (9)1-Nitro-2-Phenoxybenzene (4)1-Nitro-4-Phenoxybenzene (5)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)2,3,5,6,8,9,11,12-Octahydrobenzo[B][1,4,7,10,13]Pentaoxacyclopentadecine (8)2,3-Dimethoxypyridine (7)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dichloro-1-Methoxybenzene (18)2,4-Difluoro-1-Methoxybenzene (25)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethoxypyrimidine (13)2,6-Dimethoxypyridine (11)2-(2-Methoxyphenyl)Acetic Acid (16)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(4-Methoxyphenyl)Acetic Acid (19)2-(Benzyloxy)Benzaldehyde (13)2-(Benzyloxy)Naphthalene (5)2-(Benzyloxy)Phenol (5)2-(Methoxymethyl)Morpholine (4)2-(Methoxymethyl)Pyrrolidine (6)2-(Phenoxymethyl)Oxirane (13)2-(Phenoxymethyl)Pyridine (5)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-3-Methoxypyrazine (5)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-5-Methoxyaniline (8)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Ethoxynaphthalene (4)2-Ethoxypyridine (20)2-Ethoxypyrimidine (7)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-6-Methoxypyridine (6)2-Isopropoxypyridine (16)2-Methoxy-1,1'-Biphenyl (7)2-Methoxy-1,3,5-Triazine (10)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-Methylpyridine (5)2-Methoxy-6-Methylpyridine (14)2-Methoxy-6-Nitrophenol (5)2-Methoxybenzamide (9)2-Methoxybenzenesulfonyl Chloride (15)2-Methoxynaphthalene (22)2-Methoxyphenol (197)2-Methoxypyrazine (45)2-Methoxypyridine (436)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methoxythiophene (7)2-Methyl-N-Phenylaniline (6)2-Phenoxyacetonitrile (11)2-Phenoxyaniline (4)2-Phenoxybenzonitrile (5)2-Phenoxyethan-1-Ol (14)2-Phenoxypropanoic Acid (13)2-Phenoxypyrimidine (8)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxythiazole (5)2-Propoxypyridine (9)3,5-Dimethoxypyridine (4)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Aniline (12)3-(Benzyloxy)Benzaldehyde (13)3-(Benzyloxy)Benzoic Acid (5)3-(Benzyloxy)Phenol (5)3-(Methoxymethyl)Morpholine (4)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methoxybenzaldehyde (7)3-Chloro-4-Methoxybenzoic Acid (5)3-Ethoxypyridine (12)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-4-Methoxybenzoic Acid (6)3-Methoxypiperidine (7)3-Methoxypyridazine (17)3-Methoxypyridine (52)3-Methoxythiophene (9)3-Phenoxyaniline (2)3-Phenoxybenzaldehyde (7)3-Phenoxybenzoic Acid (6)3-Phenoxybenzonitrile (5)3-Phenoxypropanoic Acid (14)3-Phenoxypyrrolidine (5)4-(3-Phenoxypropyl)Morpholine (7)4-(Benzyloxy)Aniline (8)4-(Benzyloxy)Benzaldehyde (23)4-(Benzyloxy)Benzoic Acid (5)4-(Benzyloxy)Phenol (2)4-(Difluoromethoxy)Aniline (6)4-(Dimethoxymethyl)Pyrimidine (5)4-(Phenylethynyl)Phenol (7)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-6-Methoxypyrimidine (5)4-Ethoxypyridine (7)4-Ethoxypyrimidine (6)4-Methoxy-1,1'-Biphenyl (4)4-Methoxy-1H-Indazole (7)4-Methoxy-1H-Indole (11)4-Methoxy-2-Methylpyrimidine (8)4-Methoxy-N-Phenylaniline (5)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methoxypyridazine (8)4-Methoxypyridine (136)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Phenoxyaniline (6)4-Phenoxybenzaldehyde (12)4-Phenoxybenzoic Acid (4)4-Phenoxypyridine (7)4-Phenoxypyrimidine (5)4-Phenoxyquinoline (5)4-Phenoxytetrahydro-2H-Pyran (5)5-(Benzyloxy)Pyrimidine (5)5-Fluoro-2-Methoxypyridine (15)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methoxy-1H-Indazole (5)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methoxy-2-Nitroaniline (7)5-Methoxyindoline (4)5-Methoxyisobenzofuran-1(3H)-One (5)5-Methoxyisoquinoline (6)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1H-Indazole (14)6-Methoxy-1H-Indole (12)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)6-Methoxybenzo[D]Thiazole (6)6-Methoxybenzofuran (4)6-Methoxychromane (5)6-Methoxyisoindolin-1-One (3)6-Methoxyquinoxaline (6)7-(Benzyloxy)Quinoline (6)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Methoxy-1H-Indazole (5)7-Methoxy-1H-Indole (8)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)7-Methoxyisoquinoline (5)8-Methoxyisoquinoline (7)8-Methoxyquinazoline (3)Butoxybenzene (51)Ethoxybenzene (285)Ethyl 2-Phenoxyacetate (10)Isobutoxybenzene (22)Isopropoxybenzene (85)Methoxycyclohexane (7)Methyl 2-Methoxybenzoate (70)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-Methoxybenzoate (70)Methyl 4-Phenoxybenzoate (3)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(4-Phenoxyphenyl)Acetamide (4)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)Phenethoxybenzene (23)Propoxybenzene (63)Tert-Butoxybenzene (19)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)
Fluorinated Building Blocks (99063)
Dichlorofluorobenzene (23)Difluoro (901)Difluoroaniline (37)Difluorobenzaldehyde (33)Difluorobenzamide (6)Difluorobenzenesulfonamide (5)Difluorobenzoate (59)Difluoroethyl (27)Difluoroethyl (27)Difluoromethoxy (200)Difluoromethoxy (200)Difluoropropan (7)Difluoropropan (7)Fluindamine (32)Fluoroacetanilide (5)Fluoroacetophenone (8)Fluoroaniline (65)Fluoroanisole (9)Fluorobenzaldehyde (69)Fluorobenzamide (28)Fluorobenzenesulfonamide (7)Fluorobenzenethiol (6)Fluorobenzylamine (10)Fluorobromobenzene (3)Fluorocinnamic (10)Fluorocinnamic (10)Fluorocinnamic Acid (9)Fluorocyclopropanecarboxylic (9)Fluoroethoxy (4)Fluoroethyl (8)Fluoroethyl (8)Fluoroindan (3)Fluoroindan (3)Fluoroisonicotinaldehyde (7)Fluoroisonicotinate (8)Fluoroisonicotinic (13)Fluoroisonicotinic Acid (13)Fluoromethyl (15)Fluoromethyl (15)Fluoronicotinaldehyde (20)Fluoronicotinamide (3)Fluoronicotinic (19)Fluoronicotinic (19)Fluoronicotinic Acid (14)Fluorophenylisocyanate (3)Fluoropropan (15)Fluoropropan (15)Fluorostyryl (7)Fluorosulfonyl (12)Fluorosulfonyl (12)Hexafluoro (9)Hexafluoro (9)Hexafluoropropan (4)Hexafluoropropan (4)Nonafluoro (2)Nonafluoro (2)Octafluoro (2)Octafluoro (2)Pentafluoro (4)Pentafluorobenzoate (4)Tetrafluoro (12)Tetrafluoro (12)Tetrafluoroaniline (7)Tetrafluoroethoxy (3)Tetrafluoroethoxy (3)Trifluoro (271)Trifluoro (271)Trifluoroacetamide (8)Trifluoroacetyl (13)Trifluoroaniline (11)Trifluorobenzaldehyde (9)Trifluorobenzoate (14)Trifluorobut (36)Trifluorobut (36)Trifluoroethan (2)Trifluoroethan (2)Trifluoroethanamine (23)Trifluoroethanol (6)Trifluoroethoxy (60)Trifluoroethoxy (60)Trifluoroethyl (63)Trifluoromethanesulfonamide (4)Trifluoromethanesulfonyl (22)Trifluoromethoxy (480)Trifluoromethoxy (480)Trifluoromethylthio (5)Trifluoromethylthio (5)Trifluoropropane (36)Trifluoropropanoate (5)Trifluoropropyl (9)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Difluorophenyl)Boronic Acid (28)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Fluorophenyl)Boronic Acid (229)(2-Fluorophenyl)Hydrazine (22)(2-Fluorophenyl)Methanamine (49)(2-Fluorophenyl)Methanol (60)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Fluorophenyl)Boronic Acid (169)(3-Fluorophenyl)Methanol (58)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Fluorophenyl)Boronic Acid (93)(4-Fluorophenyl)Methanamine (27)(4-Fluorophenyl)Methanol (29)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,2,3,4,5-Pentafluorobenzene (51)1,2,3,4-Tetrafluorobenzene (73)1,2,3-Trifluorobenzene (156)1,2,4-Trifluorobenzene (210)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-4-Fluorobenzene (15)1,2-Difluoro-3-Iodobenzene (13)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-3-Methylbenzene (23)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Methoxybenzene (19)1,2-Difluoro-4-Nitrobenzene (43)1,2-Difluorobenzene (658)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dichloro-2-Fluorobenzene (23)1,3-Difluoro-2-Iodobenzene (12)1,3-Difluoro-2-Methylbenzene (18)1,3-Difluoro-2-Nitrobenzene (16)1,4-Dichloro-2-Fluorobenzene (11)1,4-Difluoro-2-Iodobenzene (8)1,4-Difluoro-2-Nitrobenzene (28)1,4-Difluorobenzene (361)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Fluorophenyl)Piperazine (8)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-Fluorophenyl)Ethan-1-One (63)1-(4-Fluorophenyl)Ethan-1-One (36)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)1-Benzyl-4-Fluorobenzene (2)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Cyclohexyl-2-Fluorobenzene (4)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethynyl-2-Fluorobenzene (10)1-Fluoro-2,3-Dimethylbenzene (8)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Methylbenzene (255)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3,5-Dimethylbenzene (12)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Methylbenzene (255)1-Fluoro-3-Nitrobenzene (216)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-Iodobenzene (65)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Methylbenzene (140)1-Fluoro-4-Phenoxybenzene (8)1-Fluorobicyclo[1.1.1]Pentane (4)1-Fluoronaphthalene (23)2'-Fluoro-1,1':4',1''-Terphenyl (6)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,3-Difluoroaniline (34)2,3-Difluorobenzaldehyde (18)2,3-Difluorobenzoic Acid (35)2,3-Difluorobenzonitrile (29)2,3-Difluorophenol (36)2,3-Difluoropyridine (13)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dichloro-1-Fluorobenzene (27)2,4-Difluoro-1-Iodobenzene (14)2,4-Difluoro-1-Methoxybenzene (25)2,4-Difluoro-1-Nitrobenzene (46)2,4-Difluoroaniline (44)2,4-Difluorobenzaldehyde (19)2,4-Difluorobenzoic Acid (29)2,4-Difluorobenzonitrile (21)2,4-Difluorophenol (21)2,5-Difluoroaniline (34)2,5-Difluorobenzoic Acid (32)2,5-Difluoropyridine (8)2,6-Difluoroaniline (23)2,6-Difluorobenzaldehyde (25)2,6-Difluorobenzoic Acid (33)2,6-Difluorobenzonitrile (28)2,6-Difluorophenol (24)2,6-Difluoropyridine (29)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Fluorophenyl)Acetonitrile (30)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Fluorophenyl)Pyrrolidine (5)2-(4-Fluorophenyl)-1H-Indole (4)2-(4-Fluorophenyl)Acetic Acid (30)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (16)2-Amino-3-Fluorobenzoic Acid (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorophenol (9)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-3-Fluoropyridine (20)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluorobenzaldehyde (10)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-4-Fluorophenol (9)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorobenzoic Acid (8)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-6-Fluorophenol (5)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1,3-Dimethylbenzene (14)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoro-N-Methylbenzamide (12)2-Fluoro-N-Phenylaniline (4)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluoroaniline (262)2-Fluorobenzaldehyde (175)2-Fluorobenzamide (32)2-Fluorobenzenesulfonamide (12)2-Fluorobenzenesulfonyl Chloride (31)2-Fluorobenzoic Acid (220)2-Fluoropyridine (15)2-Fluoropyrimidine (9)3,3-Difluoropiperidine (29)3,3-Difluoropyrrolidine (29)3,4-Difluoroaniline (44)3,4-Difluorophenol (19)3,5-Difluoropyridine (12)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-Chloro-2-Fluoroaniline (9)3-Fluoro-1,1'-Biphenyl (16)3-Fluoro-2-Iodoaniline (8)3-Fluoro-2-Methylaniline (9)3-Fluoro-2-Methylpyridine (15)3-Fluoro-4-Nitroaniline (7)3-Fluoroaniline (289)3-Fluorobenzaldehyde (137)3-Fluorobenzamide (26)3-Fluorobenzenesulfonyl Chloride (22)3-Fluorobenzoic Acid (206)3-Fluorophenol (180)3-Fluoropiperidine (26)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Fluorothiophene (6)4,4-Difluoropiperidine (5)4-(2-Fluorophenyl)Morpholine (8)4-(4-Fluorophenyl)Thiazole (9)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-1H-Indazole (22)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-2-Nitroaniline (14)4-Fluoroaniline (225)4-Fluorobenzaldehyde (78)4-Fluorobenzamide (19)4-Fluorobenzenesulfonyl Chloride (26)4-Fluorobenzo[D]Thiazole (6)4-Fluorobenzoic Acid (114)4-Fluorobenzonitrile (89)4-Fluoroisoquinoline (6)4-Fluorophenol (111)4-Fluoropyrimidine (8)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Fluoro-2-Methylpyridine (8)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochromane (6)5-Fluoroindoline (3)5-Fluoroisoindolin-1-One (3)5-Fluoropyridin-2-Amine (15)5-Fluoropyrimidine (11)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1H-Indazole (15)6-Fluoro-1H-Indole (17)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluorobenzo[D]Thiazole (5)6-Fluorochromane (6)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1H-Indazole (12)7-Fluoro-1H-Indole (24)7-Fluorobenzo[D]Thiazole (9)7-Fluoroindoline-2,3-Dione (6)7-Fluoroisoquinoline (3)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluorochromane (5)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Fluoroisoquinoline (10)8-Fluoroquinazoline (4)Benzenesulfonyl Fluoride (51)Ethyl 2-Fluorobenzoate (37)Ethyl 3-Fluorobenzoate (34)Fluorobenzene (9967)Methyl 2,6-Difluorobenzoate (17)Methyl 2-Fluorobenzoate (132)Methyl 3-Fluorobenzoate (136)Methyl 4-Fluorobenzoate (75)Methyl 6-Fluoronicotinate (4)N-(3-Fluorophenyl)Acetamide (14)N-(4-Fluorophenyl)Benzamide (3)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl Trifluoromethanesulfonate (27)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Trifluoro(Phenyl)Borate (80)
Guanidines (776)
Biguanide (2)Biguanide (2)
Hydrazides (3103)
Acetohydrazide (17)Acetohydrazide (17)Chlorobenzhydrazide (3)Dihydrazide (5)Dihydrazide (5)Fluorobenzohydrazide (6)Pyrazine-2-Carbohydrazide (3)
Hydrazines (6277)
Dichlorophenylhydrazine (3)Hydrazinecarbothioamide (2)Hydrazinecarboxamide (1)Hydrazinylbenzoate (6)(2-Bromophenyl)Hydrazine (8)(2-Chlorophenyl)Hydrazine (16)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)Hydrazine (22)(3-Chlorophenyl)Hydrazine (12)2-Hydrazineylpyridine (32)2-Hydrazineylpyrimidine (6)3-Hydrazineylpyridine (8)4-Hydrazineylpiperidine (5)Isonicotinohydrazide (6)Phenylhydrazine (153)Picolinohydrazide (5)
Hydrazones (2042)
1-Benzylidene-2-Phenylhydrazine (4)
Hydroxylamines (623)
N-Hydroxybenzamide (8)
Iodides (14083)
Diiodo (19)Diiodobenzoate (5)Iodoaniline (60)Iodoanisole (5)Iodobenzaldehyde (38)Iodobenzamide (6)Iodobutane (1)Iodobutane (1)Iodoethoxy (6)Iodoethoxy (6)Iodoethyl (5)Iodoethyl (5)Iodomethyl (26)Iodomethyl (26)Iodonicotinaldehyde (6)Iodonicotinic (14)Iodonicotinic (14)Iodopropyl (4)Iodopropyl (4)(2-Iodophenyl)(Phenyl)Methanone (4)(2-Iodophenyl)Methanol (12)(3-Iodophenyl)Boronic Acid (5)(3-Iodophenyl)Methanol (13)1,2-Benziodoxol-3-(1H)-One (6)1,2-Difluoro-3-Iodobenzene (13)1,2-Diiodobenzene (10)1,3-Dibromo-2-Iodobenzene (4)1,3-Dichloro-2-Iodobenzene (5)1,3-Difluoro-2-Iodobenzene (12)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Diiodobenzene (59)1,4-Dibromo-2-Iodobenzene (3)1,4-Difluoro-2-Iodobenzene (8)1-(2-Iodophenyl)Ethan-1-One (4)1-(3-Iodophenyl)Ethan-1-One (7)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Iodobenzene (9)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Bromo-2-Iodobenzene (65)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Iodobenzene (70)1-Bromo-4-Iodobenzene (67)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Iodobenzene (65)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-4-Iodobenzene (49)1-Ethyl-2-Iodobenzene (6)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-4-Iodobenzene (65)1-Iodo-2,3-Dimethylbenzene (8)1-Iodo-2,4-Dimethylbenzene (9)1-Iodo-2-(Trifluoromethoxy)Benzene (6)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-2-Isopropylbenzene (4)1-Iodo-2-Methoxybenzene (50)1-Iodo-2-Methylbenzene (91)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-(Trifluoromethoxy)Benzene (6)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Iodo-3-Methoxybenzene (48)1-Iodo-3-Methylbenzene (60)1-Iodo-3-Nitrobenzene (45)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)2,4-Difluoro-1-Iodobenzene (14)2,6-Dichloro-4-Iodopyridine (4)2,6-Diiodoaniline (8)2,6-Diiodophenol (16)2-Bromo-3-Iodopyridine (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Iodopyridine (5)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-4-Iodopyridine (19)2-Chloro-5-Iodopyridine (18)2-Chloro-6-Iodophenol (3)2-Chloro-6-Iodopyridine (9)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Iodopyridine (8)2-Fluoro-6-Iodoaniline (7)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodo-1,3-Dimethylbenzene (15)2-Iodo-1,4-Dimethylbenzene (5)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-4-Methylaniline (5)2-Iodo-6-Methylpyridine (5)2-Iodo-6-Nitroaniline (3)2-Iodo-9H-Fluorene (8)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Iodobenzaldehyde (17)2-Iodobenzamide (4)2-Iodobenzene-1,3-Diol (3)2-Iodobenzoic Acid (47)2-Iodobenzonitrile (26)2-Iodonaphthalene (5)2-Iodophenol (63)2-Iodopyrazine (25)2-Iodopyridine (27)2-Iodopyrimidine (8)2-Iodothiophene (14)3-Chloro-2-Iodoaniline (3)3-Chloro-4-Iodoaniline (3)3-Fluoro-2-Iodoaniline (8)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Iodobenzaldehyde (28)3-Iodobenzoic Acid (55)3-Iodobenzonitrile (27)3-Iodoimidazo[1,2-A]Pyridine (10)3-Iodophenol (21)3-Iodopyridazine (5)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Iodotetrahydrofuran (3)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Iodoaniline (8)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Iodoaniline (3)4-Chloro-5-Iodopyrimidine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-3-Iodobenzoic Acid (5)4-Iodo-1,1'-Biphenyl (9)4-Iodo-1H-Pyrazole (9)4-Iodo-N,N-Diphenylaniline (3)4-Iodopyridine (17)4-Iodopyrimidine (9)5-Bromo-2-Iodopyridine (5)5-Iodo-1H-Imidazole (4)5-Iodo-1H-Pyrazole (4)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Iodopyrimidine (5)6-Chloro-5-Iodopyridin-2-Amine (3)Ethyl 2-Iodobenzoate (4)Ethyl 3-Iodobenzoate (11)Methyl 2-Iodobenzoate (28)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 4-Amino-3-Iodobenzoate (7)N-(2-Iodophenyl)Acetamide (8)Phenyl(O-Tolyl)Iodonium (14)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)
Isocyanates and Isothiocyanates (237)
Isocyanate (4)Isocyanate (4)(Isothiocyanatomethyl)Benzene (6)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)Isocyanatobenzene (47)Isothiocyanatobenzene (39)
Isocyanides (69)
Isocyanato (7)Isocyanide (1)Isothiocyanato (5)Isothiocyanato (5)
Ketones (40074)
Acetylacetonate (26)Bromoethanone (4)Butanedione (6)Butanedione (6)Butanone (10)Butanone (10)Carbonyl-Phenyl-Boronic Acid/Ester (184)Chloroethanone (2)Dicarbonyl (2)Dicarbonyl (2)Dichloroacetophenone (5)Dienone (2)Diethanone (5)Diethanone (5)Dione (1793)Dioxobutanoate (2)Enone (21)Ethanone (1026)Heptanedionato (7)Heptanedionato (7)Hydroxyethanone (3)Methyl-Pyrazolone (87)Oxoacetaldehyde (4)Oxoazepane (3)Oxoazepane (3)Oxochroman (5)Oxotetrahydro (11)Pyrimidinone (3)Tetraone (48)Tetraone (48)Trifluoroacetophenone (9)Trifluoroethanone (15)(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Hydroxyphenyl)(Phenyl)Methanone (24)(2-Iodophenyl)(Phenyl)Methanone (4)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)(Phenyl)Methanone (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Bromophenyl)(Phenyl)Methanone (9)(4-Chlorophenyl)(Phenyl)Methanone (10)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Hydroxyphenyl)(Phenyl)Methanone (3)(4-Methoxyphenyl)(Phenyl)Methanone (7)(4-Nitrophenyl)(Phenyl)Methanone (3)(R)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-8-One (8)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1,3-Diphenylpropan-1-One (9)1,4-Diazepan-5-One (9)1,4-Dihydroisoquinolin-3(2H)-One (5)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-One (27)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-(2-Hydroxyphenyl)Ethan-1-One (73)1-(2-Iodophenyl)Ethan-1-One (4)1-(2-Methoxyphenyl)Ethan-1-One (33)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Fluorophenyl)Ethan-1-One (63)1-(3-Hydroxyphenyl)Ethan-1-One (19)1-(3-Iodophenyl)Ethan-1-One (7)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Fluorophenyl)Ethan-1-One (36)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Benzofuran-2-Yl)Ethan-1-One (3)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(M-Tolyl)Ethan-1-One (37)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-(O-Tolyl)Ethan-1-One (26)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Pyrazin-2-Yl)Ethan-1-One (5)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-4-Yl)Ethan-1-One (14)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-(Thiazol-2-Yl)Ethan-1-One (9)1-(Thiophen-2-Yl)Ethan-1-One (17)1-Aminoanthracene-9,10-Dione (8)1-Benzylindoline-2,3-Dione (5)1-Benzylpiperidin-3-One (5)1-Chloroanthracene-9,10-Dione (6)1-Hydroxyanthracene-9,10-Dione (11)1-Methylpiperazin-2-One (6)1-Methylpyrrolidin-2-One (13)1-Phenylbutan-1-One (13)1-Phenylpentan-1-One (12)1-Phenylpiperidin-2-One (8)1-Phenylpropan-2-One (36)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2,2-Dimethyl-1-Phenylpropan-1-One (8)2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2,3-Dihydrofuran-3-One (9)2,3-Dihydropyridin-2-One (5)2,5-Dichlorobenzoic Acid (13)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Benzalacetophenone (36)2-Benzoylbenzoic Acid (10)2-Chloro-1-Phenylethan-1-One (20)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chloroquinazolin-4(3H)-One (4)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Hydroxyquinolin-4(1H)-One (3)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methyl-1-Phenylpropan-1-One (20)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)2-Methylcyclohexan-1-One (3)2-Methylisoindolin-1-One (7)2-Methylisoindoline-1,3-Dione (5)2-Methylpyridazin-3(2H)-One (7)2-Oxo-2-Phenylacetaldehyde (12)2-Oxo-2-Phenylacetic Acid (17)3,3-Difluoropiperidin-4-One (3)3,3-Dimethylcyclohexan-1-One (4)3,3-Dimethylpiperidin-4-One (3)3,4-Dihydroquinoxalin-2(1H)-One (7)3-Acetyl-2H-Chromen-2-One (3)3-Aminopyrrolidin-2-One (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)3-Chloro-1-Phenylpropan-1-One (10)3-Fluoropiperidin-4-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (21)3-Hydroxypyrrolidin-2-One (4)3-Methylcyclohexan-1-One (9)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methylpiperazin-2-One (7)3-Methylpyrimidin-4(3H)-One (6)3-Oxo-3-Phenylpropanenitrile (21)3-Oxo-N-Phenylbutanamide (10)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylacrylaldehyde (29)3-Phenylimidazolidine-2,4-Dione (4)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-Benzylmorpholin-3-One (6)4-Bromoisoindolin-1-One (3)4-Bromopyridazin-3(2H)-One (3)4-Chloro-1-Phenylbutan-1-One (8)4-Chloropyridazin-3(2H)-One (4)4-Fluoroindoline-2,3-Dione (3)4-Hydroxy-2H-Chromen-2-One (10)4-Hydroxydihydrofuran-2(3H)-One (14)4-Hydroxypiperidin-2-One (3)4-Hydroxypyrrolidin-2-One (7)4-Methyl-2H-Chromen-2-One (27)4-Methylisobenzofuran-1(3H)-One (3)4-Oxo-4-Phenylbutanoic Acid (16)4-Phenylbutan-2-One (14)4-Phenylcyclohexan-1-One (11)4-Phenylmorpholin-3-One (6)4-Phenylpyrrolidin-2-One (7)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Bromoisoindolin-1-One (8)5-Bromoisoindoline-1,3-Dione (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloroisoindoline-1,3-Dione (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochroman-4-One (3)5-Fluoroindolin-2-One (4)5-Fluoroisoindolin-1-One (3)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Hydroxypiperidin-2-One (3)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Methylindolin-2-One (3)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Bromoisoindolin-1-One (4)6-Fluorochroman-4-One (5)6-Fluoroindoline-2,3-Dione (3)6-Fluoroisobenzofuran-1(3H)-One (3)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methoxyisoindolin-1-One (3)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)7,8-Dihydroquinolin-5(6H)-One (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromochroman-4-One (4)7-Bromoindoline-2,3-Dione (3)7-Bromoquinazolin-4(3H)-One (4)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Fluorochroman-4-One (5)7-Fluoroindolin-2-One (3)7-Fluoroquinazolin-4(3H)-One (4)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methoxychroman-4-One (3)7-Methylindoline-2,3-Dione (7)8-Bromochroman-4-One (4)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluoroisoquinolin-1(2H)-One (3)8-Methylchroman-4-One (4)Acetophenone (1120)Azepan-2-One (18)Benzo[Cd]Indol-2(1H)-One (5)Benzofuran-2(3H)-One (7)Chroman-2-One (5)Cyclobutanone (24)Cyclohex-2-En-1-One (27)Cyclohexane-1,3-Dione (12)Cyclopent-2-En-1-One (21)Cyclopentane-1,3-Dione (6)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Dihydrofuran-2,5-Dione (12)Dihydrofuran-3(2H)-One (7)Dihydrothiophen-3(2H)-One (4)Ethene-1,1-Diyldibenzene (10)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 3-Oxo-3-Phenylpropanoate (41)Furan-2(5H)-One (26)Isoquinolin-1-Ol (9)Methyl 3-Oxo-3-Phenylpropanoate (16)Morpholin-3-One (11)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(M-Tolyl)Methanone (3)Phenyl(P-Tolyl)Methanone (4)Phenyl(Pyridin-3-Yl)Methanone (9)Phenyl(Thiophen-2-Yl)Methanone (6)Piperidine-2,4-Dione (5)Propiophenone (59)Pyrimidine-4,6(1H,5H)-Dione (3)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tetrahydropyrimidin-2(1H)-One (6)
Mercaptos (11)
Mercaptopropanoate (10)
Nitrates and Nitrites (1)
Nitriles (28529)
Acetonitrile (255)Acrylonitrile (8)Aminobutanenitrile (5)Aminocyclohexanecarbonitrile (6)Bromobenzonitrile (15)Bromonicotinonitrile (9)Bromophenylacetonitrile (2)Butanenitrile (2)Butanenitrile (2)Chlorobenzonitrile (27)Chloroisonicotinonitrile (4)Chloronicotinonitrile (40)Cyanide (434)Cyanide (434)Cyanoacetamide (4)Cyanoacetate (14)Cyanobenzaldehyde (4)Cyanobenzoate (27)Cyanobenzoic (20)Cyanoethyl (15)Cyanoethyl (15)Cyanoisonicotinate (4)Cyanomethyl (42)Cyanomethyl (42)Cyanonicotinate (8)Cyanophenoxy (8)Cyanophenyl (64)Cyanophenylboronic (5)Cyanopropan (4)Cyanopropan (4)Diacetonitrile (1)Diaminobenzonitrile (8)Dibromoisonicotinonitrile (3)Dicarbonitrile (45)Dicarbonitrile (45)Dichlorobenzonitrile (12)Dichloroisonicotinonitrile (4)Difluorobenzonitrile (41)Fluorobenzonitrile (85)Fluoroisonicotinonitrile (5)Fluoronicotinonitrile (14)Fluorophenylacetonitrile (8)Fluoropicolinonitrile (13)Formylnicotinonitrile (5)Formylnicotinonitrile (5)Hydrazinylbenzonitrile (6)Iodobenzonitrile (44)Iodonicotinonitrile (8)Malononitrile (43)Malononitrile (43)Methoxyisonicotinonitrile (7)Methoxyisonicotinonitrile (7)Methoxynicotinonitrile (18)Methoxynicotinonitrile (18)Methylnicotinonitrile (57)Methylnicotinonitrile (57)Methylpropanenitrile (9)Methylpropanenitrile (9)Nitropicolinonitrile (10)Oxopropanenitrile (8)Phenylacrylonitrile (21)Propanenitrile (41)Propanenitrile (41)Pyrazino-Nitrile (50)Tetrafluorobenzonitrile (5)Thiocyanatoaniline (3)Tricarbonitrile (5)Tricarbonitrile (5)Trifluorobenzonitrile (7)Trifluoromethylbenzonitrile (5)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclopropane-1-Carbonitrile (19)1H-Imidazole-4-Carbonitrile (2)1H-Indazole-3-Carbonitrile (9)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-5-Carbonitrile (5)1H-Indole-6-Carbonitrile (4)1H-Indole-7-Carbonitrile (6)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-3-Carbonitrile (9)2,3-Difluorobenzonitrile (29)2,4-Dichlorobenzonitrile (4)2,4-Difluorobenzonitrile (21)2,6-Dibromobenzonitrile (4)2,6-Dichlorobenzonitrile (8)2,6-Difluorobenzonitrile (28)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(2-Bromophenyl)Acetonitrile (10)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Fluorophenyl)Acetonitrile (30)2-(3-Chlorophenyl)Acetonitrile (16)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(Bromomethyl)Benzonitrile (15)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethyl)Benzonitrile (35)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorobenzonitrile (3)2-Aminonicotinonitrile (6)2-Bromo-6-Fluorobenzonitrile (7)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-N-Methylaniline (4)2-Chlorobenzonitrile (99)2-Hydroxybenzonitrile (45)2-Iodobenzonitrile (26)2-Naphthonitrile (15)2-Nitrobenzonitrile (37)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Phenoxyacetonitrile (11)2-Phenoxybenzonitrile (5)2-Phenylacetonitrile (172)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethyl)Benzonitrile (47)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromobenzonitrile (110)3-Chloro-2-Fluorobenzonitrile (7)3-Chlorobenzonitrile (100)3-Chloropyrazine-2-Carbonitrile (6)3-Fluoropicolinonitrile (5)3-Hydroxybenzonitrile (40)3-Iodobenzonitrile (27)3-Nitrobenzonitrile (59)3-Oxo-3-Phenylpropanenitrile (21)3-Phenoxybenzonitrile (5)4-Amino-2-Chlorobenzonitrile (8)4-Chloropyrimidine-5-Carbonitrile (6)4-Cyanophenyl Benzoate (11)4-Cyclohexylbenzonitrile (10)4-Fluorobenzonitrile (89)4-Nitrobenzonitrile (25)5-Fluoropicolinonitrile (5)6-Methylnicotinonitrile (7)6-Methylpicolinonitrile (10)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-4-Carbonitrile (27)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[D]Thiazole-2-Carbonitrile (11)Benzonitrile (1312)Furan-2-Carbonitrile (8)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinonitrile (16)Isoquinoline-1-Carbonitrile (7)Methyl 2-Cyanobenzoate (22)Methyl 3-Cyanobenzoate (29)Morpholine-2-Carbonitrile (4)Nicotinonitrile (82)Pyrazine-2-Carbonitrile (15)Pyrimidine-2-Carbonitrile (14)Pyrimidine-4-Carbonitrile (9)Pyrimidine-5-Carbonitrile (6)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-3-Carbonitrile (6)Thiazole-5-Carbonitrile (7)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbonitrile (13)
Nitroes (23714)
Difluoronitrobenzene (9)Dinitro (7)Dinitroaniline (5)Nitroacetophenone (7)Nitroaniline (211)Nitrobenzaldehyde (100)Nitrobenzamide (35)Nitrobenzenesulfonamide (26)Nitrobenzonitrile (106)Nitrobenzotrifluoride (16)Nitroisophthalate (4)(2-Nitrophenyl)Boronic Acid (13)(2-Nitrophenyl)Methanol (29)(2-Nitrovinyl)Benzene (28)(3-Nitrophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)Boronic Acid (32)(3-Nitrophenyl)Methanol (31)(4-Nitrophenyl)(Phenyl)Methanone (3)(4-Nitrophenyl)Methanol (17)1,2-Dichloro-4-Nitrobenzene (16)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Nitrobenzene (43)1,2-Dimethyl-3-Nitrobenzene (6)1,2-Dinitrobenzene (6)1,3-Dibromo-2-Nitrobenzene (4)1,3-Dichloro-2-Nitrobenzene (5)1,3-Difluoro-2-Nitrobenzene (16)1,3-Dimethyl-2-Nitrobenzene (9)1,3-Dinitrobenzene (31)1,4-Difluoro-2-Nitrobenzene (28)1,4-Dimethyl-2-Nitrobenzene (10)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Tert-Butyl)-2-Nitrobenzene (4)1-(Tert-Butyl)-3-Nitrobenzene (7)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Nitrobenzene (161)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-3-Nitrobenzene (216)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-Nitrobenzene (45)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-Nitrobenzene (90)1-Methyl-2-Nitrobenzene (176)1-Methyl-3-Nitrobenzene (147)1-Methyl-4-Nitrobenzene (82)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-2-Phenoxybenzene (4)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Nitro-4-Phenoxybenzene (5)1-Nitronaphthalene (3)2,4-Dichloro-1-Nitrobenzene (19)2,4-Difluoro-1-Nitrobenzene (46)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethyl-1-Nitrobenzene (15)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(4-Nitrophenyl)Acetic Acid (9)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Nitroaniline (12)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Nitrophenol (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-6-Nitroaniline (11)2-Chloro-6-Nitrophenol (7)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-6-Nitroaniline (3)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Nitrophenol (5)2-Methyl-3-Nitrobenzoic Acid (7)2-Methyl-3-Nitropyridine (9)2-Methyl-6-Nitroaniline (10)2-Nitro-1H-Pyrrole (5)2-Nitro-N-Phenylaniline (3)2-Nitrobenzaldehyde (53)2-Nitrobenzoic Acid (65)2-Nitrobenzonitrile (37)2-Nitrofuran (9)2-Nitronaphthalene (4)2-Nitropyridine (40)2-Nitrothiophene (20)3-Chloro-2-Nitroaniline (5)3-Chloro-4-Nitroaniline (5)3-Fluoro-4-Nitroaniline (7)3-Methoxy-2-Nitrobenzaldehyde (3)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methyl-5-Nitropyridine (4)3-Nitroaniline (98)3-Nitrobenzaldehyde (49)3-Nitrobenzamide (17)3-Nitrobenzene-1,2-Diol (6)3-Nitrobenzenesulfonamide (8)3-Nitrobenzoic Acid (109)3-Nitrobenzonitrile (59)3-Nitrophenol (72)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Nitrothiophene (6)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-2-Nitroaniline (14)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Methyl-3-Nitroaniline (8)4-Methyl-3-Nitropyridine (8)4-Nitro-1H-Indazole (10)4-Nitro-1H-Indole (6)4-Nitro-1H-Pyrazole (8)4-Nitroaniline (65)4-Nitrobenzaldehyde (18)4-Nitrobenzene-1,3-Diol (5)4-Nitrobenzoic Acid (35)4-Nitrobenzonitrile (25)4-Nitrophenol (67)4-Nitropyridine (11)5-(4-Nitrophenyl)Oxazole (3)5-Methoxy-2-Nitroaniline (7)5-Methyl-2-Nitroaniline (6)5-Nitro-1H-Indazole (5)5-Nitro-1H-Indole (6)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Nitrobenzo[D][1,3]Dioxole (4)5-Nitrobenzo[D]Thiazole (3)5-Nitroisoquinoline (7)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1H-Indazole (9)6-Nitro-1H-Indole (8)6-Nitrobenzo[D]Thiazole (3)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Nitro-1H-Indazole (11)7-Nitro-1H-Indole (11)Ethyl 2-Nitrobenzoate (9)Ethyl 3-Nitrobenzoate (22)Ethyl Cinnamate (26)Methyl 2-Nitrobenzoate (54)Methyl 3-Nitrobenzoate (109)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Nitrobenzoate (29)N-(2-Nitrophenyl)Acetamide (11)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)Nitrobenzene (2309)
Oximes (561)
Phenols (1786)
Aminophenol (9)Bromophenol (13)Chlorophenol (28)Dibromophenol (9)Dichlorophenol (17)Difluorophenol (36)Dihydroxybenzaldehyde (16)Dihydroxybenzamide (6)Dihydroxybenzoate (15)Dihydroxybenzoic (17)Dihydroxybenzonitrile (6)Dihydroxyphenyl (98)Dihydroxystyryl (4)Diiodophenol (7)Fluorophenol (73)Hydroxyacetophenone (16)Hydroxybenzaldehyde (88)Hydroxybenzamide (24)Hydroxybenzenesulfonic (4)Hydroxybenzenesulfonic Acid (3)Hydroxybenzoate (113)Hydroxybenzohydrazide (4)Hydroxybenzoic (89)Hydroxybenzonitrile (60)Hydroxybenzoyl (1)Hydroxyphenoxy (7)Hydroxyphenylacetic (7)Hydroxyphenylacetic Acid (7)Hydroxyphenylboronic (8)Hydroxypropiophenone (3)Iodophenol (41)Nitrophenol (134)Tetrafluorophenol (9)Trifluorophenol (5)Trihydroxybenzaldehyde (5)Trihydroxybenzoate (12)Trihydroxybenzoic (5)Trihydroxybenzoic Acid (4)Trihydroxyphenyl (10)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1-(2-Hydroxyphenyl)Ethan-1-One (73)1-(3-Hydroxyphenyl)Ethan-1-One (19)1-Hydroxyanthracene-9,10-Dione (11)2,3-Dichlorophenol (9)2,3-Difluorophenol (36)2,4-Dibromophenol (16)2,4-Difluorophenol (21)2,5-Dichlorophenol (7)2,6-Dibromophenol (21)2,6-Dichlorophenol (16)2,6-Difluorophenol (24)2,6-Diiodophenol (16)2,6-Dimethylphenol (19)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(3-Hydroxyphenyl)Acetic Acid (7)2-(Benzyloxy)Phenol (5)2-(Difluoromethoxy)Phenol (5)2-(Tert-Butyl)Phenol (56)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethyl)Phenol (23)2-Amino-3-Bromophenol (3)2-Amino-3-Chlorophenol (4)2-Aminophenol (107)2-Benzylphenol (8)2-Bromo-3-Methylphenol (4)2-Bromo-6-Methylphenol (7)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Chloro-4-Fluorophenol (9)2-Chloro-4-Nitrophenol (5)2-Chloro-6-Methylphenol (5)2-Chloro-6-Nitrophenol (7)2-Chlorobenzene-1,3-Diol (4)2-Chlorophenol (163)2-Ethylphenol (10)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Hydroxybenzonitrile (45)2-Iodobenzene-1,3-Diol (3)2-Iodophenol (63)2-Isopropylphenol (28)2-Methoxyphenol (197)3,4-Dibromophenol (3)3,4-Difluorophenol (19)3-(Benzyloxy)Phenol (5)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)Phenol (43)3-Bromo-2-Fluorophenol (5)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluorophenol (11)3-Bromobenzene-1,2-Diol (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chlorobenzene-1,2-Diol (6)3-Chlorophenol (112)3-Fluorophenol (180)3-Hydroxybenzonitrile (40)3-Iodophenol (21)3-Nitrobenzene-1,2-Diol (6)3-Nitrophenol (72)4-(Benzyloxy)Phenol (2)4-(Trifluoromethyl)Phenol (18)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorophenol (5)4-Benzylphenol (14)4-Chlorobenzene-1,3-Diol (6)4-Fluorophenol (111)4-Hydroxybenzenesulfonic Acid (5)4-Nitrobenzene-1,3-Diol (5)4-Nitrophenol (67)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)Ethyl 2-Hydroxybenzoate (18)Ethyl 3-Hydroxybenzoate (12)M-Cresol (147)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-Hydroxybenzoate (74)Methyl 3-Hydroxybenzoate (58)O-Cresol (164)P-Cresol (71)Pyrocatechol (131)Resorcinol (146)
Phosphoruses (827)
Diethoxyphosphoryl (5)Diisopropylphosphoramidite (4)Dimethoxyphosphoryl (4)Dimethoxyphosphoryl (4)Dimethylphosphine (28)Dioxaphosphepine (146)Diphosphonic (9)Phosphorothioate (1)1,1,1-Trifluoro-N-(4-Oxido-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepin-4-Yl)Methanesulfonamide (16)Diethyl Benzylphosphonate (17)Dimethyl(Phenyl)Phosphine Oxide (20)Ethyltriphenylphosphonium (2)Methyltriphenylphosphonium (3)Phenyl Phosphate (3)Phenylphosphonic Acid (6)
Polycyclic Aromatic Hydrocarbons (6)
Protective Groups (23)
Saturated Aliphatic Fused Rings (2)
(8Ar,12Br,14Br)-1,2,3,4,4A,5,6,6A,6B,7,8,8A,9,10,11,12,12A,12B,13,14B-Icosahydropicene (2)
Silicon Compounds (450)
Butyldimethylsilyl (94)Butyldimethylsilyl (94)Butyldimethylsilyloxy (8)Dimethylsilane (16)Dimethylsilane (16)Dimethylsilyl (4)Tetramethyldisiloxane (3)Tetramethyldisiloxane (3)Triethoxysilyl (13)Triethoxysilyl (13)Triisopropylsilyl (22)Triisopropylsilyl (22)Trimethoxysilane (19)Trimethoxysilane (19)Trimethylsilane (155)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)Tert-Butyldimethyl(Phenoxy)Silane (17)Tetraphenylsilane (7)Trimethoxy(Phenyl)Silane (6)Trimethyl(Phenyl)Silane (22)Trimethyl(Phenylethynyl)Silane (23)
Sulfamides (10218)
Dimethylsulfamoyl (5)Dimethylsulfamoyl (5)Methanesulfonamide (54)Methanesulfonamide (54)Methylmethanesulfonamide (3)Methylmethanesulfonamide (3)Methylsulfonamido (4)Methylsulfonamido (4)Sulfinamide (55)Sulfinamide (55)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluorobenzenesulfonamide (12)2-Methylbenzenesulfonamide (8)3-Nitrobenzenesulfonamide (8)4-Amino-N-Phenylbenzenesulfonamide (3)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Chloro-N-Phenylbenzenesulfonamide (4)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methyl-N-Phenylbenzenesulfonamide (13)N,N-Diethylbenzenesulfonamide (8)N,N-Dimethylbenzenesulfonamide (23)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(O-Tolyl)Benzenesulfonamide (4)N-(Tert-Butyl)Benzenesulfonamide (14)N-Ethylbenzenesulfonamide (8)N-Isopropylbenzenesulfonamide (8)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylbenzenesulfonamide (15)N-Phenylbenzenesulfonamide (81)N-Phenylmethanesulfonamide (37)Phenylmethanesulfonamide (13)Pyridine-2-Sulfonamide (6)
Sulfides (10123)
Methylthio (432)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)1,2-Diphenyldisulfane (19)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-(Methylthio)Pyridine (5)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Methylthio)Thiazole (5)2-(Propylthio)Pyrimidine (5)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Methyl-2-(Methylthio)Pyrimidine (7)5-Bromo-2-(Methylthio)Pyrimidine (6)Benzyl(Phenyl)Sulfane (5)Ethyl(Phenyl)Sulfane (8)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl(Trifluoromethyl)Sulfane (23)
Sulfonates (1160)
4-Methylbenzenesulfonate (9)
Sulfones (3927)
(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(Ethylsulfonyl)Benzene (8)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Methylsulfonyl)Piperazine (5)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-(Phenylsulfonyl)-1H-Imidazole (5)1-(Phenylsulfonyl)Azetidine (7)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Methyl-3-(Methylsulfonyl)Benzene (5)2-(Methylsulfonyl)Aniline (3)2-(Methylsulfonyl)Pyridine (11)2-(Methylsulfonyl)Pyrimidine (25)3-(Methylsulfonyl)Aniline (7)3-(Methylsulfonyl)Benzoic Acid (6)3-(Methylsulfonyl)Pyridine (5)Benzenesulfonyl Fluoride (51)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)Tetrahydrothiophene 1,1-Dioxide (13)
Sulfonic Acids (1261)
Aminobenzenesulfonic (4)Bromobenzenesulfonic Acid (4)Disulfonic (9)Disulfonic (9)Ethanesulfonic (3)Methanesulfonic (2)Methanesulfonic (2)Methylbenzenesulfonate (144)Propanesulfonic Acid (2)Trifluoromethanesulfonic (4)2-Aminobenzenesulfonic Acid (9)2-Methylbenzenesulfonic Acid (8)3-Aminobenzenesulfonic Acid (6)4-Chlorobenzenesulfonic Acid (4)4-Hydroxybenzenesulfonic Acid (5)Naphthalene-2-Sulfonic Acid (4)Pyridine-3-Sulfonic Acid (6)
Sulfonyl Chlorides (4029)
Fluorobenzenesulfonyl (12)1H-Pyrazole-4-Sulfonyl Chloride (8)2-Bromobenzenesulfonyl Chloride (8)2-Chlorobenzenesulfonyl Chloride (24)2-Fluorobenzenesulfonyl Chloride (31)2-Methoxybenzenesulfonyl Chloride (15)2-Methylbenzenesulfonyl Chloride (22)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-Chlorobenzenesulfonyl Chloride (21)3-Fluorobenzenesulfonyl Chloride (22)4-Chlorobenzenesulfonyl Chloride (12)4-Fluorobenzenesulfonyl Chloride (26)Isoquinoline-5-Sulfonyl Chloride (3)Methyl 2-(Chlorosulfonyl)Benzoate (7)Phenylmethanesulfonyl Chloride (20)
Sulfonyl Hydrazides (25)
Benzenesulfonohydrazide (12)
Sulfoxides (333)
(Methylsulfinyl)Benzene (7)
Thioesters (625)
Thiols (468)
Dithiole (9)Dithiole (9)Ethanethioate (9)Ethanethioate (9)Methanethiol (6)1H-Benzo[D]Imidazole-2-Thiol (10)2-Chlorobenzenethiol (7)2-Mercaptoquinazolin-4(3H)-One (3)Benzo[D]Oxazole-2-Thiol (6)Benzo[D]Thiazole-2-Thiol (11)Phenylmethanethiol (16)Pyridine-2-Thiol (8)Pyrimidine-2-Thiol (6)
Thiophenols (3045)
Thioureas (1128)
Carbamimidothioate (4)1,3-Diphenylthiourea (8)1-Phenylthiourea (33)
Trifluoromethyls (28951)
Trifluoromethyl-Picolinamide (7)Trifluoromethylaniline (3)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-(Trifluoromethyl)Phenyl)Methanol (21)(4-(Trifluoromethyl)Phenyl)Boronic Acid (22)(Perfluoropropane-2,2-Diyl)Dibenzene (7)(Trifluoromethyl)Benzene (1336)1,3-Bis(Trifluoromethyl)Benzene (70)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-(Trifluoromethyl)Benzene (126)1-Fluoro-3-(Trifluoromethyl)Benzene (98)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-(Trifluoromethyl)Benzene (53)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methyl-2-(Trifluoromethoxy)Benzene (5)1-Methyl-2-(Trifluoromethyl)Benzene (43)1-Methyl-3-(Trifluoromethyl)Benzene (22)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-(Trifluoromethyl)Aniline (58)2-(Trifluoromethyl)Benzaldehyde (27)2-(Trifluoromethyl)Benzamide (6)2-(Trifluoromethyl)Benzoic Acid (33)2-(Trifluoromethyl)Benzonitrile (35)2-(Trifluoromethyl)Phenol (23)2-(Trifluoromethyl)Pyrazine (6)2-(Trifluoromethyl)Pyridine (6)2-(Trifluoromethyl)Pyrimidine (27)2-(Trifluoromethyl)Quinazoline (4)2-(Trifluoromethyl)Thiazole (11)2-(Trifluoromethyl)Thiophene (11)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Aniline (102)3-(Trifluoromethyl)Benzaldehyde (31)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-(Trifluoromethyl)Benzoic Acid (52)3-(Trifluoromethyl)Benzonitrile (47)3-(Trifluoromethyl)Phenol (43)3-(Trifluoromethyl)Pyridazine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (52)3-Chloro-4-(Trifluoromethyl)Aniline (5)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4-(Trifluoromethoxy)Aniline (26)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-(Trifluoromethyl)Phenol (18)4-(Trifluoromethyl)Pyridine (14)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-(Trifluoromethyl)Thiazole (7)4-Bromo-3-(Trifluoromethyl)Aniline (7)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)6-(Trifluoromethyl)-1H-Indazole (6)6-(Trifluoromethyl)-1H-Indole (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 3-(Trifluoromethyl)Benzoate (22)N-Phenyl-4-(Trifluoromethyl)Aniline (3)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(Trifluoromethyl)Sulfane (23)
Ureas (1841)
Other Function Groups (5)
Organometallic Reagents
Organoborons (34729)
Fluorene-Phenyl-Boronic Acid/Ester (4)Hydroxymethyl-Phenyl-Boronic-Acid (31)Methoxyphenylboronic-Acid (32)Phenyl-Naphthalene-Boronic Acid/Ester (9)(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)(1H-Indol-2-Yl)Boronic Acid (3)(2,3-Dichlorophenyl)Boronic Acid (11)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Dichlorophenyl)Boronic Acid (6)(2,6-Difluorophenyl)Boronic Acid (28)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-Bromophenyl)Boronic Acid (39)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(2-Fluorophenyl)Boronic Acid (229)(2-Nitrophenyl)Boronic Acid (13)(3,4-Dichlorophenyl)Boronic Acid (10)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)Boronic Acid (121)(3-Fluorophenyl)Boronic Acid (169)(3-Iodophenyl)Boronic Acid (5)(3-Nitrophenyl)Boronic Acid (32)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(4-(Trifluoromethyl)Phenyl)Boronic Acid (22)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Fluorophenyl)Boronic Acid (93)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(E)-4,4,5,5-Tetramethyl-2-Styryl-1,3,2-Dioxaborolane (16)1,3,2-Dioxaborinane (6)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Cyclopropylphenyl)-1,3,2-Dioxaborolane (5)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(4-Cyclopropylphenyl)-1,3,2-Dioxaborolane (8)2-(4-Fluorophenyl)-1,3,2-Dioxaborinane (5)2-([1,1'-Biphenyl]-4-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Cyclohex-1-En-1-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-(M-Tolyl)-1,3,2-Dioxaborinane (4)2-Benzyl-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (12)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(Naphthalen-1-Yl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(Naphthalen-2-Yl)-1,3,2-Dioxaborolane (12)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzofuran-2-Ylboronic Acid (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Cyclohex-1-En-1-Ylboronic Acid (4)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Isoquinolin-4-Ylboronic Acid (3)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)Naphthalen-1-Ylboronic Acid (4)Naphthalen-2-Ylboronic Acid (8)Phenylboronic Acid (1286)Pyridin-2-Ylboronic Acid (9)Pyridin-3-Ylboronic Acid (49)Pyridin-4-Ylboronic Acid (21)Pyrimidin-5-Ylboronic Acid (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)Tetraphenylborate (8)Thiophen-2-Ylboronic Acid (20)
Organosilicons (73)
Organotins (5)
Other Organometallic Reagents (1)
Specialty Synthesis
Ionic Liquids (738)
Synthetic Reagents
C-C Bond Formation (62)
Condensation Agents (74)
Fluorination Reagents (20)
Halogenation Reagents (20)
Inorganic Salts (25506)
Phase Transfer Catalysts (29)
Other Synthetic Reagents (106)
Materials Science
Electronic Materials
Contact Printing & Self-Assembly Materials (77)
Liquid Crystal (LC) Materials (413)
Molecular Conductors (80)
Organic Field-Effect Transistors (OFETs) (86)
Organic Light-Emitting Diode (OLED) Materials (22)
4-(Diphenylamino)Benzaldehyde (8)4-Bromo-N,N-Bis(4-Methoxyphenyl)Aniline (3)4-Methoxy-N,N-Diphenylaniline (5)4-Methyl-N,N-Diphenylaniline (6)
Photoresist Materials (249)
Silane Coupling Agents (176)
Energy and Battery Materials
Battery Additives (75)
Battery Electrolytes Materials (16)
Battery Solvent Materials (24)
Electrode Active Materials (4)
Ionic Liquids (738)
Organic Redox Flow Battery Materials (26)
Solution & Vapor Deposition Precursors (31)
Material Building Blocks
Alkyl Chain Building Blocks (93)
Ligands for Functional Metal Complexes (198)
Liquid Crystal (LC) Building Blocks (558)
Phthalocyanine Building Blocks (71)
Small Molecule Semiconductor Building Blocks (1878)
Organic Frameworks and Supramolecular Materials
Covalent Organic Framework (COF) Linkers (1087)
Metal Organic Framework (MOF) Linkers (1693)
Metal Organic Frameworks (MOFs) (85)
Organic Framework Building Blocks (218)
Supramolecular Host Materials  (185)
Polymer Additives
Antioxidants (81)
Crosslinking Agents (75)
Flame Retardants (35)
Light Stabilizers (67)
Plasticizers (84)
Polymerization Catalysts (156)
Polymerization Initiators (141)
Polymerization Reagents (170)
Surfactants (340)
Other Additives (34)
Polymer Reagents
Dendrimer Materials (59)
Ion Exchange Resins (7)
Monomers (3050)
Photopolymer Monomers (180)
Polybenzoxazole and Polyimide Raw Materials (240)
Polymer Semiconductor Monomers (269)
Polymers (375)
Quantum Dots and Micro/Nano Materials
Nanocarbon Materials (45)
Quantum Dots (QD) Capping Agents (178)
Quantum Dots (QD) Synthetic Reagents (13)
Solar Cells and Photonic Materials
Donor Intermediates & Acceptor Intermediates (1029)
Dye-Sensitized Solar Cell (DSSC) Materials (130)
Dyes and Pigments (392)
Organic Non-Linear Optical (NLO) Materials (39)
Organic Phto-Voltaics (OPV) Materials (185)
Perovskite Solar Cell (PSC) Materials (278)
Visible Light Photoredox Catalysts (29)
Other Functional Materials
Aggregation-Induced Emission Materials (169)
Inorganic Compounds and Ceramic Materials (33)
Magnetic Materials (50)
Life Science
Inhibitors/Agonists
ADC (371)
ADC Linker (371)
Angiogenesis (1714)
ALK (86)Bcr-Abl (105)BTK (149)EGFR (403)FAK (56)FGFR (136)FLT3 (134)HER2 (31)HIF (112)JAK (245)PDGFR (127)Src (110)Syk (40)VDA (1)VEGFR (271)
Anti-Infection (4763)
3CLpro (41)Antibacterial (2101)Antifungal (525)Antiparasitic (648)Antiprotozoal (2)Antiviral (48)Arenavirus (5)BVDV (3)CMV (30)Dengue Virus (36)EBV (14)Enterovirus (33)FCoV (3)Filovirus (14)Flavivirus (64)GraR (1)HBV (151)HCV (222)HHV (1)HIV (447)HIV Integrase (39)HIV Protease (68)HPV (10)HRV (3)HSV (75)Influenza Virus (251)LpxC (2)M2 proton channel (2)MERS-CoV (1)Neuraminidase (4)NNRTI (12)NRTI (22)Orthopoxvirus (28)Penicillin-Binding Protein (7)PLP (13)Prion (1)Protein Synthesis (4)Reverse Transcriptase (99)RSV (43)SAMHD1 (1)SARS-CoV (298)SQLE (5)TMV (12)Viral MTase (3)Virus Protease (62)VSV (1)β-lactamase (51)
Antibody-Drug Conjugate/ADC Related (647)
ADC Linker (371)ADC Toxins (123)Payload-Linker Conjugate (165)
Apoptosis (2443)
Apoptosis (2143)Apoptosis Inducer (1407)Bcl-2 (195)Bcl-6 (6)BRK (3)c-Myc (47)c-RET (64)C/EBP (2)Caspase (170)DAPK (12)Ferroptosis (109)FKBP (15)GDNF Receptor (1)IAP (48)IDO (70)MDM2 (143)MRCK (2)Necroptosis (33)p32 (1)p53 (41)PERK (35)PKD (10)Pyroptosis (13)RIP Kinase (84)Survivin (12)Thymidylate Synthase (24)TNF (22)TNF Receptor (117)TNF-alpha (30)
Autophagy (745)
ATG4B (4)ATTECs (3)AUTACs (7)Autophagy (730)Beclin1 (1)FKBP (15)LC3 (1)LRRK2 (32)Lysosome (1)mitoNEET (1)Mitophagy (3)PPT (1)SPHK (27)TFEB (1)ULK (17)
Cell Cycle (4595)
Antifolate (31)APC (6)Aurora Kinase (87)BUB (3)Casein Kinase (101)CDK (475)Chk (46)CRISPR/Cas9 (7)CRM1 (17)DHFR (55)DNA polymerase θ (2)DNA/RNA Synthesis (620)DOCK (3)DYRK (60)E2F (2)eIF (43)Endonuclease (3)FOXM1 (3)G-quadruplex (6)Haspin Kinase (8)HDAC (336)HGF (1)HSF (4)HSP (161)IRE1 (27)Kinesin (35)Lats kinase (1)LIMK (17)Mad2 (1)Microtubule/Tubulin (305)MKLP (1)Mps1 (21)MTH2 (1)Nucleoside Antimetabolite/Analog (1441)p21 (1)PAK (30)PDI (1)PKMYT1 (2)PLK (50)PPAR (193)PTEN (5)RAD51 (18)Rho (14)RNA polymerase 2 (1)RNA polymerase 1 (2)ROCK (90)Separase (1)Sirtuin (129)SRPK (51)STK33 (2)TACC (3)Telomerase (21)TOPK (1)Topoisomerase (271)Wee1 (16)YB-1 (5)
Cytoskeleton (728)
Actin (1)Arp2/3 Complex (6)CYTH (1)Cytoplasmic dynein (1)Dynamin (14)FAK (56)Filamin-A (1)Gap Junction (11)Integrin (134)Kinesin (35)MARK (1)Microtubule/Tubulin (305)MLCK (5)Mps1 (21)Myosin (25)PAK (30)ROCK (90)Spastin (1)
DNA Damage (3023)
ADAR (1)AP endonuclease (1)ATAD5 (1)ATM/ATR (67)Aurora Kinase (87)Casein Kinase (101)ClpP (5)CRISPR/Cas9 (7)DNA Alkylator/Crosslinker (75)DNA-PK (39)DNA/RNA Synthesis (620)HDR (1)HSP (161)MRE11 (1)MTH1 (8)Nucleoside Antimetabolite/Analog (1441)OGG (3)p97 (15)PARP (175)RAD51 (18)RAD52 (3)Telomerase (21)Topoisomerase (271)WRN (5)YB-1 (5)
Endocrinology/Hormones (826)
5 Alpha Reductase (2)ACE (76)Adrenergic Receptor (184)Androgen Receptor (96)Aromatase (8)ERR (218)GHSR (21)Glucocorticoid Receptor (44)GNRH Receptor (19)Mineralocorticoid Receptor (12)Opioid Receptor (54)Progesterone Receptor (9)PTHR (1)Renin (18)Sepiapterin reductase (2)SSTR (28)Taste receptor (3)Thyroid Hormone Receptor (7)TPO (4)TRHR (1)TSH Receptor (17)TTR (7)
Endoplasmic Reticulum Stress (567)
Antioxidant (33)IRE1 (27)JNK (79)PDI (1)PERK (35)ROS (398)
Epigenetics (2366)
AMPK (105)Aurora Kinase (87)DNA Methyltransferase (43)Epigenetic Reader Domain (396)FTO (15)HDAC (336)HIF (112)Histone Acetyltransferase (95)Histone Demethylase (147)Histone Methyltransferase (294)JAK (245)MBD-containing protein (1)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (157)SF3B1 (3)Sirtuin (129)TET (8)
Ferroptosis Signaling Pathway (78)
ABC Transporter (2)ACC (22)GPx (25)SCD (18)SLC (6)VDAC (6)
GPCR/G Protein (3483)
5-HT Receptor (402)Adenosine Receptor (169)Adenylyl Cyclase (1)Adiponectin Receptor (2)Adrenergic Receptor (184)Amylin receptor (1)Angiotensin Receptor (72)Apelin Receptor (22)Bombesin Receptor (7)Bradykinin Receptor (17)cAMP (34)Cannabinoid Receptor (65)CaSR (23)CCR (89)CGRP Receptor (14)Chemerin Receptor (2)Cholecystokinin Receptor (32)CRF Receptor (19)CXCR (112)Dopamine Receptor (170)Endothelin Receptor (47)Epac (9)G protein (2)GHSR (21)GLP Receptor (25)Glucagon Receptor (50)GNRH Receptor (19)GPCR (203)GPCR19 (2)GPR109A (1)GPR119 (2)GPR139 (3)GPR24 (1)GPR35 (1)GPR40 (7)GPR52 (4)GPR6 (3)GPR68 (2)GPR84 (1)GPR88 (10)Guanylate Cyclase (31)HCAR (2)Histamine Receptor (239)ICMT (61)Kisspeptin Receptor (2)LHCGR (39)LPA Receptor (11)LPL Receptor (118)Melanocortin Receptor (31)mGluR (226)Motilin Receptor (1)MRGPR (13)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NMUR (2)NPFF receptor (3)Opioid Receptor (54)OXTR (10)P2Y Receptor (77)PACAP Receptor (3)PAFR (38)PAR (55)Prostaglandin Receptor (217)Ras (275)RGS (6)RXFP Receptor (14)Sigma Receptor (53)SOS (7)SRPK (51)SSTR (28)SUCNR1 (4)TAAR (8)TSH Receptor (17)Urotensin Receptor (7)Vasopressin Receptor (23)β-arrestin (17)
Hedgehog (Hh) (832)
BMI-1 (3)c-Myc (47)Casein Kinase (101)CDK (475)Cytoplasmic dynein (1)Gli (6)GSK-3 (126)PKA (59)Smo (36)ULK (17)
Hippo (80)
Lats kinase (1)MAP4K (47)MST (2)TEAD (10)YAP (28)
Immunology/Inflammation (2700)
AIM2 (5)AP-1 (14)Arginase (15)Calcineurin (8)CCR (89)CD19 (1)CD20 (2)CD22 (2)CD28 (2)CD28-B7 (1)CD3 (3)CD38 (10)CD47 (6)CD6 (1)CD73 (26)CD80 (1)cGAS (8)Complement System (45)COX (344)CRTH2 (9)CTLA-4 (2)CXCR (112)CYPA (1)FAP (17)FKBP (15)FLAP (17)FPR (17)Galectin (3)Glucocorticoid Receptor (44)Glycoprotein VI (3)GM-CSF (2)Histamine Receptor (239)HMGB (1)IFNAR (24)IL (172)IL Receptor (9)Immunology & Inflammation Related (75)IRAK (71)IRF3 (1)LAG-3 (1)LanC-like protein (1)Legumain (1)LTA4H (3)LTR (71)MALT1 (24)MIF (18)MyD88 (6)NADPH Oxidase (32)NFAT (11)NLR (73)NO Synthesis (6)NOS (186)NOT (1)Nrf2 (99)PD-1/PD-L1 (80)PG Synthase (30)PSMA (13)Pyroptosis (13)ROS (398)Ros1 (18)S100A9 (1)Scavenger receptor (1)SIK (15)SOD (4)SPHK (27)STING (98)TENT (1)Thrombopoietin Receptor (11)Tim3 (4)TLR (163)TSPO (2)VISTA (1)XBP1 (1)
JAK-STAT-Signaling (837)
EGFR (403)JAK (245)Pim (58)STAT (160)
MAPK/ERK Pathway (712)
AP-1 (14)ERK (166)HPK1 (2)JNK (79)KLF (5)MAP3K (24)MAP3K12 (1)MAP4K (47)MAP4K4 (5)MAP4K6 (1)MEK (99)MK2 (11)MLK (14)MNK (11)p38 MAPK (163)Raf (106)RSK (33)TAOK (1)
Membrane Transporter/Ion Channel (1711)
ABC Transporter (2)AKK1 (3)ANT (1)AQP (5)AQP3 (1)ARF (2)ATP synthase (19)ATPase (41)BCRP (23)Calcium Channel (269)CFTR (61)Chloride Channel (30)CRAC Channel (14)CRM1 (17)EAAT (3)Efflux pump (1)ENT (2)Ferroportin (2)GABA Receptor (188)GLUT (32)Glutamate transporter (21)Glycine transporter (23)HCN Channel (2)IBAT (10)ITPKA (2)MAT (24)MCT (17)Na+/Ca2+ Exchanger (15)Na+/K+ ATPase (16)Na/HCO3 cotransporter (1)NKCC (1)Oct (11)OCTN (1)Organic Anion Transporter (1)P-gp (53)P2X Receptor (79)Piezo (4)Potassium Channel (287)Proton Pump (54)SEO1 (1)SGLT (44)SLC (6)Sodium Channel (195)SV2 (2)TRP Channel (182)URAT1 (18)Urea Transporter (2)VDAC (6)VRAC (1)
Metabolic Enzyme (3492)
15-PGDH (2)2OG Oxygenase (1)3-PGDH (2)3MST (1)6PGD (2)ACAT (38)ACC (22)ACMSD (2)Aconitate hydratase (1)ACS (3)Adenosine Deaminase (12)Adenosylhomocysteinase (8)ADP-ribosyltransferase (1)AhR (49)AKR (15)ALDH (30)Aldose Reductase (54)Aminopeptidase (28)Antifolate (31)AO (1)ApoE (1)Arginase (15)Asparagine synthetase (1)ATF/CREB proteins (2)ATP Citrate Lyase (6)ATP synthase (19)BDK (1)Beta-glucuronidase (3)Carbonic Anhydrase (121)Carboxylesterase (23)Carboxypeptidase (7)Cardiolipin Peroxidase (1)Cathepsin (98)Ceramidase (4)CETP (15)Cholesterol Transporter (1)CPA (5)CPSI (2)Creatine kinase (1)Cryptochrome (5)CSE (2)CYP51 (1)D-amino acid oxidase (3)D6D (1)DAPA synthase (1)Decarboxylase (8)Dehydrogenase (156)DGAT (62)DGK (20)Dopamine β-hydroxylase (8)E-NTPDase (1)Elastase (32)Enolase (7)Enteropeptidase (5)ERAP (3)FABP (8)Factor Xa (45)Farnesyl Transferase (4)FAS (35)FBPase (4)Ferroptosis (109)FOXO (3)FPR (17)FTO (15)Fumarate hydratase (2)FVII (2)FXR (71)G0/G1 switch protein 2 (2)Galactosidases (5)GCN (1)GCS (3)GGTase (6)Glucokinase (26)Glucosidase (131)GLUT (32)Glutaminase C (2)Glutathione Reductase (1)Glyoxalase (14)GOAT (1)GPx (25)GSNOR (3)GST (16)Hexokinase (8)HMGCR (45)HPSE (2)Hydrolase (12)Hydroxylase (24)IDH (37)IDO (70)Ketohexokinase (5)LDL (11)LDLR (1)Lipase (93)Lipoxygenase (109)LOX (4)LRH-1 (4)LXR (27)MAGL (2)MASTL (1)MDH (3)MetAP (10)MGAT (7)Mineralocorticoid Receptor (12)Mitochondrial Electron Transport Chain (3)Mitochondrial Metabolism (98)MPC (3)NAMPT (33)Neprilysin (20)NNMT (8)NPP (2)NPR (15)NQO (2)OGT (2)OPA1 (1)P448 (1)P450 (261)PAI-1 (25)PARG (12)PDE (366)PDHK (12)PEPCK (2)PGAM1 (1)PGC-1α (4)PHGDH (5)Phospholipase (108)Phosphorylase (10)PI5P4K (11)PKM1 (2)PKM2 (6)Procollagen C Proteinase (1)Proprotein convertases (5)Pyruvate Kinase (28)QR (2)RAR/RXR (86)RBP (3)REV-ERB (4)ROR (67)SCD (18)sEH (33)SGK (15)SHMT (7)Sialyltransferase (1)Sphingosine acyltransferase (2)SQOR (2)Srx (1)Steroid Sulfatase (8)TDO (3)TGH (1)Thioredoxin (12)Thrombin (43)Thymidylate Synthase (24)Transferase (80)Transketolase (7)TrxR (11)Trypanothione reductase (1)UGT (3)VD/VDR (47)Xanthine Oxidase (49)αKGD (2)
Neuronal Signaling (3852)
5-HT Receptor (402)AAK1 (17)AChE (43)AChR (348)Adenosine Kinase (5)Adrenergic Receptor (184)AMPAR (54)Amylin receptor (1)Amyloid-β (172)Calcium Channel (269)CaMK (54)Cannabinoid Receptor (65)CGRP Receptor (14)Cholecystokinin Receptor (32)Cholinesterase (235)CHT (1)COMT (16)DAT (21)Dopamine Receptor (170)Endorphin (1)Enkephalinase (3)FAAH (45)GABA Receptor (188)Glucosylceramide Synthase (13)GluR (208)GPR119 (2)GPR139 (3)GPR24 (1)Histamine Receptor (239)Huntingtin (3)Imidazoline Receptor (14)Kainate receptor (5)MAO (195)Melanocortin Receptor (31)mGluR (226)MT Receptor (12)NET (3)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NGF (3)NK Receptor (57)NMDA (1)NMDAR (50)Notch (26)Nurr1 (7)OLIG2 (1)Opioid Receptor (54)OX Receptor (50)P2X Receptor (79)Proprotein convertases (5)QC (3)RAGE (3)REST (1)Ryanodine Receptor-1 (1)S100β (1)Secretase (112)SERT (27)Sigma Receptor (53)SMS (4)SSRIs (5)Substance P (2)TAAR (8)Tau Protein (28)TLX (1)Trk Receptor (80)TRP Channel (182)TTR (7)α-synuclein (1)
NF-κB Signaling Pathway (540)
IKK (74)MALT1 (24)NF-κB (419)Nrf2 (99)Pirin (3)RANKL (1)RANKL/RANK (3)RIP Kinase (84)TAK1 (3)
Notch Signaling Pathway (763)
ERK (166)Gli (6)MRCK (2)Notch (26)p53 (41)ROCK (90)TGF-beta/Smad (381)β-catenin (71)
PI3K/AKT/mTOR (1044)
Akt (207)AMPK (105)ATM/ATR (67)DNA-PK (39)FOXO (3)GSK-3 (126)MELK (9)mTOR (187)PDK (22)PDK-1 (3)PI3K (340)PI4K (28)PIKfyve (9)PIN1 (10)PTEN (5)RSK (33)
PPAR Signaling Pathway (2131)
ACS (3)Akt (207)AMPK (105)AQP (5)Bcl-6 (6)FABP (8)FATP (3)IL (172)LXR (27)MMP (179)NF-κB (419)NLR (73)OxPhos (4)PDK-1 (3)PEPCK (2)PPAR (193)RAR/RXR (86)RGS (6)ROS (398)SCD (18)SGK (15)Sirtuin (129)STAT (160)TNF-alpha (30)
Protease (697)
ADAMTS (5)Aspartic Protease (2)Cysteine Protease (24)Dipeptidase 1 (2)DP-IV (2)DPP1 (2)DPP2 (2)DPP4 (72)Glutaminase (25)MMP (179)NEP (4)PE (2)Proteasome (122)Ser/Thr Protease (164)SPP (1)Tyrosinase (100)
Protein Tyrosine Kinase/RTK (2741)
Ack1 (5)ALK (86)Bcr-Abl (105)BMX Kinase (3)BRK (3)BTK (149)c-FMS (60)c-Kit (87)c-Met/HGFR (131)c-RET (64)DDR1/DDR2 Receptor (22)DYRK (60)EGFR (403)Ephrin Receptor (16)ErbB (6)FAK (56)FGF (2)FGFR (136)FLT3 (134)GAK (624)HER2 (31)IGF-1R (28)Insulin Receptor (26)ITK (18)JAK (245)MRCK (2)PDGFR (127)PTK (7)Pyk2 (4)Ros1 (18)SHP2 (48)Src (110)Syk (40)TAM Receptor (50)Tie-2 (16)Trk Receptor (80)VEGFR (271)
Pyroptosis (993)
Caspase (170)Cathepsin (98)IL (172)MyD88 (6)NF-κB (419)TLR (163)
Stem Cells (1527)
BMI-1 (3)Casein Kinase (101)CREB (5)ERK (166)Frizzled (2)Gli (6)GSK-3 (126)Hedgehog (32)JAK (245)LIN28 (4)MST (2)Notch (26)Notum (2)PKA (59)PORCN (10)ROCK (90)sFRP-1 (1)Smo (36)SOD1 (2)STAT (160)TGF-beta/Smad (381)Wnt (104)YAP (28)β-catenin (71)
TGF-beta/Smad (458)
Bcr-Abl (105)PKC (157)ROCK (90)TGF-beta/Smad (381)
Toll-Like Receptor (TLR) (549)
CREB (5)IKK (74)IRAK (71)IRF3 (1)JNK (79)MyD88 (6)p38 MAPK (163)TAK1 (3)TLR (163)
Ubiquitin (370)
DUB (83)E1/E2/E3 Enzyme (142)FBXO (2)NAE (8)p97 (15)Proteasome (122)SUMO (4)
Vitamin D Related/Nuclear Receptor (587)
Androgen Receptor (96)Glucocorticoid Receptor (44)LXR (27)Mineralocorticoid Receptor (12)PPAR (193)Progesterone Receptor (9)RAR/RXR (86)REV-ERB (4)ROR (67)Thyroid Hormone Receptor (7)VD/VDR (47)
Wnt Signaling Pathway (2371)
AP-1 (14)APC (6)ATF/CREB proteins (2)c-Myc (47)Calcineurin (8)CaMK (54)Casein Kinase (101)CDK (475)CREB (5)Frizzled (2)GSK-3 (126)JNK (79)MMP (179)NF-κB (419)NFAT (11)p300/CBP/PROTAC (2)PDE (366)Phospholipase (108)PKC (157)PKG (10)Rho (14)ROCK (90)ROR (67)Wnt (104)β-catenin (71)
Other Inhibitors/Agonists (3218)
20-HETE (2)AIMP2-DX2 (2)Amino Acids and Amino Acid Derivatives (126)Aminoacyl-tRNA Synthetase (18)Anesthetic (3)Anti-inflammation (30)Anti-Thyroid Agent (1)Anti-tumor (7)Anti-ulcer (1)Antioxidant (33)Antispasmodic Agent (3)ASGPR (11)Bcat (11)c-RET (64)Cancer Stem Cells (2)CAR (5)Cardiac transcription factor (2)CBFβ-SMMHC (1)CD20 (2)CD52 (1)CD73 (26)CerK (1)Chelating Agent (15)Choleretic (1)Choline Kinase (3)CNT (1)CRTH2 (9)CSE (2)DCLK (1)DcpS (1)Decarboxylase (8)Dehydrogenase (156)Diabetes (2)Diuretic (1)Drug Metabolite (286)DUE-B (1)E2F (2)ECE (2)Endogenous Metabolite (1247)ERO1 (2)FAP (17)FATP (3)Fer/FerT (1)FPP synthase (1)Fucosyltransferase (4)Fungicide (60)G protein (2)Galectin (3)Galectin-3 (12)GBF1 (1)GCase (4)Glucocorticoid Receptor (44)GRK (21)Herbicide (17)HIPK2 (3)Histidine kinase (1)HNF4α (1)HPPD (3)HRGP (1)Hydroxylase (24)IgE (2)IMP1 (1)Importin β (1)Insecticide (27)ITPKA (2)LAT1 (3)LDL (11)Lipase (93)Lipocalin-2 (1)LYTACs (8)MALAT1 (1)MITF (1)MLKL (4)Molecular Glues (41)MPO (5)MTTP (8)Muscle Relaxant (1)MYOF (1)NAADP (1)Neuroprotection/neurogenic Agent (4)NMD (1)NT (2)Nur77 (8)O-GlcNAcase (9)O-glycosylation (1)OSBP (1)OSBPL (1)OSC (2)Osteoclasts/Bone/Osteogenesis (15)OxPhos (4)PAM complex (1)PANK (2)PAX2 (1)PBR (4)PCA1 (1)PCSK9 (7)PDX1 (1)PEPT (1)PFKFB3 (7)Phosphatase (248)Phosphorylase (10)Photosensitizer (6)PIN1 (10)PKG (10)Platelet (5)PME-1 (2)PMO/MNA (4)PNP (1)PREP (20)Protein Synthesis (4)PXR (3)Quorum Sensing (57)RasGAP (2)Rev-ErbA (3)RUNX (7)SAP (1)SMARC (6)SQS (4)SREBP (5)SRPK (51)Sweetener (3)Tgase (2)Thioredoxin (12)TIR1 (1)TNIK (8)TNK (4)TNNI3K (1)UGT1A1 (1)Urease (5)vanin (4)VDA (1)Vitamin (61)VPS (3)XOR (1)α-amylase (15)Others (2611)
Inhibitory Monoclonal Antibody
Human Inhibitory Monoclonal Antibody (62)
Amyloid-β/monoclonal antibody (2)CA Ⅸ/monoclonal antibody (1)CCR/monoclonal antibody (1)CD19/monoclonal antibody (1)CD20/monoclonal antibody (2)CD22/monoclonal antibody (1)CD25/monoclonal antibody (1)CD3/monoclonal antibody (1)CD38/monoclonal antibody (1)CD4/monoclonal antibody (1)CD40/monoclonal antibody (1)CD47/monoclonal antibody (1)CD52/monoclonal antibody (1)CD6/monoclonal antibody (1)CD62p/monoclonal antibody (1)CD73/monoclonal antibody (1)CGRP Receptor/monoclonal antibody (2)Complement System/monoclonal antibody (1)CTLA-4/monoclonal antibody (1)EGFR/monoclonal antibody (2)HER2/monoclonal antibody (2)IFNAR/monoclonal antibody (1)IgE/monoclonal antibody (2)IGF-1R/monoclonal antibody (1)IL-13/monoclonal antibody (1)IL-17a/monoclonal antibody (1)IL-1β/monoclonal antibody (1)IL-23/monoclonal antibody (2)IL-4Ra/monoclonal antibody (1)IL-5/monoclonal antibody (1)IL-5Rα/monoclonal antibody (1)IL-6/monoclonal antibody (3)Integrin/monoclonal antibody (1)KIR/monoclonal antibody (1)LAG-3/monoclonal antibody (1)PCSK9/monoclonal antibody (2)PD-1/PD-L1/monoclonal antibody (4)RANKL /monoclonal antibody (1)Sclerostin/monoclonal antibody (1)SLAMF7/monoclonal antibody (1)TIGIT/monoclonal antibody (1)Tim3/monoclonal antibody (1)TNF Receptor/monoclonal antibody (3)TNF-alpha/monoclonal antibody (2)TROP2/monoclonal antibody (1)VEGFR/monoclonal antibody (1)
Animal Modeling Reagents
Circulatory System Disease Models (11)
Cardiomyopathy Model (1)Heart Disease Correlation Model (2)Heart Failure Model (1)Hyperlipidemia Model (1)Hypertension Model (3)Thrombolysis Model (2)Vascular Inflammation Model (1)
Digestive System Disease Models (17)
Gallstone Model (1)Gastrointestinal Disease Model (8)Liver Disease Model (5)Pancreatic Disease Model (3)
Endocrine System Disease Models (12)
Aging Model (1)Diabetes Model (4)Hyperuricemia Model (8)
Immune and Inflammatory Disease Models (29)
Arthritis Model (1)Cystitis Model (1)Dermatitis Model (1)Ear Edema Model (1)Encephalomyelitis Model (2)Foot Edema Model (2)Gastrointestinal Inflammation and Ulcer Model (8)Gouty Arthritis Model (1)Liver Inflammation Model (2)Myocarditis Model (2)Nephritis Model (1)Pancreatitis Model (5)Psoriasis Model (3)Systemic Lupus Erythematosus Model (2)
Nervous System Disease Models (10)
Alzheimers Disease Model (3)Epilepsy Model (3)Neuropathic Pain Model (1)Parkinsons Disease Model (3)Schizophrenia Model (1)
Otorhinolaryngological Disease Models (4)
Cataract Model (1)Gingival Hyperplasia Model (2)Optic Neuropathy Model (1)Other Otorhinolaryngological Disease Model (1)
Skin Disease Models (1)
Atopic Dermatitis Model (1)
Tumor Models (9)
Breast Tumor Model (2)Colon Tumor Model (1)Esophageal Tumor Model (1)Kidney Tumor Model (1)Liver Tumor Model (1)Lung Tumor Model (2)Skin Tumor Model (2)Uterine Fibroid Model (1)
Urinary System Disease Models (19)
Aging Model (1)Chronic Kidney Disease Model (2)Diabetes Model (4)Hyperuricemia Model (8)Kidney Stone Model (1)Nephrotoxicity Model (1)Renal Injury Model (5)Other Urinary System Disease Model (3)
Antibiotic and Antivirus
Function (133)
Anti-bacterial Antibiotic (2)Anti-fungal Antibiotic (7)Antivirus (62)Cell Culture Antibiotic (2)Insect Repellent (42)Plant Tissue Culture Antibiotic (2)Preservative and Disinfectant (20)
Structure (8762)
Amino Acid Derivative (3)Aminoglycoside (9)Ansamycin (2)Cephalosporin (7)Chloramphenicol (1)Imidazole (6042)Macrolide (8)Nucleoside (5)Penicillin (3)Pyridine / Pyrimidine (6)Quinolone (19)Sulfonamide (17)Tetracycline (6)β-Lactam (4)Other Antibiotics (35)Others (2611)
Biochemical Reagents
Amino Acids (799)
Amino Acid Amide (17)Biologically Modified Amino Acid (29)C-protective Amino Acid (194)N-protective Amino Acid (438)Non-protein Amino Acid (115)Protein Amino Acid (55)Side Chain Protected Amino Acid (25)
Biological Buffers (2643)
Good's Buffer (19)Other Buffers (13)Others (2611)
Cross-Linking Agents (33)
Amino-amino Crosslinker (7)Amino-sulfhydryl Crosslinker (15)Photoreactive Crosslinker (3)Sulfhydryl-carbonyl Crosslinker (1)Sulfhydryl-sulfhydryl Crosslinker (4)Other Reactive Crosslinkers (3)
Denaturants (2)
Surface Active Agent (2)
Detergents (18)
Amphoteric Surfactant (4)Anionic Surfactant (3)Cationic Surfactant (2)Nonionic Surfactant (6)Sulfonated Betaine (3)
Lipids (219)
Aliphatic Acyl (210)Glycerol Lipid (7)Sphingolipid (2)
Polypeptides (39)
Dipeptide and Tripeptide (36)Oligopeptide (3)
Steroids (2675)
Bile Acid (49)Cholestane (3)Estrogen (1)Plant Sterol (10)Steroidal Glycoside (3)Other Steroids (2)Others (2611)
Sugar and Derivatives (151)
Sugar (137)Sugar Alcohol (15)
Sweeteners (For Research Experiments) (18)
Artificial sweetener (6)Natural sweetener (12)
Cancer
Cancer Stem Cells (2475)
Cathepsin (98)CXCR (112)Hedgehog (32)IL (172)IL Receptor (9)Integrin (134)MIF (18)MMP (179)NF-κB (419)NOS (186)Notch (26)PDGFR (127)PPAR (193)STAT (160)TGF-beta/Smad (381)VEGFR (271)Wnt (104)YAP (28)
Tumor Development and Microenvironment Evolution (1825)
ALK (86)AP-1 (14)CAR (5)CCR (89)Complement System (45)COX (344)DDR1/DDR2 Receptor (22)ErbB (6)GABA Receptor (188)GSK-3 (126)IFNAR (24)IRAK (71)JAK (245)LAG-3 (1)NLR (73)Nrf2 (99)PD-1/PD-L1 (80)STING (98)Syk (40)TLR (163)TNF-alpha (30)TNK (4)
Tumor Epigenetics and Gene Regulation (2861)
Aminoacyl-tRNA Synthetase (18)ATM/ATR (67)DNA Methyltransferase (43)DNA/RNA Synthesis (620)Epigenetic Reader Domain (396)HDAC (336)HIF (112)Histone Acetyltransferase (95)Histone Demethylase (147)Histone Methyltransferase (294)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (157)RNA polymerase 1 (2)Sirtuin (129)TET (8)Topoisomerase (271)
Tumor Growth, Proliferation and Apoptosis (2213)
Akt (207)Aurora Kinase (87)Bcl-2 (195)c-Met/HGFR (131)c-Myc (47)EGFR (403)ERK (166)HER2 (31)MEK (99)MLKL (4)mTOR (187)p53 (41)PI3K (340)PTEN (5)Raf (106)Ras (275)ROR (67)Telomerase (21)
Tumor Metabolism (1274)
ACC (22)ALDH (30)AMPK (105)Arginase (15)ATP Citrate Lyase (6)Dehydrogenase (156)FBPase (4)FTO (15)GLUT (32)Glutaminase (25)Hexokinase (8)IDH (37)IDO (70)MCT (17)MDH (3)NADPH Oxidase (32)OGT (2)P450 (261)PDHK (12)PHGDH (5)PKM2 (6)ROS (398)SHMT (7)SLC (6)SOD (4)SREBP (5)
Cell Biology
Cell Analysis (2)
Cell Proliferation and Cytotoxicity (2)
Cell Apoptosis/Death Detection (1419)
Apoptosis Inducer (1407)Apoptosis Inhibitor (2)Iron death Inhibitor (10)
Cell Culture (292)
Additive and Auxiliary Reagent (130)Cell Assay Reagents (9)Cell Staining (3)Organoid Culture Additive (90)Stem Cell Induction (83)
Enzymology
Enzyme Inhibitors (206)
Acetaldehyde Dehydrogenase Inhibitor (1)Acyltransferase Inhibitor (4)Alkaline Phosphatase Inhibitor (2)Angiotensin Converting Enzyme Inhibitor (4)ATP Enzyme Inhibitor (7)Calcineurin Inhibitor (1)Carbonic Acid Dehydratase Inhibitor (2)Caspase Inhibitor (2)Cyclooxygenase (COX) Inhibitor (47)DNA Topoisomerase II Inhibitor (11)Hypoxia Inducible Factor (HIF) Inhibitor (3)Inosine Monophosphate (IMP) Dehydrogenase Inhibitor (10)Leukotriene A4 Hydrolase Inhibitor (3)Lipoxygenase Inhibitor (11)Monoamine Oxidase Inhibitor (4)NADH Peroxidase Inhibitor (2)Pancreatic Lipase Inhibitor (2)Phosphodiesterase Inhibitor (20)Protease Inhibitor (20)Reverse Transcriptase Inhibitor (16)Starch Glucosidase Inhibitor (3)Thromboxane Synthase Inhibitor (2)Topoisomerase I Inhibitor (8)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)
Enzyme Preparation (63)
Cyclooxygenase (COX) (46)E3 Ubiquitin Ligase (2)Hydrolase (12)Nitric Oxide Metabolism (3)
Enzyme Substrates (4)
Peroxidase Substrate (2)β-Glucuronidase Substrate (2)
Fluorescent Probe / Staining
Cell Biology Fluorescent Dyes (61)
Apoptosis Dyes (6)BODIPY (21)Cytoplasm Dyes (5)Cytotoxicity Analysis Dyes (12)Endocytosis and pinocytosis Dyes (5)Endoplasmic Reticulum Dyes (2)Exosome Dyes (4)Lipid Droplet Dyes (3)Lysosome Dyes (4)Membrane Dyes (4)Mitochondrial Dyes (5)NOS Dyes (6)Nucleic Acid Dyes (1)Nucleus Dyes (10)PH Indicators (18)ROS Dyes (27)
Fluorescence Labeling Reagents (2848)
Anthocyanine (1)Boron Dipyrrole Methylene  (2)Coumarin (8)Danacyl (2)Fluoressin (7)Nitrobenzoxadiazole (NBD) (2)Pyrene (6)Other Fluorescence Labeling Reagents (213)Others (2611)
Fluorescent Dyes (2797)
Acridine Dye (8)Blood Dyes (2)Cancer Analysis Dyes (8)Coumarine Dye (57)Cyanine Dye (25)Neuroscience Analysis Dyes (33)Protein (3)Other Fluorescent Dyes (7)Others (2611)
Molecular Biology
Extraction and Analysis Of Nucleic Acid (5)
Hybridization Reagent (3)Probe (2)
Gene Cloning (21)
Buffer (21)
Nucleic Acid Electrophoresis (5)
Electrophoretic Buffer (3)Gelatin (2)
Natural Products
Acanthaceae (20)
Adhatoda (4)Andrographis (9)Justicia (4)Phlogacanthus (2)Strobilanthes (1)
Aceraceae (2)
Acer (2)
Adiantaceae (2)
Adiantum (2)
Alariaceae (76)
Acanthopanax (5)Aralia (8)Diplopanax (3)Eleutherococcus (3)Hedera (3)Oplopanax (1)Panax (53)
Alismataceae (2)
Alisma (2)
Amaranthaceae (5)
Achyranthes (3)Celosia (1)Cyathula (1)
Amaryllidaceae (23)
Agave (4)Allium (5)Curculigo (10)Lycoris (3)Narcissus (1)
Anacardiaceae (15)
Lannea (1)lodes (1)Mangifera (6)Rhus (4)Toxicodendron (3)
Annonaceae (19)
Annona (2)Fissistigma (6)Goniothalamus (4)Guatteria (1)Miliusa (1)Orophea (2)Polyalthia (2)Uvaria (1)
Apocynaceae (45)
Alstonia (3)Apocynum (1)Aspidosperma (1)Catharanthus (5)Cerbera (5)Kopsia (1)Nerium (10)Plumeria (2)Rauvolfia (9)Thevetia (3)Trachelospermum (4)Voacanga (1)
Aquifoliaceae (3)
Ilex (3)
Araceae (14)
Acorus (10)Eminium (2)Pinellia (2)
Aristolochiaceae (15)
Aristolochia (11)Asarum (3)Holostylis (1)
Asclepiadaceae (19)
Cryptolepis (3)Cynanchum (7)Marsdenia (5)Periploca (4)
Asparagaceae (11)
Eucomis (2)Muscari (1)Scilla (8)
Asteraceae (228)
Achillea (3)Ageratum (1)Ambrosia (2)Arctium (2)Arnica (1)Artemisia (25)Aster (2)Atractylodes (9)Aucklandia (5)Bellis (1)Blumea (4)Cacalia (1)Carpesium (1)Carthamus (7)Centaurea (5)Centipeda (4)Chrysactinia (4)Chrysanthemum (6)Cichorium (2)Cirsium (2)Conyza (1)Coreopsis (1)Cosmos (1)Crepis (3)Cynara (1)Dahlia (2)Dittrichia (1)Doronicum (1)Echinacea (2)Eclipta (6)Elephantopus (1)Erigeron (3)Eupatorium (20)Gnaphalium (1)Gynura (2)Helianthus (4)Heterotheca (1)Inula (8)Kalimeris (1)Laggera (13)Laurentia (1)Ligularia (4)Matricaria (2)Petasites (2)Pulicaria (4)Saussurea (3)Scorzonera (2)Senecio (9)Siegesbeckia (2)Silybum (5)Smallanthus (1)Stevia (10)Tagetes (4)Telekia (1)Tessaria (1)Tussilago (2)Verbesina (1)Vernonia (5)Wedelia (2)Xanthium (6)Zinnia (1)
Athyriaceae (1)
Cystopteris (1)
Balsaminaceae (5)
Impatiens (5)
Berberidaceae (37)
Berberis (3)Bongardia (1)Caulophyllum (2)Dysosma (3)Epimedium (26)Sinopodophyllum (2)
Betulaceae (11)
Alnus (6)Betula (1)Carpinus (1)Corylus (3)
Bignoniaceae (16)
Catalpa (8)Crescentia (2)Incarvillea (1)Kigelia (1)Macfadyena (1)Markhamia (1)Oroxylum (2)
Blechnaceae (1)
Woodwardia (1)
Boraginaceae (18)
Arnebia (2)Echium (1)Ehretia (1)Lithospermum (13)Tournefortia (1)
Burseraceae (11)
Boswellia (3)Canarium (5)Commiphora (3)
Buxaceae (3)
Buxus (3)
By Structure (5433)
Alkaloids (149)Coumarins (21)Lignans (36)Phenols (1786)Phenylpropanane (54)Quinones (35)Natural Products-Other Structure (3377)
Calophyllaceae (8)
Pseudostellaria (2)Stellaria (1)Vaccaria (5)
Campanulaceae (14)
Codonopsis (1)Lobelia (2)Platycodon (10)Sphenoclea (1)
Cannabaceae (11)
Cannabis (3)Humulus (8)
Caprifoliaceae (23)
Lonicera (20)Sambucus (1)Viburnum (2)
Celastraceae (16)
Celastrus (3)Euonymus (2)Maytenus (1)Tripterygium (10)
Cephalotaxaceae (10)
Cephalotaxus (10)
Chenopodiaceae (3)
Kochia (1)Spinacia (1)Suaeda (1)
Chloranthaceae (11)
Chloranthus (10)Sarcandra (1)
Clusiaceae (94)
Alliaria (1)Brassica (6)Calophyllum (6)Cratoxylum (2)Descurainia (1)Eruca (1)Garcinia (47)Hypericum (15)Isatis (2)Lepidium (4)Mammea (1)Mesua (1)Raphanus (3)Sinapis (3)Symphonia (1)
Combretaceae (6)
Calycopteris (1)Combretum (2)Terminalia (3)
Convolvulaceae (2)
Erycibe (1)Ipomoea (1)
Coriariaceae (2)
Coriaria (2)
Cornaceae (2)
Cornus (2)
Crassulaceae (12)
Rhodiola (7)Sedum (5)
Cucurbitaceae (44)
Bolbostemma (1)Bryonia (1)Cucumis (1)Cucurbita (1)Echinocystis (1)Gynostemma (4)Hemsleya (2)Herpetospermum (1)Lagenaria (3)Luffa (1)Momordica (9)Siraitia (17)Trichosanthes (2)
Cupressaceae (11)
Chamaecyparis (2)Juniperus (5)Platycladus (4)
Cyperaceae (5)
Carex (2)Cyperus (3)
Daphniphyllaceae (36)
Aquilaria (10)daphne (3)Daphniphyllum (1)Edgeworthia (1)Excoecaria (1)Pieris (2)Stellera (10)Wikstroemia (8)
Dennstaedtiaceae (1)
Dennstaedtia (1)
Dicksoniaceae (4)
Cibotium (4)
Dioscoreaceae (11)
Dioscorea (11)
Dipsacaceae (2)
Dipsacus (2)
Dryopteridaceae (4)
Dryopteris (4)
Elaeagnaceae (7)
Elaeagnus (2)Hippophae (5)
Equisetaceae (3)
Equisetum (3)
Erythroxylaceae (1)
Erythroxylum (1)
Eucommiaceae (12)
Eucommia (12)
Euphorbiaceae (46)
Breynia (1)Croton (7)Endospermum (1)Euphorbia (10)Excoecaria (1)Flueggea (1)Hevea (3)Jatropha (5)Macaranga (1)Mallotus (1)Phyllanthus (11)Suregada (2)Trigonostemon (2)
Fabaceae (348)
Abrus (1)Acacia (9)Adenanthera (1)Albizia (1)Ammothamnus (1)Antheroporum (1)Astragalus (23)Butea (1)Caesalpinia (18)Cajanus (3)Campylotropis (1)Cassia (26)Cicer (1)Crotalaria (5)Cytisus (3)Dalbergia (10)Derris (13)Desmodium (3)Erythrina (13)Flemingia (3)Genista (1)Glycine (22)Glycyrrhiza (41)Griffonia (1)Hedysarum (1)Lespedeza (5)Leucaena (3)Lotus (5)Lupinus (8)Maackia (4)Medicago (1)Millettia (6)Mimosa (1)Mucuna (2)Ononis (2)Parochetus (2)Phyllodium (1)Pisum (1)Pongamia (1)Prosopis (2)Psoralea (18)Pterocarpus (1)Pterolobium (1)Pueraria (25)Robinia (2)Saraca (1)Senna (1)Sophora (36)Spartium (1)Spatholobus (2)Styphnolobium (1)Trifolium (6)Trigonella (2)Vicia (2)Wisteria (2)
Fagaceae (2)
Castanea (1)Lithocarpus (1)
Gentianaceae (28)
Anthocleista (1)Canscora (1)Gentiana (16)Gentianella (1)Halenia (1)Swertia (8)
Geraniaceae (3)
Geranium (2)Pelargonium (1)
Gesneriaceae (1)
Lysionotus (1)
Ginkgoaceae (9)
Ginkgo (9)
Gnetaceae (4)
Gnetum (4)
Hamamelidaceae (2)
Hamamelis (1)Loropetalum (1)
Hernandiaceae (129)
Ammi (2)Angelica (32)Bupleurum (13)Centella (4)Cnidium (9)Cuminum (1)Ferula (3)Heracleum (13)Hernandia (2)Ledebouriella (1)Ligusticopsis (1)Ligusticum (9)Notopterygium (7)Oenanthe (1)Petroselinum (2)Peucedanum (20)Pimpinella (1)Saposhnikovia (7)Seseli (1)
Hippocastanaceae (5)
Aesculus (5)
Illiciaceae (7)
Illicium (7)
Iridaceae (19)
Belamcanda (8)Crocus (6)Eleutherine (3)Iris (2)
Juglandaceae (6)
Diospyros (2)Engelhardtia (1)Juglans (1)Sesamum (2)
Juncaceae (5)
Juncus (5)
Lamiaceae (140)
Ajuga (2)Ballota (1)Clinopodium (3)Coleus (2)Dracocephalum (3)Elsholtzia (1)Isodon (5)Lamiophlomis (1)Leonurus (9)Marrubium (2)Mentha (4)Mosla (2)Perilla (4)Phlomis (1)Plectranthus (1)Pogostemon (1)Rosmarinus (5)Salvia (45)Scutellaria (40)Stachys (2)Tectona (1)Thymus (5)
Lauraceae (22)
Cinnamomum (7)Cryptocarya (3)Endlicheria (1)Laurus (1)Lindera (4)Litsea (1)Nectandra (2)Ocotea (3)
Lepidoziaceae (1)
Lepidozia (1)
Lichenes (1)
Usnea (1)
Liliaceae (78)
Aloe (4)Anemarrhena (9)Asparagus (1)Dracaena (11)Fritillaria (3)Hosta (1)Lilium (3)Liriope (3)Ophiopogon (28)Paris (8)Polygonatum (3)Smilax (1)Trillium (1)Tupistra (1)Veratrum (1)
Linaceae (2)
Linum (2)
Loganiaceae (5)
Buddleja (2)Gelsemium (1)Strychnos (2)
Loranthaceae (1)
Taxillus (1)
Lycopodiaceae (3)
Lycopodium (3)
Lygodiaceae (1)
Lygodium (1)
Lythraceae (11)
Lawsonia (4)Punica (7)
Magnoliaceae (24)
Liriodendron (4)Magnolia (19)Michelia (1)
Malvaceae (5)
Abelmoschus (1)Gossypium (1)Guazuma (2)Hibiscus (1)
Meliaceae (24)
Aglaia (12)Amoora (2)Aphanamixis (3)Melia (4)Walsura (3)
Menispermaceae (13)
Cocculus (2)Diploclisia (1)Menispermum (1)Stephania (5)Tinospora (3)Triclisia (1)
Moraceae (69)
Artocarpus (2)Broussonetia (13)Cudrania (16)Morus (37)Trilepisium (1)
Moringaceae (7)
Moringa (7)
Musaceae (13)
Musa (10)Musella (3)
Myricaceae (6)
Morella (6)
Myristicaceae (7)
Myristica (7)
Myrsinaceae (1)
Ardisia (1)
Myrtaceae (27)
allspice (1)Eucalyptus (16)Psidium (6)Rhodomyrtus (1)Syzygium (3)
Nartheciaceae (4)
Narthecium (1)Philydrum (1)Xanthorrhoea (2)
Nelumbonaceae (3)
Nelumbo (3)
Nyctaginaceae (33)
Atropa (1)Boerhavia (3)Capsicum (5)Datura (7)Lycium (3)Mirabilis (1)Nicotiana (2)Physalis (4)Solanum (6)Withania (1)
Nyssaceae (52)
Camptotheca (6)Gaultheria (1)Pyrola (2)Rhododendron (5)Vaccinium (38)
Oleaceae (37)
Abeliophyllum (1)Forsythia (12)Fraxinus (4)Jasminum (6)Ligustrum (11)Olax (1)Osmanthus (1)Syringa (1)
Orchidaceae (28)
Anoectochilus (1)Bletilla (2)Cremastra (2)Dendrobium (7)Gastrodia (3)Gymnadenia (8)Pholidota (3)Vanda (1)Vanilla (1)
Orobanchaceae (10)
Cistanche (10)
Paeoniaceae (6)
Paeonia (6)
Palmae (6)
Areca (4)Euterpe (1)Trachycarpus (1)
Pandanaceae (3)
Pandanus (3)
Papaveraceae (26)
Chelidonium (10)Corydalis (8)Glaucium (1)Hylomecon (1)Hypecoum (1)Macleaya (2)Papaver (1)Sanguinaria (2)
Parmeliaceae (4)
Parmelia (4)
Passifloraceae (2)
Passiflora (2)
Pentaphylacaceae (1)
Adinandra (1)
Phyllanthaceae (4)
Securinega (3)Uapaca (1)
Phytolaccaceae (6)
Microtea (1)Phytolacca (5)
Pinaceae (35)
Abies (2)Cedrus (4)Larix (1)Pinus (18)Pseudolarix (9)Tsuga (1)
Piperaceae (28)
Piper (28)
Pittosporaceae (1)
Pittosporum (1)
Plantaginaceae (2)
Picrorhiza (1)Plantago (1)
Plumbaginaceae (2)
Limoniastrum (1)Plumbago (1)
Poaceae (14)
Avena (2)Coix (1)Hordeum (2)Leptochloa (1)Oryza (1)Phyllostachys (1)Poa (2)Saccharum (1)Secale (2)Zea (1)
Podocarpaceae (8)
Podocarpus (8)
Polygalaceae (32)
Polygala (31)Securidaca (1)
Polygonaceae (40)
Atraphaxis (2)Fallopia (3)Polygonum (9)Rheum (22)Rumex (4)
Polypodiaceae (2)
Phymatopteris (2)
Pontederiaceae (1)
Monochoria (1)
Portulacaceae (1)
Talinum (1)
Primulaceae (4)
Lysimachia (3)Primula (1)
Proteaceae (4)
Grevillea (1)Helicia (3)
Ranunculaceae (45)
Aconitum (2)Anemone (6)Cimicifuga (9)Clematis (3)Coptis (7)Delphinium (2)Hydrastis (2)Pulsatilla (10)Semiaquilegia (1)Thalictrum (3)
Resedaceae (1)
Reseda (1)
Rhamnaceae (16)
Hovenia (1)Rhamnus (11)Ziziphus (4)
Rhizophoraceae (3)
Cassipourea (1)Kandelia (2)
Rosaceae (31)
Agrimonia (4)Crataegus (4)Exochorda (5)Filipendula (2)Malus (1)Photinia (1)Potentilla (1)Pourthiaea (1)Prunus (3)Rosa (3)Rubus (3)Sanguisorba (1)Sorbus (1)Spiraea (1)
Rubiaceae (69)
Borreria (1)Cinchona (2)Coffea (3)Emmenopterys (1)Galium (5)Gardenia (11)Hedyotis (8)Knoxia (2)Mitragyna (1)Morinda (4)Mussaenda (1)Nauclea (2)Paederia (5)Pausinystalia (2)Pentas (1)Rubia (14)Uncaria (6)
Rutaceae (162)
Aegle (1)Boenninghausenia (2)Cedrelopsis (1)Citrus (38)Clausena (7)Dictamnus (8)Euodia (1)Evodia (13)Flindersia (1)Fortunella (1)Glycosmis (3)Haplophyllum (3)Melicope (1)Micromelum (11)Murraya (21)Phebalium (2)Phellodendron (8)Ptaeroxylon (1)Ruta (3)Skimmia (1)Tetradium (1)Toddalia (14)Zanthoxylum (20)
Salicaceae (2)
Populus (2)
Santalaceae (3)
Thesium (3)
Sapindaceae (10)
Dodonaea (10)
Saururaceae (6)
Houttuynia (1)Saururus (5)
Saxifragaceae (11)
Astilbe (1)Bergenia (1)Dichroa (3)Hydrangea (5)Penthorum (1)
Schisandraceae (18)
Kadsura (5)Schisandra (13)
Scrophulariaceae (33)
Bacopa (6)Euphrasia (1)Limnophila (1)Linaria (2)Melampyrum (1)Paulownia (1)Pedicularis (2)Picria (3)Rehmannia (12)Scrophularia (4)
Selaginellaceae (3)
Selaginella (3)
Simaroubaceae (32)
Ailanthus (8)Brucea (8)Eurycoma (1)Picrasma (14)Quassia (1)
Sinopteridaceae (17)
Onychium (4)Pteridium (3)Pteris (10)
Stemonaceae (1)
Stemona (1)
Sterculiaceae (4)
Casearia (1)Gynocardia (2)Hydnocarpus (1)
Styracaceae (3)
Styrax (3)
Tamaricaceae (1)
Tamarix (1)
Taxaceae (8)
Taxus (7)Torreya (1)
Taxodiaceae (5)
Cryptomeria (2)Sequoia (3)
Theaceae (9)
Camellia (9)
Tiliaceae (2)
Microcos (1)Tilia (1)
Toricelliaceae (3)
Toricellia (3)
Tropaeolaceae (1)
Tropaeolum (1)
Typhaceae (4)
Typha (4)
Ulmaceae (1)
Ulmus (1)
Valerianaceae (19)
Nardostachys (4)Patrinia (5)Valeriana (10)
Verbenaceae (39)
Callicarpa (10)Clerodendrum (7)Duranta (1)Gmelina (1)Lippia (1)Stachytarpheta (1)Verbena (2)Vitex (16)
Violaceae (7)
Viola (7)
Viscaceae (2)
Viscum (2)
Vitaceae (18)
Ampelopsis (4)Turpinia (2)Vitis (12)
Winteraceae (4)
Drimys (4)
Zingiberaceae (79)
Aframomum (1)Alpinia (25)Amomum (1)Boesenbergia (2)Curcuma (33)Kaempferia (1)Zingiber (16)
Zygophyllaceae (6)
Peganum (4)Tribulus (2)
Pharmaceutical Research
Animal Modeling Agents (46)
Cardio-cerebrovascular Disease Model (2)Diabete Model (1)Inflammation Model (21)Lifestyle-related Disease Model (10)Nervous System Model (5)Pain and Pruritus Model (8)Tumor Model (6)Other Modeling Agents (6)
Classical Positive Drugs (61)
Cardiovascular System (20)Diabete (30)Digestive System (11)
Drug Analysis (663)
Drug Standard (208)Plant Standard (457)
Drug Delivery (560)
Cationic Lipids (119)Cholesterol (10)Fluorescent Lipids (1)Pegylated Lipids (11)Phospholipids (175)
Pharmacy Related (27)
Biomaterial (2)Classical Raw Material Drug (2)Cosolvents (12)Medicinal Excipient (14)
Small Molecule Positive Drugs (2843)
Anti-allergy (5)Anti-inflammation (30)Anti-osteoporosis (2)Anti-rheumatoid Arthritis (6)Anti-tumor (7)Antivirus (62)Depressurization (18)Diabete (30)Neurotransmitter (32)Reduce Blood Lipid (6)Other Compounds (66)Others (2611)
PROTACS
E3 Ligand-Linker Conjugate (166)
CRBN Ligand-Linkers (117)VHL Ligand-Linkers (49)
E3 Ligands (72)
CRBN Inactive Ligand (4)CRBN Ligand (56)IAP Ligand (2)MDM2 Ligand (2)VHL Ligand (8)
Molecular Glue (31)
Bcl-6/PROTAC (3)Casein Kinase 1α/PROTAC (2)Cyclin K/PROTAC (5)GSPT1/PROTAC (5)IKZF1/3/PROTAC (7)mHTT/PROTAC (2)PDE6D/PROTAC (2)RBM39/PROTAC (4)β-catenin/PROTAC (1)
Warhead (1)
Bcr-Abl/Warhead Ligand (1)
Vesicle
Exosome (2591)
ApoE (1)ARF (2)Calcium Channel (269)Ceramidase (4)FGF (2)HBV (151)HIV (447)HSP (161)HSV (75)Integrin (134)LPL Receptor (118)MicroRNA (16)mTOR (187)Neurotransmitter (32)p53 (41)PD-1/PD-L1 (80)Phospholipase (108)Ras (275)STAT (160)TGF-beta/Smad (381)
Parkinson'S Disease and Alzheimer'S Disease (5789)
Akt (207)AMPAR (54)Apoptosis (2143)Caspase (170)CDK (475)CREB (5)Dopamine Receptor (170)Dopamine β-hydroxylase (8)ERK (166)Glucagon Receptor (50)GPCR (203)GSK-3 (126)IL (172)JAK (245)JNK (79)LRRK2 (32)MyD88 (6)NF-κB (419)Notch (26)p53 (41)PI3K (340)PKA (59)PTEN (5)RAGE (3)Ras (275)Rho (14)ROCK (90)ROS (398)Secretase (112)STAT (160)STING (98)Tau Protein (28)TLR (163)TNF (22)Tyrosinase (100)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)Wnt (104)α-synuclein (1)β-catenin (71)
Zoology and Botany
Pesticide Composition (103)
Fungicide (60)Herbicide (17)Insecticide (27)
Home Cart Sign in  
/
Inhibitors/Agonists
/
PI3K/AKT/mTOR
/
mTOR
/
Temsirolimus
/
Inhibitors/Agonists
/
PI3K/AKT/mTOR
/
mTOR
/
Chemical Structure| 162635-04-3 Chemical Structure| 162635-04-3

Structure of Temsirolimus
CAS No.: 162635-04-3

Chemical Structure| 162635-04-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Temsirolimus is an mTOR inhibitor with an IC50 of 1.76 μM, activating autophagy and preventing the deterioration of cardiac function in animal models.

Synonyms: CCI-779; Torisel; Torisel

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

Quality Control of Temsirolimus Purity: 95% SDS Specification
COA

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 NMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 CNMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 HPLC

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 LC-MS

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations      Show More

Leclercq, Gabrielle ; Haegel, Hélène ; Toso, Alberto ; Zimmermann, Tina ; Green, Luke ; Steinhoff, Nathalie , et al.

DOI: PubMed ID:

Abstract: Background: T cell engaging therapies, like chimeric antigen receptor T cells and T cell bispecific antibodies (TCBs), efficiently redirect T cells towards tumor cells, facilitating the formation of a cytotoxic synapse and resulting in subsequent tumor cell killing, a process that is accompanied by the release of cytokines. Despite their promising efficacy in the clinic, treatment with TCBs is associated with a risk of cytokine release syndrome (CRS). The aim of this study was to identify small molecules able to mitigate cytokine release while retaining T cell-mediated tumor killing. Methods: By screening a library of 52 Food and Drug Administration approved kinase inhibitors for their impact on T cell proliferation and cytokine release after CD3 stimulation, we identified mTOR, JAK and Src kinases inhibitors as potential candidates to modulate TCB-mediated cytokine release at pharmacologically active doses. Using an in vitro model of target cell killing by human peripheral blood mononuclear cells, we assessed the effects of mTOR, JAK and Src kinase inhibitors combined with 2+1 T cell bispecific antibodies (TCBs) including CEA-TCB and CD19-TCB on T cell activation, proliferation and target cell killing measured by flow cytometry and cytokine release measured by Luminex. The combination of mTOR, JAK and Src kinase inhibitors together with CD19-TCB was evaluated in vivo in non-tumor bearing stem cell humanized NSG mice in terms of B cell depletion and in a lymphoma patient-derived xenograft (PDX) model in humanized NSG mice in terms of antitumor efficacy. Results: The effect of Src inhibitors differed from those of mTOR and JAK inhibitors with the suppression of CD19-TCB-induced tumor cell lysis in vitro, whereas mTOR and JAK inhibitors primarily affected TCB-mediated cytokine release. Importantly, we confirmed in vivo that Src, JAK and mTOR inhibitors strongly reduced CD19-TCB-induced cytokine release. In humanized NSG mice, continuous treatment with a Src inhibitor prevented CD19-TCB-mediated B cell depletion in contrast to mTOR and JAK inhibitors, which retained CD19-TCB efficacy. Ultimately, transient treatment with Src, mTOR and JAK inhibitors minimally interfered with antitumor efficacy in a lymphoma PDX model. Conclusions: Taken together, these data support further evaluation of the use of Src, JAK and mTOR inhibitors as prophylactic treatment to prevent occurrence of CRS.

Purchased from AmBeed: ; ; ; ;

Leclercq, Gabrielle ;

Abstract: T cell bispecific antibodies (TCBs) are a novel class of T cell engagers redirecting T cells towards tumor cells, facilitating the formation of a cytotoxic synapse and resulting in tumor celllysis. On-target activity of TCBs may come with a risk of Cytokine Release Syndrome (CRS), characterized by elevated levels of pro-inflammatory cytokines in the serum, such as IL-6, IL-1β, TNF-α or IFN-γ and over activation of immune cells. Besides, the expression of the tumorassociated antigen on healthy cells may induce off-tumor activity of the TCB and contribute to inflammation. Despite the use of step-up dosing, glucocorticoids, or tocilizumab to manage or prevent these safety liabilities, they remain the major dose-limiting toxicities associated with the treatment of T cell engagers, highlighting the need to develop preventive mitigation treatments. To this aim, we investigated the biological mechanisms and the chronology of events involved in TCB-mediated cytokine release and explored mitigation strategies that might retain profound treatment efficacy while reducing cytokine release. Using an in vitro co-culture of peripheral blood mononuclear cells (PBMCs) or total leukocytes(PBMCs + neutrophils) and target cells with the respective TCBs, or whole blood treated with a B cell depleting TCB, we confirmed the contribution of T cell and myeloid cells and revealed the role of neutrophils in the TCB-mediated cytokine release. In the same model, the use of anticytokine neutralizing antibodies provided insights into the chronology of events triggering the cascade of cytokines after TCB stimulation. Ultimately this work guided the evaluation of mitigation strategies directed against T-cell derived cytokine release by targeting kinases involved in signaling pathways downstream of the T cell receptor (TCR) after stimulation with TCBs. A novel small molecule-kinase inhibitors screen identified mTOR, JAK and Src inhibitors as candidates to switch-off T-cell derived cytokine release. We validated the effects of these kinase inhibitors and fine-tuned their effective doses in in vitro co-cultures of peripheral blood mononuclear cells (PBMCs) and tumor cells with the respective TCBs. In vivo, we used nontumor or tumor-bearing-humanized NSG mice to assess the effect of mTOR, JAK and Srcinhibitors on CD19-TCB-mediated cytokine release and anti-tumor efficacy. Altogether, we confirmed the biological mechanisms of the TCB-mediated cytokine cascade and revealed the contribution of neutrophils. Our work on kinase inhibitors highlights their differential activities on the inhibition of cytokine release and/or T cell cytotoxicity and demonstrates the decoupling between both mechanisms. Our data open new horizons for the prophylactic mitigation of CRS with the use of FDA approved mTOR and JAK inhibitors or the transient use of the Src inhibitor dasatinib. Finally, our results also indicate that dasatinib may serve as an “antidote” against adverse events related to the treatment with TCBs such as high grade CRS or unpredictable off-tumor activity of TCBs, a strategy which is now implemented the clinic.

Purchased from AmBeed: ; ; ; ;

Alternative Products

Product Details of Temsirolimus

CAS No. :162635-04-3
Formula : C56H87NO16
M.W : 1030.29
SMILES Code : O=C([C@@]1(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@@H](C)C([C@@H]([C@@H](/C(C)=C/[C@H]2C)O)OC)=O)C)OC)O1)C)C(N3CCCC[C@H]3C(O[C@@H](CC2=O)[C@@H](C[C@@H]4C[C@H]([C@H](OC(C(C)(CO)CO)=O)CC4)OC)C)=O)=O
Synonyms :
CCI-779; Torisel; Torisel
MDL No. :MFCD00934421

Safety of Temsirolimus

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Temsirolimus

PI3K-AKT

Isoform Comparison

Biological Activity

Target

  • mTOR

    mTOR, IC50:1.76 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
Caki-1 cells 0.1 μM 24 h B7-H4 gene expression was upregulated PMC9104196
786-O cells 0.1 μM 24 h B7-H4 gene expression was upregulated PMC9104196
A-498 cells 0.1 μM 24 h B7-H4 gene expression was not consistently increased PMC9104196
JN-DSRCT cells 1 mM 9 days To test the effect of Temsirolimus on the proliferation of JN-DSRCT cells, results showed that Temsirolimus significantly inhibited cell proliferation with an IC50 value of 0.042. PMC8980094
OCI-AML3 cells 2.42 μM 24 h Temsirolimus treatment inhibited p-AKT (Ser473) and p-S6 (Ser240/244), upregulated AKT3, and decreased the expression of total AKT and STAT3. PMC5685227
U937 cells 2.42 μM 24 h Temsirolimus treatment inhibited p-AKT (Ser473) and p-S6 (Ser240/244). PMC5685227
Detroit 562 10 μM 2 h and 30 min Temsirolimus predominantly inhibited P70 in Detroit 562 cells with no significant effects on the phosphorylation of MAPK and/or Akt. PMC2360107
HEP2 10 μM 2 h and 30 min Temsirolimus induced Akt activation and blocked P70 in HEP2 cells. PMC2360107
H1_DL2 cells 0.05, 5, 10 µM 72 h Combined use of vemurafenib and temsirolimus inhibited tumor cell growth and proliferation in H1_DL2 cells in vitro, compared to single drug treatment, showing a synergistic effect. PMC4057758
H3 cells 0.05, 5, 10 µM 72 h In H3 cells, the combined treatment was less effective compared to H1_DL2 cells, indicating lower sensitivity to the therapy. PMC4057758
MDCKII-Bcrp1 cells 5 μM 60 min To study the inhibitory effect of Temsirolimus on Bcrp1 functional activity, results showed that Temsirolimus significantly increased cellular accumulation of Vandetanib and eliminated its efflux ratio PMC3402233
MDCK-MDR1 cells 0.5–50μM To study the inhibitory effect of Temsirolimus on P-gp functional activity, results showed that Temsirolimus significantly increased cellular accumulation of [3H]digoxin PMC3402233

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice LmnaH222P/H222P mouse model Intraperitoneal injection 5 mg/kg Once daily for two weeks Temsirolimus improved cardiac function in LmnaH222P/H222P mice by inhibiting mTORC1 activity, reducing left ventricular diameters, increasing fractional shortening, and decreasing mRNA levels of atrial natriuretic peptide. PMC3700376
Mice ALL xenograft model Intraperitoneal 5 mg/kg Daily, 5 days a week To evaluate the antitumor effect of Temsirolimus in the ALL xenograft model, results showed that Temsirolimus exhibited some antitumor activity in the ALL xenograft model. PMC3833621
Nude mice HEP2 and Detroit 562 xenograft models Intraperitoneal injection 20 mg/kg Once daily for 28 days Temsirolimus showed significant tumor growth inhibition in both HEP2 and Detroit 562 xenograft models, and synergistic antitumor effects were observed in the Detroit 562 model when combined with an EGFR inhibitor. PMC2360107
Mice Lymphoma xenograft model Intraperitoneal 5 mg/kg Every other day for 2 weeks Combined oral metformin and Temsirolimus significantly inhibited lymphoma growth and augmented cell autophagy PMC3317343
FVB wild type mice Not specified Intravenously 10mg/kg Single dose To study the effect of Temsirolimus on Vandetanib brain penetration, results showed that Temsirolimus had no significant effect on Vandetanib brain uptake PMC3402233

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03629847 Neuroendocrine Tumors Phase 1 Phase 2 Recruiting December 2018 Saudi Arabia ... More >> Oncology Centre, King Faisal Specialist Hospital & Research Center Recruiting Riyadh, Saudi Arabia, 11211 Contact: Ali Aljubran, MD    966-1-4647272 ext 32084    ajubran@kfshrc.edu.sa    Contact: Lani Cabangon, RN    966-1-4647272 ext 32089    lcabangon06@kfshrc.edu.sa    Sub-Investigator: Hussein Raef          Sub-Investigator: Nora Alkahtani, MD          Sub-Investigator: Shouki Bazarbashi, MD          Sub-Investigator: Ahmed Alzahrani, MD          Sub-Investigator: Mohamed Alsubayel, MD          Sub-Investigator: Monther Kabbani, MD          Sub-Investigator: Hamad Albahli, MD          Sub-Investigator: Hadeel Almana, MD Less <<
NCT01184326 Solid Tumor K... More >>idney Cancer Less << Phase 1 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01184326 - Completed - -
NCT02343718 Recurrent Lymphoma ... More >> Refractory Lymphoma Solid Tumours Central Nervous System Less << Phase 1 Active, not recruiting December 31, 2018 Canada, British Columbia ... More >> Children's and Women's Health Centre of BC Branch Vancouver, British Columbia, Canada, V6H 3V4 Canada, Nova Scotia Izaak Walton Killam (IWK) Health Centre Halifax, Nova Scotia, Canada, B3K 6R8 Canada, Ontario McMaster Children's Hospital Hamilton, Ontario, Canada, L8N 3Z5 Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada, K1H 8L1 Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec CHU Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 Less <<
NCT01170052 Mantle Cell Lymphoma Phase 1 Phase 2 Withdrawn(insufficient enrollm... More >>ent) Less << April 2014 Germany ... More >> Dept. of Hematology and Oncology, Charité, Campus Charité Mitte Berlin, Germany, 10117 Dept. of Hematology and Oncology, Charité, Campus Benjamin Franklin Berlin, Germany, 12203 Dept. of Hematology and Oncology, Charité, Campus Virchow Klinikum Charité Berlin, Germany, 13353 Less <<
NCT00429793 - Completed - -
NCT01430572 Advanced Cancers ... More >> Solid Tumors Less << Phase 1 Active, not recruiting October 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01111825 Breast Cancer Phase 1 Phase 2 Completed - United States, Arizona ... More >> Western Regional Medical Center, Inc. Goodyear, Arizona, United States, 85338 United States, California USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, New York Memorial Sloan Kettering Cancer Center (MSKCC) New York, New York, United States, 10065 Weill Cornell Medical College - New York - Presbyterian Hospital New York, New York, United States, 10065 Denmark Roskilde Hospital Roskilde, Denmark, 4000 France Institut Gustave Roussy Villejuif, France, 94800 Hong Kong UNIMED Medical Institute Wan Chai, Hong Kong Spain Hospital Universitario Sant Joan de Reus Tarragona, Reus, Spain, 43204 Hospital Universitario Vall d'Hebron Barcelona, Spain, 08035 Hospital Universitari Arnau de Vilanova de Lleida Lleida, Spain, 25006 United Kingdom Edinburgh Cancer Center, Western General Hospital Edinburgh, United Kingdom, EH4 2XU The Royal Marsden NHS Foundation Trust London, United Kingdom, SW3 6JJ Less <<
NCT00429793 Fallopian Tube Cancer ... More >> Primary Peritoneal Cavity Cancer Recurrent Ovarian Epithelial Cancer Less << Phase 2 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT01078142 Follicular Lymphoma ... More >> Mantle Cell Lymphoma Less << Phase 1 Phase 2 Completed - Germany ... More >> Universitätsmedizin Mainz Mainz, Rheinland-Pfalz, Germany, 55131 Less <<
NCT01051557 Adult Anaplastic Astrocytoma ... More >> Adult Anaplastic Oligodendroglioma Adult Diffuse Astrocytoma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Mixed Glioma Adult Oligodendroglioma Recurrent Adult Brain Neoplasm Less << Phase 1 Phase 2 Terminated - United States, New Jersey ... More >> Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Commack Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01111825 - Completed - -
NCT01948960 Breast Neoplasms Phase 4 Completed - Netherlands ... More >> Maasziekenhuis Pantein Boxmeer, Netherlands Spaarne Gasthuis Hoofddorp, Netherlands Maastricht University Medical Center Maastricht, Netherlands St. Antonius Ziekenhuis Nieuwegein, Netherlands Radboud university medical center Nijmegen, Netherlands Bernhoven Ziekenhuis Uden, Netherlands Isala Klinieken Zwolle, Netherlands Less <<
NCT01051557 - Terminated - -
NCT01026792 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma Recurrent Cervical Carcinoma Stage IIIA Cervical Cancer Stage IIIB Cervical Cancer Stage IVA Cervical Cancer Stage IVB Cervical Cancer Less << Phase 2 Completed - Canada, Ontario ... More >> National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada, K7L 3N6 Less <<
NCT02138929 Esophageal Cancer Phase 1 Active, not recruiting November 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01026792 - Completed - -
NCT01326468 Head and Neck Cancer Not Applicable Withdrawn(funding) - -
NCT01529138 Cancer Phase 1 Completed - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00770263 Solid Tumors Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01642732 - Terminated(Lack of accrual and... More >> funding expires in June, 2014.) Less << - -
NCT02305810 Pancreatic Neuroendocrine Tumo... More >>ur Metastatic Less << Phase 2 Completed - Italy ... More >> European Institute of Oncology Milan, Italy Less <<
NCT01065662 Endometrial Cancer ... More >> Ovarian Cancer Cervical Cancer Fallopian Tube Cancer Peritoneal Cancer Less << Phase 1 Active, not recruiting December 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01155258 Extensive Stage Small Cell Lun... More >>g Cancer Hereditary Paraganglioma Male Breast Cancer Malignant Paraganglioma Metastatic Gastrointestinal Carcinoid Tumor Metastatic Pheochromocytoma Pancreatic Polypeptide Tumor Recurrent Breast Cancer Recurrent Cervical Cancer Recurrent Endometrial Carcinoma Recurrent Gastrointestinal Carcinoid Tumor Recurrent Islet Cell Carcinoma Recurrent Neuroendocrine Carcinoma of the Skin Recurrent Non-small Cell Lung Cancer Recurrent Ovarian Epithelial Cancer Recurrent Ovarian Germ Cell Tumor Recurrent Pheochromocytoma Recurrent Prostate Cancer Recurrent Renal Cell Cancer Recurrent Small Cell Lung Cancer Recurrent Uterine Sarcoma Regional Gastrointestinal Carcinoid Tumor Regional Pheochromocytoma Stage III Cervical Cancer Stage III Endometrial Carcinoma Stage III Neuroendocrine Carcinoma of the Skin Stage III Ovarian Epithelial Cancer Stage III Ovarian Germ Cell Tumor Stage III Prostate Cancer Stage III Renal Cell Cancer Stage III Uterine Sarcoma Stage IIIA Breast Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Breast Cancer Stage IIIB Non-small Cell Lung Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Stage IV Endometrial Carcinoma Stage IV Neuroendocrine Carcinoma of the Skin Stage IV Non-small Cell Lung Cancer Stage IV Ovarian Epithelial Cancer Stage IV Ovarian Germ Cell Tumor Stage IV Prostate Cancer Stage IV Renal Cell Cancer Stage IV Uterine Sarcoma Stage IVA Cervical Cancer Stage IVB Cervical Cancer Thyroid Gland Medullary Carcinoma Less << Phase 1 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01079286 Renal Cell Cancer ... More >> Cancer Less << Phase 1 Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Netherlands, 1105AZ Less <<
NCT01051791 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Terminated - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01289912 Tuberous Sclerosis Complex Phase 2 Completed - United States, Massachusetts ... More >> Boston Children's Hospital Boston, Massachusetts, United States, 02115 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT01051791 - Terminated - -
NCT02049047 Thymoma and Thymic Carcinoma Phase 2 Active, not recruiting January 2019 Italy ... More >> Istituto Clinico Humanitas Rozzano, MI, Italy, 20089 Less <<
NCT01854606 CD79 Mutant or ABC-subtype Dif... More >>fuse Large B-Cell Lymphoma Less << Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine Dept of Oncology. Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan Kettering Cancer Center Onc. Dept. New York, New York, United States, 10065 United States, Tennessee Sarah Cannon Research Institute Dept of Onc Nashville, Tennessee, United States, 37203 France Novartis Investigative Site Rouen Cedex 1, France, 76038 Germany Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Muenchen, Germany, 81377 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Novartis Investigative Site New Territories, Hong Kong Italy Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Milano, MI, Italy, 20141 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3015 CE Novartis Investigative Site Rotterdam, Netherlands, 3075 EA Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 Less <<
NCT02332902 - Completed - -
NCT00516165 - Completed - -
NCT01642732 Prostate Cancer Phase 1 Terminated(Lack of accrual and... More >> funding expires in June, 2014.) Less << - United States, District of Col... More >>umbia Georgetown University Washington, D.C., District of Columbia, United States, 20057 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT02332902 Neurofibromatosis 1 Phase 2 Completed - United States, Texas ... More >> The University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT00976248 - Completed - -
NCT01289912 - Completed - -
NCT02338570 Renal Cell Carcinoma Phase 4 Terminated(Stopped on November... More >> 16th 2016, because of recruitment failure.) Less << - Italy ... More >> Spedali Civili Brescia, Italy Ospedale A Perrino Brindisi, Italy Istituto Europeo di Oncologia Milano, Italy Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale Napoli, Italy AOU Maggiore della Carità Novara, Italy Casa di Cura La Maddalena Palermo, Italy Unicampus Biomedico Roma, Italy AOU San Giovanni di Dio e Ruggi D'Aragona Salerno, Italy Less <<
NCT00976248 Waldenstrom's Macroglobulinemi... More >>a Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01902160 Recurrent Adult Hodgkin Lympho... More >>ma Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01246817 Renal Cell Cancer PHASE2 UNKNOWN - University Medical Centre Nijm... More >>egen, Nijmegen, Gelderland, 6500 HB, Netherlands Less <<
NCT00516165 Hepatocellular Carcinoma Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01419639 - Completed - -
NCT01773460 Metastatic Breast Cancer Phase 3 Terminated(Study was stopped t... More >>erminated early due to low recruitment.) Less << - Germany ... More >> Klinikum Offenbach Offenbach, Hessen, Germany, 63069 Less <<
NCT01419639 Neurofibromatosis Type II Phase 2 Completed - United States, New York ... More >> New York University Medical Center New York, New York, United States, 10016 Less <<
NCT01514448 Metastatic Renal Cell Carcinom... More >>a (mRCC) Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Chemnitz, Germany, 09130 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Hannover, Germany, 30559 Novartis Investigative Site Hof, Germany, 95028 Novartis Investigative Site Kassel, Germany, 34125 Novartis Investigative Site Langen, Germany, 63225 Novartis Investigative Site Leipzig, Germany, 04357 Novartis Investigative Site Magdeburg, Germany, 39120 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Ravensburg, Germany, 88214 Novartis Investigative Site Velbert, Germany, 42551 Novartis Investigative Site Wiesbaden, Germany, 65191 Novartis Investigative Site Wolfsburg, Germany, 38440 Less <<
NCT00782275 - Completed - -
NCT01525719 Cholangiocarcinoma Phase 2 Unknown June 2014 -
NCT03697408 Classical Hodgkin Lymphoma Phase 1 Phase 2 Not yet recruiting January 2027 United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Terease Waite, RN       Terese.Waite@uphs.upenn.edu    Contact: Tanya Latorre, RN       Tanya.Latorre@uphs.upenn.edu Less <<
NCT00703170 Resistant Solid Malignancies Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00877773 Advanced Cancers PHASE1|PHASE2 TERMINATED 2025-06-14 UT MD Anderson Cancer Center, ... More >>Houston, Texas, 77030, United States Less <<
NCT00877773 Advanced Cancers PHASE1|PHASE2 TERMINATED 2025-06-14 UT MD Anderson Cancer Center, ... More >>Houston, Texas, 77030, United States Less <<
NCT03525834 Renal Angiomyolipoma Phase 4 Recruiting December 29, 2021 China, Hubei ... More >> Novartis Investigative Site Recruiting Wuhan, Hubei, China, 430030 Less <<
NCT02908035 Chronic Limb Ischemia Phase 2 Recruiting September 2019 United States, Arkansas ... More >> Arkansas Heart Hospital Recruiting Little Rock, Arkansas, United States, 72211 Contact: Stacey Tefteller    501-978-8621    Stacey.Tefteller@arheart.com    Principal Investigator: Ian Cawich, MD          United States, California St. Joseph Hospital of Orange Heart and Vascular Center Not yet recruiting Orange, California, United States, 92868 Contact: Sandy Chung       sandy.chung@stjoe.org    Principal Investigator: Mahmood K. Razavi, MD          United States, Colorado Denver Veterans Administration Hospital Recruiting Denver, Colorado, United States, 80220 Contact: Caitlin Kielhorn    303-399-8020 ext 4019    caitlin.kielhorn@ucdenver.edu    Principal Investigator: Ehrin J Armstrong, MD MSc FACC FSCAI FSVM          United States, Illinois Advocate Christ Medical Center Recruiting Oak Lawn, Illinois, United States, 60453 Contact: Christopher Doherty, RN BSN CCRN    708-684-4618    christopher.doherty@advocatehealth.com    Principal Investigator: Jaafer Golzar, MD          United States, Ohio University Hospital Recruiting Cleveland, Ohio, United States, 44106 Contact: Maria Uchbar       Maria.Zeuli@uhhospitals.org    Principal Investigator: Medhi Shishehbor, DO, PHD, MPH          United States, Pennsylvania Einstein Medical Center Recruiting Philadelphia, Pennsylvania, United States, 19141 Contact: Kinnari Murthy, MPH    215-456-6736    MurthyK@einstein.edu    Principal Investigator: Jon George, MD          United States, South Dakota Sanford Research Recruiting Sioux Falls, South Dakota, United States, 57101 Contact: Karla Reilly, RN    605-312-7329    karla.reilly@sanfordhealth.org    Principal Investigator: Angelo Santos, MD          United States, Texas Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Ivan Marin    520-445-9352    Ivan.Marin@bcm.edu    Principal Investigator: Miguel Montero-Baker, MD Less <<
NCT01514448 - Completed - -
NCT01020305 Prostate Cancer ... More >> Prostatic Neoplasms Castrate-resistant Prostate Cancer (CRPC) Androgen-insensitive Prostate Cancer Hormone-refractory Prostate Cancer Metastatic Disease Less << Phase 1 Phase 2 Terminated(Decision by funding... More >> sponsor due to poor accrual) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01596140 Advanced Cancer ... More >> Solid Tumor Less << Phase 1 Active, not recruiting December 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01046045 Chronic Allograft Dysfunction ... More >>in Renal Transplantation Less << Phase 4 Completed - Hong Kong ... More >> Prince of Wales Hospital Hong Kong, Hong Kong Less <<
NCT01020305 - Terminated(Decision by funding... More >> sponsor due to poor accrual) Less << - -
NCT01880749 Neurofibromatosis Type 2 ... More >> Vestibular Schwannomas Meningiomas Less << Early Phase 1 Active, not recruiting December 2019 United States, New York ... More >> New York University School of Medicine New York, New York, United States, 10016 Less <<
NCT00596557 Chronic Rejection of Cardiac T... More >>ransplant Less << Phase 4 Completed - Israel ... More >> Cardiology Department, Rabin Medical Center Petah Tikva, Israel, 49100 Less <<
NCT01008917 Hepatocellular Carcinoma Phase 1 Completed - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 United States, Illinois Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT01412515 Kaposi Sarcoma Phase 2 Terminated(results from interi... More >>m analysis conducted to study interruption) Less << - France ... More >> Hospital Saint Louis Paris, France, 75010 Less <<
NCT01061606 - Terminated(Poor accrual) - -
NCT00446368 Carcinoma, Renal Cell Phase 2 Completed - United States, Texas ... More >> Baylor College of Medicine - Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT01061606 Recurrent Uterine Sarcoma ... More >> Uterine Carcinosarcoma Less << Phase 2 Terminated(Poor accrual) - United States, California ... More >> Tower Cancer Research Foundation Beverly Hills, California, United States, 90211-1850 City of Hope Duarte, California, United States, 91010 Los Angeles County-USC Medical Center Los Angeles, California, United States, 90033 City of Hope Medical Group Inc Pasadena, California, United States, 91105 University of California at Davis Cancer Center Sacramento, California, United States, 95817 United States, Connecticut University of Connecticut Farmington, Connecticut, United States, 06030 Yale University New Haven, Connecticut, United States, 06520 United States, New Jersey Morristown Memorial Hospital Morristown, New Jersey, United States, 07962 The Valley Hospital-Luckow Pavilion Paramus, New Jersey, United States, 07652 United States, New York Women's Cancer Care Associates LLC Albany, New York, United States, 12208 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467-2490 Beth Israel Medical Center New York, New York, United States, 10003 New York University Langone Medical Center New York, New York, United States, 10016 Saint Luke's Roosevelt Hospital Center - Roosevelt Division New York, New York, United States, 10019 Presbyterian-Weill Medical College New York, New York, United States, 10021 Mount Sinai School of Medicine New York, New York, United States, 10029 Children's Hospital of New York Presbyterian New York, New York, United States, 10032 Columbia University College of Physicians and Surgeons New York, New York, United States, 10032 United States, Pennsylvania Penn State Hershey Children's Hospital Hershey, Pennsylvania, United States, 17033 United States, Texas University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT01625156 Adult Solid Neoplasm Phase 1 Completed - United States, Wisconsin ... More >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Wisconsin Clinical Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00982631 Advanced/Recurrent Breast Canc... More >>er Endometrial Cancer Ovarian Cancer Less << Phase 1 Unknown August 2012 Netherlands ... More >> University Medical Center Nijmegen st Radboud Recruiting Nijmegen, Gelderland, Netherlands, 6525 GH Contact: C.M.L van Herpen, md, Phd    +31 24 3610353    c.vanherpen@onco.umcn.nl    Principal Investigator: C.M.L van Herpen, Md, Phd Less <<
NCT01567475 Non-Hodgkin's Lymphomas Phase 1 Completed - France ... More >> Service des Maladies du Sang - CHRU de Lille Lille, France, 59037 Service Hématologie - Hôtel Dieu de NANTES Nantes, France, 44035 Service Hématologie - CHU Lyon Sud Pierre-Bénite, France, 69495 Service Hématologie - Centre Henri Becquerel Rouen, France, 76038 Service Hématologie - Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT01180049 Non-Hodgkin's Lymphoma Phase 4 Completed - -
NCT02809404 - Completed - Netherlands ... More >> Radboud university medical center Nijmegen, Netherlands Less <<
NCT02155920 Recurrent Childhood Ependymoma Phase 2 Completed - United States, California ... More >> Lucile Packard Children's Hospital Stanford University Stanford, California, United States, 94305 United States, New York New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders New York, New York, United States, 10016 United States, Texas UT Southwestern Medical Center / Children's Medical Center Dallas, Texas, United States, 75390 Baylor College of Medicine / Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT01545817 Carcinoma, Renal Cell Phase 2 Terminated(Due to changes in t... More >>he RCC treatment landscape, info gained is no longer clinically relevant to patients. Data collected is deemed sufficient to meet objectives.) Less << - Australia, Australian Capital ... More >>Territory Novartis Investigative Site Garran, Australian Capital Territory, Australia, 2606 Australia, New South Wales Novartis Investigative Site Kogarah, New South Wales, Australia, 2217 Australia, Queensland Novartis Investigative Site Auchenflower, Queensland, Australia, 4066 Novartis Investigative Site Southport, Queensland, Australia, 4215 Australia, South Australia Novartis Investigative Site Elizabeth Vale, South Australia, Australia, 5112 Novartis Investigative Site Kurralta Park, South Australia, Australia, 5037 Novartis Investigative Site Woodville, South Australia, Australia, 5011 Australia, Victoria Novartis Investigative Site Footscray, Victoria, Australia, 3011 Novartis Investigative Site Frankston, Victoria, Australia, 3199 Australia, Western Australia Novartis Investigative Site Nedlands, Western Australia, Australia, 6009 Novartis Investigative Site Perth, Western Australia, Australia, 6001 Korea, Republic of Novartis Investigative Site Gyeonggi-do, Korea, Republic of, 410-769 Novartis Investigative Site Seoul, Korea, Republic of, 110-744 Novartis Investigative Site Seoul, Korea, Republic of, 135-710 Novartis Investigative Site Seoul, Korea, Republic of, 138-736 Less <<
NCT00782275 Renal Cell Carcinoma ... More >> Kidney Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Tennessee Vanderbilt Univeristy Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00998036 Triple Negative Breast Cancer Phase 1 Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00483262 - Completed - -
NCT01997255 Sturge Weber Syndrome Phase 2 Withdrawn(Site did not want to... More >> pursue study) Less << - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00483262 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University in Saint Louis St. Louis, Missouri, United States, 63110 Less <<
NCT00996346 Sarcoma Phase 1 Terminated(Original PI left in... More >>stitution and sponsor decided to end support.) Less << - United States, New Mexico ... More >> University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 Less <<
NCT00996346 - Terminated(Original PI left in... More >>stitution and sponsor decided to end support.) Less << - -
NCT03359538 Amyotrophic Lateral Sclerosis Phase 2 Recruiting September 19, 2019 Italy ... More >> Centro Sla, Irccs A.O.U. S.Martino Ist, Genova Not yet recruiting Genova, Italy Contact: Claudia Caponnetto, MD          Centro Clinico Nemo, Fondazione Serena Onlus, Milano Not yet recruiting Milano, Italy Contact: Christian Lunetta, MD          Centro Sla, Irccs Fondazione Salvatore Maugeri, Milano Not yet recruiting Milano, Italy Contact: Kalliopi Marinou, MD          Centro Sla, Irccs Istituto Carlo Besta, Milano Not yet recruiting Milano, Italy Contact: Eleonora Dalla Bella, MD          Centro Sla, Ospedale Civile S. Agostino Estense, A.O.U. Modena Recruiting Modena, Italy, 41126 Contact: Jessica Mandrioli, MD    +390593961722       Centro Sla, A.O.U. Maggiore Della Carita', Novara Not yet recruiting Novara, Italy Contact: Letizia Mazzini, MD          Centro Sla, Universita' Di Padova Not yet recruiting Padova, Italy Contact: Gianni Sorarù, MD          Centro Sla, Universita' Di Torino Not yet recruiting Torino, Italy Contact: Adriano Chiò, Prof. Less <<
NCT01827943 Relapsed Bladder Cancer PHASE2 COMPLETED 2025-12-16 CHU de Bordeaux, Bordeaux, 330... More >>76, France|Centre Fran?ois Baclesse, Caen, 14076, France|Centre Jean Perrin, Clermont Ferrand, 63011, France|CHU Henri Mondor, Créteil, 94010, France|Centre Léon Bérard, Lyon, 69373, France|H?pital d'instruction des armées du Val-de-Grace, Paris, 75230, France|CHU de Rouen, Rouen, 76031, France|Institut Claudius Regaud, Toulouse, 31052, France|CHU de Toulouse, Toulouse, 31059, France Less <<
NCT00703625 Resistant Solid Malignancies Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01780948 Difference of 12-hour AUC Not Applicable Completed - Thailand ... More >> King Chulalongkorn Memorial Hospital Bangkok, Thailand, 10330 Less <<
NCT00933374 Bladder Cancer Phase 2 Terminated(delayed recruitment... More >>) Less << - Germany ... More >> Klinik für Urologie, Klinikum rechts der Isar der TU München München, Bavaria, Germany, 81675 Heinrich-Heine-University of Duesseldorf, Department of Urology Duesseldorf, NRW, Germany, 40225 Universitätsklinik Essen, Klinik für Urologie Essen, NRW, Germany, 45122 Klinik für Urologie, Universitätsklinikum Muenster Muenster, NRW, Germany, 48149 Klinik für Urologie und Kinderurologie, Universitätsklinikum des Saarlandes Homburg, Saarland, Germany, 66421 Universitätsklinik Hamburg, Medizinische Klinik und Poliklinik Onkologie - Hämatologie Hamburg, Germany, 20246 Less <<
NCT01172769 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 2 Completed - Germany ... More >> Charitè Berlin Campus Benjamin Franklin Medical Clinic III Berlin, Germany, 12203 Ev. Bethesda- Johanniter Klinikum GmbH Clinic for Heamatology and medical Oncology Duisburg, Germany, 47228 Universitaetsklinikum Essen Clinic and Policlinic for internal medicine (Cancerresearch) Essen, Germany, 45147 Universitätsklinikum Halle Clinic and Policlinic of internal Medicine IV Halle, Germany, 06120 Medical School Hannover Clinic for Heamatology, Hemostaseology, Oncology and stem cell transplantation Hannover, Germany, 30625 Universitätsklinikum Jena Clinic for Ear, Nose and Throat Jena, Germany, 07743 Universitätsklinikum Leipzig Clinic and Policlinic for Ear, Nose and Thorat Leipzig, Germany, 04103 Less <<
NCT01567930 Unresectable or Metastatic Hep... More >>atocellular Carcinoma Less << PHASE2 UNKNOWN 2025-03-13 Boston Baskin Cancer Foundatio... More >>n, Memphis, Tennessee, 38120, United States Less <<
NCT01517243 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Active, not recruiting December 2018 United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, Vermont University of Vermont, Vermont Cancer Center Burlington, Vermont, United States, 05401 Less <<
NCT01180049 - Completed - -
NCT01122615 Renal Cell Cancer ... More >> Kidney Cancer Less << Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01490476 Neurofibromatosis 2 Phase 2 Completed - France ... More >> Hôpital Beaujon, 100 boulevard du Général Leclerc Clichy, France, 92110 Less <<
NCT00887640 - Terminated - -
NCT00919035 - Completed - -
NCT00887640 Prostate Cancer Phase 2 Terminated - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 Less <<
NCT00921310 Carcinoma, Non-Small-Cell Lung Phase 1 Phase 2 Terminated(Withdrawal of fundi... More >>ng from sponsor) Less << - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01210482 Renal Cell Carcinoma COMPLETED 2018-05-31 Kyusyu University Hospital, Fu... More >>kuoka-shi, Fukuoka PREF, Japan Less <<
NCT00563147 Renal Cell Carcinoma Phase 1 Completed - United States, California ... More >> UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 Stanford University Stanford, California, United States, 94305 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, Texas The Methodist Hospital Research Institute Houston, Texas, United States, 77030 Less <<
NCT00919035 Prostate Cancer Phase 2 Completed - United States, Illinois ... More >> Oncology Specialists, SC Niles, Illinois, United States, 60714 Oncology Specialists, S.C. Park Ridge, Illinois, United States, 60068 Less <<
NCT00921310 - Terminated(Withdrawal of fundi... More >>ng from sponsor) Less << - -
NCT01016769 Squamous Cell Cancer ... More >> Head and Neck Cancer Less << Phase 1 Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States, 07939 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT01281943 Liver Neoplasms Phase 2 Withdrawn(Doxil Shortage) May 2014 -
NCT01420601 - Completed - Japan ... More >> Kinki University Hospital Osakasayama, Osaka, Japan, 589-8511 Less <<
NCT01851408 Melanoma Recu... More >>rrent Melanoma Stage III Melanoma Stage IV Melanoma Less << Phase 2 Withdrawn(No progression of Ph... More >>ase 1 trial to Phase 2.) Less << - -
NCT00796796 Carcinoma, Non-Small-Cell Lung Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT02420613 Diffuse Intrinsic Pontine Glio... More >>ma Less << Phase 1 Recruiting October 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01025453 Thyroid Cancer Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT01025453 - Completed - -
NCT01074086 AML Phase 1 Completed - France ... More >> Sophie Park Paris, France, 75014 Less <<
NCT01281917 Non-Hodgkins Lymphoma Phase 2 Completed - United States, South Dakota ... More >> Rapid City Regional Hospital John T. Vucurevich Cancer Care Institute Rapid City, South Dakota, United States, 57701 United States, Wisconsin Aurora Baycare Medical Center-GreenBay Green Bay, Wisconsin, United States, 54143 St Vincent Regional Cancer Center CCOP Green Bay, Wisconsin, United States, 54301 Bellin Memorial Hospital, Inc Green Bay, Wisconsin, United States, 54313 Gunderson Lutheran Health System La Crosse, Wisconsin, United States, 54601 UW Health Oncology- 1 S Park Madison, Wisconsin, United States, 53715 University Of Wisconsin Cancer Center Madison, Wisconsin, United States, 53792 Aurora BayCare Medical Center Marinette, Wisconsin, United States Marshfield Clinic Marshfield, Wisconsin, United States, 54449 Columbia St Mary's, Inc Milwaukee, Wisconsin, United States, 53211 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Aurora Sheboygan Memorial Medical Center Sheboygan, Wisconsin, United States, 53081 Aurora Medical Center in Summit Summit, Wisconsin, United States, 53066 Aurora Medical Center in Two Rivers Two Rivers, Wisconsin, United States, 54241 Waukesha Memorial Hospital Waukesha, Wisconsin, United States, 53188 Aspirus Wausau Hospital Wausau, Wisconsin, United States, 54401 Aurora Health Care Metro, Inc. Wauwatosa, Wisconsin, United States, 53226 UW Cancer Center-Riverview Wisconsin Rapids, Wisconsin, United States, 54494 Less <<
NCT01281917 - Completed - -
NCT01529593 Advanced Cancers Phase 1 Recruiting March 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01417065 Advanced Cancer EARLY_PHASE1 COMPLETED - UT MD Anderson Cancer Center, ... More >>Houston, Texas, 77030, United States Less <<
NCT01063478 Non-Small Cell Lung Cancer Phase 1 Terminated(Poor accrual) - United States, Illinois ... More >> University of Chicago Medical Center Chicago, Illinois, United States, 60637 Less <<
NCT01509560 Condition After Allogenic Peri... More >>pheral Stem Cell Transplantation (SCT) Less << Phase 2 Completed - Germany ... More >> Zentrum für Knochenmark- und Blutstammzelltransplantation, Wiesbaden, Hessen, Germany, 65191 Less <<
NCT01158651 Glioma Phase 2 Active, not recruiting December 2018 United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Illinois Children's Lurie Hospital Chicago, Illinois, United States, 60611 University of Chicago Chicago, Illinois, United States, 60637 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, Missouri Washington University Saint Louis, Missouri, United States, 63110 United States, New York New York University Medical Center New York, New York, United States, 10016 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19096 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Less <<
NCT00823459 Low-grade Glioma ... More >> Astrocytoma Oligodendroglioma Mixed Oligoastrocytoma Less << Phase 2 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 Less <<
NCT00942747 Recurrent or Refractory Primar... More >>y CNS Lymphoma Less << Phase 2 Unknown June 2014 Germany ... More >> Charité Campus Benjamin Franklin Recruiting Berlin, Germany, 12200 Contact: Agnieszka Korfel, MD    +49308445 ext 4096    agnieszka.korfel@charite.de    Contact: Philipp Kiewe, MD    +493064499 ext 5225    philipp.kiewe@charite.de    Sub-Investigator: Philipp Kiewe, MD          Principal Investigator: Agnieszka Korfel, MD          Sub-Investigator: Martin Neumann, MD          Sub-Investigator: Stephan Kreher, MD          Neurology, Knappschaftskrankenhaus Bochum, Bochum University Recruiting Bochum, Germany, 44892 Contact: Uwe Schlegel, MD    +49-2342993701    simone.middelhauve@kk-bochum.de    Contact: Simone Middelhauve    +49-2342993701    simone.middelhauve@kk-bochum.de    Neurology, University Hospital Bonn Recruiting Bonn, Germany, 53127 Contact: Ulrich Herrlinger, MD    +49-222828719887    christiane.landwehr@ukb.uni-bonn.de    Contact: Christiane Landwehr    +49-222828719887    christiane.landwehr@ukb.uni-bonn.de    Hematology, Klinikum Frankfurt/Oder Not yet recruiting Frankfurt an der Oder, Germany, 15236 Contact: Michael Kiel, MD    +4933-55484604    melanie.binsker@klinikum-ffo.de    Contact: Melanie Binsker    +4933-55484604    melanie.binsker@klinikum-ffo.de    Hematology, University Hospital Heidelberg Not yet recruiting Heidelberg, Germany, 69120 Contact: Gerlinde Egerer, MD    +49-6221568029    martina.gronkowski@med.uni-heidelberg.de    Contact: Martina Gronkowski    +49-6221568029    martina.gronkowski@med.uni-heidelberg.de    Klinikum Grosshadern, University Hospital Munich Recruiting Munich, Germany, 81377 Contact: Martin Dreyling, MD    +498970955202    carmen.carlucci@med.uni-muenchen.de    Contact: Carmen Carlucci    +498970955202    carmen.carlucci@med.uni-muenchen.de Less <<
NCT01049841 Pediatric Solid Tumors Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01204450 Brain and Central Nervous Syst... More >>em Tumors Neuroblastoma Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Terminated(Funding has become ... More >>unavailable) Less << - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Carolina Healthcare System Charlotte, North Carolina, United States Less <<
NCT01404104 Renal Cell Carcinoma Not Applicable Completed - Canada, Ontario ... More >> St. Joseph's Healthcare Hamilton Hamilton, Ontario, Canada, L8N 4A6 Less <<
NCT01653067 Diffuse Large B-Cell Lymphoma Phase 2 Unknown July 2018 Germany ... More >> University Hospital Freiburg Freiburg, Baden-Württemberg, Germany, 79106 University of Heidelberg Hospital Heidelberg, Baden-Württemberg, Germany, 69120 University Hospital Ulm Ulm, Baden-Württemberg, Germany, 89081 University Hospital Erlangen Erlangen, Bayern, Germany, 91054 Ludwig-Maximilians-University of Munich Munich, Bayern, Germany, 81377 Technische Universität München Munich, Bayern, Germany, 81675 Johann Wolfgang Goethe University Hospitals, Frankfurt Frankfurt, Hessen, Germany, 60590 Johannes Guttenberg University Mainz Mainz, Rheinland-Pfalz, Germany, 55101 Charité University Berlin Berlin, Germany, 12200 Less <<
NCT01050985 Advanced Solid Tumors Phase 1 Completed - United States, District of Col... More >>umbia Georgetown University Medical Center Washington, District of Columbia, United States, 20057 Less <<
NCT02389309 Solid Tumors Phase 1 Recruiting October 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00838955 Hodgkin's Lymphoma PHASE2 TERMINATED 2025-10-17 Loyola Univeristy Medical Cent... More >>er, Cardinal Bernardin Cancer Center, Maywood, Illinois, 60153, United States Less <<
NCT02093598 Carcinoma, Endometrioid|mTOR P... More >>rotein Less << PHASE2 COMPLETED 2025-03-14 Barcelona, Spain|Madrid, Spain... More >>|Valencia, Spain Less <<
NCT01072890 Solid Tumors Phase 1 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT00790036 Diffuse Large B-cell Lymphoma Phase 3 Completed - -
NCT01804374 Metastatic Osteosarcoma ... More >> Relapsed Osteosarcoma Less << Phase 2 Completed - Italy ... More >> Fondazione del Piemonte per l'Oncologia IRCC Candiolo Candiolo, Torino, Italy, 10060 Less <<
NCT01061788 Advanced Solid Tumors, Non-sma... More >>ll Cell Lung Cancer Less << Phase 1 Active, not recruiting June 2019 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00112840 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 1 Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT01936519 Immunosuppression ... More >> Renal Failure Less << Not Applicable Active, not recruiting December 2019 United States, Pennsylvania ... More >> Penn State College of Medicine; Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT00526591 Prostate Cancer Phase 2 Terminated(Slow accrual) - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT03243019 Lymphatic Malformation ... More >> Pediatric Less << Phase 2 Recruiting February 2022 France ... More >> Hôpital Jeanne de Flandres, CHU Recruiting Lille, France Principal Investigator: pierre Fayoux, MD Less <<
NCT00363051 Islet Cell Carcinoma ... More >> Neuroendocrine Carcinoma Neuroendocrine Tumor Pancreatic Neoplasms Less << Phase 2 Completed - -
NCT00790036 - Completed - -
NCT00363051 - Completed - -
NCT00631371 Renal Cell Carcinoma Phase 3 Completed - -
NCT01242631 Testicular Cancer ... More >> Germ Cell Cancer Less << Phase 2 Completed - Germany ... More >> Vivantes Klinikum am Urban Berlin, Germany, 10967 Universitatsklinikum Essen Essen, Germany, 45122 Universitatsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Hannover Medical School Hannover, Germany, 30625 Universitatsklinikum Schieswig-Holstein - Campus Kiel Kiel, Germany, 24105 Universitatsklinikum Marburg Marburg, Germany, 35043 Klinikum Harlaching München München, Germany, 81545 Universitatsklinikum der Eberhard-Karls-Universitat Tübingen Tübingen, Germany, 72076 Less <<
NCT00788060 Renal Cell Carcinoma Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27705 Less <<
NCT00112840 - Completed - -
NCT02842749 Pancreatic Neuroendocrine Tumo... More >>rs Less << Phase 4 Recruiting December 2, 2024 China, Beijing ... More >> Novartis Investigative Site Recruiting Beijing, Beijing, China, 100730 China, Shanghai Novartis Investigative Site Recruiting Shanghai, Shanghai, China, 200032 China Novartis Investigative Site Recruiting Beijing, China, 100039 Novartis Investigative Site Recruiting Guangzhou, China, 510060 Less <<
NCT00411619 - Completed - -
NCT01076543 AIDS-Related Hodgkin Lymphoma ... More >> Recurrent Adult Hodgkin Lymphoma Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Non-Hodgkin Lymphoma Recurrent T-Cell Non-Hodgkin Lymphoma Waldenstrom Macroglobulinemia Less << Phase 1 Phase 2 Active, not recruiting - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Illinois CancerCare-Peoria Peoria, Illinois, United States, 61615 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62702 Southern Illinois University School of Medicine Springfield, Illinois, United States, 62702 United States, Indiana Fort Wayne Medical Oncology and Hematology Inc-Parkview Fort Wayne, Indiana, United States, 46845 Indiana University/Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Missouri Mercy Hospital Saint Louis Saint Louis, Missouri, United States, 63141 Less <<
NCT00631371 - Completed - -
NCT01566279 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Not Applicable Completed - Netherlands ... More >> NKI-AVL Amsterdam, Noord Holland, Netherlands, 1066 CX Erasmus Medical Center Rotterdam, Zuid Holland, Netherlands, 3075 EA University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Less <<
NCT00526591 - Terminated(Slow accrual) - -
NCT00494091 Advanced Renal Cell Carcinoma Phase 2 Completed - China, Jiangsu ... More >> Pfizer Investigational Site Nanjing, Jiangsu, China, 210002 China Pfizer Investigational Site Beijing, China, 100021 Pfizer Investigational Site Beijing, China, 100036 Pfizer Investigational Site Beijing, China, 100730 Pfizer Investigational Site Shanghai, China, 200032 Pfizer Investigational Site Shanghai, China, 200127 Japan Pfizer Investigational Site Chiba, Japan Pfizer Investigational Site Fukuoka, Japan Pfizer Investigational Site Gunma, Japan Pfizer Investigational Site Hokkaido, Japan Pfizer Investigational Site Ibaraki, Japan Pfizer Investigational Site Kagawa, Japan Pfizer Investigational Site Kagoshima, Japan Pfizer Investigational Site Kyoto, Japan Pfizer Investigational Site Nara, Japan Pfizer Investigational Site Okayama, Japan Pfizer Investigational Site Osaka, Japan Pfizer Investigational Site Shizuoka, Japan Pfizer Investigational Site Tokyo, Japan Pfizer Investigational Site Yamagata, Japan Korea, Republic of Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Pfizer Investigational Site Seoul, Korea, Republic of, 120-752 Pfizer Investigational Site Seoul, Korea, Republic of, 135 710 Pfizer Investigational Site Seoul, Korea, Republic of, 138-736 Less <<
NCT00494091 - Completed - -
NCT00928798 Birt-Hogg-Dubé Syndrome Phase 3 Completed - Netherlands ... More >> VU Medical Centre Amsterdam Amsterdam, Netherlands, 1081 HV Maastricht University Medical Centre Maastricht, Netherlands, 6229 HX Less <<
NCT01648465 Gastrointestinal Tumors ... More >> Pancreatic Tumors Gastrointestinal Neuroendocrine Tumors Pancreatic Neuroendocrine Tumors Less << Phase 2 Active, not recruiting September 2018 Greece ... More >> 2nd Dept of Internal Medicine, Agios Savvas Cancer Hospital Athens, Greece, 11522 Dept of Medical Oncology, 251 General Airforce Hospital Athens, Greece, 11525 2nd Dept of Internal Medicine, General Hospital of Athens "Hippokratio" Athens, Greece, 11527 2nd Dept of Internal Medicine, Propaedeutic, University Hospital "Attikon" Athens, Greece, 12462 4th Dept of Internal Medicine, University Hospital "Attiko" Athens, Greece, 12462 3rd Dept of Medical Oncology, Agii Anargiri Cancer Hospital Athens, Greece, 14564 2nd Dept of Medical Oncology, Metropolitan Hospital Athens, Greece, 18547 Dept of Medical Oncology, University Hospital of Heraklion Heraklion, Greece, 71110 Dept of Medical Oncology, Ioannina University Hospital Ioannina, Greece, 45110 Division of Oncology, Dept of Internal Medicine, University Hospital of Patras Patra, Greece, 26504 Dept of Medical Oncology, Papageorgiou General Hospital Thessaloniki, Greece, 56429 Dept of Medical Oncology, Thermi Clinic Thessaloniki, Greece, 57001 Less <<
NCT01256385 Recurrent Hypopharyngeal Squam... More >>ous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Recurrent Laryngeal Verrucous Carcinoma Recurrent Lip and Oral Cavity Squamous Cell Carcinoma Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma Recurrent Oral Cavity Verrucous Carcinoma Recurrent Oropharyngeal Squamous Cell Carcinoma Recurrent Salivary Gland Carcinoma Salivary Gland Squamous Cell Carcinoma Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary Stage IV Hypopharyngeal Squamous Cell Carcinoma Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma Stage IVA Laryngeal Squamous Cell Carcinoma Stage IVA Laryngeal Verrucous Carcinoma Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma Stage IVA Major Salivary Gland Carcinoma Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage IVA Oral Cavity Verrucous Carcinoma Stage IVA Oropharyngeal Squamous Cell Carcinoma Stage IVB Laryngeal Squamous Cell Carcinoma Stage IVB Laryngeal Verrucous Carcinoma Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma Stage IVB Major Salivary Gland Carcinoma Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage IVB Oral Cavity Verrucous Carcinoma Stage IVB Oropharyngeal Squamous Cell Carcinoma Stage IVC Laryngeal Squamous Cell Carcinoma Stage IVC Laryngeal Verrucous Carcinoma Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma Stage IVC Major Salivary Gland Carcinoma Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage IVC Oral Cavity Verrucous Carcinoma Stage IVC Oropharyngeal Squamous Cell Carcinoma Tongue Carcinoma Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Colorado University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Loyola University Medical Center Maywood, Illinois, United States, 60153 Illinois CancerCare-Peoria Peoria, Illinois, United States, 61615 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62702 Southern Illinois University School of Medicine Springfield, Illinois, United States, 62702 United States, Indiana Fort Wayne Medical Oncology and Hematology Inc-Parkview Fort Wayne, Indiana, United States, 46845 Indiana University/Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Metro Minnesota Community Oncology Research Consortium Saint Louis Park, Minnesota, United States, 55416 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Mercy Hospital Saint Louis Saint Louis, Missouri, United States, 63141 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 China, Hong Kong Chinese University of Hong Kong-Prince of Wales Hospital Shatin, Hong Kong, China, OX1 3UJ Less <<
NCT01026623 Hormone-Resistant Prostate Can... More >>cer Prostate Adenocarcinoma Recurrent Prostate Carcinoma Stage IV Prostate Cancer Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT03324373 Renal Cell Carcinoma Phase 1 Not yet recruiting April 30, 2021 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Yousef Zakharia, MD    319-384-8076    yousef-zakharia@uiowa.edu Less <<
NCT00934895 Breast Cancer Phase 1 Phase 2 Terminated(Closed early due to... More >> slow accrual) Less << - United States, New Jersey ... More >> Cooper Hospital/University Medical Center Camden, New Jersey, United States, 08103 Rutgers Cancer Institute of New Jersey (Hamilton) Hamilton, New Jersey, United States, 08690 Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT00411619 Tuberous Sclerosis ... More >> Subependymal Giant Cell Astrocytoma Less << Phase 1 Phase 2 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT01035229 Carcinoma Phase 3 Completed - -
NCT01256385 - Completed - -
NCT01070316 Epilepsy Tube... More >>rous Sclerosis Complex Less << Phase 1 Phase 2 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT03355794 Diffuse Intrinsic Pontine Glio... More >>ma Malignant Glioma of Brain High Grade Glioma Bithalamic High Grade Glioma Brainstem Glioma Glioblastoma Anaplastic Astrocytoma Less << Phase 1 Recruiting January 1, 2022 United States, District of Col... More >>umbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Eugene Hwang, MD    202-476-5046    ehwang@childrensnational.org    United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Not yet recruiting Chicago, Illinois, United States, 60611 Contact: Stewart Goldman, MD    312-227-4090    Sgoldman@luriechildrens.org    United States, North Carolina Levine Cancer Institute Recruiting Charlotte, North Carolina, United States, 28204 Contact: David A Gass, MD    704-381-9900    David.Gass@atriumhealth.org    United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Mariko DeWire, MD    513-803-1126    mariko.dewire-schottmiller@cchmc.org    Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Laura Fossett    513-636-9419    Laura.Fossett@cchmc.org    United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Patricia Baxter, MD    832-824-4681    pabaxter@txch.org    United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Sarah Leary, MD    206-987-2106    CBDCIntake@seattlechildrens.org Less <<
NCT01014234 Kidney Transplantation Phase 2 Completed - Italy ... More >> Policlinico Fondazione IRCCS "San Matteo" Pavia, Italy, 27100 Less <<
NCT01070316 - Completed - -
NCT01935128 Renal Transplant Phase 4 Active, not recruiting December 2020 United States, Ohio ... More >> University of Toledo, Health Science Campus Toledo, Ohio, United States, 43614 Less <<
NCT00729482 Stomach Neoplasm Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa, Korea, Republic of, 138-736 Less <<
NCT01035229 - Completed - -
NCT02017860 Neoplasms Phase 2 Active, not recruiting October 31, 2019 Japan ... More >> Novartis Investigative Site Matsuyama, Ehime, Japan, 791-0280 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Osaka-city, Osaka, Japan, 540-0006 Novartis Investigative Site Kitaadachi-gun, Saitama, Japan, 362-0806 Less <<
NCT00729482 - Completed - -
NCT01263951 Differentiated Thyroid Cancer Phase 2 Active, not recruiting - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01016015 - Completed - -
NCT02736227 Liver Transplantation Not Applicable Recruiting March 2019 United States, Illinois ... More >> Northwestern University Comprehensive Transplant Center Recruiting Chicago, Illinois, United States, 60611 Contact: Josh Levitsky, MD    312-695-4413 Less <<
NCT02273752 Estrogen Receptor-positive Bre... More >>ast Cancer Gastrinoma Glucagonoma HER2-negative Breast Cancer Insulinoma Mucositis Oral Complications Pancreatic Polypeptide Tumor Progesterone Receptor-positive Breast Cancer Recurrent Breast Cancer Recurrent Islet Cell Carcinoma Recurrent Renal Cell Cancer Somatostatinoma Stage III Renal Cell Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Stage IV Renal Cell Cancer Less << Phase 2 Terminated(Slow accrual) - United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT02273752 - Terminated(Slow accrual) - -
NCT02188550 Ovarian Cancer ... More >> Endometrial Cancer Less << Phase 2 Unknown - United States, Maryland ... More >> Sinai Hospital of Baltimore, Inc. Recruiting Baltimore, Maryland, United States, 21215 Contact: Judy Bosley, BSN, RN    410-601-6120    jbosley@lifebridgehealth.org    Contact: Melissa Loomis    410-601-6120    mloomis@lifebridgehealth.org    Principal Investigator: Kenneth Miller, M.D. Less <<
NCT01620307 H1N1 Pneumonia ... More >> Hypoxemia Less << Phase 2 Completed - -
NCT01016015 Metastatic Osteosarcoma ... More >> Recurrent Adult Soft Tissue Sarcoma Recurrent Osteosarcoma Stage III Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Less << Phase 2 Completed - -
NCT01034631 Renal Cell Carcinoma Phase 1 Phase 2 Completed - -
NCT02812940 Graft-versus-Host Disease Phase 2 Recruiting June 2019 Germany ... More >> University of Cologne Recruiting Cologne, Germany, 50924 Contact: Christoph Scheid, MD PhD    49221478 ext 6296    c.scheid@uni-koeln.de    Sub-Investigator: Udo Holtick, MD Less <<
NCT00827359 Renal Cell Carcinoma ... More >> Renal Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States Dana-Farber Cancer Institute Boston, Massachusetts, United States United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01034631 - Completed - -
NCT01057277 Head and Neck Cancer Phase 1 Terminated(Pharmaceutical co- ... More >>re aligned their specialties- no longer will fund H&N ca) Less << - United States, Rhode Island ... More >> Rhode Island Hospital Providence, Rhode Island, United States, 02903 Less <<
NCT00789828 - Completed - -
NCT00976755 Prostate Cancer Phase 2 Active, not recruiting December 31, 2031 Switzerland ... More >> Kantonspital Aarau Aarau, Switzerland, CH-5001 Kantonsspital Baden Baden, Switzerland, 5404 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Inselspital Bern Bern, Switzerland, CH-3010 Spitalzentrum Biel Biel, Switzerland, CH-2501 Kantonsspital Graubuenden Chur, Switzerland, 7000 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Luzern Luzern, Switzerland, 6000 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Kantonsspital Winterthur Winterthur, Switzerland, 8401 UniversitaetsSpital Zuerich Zurich, Switzerland, 8091 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT01057277 - Terminated(Pharmaceutical co- ... More >>re aligned their specialties- no longer will fund H&N ca) Less << - -
NCT00789828 Tuberous Sclerosis ... More >> Subependymal Giant Cell Astrocytoma Less << Phase 3 Completed - -
NCT02025712 Hormone Receptor Positive Mali... More >>gnant Neoplasm of Breast Less << Phase 2 Unknown - China ... More >> Unimed Medical Institute Not yet recruiting Hong Kong, China Contact: Louis Chow    (852)28610286       Principal Investigator: Louis Chow Less <<
NCT00843531 Neuroendocrine Tumors Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT02240719 Recurrent Adult Diffuse Large ... More >>Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Refractory Chronic Lymphocytic Leukemia Multiple Myeloma Less << Phase 1 Active, not recruiting December 2019 United States, California ... More >> University of California Davis Sacramento, California, United States, 95817 Less <<
NCT03198949 Epilepsy and Focal Cortical Dy... More >>splasia II Less << Phase 3 Not yet recruiting April 30, 2020 -
NCT01931163 Breast Cancer ... More >> Triple Negative Breast Cancer Less << Phase 2 Active, not recruiting August 2019 United States, Texas ... More >> The Methodist Hospital Houston, Texas, United States, 77030 Houston Methodist Hospital Willowbrook Houston, Texas, United States, 77070 Houston Methodist Hospital Sugar Land Sugar Land, Texas, United States, 77479 Less <<
NCT01561404 Disorder Related to Renal Tran... More >>splantation Exercise, Aerobic Muscle Strength Less << Phase 4 Terminated(lack of potential p... More >>atients) Less << - Spain ... More >> Nephrology Department. Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelone, Spain, 08907 Less <<
NCT01552434 Advanced Malignant Neoplasm ... More >> Castleman Disease Digestive System Carcinoma Erdheim-Chester Disease Lip and Oral Cavity Carcinoma Lymphangioleiomyomatosis Malignant Endocrine Neoplasm Malignant Female Reproductive System Neoplasm Malignant Male Reproductive System Neoplasm Malignant Neoplasm Malignant Respiratory Tract Neoplasm Malignant Thoracic Neoplasm Malignant Urinary System Neoplasm Mesothelial Neoplasm Metastatic Malignant Neoplasm Metastatic Urothelial Carcinoma Neurofibromatosis Type 2 Recurrent Adult Soft Tissue Sarcoma Recurrent Breast Carcinoma Recurrent Childhood Soft Tissue Sarcoma Recurrent Digestive System Carcinoma Recurrent Female Reproductive System Carcinoma Recurrent Male Reproductive System Carcinoma Recurrent Malignant Neoplasm Recurrent Pharyngeal Carcinoma Recurrent Thyroid Gland Carcinoma Refractory Malignant Neoplasm Soft Tissue Neoplasm Stage III Breast Cancer AJCC v7 Stage III Pharyngeal Cancer Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7 Stage IV Pharyngeal Cancer Stage IVA Pharyngeal Cancer Stage IVB Pharyngeal Cancer Stage IVC Pharyngeal Cancer Thyroid Gland Neoplasm Less << Phase 1 Recruiting March 31, 2021 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Sarina A. Piha-Paul    713-563-1930       Principal Investigator: Sarina A. Piha-Paul Less <<
NCT01374451 - Terminated(The study was stopp... More >>ed for not meeting the primary endpoint for PFS.) Less << - -
NCT01198184 Endometrial Papillary Serous C... More >>arcinoma Recurrent Endometrial Carcinoma Recurrent Renal Cell Cancer Stage III Endometrial Carcinoma Stage III Renal Cell Cancer Stage IV Endometrial Carcinoma Stage IV Renal Cell Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - Canada, Ontario ... More >> Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01412892 Neurofibromatosis Type 1 ... More >> Plexiform Neurofibroma Neurofibromatoses Less << Phase 2 Completed - France ... More >> Henri Mondor Hospital Creteil, France, 94010 Less <<
NCT00515086 Glioblastoma Multiforme Phase 2 Terminated(Early termination d... More >>ue to slow enrollment and protocol-defined stopping rule.) Less << - United States, California ... More >> UCLA Los Angeles, California, United States, 90095 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina Duke University - Preston Robert Tisch Brain Tumor Center Durham, North Carolina, United States, 27710 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45219 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less <<
NCT01374451 Islet Cell Tumor Phase 2 Terminated(The study was stopp... More >>ed for not meeting the primary endpoint for PFS.) Less << - -
NCT00942682 Neuroendocrine Tumor ... More >> Carcinoid Tumor Pancreatic Neuroendocrine Tumor Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00515086 - Terminated(Early termination d... More >>ue to slow enrollment and protocol-defined stopping rule.) Less << - -
NCT03256864 Liver Transplantation Phase 4 Recruiting April 2019 Taiwan ... More >> Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan Contact: Wei-Chen Lee    03-3281200 ext 3631 Less <<
NCT02062892 Kidney Transplantation Phase 4 Withdrawn(Patients meeting the... More >> inclusion/ exclusion criteria did not agree to participate. It became obvious that recruitment goals could not be met.) Less << - -
NCT01827618 Invasive Bladder Cancer Stage ... More >>II Less << Early Phase 1 Completed - United States, Texas ... More >> UT Health Science Center San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00255658 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Texas ... More >> Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00629525 Hormone Refractory Prostate Ca... More >>ncer Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University MEdical Center Durham, North Carolina, United States, 27710 Less <<
NCT01251458 Inoperable HCC PHASE1|PHASE2 COMPLETED 2025-01-16 Department of Clinical Oncolog... More >>y, Prince of Wales Hospital, Hong Kong, Hong Kong Less <<
NCT03285802 Uterine Cancer Phase 2 Phase 3 Active, not recruiting December 31, 2020 United States, Maryland ... More >> Greater Baltimore Medical Center Baltimore, Maryland, United States, 21204 Less <<
NCT00629525 - Completed - -
NCT01079481 Small Cell Lung Cancer Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT00716573 Cardiac Transplantation ... More >> Chronic Renal Insufficiency Less << Phase 4 Completed - France ... More >> Hospices Civils de Lyon Lyon, France Less <<
NCT00414440 Autosomal Dominant Polycystic ... More >>Kidney Disease Less << Phase 4 Completed - Austria ... More >> Novartis Investigative Site Innsbruck, Austria, INNSBRUCK Novartis Investigative Site Linz, Austria, A-4010 Novartis Investigative Site Wien, Austria, 1090 France Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Grenoble, France, 38043 Novartis Investigative Site Nantes Cedex, France, 44035 Novartis Investigative Site Paris cedex 15, France, 75015 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt am Main, Germany, 60596 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Homburg, Germany, 66421 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Koeln, Germany, 51109 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Lübeck, Germany, 23538 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Würzburg, Germany, 97080 Less <<
NCT00574366 Breast Cancer Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT01152840 Adenoid Cystic Carcinoma Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT00879333 Advanced Gastric Cancer Phase 3 Completed - -
NCT00555256 Non-Small Cell Lung Cancer Phase 1 Completed - United States, Missouri ... More >> Washington University School of medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00414440 - Completed - -
NCT01024946 Malignant Pleural Mesothelioma Phase 2 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT03767660 Blue Rubber Bleb Nevus Syndrom... More >>e Venous Malformation Less << Phase 4 Recruiting July 1, 2022 China, Beijing ... More >> Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences Recruiting Beijing, Beijing, China, 100000 Contact: Jiaolin Zhou, MD    13910136704    conniezhjl@163.com Less <<
NCT01024946 - Completed - -
NCT00671112 714leukemia L... More >>ymphoma Less << Phase 1 Terminated(Treatment ineffecti... More >>ve) Less << - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01535989 B-cell Lymphoma Refractory Phase 1 Completed - Switzerland ... More >> Oncology Institute of Southern Switzerland Bellinzona, Ticino, Switzerland, 6500 InselSpital, Universitätsspital Bern Bern, Switzerland, 3010 Kantonsspital St.Gallen San Gallen, Switzerland, 9007 Less <<
NCT00880282 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 1 Completed - -
NCT01031381 - Completed - -
NCT01031381 Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Carcinoma Less << Phase 2 Completed - United States, Pennsylvania ... More >> Magee-Womens Hospital of UPMC Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01009957 Polycystic Kidney Diseases Phase 2 Phase 3 Terminated(After primary compl... More >>etition date, experimental drug was no longer available) Less << - Italy ... More >> A.O. Spedali Civili Di Brescia Brescia, Italy Alessandro Manzoni Hospital, Nephrology and Dialysis Department Lecco, Italy, 23900 Modena Hospital Modena, Italy, 41100 Dipartimento di Patologia Sistematica - Università Federico 2° Napoli, Italy, 80138 Ospedale "Guglielmo da Saliceto" - Nephrology and Dialysis Department Piacenza, Italy, 29100 C.M.I.D. - Presidi Ospedalieri ASL 4 Torino, Italy, 10152 Ospedale Civile San Bortolo Vicenza Vicenza, Italy Less <<
NCT00374140 Small Cell Lung Cancer Phase 2 Completed - United States, Ohio ... More >> UPMC Cancer Center - Teramana Cancer Center - Steubenville Steubenville, Ohio, United States, 43952 United States, Pennsylvania UPMC Cancer Center - Beaver Beaver, Pennsylvania, United States, 15009 UPMC Cancer Center - Clairton Clairton, Pennsylvania, United States, 15025 UPMC Cancer Center - Arnold Palmer Pavilion - Greensburg Greensburg, Pennsylvania, United States, 15601 UPMC Cancer Center - Oakbrook Commons - Greensburg Greensburg, Pennsylvania, United States, 15601 UPMC Cancer Center - Indiana Indiana, Pennsylvania, United States, 15701 UPMC Cancer Center - John P. Murtha Pavilion - Johnstown Johnstown, Pennsylvania, United States, 15901 UPMC Cancer Center - McKeesport McKeesport, Pennsylvania, United States, 15132 UPMC Cancer Center - Monroeville Monroeville, Pennsylvania, United States, 15146 UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group Moon, Pennsylvania, United States, 15108 UPMC Cancer Center - New Castle New Castle, Pennsylvania, United States, 16105 UPMC Cancer Center - St. Margaret's Pittsburgh, Pennsylvania, United States, 15215 UPMC Cancer Center - Mercy Pittsburgh, Pennsylvania, United States, 15219 University of Pittsburgh Cancer Institute - Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 UPMC Cancer Center - Passavant Pittsburgh, Pennsylvania, United States, 15237 UPMC Cancer Center - Upper St. Clair Pittsburgh, Pennsylvania, United States, 15241 UPMC Cancer Center - Uniontown Uniontown, Pennsylvania, United States, 15401 UPMC Cancer Center - Washington Washington, Pennsylvania, United States, 15301 UPMC Cancer Center - North Hills Wexford, Pennsylvania, United States, 15090 Less <<
NCT00879333 - Completed - -
NCT02451696 Epilepsy Tube... More >>rous Sclerosis Complex Focal Cortical Dysplasia Less << Phase 2 Recruiting June 2020 United States, New York ... More >> New York University Langone Medical Center Recruiting New York, New York, United States, 10016 Contact: Maria Hopkins    646-558-0842    Maria.Hopkins@nyumc.org    Contact: Anjanette Burns    347-578-4066    anjanette.burns@nyumc.org    Sub-Investigator: Howard Weiner, MD          Sub-Investigator: Maria Hopkins, RN          Sub-Investigator: Erin Conway, RN          Sub-Investigator: Spiros Manolatos Less <<
NCT00374140 - Completed - -
NCT00510068 - Completed - -
NCT00693433 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 1 Completed - United States, California ... More >> Veteran's Administration Medical Center Las Angeles, California, United States, 90073 Less <<
NCT00072176 Endometrial Adenocarcinoma ... More >> Endometrial Adenosquamous Cell Carcinoma Endometrial Clear Cell Carcinoma Endometrial Papillary Serous Carcinoma Recurrent Endometrial Carcinoma Stage IIIA Endometrial Carcinoma Stage IIIB Endometrial Carcinoma Stage IIIC Endometrial Carcinoma Stage IVA Endometrial Carcinoma Stage IVB Endometrial Carcinoma Less << Phase 2 Completed - Canada, Ontario ... More >> National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada, K7L 3N6 Less <<
NCT01609673 End Stage Renal Failure With R... More >>enal Transplant Less << Not Applicable Terminated(The inclusion of pr... More >>oposed sample turned to be infeasible due to Ethical Non-approval of 2 research sites and another site no transplant activity since 2012.) Less << - Brazil ... More >> Hospital São João de Deus/Fundação Geraldo Corrêa Divinópolis, MG, Brazil, 35500-227 Hospital Márcio Cunha/Fundação São Francisco Xavier Ipatinga, MG, Brazil, 35160-158 Fundação IMEPEN Juiz de Fora, MG, Brazil, 36036-330 Hospital do Rim de MOntes Claros/Irmandade Nossa Senhora das Mercês Montes Claros, MG, Brazil, 39400-103 Less <<
NCT00072176 - Completed - -
NCT01730209 Tuberous Sclerosis Complex ... More >> TSC Related Cognitive Disability TSC Related Autism TSC Related Learning Problems Less << Phase 2 Phase 3 Unknown November 2016 Netherlands ... More >> Erasmus Medical Center Recruiting Rotterdam, Netherlands Contact: M.C.Y. de Wit, MD. PhD.    +31 10 703 6956    tubereuzesclerose@erasmusmc.nl    Principal Investigator: M.C.Y. de Wit, MD. PhD.          Sub-Investigator: I.E. Overwater, MSc Less <<
NCT00510068 Advanced Neuroendocrine Tumors... More >> of Pancreatic Origin Less << Phase 3 Completed - -
NCT01182883 Brain Stem Neoplasms ... More >> Glioma Pinealoma Less << Phase 1 Withdrawn April 4, 2012 -
NCT02008019 Chondrosarcoma Phase 2 Suspended(The study was suspen... More >>ded since july 27th 2016 because of unavailability of Everolimus) Less << August 2019 France ... More >> Institut Bergonié Bordeaux, Gironde, France, 33076 Institut Claudius Regaud Toulouse, Haute Garonne, France, 31052 Centre Hospitalier Universitaire de Limoges, Hôpital Dupuytren Limoges, Haute Vienne, France, 87042 Institut Régional du Cancer de Montpellier Montpellier, Hérault, France, 34298 Centre Hospitalier Régional Universitaire de Tours, Hôpital Trousseau Tours, Indre et Loire, France, 37044 Centre Hospitalier Universitaire de Nantes, Hôtel Dieu Nantes, Loire Atlantique, France, 44093 Institut de Cancérologie de l'Ouest - René Gauducheau Saint-Herblain, Loire Atlantique, France, 44805 Institut de Cancérologie de Lorraine Vandoeuvre-les-Nancy, Meurthe et Moselle, France, 54511 Centre Oscar Lambret Lille, Nord, France, 59000 CHRU de Lille - Hôpital Roger Salengro Lille, Nord, France, 59037 Centre Léon Bérard Lyon, Rhône, France, 69373 Institut Gustave Roussy Villejuif, Val de Marne, France, 94805 Less <<
NCT02236572 Breast Cancer Phase 2 Unknown September 2018 United States, Connecticut ... More >> Yale University New Have, Connecticut, United States, 06520 Less <<
NCT02493465 Left Ventricular Hypertrophy Phase 4 Unknown July 2017 Brazil ... More >> Instituto de Urologia e Nefrologia Recruiting São José do Rio Preto, São Paulo, Brazil, 15015-200 Contact: Mario Abbud, MD.PhD    551740099165    mabbud@terra.com.br    Contact: Ananda F Calori    551740099167    estudos@iun.com.br Less <<
NCT01595009 - Completed - -
NCT03114527 Soft Tissue Sarcoma Phase 2 Recruiting May 2019 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Suzanne George, MD    617-632-5204    sgeorge2@partners.org    United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Sujana Movva, MD    215-728-2814    sujana.movva@fccc.edu Less <<
NCT01663805 Delayed Function of Renal Tran... More >>splant Less << Phase 4 Unknown June 2015 Brazil ... More >> Instituto de Urologia e Nefrologia Recruiting São José do Rio Preto, São Paulo, Brazil, 15015-200 Contact: Mario Abbud, MD.PhD    551740099191    mabbud@terra.com.br    Contact: Amanda Calori    551740099167    estudos@iun.com.br    Principal Investigator: Mario Abbud, MD.PhD          Instituto de Urologia e Nefrologia Recruiting São José do Rio Preto, São Paulo, Brazil, 15015-200 Contact: Mario Abbud, MD,Phd    551740099191    mabbud@terra.com.br    Contact: Amanda Calori    551740099191    estudos@iun.com.br    Principal Investigator: Mario Abbud, MD,Phd          Sub-Investigator: Ida Fernandes, MD          Instituto de Urologia e Nefrologia Recruiting São José do Rio PReto, São Paulo, Brazil, 15015200 Contact: Mario Abbud, MD,Phd    551740099191    mabbud@terra.com.br    Contact: Amanda Calori    551740099167    estudos@iun.com.br Less <<
NCT01403415 Childhood B Acute Lymphoblasti... More >>c Leukemia Childhood T Acute Lymphoblastic Leukemia Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Lymphoblastic Lymphoma Less << Phase 1 Completed - -
NCT01595009 Neuroendocrine Tumors Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Chemnitz, Germany, 09113 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Homburg, Germany, 66421 Novartis Investigative Site Kassel, Germany, 34125 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Muenchen, Germany, 81377 Novartis Investigative Site Osnabrück, Germany, 49076 Novartis Investigative Site Weiden, Germany, 92637 Less <<
NCT01911546 - Completed - -
NCT01087554 Advanced Cancer Phase 1 Active, not recruiting March 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02454478 Carcinoma, Renal Cell Phase 1 Terminated - Japan ... More >> Eisai Trial Site #1 Chiba, Japan Eisai Trial Site #1 Tokyo, Japan Eisai Trial Site #2 Tokyo, Japan Less <<
NCT00636922 Acute Myeloid Leukemia Phase 1 Unknown January 2014 Australia, Victoria ... More >> BaysideHealth, The Alfred Hospital Melbourne, Victoria, Australia, 3004 Less <<
NCT01582191 Advanced Cancers Phase 1 Recruiting May 2026 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01911546 Highly-sensitized Kidney Trans... More >>plant Recipients Less << Phase 2 Completed - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT00761644 Advanced Cancer Phase 1 Active, not recruiting August 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01713946 - Completed - -
NCT01714765 Metastatic Clear Cell Renal Ca... More >>ncer Less << Phase 1 Completed - United Kingdom ... More >> Barts Health NHS Trust London, United Kingdom, EC1M 7BE Less <<
NCT01083368 Prostate Cancer Phase 1 Phase 2 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 CCF-Willoughby Hills Willoughby Hills, Ohio, United States, 44094 Less <<
NCT01010126 Adult Hepatocellular Carcinoma... More >> Advanced Adult Hepatocellular Carcinoma Endometrial Serous Adenocarcinoma Localized Non-Resectable Adult Liver Carcinoma Lung Carcinoid Tumor Malignant Pancreatic Gastrinoma Malignant Pancreatic Glucagonoma Malignant Pancreatic Insulinoma Malignant Pancreatic Somatostatinoma Metastatic Digestive System Neuroendocrine Tumor G1 Ovarian Carcinosarcoma Ovarian Endometrioid Adenocarcinoma Ovarian Seromucinous Carcinoma Ovarian Serous Surface Papillary Adenocarcinoma Pancreatic Alpha Cell Adenoma Pancreatic Beta Cell Adenoma Pancreatic Delta Cell Adenoma Pancreatic G-Cell Adenoma Pancreatic Polypeptide Tumor Recurrent Adult Liver Carcinoma Recurrent Digestive System Neuroendocrine Tumor G1 Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Pancreatic Neuroendocrine Carcinoma Recurrent Primary Peritoneal Carcinoma Recurrent Uterine Corpus Carcinoma Regional Digestive System Neuroendocrine Tumor G1 Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Cancer Stage IIIA Primary Peritoneal Cancer Stage IIIA Uterine Corpus Cancer Stage IIIB Fallopian Tube Cancer Stage IIIB Ovarian Cancer Stage IIIB Primary Peritoneal Cancer Stage IIIB Uterine Corpus Cancer Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Cancer Stage IIIC Primary Peritoneal Cancer Stage IIIC Uterine Corpus Cancer Stage IV Fallopian Tube Cancer Stage IV Ovarian Cancer Stage IV Primary Peritoneal Cancer Stage IVA Uterine Corpus Cancer Stage IVB Uterine Corpus Cancer Uterine Carcinosarcoma Less << Phase 2 Completed - -
NCT01713946 Tuberous Sclerosis Complex-ass... More >>ociated Refractory Seizures Less << Phase 3 Completed - -
NCT00936858 Thyroid Cancer Phase 2 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Mt. Sinai Medical Center New York, New York, United States, 10029 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00729586 - Completed - -
NCT00062751 Breast Neoplasms Phase 2 Completed - -
NCT00466466 Small-Cell Lung Cancer Phase 1 Completed - United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Colorado University of Colorado Health Sciences Center Aurora, Colorado, United States, 80045 United States, Massachusetts Dana Faber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Cancer Therapy and Research Center at UTHSCSA San Antonio, Texas, United States, 78229 France Novartis Investigative Site Paris, France Less <<
NCT00149981 Organ Transplantation Phase 4 Completed - -
NCT00729586 Endometrial Carcinoma ... More >> Recurrent Uterine Corpus Carcinoma Stage IIIA Uterine Corpus Cancer Stage IIIB Uterine Corpus Cancer Stage IIIC1 Uterine Corpus Cancer Stage IIIC2 Uterine Corpus Cancer Stage IVA Uterine Corpus Cancer Stage IVB Uterine Corpus Cancer Less << Phase 2 Completed - -
NCT00703807 Endometrial Cancer Phase 1 Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT00081874 Leukemia Mant... More >>le Cell Lymphoma Myelofibrosis Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02152943 Breast Cancer ... More >> Solid Tumors Less << Phase 1 Recruiting July 1, 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00876395 Breast Cancer Phase 3 Completed - -
NCT00062751 - Completed - -
NCT00281957 Recurrent Melanoma ... More >> Stage IV Melanoma Less << Phase 2 Completed - -
NCT00084916 Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Blastic Phase Chronic Myelogenous Leukemia Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01529554 Acute Coronary Syndromes Phase 1 Phase 2 Recruiting December 31, 2019 Switzerland ... More >> University Hospital Bern Recruiting Bern, Switzerland Contact: Stephan Windecker, Professor       stephan.windecker@insel.ch    Principal Investigator: Stephan Windecker, Professor          University Hospital Geneva Recruiting Geneva, Switzerland Contact: Francois Mach, Professor       francois.mach@hcuge.ch    Principal Investigator: Francois Mach, Professor          Cardiocentro Ticino Recruiting Lugano, Switzerland Contact: Tiziano Moccetti, Professor          Contact       tiziano.moccetti@cardiocentro.org    Principal Investigator: Tiziano Moccetti, Professor          University Hospital Zurich Recruiting Zurich, Switzerland Contact: Andrea Denegri, MD    +41 44 255 ext 99 78    andrea.denegri@usz.ch    Principal Investigator: Andrea Denegri, MD Less <<
NCT00281957 - Completed - -
NCT03163667 Clear Cell Renal Cell Carcinom... More >>a Less << Phase 2 Recruiting December 2020 -
NCT02444390 Metastatic Breast Cancer Not Applicable Active, not recruiting October 2021 France ... More >> Institut de Cancérologie de l'Ouest/Paul Papin Angers, France Centre Jean Perrin Clermont-Ferrand, France Centre Léon Bérard Lyon, France Institut de Cancérologie de l'Ouest/Rene Gauducheau Nantes, France Centre Antoine Lacassagne Nice, France Institut Curie Paris, France Clinique Armoricaine de Radiologie Saint-Brieuc, France INSTITUT DE CANCEROLOGIE Lucien Neuwirth St PRIEST EN JAREZ, France Centre Paul Strauss Strasbourg, France Institut Claudius Regaud Toulouse, France Institut de Cancerologie de Lorraine Alexis Vautrin Vandoeuvre-les-nancy, France Gustave Roussy Villejuif, France Less <<
NCT03228576 - Recruiting April 14, 2020 France ... More >> Amiens University Hospital Recruiting Amiens, France, 80000 Contact: WESTEEL Pierre-François, MD          Angers University Hospital Recruiting Angers, France, 49100 Contact: SAYEGH Johnny, MD          Caen University Hospital Recruiting Caen, France, 14033 Contact: BOUVIER Nicolas, MD          Clermont Ferrand University Hospital Recruiting Clermont-Ferrand, France, 63000 Contact: HENG Anne-Elisabeth, PhD          Centre Hospitalier Universitaire de Poitiers Recruiting Poitiers, France, 86000 Contact: Antoine THIERRY          Rennes University Hospital Recruiting Rennes, France, 35000 Contact: GOLBIN Léonard, MD          Rouen University Hospital Recruiting Rouen, France, 76000 Contact: ETIENNE Isabelle, MD          Strasbourg University Hospital Recruiting Strasbourg, France, 67000 Contact: CAILLARD Sophie, MD          Tours University Hospital Recruiting Tours, France, 37000 Contact: BUCHLER Mathias, PhD Less <<
NCT01259063 - Completed - -
NCT00303732 Kidney Cancer ... More >> Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT00809185 Myelodysplastic Syndromes Phase 2 Terminated(slow accrual) - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00809185 - Terminated(slow accrual) - -
NCT01379521 Hepatocellular Carcinoma Phase 2 Terminated(The study was termi... More >>nated due to low enrollment. This resulted in the study being underpowered and inconclusive.) Less << - Hong Kong ... More >> Novartis Investigative Site Hong Kong, Hong Kong Taiwan Novartis Investigative Site Kaohsiung, Taiwan, 807 Novartis Investigative Site Kaohsiung, Taiwan, 83301 Novartis Investigative Site Lin-Kou, Taiwan, 33305 Thailand Novartis Investigative Site Chiang Mai, Thailand, 50200 Less <<
NCT00397982 - Completed - -
NCT00688753 Carcinoma Ren... More >>al Cell Non Clear Cell Renal Carcinoma Papillary Cell Renal Carcinoma Adenocarcinoma Less << Phase 2 Completed - Belgium ... More >> Novartis Investigative Site Brussels, Belgium, BE-B-1200 Novartis Investigative Site Gent, Belgium, 9000 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Marseille, France, 13273 Novartis Investigative Site Paris, France, 75015 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Muenster, Germany, 48149 Italy Novartis Investigative Site Arezzo, AR, Italy, 52100 Novartis Investigative Site Cremona, CR, Italy, 26100 Novartis Investigative Site Pavia, PV, Italy, 27100 Novartis Investigative Site Napoli, Italy, 80132 Poland Novartis Investigative Site Otwock, Poland, 05-400 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08003 Novartis Investigative Site Barcelona, Cataluña, Spain, 08907 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46009 Novartis Investigative Site Barcelona, Spain, 08041 Less <<
NCT00397982 Recurrent Melanoma ... More >> Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma Less << Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Virginia University of Virginia Cancer Center Charlottesville, Virginia, United States, 22908 Less <<
NCT03493152 - - - -
NCT01379521 - Terminated(The study was termi... More >>nated due to low enrollment. This resulted in the study being underpowered and inconclusive.) Less << - -
NCT00107237 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 United States, North Carolina Duke Univaersity Medical Center Durham, North Carolina, United States, 27710 United States, Texas MD Anderson Cancer Center/University of Texas Houston, Texas, United States, 77030 Less <<
NCT00086840 Recurrent Adult Diffuse Large ... More >>Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Less << Phase 2 Terminated(Administratively co... More >>mplete.) Less << - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01333085 Head and Neck Cancer Phase 1 Phase 2 Completed - France ... More >> Hopital Beaujon Clichy, France, 92110 Centre Léon Berard Lyon, France, 69000 Institut Curie Paris, France, 75005 Hôpital Privé Saint Joseph Paris, France, 75014 Institut Claudius Regaud Toulouse, France, 31052 Less <<
NCT00688753 - Completed - -
NCT03500367 Uterine Fibroids Phase 4 Recruiting December 31, 2022 China, China/Beiing ... More >> Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences Recruiting Beijing, China/Beiing, China, 100000 Contact: Fengzh Feng, MD    18612671869 ext +86    fengfzh@pumch.cn Less <<
NCT02321501 Head and Neck Cancer ... More >> Lung Cancer Less << Phase 1 Recruiting June 2024 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT03493165 - - - -
NCT00799188 Cardiac Transplantation ... More >> Skin Cancer Less << Phase 3 Unknown - France ... More >> HOSPICES CIVILS de LYON Lyon, France Less <<
NCT00448149 Carcinoma, Renal Cell Phase 1 Phase 2 Completed - United States, Texas ... More >> The Methodist Hospital Research Institute Houston, Texas, United States, 77030 Less <<
NCT00075647 Adenocarcinoma of the Pancreas... More >> Recurrent Pancreatic Cancer Stage II Pancreatic Cancer Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Less << Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00756340 Recurrent or Refractory Solid ... More >>Tumors CNS Malignancies Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01488487 Advanced Adult Hepatocellular ... More >>Carcinoma Less << Phase 2 Completed - United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, North Carolina University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Less <<
NCT02387099 Breast Cancer ... More >> Hormone Receptor Positive Tumor Less << Phase 2 Recruiting March 2018 Germany ... More >> Sana Klinikum Offenbach / German Breast Group Not yet recruiting Neu Isenburg, Hessen, Germany, 63263 Contact: Sibylle Loibl, PD.MD    +49 6102 7840 ext 426    Sibylle.Loibl@GermanBreastGroup.de    Principal Investigator: Sibylle Loibl, MD          TU Dresden Recruiting Dresden, Sachsen, Germany, 01307 Principal Investigator: Karin Kast, MD, Prof          Recruiting Bielefeld, Germany, 33604 University of Erlangen Recruiting Erlangen, Germany, 91054 Recruiting Essen, Germany, 45136 Not yet recruiting Goslar, Germany, 38642 Recruiting Hanau, Germany, 63450 Active, not recruiting Karlsruhe, Germany, 76135 Active, not recruiting Kiel, Germany, 24105 Active, not recruiting Köln, Germany, 50931 Recruiting Mainz, Germany, 55131 Active, not recruiting München, Germany, 80638 Recruiting Rotenburg, Germany, 27356 Recruiting Weinheim, Germany, 69469 Less <<
NCT01488487 - Completed - -
NCT01259063 Bladder Cancer Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01231659 Postmenopausal Women ... More >> Locally Advanced Metastatic Breast Cancer Metastatic Breast Cancer Less << Phase 4 Completed - Israel ... More >> Novartis Investigative Site Jerusalem, Israel, 91120 Novartis Investigative Site Kfar Saba, Israel, 4428164 Novartis Investigative Site Petach Tikva, Israel, 49100 Novartis Investigative Site Ramat Gan, Israel, 5265601 Novartis Investigative Site Rehovot, Israel, 76100 Novartis Investigative Site Tel Aviv, Israel, 62439 Novartis Investigative Site Tel Aviv, Israel, 64239 Less <<
NCT02048384 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 1 Phase 2 Active, not recruiting June 2019 United States, Arizona ... More >> Scottsdale Healthcare Hospitals DBA Honor Health Scottsdale, Arizona, United States, 85258 United States, Maryland Johns Hopkins SKCCC Baltimore, Maryland, United States, 21231 Less <<
NCT00659568 Breast Cancer ... More >> Endometrial Cancer Kidney Cancer Lung Cancer Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - Canada, Ontario ... More >> London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada, N6A 4L6 Less <<
NCT00874562 Acute Lymphoblastic Leukemia Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT01317615 Carcinoma, Large Cell ... More >> Neuroendocrine Tumors Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Bremen, Germany, 28177 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Gauting, Germany, 82131 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Hemer, Germany, 58675 Novartis Investigative Site Koeln, Germany, 51109 Novartis Investigative Site Leipzig, Germany, 04177 Novartis Investigative Site Ulm, Germany, 89081 Less <<
NCT01653041 Kidney Transplantation Phase 4 Completed - Brazil ... More >> Hospital do Rim e Hipertensão São Paulo, Brazil, 04038-002 Less <<
NCT00613132 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT01317615 - Completed - -
NCT00719264 Carcinoma Ade... More >>nocarcinoma Renal Cell Nephroid Carcinoma Hypernephroid Less << Phase 2 Completed - -
NCT00087074 Gastrointestinal Stromal Tumor... More >> Recurrent Adult Soft Tissue Sarcoma Stage I Adult Soft Tissue Sarcoma Stage II Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01217177 Locally Advanced Cervical Canc... More >>er Less << Phase 1 Completed - Brazil ... More >> Novartis Investigative Site Rio de Janeiro, RJ, Brazil, 20230-130 Novartis Investigative Site Rio de Janeiro, Brazil Less <<
NCT00719264 - Completed - -
NCT02429869 HIV Kidney Tr... More >>ansplant Liver Transplant Less << Phase 4 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 Less <<
NCT01152801 Metastatic Renal Cell Carcinom... More >>a Less << Phase 1 Completed - China, Hubei ... More >> Novartis Investigative Site Wuhan, Hubei, China, 430030 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210002 China Novartis Investigative Site Beijing, China, 100028 Novartis Investigative Site Beijing, China, 100036 Novartis Investigative Site Guangzhou, China, 510060 Novartis Investigative Site Shanghai, China, 200127 Novartis Investigative Site Shanghai, China, 200433 Less <<
NCT01455649 Kidney Transplant ... More >> Immunosuppression Less << Phase 4 Unknown November 2013 Brazil ... More >> Hospital federal de Bonsucesso Not yet recruiting Rio de Janeiro, Brazil, 21041-030 Less <<
NCT00597506 Colorectal Adenocarcinoma Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00597506 - Completed - -
NCT01499160 - Terminated(low accrual) - -
NCT03070301 Neuroendocrine Tumors Phase 2 Recruiting February 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Jeffrey Clark, MD    617-724-4000       Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02115 Contact: Jennifer Chan, MD          Beth Israel Deaconess Medical Center Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Andrea Bullock, MD    617-667-2100       United States, New York Memoral Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Diane Reidy-Lagunes, MD,MS    646-888-4185       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Diane Reidy-Lagunes, MD    646-888-4185       Contact: Nitya Raj, MD    646-888-4849       Principal Investigator: Diane Reidy-Lagunes, MD          United States, Texas Md Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Arvind Dasari, MD Less <<
NCT02134899 Autosomal Dominant Polycystic ... More >>Kidney Disease Less << Phase 3 Completed - France ... More >> Bicêtre Hospital Le Kremlin-Bicêtre, France, 94275 Less <<
NCT01499160 Breast Neoplasms ... More >> Endocrine Breast Diseases Neoplasm Metastasis Less << Phase 2 Terminated(low accrual) - United States, Maryland ... More >> University of Maryland Marlene & Stewart Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Less <<
NCT01378377 Advanced Solid Tumor Phase 1 Terminated(The trial was stopp... More >>ed due to the toxicities observed with the combination of pimasertib and temsirolimus.) Less << - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States United States, Massachusetts For Recruiting Locations in the US contact US Medical Information in Rockland, Massachusetts, United States United States, Texas The University of Texas MD Anderson Cancer Center Houston, Texas, United States Less <<
NCT00707135 Advanced Cancer Phase 1 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01378377 - Terminated(The trial was stopp... More >>ed due to the toxicities observed with the combination of pimasertib and temsirolimus.) Less << - -
NCT00942734 - Completed - -
NCT01614197 Lymphoblastic Leukemia, Acute,... More >> Childhood Lymphoblastic Lymphoma Peripheral T-cell Lymphoma Less << Phase 1 Recruiting December 2019 -
NCT01646021 Mantle Cell Lymphoma Phase 3 Completed - -
NCT01598038 Renal Cell Carcinoma Not Applicable Terminated - France ... More >> Centre François Baclesse Caen, France, 14076 Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT00101088 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Blastic Phase Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia Relapsing Chronic Myelogenous Leukemia Less << Phase 1 Terminated - United States, California ... More >> University of California Medical Center At Irvine-Orange Campus Orange, California, United States, 92868 Less <<
NCT01646021 - Completed - -
NCT01068249 Endometrial Cancer Phase 2 Active, not recruiting April 2021 United States, New Jersey ... More >> Morristown Memorial Hospital, Women's Cancer Center Morristown, New Jersey, United States, 07962 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01152827 Pheochromocytoma ... More >> Extra-adrenal Paraganglioma Non-functioning Carcinoid Less << Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02753309 Bladder Cancer Early Phase 1 Recruiting December 2018 United States, Texas ... More >> University of Texas Health Science Center at San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Kerri Kendrick, MPAS    210-567-5676    kendrick@uthscsa.edu    Principal Investigator: Robert Svatek, MD Less <<
NCT01381692 Cognitive Side Effects of Canc... More >>er Therapy Fatigue Neurotoxicity Syndrome Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Therapy-Related Toxicity Waldenstrom Macroglobulinemia Less << Phase 1 Phase 2 Active, not recruiting - United States, Colorado ... More >> Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States, 80218 United States, Georgia Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Pennsylvania Geisinger Medical Center Danville, Pennsylvania, United States, 17822 University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Wisconsin Gundersen Lutheran Medical Center La Crosse, Wisconsin, United States, 54601 Marshfield Clinic Marshfield, Wisconsin, United States, 54449 Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Marshfield Clinic-Minocqua Center Minocqua, Wisconsin, United States, 54548 Less <<
NCT01055795 Advanced Solid Tumors Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT03578432 Salivary Gland Dysfunction ... More >> Xerostomia Head and Neck Cancer Less << Early Phase 1 Recruiting June 1, 2020 United States, Arizona ... More >> The University of Arizona Cancer Center Recruiting Phoenix, Arizona, United States, 85012 Contact: Grace Ma    602-827-2683    gracex5ma@email.arizona.edu    Principal Investigator: Panayiotis Savvides Less <<
NCT00942734 Head And Neck Cancer Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00863655 Breast Cancer Phase 3 Completed - -
NCT00863655 - Completed - -
NCT01167530 Non-small Cell Lung Cancer ... More >> Locally Advanced Disease Less << Phase 1 Unknown July 2014 France ... More >> Institut Gustave Roussy Recruiting Villejuif, France, 94800 Contact: Eric DEUTSCH, MD    33 1 42114413    eric.deutsch@igr.fr    Contact: Jean-Pierr PIGNON, MD    33 1 42114565    jean-pierre.pignon@igr.fr Less <<
NCT00570921 Breast Cancer Phase 2 Completed - United States, Kentucky ... More >> University of Kentucky Lexington, Kentucky, United States, 40536 Less <<
NCT00570921 - Completed - -
NCT00830895 Renal Cell Carcinoma Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00926107 Ovarian Cancer PHASE2 TERMINATED 2025-10-11 "Alexandra" Hospital, Dept. of... More >> Clinical Therapeutics, Oncology, Athens, 11528, Greece|"Attikon" University Hospital, 2nd Dept. of Internal Medicine-Propaedeutic, Oncology Section, Athens, 12461, Greece|Hygeia Hospital, 1st Dept. of Medical Oncology, Athens, 15123, Greece|Hygeia Hospital, 2nd Dept. of Medical Oncology, Athens, 15123, Greece|Agii Anargiri Cancer Hospital, 3rd Dept. of Medical Oncology, Athens, Greece|Chania General Hospital, Oncology Dept., Chania, 73100, Greece|Ioannina University Hospital, Dept. of Medical Oncology, Ioannina, 45110, Greece|Larissa University Hospital, Oncology Dept., Larissa, 41110, Greece|University Hospital of Patras, Oncology Dept, Patras, 26500, Greece|Metropolitan Hospital, 1st Dept. of Medical Oncology, Pireaus, 18547, Greece|Metropolitan Hospital, 2nd Dept. of Medical Oncology, Pireaus, 18547, Greece|"Papageorgiou" General Hospital, Dept. of Medical Oncology, Thessaloniki, 56429, Greece Less <<
NCT00699491 - Completed - -
NCT02080624 Sturge- Weber Syndrome Phase 2 Completed - Spain ... More >> Clinica Universidad de Navarra Pamplona, Navarra, Spain, 31008 Less <<
NCT00688623 Carcinoma Neu... More >>roendocrine Non Functioning Neuroendocrine Tumors/NET Non Syndromic Neuroendocrine Tumors/NET Carcinoids Non Functioning Less << Phase 2 Completed - Germany ... More >> Novartis Investigative Site Bad Berka, Germany, 99438 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Mainz, Germany, 55131 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Viagrande, CT, Italy, 95029 Novartis Investigative Site Roma, RM, Italy, 00189 Poland Novartis Investigative Site Gdansk, Poland, 80-952 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08907 Novartis Investigative Site Barcelona, Cataluña, Spain United Kingdom Novartis Investigative Site Glasgow - Scotland, United Kingdom, G12 OYN Novartis Investigative Site Manchester, United Kingdom, M20 9BX Less <<
NCT01960829 Melanoma TOR ... More >>Serine-Threonine Kinases Neoplasm Metastasis Less << Phase 2 Unknown - China, Beijing ... More >> LuSi Recruiting Beijing, Beijing, China, 100142 Contact: Lu Si, MD    0086018819 ext 6951    silu.net@hotmail.com Less <<
NCT00640978 Pancreatic Cancer Phase 2 Terminated(Significant Adverse... More >> Effects - Futility) Less << - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00699491 Male Breast Carcinoma ... More >> Recurrent Breast Carcinoma Stage IV Breast Cancer AJCC v6 and v7 Less << Phase 1 Phase 2 Completed - -
NCT01252251 Uveal Melanoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00512668 Adenocarcinoma of the Prostate... More >> Recurrent Prostate Cancer Less << Phase 1 Terminated - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02579044 Progeria Phase 1 Phase 2 Recruiting December 2021 United States, Massachusetts ... More >> Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Monica E Kleinman, MD       monica.kleinman@childrens.harvard.edu Less <<
NCT02201212 TSC1 TSC2 ... More >> Tuberous Sclerosis Complex MTOR Less << Phase 2 Active, not recruiting January 2022 United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01182168 Bladder Cancer ... More >> Renal Pelvis Cancer Ureter Cancer Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00678769 Malignant Neoplasm Phase 1 Completed - United States, Michigan ... More >> Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00640978 - Terminated(Significant Adverse... More >> Effects - Futility) Less << - -
NCT00855114 Breast Cancer Phase 2 Withdrawn(Withdrawn due to no ... More >>accrual) Less << - United States, Minnesota ... More >> University of Minnesota Children's Hospital - Fairview Minneapolis, Minnesota, United States, 55455 Less <<
NCT03174171 Primary Aldosteronism Phase 2 Recruiting December 2018 Switzerland ... More >> University Hospital Basel Recruiting Basel, Basel Stadt, Switzerland, 4031 Contact: Marc Y Donath, Prof.    0041 61 265 50 78    marc.donath@usb.ch Less <<
NCT00949026 Brain Neoplasms Phase 1 Withdrawn(No accrual) - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT01125293 Waldenstrom's Macroglobulinemi... More >>a Less << Phase 1 Phase 2 Active, not recruiting February 2020 United States, Colorado ... More >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Massachusetts Milford Hospital Boston, Massachusetts, United States, 01757 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00714025 Transitional Cell Carcinoma Phase 2 Completed - Belgium ... More >> Cliniques Universitaires St Luc-UCL Bruxelles, Belgium, 1200 Less <<
NCT01252251 - Completed - -
NCT02687958 Neuroendocrine Carcinoma Phase 2 Recruiting May 2017 Italy ... More >> S.C. Oncologia - Policlinico Active, not recruiting Modena, Emilia - Romagna, Italy, 41124 U.O. Oncologia Medica 1 - AOU Pisana Recruiting Pisa, Tuscany, Italy, 56126 Contact: Cinzia Orlandini, SC          Principal Investigator: Sergio Ricci, MD          Azienda Ospedaliera "Spedali Civili di Brescia" Active, not recruiting Brescia, Italy, 25123 Azienda Ospedaliera Universitaria Careggi Recruiting Florence, Italy, 50134 Contact: Luisa Di Cerbo, SC    +390557947298    luisa.dicerbo@libero.it    Contact: Alessandro Di Costanzo, SC    +390557947298    adicostanzo.oncmed@hotmail.com    Principal Investigator: Francesco Di Costanzo, MD          Principal Investigator: Lorenzo Antonuzzo, MD          Istituto Europeo di Oncologia Active, not recruiting Milano, Italy, 20141 Less <<
NCT02449538 Solid Tumor Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical center Seoul, Korea, Republic of, 135-710 Less <<
NCT01805271 Primary Non-metastatic Breast ... More >>Cancer Who Remain Disease-free Less << Phase 3 Recruiting June 2031 France ... More >> Centre Leon Berard Recruiting Lyon, France Principal Investigator: Thomas Bachelot          Gustave Roussy Recruiting Villejuif, France Principal Investigator: Fabrice Andre Less <<
NCT00112736 - Completed - -
NCT00112736 Adult Anaplastic Astrocytoma ... More >> Adult Anaplastic Oligodendroglioma Adult Diffuse Astrocytoma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Mixed Glioma Adult Pilocytic Astrocytoma Adult Pineal Gland Astrocytoma Adult Subependymal Giant Cell Astrocytoma Recurrent Adult Brain Tumor Less << Phase 1 Phase 2 Completed - United States, California ... More >> University of California Los Angeles Los Angeles, California, United States, 90095 University of California San Francisco San Francisco, California, United States, 94115 United States, Maryland National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States, 20814 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 University of Texas Health Science Center San Antonio, Texas, United States, 78229 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00079456 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 2 Completed - United States, Ohio ... More >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT01206140 - Completed - -
NCT02539459 Sporadic Angiomyolipomas (AMLs... More >>) Less << Phase 2 Terminated(Extreme toxicity, m... More >>et toxicity stopping rules) Less << - United States, Connecticut ... More >> Yale School of Medicine New Haven, Connecticut, United States United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States United States, Minnesota Mayo Clinic Rochester, Minnesota, United States United States, New York Memorial Sloan Kettering New York, New York, United States United States, North Carolina Duke University Health System Durham, North Carolina, United States United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 University of Pennsylvania Philadelphia, Pennsylvania, United States United States, Texas M D Anderson Cancer Center Houston, Texas, United States Less <<
NCT01022996 Hodgkin Lymphoma Phase 2 Completed - United States, California ... More >> University of California at Los Angeles UCLS School of Medicine Los Angeles, California, United States, 90095 United States, Colorado Rocky Mountain Cancer Centers RMCC - Aurora Greenwood Village, Colorado, United States United States, Florida MD Anderson Cancer Center - Orlando Orlando, Florida, United States, 32806 United States, Georgia Emory University School of Medicine/Winship Cancer Institute Emory University Med School Atlanta, Georgia, United States, 30322 United States, Illinois Lurie Children's Hospital of Chicago Robert H. Lurie Comp Cancer Chicago, Illinois, United States, 60611 United States, Indiana Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Karmanos Cancer Institute Karmanos-1 Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic - Rochester Mayo Lymphoma Group Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School Of Medicine-Siteman Cancer Ctr StudyCoordinator:CLBH589B2201 St. Louis, Missouri, United States, 63110 United States, New York New York Presbyterian Hospital Weill Cornell Med Ctr New York, New York, United States, 10021 United States, North Carolina Duke University Medical Center Duke University Medical Ctr Durham, North Carolina, United States, 27710 United States, Tennessee University of Tennessee Cancer Institute Univ Tennessee Cancer Memphis, Tennessee, United States, 38104 United States, Texas University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(3) Houston, Texas, United States, 77030-4009 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Clinical Science Center - H4 Madison, Wisconsin, United States, 53792 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01022996 - Completed - -
NCT00398515 Refractory Multiple Myeloma ... More >> Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT01206140 Recurrent Adult Soft Tissue Sa... More >>rcoma Stage III Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Less << Phase 2 Completed - United States, California ... More >> Tower Cancer Research Foundation Beverly Hills, California, United States, 90211-1850 City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 University of California Davis Phase 2 Consortium Sacramento, California, United States, 95817 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00458237 Breast Cancer Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT02056587 Metastatic Renal Cell Carcinom... More >>a Less << Phase 4 Completed - Russian Federation ... More >> Tatarstan Regional Cancer Center Kazan, Tatarstan, Russian Federation, 420029 Altai Regional Cancer Center Barnaul, Russian Federation N.N. Blokhin Russian Cancer Research Center Moscow, Russian Federation, 115478 Less <<
NCT01198665 Peripheral T Cell Lymphoma Uns... More >>pecified Anaplastic Large Cell Lymphoma, ALK-negative Angioimmunoblastic T Cell Lymphoma Cutaneous T Cell Lymphoma Less << Phase 1 Phase 2 Completed - Korea, Republic of ... More >> National Cancer Center Goyang-si, Kyoungki-do, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of, 135710 Asan Medical Center Seoul, Korea, Republic of Korea Cancer Center Hospital Seoul, Korea, Republic of Yonsei Medical Center, Severance Hospital Seoul, Korea, Republic of Less <<
NCT01248403 Advanced Gastric Cancer ... More >> Esophagogastric Junction Cancer Less << Phase 3 Active, not recruiting August 2018 Germany ... More >> Krankenhaus Nordwest Frankfurt/Main, Germany, 60488 Less <<
NCT00458237 - Completed - -
NCT00457119 Non Small Cell Lung Cancer Phase 1 Completed - United States, District of Col... More >>umbia Georgetown University/Lombardi Cancer Center StudyCoordinator:CRAD001C2114 Washington, District of Columbia, United States, 20007-2197 United States, Louisiana LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Feist-Weiller Cancer Center New Orleans, Louisiana, United States, 70115 United States, Texas U of TX Southwestern Medical Center - SimmonsCompCancerCtr Clinical Research Office Dallas, Texas, United States, 75390-9151 MD Anderson Cancer Center/University of Texas Thoractic Head/Neck Med. Onc. Houston, Texas, United States, 77030-4009 Australia, South Australia Novartis Investigative Site Adelaide, South Australia, Australia, 5000 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 Germany Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Heidelberg, Germany, 69126 Less <<
NCT01324492 Lung Neuroendocrine Neoplasm Phase 1 Completed - China, Beijing ... More >> Novartis Investigative Site Beijing, Beijing, China, 100730 China, Guangdong Novartis Investigative Site Guangzhou, Guangdong, China, 510030 China, Jilin Novartis Investigative Site Changchun, Jilin, China China, Liaoning Novartis Investigative Site Shenyang, Liaoning, China Less <<
NCT00610493 Advanced Cancer Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02328963 Transplantation Infection ... More >> Cytomegalovirus Infection Less << Phase 4 Completed - France ... More >> CHU de Bordeaux Bordeaux, France, 33000 CHU La Cavale Blanche Brest, France, 29609 CHRU Caen - Hôpital de Caen Caen, France, 14033 CHU de Limoges - Hôpital Dupuytren Limoges, France Hôpital Edouard Herriot Lyon, France, 69003 APHP - Hôpital Necker Paris, France, 75015 APHP - Kremlin Bicetre Paris, France, 94275 CHRU Strasbourg Strasbourg, France CHU de Toulouse - Hôpital Rangueil Toulouse, France, 31000 Less <<
NCT02109913 Hormone Receptor Positive Mali... More >>gnant Neoplasm of Breast Metastatic Breast Cancer Less << Not Applicable Active, not recruiting January 2019 Netherlands ... More >> VU University Medical Center Amsterdam, Noord-Holland, Netherlands, 1007 MB Flevoziekenhuis Almere, Netherlands BovenIJ Ziekenhuis Amsterdam, Netherlands The Netherlands Cancer Institute Amsterdam, Netherlands Gelre Apeldoorn, Netherlands Rijnstate Ziekenhuis Arnhem, Netherlands Amphia Ziekenhuis Breda, Netherlands Reinier de Graaf Groep Delft, Netherlands Haga Den Haag, Netherlands MC Haaglanden Den Haag, Netherlands Gemini Den Helder, Netherlands Deventer Ziekenhuis Deventer, Netherlands Maxima Medisch Centrum Eindhoven, Netherlands Groene Hart Ziekenhuis Gouda, Netherlands Tergooi ziekenhuizen Hilversum, Netherlands Spaarne Ziekenuis Hoofddorp, Netherlands MC Leeuwarden Leeuwarden, Netherlands LUMC Leiden, Netherlands Canisius Ziekenhuis Nijmegen, Netherlands Bravis Roosendaal And Bergen Op Zoom, Netherlands Erasmus University Medical Center Rotterdam, Netherlands Ikazia Rotterdam, Netherlands Vlietland Schiedam, Netherlands Orbis MC Sittard, Netherlands Elisabeth - Tweesteden Tilburg, Netherlands UMC Utrecht Utrecht, Netherlands VieCuri Venray, Netherlands Isala Zwolle, Netherlands Less <<
NCT01387880 Metastatic Colorectal Cancer Phase 2 Completed - Denmark ... More >> Herlev University Hospital Herlev, Copenhagen, Denmark, 2730 Less <<
NCT00972335 Intracranial Meningioma Phase 2 Terminated(Study terminated ea... More >>rly due to slow accrual) Less << - United States, Florida ... More >> Florida Hospital Cancer Insitute Orlando, Florida, United States, 32804 United States, Kentucky Norton Cancer Institute Louisville, Kentucky, United States, 40207 United States, Nebraska Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 United States, Tennessee UT Cancer Insititute Memphis Memphis, Tennessee, United States, 38104 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less <<
NCT00390195 Hepatocellular Carcinoma Phase 1 Phase 2 Unknown June 2011 Taiwan ... More >> National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Her-Shyong Shiah, M.D.    +886-6-208-3422 ext 65113    hsshiah@nhri.org.tw    Principal Investigator: Li-Tzong Chen, M.D., Ph.D.          Sub-Investigator: Jang-Yang Chang, M.D.          Sub-Investigator: Wu-Chou Su, M.D.          Sub-Investigator: Her-Shyong Shiah, M.D.          Tri-Service General Hospital Active, not recruiting Taipei, Taiwan, 11490 Less <<
NCT00106353 Adenocarcinoma|Neoplasms PHASE1|PHASE2 COMPLETED 2025-01-12 Pfizer Investigational Site, B... More >>irmingham, Alabama, 35233, United States|Pfizer Investigational Site, San Francisco, California, 94143, United States|Pfizer Investigational Site, Chicago, Illinois, 60614, United States|Pfizer Investigational Site, Indianapolis, Indiana, 46202, United States|Pfizer Investigational Site, Boston, Massachusetts, 02115, United States|Pfizer Investigational Site, New York, New York, 10032, United States|Pfizer Investigational Site, New York, New York, 11021, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, 19104-4318, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, 19104, United States|Pfizer Investigational Site, Greenville, South Carolina, 29605, United States|Pfizer Investigational Site, Memphis, Tennessee, 38105-2794, United States|Pfizer Investigational Site, Houston, Texas, 77030-2399, United States|Pfizer Investigational Site, Houston, Texas, 77030, United States|Pfizer Investigational Site, Seattle, Washington, 98105, United States|Pfizer Investigational Site, Calgary, Alberta, T3B 6A8, Canada|Pfizer Investigational Site, Edmonton, Alberta, T6G 2B7, Canada|Pfizer Investigational Site, Vancouver, British Columbia, V6H 3V4, Canada|Pfizer Investigational Site, Halifax,, Nova Scotia, B3K 6R8, Canada|Pfizer Investigational Site, London, Ontario, N6A 4G5, Canada|Pfizer Investigational Site, Toronto, Ontario, M5G 1X8, Canada|Pfizer Investigational Site, Paris Cedex 05, 75248, France|Pfizer Investigational Site, Villejuif, 94805, France|Pfizer Investigational Site, Muenster, 48149, Germany|Pfizer Investigational Site, Mexico City, 04530, Mexico|Pfizer Investigational Site, Lublin, 20- 093, Poland|Pfizer Investigational Site, Lublin, 20-093, Poland|Pfizer Investigational Site, Warszawa, 04-730, Poland|Pfizer Investigational Site, Moscow, 115478, Russian Federation|Pfizer Investigational Site, Moscow, 117513, Russian Federation|Pfizer Investigational Site, Saint Petersburg, 197110, Russian Federation Less <<
NCT01567488 Gastrointestinal Neoplasms Phase 2 Completed - Spain ... More >> Instituto Catalán de Oncologia Hospitalet de Llobregat, Barcelona, Spain, 08907 Less <<
NCT03298958 Bladder Cancer Phase 3 Not yet recruiting May 1, 2022 United States, Texas ... More >> University of Texas Health Science Center at San Antonio Not yet recruiting San Antonio, Texas, United States, 78229 Contact: Emily M Rios, BA    210-567-3224    riose3@uthscsa.edu    Principal Investigator: Robert Svatek, MD Less <<
NCT00106353 Adenocarcinoma|Neoplasms PHASE1|PHASE2 COMPLETED 2025-01-12 Pfizer Investigational Site, B... More >>irmingham, Alabama, 35233, United States|Pfizer Investigational Site, San Francisco, California, 94143, United States|Pfizer Investigational Site, Chicago, Illinois, 60614, United States|Pfizer Investigational Site, Indianapolis, Indiana, 46202, United States|Pfizer Investigational Site, Boston, Massachusetts, 02115, United States|Pfizer Investigational Site, New York, New York, 10032, United States|Pfizer Investigational Site, New York, New York, 11021, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, 19104-4318, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, 19104, United States|Pfizer Investigational Site, Greenville, South Carolina, 29605, United States|Pfizer Investigational Site, Memphis, Tennessee, 38105-2794, United States|Pfizer Investigational Site, Houston, Texas, 77030-2399, United States|Pfizer Investigational Site, Houston, Texas, 77030, United States|Pfizer Investigational Site, Seattle, Washington, 98105, United States|Pfizer Investigational Site, Calgary, Alberta, T3B 6A8, Canada|Pfizer Investigational Site, Edmonton, Alberta, T6G 2B7, Canada|Pfizer Investigational Site, Vancouver, British Columbia, V6H 3V4, Canada|Pfizer Investigational Site, Halifax,, Nova Scotia, B3K 6R8, Canada|Pfizer Investigational Site, London, Ontario, N6A 4G5, Canada|Pfizer Investigational Site, Toronto, Ontario, M5G 1X8, Canada|Pfizer Investigational Site, Paris Cedex 05, 75248, France|Pfizer Investigational Site, Villejuif, 94805, France|Pfizer Investigational Site, Muenster, 48149, Germany|Pfizer Investigational Site, Mexico City, 04530, Mexico|Pfizer Investigational Site, Lublin, 20- 093, Poland|Pfizer Investigational Site, Lublin, 20-093, Poland|Pfizer Investigational Site, Warszawa, 04-730, Poland|Pfizer Investigational Site, Moscow, 115478, Russian Federation|Pfizer Investigational Site, Moscow, 117513, Russian Federation|Pfizer Investigational Site, Saint Petersburg, 197110, Russian Federation Less <<
NCT00411788 - Completed - -
NCT00972335 - Terminated(Study terminated ea... More >>rly due to slow accrual) Less << - -
NCT00411788 Breast Cancer Phase 2 Completed - United States, Connecticut ... More >> Bridgeport Hospital Bridgeport, Connecticut, United States, 06610 Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06519 Less <<
NCT02091973 microRNA Profiles Not Applicable Unknown December 2015 Thailand ... More >> Chulalongkorn University Recruiting Bangkok, Thailand, 10330 Contact: Wiwat Chancharoenthana, MD, MSc    6622564251 ext 106    wiwatmd@hotmail.com Less <<
NCT03386539 Pediatric Heart Transplantatio... More >>n Immunosuppression Chronic Kidney Diseases Cardiac Allograft Vasculopathy Heart Transplant Failure and Rejection Post-transplant Lymphoproliferative Disorder Heart Transplant Infection Less << Phase 3 Recruiting September 2021 -
NCT01665768 CD20+, B-cell Lymphomas ... More >> Mantle Cell Lymphoma Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) Transformed Lymphoma/DLBCL/PMBCL Hodgkin's Disease Gray Zone Lymphoma Less << Phase 2 Active, not recruiting July 2020 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT01390519 - Completed - Norway ... More >> Novartis Investigative Site Kristiansand, Norway, 4615 Novartis Investigative Site Tromsø, Norway, 9038 Novartis Investigative Site Trondheim, Norway, 7006 Less <<
NCT00113360 - Completed - -
NCT00113360 Neuroendocrine Carcinoma ... More >> Islet Cell Carcinoma Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01470209 Solid Tumors ... More >>Lung Cancer Less << Phase 1 Completed - United States, Georgia ... More >> Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT00767819 Progressive Sarcoma Phase 2 Completed - Germany ... More >> Novartis Investigative Site Bad Saarow, Germany, 15526 Novartis Investigative Site Duesseldorf, Germany, 40479 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Muenchen, Germany, 81377 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Less <<
NCT03660930 Soft Tissue Sarcoma Phase 1 Phase 2 Not yet recruiting February 28, 2021 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Not yet recruiting Seattle, Washington, United States, 98109 Contact: Roxanne Moore    206-606-6425    romoore@seattlecca.org    Principal Investigator: Lee Cranmer, MD Less <<
NCT01668784 Advanced or Metastatic (Medica... More >>lly or Surgically Unresectable) Clear-cell Renal Cell Carcinoma Less << Phase 3 Active, not recruiting September 28, 2018 -
NCT01932177 Metastatic or Locally Advanced... More >> Solid Tumors Less << Phase 1 Unknown October 2015 France ... More >> Hospices Civils de Lyon Recruiting Lyon, France, 69002 Less <<
NCT00955773 Cancer Phase 1 Completed - United States, Tennessee ... More >> GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 France GSK Investigational Site Paris Cedex 20, France, 75970 Less <<
NCT01169701 Renal Transplant Phase 4 Completed - Spain ... More >> Novartis Investigative Site Malaga, Andalucia, Spain, 29010 Novartis Investigative Site Hospitalet de Llobregat, Barcelona, Spain, 08907 Novartis Investigative Site Barcelona, Catalunya, Spain, 08025 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Barcelona, Cataluña, Spain, 08003 Novartis Investigative Site Madrid, Spain, 28040 Novartis Investigative Site Madrid, Spain, 28041 Novartis Investigative Site Madrid, Spain Less <<
NCT01169701 - Completed - -
NCT01281514 Fallopian Tube Cancer ... More >> Peritoneal Cavity Cancer Recurrent Ovarian Epithelial Cancer Less << Phase 1 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT01187199 Advanced Cancer Phase 1 Active, not recruiting August 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01007942 - Completed - -
NCT00323739 Kidney Cancer Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Gainsville Hematology Oncology Associates Gainesville, Florida, United States, 32605 Integrated Community Oncology Network Jacksonville, Florida, United States, 32256 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Georgia Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Louisiana Baton Rouge General Medical Center Baton Rouge, Louisiana, United States, 70806 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT02520063 Breast Cancer Phase 1 Phase 2 Recruiting February 2021 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Christos Vaklavas, M.D.    205-934-5677    cvaklavas@uabmc.edu    Principal Investigator: Christos Vaklavas, M.D.          Principal Investigator: Andres Forero-Torres, M.D. Less <<
NCT01668784 - Active, not recruiting - -
NCT00323739 - Completed - -
NCT01007942 HER2/Neu Over-expressing Local... More >>ly Advanced Breast Cancer Metastatic Breast Cancer Less << Phase 3 Completed - -
NCT00985192 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, California ... More >> Central Hematology Oncology Medical Group, Inc. Alhambra, California, United States, 91801 Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 St. Jude Heritage Medical Group at Virginia K. Crosson Cancer Center Fullerton, California, United States, 92835 Antelope Valley Cancer Center Lancaster, California, United States, 93534 Pacific Shores Medical Group Long Beach, California, United States, 90813 Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Translational Oncology Research International (TORI) Network Los Angeles, California, United States, 90095 North Valley Hematology/Oncology Medical Group Northridge, California, United States, 91328 Wilshire Oncology Medical Group, Inc. Pomona, California, United States, 91767 Cancer Care Associates Medical Group, Inc. Redondo Beach, California, United States, 90277 TORI REDONDO BEACH (Cancer Care Associates Medical Group, Inc.) Redondo Beach, California, United States, 90277 Sansum Medical Clinic Santa Barbara, California, United States, 93105 Santa Barbara Hematology Oncology Medical Group, Inc. Santa Barbara, California, United States, 93105 Central Coast Medical Oncology Corporation Santa Maria, California, United States, 93454 Trivalley Oncology Hematology Westlake village, California, United States, 91361 United States, Georgia Suburban Hematology-Oncology Associates, P.A. Lawrenceville, Georgia, United States, 30045 Northwest Georgia Oncology Centers, P.C. Marietta, Georgia, United States, 30060 United States, Nevada Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89109 Less <<
NCT00417677 Renal Cell Carcinoma Phase 1 Phase 2 Terminated(Decision was made n... More >>ot to attempt a lower dose) Less << - United States, Maryland ... More >> Baltimore, Maryland, United States, 21231 United States, Massachusetts Boston, Massachusetts, United States, 02215 United States, New York New York, New York, United States, 10021 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT01365468 - Terminated(Poor patients' accr... More >>ual) Less << - -
NCT03140449 Facial Angiofibroma Phase 3 Completed - -
NCT00985192 - Completed - -
NCT01365468 Plexiform Neurofibroma Associa... More >>ted With Neurofibromatosis Type 1 Less << Phase 2 Terminated(Poor patients' accr... More >>ual) Less << - Israel ... More >> Novartis Investigative Site Tel-Aviv, Israel, 6423906 Novartis Investigative Site Tel-Hashomer, Israel, 52621 Less <<
NCT01127763 - Completed - -
NCT01783444 Breast Cancer Phase 2 Completed - -
NCT02531932 Breast Cancer Phase 2 Recruiting December 2018 United States, New York ... More >> Mount Sinai Downtown Recruiting New York, New York, United States, 10011 Contact: , MD          Principal Investigator: Paula Klein, MD          Mount Sinai West Recruiting New York, New York, United States, 10019 Principal Investigator: Anupama Goel, MD          Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Principal Investigator: Amy Tiersten, MD Less <<
NCT01684449 Advanced Soft Tissue Sarcoma Phase 1 Phase 2 Completed - Spain ... More >> H. Universitario de Canarias Tenerife, Santa Cruz de Tenerife, Spain, 38320 H. Sant Pau Barcelona, Spain, 08024 Institut Català d'Oncologia - Hospital Duran i Reynals L'Hospitalet de Llobregat, Spain H. La Paz Madrid, Spain Hospital Universitario 12 de Octubre Madrid, Spain Hospital Universitario Puerta de Hierro Majadahonda, Spain H. Son Espases Mallorca, Spain Instituto Valenciano de Oncología Valencia, Spain H. Universitario Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT01226056 Advanced Solid Tumors Phase 1 Phase 2 Suspended(toxicity (protocol a... More >>mendment under approval)) Less << December 2012 Italy ... More >> Istituto Europeo di Oncologia, Milano, Italy, 20141 Less <<
NCT02860494 Facial Angiofibromas Phase 2 Phase 3 Not yet recruiting September 2022 France ... More >> Hopital Femme Mère Enfant Not yet recruiting Bron, France Contact: Vincent DES PORTES, Pr          Contact: Segolene Gaillard, Project manager    (0)4 27 85 77 28 ext +33    segolene.gaillard@chu-lyon.fr Less <<
NCT01627067 Breast Cancer Phase 2 Active, not recruiting September 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02077933 Neoplasms Bre... More >>ast Neoplasms Kidney Neoplasms Pancreatic Neuroendocine Neoplasms Less << Phase 1 Active, not recruiting November 30, 2018 United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, New York Memorial Sloan Kettering Cancer Center SC - BYL719Z2102 New York, New York, United States, 10065 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Bordeaux, France, 33076 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Essen, Germany, 45136 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Hannover, Germany, 30625 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Hungary Novartis Investigative Site Budapest, Hungary, H-1077 Italy Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site Milano, MI, Italy, 20141 Novartis Investigative Site Modena, MO, Italy, 41124 Novartis Investigative Site Verona, VR, Italy, 37126 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Novartis Investigative Site Utrecht, Netherlands, 3584CX Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Madrid, Spain, 28007 Novartis Investigative Site Madrid, Spain, 28034 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M20 4BX Less <<
NCT01127763 Breast Cancer Phase 2 Completed - United States, New York ... More >> NYU Clinical Cancer Center New York, New York, United States, 10016 Less <<
NCT00436618 Leukemia Lymp... More >>homa Lymphoproliferative Disorder Less << Phase 2 Active, not recruiting December 2020 United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00436618 - Active, not recruiting - -
NCT00408655 Ovarian Sarcoma ... More >> Ovarian Stromal Cancer Recurrent Endometrial Carcinoma Recurrent Ovarian Epithelial Cancer Recurrent Ovarian Germ Cell Tumor Stage III Endometrial Carcinoma Stage III Ovarian Epithelial Cancer Stage III Ovarian Germ Cell Tumor Stage IV Endometrial Carcinoma Stage IV Ovarian Epithelial Cancer Stage IV Ovarian Germ Cell Tumor Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - Canada, Ontario ... More >> National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada, K7L 3N6 Less <<
NCT00449748 Systemic Mastocytosis Phase 2 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01434602 Brain Tumor G... More >>lioblastoma Anaplastic Glioma Less << Phase 1 Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00622258 Non-Hodgkin's Lymphoma Phase 1 Completed - Japan ... More >> Novartis Investigative Site Nagoya-city, Aichi, Japan, 466-8650 Novartis Investigative Site Nagoya, Aichi, Japan, 460-0001 Novartis Investigative Site Kashiwa, Chiba, Japan Novartis Investigative Site Isehara-city, Kanagawa, Japan, 259-1193 Novartis Investigative Site Sendai-city, Miyagi, Japan, 980-8574 Novartis Investigative Site Chuo-ku, Tokyo, Japan Novartis Investigative Site Fukuoka, Japan, 811-1395 Novartis Investigative Site Kyoto, Japan, 602-8566 Less <<
NCT02970630 Kidney Transplantation Phase 2 Completed - Italy ... More >> Ospedale Ca' Granda - Niguarda Milano, Italy Ospedale Maggiore Policlinico Milano, Italy Azienda Ospedaliera di Padova Padova, Italy Policlinico "A. Gemelli" Rome, Italy Policlinico "Le Scotte" Siena, Italy Azienda Ospedaliera S. Giovanni Battista Torino, Italy Less <<
NCT00449748 - Completed - -
NCT00286156 - Completed - -
NCT00286156 Polycystic Kidney Diseases Phase 1 Phase 2 Completed - United States, Ohio ... More >> The Cleveland Clinic- main campus Cleveland, Ohio, United States, 44195 Less <<
NCT01185366 Kidney Cancer Phase 2 Active, not recruiting August 2019 United States, Massachusetts ... More >> Dana-Farber Cancer Institute/Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute - University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT01174199 Prostate Cancer ... More >> Adenocarcinoma of the Prostate Hormone-resistant Prostate Cancer Recurrent Prostate Cancer Stage IV Prostate Cancer Less << Phase 1 Terminated(no value in finding... More >> efficacy) Less << - United States, Maryland ... More >> The Sydney Kimmel Comprehensive Center at John Hopkins Baltimore, Maryland, United States, 21287 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01058408 Head and Neck Cancer Phase 1 Terminated - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00290472 - Completed - -
NCT00290472 B-cell Chronic Lymphocytic Leu... More >>kemia Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Malignant Neoplasm Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Splenic Marginal Zone Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Evanston Hospital CCOP Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Adventist La Grange Memorial Hospital La Grange, Illinois, United States, 60525 Loyola University Medical Center Maywood, Illinois, United States, 60153 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 60702 United States, Indiana Fort Wayne Medical Oncology and Hematology Inc-Parkview Fort Wayne, Indiana, United States, 46845 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Michigan Oncology Care Associates PLLC Saint Joseph, Michigan, United States, 49085 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00920309 Autosomal Dominant Polycystic ... More >>Kidney Disease Less << Phase 2 Phase 3 Terminated(This study was stop... More >>ped after larger studies published in the NEJM failed to show a benefit in treating ADPKD) Less << - United States, Connecticut ... More >> Yale Center for Clinical Investigation New Haven, Connecticut, United States, 06520 Less <<
NCT00920309 - Terminated(This study was stop... More >>ped after larger studies published in the NEJM failed to show a benefit in treating ADPKD) Less << - -
NCT00187174 Tumors Brain ... More >>Tumors Rhabdomyosarcoma Sarcoma, Soft Tissue Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01058655 - Completed - -
NCT00979966 Non-clear Cell Renal Cell Canc... More >>er Less << Phase 2 Completed - Germany ... More >> Charité - Campus Virchow Klinikum Berlin, Germany Charité - Mitte Berlin, Germany Vivantes Klinikum am Urban Berlin, Germany Evangelische Kliniken Bonn gGmbH - Johanniter-Krankenhaus Bonn, Germany Universitätsklinikum Düsseldorf Düsseldorf, Germany Universitätsklinikum Essen Essen, Germany Klinikum der J.W. Goethe Universität Frankfurt, Germany Martin-Luther-Universität Halle-Wittenberg Halle, Germany Universitätskrankenhaus Jena Jena, Germany UK-SH Campus Lübeck Lübeck, Germany Klinikum Oldenburg gGmbH Oldenburg, Germany Klinikum Stuttgart, Katharinenhospital Stuttgart, Germany Facharzt für Innere Medizin, Viersen, Germany Kliniken Nordoberpfalz AG - Klinikum Weiden Weiden, Germany Less <<
NCT00775593 Leukemia Phase 2 Completed - Italy ... More >> Azienda ospedaliera Nuovo ospedale "Torrette" Ancona, Italy Azienda Ospedaliero-Universitaria Policlinico Consorziale Bari, Italy Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi Bologna, Italy, 40138 Ospedale Ferrarotto Catania, Italy, 95124 Ospedale Regionale A. Pugliese Catanzaro, Italy, 88100 Azienda ospedaliera di Rilievo Nazionale "A. Cardarelli" Napoli, Italy Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Napoli, Italy S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Novara, Italy A.O. Universitaria S. Luigi Gonzaga di Orbassano Orbassano, Italy Azienda Ospedaliero - Universitaria di Parma Parma, Italy Azienda ASL di Pescara Pescara, Italy, 61100 Complesso Ospedaliero S. Giovanni Addolorata Roma, Italy Ospedale S. Eugenio Roma, Italy S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena Roma, Italy Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy Policlinico di Tor Vergata Rome, Italy, 00133 Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 Serv. di Ematologia Ist. di Ematologia ed Endocrinologia Sassari, Italy Policlinico G. B. Rossi - Borgo Roma Verona, Italy, 37134 Less <<
NCT00830466 Port Wine Stain Phase 1 Completed - United States, California ... More >> Beckman Laser Institute and Medical Clinic Irvine, California, United States, 92612 Less <<
NCT00378014 Liver Transplantation Phase 3 Completed - Austria ... More >> Novartis Investigative Site Innsbruck, Austria, A-6020 Novartis Investigative Site Wien, Austria, A-1090 Germany Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Jena, Germany, 07740 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Tübingen, Germany, 72076 Netherlands Novartis Investigative Site Groningen, Netherlands, 9713 GZ Novartis Investigative Site Rotterdam, Netherlands, 3015 CE Switzerland Novartis Investigative Site Genève, Switzerland, 1211 Novartis Investigative Site Zurich, Switzerland, 8091 Less <<
NCT00827684 Metastatic Colorectal Cancer Phase 2 Completed - Denmark ... More >> Rigshospitalet, Department of Oncology Copenhagen, Denmark, DK-2100 Vejle Hospital, Dept. of Oncology Vejle, Denmark Less <<
NCT02096107 Graft Dysfunction ... More >> Interstitial Fibrosis Less << Phase 4 Completed - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT00426556 Metastatic Breast Cancer Phase 1 Completed - United States, California ... More >> Wilshire Oncology Medical Group La Verne *see Various Departments*, California, United States Compassionate Cancer Care Medical Group Dept.ofCCCMG Fountain Valley, California, United States, 92708 Loma Linda University Dept.ofLomaLindaCancerCent(3) Loma Linda, California, United States, 92354 University of California at Los Angeles Dept.of UCLA Dept.ofMed. Los Angeles, California, United States, 90095 United States, Florida Florida Cancer Research Institute Davie, Florida, United States, 33328 United States, Georgia Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2) Atlanta, Georgia, United States, 30322 United States, Illinois North Shore University Health System Evanston, Illinois, United States, 60201 United States, Maryland Peninsula Regional Medical Center Deptof Oncology and Hematology Salisbury, Maryland, United States, 21801 United States, Missouri Washington University School Of Medicine-Siteman Cancer Ctr StudyCoordinator:CRAD001J2101 St. Louis, Missouri, United States, 63110 United States, South Carolina Cancer Centers of the Carolinas CC of C -Eastside Greenville, South Carolina, United States, 29605 United States, Texas Sammons Cancer Center - Texas Oncology Dallas, Texas, United States, 78246 Belgium Novartis Investigative Site Charleroi, Belgium, 6000 Novartis Investigative Site Liege, Belgium, 4000 Novartis Investigative Site Turnhout, Belgium, 2300 France Novartis Investigative Site Paris, France, 75970 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Novartis Investigative Site Toulouse Cedex 9, France, 31059 Novartis Investigative Site Villejuif Cedex, France, 94805 Netherlands Novartis Investigative Site Maastricht, Netherlands, 6229 HX Spain Novartis Investigative Site Lleida, Cataluna, Spain, 25198 Less <<
NCT00378014 - Completed - -
NCT00426556 - Completed - -
NCT01283334 Head and Neck Neoplasms ... More >> Cancer of the Head and Neck Less << Phase 1 Phase 2 Completed - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT02096107 - Completed - -
NCT00695344 Cardiac Transplant Phase 4 Unknown June 2010 Spain ... More >> Hospital Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Clínica Universitaria de Navarra Pamplona, Navarra, Spain, 31008 Hospital Clinic de Barcelona Barcelona, Spain, 08036 Hospital Santa Creu i Sant Pau Barcelona, Spain, 08041 Hospital de Bellvitge Barcelona, Spain, 08907 Hospital Gregorio Marañón Madrid, Spain, 28007 Hospital Puerta de Hierro Madrid, Spain, 28035 Hospital 12 de Octubre Madrid, Spain, 28041 Less <<
NCT01427946 Non-small Cell Lung Cancer Phase 1 Phase 2 Completed - United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10017 Less <<
NCT01283334 - Completed - -
NCT00392821 Kidney Cancer Phase 1 Phase 2 Completed - United States, Florida ... More >> Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 Norton Cancer Institute Louisville, Kentucky, United States, 40207 United States, Missouri Research Medical Center Kansas City, Missouri, United States, 64132 United States, New Jersey Hematology Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07960 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00775593 - Completed - -
NCT00968591 Hepatic Insufficiency Phase 1 Completed - Germany ... More >> Novartis Investigative Site Frankfurt, Germany Russian Federation Novartis Investigative Site Moscow, Russian Federation Singapore Novartis Investigative Site Singapore, Singapore Less <<
NCT01624948 BK Virus Infection Phase 4 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 Less <<
NCT01058655 Gastrointestinal Cancer Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00423865 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01927588 Cytomegalovirus Infections Phase 4 Unknown November 2015 -
NCT00392821 - Completed - -
NCT01624948 - Completed - -
NCT00973713 Cholangiocarcinoma Phase 2 Unknown March 2012 Australia, Victoria ... More >> Austin Health Recruiting Melbourne, Victoria, Australia, 3084 Contact: Effie Roiniotis, RN    +61394963576    effie.roiniotis@ludwig.edu.au    Principal Investigator: Niall Tebbutt, FRACP Less <<
NCT01196429 - Completed - -
NCT03596970 Liver Transplantation Phase 3 Withdrawn December 2020 -
NCT00790400 Tuberous Sclerosis Complex (TS... More >>C) Lymphangioleiomyomatosis (LAM) Less << Phase 3 Completed - -
NCT01608412 Kidney Transplant Recipients Phase 4 Unknown July 2014 Brazil ... More >> Hospital de Clínicas de Porto Alegre Recruiting Porto Alegre, RS, Brazil, 90035-903 Less <<
NCT01196429 Ovarian Clear Cell Cystadenoca... More >>rcinoma Stage III Ovarian Cancer Stage IV Ovarian Cancer Less << Phase 2 Completed - -
NCT02036554 Kidney; Complications, Allogra... More >>ft Less << Phase 4 Unknown December 2015 Korea, Republic of ... More >> division of nephrology;Seoul St Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: Chul Woo Yang    82-2-2258-6851    yangch@catholic.ac.kr Less <<
NCT02504892 Renal Cancer ... More >>Birt-Hogg-Dube Syndrome Less << Phase 2 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01275222 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Dana Faber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York College of Physicians & Surgeons of Columbia University New York, New York, United States, 10032 United States, Pennsylvania Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Belgium Novarts Investigative Site Edegem, Belgium, 2650 Novarts Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Lille Cedex, France, 59020 Novartis Investigative Site Lyon Cedex 08, France, 69373 Novartis Investigative Site Marseille, France, 13005 Novartis Investigative Site Villejuif, France, 94805 Germany Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Frankfurt, Germany, 60488 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Koln, Germany, 50973 Novartis Investigative Site Muenchen, Germany, 81377 Novartis Investigative Site Tubingen, Germany, 72076 Less <<
NCT00790400 - Completed - -
NCT01978171 - Completed - Netherlands ... More >> Antonius Ziekenhuis Nieuwegein, Netherlands Radboud university medical center Nijmegen, Netherlands Less <<
NCT00819546 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 1 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00406276 Lung Cancer Phase 1 Phase 2 Terminated(data analysis showe... More >>d insufficient drug efficacy) Less << - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00804336 Neuroendocrine Tumor ... More >> Carcinoid Tumor Pancreatic Neuroendocrine Tumor Less << Phase 1 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Less <<
NCT00630344 Prostate Cancer Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00630344 - Completed - -
NCT03387020 Central Nervous System Embryon... More >>al Tumor, Not Otherwise Specified Malignant Glioma Recurrent Atypical Teratoid/Rhabdoid Tumor Recurrent Childhood Ependymoma Recurrent Diffuse Intrinsic Pontine Glioma Recurrent Medulloblastoma Refractory Diffuse Intrinsic Pontine Glioma Less << Phase 1 Recruiting July 31, 2020 United States, California ... More >> Children's Hospital Los Angeles Not yet recruiting Los Angeles, California, United States, 90026 Contact: Girish Dhall, MD    323-361-4629    gdhall@chla.usc.edu    Principal Investigator: Girish Dhall, MD          Lucile Packard Children Hospital Stanford University Not yet recruiting Palo Alto, California, United States, 94304 Contact: Michelle Monje    650-721-5750    mmonje@stanford.edu    United States, Colorado Children's Hospital Colorado Not yet recruiting Aurora, Colorado, United States, 80045 Contact: Kathleen Dorris    720-777-1234    kathleen.dorris@childrenscolorado.org    United States, District of Columbia Children's National Medical Center Not yet recruiting Washington, District of Columbia, United States, 20010 Contact: Eugene Hwang, M.D.    202-476-5046    ehwang@childrensnational.org    Contact: Sabrina Malik    202-476-5115    smalik@childrensnational.org    Principal Investigator: Eugene Hwang, M.D.          United States, Georgia Children's Healthcare of Atlanta Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Tobey MacDonald    404-727-1447    tobey.macdonald@emory.edu    United States, Maryland National Cancer Institute Pediatric Oncology Branch Not yet recruiting Bethesda, Maryland, United States, 20892 Contact: Kathlerine E. Warren    301-435-4683    warrenk@mail.nih.gov    Principal Investigator: Kathlerine E. Warren          United States, New York Memorial Sloan Kettering Cancer Center Not yet recruiting New York, New York, United States, 10065 Contact: Ira Dunkel    212-639-2153    dunkeli@mskcc.org    Principal Investigator: Ira Dunkel          United States, Ohio Cincinnati Children Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Maryam Fouladi    513-803-0721    maryam.fouladi@cchmc.org    Principal Investigator: Maryam Fouladi          United States, Pennsylvania Children Hospital of Pittsburgh of UPMC Not yet recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Ian Pollack    412-692-5881    Pollaci@chp.edu    Principal Investigator: Ian Pollack, MD          United States, Tennessee Pediatric Brain Tumor Consortium Not yet recruiting Memphis, Tennessee, United States, 38105 Contact: Mariko D. DeWire    513-636-4266    mariko.dewire@cchmc.org    Principal Investigator: Mariko D. DeWire          St. Jude Children Research Hospital Not yet recruiting Memphis, Tennessee, United States, 38105 Contact: Giles Robinson, MD    901-595-2907    giles.robinson@stjude.org    United States, Texas Texas Children's Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Patricia Baxter, MD    832-824-4681    pabaxter@txch.org    Contact: Susan Burlingame, CCRP    832-824-1532    sxburlin@txch.org    Principal Investigator: Patricia Baxter, MD Less <<
NCT00406276 - Terminated(data analysis showe... More >>d insufficient drug efficacy) Less << - -
NCT02246127 Neuroendocrine Tumors Phase 3 Recruiting June 2020 -
NCT03173560 Renal Cell Carcinoma Phase 2 Recruiting September 15, 2019 -
NCT02397083 Endometrial Cancer Phase 2 Recruiting September 2026 United States, Texas ... More >> Memorial City Recruiting Houston, Texas, United States, 77024 Lyndon B. Johnson General Hospital (LBJ) Recruiting Houston, Texas, United States, 77026 University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 The Woman's Hospital of Texas Recruiting Houston, Texas, United States, 77054 Less <<
NCT00419159 Colorectal Cancer Phase 2 Completed - United States, Nevada ... More >> Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Less <<
NCT00419159 - Completed - -
NCT00586443 Solid Tumors Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01218555 Solid Organ Malignancies ... More >> Adenoidcystic Carcinoma Neuroendocrine Tumors Less << Phase 1 Completed - United States, Georgia ... More >> Grady Health System Atlanta, Georgia, United States, 30303 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT01272141 Breast Neoplasms ... More >> Breast Cancer Cancer of the Breast Less << Phase 2 Terminated(Slow accrual, Fundi... More >>ng stopped) Less << - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory Midtown (Crawford Long Hospital) Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30329 Less <<
NCT01272141 - Terminated(Slow accrual, Fundi... More >>ng stopped) Less << - -
NCT03740334 Acute Lymphoblastic Leukemia A... More >>LL Less << Phase 1 Not yet recruiting September 1, 2023 United States, Massachusetts ... More >> Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Andrew E Place, MD, PhD    617-632-2313    andrew_place@dfci.harvard.edu    Principal Investigator: Andrew E Place, MD, PhD Less <<
NCT02577458 Renal Cell Carcinoma Recurrent Phase 1 Recruiting June 2018 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Xinan Sheng, M.D    010-88196951    doctor_sheng@126.com Less <<
NCT00967928 Cervical Cancer Phase 1 Withdrawn(Lack of enrollment) December 2010 -
NCT01797120 - Completed - -
NCT01108445 Advanced Non-clear Cell Renal ... More >>Cell Carcinoma Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 United States, Indiana Indiana University Melvin and Bran Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Michigan Karmanos Cancer Institute/Wayne State University Detroit, Michigan, United States, 48201 United States, Missouri Washington Univ in St. Louis-School of Medicine Saint Louis, Missouri, United States, 63110 United States, North Carolina Duke Univeristy Medical Center Durham, North Carolina, United States, 27708 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Tennessee SCRI Nashville, Tennessee, United States, 37203 The Vanderbilt Clinic, Henry-Joyce Cancer Center Nashville, Tennessee, United States, 37212 Canada, British Columbia BC Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba, Med Onc, Dept Hem and Onc Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Ontario London Health Sciences Center London, Ontario, Canada, N6A-4L6 United Kingdom Cambridge Cancer Trials Centre Cambridge, England, United Kingdom, CB2 0QQ The Royal Marsden NHS London, England, United Kingdom, 8W3 6JJ The Christie Hospital NHS Manchester, England, United Kingdom, M20 4BX Weston Park Hospital Sheffield, England, United Kingdom, S10 2SJ Churchill Hospital Headington, Oxford, United Kingdom, OX3 7LJ Beatson West Scotland Cancer Centre Glasgow, Scottland, United Kingdom, G12 0YN Less <<
NCT01888042 Kidney Cancer Phase 2 Terminated - France ... More >> Gustave Roussy Villejuif, Val de Marne, France, 94805 Less <<
NCT00776373 ALL Burkitt's... More >> Lymphoma Lymphoblastic Leukemia CML Less << Phase 1 Phase 2 Terminated - United States, Pennsylvania ... More >> University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19066 Less <<
NCT03161340 Recurrent Implantation Failure Phase 2 Completed - Iran, Islamic Republic of ... More >> Qom ACECR ART Center Qom, Iran, Islamic Republic of Estern Azarbaijan ACECR ART center Tabriz, Iran, Islamic Republic of Less <<
NCT01649960 Aging CAD Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester and Mayo Health System sites in Austin and Albert Lea, Minnesota Rochester, Minnesota, United States, 55905 Less <<
NCT01797120 Metastatic Breast Cancer Phase 2 Completed - -
NCT01282697 Refractory Solid Tumors in Chi... More >>ldren Less << Phase 1 Unknown August 2014 France ... More >> Hôpital des Enfants - Groupe Hospitalier Pellegrin Not yet recruiting Bordeaux, France, 33076 Contact: Yves PEREL, MD, PhD          Principal Investigator: Yves PEREL, MD, PhD          Centre Oscar Lambret Not yet recruiting Lille, France, 59020 Contact: Pierre LEBLOND, MD          Principal Investigator: Pierre LEBLOND, MD          Institut Hémato-Oncologie Pédiatrique (IHOP) Not yet recruiting Lyon, France, 67008 Contact: Didier FRAPPAZ, MD          Principal Investigator: Didier FRAPPAZ, MD          CHU La Timone Not yet recruiting Marseille, France, 13005 Contact: Nicolas ANDRE, MD          Principal Investigator: Nicolas ANDRE          CHU Mère-Enfants Not yet recruiting Nantes, France, 44093 Contact: Nadège CORRADINI, MD          Principal Investigator: Nadège CORRADINI, MD          Institut Curie Not yet recruiting Paris, France, 75005 Contact: Isabelle AERTS, MD          Principal Investigator: Isabelle AERTS, MD          Hôpitaux Universitaires de Strasbourg Not yet recruiting Strasbourg, France, 67098 Contact: Natacha ENTZ-WERLE, MD, PhD          Principal Investigator: Natacha ENTZ-WERLE, MD, PhD          Hôpital des Enfants Not yet recruiting Toulouse, France, 31059 Contact: Hervé RUBIE, MD          Principal Investigator: Hervé RUBIE, MD          Institut Gustave Roussy Not yet recruiting Villejuif, France, 94805 Contact: Birgit GEOERGER, MD          Principal Investigator: Birgit GEOERGER, MD Less <<
NCT01108445 - Completed - -
NCT01305941 HER-2 Positive Breast Cancer Phase 2 Completed - United States, Alabama ... More >> University Of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Carolinas Healthcare System Charlotte, North Carolina, United States, 28203 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37212 Less <<
NCT02985125 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 1 Phase 2 Recruiting December 2022 United States, District of Col... More >>umbia Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Michael J Pishvaian, MD, PhD    202-444-2144    pishvaim@georgetown.edu    Contact: Syed Hasan    202-687-2939    smh92@georgetown.edu Less <<
NCT01305941 - Completed - -
NCT02106507 Prostate Cancer Phase 1 Active, not recruiting April 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00857259 Choroidal Neo-Vascular Age-ons... More >>et Macular Degeneration Age-related Macular Degeneration Less << Phase 2 Terminated - United States, California ... More >> Retina-Vitreous Associates Medical Group Beverley Hills, California, United States, 90211 Retinal Consultants Medical Group, Inc. Sacramento, California, United States United States, Colorado Porter Adventist Hospital, Diagnostic Eye Laboratory Denver, Colorado, United States, 80210 United States, Missouri Discover Vision Center Independence, Missouri, United States, 64055 United Kingdom Novartis Investigative Site Bristol, United Kingdom Novartis Investigative Site Frimley, United Kingdom Novartis Investigative Site Liverpool, United Kingdom Novartis Investigative Site London, United Kingdom Novartis Investigative Site Oxford, United Kingdom Novartis Investigative site Portsmouth, United Kingdom Novartis Investigative Site Southampton, United Kingdom Novartis Investigator Site Wolverhampton, United Kingdom Less <<
NCT00702052 Lymphoma, Mantle- Cell Phase 2 Completed - -
NCT01149434 Cancer Neuroe... More >>ndocrine Ovarian Cancer Colon Cancer Less << Phase 1 Phase 2 Terminated(Lack of drug effica... More >>cy) Less << - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT03176238 Post Menopausal Breast Cancer Phase 3 Active, not recruiting September 28, 2018 -
NCT01149434 - Terminated(Lack of drug effica... More >>cy) Less << - -
NCT02344550 Metastatic Breast Cancer Phase 2 Recruiting August 2018 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Sung Bae Kim, M.D., Ph D.    82-2-3010-3217    sbkim3@amc.seoul.kr Less <<
NCT00968253 Leukemia Acut... More >>e Lymphocytic Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00968253 - Completed - -
NCT00443937 Renal Transplantation Phase 4 Completed - Germany ... More >> Charité-Universitätsmedizin Berlin, Germany, 10117 Less <<
NCT01188889 Chronic Myeloid Leukemia Phase 1 Phase 2 Withdrawn(Unable to obtain suf... More >>ficient funding.) Less << December 2017 United States, Michigan ... More >> University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Less <<
NCT00857259 - Terminated - -
NCT02616848 Triple Negative Breast Cancer Phase 1 Unknown - Italy ... More >> AO Cremona Recruiting Cremona, Lombardia, Italy, 26100 Contact: Daniele Generali, Prof    daniele.genrali@gmail.com    daniele.generali@gmail.com Less <<
NCT02031536 Gastrinoma Gl... More >>ucagonoma Insulinoma Liver Metastases Pancreatic Polypeptide Tumor Recurrent Islet Cell Carcinoma Somatostatinoma Less << Phase 2 Terminated(Slow accrual) April 2017 United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT02028364 Breast Cancer Phase 2 Active, not recruiting January 2020 Belgium ... More >> institut Jules Bordet Bruxelles, Belgium, 1000 Cliniques Universtaires Saint-Luc Bruxelles, Belgium, 1200 UZ Leuven Leuven, Belgium, 3000 CHU Ambroise Paré Mons, Belgium, 7000 Clinique et Maternité Sainte Elisabeth Namur, Belgium, 5000 Less <<
NCT00523432 Genital Neoplasms, Female Phase 1 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01628913 Pancreatic Neuroendocrine Tumo... More >>rs (pNET) Less << Phase 2 Terminated(This trial was term... More >>inated based on an interim analysis as BEZ235 did not demonstrate a progression free survival advantage to everolimus treatment.) Less << - United States, California ... More >> Cedars Sinai Medical Center SC-3 Los Angeles, California, United States, 90048 United States, Colorado University of Colorado Univ Colorado Aurora, Colorado, United States, 80045 United States, Kentucky University of Kentucky Univ Kebtucky Lexington, Kentucky, United States, 40536-0098 United States, New York Montefiore Medical Center SC Bronx, New York, United States, 10467 France Novartis Investigative Site Lyon, France, 69437 Novartis Investigative Site Montpellier Cedex 5, France, 34298 Novartis Investigative Site Paris, France, 75015 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Pisa, PI, Italy, 56126 Novartis Investigative Site Roma, RM, Italy, 00189 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1105 AZ Novartis Investigative Site Groningen, Netherlands, 9713 GZ Russian Federation Novartis Investigative Site Kazan, Russian Federation, 420029 Spain Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Madrid, Spain, 28034 Novartis Investigative Site Madrid, Spain, 28046 Switzerland Novartis Investigative Site Luzern, Switzerland, 6000 United Kingdom Novartis Investigative Site Glasgow, United Kingdom, G11 6NT Novartis Investigative Site London, United Kingdom, NW3 2QG Novartis Investigative Site London, United Kingdom, SE1 9RT Novartis Investigative Site Manchester, United Kingdom, M20 9BX Novartis Investigative Site Sheffield, United Kingdom, S10 2SJ Less <<
NCT01628913 - Terminated(This trial was term... More >>inated based on an interim analysis as BEZ235 did not demonstrate a progression free survival advantage to everolimus treatment.) Less << - -
NCT02077556 Drug Interaction Potentiation Phase 4 Recruiting February 2019 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Meng-Kun Tsai    +886-972651461    mengkuntsai@ntu.edu.tw Less <<
NCT02376985 Breast Cancer Phase 3 Recruiting May 31, 2019 Japan ... More >> Tokai University, School of Medicine Recruiting Isehara, Kanagawa, Japan, 259-1193 Contact: Naoki Niikura       niikura@is.icc.u-tokai.ac.jp    Contact: Yoshihide Ota    +81 463-93-1121    yotaorsg@ybb.ne.jp Less <<
NCT00335764 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Less << Phase 1 Phase 2 Completed - United States, California ... More >> University of California at Los Angeles Los Angeles, California, United States, 90095 University of California San Francisco San Francisco, California, United States, 94115 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00335764 - Completed - -
NCT00788580 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Withdrawn(Study was discontinu... More >>ed.) Less << - -
NCT02724332 Hepatocellular Carcinoma ... More >> Rapamycin Less << Phase 1 Completed - China, Shanghai ... More >> Eastern hepatobilliary surgery hospital Shanghai, Shanghai, China, 200438 Less <<
NCT01148628 Advanced Solid Tumors Phase 1 Unknown December 2011 Italy ... More >> Fondazione IRCSS Istituto Nazionale dei Tumori Milan, Italy, 20133 Istituto Europeo di Oncologia Milan, Italy, 20141 Switzerland Istituto Oncologico della Svizzera Italiana Bellinzona, Switzerland, 6500 Less <<
NCT00253318 Breast Cancer Phase 1 Terminated(Toxicity and Lack o... More >>f Efficacy) Less << - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77230-1439 Less <<
NCT01396408 Advanced Rare Tumours Phase 2 Active, not recruiting December 2018 Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Izaak Walton Killam (IWK) Health Centre Halifax, Nova Scotia, Canada, B3K 6R8 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 CHU Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Saskatoon Cancer Centre Saskatoon, Saskatchewan, Canada, S7N 4H4 Less <<
NCT01120249 Kidney Cancer Phase 3 Active, not recruiting October 2021 -
NCT00651482 - Terminated(slow accrual) - -
NCT01516723 Coronary Artery Disease ... More >> Coronary Disease Coronary Stenosis Less << Phase 3 Active, not recruiting May 2020 Belgium ... More >> AZ Middelheim Antwerpen, Belgium, 2020 Netherlands AMC Amsterdam, Netherlands, 1105AZ Catharina Ziekenhuis Eindhoven, Netherlands, 5602ZA St Antonius Hospital Nieuwegein, Netherlands, 3435CM Less <<
NCT00576680 Pancreatic Neuroendocrine Tumo... More >>r Less << Phase 1 Phase 2 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01594268 Kidney Transplant Phase 4 Completed - Korea, Republic of ... More >> Novartis Investigative Site Seoul, Korea, Korea, Republic of, 120-752 Novartis Investigative Site Seoul, Korea, Republic of, 135-720 Novartis Investigative Site Seoul, Korea, Republic of, 738-736 Novartis Investigative Site Suwon, Korea, Republic of, 442-721 Less <<
NCT02120469 Estrogen Receptor Negative ... More >> HER2/Neu Negative Progesterone Receptor-negative Stage IV Breast Cancer Triple-negative Breast Carcinoma Less << Phase 1 Active, not recruiting December 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 City of Hope Rancho Cucamonga Rancho Cucamonga, California, United States, 91730 South Pasadena Cancer Center South Pasadena, California, United States, 91030 Less <<
NCT01298713 Breast Neoplasms ... More >> mTor Protein Less << Phase 2 Completed - France ... More >> Hopital Hotel Dieu Paris, France, 75004 Less <<
NCT01843348 - Completed - -
NCT00591734 - Completed - -
NCT01843348 Kidney Transplantation ... More >> Renal Transplantation Less << Phase 3 Completed - France ... More >> Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Creteil, France, 94010 Novartis Investigative Site Dijon, France, 21079 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Lyon, France, 69437 Novartis Investigative Site Nantes, France, 44035 Novartis Investigative Site Paris, France, 75970 Novartis Investigative Site Poitiers, France, 86000 Novartis Investigative Site St Priest en Jarez Cedex, France, 42277 Novartis Investigative Site Strasbourg, France, 67091 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Germany Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Bochum, Germany, 44892 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Erlangen, Germany, 91052 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Tübingen, Germany, 72076 Less <<
NCT00591734 Metastatic Melanoma Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 Gulfcoast Oncology Associates St. Petersburg, Florida, United States, 33705 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Indiana Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Pennsylvania Consultants in Medical Oncology and Hematology Drexel Hill, Pennsylvania, United States, 19026 United States, Tennessee Chattanooga Oncology & Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Texas South Texas Oncology and Hematology San Antonio, Texas, United States, 78258 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT00729638 Multiple Myeloma Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226` Less <<
NCT03632317 Glioma Diffus... More >>e Intrinsic Pontine Glioma Less << Phase 2 Recruiting September 2025 United States, Michigan ... More >> University of Michigan Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Carl Koschmann, M.D.    734-615-2736    ckoschma@umich.edu    Principal Investigator: Carl Koschmann, MD Less <<
NCT00651482 Kidney Neoplasms ... More >> Kidney (Renal Cell) Cancer Less << Phase 2 Terminated(slow accrual) - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01624766 Advanced Malignant Neoplasm ... More >> Metastatic Malignant Neoplasm Recurrent Malignant Neoplasm Refractory Malignant Neoplasm Less << Phase 1 Active, not recruiting June 30, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01099527 Metastatic Gastric Cancer Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Samsung Cancer Center Seoul, Korea, Republic of Less <<
NCT01508104 Cancer Phase 1 Terminated(funding) - United States, Ohio ... More >> University of Cincinnati Cincinnati, Ohio, United States, 45267-0502 Less <<
NCT01678664 Neuroendocrine Tumors ... More >> Hepatic Metastases Metastases Less << Phase 2 Active, not recruiting April 2019 France ... More >> CHU Angers, France Hôpital Avicenne Bobigny, France Hôpital Saint André Bordeaux, France Hôpital Côte de Nacre Caen, France CHU Clermont Ferrand, France Hôpital Beaujon Clichy, France Centre GF Leclerc Dijon, France CHU Bocage Dijon, France Hôpital Edouard Herriot Lyon, France CHU La Timone Marseille, France Hôpital Saint Joseph Marseille, France CHR Orléans, France CHU Cochin Paris, France Hôpital Européen Georges Pompidou Paris, France Hôpital Robert Debré Reims, France CHU Rouen, France Hôpital Rangueil Toulouse, France Hôpital Trousseau Tours, France Institut Gustave Roussy Villejuif, France Less <<
NCT00828594 Hepatocellular Carcinoma Phase 1 Terminated - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 UCLA Department of Medicine Los Angeles, California, United States, 90005 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of Netherlands Novartis Investigative Site Amsterdam, Netherlands Spain Novartis Investigative Site Barcelona, Spain Novartis Invstigative Site Madrid, Spain Taiwan Novartis Investigative Site Tainan, Taiwan Less <<
NCT00412061 - Completed - -
NCT02803892 Diabetes Mellitus, Type 1 Phase 2 Recruiting March 2019 Italy ... More >> IRCCS San Raffaele Scientific Institute Recruiting Milan, Italy, 20132 Contact: Lorenzo Piemonti, MD       piemonti.lorenzo@hsr.it    Contact: Andrea Bolla, MD       andrea.bolla@hsr.it    Principal Investigator: Andrea Bolla, MD          Principal Investigator: Lorenzo Piemonti, MD          Principal Investigator: Emanuele Bosi, MD Less <<
NCT00412061 Carcinoid Tumor ... More >> Malignant Carcinoid Syndrome Less << Phase 3 Completed - -
NCT01612299 Renal Transplant Not Applicable Withdrawn(Funding was withdraw... More >>n for this study by the sponsor.) Less << - United States, Kentucky ... More >> University of Kentucky Lexington, Kentucky, United States, 40536 Less <<
NCT00828503 Cytomegalovirus Disease Phase 2 Unknown June 2014 Austria ... More >> Medical University of Vienna Recruiting Vienna, Austria, 1090 Sub-Investigator: Manfred Hecking, MD Less <<
NCT00927966 Sarcoma Solid... More >> Tumor Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01563354 Neuroendocrine Carcinoma of th... More >>e Lung and Thymus Less << Phase 2 Active, not recruiting June 28, 2019 -
NCT00016328 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Less << Phase 2 Completed - United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less <<
NCT00553150 - Active, not recruiting - -
NCT00553150 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Active, not recruiting - -
NCT00329719 - Completed - -
NCT00331409 Kidney Cancer Phase 2 Completed - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00331409 - Completed - -
NCT00912340 - Completed - -
NCT00329719 Adult Glioblastoma ... More >> Adult Gliosarcoma Recurrent Adult Brain Neoplasm Less << Phase 1 Phase 2 Completed - -
NCT00912340 Breast Cancer Phase 2 Completed - United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Illinois Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States, 60611 United States, Wisconsin University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT01139138 Colorectal Cancer ... More >> Colorectal Carcinoma Colorectal Tumors Neoplasms, Colorectal Less << Phase 1 Phase 2 Completed - Australia, South Australia ... More >> The Queen Elizabeth Hospital Adelaide, South Australia, Australia, 5011 Less <<
NCT00087685 Endometrial Cancer Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01266837 Metastatic Renal Cell Carcinom... More >>a Failure of Exactly One Prior VEGF-targeted Therapy Less << Phase 4 Completed - Germany ... More >> Charitè Campus Benjamin Franklin Berlin, Germany, 12203 Klinik und Poliklinik für Urologie , Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden Dresden, Germany, 01307 Urologie - Waldkrankenhaus St. Marien Erlangen, Germany, 91054 Klinik für Innere Medizin (Tumorforschung), Universitätsklinikum Essen Essen, Germany, 45122 Zentrum Innere Medizin, Medizinische Hochschule Hannover Hannover, Germany, 30625 Klinik für Urologie und Kinderurologie, Universitätsklinikum des Saarlandes Homburg, Germany, 66421 Klinik für Urologie, Universitätsklinikum Jena Jena, Germany, 07743 5. Medizinische Klinik, Klinikum Nürnberg Nürnberg, Germany, 90419 Less <<
NCT01059318 Lymphangioleiomyomatosis Phase 2 Completed - United States, Massachusetts ... More >> Center for LAM Research and Clinical Care Boston, Massachusetts, United States, 02115 United States, Ohio University of Cincinnati, Department of Internal Medicine, Pulmonary, Critical Care & Sleep Medicine, Cincinnati, Ohio, United States, 45267 France Novartis Investigative Site Lyon, France Germany Novartis Investigative Site Grosshansdorf, Germany Novartis Investigative Site Leipzig, Germany Italy Novartis Investigative Site Milan, Italy Less <<
NCT00352443 Lymphoma Unsp... More >>ecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 University of California Davis Cancer Center Sacramento, California, United States, 95817 United States, Colorado University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado, United States, 80045 United States, Kentucky Lucille P. Markey Cancer Center at University of Kentucky Lexington, Kentucky, United States, 40536-0093 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0942 United States, Washington University Cancer Center at University of Washington Medical Center Seattle, Washington, United States, 98195-6043 Less <<
NCT00574769 Prostate Cancer Phase 1 Phase 2 Completed - United States, California ... More >> Westside Prostate Cancer Center, University of Southern California Beverly Hills, California, United States, 90211 USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01012869 Coronary Occlusions Phase 4 Completed - United States, Texas ... More >> Dallas VA Medical Center Dallas, Texas, United States, 75216 Less <<
NCT00033267 Recurrent Mantle Cell Lymphoma Phase 2 Completed - United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less <<
NCT02283658 Ovarian Endometrioid Adenocarc... More >>inoma Ovarian Seromucinous Carcinoma Ovarian Serous Cystadenocarcinoma Ovarian Serous Surface Papillary Adenocarcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Ovarian Germ Cell Tumor Recurrent Primary Peritoneal Carcinoma Undifferentiated Ovarian Carcinoma Less << Phase 2 Active, not recruiting November 2018 United States, Florida ... More >> Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00496600 Refractory Malignancy Phase 1 Completed - United States, New Jersey ... More >> The Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 Less <<
NCT00087685 - Completed - -
NCT02569125 Segmental Overgrowth Syndrome Phase 2 Withdrawn(Change in supply of ... More >>study medication) Less << - Germany ... More >> Vivantes Klinikum Neukölln Berlin, Germany, 12351 Universitätsklinikum Bonn Bonn, Germany, 53113 Universitätsklinikum Freiburg Freiburg, Germany, 79106 Universitätsklinikum Leipzig Leipzig, Germany, 04103 Less <<
NCT00775073 Hepatocellular Carcinoma Phase 2 Completed - Germany ... More >> Medizinische Klinik 1 University of Erlangen Erlangen, Bavaria, Germany, 91054 Zollernalbklinikum Balingen, Germany, 72336 Charité, Campus Virchow Klinikum, Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie Berlin, Germany, 13353 Universitaetsklinikum Bonn, Medizinische Klinik und Poliklinik I Bonn, Germany, 53105 Klinikum der J.-W.-Goethe-Universitaet, Medizinische Klinik I Frankfurt, Germany, 60590 Medizinische Universitaetsklinik Freiburg, Innere Medizin II Freiburg, Germany, 79095 Martin-Luther-Universitaet Halle-Wittenberg, Universitaetsklinik und Poliklinik für Innere Medizin I Halle, Germany, 06120 Medizinische Hochschule Hannover, Zentrum Innere Medizin Hannover, Germany, 30625 Universitätsklinikum des Saarlandes Klinik für Innere medizin II Homburg/Saar, Germany, 66421 Medizinische Fakultaet der Otto-von-Guericke-Universitaet, Klinik für Gastroenterologie, Hepatologie und Infektiologie Magdeburg, Germany, 39120 Less <<
NCT02023359 - Completed - Denmark ... More >> Aalborg Universitetshospital, Clinical Research unit Department of oncology, Klinik Kirurgi-kræft, Hobrovej 18-22 Aalborg, Denmark, 9000 Onkologisk Afdelning, SVS Esbjerg Esbjerg, Denmark, 6700 Department of Oncology, Odense University Hospital Odense, Denmark Less <<
NCT01222715 Adult Rhabdomyosarcoma ... More >> Childhood Alveolar Rhabdomyosarcoma Childhood Pleomorphic Rhabdomyosarcoma Childhood Rhabdomyosarcoma With Mixed Embryonal and Alveolar Features Previously Treated Childhood Rhabdomyosarcoma Recurrent Adult Soft Tissue Sarcoma Recurrent Childhood Rhabdomyosarcoma Less << Phase 2 Completed - -
NCT01222715 - Completed - -
NCT00814788 Prostate Cancer Phase 2 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT00814788 - Completed - -
NCT00529802 Carcinoma, Renal Cell Phase 2 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Oncology/Hematology Associates Peoria, Illinois, United States, 61615 United States, Massachusetts Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States, 02215 United States, Missouri Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina The University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01410448 Kidney Transplantation Phase 3 Completed - Italy ... More >> Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site Coppito, AQ, Italy, 67100 Novartis Investigative Site Bari, BA, Italy, 70124 Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Brescia, BS, Italy, 25123 Novartis Investigative Site Cagliari, CA, Italy, 09134 Novartis Investigative Site Catania, CT, Italy, 95123 Novartis Investigative Site Firenze, FI, Italy, 50139 Novartis Investigative Site Milano, MI, Italy, 20132 Novartis Investigative Site Milano, MI, Italy, 20162 Novartis Investigative Site Modena, MO, Italy, 41100 Novartis Investigative Site Palermo, PA, Italy, 90127 Novartis Investigative Site Padova, PD, Italy, 35128 Novartis Investigative Site Pavia, PV, Italy, 27100 Novartis Investigative Site Roma, RM, Italy, 00144 Novartis Investigative Site Roma, RM, Italy, 00152 Novartis Investigative Site Roma, RM, Italy, 00161 Novartis Investigative Site Roma, RM, Italy, 00168 Novartis Investigative Site Salerno, SA, Italy, 84131 Novartis Investigative Site Siena, SI, Italy, 53100 Novartis Investigative Site Verona, VR, Italy, 37126 Novartis Investigative Site Novara, Italy, 28100 Less <<
NCT01410448 - Completed - -
NCT01157858 Polycystic Liver Disease Phase 2 Completed - Netherlands ... More >> Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB Less <<
NCT01767194 Ganglioneuroblastoma ... More >> Recurrent Neuroblastoma Less << Phase 2 Completed - -
NCT01341834 Nasopharyngeal Carcinoma, Lymp... More >>homas, Any EBV+ Solid Tumour Less << Phase 1 Active, not recruiting December 2018 Singapore ... More >> National Cancer Center Singapore Singapore, Singapore, 169690 Less <<
NCT01154439 Leukemia Phase 1 Active, not recruiting December 2018 Italy ... More >> Ematologia con trapianto- AOU Policlinico Consorziale di Bari Bari, Italy Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Napoli, Italy Università La Sapienza Roma, Italy, 00100 Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy Azienda Ospedaliera Universitaria Policlinico Tor Vergata Rome, Italy, 00133 Less <<
NCT00632268 Metastatic Gastric Cancer Phase 2 Completed - Taiwan ... More >> Department of Oncology, National Taiwan University Hospital Taipei, Taiwan, 10002 Less <<
NCT00079235 Recurrent Non-small Cell Lung ... More >>Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less <<
NCT01797523 Endometrial Cancer Phase 2 Active, not recruiting October 2020 United States, Florida ... More >> Sacred Heart Health Systems Pensacola, Florida, United States, 32504 United States, New Jersey MD Anderson Cooper Cancer Center Voorhees, New Jersey, United States, 08043 United States, Texas Memorial City Medical Center Houston, Texas, United States, 77024 Lyndon B Johnson General Hospital Houston, Texas, United States, 77026 University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 The Woman's Hospital of Texas Houston, Texas, United States, 77054 Less <<
NCT00195299 Squamous Cell Carcinoma COMPLETED 2025-02-07 Shreveport, Louisiana, 71130, ... More >>United States Less <<
NCT00529802 - Completed - -
NCT00803816 Uveitis Phase 2 Completed - Germany ... More >> Department of Ophthalmology at St. Franziskus Hospital Muenster, Germany, 48145 Less <<
NCT00858663 Head and Neck Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00800917 Glioblastoma Multiforme Phase 2 Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark Less <<
NCT00787969 Lymphoma Phase 1 Completed - -
NCT02143726 Refractory Hurthle Cell Thyroi... More >>d Cancer Less << Phase 2 Recruiting - United States, Florida ... More >> Mayo Clinic in Florida Suspended Jacksonville, Florida, United States, 32224-9980 United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Site Public Contact    312-695-1301    cancer@northwestern.edu    Principal Investigator: Maria Matsangou          United States, Iowa Siouxland Regional Cancer Center Recruiting Sioux City, Iowa, United States, 51101 Contact: Site Public Contact    712-252-0088       Principal Investigator: Donald B. Wender          United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Site Public Contact    800-865-1125       Principal Investigator: Francis P. Worden          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Site Public Contact    855-776-0015       Principal Investigator: Ashish V. Chintakuntlawar          United States, Nebraska Nebraska Methodist Hospital Recruiting Omaha, Nebraska, United States, 68114 Contact: Site Public Contact    402-354-5144       Principal Investigator: Yungpo B. Su          United States, New Jersey Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Sleepy Hollow Suspended Sleepy Hollow, New York, United States, 10591 United States, North Carolina Southeastern Medical Oncology Center-Clinton Recruiting Clinton, North Carolina, United States, 28328 Contact: Site Public Contact    919-587-9077    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Southeastern Medical Oncology Center-Goldsboro Recruiting Goldsboro, North Carolina, United States, 27534 Contact: Site Public Contact    919-587-9077    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Wayne Memorial Hospital Recruiting Goldsboro, North Carolina, United States, 27534 Contact: Site Public Contact    919-731-6687    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Southeastern Medical Oncology Center-Jacksonville Recruiting Jacksonville, North Carolina, United States, 28546 Contact: Site Public Contact    910-353-0824    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Southeastern Medical Oncology Center-Wilson Suspended Wilson, North Carolina, United States, 27893 United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Site Public Contact    800-293-5066    Jamesline@osumc.edu    Principal Investigator: Bhavana Konda          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Site Public Contact    215-728-4790       Principal Investigator: Jessica R. Bauman          United States, Wisconsin Mercy Health System Recruiting Janesville, Wisconsin, United States, 53547 Contact: Site Public Contact    800-928-1103       Principal Investigator: Emily G. Robinson Less <<
NCT01469572 Neuroendocrine Tumors Phase 1 Completed - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT02254239 Recurrent Hodgkin Lymphoma ... More >> Refractory Hodgkin Lymphoma Less << Phase 1 Suspended(Per study design) September 30, 2020 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01270321 Thyroid Cancer Phase 2 Active, not recruiting June 2019 United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02732119 Breast Cancer Phase 1 Phase 2 Active, not recruiting July 31, 2020 -
NCT01700400 Non Small Cell Lung Cancer Phase 1 Completed - United States, Arizona ... More >> University of Arizona Cancer Center Tuscon, Arizona, United States, 85724 United States, Kentucky University of Kentucky Markey Cancer Center Lexington, Kentucky, United States, 40536 United States, Oregon Providence Cancer Center Portland, Oregon, United States, 97213 United States, Washington Cancer Research And Biostatistics Clinical Trials Consortium Seattle, Washington, United States, 98101 Less <<
NCT02291913 Breast Cancer Phase 2 Active, not recruiting January 2019 United States, Florida ... More >> Florida Cancer Specialists-South Fort Myers, Florida, United States, 33916 Memorial Cancer Center Hollywood, Florida, United States, 33021 Woodlands Medical Specialists Pensacola, Florida, United States, 32503 Florida Cancer Specialists-East West Palm Beach, Florida, United States, 33401 United States, Indiana Hope Cancer Center Terre Haute, Indiana, United States, 47802 United States, Tennessee Tennessee Oncology Chattanooga, Tennessee, United States, 37404 Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 United States, Texas Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 Less <<
NCT01005199 Liver Cancer Phase 2 Completed - Austria ... More >> Medizinische Universität Wien Wien, Austria, 1090 Hungary Szent Laszlo Korhaz Budapest, Hungary, 1097 Switzerland Saint Claraspital AG Basel, Switzerland, CH-4016 Clinical Cancer Research Center at University Hospital Basel Basel, Switzerland, CH-4031 Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland, 6500 Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Liestal Liestal, Switzerland, CH-4410 CHCVS - Hôpital de Sion Sion, Switzerland, 1950 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 City Hospital Triemli Zurich, Switzerland, CH-8063 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT01789281 Neoplasms Phase 4 Recruiting May 12, 2023 -
NCT01014351 Metastatic Melanoma Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Indiana Oncology Hematology of SW Indiana Evansville, Indiana, United States, 47630 United States, Louisiana Hematology Oncology Clinic, LLP Baton Rouge, Louisiana, United States, 70809 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Missouri Research Medical Center Kansas City, Missouri, United States, 64132 United States, Nebraska Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less <<
NCT01049620 Advanced Gastric Cancer Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT00459186 Metastatic, Androgen Independe... More >>nt Prostate Cancer Prostate Cancer Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Oregon Oregon Health Science University Portland, Oregon, United States Less <<
NCT01490749 Esophageal Cancer ... More >> Neoplasms, Esophageal Less << Phase 1 Active, not recruiting May 2020 United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT00124280 Non-small-cell Lung Carcinoma Phase 2 Completed - United States, Nevada ... More >> Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, Texas MD Anderson Cancer Center, Department of Thoracic /Head and Neck Medical Oncology Houston, Texas, United States, 77030 Less <<
NCT00667485 Advanced Cancer ... More >> Metastatic Cancer Less << Phase 1 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01312064 Renal Insufficiency Phase 4 Terminated(Difficulty collecti... More >>ng) Less << - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less <<
NCT00560963 Advanced or Metastatic Pancrea... More >>tic Adenocarcinoma Less << Phase 1 Phase 2 Completed - Germany ... More >> Novartis Investigative Site Halle, Germany Novartis Investigative Site Merseburg, Germany Novartis Investigative Site München, Germany Novartis Investigative Site Oberstaufen, Germany Novartis Investigative Site Ulm, Germany Less <<
NCT00607113 Neuroendocrine Carcinoma Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01014351 - Completed - -
NCT00607113 - Completed - -
NCT00811590 Peutz-Jeghers Syndrome Phase 2 Terminated(The study was ended... More >> early due to low enrollment.) Less << - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT00593008 Pancreatic Adenocarcinoma Phase 1 Terminated - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT00811590 - Terminated(The study was ended... More >> early due to low enrollment.) Less << - -
NCT00459186 - Completed - -
NCT03415750 Hypertrophy, Left Ventricular Phase 4 Recruiting November 2018 Spain ... More >> Hospital Universitari de Bellvitge Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Contact: Edoardo Melilli, MD    0034932607385    emelilli@bellvitgehospital.cat Less <<
NCT00235794 Prostatic Neoplasms Not Applicable Completed - United States, Texas ... More >> Houston, Texas, United States, 77030 Less <<
NCT01469884 Renal Allograft ... More >> Hepatitis C Less << Phase 4 Completed - Brazil ... More >> Irmandade Da Santa Casa de Misericórdia de Porto Alegre Porto Alegre, Rio Grande Do Sul, Brazil, 90020090 Less <<
NCT01404325 Lung Transplantation Phase 3 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Homburg, Germany, 66421 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Muenchen, Germany, 81377 Less <<
NCT00300274 Graft Rejection Phase 3 Completed - -
NCT01642186 Fibrolamellar Carcinoma ... More >> Fibrolamellar Liver Cancer Less << Phase 2 Active, not recruiting July 2019 United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 United States, Maryland John Hopkins Medical Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01009801 Liver Cancer Phase 1 Phase 2 Terminated(due to slow patient... More >> recruitement.) Less << - Switzerland ... More >> Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Graubuenden Chur, Switzerland, 7000 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Clinica Luganese di Moncucco Lugano, Switzerland, 6903 Institut Central des Hopitaux Valaisans / Hôpital de Sion Sion, Switzerland, CH-1951 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT00300274 - Completed - -
NCT01025817 - Completed - -
NCT00402272 Coronary Disease ... More >> Coronary Artery Disease Coronary Restenosis Less << Phase 4 Completed - -
NCT01062399 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Active, not recruiting - -
NCT01079702 Advanced Malignancies Phase 1 Phase 2 Unknown January 2011 Netherlands ... More >> Academic Medical Center Recruiting Amsterdam, Netherlands, 1105 AZ Contact: Hanneke Wilmink, MD PhD    +31-20-5665955 ext 58919    j.w.wilmink@amc.uva.nl    Contact: Lyda ter Hofstede    +31-20-5668229    trialmedonc@amc.uva.nl    Academic Medical Center Recruiting Amsterdam, Netherlands Contact: Hanneke Wilmink, MD, PhD    +31 205665955    j.w.wilmink@amc.uva.nl    Contact: Lyda ter Hofstede    +31 205668229    trialmedonc@amc.uva.nl    Principal Investigator: Hanneke Wilmink, MD PhD Less <<
NCT01163929 Breast Cancer Phase 2 Withdrawn(Study closed by Prot... More >>ocol Review Monitoring Committee because of lack of accrual) Less << - -
NCT01023815 de Novo Kidney Transplant Reci... More >>pients Renal Transplantation Less << Phase 3 Completed - Italy ... More >> Novartis Investigative Site Ancona, Italy, 60100 Novartis Investigative Site Bologna, Italy Novartis Investigative Site Brescia, Italy Novartis Investigative Site Cagliari, Italy Novartis Investigative Site Catania, Italy Novartis Investigative Site Coppito, Italy Novartis Investigative Site Firenze, Italy Novartis Investigative Site Genova, Italy, 16132 Novartis Investigative Site Milano, Italy, 20122 Novartis Investigative Site Modena, Italy, 41100 Novartis Investigative Site Napoli, Italy Novartis Investigative Site Novara, Italy, 28100 Novartis Investigative Site Padova, Italy Novartis Investigative Site Palermo, Italy Novartis Investigative Site Parma, Italy Novartis Investigative Site Perugia, Italy, 06070 Novarits Investigative Site Pisa, Italy Novartis Investigative Site Roma, Italy Novartis Investigative Site Rome, Italy Novartis Investigative Site Salerno, Italy Novartis Investigative Site Sassari, Italy, 07100 Novartis Investigative Site Siena, Italy, 53100 Novartis Investigative Site Torino, Italy, 10126 Novartis Investigative Site Treviso, Italy Novartis InvestigativeSite Udine, Italy Novartis Investigative Site Varese, Italy Novartis Investigative Site Verona, Italy Novartis Investigative Site Vicenza, Italy Less <<
NCT00888758 Coronary Heart Disease ... More >> Percutaneous Coronary Intervention Less << Phase 4 Unknown May 2011 Czech Republic ... More >> Department of Cardiology, Masaryk hospital and University of JEP Not yet recruiting Ústí nad Labem, Czech Republic, 40113 Contact: Pavel Cervinka, MD,PhD    +420477117886    pavel.cervinka@mnul.cz    Sub-Investigator: Petr Kala, MD,P hD          Sub-Investigator: Ladislav Pesl, MD Less <<
NCT01025817 Kidney Transplant Phase 3 Completed - -
NCT00267189 Liver Transplantation Phase 3 Completed - Germany ... More >> Novartis Investigational Site Germany, Germany Switzerland Novartis Investigative Site Basel, Switzerland Less <<
NCT00267189 - Completed - -
NCT00623012 Graft Versus Host Disease Phase 1 Phase 2 Terminated(Low accrual) - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT01776567 Coronary Artery Disease Phase 4 Unknown June 2015 Australia, New South Wales ... More >> Concord Repatriation Hospital Not yet recruiting Concord, New South Wales, Australia Contact: Harry Lowe          Sub-Investigator: Harry Lowe          Australia, Queensland The Prince Charles Hospital Not yet recruiting Brisbane, Queensland, Australia Contact: Darren Walters          Sub-Investigator: Darren Walters          Australia, Victoria Northern Hospital Recruiting Epping, Victoria, Australia, 3076 Contact: Rita Wong       rita.wong@nh.org.au    Principal Investigator: Peter Barlis, MBBS PHD FRACP          St Vincent's Hospital Not yet recruiting Melbourne, Victoria, Australia, 3065 Contact: Robert Whitbourn          Sub-Investigator: Robert Whitbourn Less <<
NCT00466102 Breast Cancer Phase 2 Unknown December 2012 Germany ... More >> Dr. med. Christoph Mundhenke Kiel, Schleswig-Holstein, Germany, 24105 Less <<
NCT01023815 - Completed - -
NCT01332279 Recurrent Metastatic Squamous ... More >>Neck Cancer With Occult Primary Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Salivary Gland Squamous Cell Carcinoma Tongue Cancer Less << Phase 1 Withdrawn(Pharmaceutical co. w... More >>ithdrew support. Study was never activated and did not accrue any patients.) Less << - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00849550 Unspecified Adult Solid Tumor,... More >> Protocol Specific Cancer Less << Phase 1 Completed - United States, Illinois ... More >> Ingalls Cancer Research Center Harvey, Illinois, United States, 60426 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Less <<
NCT00623012 - Terminated(Low accrual) - -
NCT00241189 Systemic Sclerosis Phase 1 Phase 2 Completed - United States, California ... More >> Philip Clements, MD Los Angeles, California, United States, 90095-1670 Less <<
NCT01616186 Locally Metastatic Malignant N... More >>eoplasm Less << Phase 2 Withdrawn April 2016 -
NCT01062399 - Active, not recruiting - -
NCT02511639 Breast Cancer Metastatic Phase 3 Active, not recruiting June 2020 Italy ... More >> Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona Ancona, AN, Italy, 60020 Ospedale Papa Giovanni XXIII Bergamo, Bg, Italy Policlinico Sant'Orsola Malpighi Bologna, BO, Italy, 40138 ASL Brindisi "Antonio Perrini" Brindisi, BR, Italy, 72100 Azienda Spedali Civili di Brescia Brescia, BS, Italy, 25123 A.S.O. S.Croce e Carle di Cuneo Cuneo, CN, Italy, 12100 Azienda Ospedaliero - Universitaria "Policlinico - Vittorio Emanuele" Catania, CT, Italy, 95123 Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale Sant'Anna Cona, FE, Italy, 44124 Ospedale Misericordia di Grosseto Grosseto, GR, Italy, 58100 Istituto Nazionale dei Tumori IRCCS Milano, MI, Italy, 20133 Azienda Ospedaliera Universitaria di Parma Parma, PR, Italy, 43126 IRCCS - Azienda Ospedaliera S.M. Nuova Reggio Emilia, RE, Italy, 42123 Ospedale Civile Santa Chiara Trento, TN, Italy Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" Udine, UD, Italy, 33100 Ospedale Sacro Cuore - Don Calabria Negrar, VR, Italy, 37042 Ospedale dell'Angelo Mestre, Italy, 30174 Less <<
NCT01263353 Gastroenteropancreatic Neuroen... More >>docrine Tumor of the Pulmonary ot Gastroenteropancreatic System Less << Phase 1 Completed - Germany ... More >> Novartis Investigative Site Bad Berka, Germany, 99438 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Marburg, Germany, 35039 Novartis Investigative Site Muenster, Germany, 48149 Less <<
NCT01255956 In-Stent Restenosis Phase 3 Unknown July 2012 Poland ... More >> Instytut Kardiologii w Warszawie-Aninie Recruiting Warszawa, Alpejska 42, Poland, 04-628 Contact: Adam Witkowski, MD, PhD    +48 22 812 41 64       Principal Investigator: Adam Witkowski, MD, PhD          Katedra i Klinika Kardiologii Warszawskiego Uniwersytetu Medycznego Recruiting Warszawa, Banacha 1a, Poland, 02-097 Contact: Janusz Kochman, MD, PhD    +48 22 599 19 58       Principal Investigator: Janusz Kochman, MD, PhD          Klinika Kardiologii z Kliniką Kardiochirurgii Uniwersyteckiego Szpitala Klinicznego w Lodzi Recruiting Lodz, Kniaziewicza 1/5, Poland, 91-347 Contact: Zbigniew Peruga, MD, PhD    +48 42 251 62 21       Principal Investigator: Zbigniew Peruga, MD, PhD          II Department of Cardiology Medical College Jagiellonian University University Hospital in Krakow Recruiting Krakow, Kopernika 17, Poland, 31-500 Contact: Jacek Legutko, MD, PhD    +48 12 424 71 81       Principal Investigator: Jacek Legutko, MD, PhD Less <<
NCT02404051 Metastatic Breast Cancer ... More >> Breast Cancer Hormone Receptor Positive Tumor Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Locally Advanced Malignant Neoplasm Less << Phase 3 Recruiting January 2019 Italy ... More >> ASL19 - Ospedale Cardinal Massaia Recruiting Asti, Italy Azienda Ospedaliera Policlinico di Bari Not yet recruiting Bari, Italy Istituto Tumori Giovanni Paolo II Not yet recruiting Bari, Italy Azienda Ospedaliera "G. Rummo" Not yet recruiting Benevento, Italy Ospedale Fatebenefratelli `Sacro Cuore di Gesù` di Benevento Not yet recruiting Benevento, Italy A.O. Ospedale Papa Giovanni XXIII Recruiting Bergamo, Italy Presidio Ospedaliero Antonio Perrino Recruiting Brindisi, Italy Azienda Ospedaliera - A. Businco - A.S.L. N. 8 Not yet recruiting Cagliari, Italy Fondazione del Piemonte per l' Oncologia - Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Recruiting Candiolo, Italy ASL di Taranto - Polo Occidentale Not yet recruiting Castellaneta, Italy A.O.R.N.A.S. Garibaldi Nesima di Catania Recruiting Catania, Italy Fondazione per la Ricerca e la Cura dei Tumori T. Campanella - Campus S. Venuta Not yet recruiting Catanzaro, Italy Azienda Ospedaliera S. Croce e Carle Recruiting Cuneo, Italy Ospedale Infermi di Rimini Recruiting Faenza, Italy Azienda Ospedaliera Universitaria Careggi Not yet recruiting Firenze, Italy Azienda Ospedaliero - Universitaria Ospedali Riuniti di Foggia Not yet recruiting Foggia, Italy I.R.C.C.S. A.O.U San Martino - IST Recruiting Genova, Italy Ospedale Civile di guastalla Recruiting Guastalla, Italy Ospedale Civile San Salvatore - Università degli Studi L'Aquila Not yet recruiting L'Aquila, Italy Presidio Ospedaliero "Renzetti" Recruiting Lanciano, Italy Ospedale Vito Fazzi Recruiting Lecce, Italy Ospedale di Macerata Not yet recruiting Macerata, Italy AO Papardo Recruiting Messina, Italy AORN . Ospedali dei colli Monaldi-Cotugno Recruiting Napoli, Italy Azienda Ospedaliera `A. Cardarelli` (AORN) Recruiting Napoli, Italy Azienda Ospedaliera Universitaria Federico II Recruiting Napoli, Italy Istituto Nazionale per lo studio dei Tumori - Fondazione `Pascale` Recruiting Napoli, Italy A.O.U. `Maggiore della Carità` Recruiting Novara, Italy A.O.U.P. `Paolo Giaccone` Recruiting Palermo, Italy Azienda Ospedaliera S. Chiara Recruiting Pisa, Italy Ospedale F. Lotti Recruiting Pontedera, Italy Ospedale di Ravenna Recruiting Ravenna, Italy Campus Biomedico di Roma Recruiting Roma, Italy Istituto Regina Elena per lo studio e la cura dei tumori - Oncologia A Recruiting Roma, Italy Istituto Regina Elena per lo studio e la cura dei tumori - Oncologia B Recruiting Roma, Italy Azienda Ospedaliera `San Giovanni di Dio e Ruggi D'Aragona` Recruiting Salerno, Italy IRCCS - Istituto di Ricovero e Cura a Carattere Scientifico `Casa Sollievo della Sofferenza` Recruiting San Giovanni rotondo, Italy Azienda Ospedaliera Universitaria di Sassari Not yet recruiting Sassari, Italy Azienda Ospedaliero Universitaria ´S. Maria della Misericordia´ di Udine Not yet recruiting Udine, Italy "Ospedale Borgo Roma Verona Sezione di Oncologia Medica" Recruiting Verona, Italy Ospedale Sacro Cuore Don Calabria di Negrar Recruiting Verona, Italy Less <<
NCT03352427 Glioma Phase 2 Recruiting December 1, 2025 United States, Michigan ... More >> University of Michigan Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Carl Koschmann, M.D.    734-615-2736    ckoschma@umich.edu    Principal Investigator: Carl Koschmann, MD Less <<
NCT00457964 Tuberous Sclerosis ... More >> Lymphangioleiomyomatosis Less << Phase 1 Phase 2 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT02974686 Kidney Transplant Rejection ... More >> Gastrointestinal Disorder, Functional Less << Phase 4 Recruiting December 2019 United States, Missouri ... More >> Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Rowena Delos Santos, MD    314-362-4547    delossantos@wustl.edu    Principal Investigator: Rowena Delos Santos, MD          Sub-Investigator: Timothy Horwedel, PharmD          Sub-Investigator: Jennifer Hagopian, PharmD Less <<
NCT00981162 Acinar Cell Adenocarcinoma of ... More >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Colorado ... More >> University of Colorado at Denver Health Sciences Center Aurora, Colorado, United States, 80045 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT00402532 Lung Transplantation Phase 3 Completed - Germany ... More >> Hannover Medical School, Division of Thoracic and Cardiovascular Surgery Hannover, Germany, 30625 Less <<
NCT01551212 Liver Transplantation Phase 4 Completed - Germany ... More >> Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Erlangen, Germany, 91052 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Munchen, Germany, 81377 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Tübingen, Germany, 72076 Less <<
NCT00619268 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Completed - France ... More >> Centre Paul Papin Angers, France Centre Hospitalier Universitaire de Besançon Besançon, France Centre Hospitalier Universitaire de Bordeaux - Hôpital St André Bordeaux, France Institut Bergonié Bordeaux, France Centre François Baclesse Caen, France Centre Jean Perrin Clermont Ferrand, France Centre Georges François Leclerc Dijon, France Centre Hospitalier de Versailles Le Chesnay, France Centre Hospitalier Universitaire de Lille - Hôpital Claude Huriez Lille, France Centre Oscar Lambret Lille, France Centre Hospitalier Universitaire DUPUTRYEN Limoges, France Centre Léon Bérard Lyon, France, 69373 Centre Hospitalier Universiariare Lyon, Hôpital Lyon Sud Lyon, France Institut Paoli Calmette Marseille, France Centre Val d'Aurelle Montpellier, France Clinique Valdegour-Centre médical Oncogard Nîmes, France Fondation Hôpital Saint Joseph Paris, France Hopital du Val de Grâce Paris, France Hôpital Européen Georges Pompidou Paris, France Centre Hospilier Universitaire de Poitiers Poitiers, France Institut Jean Godinot Reims, France Centre Eugène Marquis Rennes, France Centre René Gauducheau Saint Herblain, France Institut de Cancérologie de la Loire Saint Priest en Jarez, France Centre Hospitalier Starsbourg Strasbourg, France Hôpital FOCH Suresnes, France Institut Claudius Regaud Toulouse, France Centre Alexis Vautrin Vandoeuvre les Nancy, France Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT00378703 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Carcinoma Stage IV Renal Cell Cancer AJCC v7 Less << Phase 2 Completed - -
NCT01784978 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Terminated(Lack of recruitment... More >>) Less << - France ... More >> Hopital Bordeaux University Bordeaux, France Greece ALEXANDRA General Hospital of Athens Athens, Greece, 11528 Spain Hospital Universitario Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital del Mar Barcelona, Spain, 08003 Hospital Universitario 12 de Octubre Madrid, Spain, 28026 Hospital Clínico San Carlos Madrid, Spain, 28040 Clara Campal. Hospital Sanchinarro Madrid, Spain, 28050 Hospital Universitario Virgen de la Victoria Málaga, Spain Hospital General Universitario de Valencia Valencia, Spain Less <<
NCT01183663 Advanced Cancers Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00378703 - Completed - -
NCT01276457 Transplantation Infection Phase 3 Completed - -
NCT01154335 Metastatic Colorectal Cancer Phase 1 Completed - United States, Florida ... More >> Florida Cancer Specialists Ft. Myers, Florida, United States, 33916 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT00109967 Recurrent Mantle Cell Lymphoma Phase 2 Completed - -
NCT00109967 - Completed - -
NCT01154335 - Completed - -
NCT02513719 - Active, not recruiting December 2019 Japan ... More >> Kimitsu Chuo Hospital Chiba, Japan, 292-8535 Kokura Memorial Hospital Fukuoka, Japan, 802-8555 Fukuoka Wajiro Hospital Fukuoka, Japan, 811-0213 Hoshi general hospital Fukushima, Japan, 963-8501 Tsuchiya General Hospital Hiroshima, Japan, 730-0811 Hyogo Prefectural Amagasaki Hospital Hyogo, Japan, 660-0828 Tsukuba Medical Center Hospital Ibaraki, Japan, 305-8558 Ishikawa Prefectual Central Hospital Ishikawa, Japan, 920-8530 Shonan Kamakura General Hospital Kanagawa, Japan, 247-8533 Tokai University Hospital Kanagawa, Japan, 259-1193 Kumamoto Chuo Hospital Kumamoto, Japan, 862-0965 Kyoto University Hospital Kyoto, Japan, 606-8507 Miyazaki City-Gun Ishikai Hospital Miyazaki, Japan, 880-0834 Kansai Rosai Hospital Nagoya, Japan, 466-8650 Nagoya Daini Red Cross Hospital Nagoya, Japan, 660-8511 Heart disease center Sakakibara hospital Okayama, Japan, 700-0804 Kurashiki Central Hospital Okayama, Japan, 710-8602 Sakurabashi Watanabe Hospital Osaka, Japan, 530-0001 Osaka police hospital Osaka, Japan, 543-0035 Osaka University Hospital Osaka, Japan, 565-0871 Tokorozawa Heart Center Saitama, Japan, 359-1142 Tokeidai memorial hospital Sapporo, Japan, 060-0031 JCHO Hokkaido Hospital Sapporo, Japan, 062-8618 Hokkaido Ohno hospital Sapporo, Japan, 063-0034 Sendai Kousei Hospital Sendai, Japan, 980-0873 Okamura memorial hospital Shizuoka, Japan, 411-0904 Tokushima Red Cross Hospital Tokushima, Japan, 773-8502 Mitsui Memorial Hospital Tokyo, Japan, 101-8643 Toranomon hospital Tokyo, Japan, 105-8470 Tokyo Women's Medical University Hospital Tokyo, Japan, 162-8666 Teikyo University Hospoital Tokyo, Japan, 173-8606 Showa University Fujigaoka hospital Yokohama, Japan, 227-8501 Saiseikai Yokohama City Tobu Hospital Yokohama, Japan, 230-8765 Less <<
NCT01276457 - Completed - -
NCT01857193 Breast Cancer Phase 1 Active, not recruiting September 16, 2019 United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Florida Sylvester Comprehensive Cancer Center Main Center Miami, Florida, United States, 33136 United States, Illinois Oncology Specialists, SC Dept.of Oncology Specialists Park Ridge, Illinois, United States, 60068-0736 United States, Massachusetts Massachusetts General Hospital Onc Dept Boston, Massachusetts, United States, 02114 United States, Michigan Karmanos Cancer Institute Dept of Onc Detroit, Michigan, United States, 48201 United States, Missouri St. Luke's Cancer Institute Kansas City, Missouri, United States, 64111 United States, New York Memorial Sloan Kettering Oncology Dept. New York, New York, United States, 10017 United States, Oregon Oregon Health and Science University SC-5 Portland, Oregon, United States, 97239 United States, Texas University of Texas MD Anderson Cancer Center Onc Dept Houston, Texas, United States, 77030 United States, Washington Northwest Medical Specialties Tacoma, Washington, United States, 98405 Belgium Novartis Investigative Site Wilrijk, Belgium, 2610 France Novartis Investigative Site Saint Herblain cedex, France, 44805 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Less <<
NCT00097968 Graft Rejection Phase 3 Completed - United States, California ... More >> UCLA Medical Center Los Angeles, California, United States, 90095 United States, Minnesota University of Minnesota, Fairfield University Hospital Minneapolis, Minnesota, United States, 55455 United States, New York Columbia Presbyterian Medical Center New York, New York, United States, 10032 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 United States, Tennessee Midstate Cardiology Nashville, Tennessee, United States, 37203 Less <<
NCT00464399 De Novo Renal Transplantation Phase 3 Completed - Norway ... More >> Novartis Investigative Site, Oslo, Norway Less <<
NCT01088893 Breast Neoplasms Phase 2 Unknown March 2013 China ... More >> Unimed Medical Institute Recruiting Hong Kong, China Contact: Louis Chow, MD    (852)28610286 Less <<
NCT01710748 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Phase 3 Unknown October 2014 Spain ... More >> Hospital Clínic i Provincial Barcelona, Spain Hospital Universitari de Bellvitge Barcelona, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Virgen de la Arrixaca Murcia, Spain Less <<
NCT01707849 Hepatitis C Recurrence After L... More >>iver Transplant Less << Phase 3 Completed - Spain ... More >> Department of HPB Surgery and Transplant, Hospital Vall d´Hebron Barcelona, Spain, 08035 Less <<
NCT01042028 Pancreatic Cancer Phase 1 Phase 2 Terminated(Emergence of FOLFIR... More >>INOX and slow recruitment) Less << - Denmark ... More >> Department of Oncology, Aarhus Hospital Aarhus, Denmark, 8000 Department of Oncology, Odense University Hospital Odense, Denmark, 5000 Less <<
NCT00409994 Rectum Cancer Phase 1 Phase 2 Active, not recruiting August 2019 Netherlands ... More >> Maastricht Radiation Oncology Maastricht, Limburg, Netherlands, 6202 AZ Less <<
NCT02023905 Low Grade Glioma ... More >> WHO Grade II Astrocytomas Oligodendrogliomas Mixed Oligoastrocytomas Less << Phase 2 Recruiting January 2019 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143-0372 Contact: Jennifer Clarke, MD, MPH    415-353-2966    Jennifer.Clarke@ucsf.edu    Contact: Tiffany Jones    415-353-9641    Tiffany.Jones@ucsf.edu    Principal Investigator: Jennifer Clarke, MD Less <<
NCT02492386 Impotence, Arteriogenic Phase 2 Phase 3 Unknown March 2017 -
NCT02844270 Heart Diseases Phase 1 Not yet recruiting December 2021 -
NCT03065387 Malignant Neoplasm of Breast ... More >> Malignant Neoplasms of Digestive Organs Malignant Neoplasms of Female Genital Organs Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites Malignant Neoplasms of Independent (Primary) Multiple Sites Malignant Neoplasms of Lip Oral Cavity and Pharynx Malignant Neoplasms of Mesothelial and Soft Tissue Malignant Neoplasms of Respiratory and Intrathoracic Organs Malignant Neoplasms of Thyroid and Other Endocrine Glands Malignant Neoplasms of Urinary Tract Neoplasms of Uncertain or Unknown Behavior Less << Phase 1 Recruiting October 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       spihapau@mdanderson.org Less <<
NCT00519324 Advanced Gastric Cancer Phase 2 Completed - Japan ... More >> Novartis investigative Site Aichi, Japan Novartis investigative Site Chiba, Japan Novartis investigative Site Ehime, Japan Novartis Investigative Site Hokkaido, Japan Novartis investigative Site Osaka, Japan Novartis investigative Site Shizuoka, Japan Novartis Investigative Site Tochigi, Japan Novartis investigative Site Tokyo, Japan Less <<
NCT01303640 Coronary Artery Disease Phase 4 Completed - Japan ... More >> Department of Cardiovascular Medicine, Kyoto University Hospital Kyoto, Japan, 606-8507 Less <<
NCT00949949 Cholangiocarcinoma of the Gall... More >>bladder Localized Gallbladder Cancer Unresectable Gallbladder Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02871791 Human Epidermal Growth Factor ... More >>2 Negative Carcinoma of Breast Hormone Receptor (HR)-Positive Breast Cancer Less << Phase 1 Phase 2 Recruiting July 2021 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Sara Tolaney, MD, MPH    617-632-2335    stolaney@partners.org    Principal Investigator: Sara Tolaney, MD, MPH Less <<
NCT02567435 Alveolar Rhabdomyosarcoma ... More >> Botryoid-Type Embryonal Rhabdomyosarcoma Embryonal Rhabdomyosarcoma Rhabdomyosarcoma Sclerosing Rhabdomyosarcoma Spindle Cell Rhabdomyosarcoma Untreated Childhood Rhabdomyosarcoma Less << Phase 3 Suspended(pending an analysis ... More >>of data) Less << November 1, 2022 -
NCT01442090 Renal Cell Carcinoma Phase 2 Completed - United States, Florida ... More >> Fort Myers, Florida, United States, 33908 Saint Petersburg, Florida, United States, 33705 United States, Massachusetts Boston, Massachusetts, United States, 02215 United States, Nevada Las Vegas, Nevada, United States, 89148 United States, New York New York, New York, United States, 10065 United States, North Carolina Durham, North Carolina, United States, 27710 United States, Ohio Cleveland, Ohio, United States, 44195 United States, Tennessee Nashville, Tennessee, United States, 37203 France Bordeaux, France, 33075 Paris, France, 75908 Villejuif, France, 94800 Germany Berlin, Germany, 10117 Hannover, Germany, 30625 München, Germany, 81377 Spain Barcelona, Spain, 08003 Barcelona, Spain, 08035 Madrid, Spain, 28041 United Kingdom Leeds, United Kingdom, LS9 7TF London, United Kingdom, EC1A 7BE London, United Kingdom, SW3 6JJ Manchester, United Kingdom, M20 4BX Sutton, United Kingdom, SM2 5PT Less <<
NCT01853423 Facial Angiofibroma Phase 1 Completed - United States, Tennessee ... More >> LeBonheur Children's Hospital Memphis, Tennessee, United States, 38103 Less <<
NCT00935792 - Completed - -
NCT00484094 - Completed - Korea, Republic of ... More >> Yeungnam University Medical Center Daegu, Korea, Republic of, 705-717 The Catholic University of Korea Uijeongbu St. Mary's Hospital Gyeonggi-do, Korea, Republic of, 480-717 Maryknoll Medical Center Pusan, Korea, Republic of, 600-730 Seoul National University Hospital (SNUH) Seoul, Korea, Republic of, 110-744 Kangdong Sacred Heart Hospital Seoul, Korea, Republic of, 134-814 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Gangnam Severance Hospital, Yonsei University Health System Seoul, Korea, Republic of, 135-720 Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 The Catholic University of Korea, Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-701 Asan Medical Center Seoul, Korea, Republic of, 138-736 Konkuk University Medical Center Seoul, Korea, Republic of, 143-729 Less <<
NCT01206764 Renal Cell Carcinoma Phase 4 Recruiting March 30, 2017 Algeria ... More >> Novartis Investigative Site Completed Alger, Algeria, 016000 Novartis Investigative Site Completed Oran, Algeria Egypt Novartis Investigative Site Recruiting Alexandria, Egypt, 21131 Novartis Investigative Site Recruiting Cairo, Egypt Novartis Investigative Site Recruiting Mansoura, Egypt India Novartis Investigative Site Completed Indore, Madhya Pradesh, India, 452 008 Novartis Investigative Site Completed Pune, Maharashtra, India, 411013 Jordan Novartis Investigative Site Recruiting Amman, Jordan, 11941 Lebanon Novartis Investigative Site Completed Beirut, Lebanon, 166830 Russian Federation Novartis Investigative Site Completed Moscow, Russian Federation, 115478 Novartis Investigative Site Completed Samara, Russian Federation, 443031 Saudi Arabia Novartis Investigative Site Recruiting Riyadh, Saudi Arabia, 11211 South Africa Novartis Investigative Site Completed Cape Town, South Africa, 7500 Novartis Investigative Site Completed Cape Town, South Africa, 7925 Novartis Investigative Site Completed Durban, South Africa, 4001 Novartis Investigative Site Completed Parktown, South Africa, 2193 Thailand Novartis Investigative Site Recruiting Bangkok, Thailand, 10400 Novartis Investigative Site Recruiting Chiang Mai, Thailand, 50200 Novartis Investigative Site Recruiting Songkla, Thailand, 90110 Tunisia Novartis Investigative Site Recruiting Ariana, Tunisia, 2080 Less <<
NCT00098553 Melanoma (Skin) Phase 2 Completed - -
NCT02294006 Well Differentiated Pancreatic... More >> Endocrine Tumor Less << Phase 2 Unknown June 2017 Italy ... More >> Fondazione IRCCS Istituto Tumori Milano Recruiting Milano, Italy, 20133 Contact: Sara Pusceddu, MD       sara.pusceddu@istitutotumori.mi.it Less <<
NCT00935792 Lymphocytic Leukemia Phase 1 Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00133887 Skin Cancer K... More >>idney Transplantation Less << Phase 3 Completed - France ... More >> Hôpital Edouard Herriot - Service de Dermatologie Lyon, France, 69003 Less <<
NCT00154310 Renal Transplantation Phase 4 Completed - Germany ... More >> Novartis Investigational Sites Nurnberg, Germany Switzerland Novartis Pharma AG Basel, Switzerland Novartis Investigational Sites Bern, Switzerland Less <<
NCT03245151 Recurrent and Refractory Solid... More >> Tumors Less << Phase 1 Phase 2 Recruiting May 31, 2022 United States, Alabama ... More >> Children's Hospital of Alabama Recruiting Birmingham, Alabama, United States, 35233 United States, California Loma Linda University Medical Center Recruiting Loma Linda, California, United States, 92350 Children's Hospital of Los Angeles Recruiting Los Angeles, California, United States, 90027 Children's Hospital of Orange County Recruiting Orange, California, United States, 92868 UCSF Medical Center at Mission Bay - Pediatric Oncology Recruiting San Francisco, California, United States, 94143 United States, Colorado Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80015 United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Not yet recruiting Chicago, Illinois, United States, 60611 United States, Indiana Riley Hospital for Children - Indiana University Recruiting Indianapolis, Indiana, United States, 46202 United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 United States, Michigan CS Mott Children's Hospital Recruiting Ann Arbor, Michigan, United States, 48109 United States, Minnesota University of Minnesota/Masonic Cancer Center Not yet recruiting Minneapolis, Minnesota, United States, 55455 United States, New York Columbia University/Herbert Irving Cancer Center Recruiting New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 United States, Texas Children's Medical Center Dallas Recruiting Dallas, Texas, United States, 75390 Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Less <<
NCT00484094 - Completed - -
NCT00098501 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00807755 Lung Cancer U... More >>nspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Terminated(Number of known tox... More >>icities observed despite a treatment-naïve population) Less << - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT01111058 Head and Neck Cancer Phase 2 Active, not recruiting July 2018 United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 University of Illinois-Chicago Chicago, Illinois, United States, 60612 The University of Chicago Medical Center Chicago, Illinois, United States, 60637 Ingalls Cancer Research Center Harvey, Illinois, United States, 60426 United States, Kansas University of Kansas Kansas City, Kansas, United States, 66160 United States, Louisiana Louisianna State University Shreveport, Louisiana, United States, 71130 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Mississippi University of Mississippi Jackson, Mississippi, United States, 39216 United States, Missouri Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 United States, South Carolina Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Texas The University of Texas Medical Branch at Galveston Galveston, Texas, United States, 77555 Less <<
NCT01313559 Castrate Resistant Prostate Ca... More >>ncer Chemotherapy Naive Prostate Cancer Prostate Cancer Less << Phase 2 Terminated(Slow accrual) - United States, Connecticut ... More >> Yale Cancer Center New Haven, Connecticut, United States, 06520 United States, Pennsylvania Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01313559 - Terminated(Slow accrual) - -
NCT01590199 Neuroendocrine Tumors Phase 1 Active, not recruiting May 1, 2020 Germany ... More >> Novartis Investigative Site Bad Berka, Germany, 99438 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Muenster, Germany, 48149 Less <<
NCT01334073 Malignant Advanced Solid Tumor... More >>s Carcinoma, Renal Cell Less << Phase 1 Completed - France ... More >> Professeur Alain RAVAUD Bordeaux, France, 33000 Professeur Jean-Pierre DELORD Toulouse, France, 31000 Less <<
NCT00154310 - Completed - -
NCT03216967 BK Virus Nephropathy After Kid... More >>ney Transplantation Less << Phase 4 Recruiting December 1, 2022 France ... More >> CHU - Hôpital Sud Not yet recruiting Amiens, France, 80054 Contact: Maité JAUREGUY, MD          CHRU d'Angers Not yet recruiting Angers, France, 49033 Contact: Johnny SAYEGH, MD          CHU - Hôpital de la Cavale Blanche Recruiting Bois-guillaume, France, 76230 Contact: Dominique BERTRAND, MD          CHU - Hôpital de la Cavale Blanche Recruiting Brest, France, 29609 Contact: Yannick LE MEUR, MD          CHU Côte de Nacre Recruiting Caen, France, 14033 Contact: Nicolas BOUVIER, MD          CHU Hôpital Gabriel Montpied Not yet recruiting Clermont-Ferrand, France, 63000 Contact: Anne Elisabeth HENG, MD          CHU - Hôpital Dupuytren Recruiting Limoges, France, 87042 Contact: Jean Philippe REROLLE, MD          AP-HP Hôpital Necker Recruiting Paris, France, 75743 Contact: Dany ANGLICHEAU, MD          AP-HP - Hôpital Georges Pompidou Not yet recruiting Paris, France, 75908 Contact: Eric THERVET, MD          CHU Poitiers - Hôpital Jean Bernard Not yet recruiting Poitiers, France, 86021 Contact: Laure ECOTIERE, MD          CHU - Hôpital Maison Blanche Not yet recruiting Reims, France, 51092 Contact: Betoul SCHVARTZ, MD          CHU Rennes - Hôpital Pontchaillou Not yet recruiting Rennes, France, 35033 Contact: Léonard GOLBIN, MD          Les Hôpitaux Universitaires Recruiting Strasbourg, France, 67000 Contact: Sophie CAILLARD, MD          CHRU - Hôpital Bretonneau Recruiting Tours, France, 37044 Contact: Matthias BUCHLER, MD Less <<
NCT00474929 Lymphoma Mult... More >>iple Myeloma and Plasma Cell Neoplasm Less << Phase 1 Phase 2 Active, not recruiting January 2019 United States, Iowa ... More >> Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242-1002 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00384969 Renal Cell Carcinoma Phase 1 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94115 Less <<
NCT00582738 Recurrent Hepatitis C Phase 2 Terminated - Argentina ... More >> Novartis Investigative site Buenos Aires, Argentina Less <<
NCT02429973 Osteosarcoma Phase 2 Completed - -
NCT00582738 - Terminated - -
NCT03580239 Prostate Cancer Phase 3 Not yet recruiting December 1, 2023 China, Tianjin ... More >> Tianjin First Center Hospital Tianjin, Tianjin, China, 300000 Tianjin Medical University General Hospital Tianjin, Tianjin, China, 300050 The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine Tianjin, Tianjin, China, 300150 Tianjin Medical Unversity Second Hospital Tianjin, Tianjin, China, 300200 Less <<
NCT00770120 Malignant Mesothelioma Phase 2 Completed - -
NCT00474929 - Active, not recruiting - -
NCT00425308 Renal Transplantation Phase 3 Completed - France ... More >> Novartis Investigative Site Paris, France Less <<
NCT00770120 - Completed - -
NCT00154297 Renal Transplantation Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00425308 - Completed - -
NCT00154297 - Completed - -
NCT00096486 Lung Cancer Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02909335 Liver Transplantation Phase 3 Not yet recruiting November 2021 France ... More >> CHU Rennes Not yet recruiting Rennes, France, 35000 Contact: Anne HESPEL, PhD       anne.hespel@chu-rennes.fr    Principal Investigator: Karim BOUDJEMA, MD, PhD Less <<
NCT02975882 Childhood Solid Neoplasm ... More >> Recurrent Central Nervous System Neoplasm Recurrent Malignant Solid Neoplasm Refractory Central Nervous System Neoplasm Refractory Malignant Solid Neoplasm Less << Phase 1 Recruiting June 3, 2020 -
NCT01269684 Kidney Transplantation Phase 4 Withdrawn(No patient has never... More >> been included in the trial) Less << - Switzerland ... More >> Novartis Investigative Site Zurich, Switzerland Less <<
NCT00522665 Colorectal Cancer Phase 1 Phase 2 Completed - United States, Illinois ... More >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 IN Onc/Hem Associates Indianapolis, Indiana, United States, 46202 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 St. Vincent Hospital & Health Centers Indianapolis, Indiana, United States, 46206 Community Regional Cancer Center Indianapolis, Indiana, United States, 46256 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Horizon Oncology Center Lafayette, Indiana, United States, 47905 Monroe Medical Associates Munster, Indiana, United States, 46321 Center for Cancer Care, Inc., P.C. New Albany, Indiana, United States, 47150 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Missouri Siteman Cancer Center St. Louis, Missouri, United States, 63110 Less <<
NCT01661283 Malignant Peripheral Nerve She... More >>ath Tumors MPNST Sarcoma Less << Phase 2 Unknown December 2017 United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294-0024 United States, District of Columbia Children's National Medical Center Washington D.C., District of Columbia, United States, 20010 United States, Illinois Ann and Robert Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Maryland Johns Hopkins Baltimore, Maryland, United States, 21218 National Cancer Institute Bethesda, Maryland, United States, 20892-1101 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University in St. Louis St. Louis, Missouri, United States, 63130 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Pennsylvania Oncology Hematology Associates Philadelphia, Pennsylvania, United States, 19106 Less <<
NCT00180479 - Completed - -
NCT00180479 Stents Corona... More >>ry Artery Disease Total Coronary Occlusion Coronary Artery Restenosis Stent Thrombosis Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Less << Phase 3 Completed - -
NCT00377962 Disorder Related to Cardiac Tr... More >>ansplantation Less << Phase 4 Completed - Denmark ... More >> Novartis Investigative Site Arhus, Denmark, DK-8200 Novartis Investigative Site Copenhagen, Denmark, 2100 Norway Novartis Investigative Site Oslo, Norway Sweden Novartis Investigative Site Goteborg, Sweden, 413 45 Novartis Investigative Site Linkoping, Sweden, 581 85 Novartis Investigative Site Lund, Sweden, 22185 Less <<
NCT00096486 - Completed - -
NCT00474786 - Completed - -
NCT01015664 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 1 Phase 2 Terminated - United States, Tennessee ... More >> Boston Baskin Caner Foundation Memphis, Tennessee, United States, 38138 Less <<
NCT00235560 Acute Myeloid Leukemia Phase 2 Completed - France ... More >> Service d'Hématologie, CHU Angers, France, 49100 Service d'Hématologie, Hôpital Jean Minjoz BESANçON, France, 25000 Service d'Hématologie CHU Purpan Toulouse, France, 31059 Less <<
NCT01801137 Urothelial Cancer Phase 2 Completed - France ... More >> Hôpital FOCH Suresnes, Ile de France, France, 92150 Less <<
NCT00377962 - Completed - -
NCT00337376 Advanced Solid Cancers Phase 1 Terminated - United States, Connecticut ... More >> Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT02248012 Neuroendocrine Carcinoma Phase 2 Unknown December 2018 Norway ... More >> Haukeland University Hospital Recruiting Bergen, Norway, 5021 Contact: Halfdan Sorbye, Prof       halfdan.sorbye@helse-bergen.no    Principal Investigator: Halfdan Sorbye, MD Less <<
NCT01281865 Adult Synovial Sarcoma ... More >> Recurrent Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00316849 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 1 Completed - United States, Florida ... More >> Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Iowa Medical Oncology and Hematology Associates-West Des Moines Clive, Iowa, United States, 50325 Mercy Capitol Des Moines, Iowa, United States, 50307 Iowa Methodist Medical Center Des Moines, Iowa, United States, 50309 Iowa Oncology Research Association CCOP Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates-Des Moines Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates Des Moines, Iowa, United States, 50314 Mercy Medical Center - Des Moines Des Moines, Iowa, United States, 50314 Iowa Lutheran Hospital Des Moines, Iowa, United States, 50316 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Dakota Altru Cancer Center Grand Forks, North Dakota, United States, 58201 Less <<
NCT00474786 Renal Cell Carcinoma Phase 3 Completed - -
NCT01017029 Cardiac Transplantation Phase 4 Completed - Italy ... More >> Novartis Investigative Site Bari, BA, Italy, 70124 Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Cagliari, CA, Italy, 09134 Novartis Investigative Site Milano, MI, Italy, 20162 Novartis Investigative Site Padova, PD, Italy, 35128 Novartis Investigative Site Pavia, PV, Italy, 27100 Novartis Investigative Site Roma, RM, Italy, 00152 Novartis Investigative Site Siena, SI, Italy, 53100 Novartis Investigative Site Torino, TO, Italy, 10126 Novartis Investigative Site Udine, UD, Italy, 33100 Novartis Investigative Site Verona, VR, Italy, 37126 Novartis Investigative Site Napoli, Italy, 80131 Less <<
NCT01017029 - Completed - -
NCT01598987 Renal Function ... More >> Liver Transplant Less << Phase 3 Completed - -
NCT01784861 Adenocarcinoma ... More >> Pancreatic Neoplasms Less << Phase 1 Phase 2 Active, not recruiting June 30, 2019 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT01598987 - Completed - -
NCT00375245 Tumors Neopla... More >>sm Metastasis Less << Phase 1 Completed - United States, Illinois ... More >> University of Chicago Hospitals Chicago, Illinois, United States, 60637 Less <<
NCT01281865 - Completed - -
NCT01268371 Coronary Artery Disease Phase 4 Unknown July 2015 Korea, Republic of ... More >> Hallym University Sacred Heart Hospital Anyang, Korea, Republic of Sejong Hospital Bucheon, Korea, Republic of Soon Chun Hyang University Hospital Bucheon Bucheon, Korea, Republic of Cheju Halla General Hospital Cheju, Korea, Republic of Soon Chun Hyang University Hospital Cheonan Cheonan, Korea, Republic of Kangwon National University Hospital Chuncheon, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Hospital Daegu, Korea, Republic of Chungnam National University Hospital Daejon, Korea, Republic of Konyang University Hospital Daejon, Korea, Republic of Gangneung Asan Hospital Gangneung, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Inje University ilsan Paik Hospital Ilsan, Korea, Republic of Gachon University Gil Hospital Incheon, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of Hallym University Hankang Sacred Heart Hospital Seoul, Korea, Republic of Hallym University Kangdong Sacred Heart Hospital Seoul, Korea, Republic of Kyunghee University Medical Center Seoul, Korea, Republic of The Catholic University of Korea Seoul ST. Mary`s Hospital Seoul, Korea, Republic of Yonsei University Gangnam Severance Hospital Seoul, Korea, Republic of St. Carollo Hospital Suncheon, Korea, Republic of Ajou University Medical Center Suwon, Korea, Republic of Catholic University ST. Vincent`s Hospital Suwon, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Yonsei University Wonju College of Medicine Wonju Christion Hospital Wonju, Korea, Republic of Pusan National University Yangsan Hospital Yangsan, Korea, Republic of Less <<
NCT02407509 Solid Tumours ... More >> Multiple Myeloma Less << Phase 1 Recruiting June 2021 United Kingdom ... More >> Royal Marsden NHS Foundation Trust Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Contact: Udai Banerji, MBBS, PhD          Guy's and St Thomas' Hospital Not yet recruiting London, United Kingdom Contact: Alison Turner, PhD       alison.turner@icr.ac.uk    Contact: Joanna Dawes, PhD       DDU3808@icr.ac.uk Less <<
NCT02742051 Breast Cancer Phase 2 Recruiting December 2019 China, Guangdong ... More >> Sun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Jieqiong Liu, M.D.,Ph.D.    8620-81332576    liujieqiong01@163.com Less <<
NCT02365415 Peripheral Pulmonary Stenosis ... More >> In-stent Stenosis Less << Phase 2 Withdrawn(Unable to enroll app... More >>ropriate patients) Less << - United States, Massachusetts ... More >> Boston Children's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02258451 Breast Neoplasms Phase 2 Active, not recruiting August 30, 2019 -
NCT01731158 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Unknown May 2016 Germany ... More >> Charité Berlin Berlin, Germany University Hospital Bonn Bonn, Germany University Hospital Dresden Dresden, Germany University Hospital Düsseldorf Düsseldorf, Germany Waldkrankenhaus St. Marien Erlangen, Germany University Hospital Essen Essen, Germany University Hospital Frankfurt Frankfurt, Germany University Hospital Freiburg Freiburg, Germany University Hospital Göttingen Göttingen, Germany Oncological Practice Hannover Hannover, Germany University Hospital Hannover Hannover, Germany University Hospital Magdeburg Magdeburg, Germany University Hospital Tübingen Tübingen, Germany Less <<
NCT01670318 Coronary Artery Disease Not Applicable Unknown December 2015 Japan ... More >> Aichi Medical University Hospital Not yet recruiting Nagakute, Aichi, Japan, 480-1195 Contact: Hiroaki Takashima          Principal Investigator: Hiroaki Takashima, MD          Toyohashi Heart Center Recruiting Toyohashi, Aichi, Japan, 441-8530 Contact: Kenya Nasu, MD          Principal Investigator: Kenya Nasu, MD          Juntendo University Urayasu Hospital Not yet recruiting Urayasu, Chiba, Japan, 279-0021 Contact: Ken Yokoyama          Principal Investigator: Ken Tokoyama, MD          Kokura Memorial Hospital Not yet recruiting Kitakyushu, Fukuoka, Japan, 802-8555 Contact: Shinichi Shirai          Principal Investigator: Shinichi Shirai, MD          Hoshi General Hospital Not yet recruiting Koriyama, Fukushima, Japan, 963-8501 Contact: Yuichi Ujiie          Sub-Investigator: Yuichi Ujiie, MD          Southern Tohoku Research Institute for Neuroscience Not yet recruiting Koriyama, Fukushima, Japan, 963-8563 Contact: Mitsuru Muto          Principal Investigator: Muto Mitsuru, MD          Gunma Prefectural Cardiovascular Center Not yet recruiting Maebashi, Gunma, Japan, 371-0004 Contact: Ren Kawaguchi          Principal Investigator: Ren Kawaguchi, MD          Gunma University Hospital Not yet recruiting Maebashi, Gunma, Japan, 371-8511 Contact: Ryuichi Funada          Principal Investigator: Ryuichi Funada, MD          Ota Memorial Hospital Not yet recruiting Ota, Gunma, Japan, 373-8585 Contact: Hidetoshi Anzai          Principal Investigator: Hidetoshi Anzai, MD          Megumino Hospital Not yet recruiting Eniwa, Hokkaido, Japan, 061-1395 Contact: Noriko Makiguchi          Principal Investigator: Noriko Makiguchi, MD          JA Hokkaido Engaru Kosei General Hospital Not yet recruiting Monbetsu, Hokkaido, Japan, 099-0404 Contact: Takahide Suzuki          Principal Investigator: Takahide Suzuki, MD          Nayoro City General Hospital Not yet recruiting Nayoro, Hokkaido, Japan, 096-8511 Contact: Masaru Yamaki          Principal Investigator: Masaru Yamaki, MD          Sapporo Cardio Vascular Clinic Not yet recruiting Sapporo, Hokkaido, Japan, 007-0849 Contact: Yoshifumi Kashima          Principal Investigator: Yoshifumi Kashima, MD          Kansai Rosai Hospital Not yet recruiting Amagasaki, Hyogo, Japan, 660-8511 Contact: Masaki Awata          Principal Investigator: Masaki Awata, MD          Kakogawa East City Hospital Not yet recruiting Kakogawa, Hyogo, Japan, 685-0115 Contact: Makoto Kadotani          Principal Investigator: Makoto Kadotani, MD          Kobe University Hospital Not yet recruiting Kobe, Hyogo, Japan, 650-0017 Contact: Toshiro Shinke          Principal Investigator: Toshiro Shinke, MD          Tsukuba Medical Center Hospital Not yet recruiting Tsukuba, Ibaragi, Japan, 305-8558 Contact: Hidetaka Nishina          Principal Investigator: Hidetaka Nishina, MD          Yokohama Rosai Hospital Not yet recruiting Yokohama, Kanagawa, Japan, 222-0036 Contact: Kazuhiko Yumoto          Principal Investigator: Kazuhiko YUmoto, MD          Yokohama City Minato Red Cross Hospital Not yet recruiting Yokohama, Kanagawa, Japan, 231-8682 Contact: Tsukasa Shimura          Principal Investigator: Tsukasa Shimura, MD          Daini Okamoto General Hospital Not yet recruiting Uji, Kyoto, Japan, 611-0025 Contact: Masaki Tanabe          Principal Investigator: Masaki Tanabe, MD          Matsumoto Kyoritsu Hospital Not yet recruiting Matsumoto, Nagano, Japan, 390-8505 Contact: Hidetoshi Abe          Principal Investigator: Hidetoshi Abe, MD          Rinku General Medical Center Not yet recruiting Izumisano, Osaka, Japan, 598-8577 Contact: Yoshihiro Takeda          Principal Investigator: Yoshihiro Takeda, MD          Hokusetsu General Hospital Not yet recruiting Takatsuki, Osaka, Japan, 569-0852 Contact: Wataru Nagamatsu          Principal Investigator: Wataru Nagamatsu, MD          SHUWA General Hospital Not yet recruiting Kasukabe, Saitama, Japan, 344-0035 Contact: Ryo Goto          Principal Investigator: Ryo Goto, MD          Kasukabe Chuo General Hospital Not yet recruiting Kasukabe, Saitama, Japan, 344-0063 Contact: Satoru Tohara          Principal Investigator: Satoru Tohara, MD          TODA CHUO General Hospital Not yet recruiting Toda, Saitama, Japan, 335-0023 Contact: Yuichi Kobori          Principal Investigator: Yuichi Kobori, MD          Seirei Mikatahara General Hospital Not yet recruiting Hamamatsu, Shizuoka, Japan, 433-8558 Contact: Yasuyo Takeuchi          Principal Investigator: Yasuyo Takeuchi, MD          Ayase Heart Hospital Not yet recruiting Adachi-ku, Tokyo, Japan, 120-0006 Contact: Hidenari Hozawa          Principal Investigator: Hidenari Hozawa, MD          Tokyo Rinkai Hospital Not yet recruiting Edogawa-ku, Tokyo, Japan, 134-0086 Contact: Motoyuki Onikura          Principal Investigator: Motoyuki Onikura, MD          Itabashi Chuo Medical Center Not yet recruiting Itabashi-ku, Tokyo, Japan, 174-0051 Contact: Hiroshi Ota          Principal Investigator: Hiroshi Ota, MD          Katsushika Medical Center Not yet recruiting Katsushika-ku, Tokyo, Japan, 125-8506 Contact: Yoshiki Uehara          Principal Investigator: Yoshiki Uehara, MD          Tokyo-Kita Social Insurance Hospital Not yet recruiting Kita-ku, Tokyo, Japan, 115-0053 Contact: Yuya Nakagawa          Principal Investigator: Yuya Nakagawa, MD          The Cardiovascular Institute Not yet recruiting Minato-ku, Tokyo, Japan, 106-0031 Contact: Yuji Oikawa          Principal Investigator: Yuji Oikawa, MD          Tokyo Metropolitan Police Hospital Not yet recruiting Nakano-ku, Tokyo, Japan, 164-8541 Contact: Masatoshi Suzuki          Principal Investigator: Masatoshi Suzuki, MD          Tokyo Metropolitan Hiroo Hospital Not yet recruiting Shibuya-ku, Tokyo, Japan, 150-0013 Contact: Yasuhiro Tanabe          Principal Investigator: Yasuhiro Tanabe, MD          NTT Medical Center Tokyo Not yet recruiting Shinagawa-ku, Tokyo, Japan, 141-8625 Contact: Masashiro Matsushita          Principal Investigator: Masashiro Matsushita, MD          Saiseikai Fukuoka General Hospital Not yet recruiting Fukuoka, Japan, 810-0001 Contact: Takeshi Serikawa          Principal Investigator: Takeshi Serikawa, MD          Saiseikai Kumamoto Hospital Not yet recruiting Kumamoto, Japan, 861-4193 Contact: Eiji Taguchi          Principal Investigator: Eiji Taguchi, MD Less <<
NCT00098241 Kidney Transplantation Phase 3 Completed - United States, Ohio ... More >> Columbus Children's Hospital Columbus, Ohio, United States, 43205-2696 Belgium Dienst Pediatrie UZ Gasthuisberg, Herestraat 49 Leuven, Belgium, 3000 Less <<
NCT01523977 Acute Lymphoblastic Leukemia Phase 1 Active, not recruiting November 2018 United States, California ... More >> UCSF San Francisco, California, United States, 94143 United States, Colorado Children's Hospital Colorado Aurora, Colorado, United States, 80045 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 United States, Massachusetts Boston Children's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Columbia University Medical Center New York, New York, United States, 12549 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT03618355 Prostate Cancer Phase 1 Recruiting August 15, 2019 United States, Texas ... More >> UT Health San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Brandi Weaver    210-567-0178    weaverb@uthscsa.edu    Contact: Allison Wheeler    (210) 567-1172    wheelerA2@uthscsa.edu    Principal Investigator: Michael Liss, MD Less <<
NCT01631058 Chronic Renal Failure (CRF) ... More >> Graft Failure Transplant; Failure, Kidney Renal Transplant Rejection Less << Phase 4 Recruiting June 2019 Brazil ... More >> Clinical Hospital of the School of Medicine, University of Sao Paulo Recruiting Sao Paulo, SP, Brazil, 05403900 Principal Investigator: Elias David-Neto, PhD          Sub-Investigator: Francine B. Lemos, PhD          Sub-Investigator: Nelson Z. Galante, PhD          Sub-Investigator: Fabiana Agena, MS          Sub-Investigator: William C Nahas, PhD          Sub-Investigator: Wilson Jacob-Filho, PhD          Sub-Investigator: Marcelo Altona, MD          Sub-Investigator: Daisa R David, PhD          Sub-Investigator: Flavio J Paula, PhD          Sub-Investigator: Paschoalina Romano, MS          Sub-Investigator: Persio AR Ebner, Biol          Sub-Investigator: Maria da Luz Fernandes, MS          Sub-Investigator: Veronica PC Coelho, PhD          Sub-Investigator: Venceslau A Coelho, MD          Sub-Investigator: Fabio Di Nizio, MD          Clinical Hospital of the School of Medicine, University of Sao Paulo Recruiting Sao Paulo, SP, Brazil, 05403900 Principal Investigator: Elias David-Neto, PhD          Sub-Investigator: Francine B. Lemos, PhD          Sub-Investigator: Nelson Z. Galante, PhD          Sub-Investigator: Fabiana Agena, MS Less <<
NCT01114529 Kidney Transplantation Phase 3 Completed - -
NCT02137837 Breast Cancer Phase 3 Suspended(lack of accrual) May 2022 -
NCT01334502 Lymphoma Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT01114529 - Completed - -
NCT01031901 Tuberous Sclerosis ... More >> Neurofibromatoses Angiofibroma Neurofibroma Less << Phase 1 Completed - United States, Texas ... More >> The University of Texas Health Science Center Houston, Texas, United States, 77030 Less <<
NCT03468478 Kidney Transplant Infection Phase 4 Recruiting June 18, 2021 Brazil ... More >> Hospital do Rim Recruiting São Paulo, Sao Paulo, Brazil, 04038002 Contact: Claudia Felipe', PharmD, PhD    551150878113    claudiafelipe@medfarm.com.br    Principal Investigator: Helio Tedesco, MD Less <<
NCT02724020 Clear-cell Metastatic Renal Ce... More >>ll Carcinoma Less << Phase 2 Active, not recruiting May 30, 2019 -
NCT03439462 Colorectal Cancer Metastatic Phase 1 Phase 2 Recruiting April 2021 United States, Arizona ... More >> HonorHealth Research Institute Recruiting Scottsdale, Arizona, United States, 85258 Contact: Joyce Schaffer, MSN RN AOCNS    480-323-1791    clinicaltrials@honorhealth.com Less <<
NCT00795886 Acute Lymphoblastic Leukemia Phase 2 Completed - United States, Utah ... More >> Primary Children's Medical Center Salt Lake City, Utah, United States, 84112 Less <<
NCT01894152 - Active, not recruiting September 2019 United States, California ... More >> Abbott Vascular Santa Clara, California, United States, 95054 Less <<
NCT01453504 Hodgkin Lymphoma Phase 1 Phase 2 Recruiting December 2018 Germany ... More >> 1st Dept. of Medicine, Cologne University Hospital Recruiting Cologne, Germany Contact: Michael Fuchs       ghsg@uk-koeln.de Less <<
NCT01164267 Marginal Zone B-cell Lymphoma Phase 2 Completed - Austria ... More >> General Hospital AKH Vienna, Austria Italy Policlinico S. Orsola Malpighi Bologna, Italy IEO Milano, Italy INT Milano, Italy Humanitas Milan, Italy San Raffaele Hospital Milan, Italy AOU Maggiore della Carità Novara, Italy IRCCS Policlinico S. Matteo Pavia, Italy AOU S. Giovanni Battista Torino, Italy Switzerland IOSI Bellinzona, Switzerland Less <<
NCT00943956 Prostate Cancer Phase 1 Completed - France ... More >> Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Less <<
NCT02081755 Carcinoma, Hepatocellular Phase 4 Recruiting August 2019 United States, California ... More >> University of California at San Francisco Recruiting San Francisco, California, United States, 94143 Principal Investigator: Ryutaro Hirose, MD          United States, Illinois Northwestern University School of Medicine Recruiting Chicago, Illinois, United States, 60611 Principal Investigator: Laura Kulik, MD          United States, Kansas University of Kansas Medical Center Recruiting Kansas City, Kansas, United States, 66160 Principal Investigator: Sean Kumer, MD          United States, Louisiana Ochsner Multi-Organ Transplant Institute Recruiting New Orleans, Louisiana, United States, 70121 Principal Investigator: Ian Carmody, MD          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Principal Investigator: Timucin Taner, MD, PhD          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Principal Investigator: William Chapman, MD          United States, New York Mount Sinai Medical Center Recruiting New York, New York, United States, 10029 Principal Investigator: Sander Florman, MD          United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Principal Investigator: Maarouf Hoteit, MD          United States, Tennessee University of Tennessee- Methodist University Hospital Recruiting Memphis, Tennessee, United States, 38104 Principal Investigator: Ryan Helmick, MD          United States, Texas Baylor University Medical Center Recruiting Dallas, Texas, United States, 75246 Principal Investigator: Goran Klintmalm, MD, PhD Less <<
NCT00170833 Renal Transplantation Phase 3 Completed - -
NCT02837757 Metastatic Renal Cancer Not Applicable Unknown November 2018 France ... More >> Centre Hospitalier Universitaire de Besançon Recruiting Besançon, France Principal Investigator: Laura MANSI, Dr          Hôpital Nord Franche-Comté Recruiting Montbéliard, France Principal Investigator: Antoine Thiery-Vuillemin, Dr          Hôpital Européen Georges Pompidou Not yet recruiting Paris, France Principal Investigator: Stephane OUDARD, Pr Less <<
NCT00012142 Prostate Cancer Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT02333565 Recurrent Meningiomas ... More >> Resistant Meningiomas Less << Phase 2 Unknown - France ... More >> Assistance Publique Hôpitaux Marseille Recruiting Marseille, France, 13354 Contact: Thomas GRAILLON, CCA    04.91.38.55.33    thomas.graillon@ap-hm.fr Less <<
NCT01230723 Coronary Heart Disease Phase 4 Unknown July 2012 Germany ... More >> Deutsches Herzzentrum Muenchen Munich, Bavaria, Germany, 80636 Klinikum rechts der Isar Munich, Bavaria, Germany, 81675 Less <<
NCT00795886 - Completed - -
NCT01341340 Atherosclerosis ... More >> Peripheral Artery Disease Peripheral Vascular Disease PAD Claudication Critical Limb Ischemia Lower Limb Disease Peripheral Arterial Occlusive Disease PAOD PVD Less << Not Applicable Terminated(Discontinued due to... More >> poor enrollment. Insufficient number of patients enrolled to permit a statistically rigorous assessment of safety and efficacy.) Less << - Belgium ... More >> Abbott Vascular International Bvba Diegem, Belgium Less <<
NCT00373815 Graft Versus Host Disease Phase 1 Terminated(high incidence of T... More >>TP, poor recrual) Less << - Germany ... More >> Medical Center, Hematology & Oncology, University of Tuebingen Tuebingen, Germany, D-72076 Less <<
NCT01047293 - Completed - -
NCT02338609 Growth and Development Phase 4 Active, not recruiting September 25, 2026 United States, California ... More >> University of California at Los Angeles SC Los Angeles, California, United States, 90095 United States, Minnesota Minnesota Epilepsy Group Saint Paul, Minnesota, United States, 55102 United States, Ohio Cincinnati Children's Hospital Medical Center SC Cincinnati, Ohio, United States, 45229-3039 United States, Texas Texas Scottish Rite Hospital for Children SC Dallas, Texas, United States, 75219 Belgium Novartis Investigative Site Brussel, Belgium, 1090 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 127412 Less <<
NCT01051570 Prostate Cancer Phase 2 Completed - United States, Illinois ... More >> Northshore University Health System Evanston, Illinois, United States, 60201 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Weisberg Cancer Treatment Center Farmington Hills, Michigan, United States, 48334 United States, New Jersey Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT01047293 Colorectal Cancer Phase 1 Phase 2 Completed - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Utah Cancer Specialists Salt Lake City, Utah, United States Less <<
NCT01051570 - Completed - -
NCT02112981 Coronary Artery Disease Not Applicable Active, not recruiting December 1, 2019 Belgium ... More >> Imelda Ziekenhuis Cardiology Bonheiden, Western Europe, Belgium, 2820 Brazil Instituto Dante Pazzanese de Cardiologia Sao Paulo, Brazil, 04012-909 Instituto do Coracao - HCFMUSP Centro de Pesquisa Clinica São Paulo, Brazil, 05403-000 Instituto do Coracao do Triangulo Mineiro Uberlândia, Brazil, 38411-186 Czechia St. Anne's Univeristy Hospital Brno Brno-střed, Brno, Czechia, 656 91 Fn Brno, Jihlavska 20 Brno, Czechia, 602 00 Latvia University of Latvia, Research Institute of Cardiology Riga, Europe, Latvia, LV1002 Macedonia, The Former Yugoslav Republic of University Clinic of Cardiology Skopje, Macedonia, The Former Yugoslav Republic of, 1000 Netherlands Catharina Cardiac Centre Eindhoven, North Brabant, Netherlands, 5623 Albert Schweitzer Dordrecht, South Holland, Netherlands, 3300 Isala Hospital Zwolle, Netherlands, 8025 Poland American Heart Institure S.A. Tychy, Silesia, Poland, 43-100 Spain Hospital Clinic Barcelona, Catalonia, Spain, 08036 United Kingdom Royal Bournemouth Hospital Bournemouth, England, United Kingdom, BH7 7DW Manchester Heart Centre Manchester, England, United Kingdom, M13 9WL. Less <<
NCT00117598 Lymphoma Phase 3 Completed - -
NCT00657982 Prostate Cancer Phase 2 Unknown - Israel ... More >> Sheba Medical Center Recruiting Tel Hashomer, Israel, 52621 Contact: Raanan Berger, MD       raanan.berger@sheba.health.gov.il Less <<
NCT01601821 Inflammation Phase 4 Completed - Iran, Islamic Republic of ... More >> Labbafinejad Hospital Tehran, Iran, Islamic Republic of Modarres Hospital Tehran, Iran, Islamic Republic of Shariati Hospital Tehran, Iran, Islamic Republic of Taleqani Hospital Tehran, Iran, Islamic Republic of Less <<
NCT02084446 Transplantation Infection ... More >> Cytomegalovirus Infections Less << Phase 4 Unknown August 2015 Brazil ... More >> Hospital Geral de Fortaleza Fortaleza, Ceará, Brazil, 60175-295 Less <<
NCT01601821 - Completed - -
NCT00997828 Coronary Artery Disease Not Applicable Active, not recruiting December 2019 China ... More >> Sir Run Run Shaw Hospital Hangzhou, China Zhongshan Hospital Shanghai, China Korea, Republic of Gangwon National Univ. Hospital Chuncheon, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of Yeungnam University Medical Center Daegu, Korea, Republic of Konyang University Hospital Daejeon, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Inje University Ilsan Paik Hospital Ilsan, Korea, Republic of National Health Insurance Corporation Ilsan Hospital Ilsan, Korea, Republic of Gachon University Gil Hospital Incheon, Korea, Republic of Inje University Pusan Paik Hospital Pusan, Korea, Republic of Pusan National University Yangsan Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Gangnam Severance Hospital Seoul, Korea, Republic of Hanyang National University Medical Center Seoul, Korea, Republic of Inje University Sanggye Paik Hospital Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Severance Hospital Seoul, Korea, Republic of The Catholic University of Korea Seoul St. Mary's Hospital Seoul, Korea, Republic of The Catholic University of Korea, Yeouido St. Mary's Hospital Seoul, Korea, Republic of St.carollo Hospital Suncheon, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Wonju Christian Hospital Wonju, Korea, Republic of Malaysia National Heart Institue Kuala Lumpur, Malaysia Sarawak General Hospital Kuching, Malaysia Thailand Siriraj Hospital Bangkok, Thailand Less <<
NCT00117702 Graft vs Host Disease Phase 2 Phase 3 Terminated(safety reasons) - Germany ... More >> Medizinische Klinik und Poliklinik I, University Clinic Carl Gustav Carus Dresden, Germany, 01307 Less <<
NCT01865747 Renal Cell Carcinoma Phase 3 Active, not recruiting June 2019 -
NCT01164176 Head and Neck Cancer Phase 2 Completed - Korea, Republic of ... More >> Hallym University Sacred Heart Hospital Anyang, Gyeonggi-do, Korea, Republic of, 431-070 Yeungnam University Medical Center Daegu, Korea, Republic of, 712-749 National Cancer Center - Korea Goyang, Korea, Republic of, 410-769 Kosin Medical Center Gospel Hospital Pusan, Korea, Republic of, 602-702 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Yonsei Cancer Center at Yonsei University Medical Center Seoul, Korea, Republic of, 120-752 Gangnam Severance Hospital Seoul, Korea, Republic of, 135-720 Less <<
NCT00170820 Renal Transplantation Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT01637194 Recurrent Adenoid Cystic Carci... More >>noma of the Oral Cavity Recurrent Basal Cell Carcinoma of the Lip Recurrent Colon Cancer Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity Recurrent Lymphoepithelioma of the Nasopharynx Recurrent Lymphoepithelioma of the Oropharynx Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity Recurrent Mucoepidermoid Carcinoma of the Oral Cavity Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Stage IV Adenoid Cystic Carcinoma of the Oral Cavity Stage IV Basal Cell Carcinoma of the Lip Stage IV Lymphoepithelioma of the Nasopharynx Stage IV Lymphoepithelioma of the Oropharynx Stage IV Mucoepidermoid Carcinoma of the Oral Cavity Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Larynx Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IV Squamous Cell Carcinoma of the Oropharynx Stage IV Verrucous Carcinoma of the Larynx Stage IV Verrucous Carcinoma of the Oral Cavity Stage IVA Colon Cancer Stage IVA Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity Stage IVA Inverted Papilloma of the Paranasal Sinus and Nasal Cavity Stage IVA Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity Stage IVA Salivary Gland Cancer Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVB Colon Cancer Stage IVB Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity Stage IVB Inverted Papilloma of the Paranasal Sinus and Nasal Cavity Stage IVB Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity Stage IVB Salivary Gland Cancer Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVC Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity Stage IVC Inverted Papilloma of the Paranasal Sinus and Nasal Cavity Stage IVC Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity Stage IVC Salivary Gland Cancer Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Tongue Cancer Less << Phase 1 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT00107016 Breast Neoplasm Phase 2 Completed - -
NCT00117598 - Completed - -
NCT00525889 Diabetes Mellitus, Type 1 Phase 1 Completed - United States, New York ... More >> Naomi Berrie Diabetes Center, Columbia University New York, New York, United States, 10032 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Washington Benaroya Research Institute Seattle, Washington, United States, 98101 Less <<
NCT00544999 Leukemia Phase 1 Unknown - France ... More >> Hopital Cochin Recruiting Paris, France, 75674 Contact: Sophie Park, MD    33-140-514-543 Less <<
NCT01711931 Coronary Artery Disease Phase 4 Completed - Switzerland ... More >> Fribourg Cantonal Hospital Fribourg, Switzerland, 1708 Less <<
NCT01198158 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Carcinoma Stage III Renal Cell Cancer AJCC v7 Stage IV Renal Cell Cancer AJCC v7 Less << Phase 3 Terminated - -
NCT00028028 Extensive Stage Small Cell Lun... More >>g Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT01229943 - Active, not recruiting - -
NCT01625377 Liver Transplantation Phase 3 Completed - France ... More >> Novartis Investigative Site Besancon cedex, France, 25030 Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Chambray les Tours, France, 37044 Novartis Investigative Site Clichy, France, 92110 Novartis Investigative Site Creteil, France, 94010 Novartis Investigative Site Grenoble, France, 38043 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Marseille, France, 13385 Novartis Investigative Site Montpellier, France, 34295 Novartis Investigative Site Nice, France, 06202 Novartis Investigative Site Paris Cedex 13, France, 75651 Novartis Investigative Site Rennes Cedex, France, 35033 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Novartis Investigative Site Villejuif, France, 94800 Less <<
NCT01215136 Transitional Cell Carcinoma ... More >> Bladder Carcinoma Urothelial Carcinoma Less << Phase 2 Active, not recruiting June 2018 United States, Alabama ... More >> University of Alabama Hematology Oncology Clinic at Medical West Birmingham, Alabama, United States, 35294 United States, Illinois Northwestern University, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 United States, Indiana Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 IU Health Central Indiana Cancer Centers Indianapolis, Indiana, United States, 46219 United States, Michigan Metro Health Cancer Care Wyoming, Michigan, United States, 49519 United States, Nebraska Nebraska Cancer Specialists Omaha, Nebraska, United States, 68114 United States, New York Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center New York, New York, United States, 10029 United States, South Carolina MUSC Hollings Cancer Center Charleston, South Carolina, United States, 29425 United States, Texas University of Texas Medical Branch Galveston, Texas, United States, 77555 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 Less <<
NCT01035450 Coronary Artery Disease Phase 4 Completed - Japan ... More >> Division of Cardiology, Kyoto University Hospital Kyoto, Japan, 606-8507 Less <<
NCT02248571 Breast Cancer Recurrent ... More >> HER2/Neu-negative Carcinoma of Breast Hormone Receptor Positive Malignant Neoplasm of Breast Less << Phase 4 Completed - Germany ... More >> iOMEDICO AG Freiburg, Baden-Wuerttemberg, Germany, 79108 Less <<
NCT00762632 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - Germany ... More >> Medical faculty of the Technical University Munich Munich, Bavaria, Germany, 81675 Less <<
NCT01865747 - Active, not recruiting - -
NCT01229943 Pancreatic Gastrinoma ... More >> Pancreatic Neuroendocrine Tumor G1 Pancreatic Neuroendocrine Tumor G2 Pancreatic Vipoma Recurrent Pancreatic Neuroendocrine Carcinoma Less << Phase 2 Active, not recruiting - -
NCT00223678 Kidney Transplant Phase 4 Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT00223678 - Completed - -
NCT00449280 Advanced Solid Tumor Phase 1 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01614301 Advanced Melanoma Phase 1 Phase 2 Unknown May 2016 Germany ... More >> University of Regensburg Recruiting Regensburg, Bavaria, Germany, 93053 Contact: Albrecht Reichle, Professor    +499419440    albrecht.reichle@UKR.de    Sub-Investigator: Martin Vogelhuber, MD          Sub-Investigator: Stephanie Mayer, MD          Sub-Investigator: Christina Hart, MD          Sub-Investigator: Matthias Grube, MD          Sub-Investigator: Susanne Gantner, MD Less <<
NCT00154284 Organ Transplantation, Renal T... More >>ransplantation Less << Phase 3 Completed - -
NCT00154284 - Completed - -
NCT01239342 - Active, not recruiting - -
NCT01889420 - Terminated(Low accrual) - -
NCT00918333 Adult Nasal Type Extranodal NK... More >>/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma B-cell Adult Acute Lymphoblastic Leukemia Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Nodal Marginal Zone B-cell Lymphoma Post-transplant Lymphoproliferative Disorder Primary Central Nervous System Non-Hodgkin Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Multiple Myeloma Splenic Marginal Zone Lymphoma T-cell Adult Acute Lymphoblastic Leukemia Waldenstr?m Macroglobulinemia Less << Phase 1 Phase 2 Active, not recruiting December 2018 United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Maryland Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States, 20892 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01625377 - Completed - -
NCT02642094 Cancer of Breast Phase 2 Recruiting December 2021 United States, Texas ... More >> University of Texas Health Science Center San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Epp Goodwin    210-450-1366    ctrcreferral@uthscsa.edu    Principal Investigator: LuShe Sun, PhD          Sub-Investigator: Ismail Jatoi, MD Less <<
NCT01239342 Metastatic Renal Cell Cancer ... More >> Recurrent Renal Cell Carcinoma Stage IV Renal Cell Cancer Less << Phase 2 Active, not recruiting December 31, 2017 United States, California ... More >> Tower Cancer Research Foundation Beverly Hills, California, United States, 90211-1850 City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 City of Hope South Pasadena South Pasadena, California, United States, 91030 United States, Pennsylvania Penn State Hershey Cancer Institute-Clinical Trials Office Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01798446 Renal Cell Carcinoma ... More >> Nonclear Cell Temsirolimus Resistance Less << Phase 2 Unknown December 2016 Korea, Republic of ... More >> Seou National University Hospital Recruiting Seoul, Korea, Republic of, 110744 Contact: Se-Hoon Lee, MD, PhD    82220722199    shlee119@snu.ac.kr    Principal Investigator: Se-Hoon Lee, MD, PhD          Sub-Investigator: Dae Seog Heo, MD, PhD          Sub-Investigator: Dong-Wan Kim, MD, PhD          Sub-Investigator: Tae Min Kim, MD, PhD          Sub-Investigator: Bhumsuk Keam, MD Less <<
NCT00918333 - Active, not recruiting - -
NCT00098007 Heart Transplantation Phase 3 Completed - -
NCT01217125 Angiomyolipoma Phase 4 Completed - -
NCT01889420 Multiple Myeloma in Relapse Phase 1 Terminated(Low accrual) - United States, New Mexico ... More >> UNM Cancer Research and Treatment Center Albuquerque, New Mexico, United States, 87131 Less <<
NCT02915783 Non Clear Cell Renal Cell Carc... More >>inoma (nccRCC) Less << Phase 2 Recruiting January 31, 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 United States, Illinois Rush University Medical Center Recruiting Chicago, Illinois, United States, 60612 United States, Massachusetts Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02214 United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 United States, Texas Texas Oncology Recruiting Dallas, Texas, United States, 75254 United States, Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Less <<
NCT00085566 - Completed - -
NCT01672151 - Completed - China, Jiangsu ... More >> Jiangsu Institute of Hematology Suzhou, Jiangsu, China, 215006 Less <<
NCT01783756 Central Nervous System Metasta... More >>ses HER2-positive Breast Cancer Male Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer Less << Phase 1 Phase 2 Active, not recruiting June 28, 2020 United States, California ... More >> Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 Less <<
NCT01954693 Tuberous Sclerosis Phase 2 Active, not recruiting August 6, 2018 United Kingdom ... More >> Cardiff University Cardiff, United Kingdom, CF14 4YS Less <<
NCT01862965 Chronic Graft-versus-host Dise... More >>ase Less << Phase 2 Active, not recruiting June 2018 Germany ... More >> Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Universitätsklinikum Jena Jena, Germany, 07743 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Mainz, Germany, 55101 Klinikum der Universität Regensburg Regensburg, Germany, 93053 Universitätsklinikum Ulm Ulm, Germany, 89081 Deutsche Klinik fuer Diagnostik GmbH Wiesbaden, Germany, 65191 Less <<
NCT00085566 Brain and Central Nervous Syst... More >>em Tumors Prostate Cancer Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Spain Vall d'Hebron University Hospital Barcelona, Spain, 08035 Less <<
NCT01204476 Gastrin-Producing Neuroendocri... More >>ne Tumor Lung Carcinoid Tumor Metastatic Digestive System Neuroendocrine Tumor G1 Pancreatic Glucagonoma Pancreatic Insulinoma Pancreatic Polypeptide Tumor Paraganglioma Recurrent Digestive System Neuroendocrine Tumor G1 Recurrent Merkel Cell Carcinoma Recurrent Pancreatic Neuroendocrine Carcinoma Regional Digestive System Neuroendocrine Tumor G1 Somatostatin-Producing Neuroendocrine Tumor Stage III Merkel Cell Carcinoma Stage IV Merkel Cell Carcinoma Thyroid Gland Medullary Carcinoma Less << Phase 1 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00793221 Coronary Artery Disease ... More >> Coronary Occlusion Percutaneous Coronary Intervention Less << Phase 3 Completed - -
NCT00521001 Melanoma (Skin) Phase 2 Completed - -
NCT02228681 Advanced, Persistent, or Recur... More >>rent Endometrial Cancer Less << Phase 2 Active, not recruiting - -
NCT02306135 - Terminated - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT00977574 Endometrial Adenocarcinoma ... More >> Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Adenocarcinoma Endometrial Serous Adenocarcinoma Recurrent Uterine Corpus Carcinoma Stage IIIA Uterine Corpus Cancer AJCC v7 Stage IIIB Uterine Corpus Cancer AJCC v7 Stage IIIC Uterine Corpus Cancer AJCC v7 Stage IVA Uterine Corpus Cancer AJCC v7 Stage IVB Uterine Corpus Cancer AJCC v7 Less << Phase 2 Active, not recruiting - -
NCT02113800 Poorly Differentiated Malignan... More >>t Neuroendocrine Carcinoma Neuroendocrine Carcinoma, Grade 3 Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3 Neuroendocrine Carcinoma, Grade 2 [Moderately Differentiated Neuroendocrine Carcinoma] That Switched to G3 Neuroendocrine Tumor, Grade 3 and Disease Progression as Measured by Response Evaluation Criteria in Solid Tumors (RECIST 1.1.) Less << Phase 2 Recruiting February 2019 Germany ... More >> Charité-Universitätsmedizin, Medizinische Klinik m. S. Hepatologie und Gastroenterologie, Campus Virchow-Klinikum Recruiting Berlin, Germany, 13353 Contact: Marianne Pavel, Prof. Dr.       marianne.pavel@charite.de    Principal Investigator: Marianne Pavel, Prof. Dr. Less <<
NCT03095040 Renal Cell Cancer Metastatic Phase 2 Phase 3 Recruiting December 2020 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Xinan Sheng, M.D    010-88196951    doctor_sheng@126.com Less <<
NCT00977574 - Active, not recruiting - -
NCT00003712 Brain and Central Nervous Syst... More >>em Tumors Metastatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Texas San Antonio Cancer Institute San Antonio, Texas, United States, 78229-3264 Less <<
NCT01449955 Posttraumatic Stress Disorder Not Applicable Completed - United States, Texas ... More >> VA North Texas Healthcare System Dallas, Texas, United States, 75216 Less <<
NCT01449955 - Completed - -
NCT01347554 - Completed - -
NCT00521001 - Completed - -
NCT01396200 Myeloma Early Phase 1 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00426530 Breast Neoplasms ... More >> Neoplasm Metastasis Less << Phase 1 Completed - Belgium ... More >> Novartis Investigative Site Bruxelles, Belgium, 1000 Novartis Investigative Site Liege, Belgium, 4000 France Novartis Investigative Site Paris, France, 75231 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Poland Novartis Investigative Site Warszawa, Poland, 02-781 Sweden Novartis Investigative Site Stockholm, Sweden, SE-171 76 Less <<
NCT01234974 Multiple Myeloma Phase 2 Withdrawn(Study never undertak... More >>en) Less << December 2013 United States, Pennsylvania ... More >> Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT00828087 Myocardial Infarction Not Applicable Completed - Italy ... More >> Azienda Ospedaliera Bolognini Seriate, Bergamo, Italy, 24068 Azienda Ospedaliero Universitaria S. Anna di Ferrara Ferrara, Italy, 44100 Netherlands Erasmus MC, Rotterdam Rotterdam, Netherlands, 3015 GD Spain Complejo Hospitalario U. A Coruña A Coruña, A Croruña, Spain, 15006 Hospital Son Dureta Palma de Mallorca, Baleares, Spain, 07014 Hospital General de Alicante Alicante, Spain, 03010 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Clínic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital de Bellvitge Barcelona, Spain, 08907 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital do Meixoeiro Vigo, Spain, 36214 Less <<
NCT01625520 Medullary Thyroid Cancer Phase 2 Completed - Italy ... More >> Department of Molecular and Clinical Endocrinology and Oncology, "Federico II" University of Naples Naples, Italy, 80131 Less <<
NCT01347554 Myocardial Infarction Phase 4 Completed - Korea, Republic of ... More >> Yonsei University Wonju College of Medicine; Wonju Severance Christian Hospital Wonju, Korea, Republic of, 220-701 Less <<
NCT00870337 Endometrial Cancer Phase 2 Completed - France ... More >> Hotel Dieu de Paris Paris, France, 75181 Less <<
NCT01807767 High Model for End-Stage Liver... More >> Disease (MELD) Score Less << Not Applicable Completed - United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT00583063 Solid Tumors Early Phase 1 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00708591 Advanced Cancer Phase 1 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00473005 Breast Cancer Phase 1 Terminated(Principal Investiga... More >>tor (Dr. Guardino) left Stanford) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00402636 Coronary Heart Disease Phase 4 Completed - Germany ... More >> 1. Medizinische Klinik, Klinikum rechts der Isar Muenchen, Germany, 81675 Deutsches Herzzentrum Muenchen Munich, Germany, 80636 Less <<
NCT01462214 Metastatic Renal Cell Cancer Phase 1 Phase 2 Completed - Netherlands ... More >> Medisch Centrum Alkmaar Alkmaar, Netherlands VU University Medical Center Amsterdam, Netherlands, 1081 HV NKI-AVL Amsterdam, Netherlands Haga Ziekenhuis Den Haag, Netherlands Medisch Centrum Haaglanden Den Haag, Netherlands Universitair Medisch Centrum Groningen Groningen, Netherlands Spaarne Ziekenhuis Hoofddorp Hoofddorp, Netherlands Medisch Centrum Leeuwarden Leeuwarden, Netherlands University Hospital Maastricht Maastricht, Netherlands St. Antonius Ziekenhuis Nieuwegein, Netherlands UMC St Radboud Nijmegen Nijmegen, Netherlands Sint Franciscus Gasthuis Rotterdam Rotterdam, Netherlands Isala Klinieken Zwolle Zwolle, Netherlands Less <<
NCT00658320 Kidney Transplantation Phase 3 Completed - Japan ... More >> Novartis Pharma K.K., Japan Tokyo, Japan, 106-8618 Less <<
NCT01781442 Renal Cell Carcinoma WITHDRAWN 2025-06-15 -
NCT00478634 Colorectal Cancer ... More >> Colorectal Carcinoma Colorectal Tumors Neoplasms, Colorectal Less << Phase 1 Completed - United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72701 United States, California Comprehensive nBlood and Cancer Care Bakersfield, California, United States, 93309 UCSD - Moores Cancer Center La Jolla, California, United States, 92037 Comprehensive Cancer Care Los Angeles, California, United States, 90095 North Valley Hematology/Oncology Medical Group: The Thomas & Dorothy Leavey Cancer Center Northridge, California, United States, 91325 Cancer Care Associates Medical Group, Inc. Redondo Beach, California, United States, 90277 United States, Connecticut Norwalk Hospital Norwalk, Connecticut, United States, 06850 United States, District of Columbia Gerogetown University Lombardi Cancer Center Washington, District of Columbia, United States, 20057 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois Oncology Specialists Park Ridge, Illinois, United States, 60068 United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Richmond University Medical Center Staten Island, New York, United States, 10310 United States, North Carolina UNC School of Medicine Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania Oncology/Hematology Associates Bethlehem, Pennsylvania, United States, 18017 United States, Texas Arlington Cancer Center Arlington, Texas, United States, 76012 Less <<
NCT00658320 - Completed - -
NCT03657420 Multiple Myeloma Phase 1 Not yet recruiting September 30, 2024 United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Andrew J. Yee, MD    617-724-4000    ayee1@mgh.harvard.edu    Principal Investigator: Andrew J. Yee, MD Less <<
NCT00228397 Multiple Sclerosis, Relapsing-... More >>Remitting Less << PHASE2 COMPLETED 2025-11-05 -
NCT01231399 - Completed - -
NCT01548807 Prostate Cancer Patients With ... More >>Detectable PSA Following Prostatectomy Less << Phase 1 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19004 Less <<
NCT01231399 Adenocarcinoma of the Esophagu... More >>s Adenocarcinoma of the Gastroesophageal Junction Diffuse Adenocarcinoma of the Stomach Intestinal Adenocarcinoma of the Stomach Mixed Adenocarcinoma of the Stomach Recurrent Esophageal Cancer Recurrent Gastric Cancer Stage IV Esophageal Cancer Stage IV Gastric Cancer Less << Phase 1 Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 South Pasadena Cancer Center South Pasadena, California, United States, 91030 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00426049 Coronary Artery Disease ... More >> Coronary Restenosis Less << Phase 3 Unknown - Germany ... More >> German Heart Institute Berlin Recruiting Berlin, Germany, 13353 Principal Investigator: Eckart Fleck, Professor Less <<
NCT02481453 Inclusion Body Myositis (IBM) Phase 2 Phase 3 Active, not recruiting April 2018 France ... More >> CIC Paris Est _Hôpital Pitié Salpêtrière Paris, France, 75651 Less <<
NCT00457808 Tuberous Sclerosis ... More >> Lymphangioleiomyomatosis Less << Phase 2 Completed - United States, Ohio ... More >> Cincinnati Childrens Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 Less <<
NCT03730428 - Active, not recruiting October 15, 2019 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Shanghai, Shanghai, China, 200032 Less <<
NCT02089334 Metastatic Renal Cell Cancer Phase 1 Phase 2 Terminated - United States, Arizona ... More >> Rexahn Site Tucson, Arizona, United States, 85719 United States, California Rexahn Site Duarte, California, United States, 91010 United States, New Mexico Rexahn Site Albuquerque, New Mexico, United States, 87106 United States, New York Rexahn Site Bronx, New York, United States, 10467 Rexahn Site New York, New York, United States, 10065 United States, Utah Rexahn Site Salt Lake City, Utah, United States, 84112 United States, Washington Rexahn Site Seattle, Washington, United States, 98101 Less <<
NCT01929642 Tuberous Sclerosis Complex ... More >> Self-injury Autism Less << Phase 2 Completed - United States, Maryland ... More >> Kennedy Krieger Institute Baltimore, Maryland, United States, 21205 Less <<
NCT02315625 Neuroendocrine Tumors ... More >> Neuroendocrine Carcinoma Neuroendocrine Neoplasms Carcinoma, Neuroendocrine Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas Less << Phase 2 Recruiting December 31, 2025 United States, Illinois ... More >> Rush University Medical Center Recruiting Chicago, Illinois, United States, 60612 Contact: Xavier Keutgen, MD    312-563-1557    xavier_keutgen@rush.edu    United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02334488 Chronic Kidney Disease Phase 3 Recruiting December 2020 France ... More >> Amiens University Hospital Recruiting Amiens, France, 80000 Contact: Pierre-François WESTEEL, MD          Angers University Hospital Recruiting Angers, France, 49100 Contact: Johnny SAYEGH, MD          Brest University Hospital Recruiting Brest, France, 29200 Contact: Yannick LE MEUR, MD, PhD          Caen University Hospital Recruiting Caen, France, 14033 Contact: Nicolas BOUVIER, MD          Clermont Ferrand University Hospital Recruiting Clermont Ferrand, France, 63000 Contact: Anne-Elisabeth HENG, MD          Limoges University Hospital Recruiting Limoges, France, 87000 Contact: Marie ESSIG, MD, PhD          Georges Pompidou European Hospital Recruiting Paris, France, 75015 Contact: Eric THERVET, MD, PhD          Necker Hospital Recruiting Paris, France, 75015 Contact: Dany ANGLICHEAU, MD, PhD          Poitiers University Hospital Recruiting Poitiers, France, 86000 Contact: Antoine THIERRY, MD          Reims University Hospital Recruiting Reims, France, 51000 Contact: Charlotte COLOSIO, MD          Rennes University Hospital Recruiting Rennes, France, 35000 Contact: Joseph RIVALAN, MD          Rouen University Hospital Recruiting Rouen, France, 76000 Contact: Isabelle ETIENNE, MD          Strasbourg University Hospital Recruiting Strasbourg, France, 67000 Contact: Sophie CAILLARD, MD          Tours University Hospital Recruiting Tours, France, 37000 Contact: Matthias BUCHLER, MD, PhD Less <<
NCT00420537 Kidney Dysfunction ... More >> Heart Transplantation Less << Phase 4 Terminated(A cluster of advers... More >>e events in everolimus arm was noted.) Less << - Italy ... More >> Policlinico S.Orsola-Malpighi Bologna, Italy, 40138 Less <<
NCT00915603 - Completed - -
NCT01706471 Planned Kidney Transplantation Phase 4 Completed - Korea, Republic of ... More >> Department of Surgery, Yonsei University College of Medicine, Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01061853 Oral Lichen Planus Phase 3 Terminated(Per protocol interm... More >>ediate analyses of 76 patients and enrollment difficulties.) Less << - France ... More >> University Hospital of REIMS Reims, Marne, France, F-51092 Hospital Avicenne-APHP Bobigny, France, 93009 University Hospital of Bordeaux-St.André Bordeaux, France, 33075 University Hospital of Lille Lille, France, 59037 University Hospital of Nice Nice, France, 06202 Hospital Saint Louis-APHP Paris, France, 75475 Hospital La Pitié-Salpêtrière APHP Paris, France, 75651 Hospital Tenon-APHP Paris, France, 75970 University hospital of Tours Tours, France, 37044 Less <<
NCT00915603 Metastatic Breast Cancer Phase 2 Completed - United States, California ... More >> Wilshire Oncology Medical Group LaVerne, California, United States, 91750 United States, Connecticut Eastern Connecticut Hematology Oncology Norwich, Connecticut, United States, 06360 United States, Florida Aventura Medical Center Aventura, Florida, United States, 33180 Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Maine Mercy Hospital Portland, Maine, United States, 04101 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Associates Bethesda, Maryland, United States, 20817 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 Mid Ohio Oncology/Hematology, Inc./ The Mark H. Zangmeister Center Columbus, Ohio, United States, 43219 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Texas Texas Oncology Dallas, Texas, United States, 75246 United States, Virginia Fairfax Northern Virginia Hem-Onc Fairfax, Virginia, United States, 22031 Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT03399994 Coronary Artery Disease ... More >> Diabetes Less << Not Applicable Recruiting January 2020 Italy ... More >> Ospedale Bolognini Not yet recruiting Seriate, Bergamo, Italy, 24068 Contact: Maurizio Tespili, MD    0353063319    tespili@katamail.com    Principal Investigator: Maurizio Tespili, MD          Ospedale San Raffaele Recruiting Miano, Milano, Italy, 20132 Contact: Azeem Latib, MD    0226437331    alatib@gmail.com    Principal Investigator: Azeem Latib, MD          Ospedale Humanitas Recruiting Rozzano, Milano, Italy, 20089 Contact: Bernhard Reimers, MD    0282247384    bernhard.reimers@humanitas.it    Principal Investigator: Bernhard Reimers, MD          Policlinico San Donato Recruiting San Donato Milanese, Milano, Italy, 20097 Contact: Luca Testa, MD    0252774987    luctes@gmail.com    Principal Investigator: Luca Testa, MD          Ospedale Sant'Anna Not yet recruiting Catanzaro, Italy, 88100 Contact: Bindo Missiroli, MD    09615070254    bindo.missiroli@virgilio.it    Principal Investigator: Bindo Missiroli, MD          Policlinico S. Matteo Not yet recruiting Pavia, Italy, 27100 Contact: Maurizio Ferrario, MD    0382501598    m.ferrario@smatteo.pv.it    Principal Investigator: Maurizio Ferrario, MD          Ospedale San Pietro, Fatebenefratelli Not yet recruiting Roma, Italy, 00189 Contact: Francesco Monti, MD    0633582119    montifrancesco@yahoo.it    Principal Investigator: Francesco Monti, MD          Ospedale Santa Chiara Not yet recruiting Trento, Italy, 38122 Contact: Simone Muraglia, MD    0461903892    simone.muraglia@apss.tn.it    Principal Investigator: Simone Muraglia, MD Less <<
NCT00533442 - Completed - -
NCT00170846 Renal Transplantation Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00170846 - Completed - -
NCT00337545 Colorectal Cancer Phase 2 Completed - United States, Washington ... More >> Swedish Cancer Institute Seattle, Washington, United States, 98104 Less <<
NCT00533442 Type 1 Diabetes Phase 2 Completed - United States, Florida ... More >> University of Miami, Miller School of Medicine Miami, Florida, United States, 33136 Less <<
NCT02831205 Percutaneous Transluminal Coro... More >>nary Angioplasty Less << Phase 4 Terminated(Due to current BVS ... More >>safety issue) Less << - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT03440801 STEMI - ST Elevation Myocardia... More >>l Infarction Less << Not Applicable Recruiting January 3, 2022 Japan ... More >> Tokorozawa Heart Center Recruiting Tokorozawa, Japan, 3591142 Contact: Masanori Taniwaki, MD    +81(0)4-2940-8611    grand_wagoneer_797@hotmail.com Less <<
NCT00510354 Progressive Gastrointestinal S... More >>tromal Tumor Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Frankfurt/M, Germany, 60590 Novartis Investigative Site Frankfurt, Germany, 60488 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Tübingen, Germany, 72076 Less <<
NCT01811667 Cardiovascular Abnormalities Phase 3 Completed - Belgium ... More >> Cliniques universitaires Saint-Luc Brussels, Belgium, 1200 Less <<
NCT00350454 Coronary Heart Disease Phase 4 Completed - Germany ... More >> 1. Medizinische Klinik, Klinikum rechts der Isar Muenchen, Germany, 81675 Deutsches Herzzentrum Muenchen Munich, Germany, 80636 Less <<
NCT01510509 Diabetes Mellitus ... More >> Percutaneous Coronary Intervention Less << Phase 4 Unknown - Finland ... More >> Heart Center, Satakunta Hospital, Pori, Finland Satakunta, Pori, Finland, 28500 Spain Hospital de Torrevieja Torrevieja, Alicante, Spain, 03180 Hospital Puerto Real de Cádiz Puerto Real, Cadiz, Spain, 11510 Hospital Universitario Puerta de Hierro Majadahonda Majadahonda, Madrid, Spain, 28222 Hospital Universitario Infanta Cristina Badajoz, Spain, 06006 Hospital Juan Ramón Jiménez de Huelva Huelva, Spain, 21005 Hospital Virgen de la Salud de Toledo Toledo, Spain, 45004 Hospital General Universitario de Valencia Valencia, Spain, 46014 Less <<
NCT00255788 Breast Cancer Phase 2 Completed - Canada, British Columbia ... More >> British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 Fraser Valley Cancer Centre at British Columbia Cancer Agency Surrey, British Columbia, Canada, V3V 1Z2 British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Toronto Sunnybrook Regional Cancer Centre at Sunnybrook and Women's College Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT00631228 - Completed - India ... More >> CARE Hospital Hyderabaad, Andhra Pradesh, India, 500034 Krishna Heart Institute, Hyderabad, Andhra Pradesh, India, 5000003 Krishna Heart Institute Ahmedabad, Gujarat, India, 380 006 Dayanand Medical College & Hospital Ludhiana, Punjab, India, 141001 Christian Medical Center (CMC) Vellore, Tamilnadu, India, 632004 SAL Hospital And Medical Institute Ahmedabad, India, 380054 Escorts Heart & Superspeciality Institute Ltd. Amritsar, India Madras Medical Mission Chennai, India, 600 037 Lisie Heart Institute,Lisie Hosp. Cochin, India Apollo Hospital Hyderabad, India, 500033 Heart & General Hospital Jaipur, India Holy Family Hospital Mumbai, India, 400050 Escorts Heart Institute & Research Centre New Delhi, India, 110 070 Fortis Hospital New Delhi, India, 110 070 Max Devki Devi Heart & Vascular Institute New Delhi, India, 110017 Escorts Heart Institute & Research Centre New Delhi, India, 110025 Jehangir Hospital Pune, India, 411001 Poona Hospital And Research Centre Pune, India, 411030 Less <<
NCT00727207 Lymphoma Phase 2 Terminated(Lack of participati... More >>ons (8 of 25)) Less << September 2014 Germany ... More >> Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Less <<
NCT02632292 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Phase 4 Terminated(Slow enrollment) January 2019 Germany ... More >> University of Luebeck Luebeck, Germany, 23538 Less <<
NCT01680861 - Completed - -
NCT01239472 Transplantation, Homologous ... More >> Immunosuppression Less << Phase 4 Unknown November 2013 Brazil ... More >> Santa Casa de Misericórdia de Belo Horizonte Recruiting Belo Horizonte, Minas Gerais, Brazil, 30150221 Principal Investigator: Andre B Pereira, PhD          Sub-Investigator: Pedro Augusto M Souza, MD          Sub-Investigator: Milton C Soares, MD          Sub-Investigator: Gustavo MC Silva, MD          Sub-Investigator: Cláudia Ribeiro, PhD Less <<
NCT01313390 Head and Neck Cancer Phase 1 Phase 2 Terminated(Lack of recruitment... More >>) Less << - United Kingdom ... More >> UCL Cancer Institute London, England, United Kingdom, WC1E 6DD Less <<
NCT00978432 Diffuse Large B-cell Lymphoma Phase 2 Terminated(The toxicity seemed... More >> to outweigh the benefit.) Less << - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00978432 - Terminated(The toxicity seemed... More >> to outweigh the benefit.) Less << - -
NCT00697372 Coronary Artery Disease ... More >> Coronary Stenosis Less << Phase 4 Completed - Italy ... More >> Institute of Cardiology - Catholic University of Sacred Heart Rome, Italy, 00168 Less <<
NCT01096199 Cancer Phase 1 Terminated - Singapore ... More >> National University Hospital Singapore, Singapore, 119074 Less <<
NCT01680861 Transplant; Failure, Kidney Phase 3 Completed - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 Less <<
NCT03139747 Thyroid Cancer Phase 2 Recruiting April 3, 2020 United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Marcia Brose, MD, PhD    855-216-0098    PennCancerTrials@emergingmed.com Less <<
NCT00886691 - Active, not recruiting - -
NCT02014753 - Unknown June 2016 Japan ... More >> Iwate Medical University Hospital Morioka, Japan, 020-8505 Less <<
NCT00886691 Recurrent Fallopian Tube Carci... More >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Less << Phase 2 Active, not recruiting - -
NCT02739685 Coronary Artery Disease Phase 4 Terminated(Slow enrollment, ac... More >>cess to devices) Less << May 2021 Germany ... More >> University of Luebeck Luebeck, Germany, 23538 Less <<
NCT03049189 Neuroendocrine Tumors Phase 3 Recruiting May 2021 Australia, New South Wales ... More >> Royal North Shore Hospital Recruiting Saint Leonards, New South Wales, Australia, 2065 Australia, Victoria Olivia Newton-John Cancer & Wellness Centre, Austin Hospital Recruiting Heidelberg, Victoria, Australia, 3084 Peter MacCallum Cancer Centre Recruiting Melbourne, Victoria, Australia, 3000 Austria Allgemeines Krankenhaus Wien Recruiting Wien, Austria, 1090 France Hospices civils de Lyon Not yet recruiting Bron, France, 69677 HP Hôpital Beaujon Recruiting Clichy, France, 92110 Institut de Recherche en Cancérologie de Montpellier (IRCM) Recruiting Montpellier, France, 34298 CHU de Nantes - Hôtel Dieu Recruiting Nantes, France, 44093 Germany Zentralklinik Bad Berka GmbH Recruiting Bad Berka, Germany, 99437 Charité - Universitätsmedizin Berlin Recruiting Berlin, Germany, 10117 Universitätsklinikum Bonn Recruiting Bonn, Germany, 53127 Universitätsklinikum Erlangen Recruiting Erlangen, Germany, 91054 Universitätsklinikum des Saarlandes Recruiting Homburg, Germany, 66421 Philipps Universität Marburg Recruiting Marburg, Germany, 35043 LMU - Klinikum der Universität München, Campus Großhadern Not yet recruiting Munich, Germany, 81377 Universitätsklinikum Würzburg Recruiting Wurzburg, Germany, 97080 Italy Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl Recruiting Meldola, Italy, 47014 European Institute of Oncology (EIO) Recruiting Milano, Italy, 20141 Netherlands Academic Medical Center, University of Amsterdam Recruiting Amsterdam, Netherlands, 1100DD Poland MSC Memorial Cancer Centre Not yet recruiting Gliwice, Poland, 44-100 Jagiellonian University Not yet recruiting Krakow, Poland, 31-501 South Africa University of Pretoria & Steve Biko Academic Hospital Recruiting Pretoria, South Africa, 0001 Switzerland Universitätsspital Basel Recruiting Basel, Switzerland, 4031 Inselspital, Universitätsspital Bern Recruiting Bern, Switzerland, 3010 United Kingdom Clatterbridge Cancer Centre NHS Foundation Trust Not yet recruiting Liverpool, United Kingdom, L7 8XP Royal Free NHS Foundation Trust Recruiting London, United Kingdom, NW3 2QG Less <<
NCT00610948 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT02536625 - Active, not recruiting May 2019 France ... More >> Centre Leon Berard Lyon, France, 69008 Centre Hospitalier Lyon Sud Pierre-Bénite, France, 69495 Less <<
NCT01186120 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Soonchunhyang University Hospital, Buchen Bucheon, Korea, Republic of Soonchunhyang University Cheonan Hospital Cheonan, Korea, Republic of Kangwon National University Hospital Chooncheon, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of Kyungpook National University Hospital Daegu, Korea, Republic of NHIC Ilsan Hospital Ilsan, Korea, Republic of Dong-A University Medical Center Pusan, Korea, Republic of Inje University Pusan Paik Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Catholic University, Kangnam St. Mary's Hospital Seoul, Korea, Republic of Less <<
NCT00170885 Kidney Transplantation Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT03190174 Undifferentiated Pleomorphic S... More >>arcoma Liposarcoma Chondrosarcoma Osteosarcoma Ewing Sarcoma Less << Phase 1 Phase 2 Recruiting April 1, 2020 United States, California ... More >> Sarcoma Oncology Research Center Recruiting Santa Monica, California, United States, 90403 Contact: Erlinda M Gordon, MD    310-552-9999    egordon@sarcomaoncology.com    Contact: Victoria Chua-Alcala    310-552-9999    vchua@sarcomaoncology.com    Principal Investigator: Erlinda M Gordon, MD          Sub-Investigator: Sant P Chawla, MD          Sub-Investigator: Kamalesh K Sankhala, MD          Sub-Investigator: Doris Quon, MD Less <<
NCT01389427 Mantle Cell Lymphoma Refractor... More >>y Less << Phase 1 Phase 2 Completed - France ... More >> CHU de Grenoble MICHALLON Grenoble Cedex 9, Hôpital Nord 217, France, 38043 Hôtel Dieu - Université de Nantes Nantes cedex, Place Alexis Ricordeau, France, 44093 Hôpital Henri Mondor Creteil, France, 94010 CHU de Dijon Dijon, France, 21000 Hôpital Saint-Eloi Montpellier, France, 34295 Hôpital Saint Louis Paris, France, 75475 Hôpital Necker Paris, France, 75743 Groupe hospitalier Sud Hôpital Haut-Lévêque Pessac, France, 33604 Centre Hospitalier Lyon Sud Pierre Benite, France, 69310 CHU Pontchaillou Rennes, France, 35003 CHU de Tours - Hôpital Bretonneau Tours, France, 37000 Less <<
NCT01028092 Renal Transplant Phase 3 Completed - France ... More >> CHU Amiens Amiens, France CHU Pellegrin - Bordeaux Bordeaux, France CHRU de BREST Brest, France, 29609 CHU Cote de Nacre Caen, France CHU Clermont Ferrand Clermont Ferrand, France CHU Dijon Dijon, France CHU Lille Lille, France CHU Limoges Limoges, France CHU Montpellier Montpellier, France CHU Nice Nice, France AP-HP Hopital Necker Paris, France CHU Poitiers Poitiers, France CHU Reims Reims, France CHU Rennes Rennes, France CHU Rouen Rouen, France Hopitaux Universitaires de Strasbourg Strasbourg, France CHU Rangueil - Toulouse Toulouse, France CHU Tours Tours, France Less <<
NCT01338090 - Completed - Netherlands ... More >> University Medical Center Groningen Groningen, Netherlands, 9713 GZ Less <<
NCT00475566 Atherosclerosis ... More >> Peripheral Vascular Disease Less << Not Applicable Completed - Austria ... More >> Landeskrankenhaus Klagenfurt Klagenfurt, Austria, 9020 Allgemeines Krankenhaus der Stadt Wien- AKH Wien Wien, Austria, 1090 Belgium Sint Blasius Hospital Dendermonde, Belgium ZOL St. Jan Gent, Belgium, 3600 University Hospital Gent, Belgium, 9000 Germany Herzzentrum Bad Krozingen Bad Krozingen, Germany, 79189 The Jewish Hospital Berlin Berlin, Germany, 13347 Herzzentrum Leipzig Leipzig, Germany, 04289 University Hospital Tübingen Tübingen, Germany, 72076 Italy Casa di Cura di Montevergine Mercogliano, Italy, 83013 Less <<
NCT01118065 Head and Neck Cancer Phase 2 Unknown - Netherlands ... More >> Leiden University Medical Center Recruiting Leiden, Netherlands, 2300 RC Contact: Contact Person    31-71-526-3486    h.w.kapiteijn@lumc.nl Less <<
NCT01544491 Prevention of Acute Rejection ... More >>in Paediatric Recipients of a Renal Transplant Less << Phase 3 Completed - -
NCT00674414 Breast Cancer Phase 2 Terminated(IDMC decision due t... More >>o accrual issue (82 pts accrued / 120 expected)) Less << - France ... More >> Centre Oscar Lambret Lille, France, 59020 Centre Leon Berard Lyon, France, 69373 Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Institut Curie Hopital Paris, France, 75248 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00909831 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT01266148 - Completed - -
NCT02811861 Renal Cell Carcinoma Phase 3 Recruiting February 2021 -
NCT00371826 Renal Transplanted Recipients Phase 4 Completed - Australia ... More >> Royal Prince Alfred Hospital NSW, Australia Westmead Hospital NSW, Australia Princess Alexandra Hospital QLD, Australia Monash Medical Centre Sale, Australia Queen Elizabeth Hospital Sale, Australia Royal Melbourne Hospital VIC, Australia Sir Charles Gairdner Hospital WA, Australia Less <<
NCT01582009 - Terminated(pts off study, PI l... More >>eft institute) Less << - -
NCT00170859 Heart Transplantation Phase 4 Completed - Germany ... More >> Novartis Investigational Site Various Cities, Germany Less <<
NCT00930475 Breast Cancer Phase 1 Phase 2 Unknown - Germany ... More >> Charité, university medicine, Berlin, CCM Recruiting Berlin, Germany, 10177 Principal Investigator: Jan Eucker, Dr. med. Less <<
NCT00371826 - Completed - -
NCT01582009 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 1 Phase 2 Terminated(pts off study, PI l... More >>eft institute) Less << - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT00402662 Metastatic Melanoma Phase 2 Terminated(unexpected level of... More >> toxicity) Less << - United States, Connecticut ... More >> Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06520-8028 Less <<
NCT03413722 - Recruiting November 1, 2019 United States, Kansas ... More >> University of Kansas Medical Center Recruiting Kansas City, Kansas, United States, 66160 Less <<
NCT00901849 Low-grade Gliomas Phase 1 Completed - United States, District of Col... More >>umbia Children's Research Institute Washington, District of Columbia, United States, 20010 Less <<
NCT01249027 - Unknown January 2017 United States, California ... More >> Abbott Vascular Santa Clara, California, United States, 95054 Less <<
NCT02432560 - Recruiting April 2020 -
NCT01266148 Renal Function and Chronic All... More >>ograft Vasculopathy Less << Phase 4 Completed - Denmark ... More >> Novartis Investigative Site Copenhagen, Denmark, DK-2100 Novartis Investigative Site Århus N, Denmark, DK-8200 Norway Novartis Investigative Site Oslo, Norway, 0424 Sweden Novartis Investigative Site Göteborg, Sweden, 413 45 Novartis Investigative Site Linkoping, Sweden, 581 85 Novartis Investigative Site Lund, Sweden, 221 85 Less <<
NCT00869999 - Completed - -
NCT01239953 In-Stent Restenosis Phase 4 Unknown - Spain ... More >> Hospital Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Hospital Universitario Marques de Valdecilla Santander, Cantabria, Spain, 39008 Hospital Universitari Son Dureta Palma de Mallorca, Illes Balears, Spain, 07014 Hospital Universitario Puerta de Hierro Majadahonda Majadahonda, Madrid, Spain, 28222 Hospital Provincial de Navarra Pamplona, Navarra, Spain, 31008 Complejo Hospitalario Universitario de Vigo Vigo, Pontevedra, Spain, 36204 Complejo Hospitalario Universitario A Coruña A Coruña, Spain, 15006 Hospital General Universitario de Alicante Alicante, Spain, 03010 Complejo Hospitalario de Torrecardenas Almeria, Spain, 04009 Hospital Universitario Infanta Cristina Badajoz, Spain, 06080 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Clinic de Barcelona Barcelona, Spain, 08036 Hospital Universitario Virgen de las Nieves Granada, Spain, 18014 Hospital Universitario de La Princesa Madrid, Spain, 28006 Hospital Clinico San Carlos Madrid, Spain, 28040 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Universitario Carlos Haya Malaga, Spain, 29010 Hospital Universitario Virgen de la Victoria Malaga, Spain, 29010 Complejo Hospitalario de Toledo Toledo, Spain, 45004 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Hospital General Universitario de Valencia Valencia, Spain, 46014 Hospital Universitario Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT00180310 Coronary Disease ... More >> Coronary Artery Disease Coronary Restenosis Less << Phase 3 Completed - -
NCT01239940 In-stent Restenosis Phase 4 Unknown - Spain ... More >> Hospital Central de Asturias Recruiting Oviedo, Asturias, Spain, 33006 Contact: Raquel del Valle, MD    0034985106112       Principal Investigator: Raquel del Valle, MD          Hospital Universitari de Bellvitge Recruiting L´Hospitalet de Llobregat, Barcelona, Spain, 08907 Contact: Angel Cequier, MD    0034932607539       Principal Investigator: Angel Cequier, MD          Hospital Universitario Marqués de Valdecilla Recruiting Santander, Cantabria, Spain, 39008 Contact: Javier Zueco, MD    0034942202744       Principal Investigator: Javier Zueco, MD          Hospital Universitari Son Dureta Recruiting Palma de Mallorca, Illes Balears, Spain, 07014 Contact: Armando Bethencourt, MD    0034971175476       Principal Investigator: Armando Bethencourt, MD          Hospital Universitario Puerta de Hierro Majadahonda Recruiting Majadahonda, Madrid, Spain, 28222 Contact: Javier Goicolea, MD    0034911917408       Principal Investigator: Javier Goicolea, MD          Hospital Provincial de Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: Roman Lezaun, MD    0034848422345       Principal Investigator: Roman Lezaun, MD          Complejo Hospitalario Universitario de Vigo Recruiting Vigo, Pontevedra, Spain, 36200 Contact: Andres Iñiguez, MD    0034986811163       Principal Investigator: Andres Iñiguez, MD          Complejo Hospitalario Universitario A Coruña Recruiting A Coruña, Spain, 15006 Contact: Nicolas Vazquez, MD    0034981178031       Principal Investigator: Nicolas Vazquez, MD          Hospital General Universitario de Alicante Recruiting Alicante, Spain, 03010 Contact: Vicente Mainar, MD    0034965938561       Principal Investigator: Vicente Mainar, MD          Complejo Hospitalario de Torrecardenas Recruiting Almeria, Spain, 04009 Contact: Rosa Lazaro, MD,    +34950016989       Principal Investigator: Rosa Lazaro, MD          Hospital Universitario Infanta Cristina Recruiting Badajoz, Spain, 06080 Contact: Jose R Lopez-Minguez, MD    0034924218125       Principal Investigator: Jose R Lopez-Minguez, MD          Hospital de la Santa Creu i Sant Pau Recruiting Barcelona, Spain, 08025 Contact: Vicens Marti, MD    0034935565851       Principal Investigator: Vicens Marti, MD          Hospital Universitari Vall d´Hebron Recruiting Barcelona, Spain, 08035 Contact: Joan Angel, MD    0034934893000       Principal Investigator: Joan Angel, MD          Hospital Clinic de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Monica Masotti, MD    0034932275519       Principal Investigator: Monica Masotti, MD          Hospital Universitario Virgen de las Nieves Recruiting Granada, Spain, 18014 Contact: Rafael Melgares, MD    0034958020564       Principal Investigator: Rafael Melgares, MD          Hospital Universitario de La Princesa Recruiting Madrid, Spain, 28006 Contact: Bernhard Seidelberger, MD    0034915202200       Principal Investigator: Bernhard Seidelberger, MD          Hospital Clínico San Carlos Recruiting Madrid, Spain, 28040 Contact: Fernnado Alfonso, MD    0034913303289    falf@hotmail.com    Principal Investigator: Fernando Alfonso, MD, PhD          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Maria T Velazquez, MD    0034913908440       Principal Investigator: Maria T Velazquez, MD          Hospital Universitario La Paz Recruiting Madrid, Spain, 28046 Contact: Raul Moreno, MD    0034917277000       Principal Investigator: Raul Moreno, MD          Hospital Universitario Carlos Haya Recruiting Malaga, Spain, 29010 Contact: Cristobal Urbano, MD    0034951290000       Principal Investigator: Cristobal Urbano, MD          Hospital Universitario Virgen de la Victoria Recruiting Malaga, Spain, 29010 Contact: Jose M Hernandez, MD    0034951032000       Principal Investigator: Jose M Hernandez, MD          Complejo Hospitalario de Toledo Recruiting Toledo, Spain, 45004 Contact: Jose Moreu, MD    +34925269188       Principal Investigator: Jose Moreu, MD          Hospital Clinico Universitario de Valencia Recruiting Valencia, Spain, 46010 Contact: Vicent Bodi, MD    0034963862658       Principal Investigator: Vicent Bodi, MD          Hospital General Universitario de Valencia Recruiting Valencia, Spain, 46014 Contact: Francisco Pomar, MD    0034961972000       Principal Investigator: Francisco Pomar, MD          Hospital Universitario Miguel Servet Recruiting Zaragoza, Spain, 50009 Contact: Maria Cruz Ferrer, MD, PhD    +34976562565       Principal Investigator: Maria Cruz Ferrer, MD, PhD Less <<
NCT01626222 Metastatic Breast Cancer Phase 3 Completed - -
NCT00869999 Diffuse Large B-cell Lymphoma Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconsess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00634920 Renal Function Phase 4 Completed - Denmark ... More >> Novartis Investigative Site Aarhus N, Denmark, 8200 Novartis Investigative Site Copenhagen, Denmark, DK-2100 Novartis Investigative Site Herlev, Denmark, 2730 Novartis Investigative Site Odense C, Denmark, DK-5000 Norway Novartis Investigative Site Oslo, Norway, 0424 Sweden Novartis Investigative Site Goteborg, Sweden, 413 45 Novartis Investigative Site Malmo, Sweden, 205 02 Novartis Investigative Site Uppsala, Sweden, 751 85 Less <<
NCT00387400 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Nova Scotia QEII Health Sciences Center Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Less <<
NCT00700258 - Recruiting December 1, 2023 -
NCT00634920 - Completed - -
NCT02646319 Advanced Malignant Neoplasm ... More >> Cervical Squamous Cell Carcinoma Endometrial Carcinoma Malignant Uterine Neoplasm Recurrent Bladder Carcinoma Recurrent Breast Carcinoma Recurrent Cervical Carcinoma Recurrent Head and Neck Carcinoma Recurrent Malignant Neoplasm Recurrent Ovarian Carcinoma Recurrent Prostate Carcinoma Recurrent Renal Cell Carcinoma Solid Neoplasm Stage III Bladder Cancer Stage III Prostate Cancer Stage III Renal Cell Cancer Stage IIIA Breast Cancer Stage IIIA Cervical Cancer Stage IIIA Ovarian Cancer Stage IIIB Breast Cancer Stage IIIB Cervical Cancer Stage IIIB Ovarian Cancer Stage IIIC Breast Cancer Stage IIIC Ovarian Cancer Stage IV Breast Cancer Stage IV Ovarian Cancer Stage IV Prostate Cancer Stage IV Renal Cell Cancer Stage IVA Bladder Cancer Stage IVA Cervical Cancer Stage IVB Bladder Cancer Stage IVB Cervical Cancer Less << Early Phase 1 Active, not recruiting May 2019 United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00936702 Carcinoma of Unknown Primary O... More >>rigin Less << Phase 2 Completed - -
NCT01443104 Coronary Artery Disease ... More >> Angina Pectoris Myocardial Infarction Less << Not Applicable Completed - Switzerland ... More >> Kantonsspital Aarau Aarau, Switzerland, 5000 Universitätsklinik Basel Basel, Switzerland, 4031 Department of Cardiology, Bern University Hospital Bern, Switzerland, 3010 HFR Freiburg Freiburg, Switzerland, 1708 Hôpitaux Universitaires de Genève Genève, Switzerland, 1211 Service de cardiologie CHUV Lausanne, Switzerland, 1010 Luzerner Kantonsspital Luzern, Switzerland, 6004 Kantonsspital St. Gallen St. Gallen, Switzerland, 9007 Stadtspital Triemli Zürich, Switzerland, 8055 Less <<
NCT00861874 Acute Myeloid Leukemia Phase 1 Completed - United States, New York ... More >> University of Rochester Rochester, New York, United States, 14642 Less <<
NCT01354301 Cytomegalovirus Infection ... More >> Renal Transplant Failure Transplant; Complication, Rejection Less << Phase 4 Completed - Brazil ... More >> Hospital do rim e Hipertensao Sao Paulo, Brazil, 04038-002 Less <<
NCT02520180 Coronary Artery Disease Phase 4 Recruiting June 2022 Denmark ... More >> Rigshospitalet Recruiting Copenhagen, Denmark Contact: Lene Holmvang, MD       Lene.Holmvang@regionh.dk    Principal Investigator: Lene Holmvang, MD Less <<
NCT00598533 Coronary Heart Disease Phase 4 Completed - Germany ... More >> Medizinische Klinik, Klinikum rechts der Isar Muenchen, Germany, 81675 Deutsches Herzzentrum Muenchen Munich, Germany, 80636 Less <<
NCT00936702 - Completed - -
NCT01677390 Renal Cell Carcinoma Phase 1 Terminated - United States, California ... More >> Stanford Cancer Center Stanford, California, United States, 94305 United States, Colorado Rocky Mountain Cancer Centers - Midtown Denver, Colorado, United States, 80218 United States, Michigan Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina UNC Lineberger Comprehensive Cancer Center / University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Rhode Island Miriam Hospital, The Providence, Rhode Island, United States, 02906 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Washington Seattle Cancer Care Alliance / University of Washington Seattle, Washington, United States, 98109-1023 Less <<
NCT01653847 End Stage Renal Failure With R... More >>enal Transplant Less << Not Applicable Active, not recruiting June 2020 United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Less <<
NCT00985374 Neoplasms Phase 1 Terminated - United States, New York ... More >> New York, New York, United States, 10017 United States, Texas San Antonio, Texas, United States, 98229 Italy Milano, Lombardia, Italy, 20133 Less <<
NCT00800722 Port Wine Stain Phase 1 Completed - United States, California ... More >> Beckman Laser Institute Medical clinic Irvine, California, United States, 92612 Less <<
NCT02269670 Estrogen Receptor-positive Bre... More >>ast Cancer HER2-negative Breast Cancer Progesterone Receptor-positive Breast Cancer Recurrent Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Less << Phase 2 Active, not recruiting October 2020 United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 Emory Saint Joseph's Hospital Atlanta, Georgia, United States, 30342 Less <<
NCT00150046 Heart Transplantation Phase 3 Completed - Germany ... More >> Novartis Investigational Site Germany, Germany Switzerland Basel Novartis Pharma AG Basel, Switzerland Less <<
NCT00680758 Breast Cancer Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Sarah Cannon Cancer Center at Centennial Medical Center Nashville, Tennessee, United States, 37203 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT01150097 Liver Transplant Recipient Phase 3 Completed - -
NCT00170794 Cardiac Transplantation Phase 3 Completed - -
NCT00022464 Melanoma (Skin) Phase 2 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-0269 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089 City of Hope Medical Group Pasadena, California, United States, 91105 University of California Davis Cancer Center Sacramento, California, United States, 95817 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Louis A. Weiss Memorial Hospital Chicago, Illinois, United States, 60640 Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States, 62526 Evanston Northwestern Health Care - Evanston Hospital Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 LaGrange Memorial Hospital LaGrange, Illinois, United States, 60525 Loyola University Medical Center Maywood, Illinois, United States, 60153 Oncology/Hematology Associates of Central Illinois, P.C. Peoria, Illinois, United States, 61602 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62701 United States, Indiana Fort Wayne Medical Oncology and Hematology, Incorporated Fort Wayne, Indiana, United States, 46885-5099 CCOP - Northern Indiana CR Consortium South Bend, Indiana, United States, 46601 United States, New York North Shore University Hospital Manhasset, New York, United States, 11030 Weill Medical College of Cornell University New York, New York, United States, 10021 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Canada, Ontario Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01090466 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 1 Phase 2 Completed - United Kingdom ... More >> Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Less <<
NCT01136733 Metastatic Renal Cell Carcinom... More >>a Less << Phase 1 Phase 2 Unknown May 2017 -
NCT00276575 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT02377648 Cardiac Allograft Vasculopathy Phase 4 Active, not recruiting December 2020 Italy ... More >> Azienda Ospedaliera Brotzu Cagliari, Italy Azienda Ospedaliera Specialistica Dei Colli Naples, Italy Azienda Ospedaliera Di Padova Padua, Italy Fondazione Irccs Policlinico San Matteo Pavia, Italy Azienda Ospedaliera San Camillo Forlanini Rome, Italy European Hospital Rome, Italy Azienda Sanitaria Universitaria Integrata Di Udine (Asuiud) Udine, Italy, 33100 Azienda Ospedaliera Universitaria Integrata Verona Verona, Italy, 37126 Netherlands Cardialysis Core Laboratory For Imaging Rotterdam, Netherlands Thoraxcenter, Universtity of Rotterdam Rotterdam, Netherlands Less <<
NCT00325325 Kidney Diseases Phase 2 Unknown - Spain ... More >> Hospital Ramón y Cajal Recruiting Madrid, Spain, 28034 Principal Investigator: Julio Pascual, MD Less <<
NCT00022724 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0942 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-6220 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00892801 Lung Cancer M... More >>etastatic Cancer Less << Phase 1 Terminated(Terminated due to l... More >>ow accrual. Study was closed to accrual prematurely and did not continue on to Phase II.) Less << - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT01520103 Her2-negative Metastatic Breas... More >>t Cancer Her2-negative Locally Advanced Breast Cancer Less << Phase 2 Completed - Germany ... More >> Hämatologisch-onkologische Gemeinschaftspraxis, Münster Münster, Germany, 48149 Less <<
NCT01150097 - Completed - -
NCT01233453 Coronary Artery Disease Phase 4 Unknown December 2015 Greece ... More >> Onassis cardiac Surgery Centre Athens, Greece Netherlands Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands Amphia Ziekenhuis Breda, Netherlands Medisch Centrum Leeuwarden Leeuwarden, Netherlands Maasstad Hospital Rotterdam, Netherlands Spain Hospital del Mar Barcelona, Spain Complejo Hospitalario Universitario Juan Canalejo Coruña, Spain Hospital Universitario Virgen Arrixaca Murcia, Spain Hospital Clinico universitario de Santiago de Compostella Santiago de Compostella, Spain Switzerland Kantonsspital Aarau Aarau, Switzerland Hopital Cantonal de Fribourg Fribourg, Switzerland Less <<
NCT00093639 Leukemia Phase 1 Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT02093845 Coronary Artery Disease ... More >> Ischemic Heart Disease Less << Not Applicable Active, not recruiting December 31, 2020 Denmark ... More >> Aarhus University Hospital Skejby, Aarhus N, Denmark, 8200 Aarhus University Hospital Aalborg Aalborg, Denmark, 9000 Odense University Hospital Odense, Denmark, 5000 Less <<
NCT00152308 Coronary Disease Phase 4 Unknown - Austria ... More >> St. Johanns Spital Recruiting Salzburg, Austria, 5020 Contact: Mathias Heigert, MD       M.heigert@salk.at    Principal Investigator: Mathias Heigert, MD          Donauspital der Stadt Wien Recruiting Vienna, Austria, 1020 Contact: Georg Norman, MD    +43 1 28802       Principal Investigator: Georg Norman, MD          Allgemeines Krankenhaus Wien Recruiting Vienna, Austria, 1090 Contact: Dietmar Glogar, MD       helmut-dietmar.glogar@univie.ac.at    Principal Investigator: Dietmar Glogar, MD          Wilhelminenspital der Stadt Wien Recruiting Vienna, Austria, 1160 Contact: Kurt Huber, MD    +43 1 49150 0    kurt.huber@meduniwien.ac.at    Principal Investigator: Kurt Huber, MD          Germany Deutsches Herzzentrum Muenchen Recruiting Munich, Germany, 80636 Contact: Adnan Kastrati, MD    +49 89 1218 4577    kastrati@dhm.mhn.de    Principal Investigator: Adnan Kastrati, MD          Kardiologische Praxis und Praxisklinik Recruiting Munich, Germany, 81379 Contact: Sigmund Silber, MD    +49 89 742 15130    sigmund@silber.com    Principal Investigator: Sigmund Silber, MD          First Medizinische Klinik rechts der Isar Recruiting Munich, Germany, 81675 Contact: Josef , Dirschinger    +49 89 4140 2947    dirschinger@med1.med.tu-muenchen.de    Principal Investigator: Josef Dirschinger, MD          Israel Hadassah University Hospital Recruiting Jerusalem, Israel, 91120 Contact: Chaim Lotan, MD       Lotan@hadassah.org.il    Principal Investigator: Chaim Lotan, MD          Sourasky Medical Center Recruiting Tel Aviv, Israel, 64239 Contact: Hylton Miller, MD       himiller@tasmc.health.gov.il    Principal Investigator: Hylton Miller, MD          Assaf Harofeh Medical Center Recruiting Zrifin, Israel, 70300 Contact: Ricardo Krakover, MD    +972 08 9779738       Principal Investigator: Ricardo Krakover, MD Less <<
NCT01023542 Renal Impairment ... More >> Liver Transplantation Everolimus Less << Phase 2 Phase 3 Unknown December 2014 Germany ... More >> Regensburg University Hospital Recruiting Regensburg, Bavaria, Germany, 93053 Contact: Andreas A Schnitzbauer, MD    +49-941944 ext 6770    andreas.schnitzbauer@klinik.uni-r.de Less <<
NCT01981304 - Unknown December 2016 -
NCT02216786 Estrogen Receptor Positive Bre... More >>ast Cancer Less << Phase 2 Active, not recruiting June 2019 -
NCT01425281 Coronary Artery Disease Not Applicable Unknown July 2018 Belgium ... More >> Abbott Vascular International BVBA Brussels, Belgium, 0886.537.933 Less <<
NCT03103893 Dermal Atrophy Phase 1 Phase 2 Recruiting June 30, 2019 United States, Pennsylvania ... More >> Drexel Dermatology Recruiting Philadelphia, Pennsylvania, United States, 19102-1101 Contact: Christina Chung, MD    215-762-5546    christina.chung@drexelmed.edu    Contact: Christian Sell    2157628367    cs389@drexel.edu    Sub-Investigator: Ibyonu Lawrence, MD Less <<
NCT03732248 Alcohol Use Disorder ... More >> Alcohol Dependence Less << Phase 1 Recruiting June 2019 United States, South Carolina ... More >> Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Michael Saladin, PhD Less <<
NCT01674140 Breast Cancer Phase 3 Recruiting January 2030 -
NCT00346918 Autosomal Dominant Polycystic ... More >>Kidney Disease (ADPKD) Less << Phase 3 Completed - Switzerland ... More >> University Hospital Zurich, Switzerland, 8091 Less <<
NCT01435031 Coronary Artery Disease (CAD) ... More >> Chronic Total Occlusion (CTO) Less << Not Applicable Completed - United States, California ... More >> Abbott Vascular Santa Clara, California, United States, 95054 Less <<
NCT02015559 Estrogen Receptor-positive Bre... More >>ast Cancer HER2-negative Breast Cancer Oral Complications Progesterone Receptor-positive Breast Cancer Recurrent Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Less << Phase 2 Active, not recruiting April 26, 2020 United States, California ... More >> Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 Less <<
NCT00390364 Colorectal Cancer Phase 2 Terminated(Withdrawn due to lo... More >>w accrual) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT01418794 Acute Coronary Syndromes Phase 4 Unknown - China, Heilongjiang ... More >> The 2nd Affiliated Hospital of Harbin Medical University Recruiting Harbin, Heilongjiang, China, 150081 Contact: Bo Yu, MD    +86-451-86605346    yubodr@163.com    China, Henan Henan Provincial People's Hospital Recruiting Zhengzhou, Henan, China, 450003 Contact: Chuan-Yu Gao, MD    +86-371-65580011    Gaocy2000@yahoo.com.cn    China, Liaoning Shenyang Northern Hospital Recruiting Shenyang, Liaoning, China, 110016 Contact: Yi Li, MD    +86-24-28851168    doctorliyi@126.com    China, Tianjin Armed Police Force Medical College Hospital Recruiting Tianjin, Tianjin, China, 300162 Contact: Tie-Min Jiang, MD    +86-22-60578777    wjyxyfy@126.com Less <<
NCT01028638 - Completed - Netherlands ... More >> University Medical Centre Groningen Groningen, Netherlands, 9700 RB Less <<
NCT01405287 Coronary Artery Disease ... More >> Atherosclerosis Acute Coronary Syndrome (ACS) Myocardial Infarction (MI) Less << Phase 2 Completed - Belgium ... More >> OLV Ziekenhuis Aalst Aalst, Belgium, 9300 AZ Middelheim Antwerp, Belgium, 2020 Finland Satakunta Central Hospital Pori, Finland, 28500 Netherlands Academisch Medisch Centrum Amsterdam, Netherlands, 1105 AZ Switzerland University Hospital Zurich Zurich, Switzerland, 8032 United Kingdom King's College Hospital London, United Kingdom, SE5 9RS Less <<
NCT03403647 Vitamin D Deficiency Not Applicable Enrolling by invitation November 2018 Israel ... More >> Sheba Medical Center Ramat Gan, Israel Less <<
NCT01435031 - Completed - -
NCT00965094 Chronic Renal Failure Phase 4 Completed - Israel ... More >> Novartis Investigative Site Haifa, Israel, 31096 Novartis Investigative Site Petach Tikva, Israel, 49100 Novartis Investigative Site Tel-Aviv, Israel, 64239 Less <<
NCT00655655 Gastrinoma Gl... More >>ucagonoma Insulinoma Metastatic Gastrointestinal Carcinoid Tumor Metastatic Pheochromocytoma Pancreatic Polypeptide Tumor Recurrent Gastrointestinal Carcinoid Tumor Recurrent Islet Cell Carcinoma Recurrent Melanoma Recurrent Neuroendocrine Carcinoma of the Skin Recurrent Non-small Cell Lung Cancer Recurrent Pheochromocytoma Recurrent Renal Cell Cancer Somatostatinoma Stage III Neuroendocrine Carcinoma of the Skin Stage IV Melanoma Stage IV Non-small Cell Lung Cancer Stage IV Renal Cell Cancer Thyroid Gland Medullary Carcinoma Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00965094 - Completed - -
NCT01489202 Coronary Artery Disease Phase 4 Unknown December 2016 Italy ... More >> University La Sapienza Not yet recruiting Rome, Italy, 00166 Principal Investigator: Francesco Pelliccia, MD, PhD Less <<
NCT01950819 End Stage Renal Disease (ESRD)... More >> Chronic Kidney Disease (CKD) Hemodialysis Renal Replacement Therapy Renal Transplantation Less << Phase 4 Completed - -
NCT01077986 Metastatic Pancreatic Cancer Phase 1 Phase 2 Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Netherlands, 1105 AZ Less <<
NCT02890069 Colorectal Cancer, Non-small C... More >>ell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Less << Phase 1 Recruiting December 19, 2019 -
NCT01285999 Atherosclerosis ... More >> Coronary Artery Disease Less << Not Applicable Unknown April 2014 China ... More >> Cardiovascular Institute and Fu Wai Hospital Beijing, China Peking Union Medical College Hospital Beijing, China Peking University First Hospital Beijing, China The Chinese People's Liberation Army General Hospital Beijing, China Huaxi Hospital of Sichuan University Chengdu, China Daqing General Oil Field Hospital Daqing, China Guangdong Cardiovascular Institute of Guangdong Provincial Hospital Guangzhou, China Guangdong Nanfang Hospital Guangzhou, China The 2nd Affiliated Hospital of Harbin Medical University Harbin, China Nanjing First Hospital Nanjing, China Shanghai 6th People's Hospital, Jiaotong University Shanghai, China Shanghai Chest Hospital of Jiaotong University Shanghai, China General Hospital of SY Military Institute Shen Yang, China TEDA International Cardiovascular Hospital Tianjin, China Xijing Hospital, Fourth Military Medical University Xi'an, China Less <<
NCT00956293 Renal Transplantation Phase 4 Terminated(The study was termi... More >>nated because the required sample size of 240-260 de novo senior renal transplant patients was not achieved within a reasonable time.) Less << - Germany ... More >> Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Duesseldorf, Germany, 40225 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Kaiserslautern, Germany, 67655 Novartis Investigative Site Koeln-Merheim, Germany, 51109 Novartis Investigative Site München, Germany, 81377 Less <<
NCT01903473 Chronic Graft-Versus-Host Dise... More >>ase Acute Graft-Versus-Host Disease Steroid Refractory Graft-Versus-Host Disease Less << Phase 2 Unknown December 2016 Belgium ... More >> Katholieke Universiteit Leuven Recruiting Leuven, Vlaams-Brabant, Belgium, 3000 Contact: Hélène Schoemans, MD    +3216346889    helene.schoemans@uzleuven.be    Contact: Johan Maertens, MD, PhD    +3216346889    johan.maertens@uzleuven.be    Principal Investigator: Hélène Shoenmans, MD          Sub-Investigator: Johan Maertens, MD, PhD          University Hospital Liège Recruiting Liège, Belgium, 4000 Contact: Frédéric Baron, MD, PhD    +3243667201    f.baron@ulg.ac.be    Contact: Yves Beguin, MD, PhD    +3243667201    yves.beguin@chu.ulg.ac.be    Principal Investigator: Frédéric Baron, MD, PhD          Sub-Investigator: Yves Beguin, MD, PhD          Sub-Investigator: Evelyne Willems, MD, PhD          Sub-Investigator: Etienne Baudoux, MD          Sub-Investigator: Chantal Lechanteur, PhD          Sub-Investigator: Olivier Giet, PhD          Sub-Investigator: Stéphanie Humblet-Baron, PhD          Sub-Investigator: Muriel Hannon Less <<
NCT03032406 Breast Cancer Stage IIB Phase 2 Recruiting January 23, 2023 United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Angela DeMichele, MD    855-216-0098    PennCancerTrials@emergingmed.com    Principal Investigator: Angela DeMichele, MD Less <<
NCT03463265 High Grade Recurrent Glioma an... More >>d Newly Diagnosed Glioblastoma Less << Phase 2 Recruiting June 2021 United States, California ... More >> John Wayne Cancer Institute Recruiting Santa Monica, California, United States, 90404 Contact: Najee Boucher    310-582-7460    najee.boucher@providence.org Less <<
NCT03373903 Respiratory Tract Infections Phase 2 Active, not recruiting July 2018 United States, Kansas ... More >> Heartland Research Associates Wichita, Kansas, United States, 67205 Less <<
NCT01289301 Disorder Related to Renal Tran... More >>splantation Immunosuppression Related Infectious Disease Virus Diseases Less << Phase 4 Unknown October 2018 Germany ... More >> University Hospital Freiburg, Transplant Outpatient Clinic Not yet recruiting Freiburg, Baden-Württemberg, Germany, D-79104 Contact: Gerd Walz, Prof. Dr.    0761 2703250    gerd.walz@uniklinik-freiburg.de    University of Erlangen/ Nürnberg, Transplant Outpatient Clinic Not yet recruiting Erlangen, Bayern, Germany, D-91054 Contact: Karl Hilgers, Prof. Dr.    +49 9131 8536267    karl.hilgers@uk-erlangen.de    Hannover Medical School, Transplant Outpatient Clinic Not yet recruiting Hannover, Niedersachsen, Germany, D-30625 Contact: Anke Schwarz, Prof. Dr.    +49 511 5322329    schwarz.anke@mh-hannover.de    Contact: Silvia Linnenweber, Dr.    +49 511 5323000    linnenweber.silvia@mh-hannover.de    University of Essen, Transplant Outpatient Clinic Not yet recruiting Essen, Ruhrgebiet, Germany, D-45122 Contact: Oliver Witzke, Prof. Dr.    +49 201 7231868    nephrologie@uk-essen.de Less <<
NCT01031446 Breast Cancer Phase 1 Phase 2 Completed - United States, Tennessee ... More >> Erlanger Cancer Center at Erlanger Hospital - Baroness Chattanooga, Tennessee, United States, 37403 West Tennessee Cancer Center at Jackson-Madison County General Hospital Jackson, Tennessee, United States, 38301 Baptist Regional Cancer Center at Baptist Riverside Knoxville, Tennessee, United States, 37901 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT01031446 - Completed - -
NCT00622869 Liver Transplantation Phase 3 Completed - -
NCT03213678 Advanced Malignant Solid Neopl... More >>asm Ann Arbor Stage III Non-Hodgkin Lymphoma Ann Arbor Stage IV Non-Hodgkin Lymphoma Malignant Glioma Recurrent Central Nervous System Neoplasm Recurrent Childhood Ependymoma Recurrent Ewing Sarcoma Recurrent Glioma Recurrent Hepatoblastoma Recurrent Langerhans Cell Histiocytosis Recurrent Malignant Germ Cell Tumor Recurrent Malignant Solid Neoplasm Recurrent Medulloblastoma Recurrent Neuroblastoma Recurrent Non-Hodgkin Lymphoma Recurrent Osteosarcoma Recurrent Peripheral Primitive Neuroectodermal Tumor Recurrent Rhabdomyosarcoma Recurrent Soft Tissue Sarcoma Refractory Central Nervous System Neoplasm Refractory Langerhans Cell Histiocytosis Refractory Malignant Germ Cell Tumor Refractory Malignant Solid Neoplasm Refractory Neuroblastoma Refractory Non-Hodgkin Lymphoma Rhabdoid Tumor Stage III Osteosarcoma AJCC v7 Stage III Soft Tissue Sarcoma AJCC v7 Stage IV Osteosarcoma AJCC v7 Stage IV Soft Tissue Sarcoma AJCC v7 Stage IVA Osteosarcoma AJCC v7 Stage IVB Osteosarcoma AJCC v7 TSC1 Gene Mutation TSC2 Gene Mutation Wilms Tumor Less << Phase 2 Recruiting September 30, 2024 -
NCT01515228 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Soon Chun Hyang University Hospital Cheonan Cheonan, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of The Catholic University of Korea, Daejeon ST. Mary's Hospital Daejeon, Korea, Republic of Gangneung Asan Hospital Gangneung, Korea, Republic of Inje University Pusan Paik Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT00622869 - Completed - -
NCT01195922 Mouth Neoplasms ... More >> Head and Neck Neoplasms Tongue Neoplasms Carcinoma, Squamous Cell Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01133678 Head and Neck Cancer Phase 2 Active, not recruiting October 2018 United States, Illinois ... More >> The University of Chicago Medical Center Chicago, Illinois, United States, 60637 NorthShore University Health System Evanston, Illinois, United States, 60201 Less <<
NCT00071968 Prostate Cancer Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1738 Less <<
NCT00956293 - Terminated(The study was termi... More >>nated because the required sample size of 240-260 de novo senior renal transplant patients was not achieved within a reasonable time.) Less << - -
NCT01079143 Renal Interstitial Fibrosis Phase 3 Completed - France ... More >> Novartis Investigative Site Caen, Cedex, France, 14033 Novartis Investigative Site Amiens cedex1, France, 80054 Novartis Investigative Site Angers, France, 49 033 Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Creteil, France, 94010 Novartis Investigative Site Grenoble, France, 38043 Novartis Investigative Site Le Kremlin Bicetre, France, 94275 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Lyon, France, 69 437 Novartis Investigative Site Nice Cedex 1, France, 06602 Novartis Investigative Site Paris cedex 15, France, 75015 Novartis Investigative Site Paris, France, 75475 Novartis Investigative Site Paris, France, 75970 Novartis Investigative Site Pierre Benite Cedex, France, 69495 Novartis Investigative Site Poitiers, France, 86000 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site St Priest en Jarez Cedex, France, 42277 Novartis Investigative Site Strasbourg, France, 67091 Novartis Investigative Site Suresnes, France, 92150 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Novartis Investigative Site Tours Cedex, France, 37044 Novartis Investigative Site Vandoeuvre Les Nancys, France, 54511 Less <<
NCT01200693 Coronary Artery Disease ... More >> Coronary Stenosis Less << Phase 4 Completed - Italy ... More >> Institute of Cardiology - Catholic University of Sacred Heart Rome, Italy, 00100 Less <<
NCT00390364 - Terminated(Withdrawn due to lo... More >>w accrual) Less << - -
NCT00123331 Heart Transplantation ... More >> Renal Failure Less << Phase 4 Completed - Germany ... More >> Medizinische Universitätsklinik, Kardiologie Heidelberg, Germany, D-69115 Less <<
NCT01195922 - Completed - -
NCT02042326 Arteriovenous Malformations Phase 2 Recruiting September 2020 Belgium ... More >> UCL Not yet recruiting Bruxelles, Belgium France CHU Amiens Recruiting Amiens, France, 80000 Principal Investigator: Bernard DEVAUCHELLE, MD, PhD          Sub-Investigator: Sylvie TESTELIN, MD, PhD          CHU Bordeaux Not yet recruiting Bordeaux, France, 33000 CHU Dijon Recruiting Dijon, France, 21000 Contact: Pierre VABRES, MD PhD          Principal Investigator: Pierre VABRES, MD PhD          CHRU Lille Not yet recruiting Lille, France, 59000 HCL Lyon Recruiting Lyon, France, 69000 Contact: Pierre BRETON, MD PhD       pierre.breton@chu-lyon.fr    Contact: Laurent GUIBAUD, MD PhD       laurent.guibaud@chu-lyon.fr    Principal Investigator: Pierre BRETON          Principal Investigator: Laurent GUIBAUD          APHM Not yet recruiting Marseille, France, 13000 Contact: Stéphanie MALLET, MD       stephanie.mallet@ap-hm.fr    Principal Investigator: Jean-Michel BARTOLI          Sub-Investigator: Stéphanie MALLET, MD          CHU Montpellier Not yet recruiting Montpellier, France, 34000 CHU Nancy Not yet recruiting Nancy, France, 54000 CHU Nice Not yet recruiting Nice, France, 06000 APHP Not yet recruiting Paris, France, 75000 CHU Strasbourg Not yet recruiting Strasbourg, France, 67000 CHU Tours Not yet recruiting Tours, France, 37000 Less <<
NCT01079143 - Completed - -
NCT01075321 Adult Nasal Type Extranodal NK... More >>/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Nodal Marginal Zone B-cell Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Splenic Marginal Zone Lymphoma Waldenstrom Macroglobulinemia Less << Phase 1 Phase 2 Active, not recruiting December 2018 United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02845804 - Recruiting July 2021 Korea, Republic of ... More >> Kangwon National University Hospital Recruiting Chuncheon, Gangwon-do, Korea, Republic of Contact: Yong-Hoon Kim          Principal Investigator: Yong-Hoon Kim          Wonju Severance Christian Hospital Recruiting Wonju, Gangwon-do, Korea, Republic of Contact: Jung-Han Yoon          Principal Investigator: Jung-Han Yoon          Sejong General Hospital Recruiting Bucheon, Gyeonggi-do, Korea, Republic of Contact: Young-Jin Choi          Principal Investigator: Young-Jin Choi          Hallym University Sacred Heart Hospital Recruiting Anyang, Korea, Republic of Contact: Sang-Ho Jo, MD,PhD          Principal Investigator: Sang-Ho Jo, MD,PhD          Busan Paik Hospital Recruiting Busan, Korea, Republic of Contact: Tae-Hyun Yang          Kosin University Gospel Hospital Recruiting Busan, Korea, Republic of Contact: Jeong Ho Heo          Dankook University Hospital Recruiting Cheonan, Korea, Republic of Contact: Byung-Eun Park, MD,PhD          Principal Investigator: Byung-Eun Park, MD,PhD          SoonChunHyang University Cheonan Hospital Recruiting Cheonan, Korea, Republic of Contact: Sang-Ho Park          Principal Investigator: Sang-Ho Park          Chungbuk National University Hospital Recruiting Chongju, Korea, Republic of Contact: Jang-Hwan Bae, MD,PhD       drcorazon@hanmail.net    Principal Investigator: Jang-Hwan Bae, MD,PhD          Yongnam University Medical Center Recruiting Daegu, Korea, Republic of Contact: Jong-Sun Park, MD,PhD       pjs@medical.yu.ac.kr    Principal Investigator: Jong-Sun Park, MD,PhD          Chonnam National University Hospital Recruiting Gwangju, Korea, Republic of Contact: Myung-Ho Jeong          Wonkwang University Hospital Recruiting Iksan, Korea, Republic of Contact: Seok-Kyo Oh, MD,PhD       oskcar@wonkwang.ac.kr    Principal Investigator: Seok-Kyo Oh, MD,PhD          Inha University Hospital Recruiting Inchon, Korea, Republic of Contact: Seong-Il Woo, MD,PhD       wjswgs@naver.com    Principal Investigator: Seong-Il Woo, MD,PhD          Presbyterian Medical Center Recruiting Jeonju, Korea, Republic of Contact: Je-Young Rhew, MD,PhD       jkrhew@hanafos.com    Principal Investigator: Je-Young Rhew, MD,PhD          Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of Contact: In-Ho Chae, MD,PhD          Principal Investigator: In-Ho Chae, MD,PhD          Gangbuk Samsung Hospital Recruiting Seoul, Korea, Republic of Contact: Ki-Cheol Sung, MD,PhD          Principal Investigator: Ki-Cheol Sung, MD,PhD          Hanyang University Medical Center Recruiting Seoul, Korea, Republic of Contact: Young-Hyo Lim          Principal Investigator: Young-Hyo Lim          Kangdong Sacred Heart Hospital Recruiting Seoul, Korea, Republic of Contact: Kyoo-Rok Han, MD,PhD       krheart@hallym.or.kr    Principal Investigator: Kyoo-Rok Han, MD,PhD          Seoul Boramae Hospital Recruiting Seoul, Korea, Republic of Contact: Sang-Hyun Kim, MD,PhD       shkimmd@snu.ac.kr    Principal Investigator: Sang-Hyun Kim, MD,PhD          Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Hyo-soo Kim, MD, PhD    +82-2-2072-2223    hyosoo@snu.ac.kr    Principal Investigator: Hyo-soo Kim, MD, PhD          Sub-Investigator: Bon-Kwon Koo, MD, PhD          Sub-Investigator: Hyun-Jae Kang, MD, PhD          Sub-Investigator: Jung-Kyu Han, MD, PhD          Sub-Investigator: Sang-Eun Lee, MD, PhD Less <<
NCT02115113 Liver Transplantation Phase 3 Unknown August 2017 Italy ... More >> Novartis Investigative Site Recruiting Ancona, AN, Italy, 60126 Novartis Investigative Site Recruiting Bari, BA, Italy, 70124 Novartis Investigative Site Recruiting Bergamo, BG, Italy, 24128 Novartis Investigative Site Recruiting Bologna, BO, Italy, 40138 Novartis Investigative Site Recruiting Cagliari, CA, Italy, 09134 Novartis Investigative Site Withdrawn Cagliari, CA, Italy, 09134 Novartis Investigative Site Recruiting Milano, MI, Italy, 20122 Novartis Investigative Site Recruiting Milano, MI, Italy, 20162 Novartis Investigative Site Recruiting Modena, MO, Italy, 41100 Novartis Investigative Site Recruiting Padova, PD, Italy, 35128 Novartis Investigative Site Recruiting Pisa, PI, Italy, 56124 Novartis Investigative Site Recruiting Roma, RM, Italy, 00144 Novartis Investigative Site Recruiting Roma, RM, Italy, 00152 Novartis Investigative Site Not yet recruiting Roma, RM, Italy, 00161 Novartis Investigative Site Recruiting Roma, RM, Italy, 00168 Novartis Investigative Site Recruiting Torino, TO, Italy, 10126 Novartis Investigative Site Recruiting Udine, UD, Italy, 33100 Novartis Investigative Site Recruiting Verona, VR, Italy, 37126 Novartis Investigative Site Recruiting Napoli, Italy, 80132 Less <<
NCT02035813 HER2-negative Und Hormone-rece... More >>ptor Positive Metastatic Breast Cancer HER2-negative Circulating Tumor Cells Postmenopausal Female Patients Less << Phase 2 Recruiting - Germany ... More >> University Hospital Ulm -Department of Gynecology Recruiting Ulm, Baden-Württemberg, Germany, 89075 Contact: Wolfgang Janni, MD, PhD Less <<
NCT00300131 - Completed - Denmark ... More >> Skejby Sygehus Aarhus, Denmark Netherlands Erasmus University Thorax Center Rotterdam, Netherlands New Zealand Auckland City Hospital Auckland, New Zealand Poland University Hospital Krakow, Poland Less <<
NCT00780104 Myeloid Leukemias ... More >> AML Leukemia CML Less << Phase 1 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00997763 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Korea, Republic of Busan Saint Mary's Hospital Busan, Korea, Republic of Soonchunhyang University Cheonan Hospital Cheonan, Korea, Republic of Cheongju Saint Mary's Hospital Cheongju, Korea, Republic of Kangwon University Hospital Chuncheon, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Daejeon St Mary's Hospital Catholic University Daejeon, Korea, Republic of Asan Medical Center GangNeung, Korea, Republic of Chonbuk National University Hospital Jeonju, Korea, Republic of Kyungsang University Hospital Jinju, Korea, Republic of Inje University Pusan Paik Hospital Pusan, Korea, Republic of Pusan Natioanal University Hospital Pusan, Korea, Republic of Hallym University Sacred Heart Hospital PyeongChon, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Hallym University Sacred Heart Hospital Seoul, Korea, Republic of Korea Veterans Hospital Seoul, Korea, Republic of Soonchunhyang University Seoul Hospital Seoul, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT01684982 Acute Myocardial Infarction Phase 4 Completed - Italy ... More >> Division of Cardiology AO Moscati Avellino, Italy, 83100 Less <<
NCT01080872 - Completed - Finland ... More >> Satakunta Central Hospital Pori, Finland, 28500 Turku University Hospital Turku, Finland Less <<
NCT00450320 Sarcoma Phase 1 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT03433183 Malignant Peripheral Nerve She... More >>ath Tumors Neurofibromatosis 1 Less << Phase 2 Not yet recruiting September 2021 -
NCT00966836 Heart Transplantation ... More >> Cardiac Allograft Vasculopathy Cytomegalovirus Infection Less << Phase 3 Unknown - Italy ... More >> Azienda Ospedaliero-Universitaria S Orsola Malpighi Recruiting Bologna, Italy Sub-Investigator: Luciano Potena, MD PhD Less <<
NCT02854618 Breast Cancer Not Applicable Recruiting December 2020 France ... More >> Centre Hospitalier Régional Universitaire Recruiting Besançon, France, 25030 Contact: Elise ROBERT       e1robert@chu-besancon.fr Less <<
NCT02864706 Heart Transplantation Phase 4 Completed - Denmark ... More >> Skejby Hospital Aarhus, Denmark, D-8000 University Hospital Rigshospitalet Copenhagen, Denmark, D-2100 Norway University Hospital Rikshospitalet Oslo, Norway, N-0372 Sweden Sahlgrenska University Hospital Gothenburg, Sweden, 41345 Lund University Hospital Lund, Sweden, 22241 Less <<
NCT02063958 Cancer Phase 1 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale, Arizona, United States, 85259-5499 United States, California Stanford Medicine Stanford, California, United States, 94305 United States, District of Columbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Maryland Center for Cancer Research, National Cancer Institute Bethesda, Maryland, United States, 20892 United States, New Jersey hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT00903188 Renal Transplantation Phase 4 Unknown April 2015 Belgium ... More >> Erasme University Hospital Recruiting Brussels, Belgium, 1070 Contact: Daniel Abramowicz, MD/PhD    +32/2/555 35 32    dabram@ulb.ac.be    Principal Investigator: Daniel Abramowicz, MD/PhD          University Hospital Brussels Recruiting Brussels, Belgium, 1090 Contact: Jacques Sennesael, MD/PhD    +32/2/477 60 55    Jacques.Sennesael@uzbrussel.be    Principal Investigator: Jacques Sennesael, MD          University Hospital Antwerp Recruiting Edegem, Belgium, 2650 Contact: Jean-Louis Bosmans, MD/PhD    +32/3/821 37 92    jeanlouis.bosmans@ua.ac.be    Contact: Angelika Jurgens, Study Coord.    +32/3/821 34 21    Angelika.Jurgens@uza.be    Principal Investigator: Jean-Louis Bosmans, MD/PhD          University Hospital, Ghent Recruiting Gent, Belgium, 9000 Contact: Patrick Peeters, MD/PhD    +32/9/332 45 13    patrick.peeters@ugent.be    Principal Investigator: Patrick Peeters, MD          University Hospital of Liege Recruiting Liège, Belgium, 4000 Contact: Catherine Bonvoisin, MD/PhD    +32/4/366 82 58    catherine.bonvoisin@chu.ulg.ac.be    Principal Investigator: Catherine Bonvoisin, MD Less <<
NCT01265030 Desmoid Tumor Phase 1 Phase 2 Recruiting December 2019 United States, California ... More >> UCLA Medical Center Recruiting Los Angeles, California, United States, 90095 Contact: Noah Federman, MD    310-825-6708    nfederman@mednet.ucla.edu    Principal Investigator: Noah Federman, MD          Sub-Investigator: Sarah Dry, MD          Rady Children's Hospital Not yet recruiting San Diego, California, United States, 92123 Contact: Sun H Choo, MD    858-966-3823    SChoo@rchsd.org    Principal Investigator: Sun H Choo, MD          United States, Florida University of Florida College of Medicine Not yet recruiting Gainesville, Florida, United States, 32611 Contact: Giselle Moore-Higgs, PhD    352-273-9050    mooregj@ufl.edu    United States, Maine Maine Medical Center Recruiting Portland, Maine, United States, 04102 Contact: Aaron R Weiss, DO    207-396-7565    weissa2@mmc.org    Principal Investigator: Aaron R Weiss, DO          United States, Minnesota University of Minnesota Not yet recruiting Minneapolis, Minnesota, United States, 55455 Contact: Brenda M Weigel, MD    612-626-5501    weige007@umn.edu    Principal Investigator: Brenda Weigel, MD          United States, Missouri Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 Contact: Michelle Manalang, MD    816-302-6808    mmanalang@chm.edu    Principal Investigator: Michelle Manalang, MD          United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98101 Contact: Douglas Hawkins    206-987-2106    doug.hawkins@seattlechildrens.org    Principal Investigator: Douglas Hawkins          United States, Wisconsin Medical College of Wisconsin Not yet recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Meghen Browning, MD    414-955-4170    mbrownin@mcw.edu    Principal Investigator: Meghen Browning, MD Less <<
NCT02681016 Ischemic Heart Disease ... More >> Coronary Atherosclerosis Coronary Artery Disease Coronary Artery Stenosis Less << Not Applicable Completed - Russian Federation ... More >> State Research Institute of CIrculation Pathology Novosibirsk, Russian Federation, 630055 Less <<
NCT01408004 Clear Cell Renal Carcinoma Phase 2 Completed - Netherlands ... More >> St. Franciscus Gasthuis Rotterdam, Zuid-Holland, Netherlands Medisch Centrum Alkmaar Alkmaar, Netherlands Acedemisch Medisch Centrum Amsterdam Amsterdam, Netherlands NKI-AVL Amsterdam, Netherlands Amphia ziekenhuis Breda Breda, Netherlands Haga Ziekenhuis Den Haag, Netherlands Maxima Medisch Centrum Eindhoven, Netherlands UMC Groningen Groningen, Netherlands Atrium Medisch Centrum Heerlen Heerlen, Netherlands Medische Centrum Leeuwarden Leeuwarden, Netherlands Acedemisch ziekenhuis Maastricht Maastricht, Netherlands St. Antonius ziekenhuis Nieuwegein, Netherlands Erasmus Medisch Centrum Rotterdam, Netherlands Orbis Medisch Centrum Sittard-Geleen, Netherlands St. Elisabeth ziekenhuis Tilburg, Netherlands UMC Utrecht Utrecht, Netherlands, 3508 GA Isala klinieken Zwolle, Netherlands Less <<
NCT00456833 Non Small Cell Lung Cancer Phase 1 Completed - United States, Georgia ... More >> Novartis Investigative Site Atlanta, Georgia, United States, 30322 United States, Illinois Novartis Investigative Site Chicago, Illinois, United States, 60637-1470 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02115 United States, Minnesota Novartis Investigative Site Rochester, Minnesota, United States, 55905 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030-4009 United States, Wisconsin Novartis Investigative Site Madison, Wisconsin, United States, 53792 Canada, British Columbia Novartis Investigative Site Richmond, British Columbia, Canada, V7C 5L9 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H2L 4M1 Denmark Novartis Investigative Site Herlev, Denmark, DK-2730 France Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Novartis Investigative Site Villejuif Cedex, France, 94805 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 115478 Less <<
NCT00805961 - Completed - -
NCT00505102 Kidney Diseases ... More >> Heart Transplantation Less << Phase 4 Unknown July 2009 Italy ... More >> Heart Transplant Center Ospedali Riuniti Bergamo, Italy, 24100 Heart Transplantad Center OspedaliRiuniti Bergamo Bergamo, Italy, 24100 Less <<
NCT03328104 Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 1 Recruiting December 31, 2019 United States, Georgia ... More >> Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Himalee Sabnis, MD, MS    404-727-3285    hsabnis@emory.edu Less <<
NCT01182649 Coronary Artery Disease ... More >> Coronary Atherosclerosis Less << Phase 3 Completed - Italy ... More >> Division of Cardiology Aorn Moscati Avellino, Italy, 83100 Less <<
NCT00856505 Hematologic Diseases Phase 1 Phase 2 Unknown March 2011 Germany ... More >> University Medical Center, Division Hematology/Oncology Recruiting Freiburg, Baden-Wuerttemberg, Germany, 79104 Contact: Reinhard Marks, MD    49-761-270 ext 3278    reinhard.marks@uniklinik-freiburg.de    Sub-Investigator: Reinhard Marks, MD          Principal Investigator: Juergen Finke, MD Less <<
NCT01510119 Metastatic Clear Cell Renal Ce... More >>ll Carcinoma Less << Phase 1 Phase 2 Active, not recruiting - United States, New Jersey ... More >> University of Medicine and Dentistry of New Jersey New Brunswick, New Jersey, United States United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh, Hillman Cancer Center Pittsburgh, Pennsylvania, United States Less <<
NCT02229136 Stomatitis Or... More >>al Mucositis Neoplasm of the Breast Malignant Tumor of Breast Less << Phase 2 Active, not recruiting September 30, 2019 United States, Texas ... More >> 12 sites incl Yakima, WA, Boulder, CO, and Austin, TX US, Texas, United States Less <<
NCT02314312 Transplantation of Kidney ... More >> Expanded Criteria Donor ECD Less << Phase 3 Unknown June 2015 -
NCT00076206 Rheumatoid Arthritis Phase 2 Terminated - -
NCT02738658 Stable Angina Phase 4 Completed - Spain ... More >> Hospital Universitari de Bellvitge L´Hospitalet de Llobregat, Barcelona, Spain, 08173 Hospital del Mar Barcelona, Spain, 08003 Hospital Clinic Barcelona, Spain, 08036 Less <<
NCT01472705 - Completed - Switzerland ... More >> Cardiology, university Fribourg Medical Center Fribourg, Switzerland, 1708 Less <<
NCT00655252 - - - -
NCT00896012 Kidney Transplantation Phase 4 Unknown December 2010 United States, New York ... More >> Buffalo General Hospital Multi-Organ Transplant Department Buffalo, New York, United States, 14203 Less <<
NCT00195195 - Completed - Sweden ... More >> Gothenburg, Sweden, SE-413 45 Stockholm, Sweden, SE-141 86 Uppsala, Sweden, SE-751 85 Less <<
NCT00332839 Renal Transplantation Phase 4 Terminated(The trial was termi... More >>nated early due to slow enrollment. It was determined that the planned sample size of 300 could not be achieved.) Less << - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69115 Novartis Investigative Site Heilbronn, Germany, 74076 Novartis Investigative Site Kaiserslautern, Germany, 67655 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Koeln, Germany, 51109 Novartis Investigative Site Muenster, Germany, 48149 Less <<
NCT01952847 Advanced Cancers Phase 3 Active, not recruiting July 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00332839 - Terminated(The trial was termi... More >>nated early due to slow enrollment. It was determined that the planned sample size of 300 could not be achieved.) Less << - -
NCT00894062 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Dongsan Medical Center, Keimyung University Daegu, Korea, Republic of, 700-712 Severance Hospital, Yonsei University Seoul, Korea, Republic of, 120-752 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT02587325 Pulmonary Hypertension Phase 1 Recruiting December 2020 United States, Arizona ... More >> University of Arizona Not yet recruiting Tucson, Arizona, United States, 85724 Contact: Valerie Bloss    520-626-8305    vbloss@email.arizona.edu    United States, California Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90502 Contact: Ronald Oudiz, MD    310-222-3560    roudiz@labiomed.org    United States, Indiana Indiana University Not yet recruiting Indianapolis, Indiana, United States, 46202 Contact: Betty Logan    317-962-9978    blogan@iuhealth.org    United States, Pennsylvania University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Mary Kunkel    412-647-4463    kunkelme@upmc.edu    United States, Virginia Inova Fairfax Hospital Recruiting Falls Church, Virginia, United States, 22042 Contact: Vinita Gupta    703-776-3697    vinita.gupta@inova.org Less <<
NCT00930930 - Completed - -
NCT03659136 Breast Neoplasms Phase 2 Recruiting January 12, 2022 France ... More >> HOP Victor Hugo Recruiting Le Mans, France, 72000 Contact: Hugues Bourgeois    +33 (0)2 43 29 79 88    essaisbourgeois@i-l-c.fr    HOP Lyon Sud Recruiting Pierre Benite, France, 69495 Contact: Benoît You    +33 (0)4 78 86 43 18    benoit.you@chu-lyon.fr    Greece University General Hospital of Heraklion Recruiting Heraklion, Greece, 71110 Contact: Dimitrios Mavroudis    00302810392750    mavroudis@uoc.gr Less <<
NCT01115803 Metastases, Neoplasm ... More >> Carcinoma, Non-small Cell Lung Renal Cell Carcinoma Neuroendocrine Tumors Less << Phase 1 Terminated(Primary objective h... More >>as been met; safety and pharmacokinetics have been characterized.) Less << - United States, Illinois ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States, 60637 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bordeaux, France, 33076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Villejuif, France, 94805 Less <<
NCT00930930 Breast Cancer Phase 2 Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35249 United States, Mississippi University of Mississippi Medical Center Research Institute Jackson, Mississippi, United States, 39213 United States, Pennsylvania Hershey Medical Center Hershey, Pennsylvania, United States, 17033 United States, Tennessee Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 MBCCOP - Meharry Medical College - Nashville Nashville, Tennessee, United States, 37208 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 United States, Texas The Methodist Hospital Research Institute Houston, Texas, United States, 77030 United States, Virginia University of Virginia Health Sciences Center Charlottesville, Virginia, United States, 22098 Less <<
NCT02441543 - Recruiting May 2018 Italy ... More >> Istituto Clinico Humanitas Recruiting Rozzano, MI, Italy, 20089 Contact: Enrico Lugli    02 8224 ext 5143    Enrico.Lugli@humanitasresearch.it    Contact: Matteo Simonelli    02 8224 ext 4559    matteo.simonelli@humanitas.it    Principal Investigator: Lugli Enrico          Sub-Investigator: Simonelli Matteo Less <<
NCT00499603 Breast Cancer Phase 2 Unknown April 2017 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02456857 Estrogen Receptor Negative ... More >> HER2/Neu Negative Invasive Breast Carcinoma Progesterone Receptor Negative Triple-Negative Breast Carcinoma Less << Phase 2 Recruiting January 31, 2021 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Stacy L. Moulder    713-792-2817       Principal Investigator: Stacy L. Moulder Less <<
NCT00499603 - Unknown - -
NCT01689688 - Unknown October 2015 Japan ... More >> Kobe University Graduate School of Medicine Recruiting Kobe, Hyogo, Japan Contact: Toshiro Shinke, MD, PhD    +81.78.382.5846    shinke@med.kobe-u.ac.jp    Principal Investigator: Toshiro Shinke, MD, PhD Less <<
NCT01500070 Peripheral Arterial Disease Phase 2 Completed - Belgium ... More >> Imelda Hospital Bonheiden, Antwerpen, Belgium, 2820 OLV Aalst Aalst, Oost-Vlaanderen, Belgium, 9300 AZ Sint-Blasius Dendermonde, Oost-Vlaanderen, Belgium, 9200 RZ Heilig Hart Tienen Tienen, Belgium, 3300 Germany Herzzentrum Leipzig Leipzig, Freistaat Sachsen, Germany, 04289 Herzzentrum Bad-Krözingen Bad-Krözingen, Land Baden-Württemberg, Germany, 79189 St. Fransiskus Hospital Münster, Nordrhein-Westfalen, Germany, 48145 New Zealand Auckland City Hospital Auckland City, Auckland, New Zealand, 1023 Less <<
NCT02874924 - Completed - -
NCT03695341 - Active, not recruiting May 15, 2019 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Shanghai, Shanghai, China, 200032 Less <<
NCT00805961 Glioblastoma Multiforme Phase 2 Completed - United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 Research Medical Center Kansas City, Missouri, United States, 64132 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT01510327 Coronary Artery Disease Phase 3 Completed - United States, Colorado ... More >> Medical Center of the Rockies (Loveland) Loveland, Colorado, United States, 80538 United States, Michigan Cardiac & Vascular Research Center of Northern Michigan Petoskey, Michigan, United States, 49770 Japan Saiseikai Yokohama-City Eastern Hospital Yokohama City, Kanagawa-ken, Japan Tokyo Women's Medical University Hospital Shinjuku-ku, Tokyo-to, Japan Sakakibara Heart Institute, Japan Research Promotion Society for Cardiovascular Diseases Fuchu-shi, Tokyo, Japan Less <<
NCT00065468 Carcinoma, Renal Cell ... More >> Kidney Neoplasms Less << Phase 3 Completed - -
NCT00065468 - Completed - -
NCT00083993 Breast Neoplasms ... More >> Neoplasm Metastasis Less << Phase 3 Terminated - -
NCT00531063 Renal Transplantation Phase 3 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00976573 Melanoma (Skin) Phase 2 Completed - -
NCT00976573 - Completed - -
NCT02688829 Coronary Heart Disease Not Applicable Completed - -
NCT01183247 Comparative Study ... More >> Immunosuppressive Agents Less << Phase 4 Completed - Switzerland ... More >> Clinic for transplantation immunology and nephrology Basel, Switzerland, 4031 Less <<
NCT01016041 Stable Angina ... More >> Unstable Angina Acute Coronary Syndrome Less << Phase 3 Completed - Netherlands ... More >> Maasstad Hospital Rotterdam, Netherlands, 3075 EA Less <<
NCT02796157 Coronary Artery Disease Not Applicable Recruiting May 2019 Korea, Republic of ... More >> Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: MYEONG-KI HONG, MD    82-2-2228-8458    MKHONG61@yuhs.ac Less <<
NCT01510327 - Completed - -
NCT00307047 Coronary Artery Disease Phase 3 Completed - -
NCT02874924 Aging Phase 2 Completed - United States, Texas ... More >> UTHSCSA San Antonio, Texas, United States, 78220 Less <<
NCT00636090 - Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01787799 - Completed - -
NCT01589978 Coronary Artery Disease Phase 4 Completed - -
NCT01787799 Atherosclerotic Lesion(s) Phase 3 Completed - Australia, Queensland ... More >> The Prince Charles Hospital Chermside, Queensland, Australia, 4032 Australia, Victoria Monash Medical Centre-Clayton Campus Clayton, Victoria, Australia, 3168 St Vincent's Hospital Melbourne Fitzroy, Victoria, Australia, 3085 Australia, Western Australia Fremantle Hospital Fremantle, Western Australia, Australia, 6160 Japan Shonan Kamakura General Hospital Kamakura-shi, Kanagawa, Japan, 247-8533 New Zealand Mercy Angiography Unit, Ltd. Auckland, New Zealand, 1003 Auckland City Hospital Auckland, New Zealand, 1010 Ascot Angiography Ltd Auckland, New Zealand, 1050 Middlemore Hospital Auckland, New Zealand, 1640 North Shore Hospital Auckland, New Zealand, 622 Christchurch Hospital NZ Christchurch, New Zealand, 8011 Singapore National University Hospital Singapore, Singapore, 119074 National Heart Centre Singapore, Singapore, 168752 Less <<
NCT00307047 - Completed - -
NCT01498692 Coronary Artery Disease Not Applicable Completed - -
NCT01680952 Kidney Transplant Patients Phase 4 Completed - Korea, Republic of ... More >> Ajou Univeristy Medical Center Suwon, KyungKi Province, Korea, Republic of Kyungpook national hospital Daegu, Korea, Republic of Severance hospital Seoul, Korea, Republic of, 120-752 Gangnam Severance hospital Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of Seoul National University hospital Seoul, Korea, Republic of Ulsan Univ Hospital Ulsan, Korea, Republic of Less <<
NCT01498692 - Completed - -
NCT01589978 - Completed - -
NCT01467986 Neuroblastoma Recurrent Phase 2 Recruiting December 2019 Germany ... More >> University Hospital Regensburg, Department of Pediatric Hematology and Oncology Recruiting Regensburg, Germany, 93053 Contact: Selim Corbacioglu, MD    +49(0)941 944-2101    selim.corbacioglu@ukr.de    Principal Investigator: Selim Corbacioglu, MD Less <<
NCT01942070 Cardiovascular Disease ... More >> Myocardial Infarction Thrombus Primary Angioplasty Less << Not Applicable Active, not recruiting March 2019 Germany ... More >> Deutsches Herzzentrum Munich Munich, Bavaria, Germany, 80636 Klinikum Rechts der Isar Munich, Bavaria, Germany, 81675 Less <<
NCT01658436 - Completed - -
NCT01658436 Pancreatic Neuroendocrine Tumo... More >>rs (pNET) Less << Phase 2 Completed - United States, Indiana ... More >> Indiana University SC Indianapolis, Indiana, United States, 46202 United States, Massachusetts Dana Farber Cancer Institute GastrointestionalCancer Clinic Boston, Massachusetts, United States, 02215 United States, New York Montefiore Medical Center SC-2 Bronx, New York, United States, 10467 United States, Ohio Ohio State Comprehensive Cancer Center/James Cancer Hospital SC Columbus, Ohio, United States, 43210 Austria Novartis Investigative Site Wien, Austria, A-1090 Belgium Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Lyon, France, 69437 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Essen, Germany, 45147 Italy Novartis Investigative Site Firenze, FI, Italy, 50134 Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Milano, MI, Italy, 20141 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3015 CE Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Madrid, Spain, 28041 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M20 4BX Less <<
NCT02014818 Coronary Artery Disease Not Applicable Active, not recruiting December 31, 2018 Japan ... More >> Kobe University Graduate School of Medicine Kobe, Japan, 657-850 Less <<
NCT01342822 - Unknown March 2014 -
NCT00499486 Pancreatic Cancer Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT03447379 Coronary Artery Occlusive Dise... More >>ase Less << Not Applicable Recruiting April 30, 2021 Korea, Republic of ... More >> Gangnam Severance Hospital Recruiting Seoul, Souel, Korea, Republic of Contact: BumKee Hong, MD    82-2-2019-3311 Less <<
NCT01592253 Acute Rejection of Renal Trans... More >>plant Less << Not Applicable Unknown December 2013 Korea, Republic of ... More >> Recruiting Seoul, Korea, Republic of Less <<
NCT00499486 - Completed - -
NCT00635284 Solid Tumors Phase 1 Completed - United States, California ... More >> Sarcoma Oncology Center Santa Monica, California, United States, 90403 United States, Texas University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01171820 Coronary Disease ... More >> Coronary Artery Disease Coronary Restenosis Less << Phase 4 Completed - Austria ... More >> Salzburger Landeskliniken Salzburg, Austria France C.H.U. - Hopital Michallon Grenoble, France CHU Lille - Hôpital Cardiologique Lille, France Germany Herzzentrum Bernau, Germany Universitätsklinikum Heidelberg, Germany Lukas Krankenhaus Neuss Neuss, Germany Herzzentrum Siegburg GmbH Siegburg, Germany Israel Sheba Medical Center Ramat Gan, Israel Italy Azienda Ospedaliera Riuniti Bergamo, Italy Ospedale Civile Mirano, Italy Azienda Ospedaliera di Padova Padova, Italy IRCCS Policlinico San Matteo Pavia, Italy Azienda Ospedaliera S. Gdi Dio Salerno Salerno, Italy Malaysia Institute Jantung Negara Kuala Lumpur, Malaysia Netherlands Medisch Centrum Alkmaar Alkmaar, Netherlands Maasstad Ziekenhuis Rotterdam, Netherlands Poland Medical University of Bydgoszcz Bydgoszcz, Poland Spain General De Alicante Alicante, Spain Hospital Belvigte de Barcelona Barcelona, Spain Hospital Santa Creu I Sant Pau Barcelona, Spain Clinico San Carlos Madrid, Spain Hospital Puerta de Hierro Madrid, Spain La Paz Madrid, Spain Hospital Virgen de la Arrixaca Murcia, Spain Hospital General de Valencia Valencia, Spain Thailand King Chulalongkorn Memorial Hospital Bangkok, Thailand United Kingdom King's College Hospital London, United Kingdom Wessex Cardiac Unit Southampton, United Kingdom, SO16 6YD Less <<
NCT00712491 Age-related Macular Degenerati... More >>on Choroidal Neovascularization Less << Phase 1 Phase 2 Terminated - United States, Arizona ... More >> Retinal Consultants of Arizona Phoenix, Arizona, United States, 85044 Less <<
NCT01583608 - Completed - Germany ... More >> Herzzentrum Brandenburg in Bernau Bernau, Germany, 16321 Klinikum Coburg GmbH Coburg, Germany, 96450 Elisabeth-Krankenhaus Essen GmbH Essen, Germany, 45138 Medical Care Center Prof. Mathey, Prof. Schofer GmbH Hamburg, Germany, 22527 Universitätsklinikum Schleswig-Holstein Kiel, Germany, 24105 Universitätsklinikum Ulm Ulm, Germany, 89081 Less <<
NCT00248313 Kidney Disease Phase 3 Completed - -
NCT00808899 - Terminated(Voluntarily closed ... More >>and terminated by the PI due to lack of feasibility) Less << - -
NCT00808899 Neuroblastoma Phase 2 Terminated(Voluntarily closed ... More >>and terminated by the PI due to lack of feasibility) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02040584 Liver Transplant Phase 3 Completed - Spain ... More >> Novartis Investigative Site Cordoba, Andalucia, Spain, 14004 Novartis Investigative Site Malaga, Andalucia, Spain, 29010 Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Oviedo, Asturias, Spain, 33011 Novartis Investigative Site Valladolid, Castilla y Leon, Spain, 47012 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Barcelona, Cataluña, Spain, 08036 Novartis Investigative Site L'Hospitalet de Llobregat, Cataluña, Spain, 08907 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Novartis Investigative Site La Coruna, Galicia, Spain, 15006 Novartis Investigative Site Santiago de Compostela, Galicia, Spain, 15706 Novartis Investigative Site Majadahonda, Madrid, Spain, 28222 Novartis Investigative Site El Palmar, Murcia, Spain, 30120 Novartis Investigative Site Pamplona, Navarra, Spain, 31008 Novartis Investigative Site Barakaldo, Pais Vasco, Spain, 48903 Novartis Investigative Site Madrid, Spain, 28007 Novartis Investigative Site Madrid, Spain, 28034 Novartis Investigative Site Madrid, Spain, 28041 Novartis Investigative Site Santa Cruz de Tenerife, Spain, 38009 Novartis Investigative Site Zaragoza, Spain, 50009 Less <<
NCT02792920 ST-elevation Acute Myocardial ... More >>Infarction STEMI Less << Not Applicable Unknown - Japan ... More >> Hyogo Brain and Heart Center Recruiting Himeji, Hyogo,, Japan, 6700981 Contact: Yoshinori Yasaka, M.D.    +81-79-293-3131       Higashi Takarazuka Sato Hospital Recruiting Takarazuka, Hyogo, Japan, 6650873 Contact: Satoru Otsuji, M.D.    +81-797-88-2200 Less <<
NCT02979873 Severe Aplastic Anemia Phase 2 Recruiting August 31, 2023 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00531011 Coronary Disease ... More >> Coronary Artery Disease Coronary Artery Stenosis Coronary Artery Restenosis Less << Phase 4 Completed - Italy ... More >> A.O. San Giovanni di Dio Agrigento, Italy Ospedale Maggiore Bologna Bologna, Italy Policlinico S. Orsola - Malpighi Bologna, Italy A.O. Cannizzaro Catania, Italy A.O. Universitaria Vittorio Emanuele - Ferrarotto - S. Bambino Catania, Italy A.O. Università Mater Domini c/o Campus Università Magna Grecia Catanzaro, Italy A.O. Universitaria OO.RR Foggia Foggia, Italy E.O. Ospedali Galliera Genova, Italy A.O. Carlo Poma Mantova, Italy Centro Cardiologico Monzino Milano, Italy Ospedale Loreto Mare Napoli, Italy A. O. Sant'Andrea Roma, Italy Ospedale Generale Madre Vannini Roma, Italy Ospedale Sandro Pertini Roma, Italy A.S.O. Molinette San Giovanni Battista di Torino Torino, Italy Ospedale Maria Vittoria Torino, Italy P.O. San Giovanni Bosco Torino, Italy San Giovanni Battista - Ospedale Molinette Torino, Italy A.O. Universitaria - Ospedale Riuniti Umberto I - G.M. Lancisi - G. Salesi Torrette Di Ancona, Italy Ospedale Civile Maggiore - Università di Verona Verona, Italy, 37142 Ospedale Civile Vicenza, Italy Ospedale Civile di Vigevano Vigevano, Italy A.O. Della Provincia di Pavia Voghera, Italy Policlinico San Marco Zingonia, Italy Less <<
NCT01171820 - Completed - -
NCT01065532 Restenosis Not Applicable Unknown December 2015 Belgium ... More >> University Hospitals Leuven Recruiting Leuven, Belgium, 3000 Contact: Tom Adriaenssens, MD    +32 16 34 24 65    tom.adriaenssens@uzleuven.be    Contact: Walter Desmet, MD, PhD    +32 16 34 24 65    walter.desmet@uzleuven.be    Principal Investigator: Tom Adriaenssens, MD          Sub-Investigator: Walter Desmet, MD, PhD          Sub-Investigator: Christophe Dubois, MD Less <<
NCT02069093 - Completed - -
NCT00862979 Heart Transplantation Phase 4 Completed - Germany ... More >> Novartis Investigative Site Bad Oeynhausen, Germany, 32545 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Leipzig, Germany, 04289 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site München, Germany, 81377 Novartis Investigative Site Regensburg, Germany, 93053 Less <<
NCT00531011 - Completed - -
NCT01137019 Coronary Heart Disease Phase 3 Unknown December 2014 Australia, Victoria ... More >> The Northern Hospital Epping, Victoria, Australia, 3076 Less <<
NCT02069093 Advanced Breast Cancer Phase 2 Completed - -
NCT00862979 - Completed - -
NCT00698607 Coronary Artery Disease Phase 4 Unknown April 2014 Korea, Republic of ... More >> Seoul National University Hospital Seoul, 28 Yongon Dong, Jongro Gu, Korea, Republic of, 110-744 Less <<
NCT00240214 - Terminated - Germany ... More >> Multiple Cities, Germany Less <<
NCT01735825 Restenosis Phase 4 Unknown December 2016 Czech Republic ... More >> University Hospital Ostrava, Czech Republic, 708 52 Less <<
NCT00134940 - Completed - Austria ... More >> Novarits Graz, Austria Novartis Investigative Site Innsbruck, Austria Novartis Wein, Austria Germany Novartis Bad Oeynhausen, Germany Novartis Investigative Site Berlin, Germany Novartis Erlangen, Germany Less <<
NCT00882219 Coronary Restenosis Phase 3 Completed - France ... More >> Hopital de Rangueil - Chu Toulouse, France, 31403 Less <<
NCT01986803 Acute ST Segment Elevation Myo... More >>cardial Infarction Less << Not Applicable Completed - Denmark ... More >> Research centre Aarhus, DK003 Aarhus, Denmark Research centre Odense, DK002 Odense, Denmark Netherlands Research centre Leeuwarden, NL002 Leeuwarden, Netherlands Research centre Nieuwegein, NL014 Nieuwegein, Netherlands Spain Research centre Barcelona, ES001 Barcelona, Spain Research centre Barcelona, ES003 Barcelona, Spain Research centre Vigo, ES004 Vigo, Spain Switzerland Research centre Bern, CH006 Bern, Switzerland Less <<
NCT00470665 Renal Allograft Recipients Phase 3 Completed - -
NCT01276834 Renal Transplantation Phase 4 Terminated(insufficient patien... More >>ts enrolled) Less << - Netherlands ... More >> University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Less <<
NCT00697112 - Completed - Argentina ... More >> Pfizer Investigational Site Caba, Buenos Aires, Argentina, 1425 Pfizer Investigational Site Caba, Buenos Aires, Argentina, C1093AAS Pfizer Investigational Site Caba, Buenos Aires, Argentina, C1181ACH Pfizer Investigational Site Caba, Buenos Aires, Argentina Pfizer Investigational Site Barrio General Paz, Cordoba, Argentina, 5016 Pfizer Investigational Site Cordoba, Argentina, 5016 Pfizer Investigational Site Santa Fe, Argentina, 3000 Pfizer Investigational Site Tucuman, Argentina, 4000 Less <<
NCT02073565 Coronary Arteriosclerosis ... More >> Non ST Segment Elevation Acute Coronary Syndrome Less << Not Applicable Active, not recruiting November 2020 -
NCT02073565 - Active, not recruiting - -
NCT02296749 Healthy Phase 1 Completed - India ... More >> Bioserve Clinical Research Pvt. Ltd Balanagar, Hyderabad, Andhra Pradesh, India, 500 037 Less <<
NCT01596062 - Completed - -
NCT02296762 Healthy Phase 1 Completed - India ... More >> Bioserve Clinical Research Pvt. Ltd Balanagar, Hyderabad, Andhra Pradesh, India, 500 037 Less <<
NCT01065519 Coronary Artery Disease Not Applicable Unknown June 2015 Belgium ... More >> University Hospitals Leuven Recruiting Leuven, Belgium, 3000 Contact: Tom Adriaenssens, MD    +32 16 34 24 65    tom.adriaenssens@uzleuven.be    Contact: Walter Desmet, MD, PhD    +32 16 34 24 65    walter.desmet@uzleuven.be    Principal Investigator: Tom Adriaenssens, MD          Sub-Investigator: Walter Desmet, MD, PhD          Sub-Investigator: Christophe Dubois, MD Less <<
NCT02057965 Renal Transplant Rejection ... More >> Fibrosis Less << Phase 2 Recruiting December 2018 Netherlands ... More >> Leiden University Medical Center Recruiting Leiden, Netherlands, 2333 ZA Principal Investigator: Marlies EJ Reinders, MD/PhD Less <<
NCT02150876 - Completed - Switzerland ... More >> University of Freiburg Freiburg, Switzerland, 1700 Less <<
NCT01596062 Renal Transplantation Phase 2 Completed - France ... More >> Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Paris cedex 15, France, 75015 Novartis Investigative Site Tours Cedex, France, 37044 Less <<
NCT00355862 Hepatocellular Carcinoma Phase 3 Completed - Germany ... More >> Regensburg University Regensburg, Bavaria, Germany, 93053 Less <<
NCT00820911 Kidney Transplantation Phase 2 Completed - -
NCT03726892 Coronary Artery Disease Not Applicable Not yet recruiting July 2022 -
NCT00697112 - Completed - -
NCT00824434 - Completed - -
NCT02134288 Delayed Graft Function Early Phase 1 Recruiting December 2017 United States, Ohio ... More >> The Ohio State Universtiy Wexner Medical Center Recruiting Columbus, Ohio, United States, 43212 Contact: Margaret Wuebker    614-293-4665    margaret.wuebker@osumc.edu    Principal Investigator: Jon Von Visger, M.D./Ph.D. Less <<
NCT03284242 End Stage Renal Disease ... More >> Kidney Transplant Less << Not Applicable Not yet recruiting December 31, 2019 United States, Kentucky ... More >> University of Kentucky Medical Center Not yet recruiting Lexington, Kentucky, United States, 40536 Less <<
NCT00824434 Atherosclerosis ... More >> Coronary Artery Disease Less << Phase 3 Completed - Australia, New South Wales ... More >> St. Vincent's Hospital - Sydney Darlinghurst, New South Wales, Australia, 2010 Royal North Shore Hospital St Leonards, New South Wales, Australia, 2065 Australia, Victoria Monash Medical Centre Clayton, Victoria, Australia, 3168 St. Vincent Hospital (Melbourne) Fitzroy, Victoria, Australia, 3065 Australia, Western Australia Fremantle Hospital Fremantle, Western Australia, Australia, 6160 Australia Royal Adelaide Hospital Adelaide, Australia, 5000 The Prince Charles Hospital Brisbane, Australia, 4032 Liverpool Hospital Liverpool, Australia, 2170 Sir Charles Gairdner Hospital Perth, Australia, 6009 Malaysia Institut Jantung Negara Kuala Lumpur, Malaysia, 50400 New Zealand Middlemore Hospital Otahuhu, Auckland, New Zealand North Shore Hospital Takapuna, Auckland, New Zealand, 0622 Christchurch Hospital Christchurch, New Zealand, 8001 Dunedin Hospital Dunedin, New Zealand, 9001 Wellington Hospital Wellington, New Zealand Singapore National University Hospital, Singapore Singapore, Singapore, 119074 National Heart Centre Singapore Singapore, Singapore, 168752 Less <<
NCT03375320 Atypical Carcinoid Tumor ... More >> Carcinoid Tumor Digestive System Neuroendocrine Neoplasm Enterochromaffin Cell Serotonin-Producing Pancreatic Neuroendocrine Tumor Functional Pancreatic Neuroendocrine Tumor Intermediate Grade Lung Neuroendocrine Neoplasm Low Grade Lung Neuroendocrine Neoplasm Lung Atypical Carcinoid Tumor Lung Carcinoid Tumor Metastatic Digestive System Neuroendocrine Tumor G1 Neuroendocrine Neoplasm Nonfunctional Pancreatic Neuroendocrine Tumor Pancreatic Neuroendocrine Tumor Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7 Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7 Stage IV Digestive System Neuroendocrine Tumor AJCC v7 Less << Phase 3 Recruiting January 1, 2021 -
NCT01524601 Disorder Related to Renal Tran... More >>splantation Hypercholesterolemia Less << Phase 4 Completed - Norway ... More >> Oslo University Hospital, Rikshospitalet Oslo, Norway, 0027 Less <<
NCT00490789 Tuberous Sclerosis ... More >> Lymphangioleiomyomatosis Less << Phase 2 Unknown September 2009 United Kingdom ... More >> University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XN Royal Sussex County Hospital Brighton, United Kingdom, BN2 5BE City Hospital Nottingham, United Kingdom, NG5 1PB Less <<
NCT02123823 Neoplasms Phase 1 Active, not recruiting December 16, 2018 -
NCT02981134 - Not yet recruiting June 2021 Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT00989066 - Completed - Brazil ... More >> CIAS Unimed Vitória Vitória, ES, Brazil Encore Goiânia, GO, Brazil Hospital Lifecenter Belo Horizonte, MG, Brazil Hospital Mater Dei Belo Horizonte, MG, Brazil Hospital Madre Tereza Nova Lima, MG, Brazil Instituto do Coração do Triângulo Mineiro Uberlândia, MG, Brazil Centro Interado de Medicina Intervencionista Belém, Pará, Brazil Maximagem Recife, PE, Brazil Hospital Cardiológico Costantini Curitiba, PR, Brazil Instituto de Neurologia de Curitiba Curitiba, PR, Brazil Hemocor Jacarepagua, RJ, Brazil Barra DOr Rio de Janeiro, RJ, Brazil Hospital Copa DOr Rio de Janeiro, RJ, Brazil Hospital Quinta DOr Rio de Janeiro, RJ, Brazil Hospital São Vicente de Paulo Passo Fundo, RS, Brazil Fundação Universitária de Cardiologia Porto Alegre, RS, Brazil Hospital Moinhos de Vento Porto Alegre, RS, Brazil Hospital São Lucas da PUC Porto Alegre, RS, Brazil Santa Casa de Porto Alegre Porto Alegre, RS, Brazil Hospital Albert Einstein São Paulo, SP, Brazil Hospital Bandeirantes São Paulo, SP, Brazil Hospital Beneficência Portuguesa São Paulo, SP, Brazil Hospital do Coração São Paulo, SP, Brazil Instituto Dante Pazzanese de Cardiologia São Paulo, SP, Brazil Less <<
NCT02579031 Coronary Artery Disease ... More >> Acute Coronary Syndrome Less << Not Applicable Active, not recruiting June 2019 Switzerland ... More >> Kantonsspital Aarau Aarau, Switzerland Universitätsspital Basel Basel, Switzerland Bern University Hospital, Dep. of Cardiology Bern, Switzerland, 3010 Universität Freiburg Freiburg, Switzerland HUG Genf, Switzerland Lausanne University Hospital Lausanne, Switzerland, 1011 Kantonsspital Luzern Luzern, Switzerland Spital Wallis Sion, Switzerland Kantonsspital St. Gallen St. Gallen, Switzerland Triemli Zürich, Switzerland Less <<
NCT01762410 Advanced Refractory Solid Tumo... More >>rs Less << Phase 1 Suspended(Sponsor decision not... More >> related to patient safety) Less << March 2016 United States, California ... More >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 India Medanta Duke Research Institute (MDRI) Gurgaon, Haryana, India, 122001 Central India Cancer Research Institute Nagpur, Maharashtra, India Meenakshi Mission Hospital & Research Centre Madurai, Tamil Nadu, India, 625107 Less <<
NCT00598637 Coronary Disease Phase 4 Completed - Germany ... More >> Bad Segeberger Kliniken Bad Segeberg, Germany Deutsches Herzzentrum Muenchen Munich, Germany, 80636 First Medizinische Klinik, Klinikum rechts der Isar Munich, Germany, 81675 Italy Azienda Ospedaliero Universitaria di Ferrara Ferrara, Italy, 44100 Less <<
NCT02109744 Acute Myelogenous Leukemia Phase 1 Phase 2 Recruiting December 2020 United States, New York ... More >> University of Rochester Recruiting Rochester, New York, United States, 14642 Contact: Haley Misch    585-275-9485    Haley_Misch@urmc.rochester.edu    Contact: Robin Boerman    585-273-1507    Robin_Boerman@urmc.rochester.edu    Principal Investigator: Jane Liesveld, MD          Sub-Investigator: Kristen O'Dwyer, MD Less <<
NCT01239654 Acute Coronary Syndrome Phase 3 Completed - Italy ... More >> Università della Magna Grecia Catanzaro, Italy, 88100 Careggi Hospital Florence, Italy, 50134 San Raffaele Hospital Milan, Italy, 20132 Ospedale Civile di Mirano Mirano, Italy, 30035 Less <<
NCT01350869 - Completed - Korea, Republic of ... More >> Asan medical center Seoul, Korea, Republic of, 138-739 Less <<
NCT02151929 ST Elevation Acute Myocardial ... More >>Infarction Less << Phase 4 Completed - Italy ... More >> Division of Cardiology Ao Moscati Avellino, Italy, 83100 Less <<
NCT03091465 - Completed - -
NCT02770651 - Enrolling by invitation December 2018 Korea, Republic of ... More >> Keimyung University Dongsan Medical Center Daegu, Korea, Republic of Less <<
NCT02254668 Intimal Proliferation ... More >> Immunosuppression Less << Phase 4 Recruiting February 2023 Switzerland ... More >> University Hospital Zurich, Division of Cardiology Recruiting Zurich, Switzerland, 8091 Contact: Christian Templin, MD, PhD    +41 (0)44 / 255 9585    christian.templin@usz.ch    Contact: Frank Ruschitzka, Professor    +41 (0)44 / 255 3957    frank.ruschitzka@usz.ch    Principal Investigator: Christian Templin, MD, PhD Less <<
NCT00467194 Liver Cancer Phase 1 Completed - Singapore ... More >> National Cancer Centre - Singapore Singapore, Singapore, 169610 Johns Hopkins Singapore International Medical Centre Singapore, Singapore, 308433 Less <<
NCT00567554 Breast Cancer Phase 3 Completed - Germany ... More >> Universitätsfrauenklinik Frankfurt / Main Frankfurt / Main, Germany Less <<
NCT01143779 Advanced Cancer Phase 1 Active, not recruiting June 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01146080 Coronary Artery Disease Phase 3 Completed - Italy ... More >> Cardiovascular Department Ospedali Riuniti di Bergamo Bergamo, BG, Italy, 24128 Less <<
NCT00916695 Coronary Artery Disease Phase 4 Unknown February 2011 Spain ... More >> Hospital Universitario Virgen Macarena Recruiting Sevilla, Spain, 41007 Contact: Rafael J Ruiz-Salmeron, PhD    +34955693440    rjruizsalmeron@yahoo.es    University Hospital Virgen Macarena Not yet recruiting Seville, Spain, 41007 Contact: Rafael j Ruiz-Salmeron, PhD    0034955693449    rjruizsalmeron@yahoo.es    Principal Investigator: Rafael J Ruiz-Salmeron, Phd          Sub-Investigator: Manuel Vizcaino, PhD          Sub-Investigator: Sergio Rodriguez-Leiras, MD          Sub-Investigator: Cesar Carrascosa, MD          Sub-Investigator: Francisco Marcos, PhD Less <<
NCT00037531 Graft vs Host Disease ... More >> Kidney Transplantation Less << Phase 3 Completed - United States, California ... More >> Los Angeles, California, United States, 90057 Los Angeles, California, United States, 90095-1752 San Diego, California, United States, 92123 Stanford, California, United States, 94304 United States, Florida Tampa, Florida, United States, 33606 United States, Georgia Atlanta, Georgia, United States, 30322 Augusta, Georgia, United States, 30912 United States, Illinois Chicago, Illinois, United States, 60637 United States, Indiana Indianapolis, Indiana, United States, 46202-5250 United States, New York New York, New York, United States, 10029 United States, North Carolina Charlotte, North Carolina, United States, 28232 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19141 Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina Charleston, South Carolina, United States, 29425-0777 Canada, Alberta Edmonton, Alberta, Canada, T6G 2B7 Canada, British Columbia Vancouver, British Columbia, Canada, V5Z 1M9 Canada, Nova Scotia Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario Toronto, Ontario, Canada, M5B 1W8 Toronto, Ontario, Canada, M5G 2C4 Canada, Quebec Montreal, Quebec, Canada, H2L 2W5 Less <<
NCT00140530 Coronary Disease Phase 4 Completed - Germany ... More >> Deutsches Herzzentrum Muenchen Munich, Germany, 80636 First Medizinische Klinik, Klinikum rechts der Isar Munich, Germany, 81675 Less <<
NCT00531440 Renal Transplantation Phase 3 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT02049229 Myocardial Infarction ... More >> Percutaneous Coronary Intervention Atherosclerosis Less << Phase 4 Recruiting October 2019 Finland ... More >> Heart Center, Helsinki University Hospital Recruiting Helsinki, Finland Contact: Mika Laine, MD, PhD,          Principal Investigator: Mika Laine, MD, PhD,          Kokkola Central Hospital Recruiting Kokkola, Finland Contact: Jussi Sia, MD          Principal Investigator: Jussi Sia, MD          Heart Center, Kuopio University Hospital Recruiting Kuopio, Finland Contact: Hannu Romppanen, MD, PhD          Principal Investigator: Hannu Romppanen, MD, PhD          Sub-Investigator: Anssi Perälä, MD          Dep.Of Cardiology, Oulu University Hospital Recruiting Oulu, Finland Contact: Kari Kervinen, adj. Prof.          Principal Investigator: Kari Kervinen, adj. Prof.          Sub-Investigator: Matti Niemelä, adj. Prof.          Sub-Investigator: Timo Mäkikallio, adj. Prof.          Heart Center, Satakunta Central Hospital Recruiting Pori, Finland, 28500 Contact: Pasi P Karjalainen, adj.Professor    +358 2 627 7500    pasi.karjalainen@satshp.fi    Sub-Investigator: Jussi Mikkelsson, MD, Phd          Sub-Investigator: Tuomas Paana, MD          Principal Investigator: Pasi P Karjalainen, adj. Professor          Heart Center, Turku University Hospital Recruiting Turku, Finland, 20100 Contact: Juhani Airaksinen, Professor       juhani.airaksinen@tyks.fi    Contact: Mikko Pietilä, MD, PhD       mikko.pietila@tyks.fi    Principal Investigator: Juhani Airaksinen, Prof.          Sub-Investigator: Mikko Pietilä, MD, PhD Less <<
NCT00552669 Coronary Heart Disease ... More >> Coronary Restenosis Less << Phase 4 Completed - Argentina ... More >> Clinica IMA Adrogue, Buenos Aires, Argentina, 1846 Sanatorio Las Lomas San Isidro, Buenos Aires, Argentina, 1354 Sanatorio Otamendi y Miroli Buenos Aires, Argentina, 1115 Less <<
NCT00443508 Kidney Diseases Phase 4 Unknown - Israel ... More >> Transplantation department, rabin Medical Center Recruiting Petach Tikva, Israel, 49202 Contact: Eytan Mor, Prof    00937 3 9376528    tikim@clalit.org.il    Principal Investigator: Eytan Mor, Prof          Sub-Investigator: Ruti Rahamimov, Dr          Sub-Investigator: Alex Yusim, Dr Less <<
NCT00634270 - Completed - -
NCT00803010 Acute Graft Versus Host Diseas... More >>e Less << Phase 2 Completed - United States, Florida ... More >> H.Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 Less <<
NCT00618345 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - -
NCT00803010 - Completed - -
NCT01412164 Coronary Artery Disease Not Applicable Unknown February 2017 China ... More >> Fuwai Hospital Beijing, China Less <<
NCT00634270 Neurofibromatosis Type 1 Phase 2 Completed - United States, Alabama ... More >> The University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, District of Columbia Children's National Medical Center Washington, D.C., District of Columbia, United States, 20010 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, Missouri Washington University Saint Louis, Missouri, United States, 63110 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-4006 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19096 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Less <<
NCT00552669 - Completed - -
NCT00676520 - Completed - -
NCT00353301 - Completed - -
NCT01412164 - Unknown - -
NCT00353301 Renal Cell Carcinoma Phase 2 Completed - United States, Colorado ... More >> University of Colorado Hospital Aurora, Colorado, United States, 80010 Less <<
NCT00676520 - Completed - United States, California ... More >> Abbott Vascular Santa Clara, California, United States, 95054 Less <<
NCT01148329 - Completed - -
NCT00768846 Coronary Artery Disease Phase 4 Unknown June 2011 Germany ... More >> 1st Medizinische Klinik Klinikum rechts der Isar Recruiting Munich, Germany, 81675 Contact: Josef Dirschinger, MD    +49-4140 ext 2947    dirschinger@med1.med.tum.de    Deutsches Herzzentrum Munich Recruiting Munich, Germany, 81675 Contact: Julinda Mehilli, MD    +49-1218- ext 4582    mehilli@dhm.mhn.de    Contact: Stefanie Schulz, MD    +49-1218- ext 1521    schulzs@dhm.mhn.de Less <<
NCT02091531 Metastatic Castration-Resistan... More >>t Prostate Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01093300 In-stent Restenosis Lesion Phase 4 Unknown - Korea, Republic of ... More >> Seoul National University Hospital Not yet recruiting Seoul, Korea, Republic of, 110-744 Principal Investigator: Hyo-Soo Kim, MD, PhD Less <<
NCT00962507 Lymphoma Mult... More >>iple Myeloma and Plasma Cell Neoplasm Less << Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 City of Hope Medical Group Pasadena, California, United States, 91105 Less <<
NCT01056744 Stents Neoint... More >>imal Proliferation Less << Phase 4 Completed - Germany ... More >> University Hospital of Jena, 1st Medical Department, Division of Cardiology Jena, Germany, 07740 Less <<
NCT00369161 Renal Transplantation Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00369161 - Completed - -
NCT00856856 Coronary Disease ... More >> Coronary Artery Disease Coronary Restenosis Less << Phase 1 Phase 2 Unknown April 2016 Australia, Victoria ... More >> St. Vincent's Hospital Melbourne, Victoria, Australia, 3065 Australia Monash Heart Melbourne, Australia Belgium Onze-Lieve VrouweZiekenhuis Aalst, Belgium Denmark Skejby Sygehus Aarhus, Denmark France Institut Hospitalier Jacques Cartier Massy, France Netherlands Catharina ZH Eindhoven Eindhoven, Netherlands Erasmus Medical Center Rotterdam, Netherlands Maasstad Ziekenhuis Rotterdam, Netherlands New Zealand Auckland City Hospital Auckland, New Zealand Christchurch Hospital Christchurch, New Zealand Poland Jagiellonian University Krakow, Poland Switzerland Inselspital Bern, Kardiologie Bern, Switzerland, 3010 Less <<
NCT01390818 Locally Advanced Solid Tumor ... More >> Metastatic Solid Tumor Breast Cancer Non Small Cell Lung Cancer Melanoma Colorectal Cancer Less << Phase 1 Completed - United States, Arizona ... More >> Pinnacle Oncology Hematology Scottsdale, Arizona, United States, 85258 United States, California Cedars Sinai Medical Center Los Angeles, California, United States, 90048 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37205 United States, Texas Cancer Therapy and Research Center San Antonio, Texas, United States, 78229 Italy Merck Serono Research Site Milan, Italy Spain Merck Serono Research Site Madrid, Spain Less <<
NCT02482974 - Completed - Turkey ... More >> Ege University Izmir, Turkey, 35100 Less <<
NCT00180453 Coronary Artery Disease ... More >> Everolimus Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Less << Phase 3 Completed - Denmark ... More >> Skejby Sygehus Aarhus, Denmark Germany Herzzentrum Bad Krozingen Bad Krozingen, Germany, 79189 Kerckhoff-Klinik Bad Nauheim, Germany, 61231 Herzzentrum Bad Oeynhausen Bad Oeynhausen, Germany, 32545 Herzzentrum Siegburg GmbH Siegburg, Germany Netherlands Academisch Medisch Centrum Amsterdam, Netherlands, 1105 AZ Erasmus Medical Center Rotterdam, Netherlands Less <<
NCT00819923 Acute Coronary Syndrome Phase 3 Unknown December 2014 Finland ... More >> Helsinki University Hospital Helsinki, Finland Jyvaskyla Central Hospital Jyvaskyla, Finland Keski-Pohjanmaan Keskusairaala Kokkola, Finland Oulu University Hospital Oulu, Finland, 90100 Satakunta Central Hospital Pori, Finland, 28500 Turku University Hospital Turku, Finland Less <<
NCT03670030 Neuroendocrine Tumors Phase 2 Not yet recruiting November 1, 2020 -
NCT00251004 - Completed - -
NCT02513732 - Active, not recruiting March 2021 Japan ... More >> Hyogo Prefectural Amagasaki Hospital Hyogo, Japan, 660-0828 Ishikawa Prefectural Central Hospital Ishikawa, Japan, 920-8530 Miyazaki Medical Association Hospital Miyazaki, Japan, 880-0834 Osaka Police Hospital Osaka, Japan, 543-0035 JCHO Hokkaido Hospital Sapporo, Japan, 062-8618 Tokushima Red Cross Hospital Tokushima, Japan, 773-8502 Mitsui Memorial Hospital Tokyo, Japan, 101-8643 Toranomon Hospital Tokyo, Japan, 105-8470 Teikyo University Hospital Tokyo, Japan, 173-8606 Showa University Fujigaoka Hospital Yokohama, Japan, 227-8501 Less <<
NCT01078038 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Sam Anyang Hospital Anyang, Korea, Republic of Soonchunhyang University Bucheon Hospital Bucheon, Korea, Republic of Busan Paik Hospital Busan, Korea, Republic of St.Mary's Catholic Medical Center Busan, Korea, Republic of Soonchunhyang University Cheonan Hospital Cheonan, Korea, Republic of St.Mary's Catholic Medical Center Cheongju, Korea, Republic of Gangwon National University Hospital Chuncheon, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Asan Medical Center GangNeung, Korea, Republic of Gwangju Christian Hospital Gwangju, Korea, Republic of Dongguk University Hospital Gyongju, Korea, Republic of St.Mary's Catholic Medical Center Inchon, Korea, Republic of Jeju Hanla Hospital Jeju, Korea, Republic of Gyeongsang Uniservity Hospital Jinju, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Hangang Sacred Heart Hospital Seoul, Korea, Republic of Seoul Veterans Hospital Seoul, Korea, Republic of St.Mary's Catholic Medical Center Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT01390818 - Completed - -
NCT01649609 BK Viremia BK... More >> Nephropathy Less << Not Applicable Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Weill Cornell Medical Center New York, New York, United States, 10065 Less <<
NCT01308346 Coronary Artery Disease Not Applicable Terminated(Due to a challengin... More >>g protocol inclusion/ exclusion criteria, only one subject was enrolled since the trial was initiated in June 2011.) Less << - Australia, Victoria ... More >> Austin Health Heidelberg, Victoria, Australia, 3084 Australia Royal Adelaide Hospital Adelaide, Australia, 5000 Monash Medical Centre Melbourne, Australia, 3168 China Queen Elizabeth Hong Kong, China Netherlands Maasstad Ziekenhuis Rotterdam, Netherlands Singapore National Heart Centre Singapore Singapore, Singapore, 168752 Less <<
NCT00251004 Kidney Transplantation ... More >> Graft Rejection Less << Phase 3 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Less <<
NCT01649609 - Completed - -
NCT03484234 Coronary Artery Disease ... More >> Coronary Stenosis Less << Not Applicable Recruiting December 30, 2022 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Seung-jung Park, MD       sjpark@amc.seoul.kr    Principal Investigator: Seung-jung Park, MD Less <<
NCT01374750 Hepatocellular Carcinoma Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT02505893 Diabetes Mellitus, Type 1 Phase 2 Recruiting May 2018 Italy ... More >> IRCCS San Raffaele Scientific Institute Recruiting Milan, Italy, 20132 Contact: Lorenzo Piemonti, MD       piemonti.lorenzo@hsr.it    Contact: Paola Maffi, MD       paola.maffi@hsr.it    Sub-Investigator: Paola Maffi, MD          Principal Investigator: Emanuele Bosi, MD          Sub-Investigator: Andrea Bolla, MD Less <<
NCT01353053 - Unknown - Brazil ... More >> Hospital Israelita Albert Einstein Recruiting Sao Paulo, SP, Brazil Contact: Lucio Requião Moura    55-11    lrequiao@nefro.epm.br    Principal Investigator: Alvaro Pacheco-Silva, Doctor Less <<
NCT01310309 - Completed - Italy ... More >> A.O. San Giovanni di Dio Agrigento, Italy Ospedale Maggiore Bologna Bologna, Italy Policlinico S. Orsola - Malpighi Bologna, Italy A.O. Cannizzaro Catania, Italy A.O. Universitaria Vittorio Emanuele - Ferrarotto - S. Bambino Catania, Italy A.O. Università Mater Domini c/o Campus Università Magna Grecia Catanzaro, Italy A.O. Universitaria OO.RR Foggia Foggia, Italy E.O. Ospedali Galliera Genova, Italy A.O. Carlo Poma Mantova, Italy Centro Cardiologico Monzino Milano, Italy Ospedale Loreto Mare Napoli, Italy A. O. Sant'Andrea Roma, Italy Ospedale Generale Madre Vannini Roma, Italy Ospedale Sandro Pertini Roma, Italy A.S.O. Molinette San Giovanni Battista di Torino Torino, Italy Ospedale Maria Vittoria Torino, Italy P.O. San Giovanni Bosco Torino, Italy San Giovanni Battista - Ospedale Molinette Torino, Italy A.O. Universitaria - Ospedale Riuniti Umberto I - G.M. Lancisi - G. Salesi Torrette Di Ancona, Italy Ospedale Civile Maggiore - Università di Verona Verona, Italy, 37142 Ospedale Civile Vicenza, Italy Ospedale Civile di Vigevano Vigevano, Italy A.O. Della Provincia di Pavia Voghera, Italy Less <<
NCT02233049 Diffuse Intrinsic Pontine Glio... More >>ma Less << Phase 2 Recruiting October 2018 France ... More >> Gustave Roussy Recruiting Villejuif, Val De Marne, France, 94805 Contact: Jacques GRILL, MD, PhD    0142116209 ext +33    jacques.grill@gustaveroussy.fr    Contact: Perrine CAPOLINO    0142114211 ext +33    perrine.capolino@gustaveroussy.fr    Principal Investigator: Jacques GRILL, MD, PhD Less <<
NCT00121810 Kidney Transplantation Phase 4 Completed - -
NCT00121810 - Completed - -
NCT03662412 Pancreatic Cancer Phase 1 Phase 2 Recruiting June 30, 2023 China, Zhejiang ... More >> The second affiliated hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310009 Contact: Qi Zhang, MD    8613819137113 Less <<
NCT03040934 Drug-Eluting Stents ... More >> Percutaneous Coronary Intervention Tomography, Optical Coherence Less << Not Applicable Not yet recruiting December 2023 -
NCT03646240 Epilepsy Intractable Phase 1 Recruiting July 2019 United States, Washington ... More >> Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Renee Rivers    206-987-1697    renee.rivers@seattlechildrens.org Less <<
NCT01658176 Breast Neoplasms Phase 2 Withdrawn April 2015 -
NCT02066623 - Active, not recruiting March 2021 -
NCT00811915 Kidney Transplantation Phase 3 Completed - France ... More >> UHAmiens Amiens, France UHAngers Angers, France, 49933 UHCaen Caen, France, 14000 UHLimoges Limoges, France UHNecker Paris, France, 75015 UHRennes Rennes, France, 35000 UHRouen Rouen, France, 76000 UHTours Tours, France Less <<
NCT01073111 Coronary Artery Disease ... More >> Atherosclerosis Less << Not Applicable Withdrawn - Japan ... More >> Hyogo College of Medicine Nishinomiya, Japan, 6638501 Less <<
NCT01712828 Healthy Phase 1 Completed - United States, Texas ... More >> Covance Clinical Research Unit Dallas Dallas, Texas, United States, 75247 Less <<
NCT00814944 Dry Eye Phase 2 Completed - United States, Massachusetts ... More >> Ophthalmic Research Associates Andover, Massachusetts, United States, 01810 Less <<
NCT02055079 Polycystic Kidney, Type 1 Auto... More >>somal Dominant Disease Polycystic Kidney, Type 2 Autosomal Dominant Disease Less << Phase 3 Recruiting December 2019 Austria ... More >> Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna Recruiting Vienna, Austria, 1090 Contact: Markus Riegersperger, MD    0043140400 ext 4391    markus.riegersperger@gmail.com    Contact: Gere Sunder-Plassmann, MD    0043140400 ext 4391    gere.sunder-plassmann@meduniwien.ac.at    Principal Investigator: Markus Riegersperger, MD          Sub-Investigator: Gere Sunder-Plassmann, MD Less <<
NCT00960648 - Unknown - Korea, Republic of ... More >> Dankook University Hospital Cheonan, Korea, Republic of Soon Chun Hyang University Hospital Cheonan Cheonan, Korea, Republic of Chungbuk National University Hospital Chonju, Korea, Republic of Kwangju Veterans Hospital Gwangju, Korea, Republic of Chonbuk National University Hospital Iksan, Korea, Republic of Wonkwang University Hospital Iksan, Korea, Republic of Inje University Ilsan Paik Hospital Ilsan, Korea, Republic of Gachon Kil Medical Center Inchon, Korea, Republic of Presbyterian Medical Center Jeonju, Korea, Republic of Gyeongsang National University Hospital Jinju, Korea, Republic of Inje University Pusan Paik Hospital Pusan, Korea, Republic of Seoul National University Bundang Hospital Seongnam, Korea, Republic of Gangnam Severance Hospital Seoul, Korea, Republic of Kyung Hee University Medical Center Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Yonsei University Medical Center Seoul, Korea, Republic of St. Carollo Hospital Suncheon, Korea, Republic of Less <<
NCT03203525 Liver Cancer Phase 1 Not yet recruiting December 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact       siqingfu@mdanderson.org Less <<
NCT00812123 Kidney Transplantation ... More >> Chronic Kidney Disease Less << Phase 4 Completed - Switzerland ... More >> University Hospital Basel, Clinic for Transplantation Immunology and Nephrology Basel, Switzerland, 4031 Less <<
NCT02008877 Malignant Peripheral Nerve She... More >>ath Tumors (MPNST) Sarcoma Less << Phase 1 Phase 2 Completed - United States, California ... More >> Sarcoma Oncology Center Santa Monica, California, United States, 90403 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University Saint Louis, Missouri, United States, 63130 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT01665053 Coronary Artery Disease Phase 3 Active, not recruiting January 2019 -
NCT00713284 Renal Transplantation Phase 4 Completed - United States, California ... More >> California Pacific Medical Center; Barry S. Levin, MD Department of Transplantation San Francisco, California, United States, 94115 Less <<
NCT01157455 Coronary Artery Diseases Phase 4 Unknown June 2013 China ... More >> Fuwai Hospital Recruiting Beijing, China Contact: Yuejin Yang       yangyjfw@yahoo.com.cn    Contact: Bo Xu       xubofuwai@gmail.com Less <<
NCT03112707 Coronary Artery Disease ... More >> Acute Coronary Syndrome Less << Phase 4 Recruiting May 1, 2019 Italy ... More >> Humanitas Research Hospital Recruiting Rozzano, Milan, Italy, 20089 Contact: Giulio Stefanini, MD, PhD    0282247384    giulio.stefanini@hunimed.eu    Principal Investigator: Giulio Stefanini, MD, PhD          Principal Investigator: Bernhard Reimers, MD Less <<
NCT02499692 Cardiovascular Diseases Not Applicable Active, not recruiting June 2017 China ... More >> AeroSpace center hospital Beijing, China the second hospital of Jilin Unversity Changcun, China Daqing General Oil Field Hospital Daqing, China Sir Run Run Shaw Hospital of Zhejiang University School of Medicine Hangzhou, China The First Hospital of Lanzhou University Lanzhou, China General Hospital of SY Military Institute Shen Yang, China TEDA International Cardiovascular Hospital Tianjin, China Wuhan Asia Heart Hospital Wuhan, China Less <<
NCT02499692 - Active, not recruiting - -
NCT00061360 Severe Aplastic Anemia Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01665053 - Active, not recruiting - -
NCT01239368 Myeloma, Plasma-Cell ... More >> Myeloma-Multiple Myelomatosis Less << Phase 1 Phase 2 Terminated(Terminated due to i... More >>nsufficient accrual.) Less << - United States, Maryland ... More >> National Institutes of Health (NIH) Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT00555373 Renal Transplant Not Applicable Completed - United States, Alabama ... More >> Pediatric Nephrology of Alabama Birmingham, Alabama, United States, 35205 United States, California UCLA Los Angeles, California, United States, 90095 Stanford University Stanford, California, United States, 94305 United States, Georgia Emory University Atlanta, Georgia, United States Less <<
NCT03065062 Lung Cancer Squamous Cell ... More >> Solid Tumors Head & Neck Cancer Pancreatic Cancer Less << Phase 1 Recruiting January 2023 United States, Massachusetts ... More >> Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Rebecca Heist, MD    617-726-1838       Principal Investigator: Rebecca Heist, MD          Beth Israel Deaconess Medical Center Not yet recruiting Boston, Massachusetts, United States, 02115 Contact: James Mier, MD    617-667-0430       Principal Investigator: James Mier, MD          Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Andrew Wolanski, NP    617-632-6623    awolanski@partners.org    Principal Investigator: Geoffrey Shapiro, MD Less <<
NCT02996318 DES In-stent Stenosis Phase 2 Phase 3 Unknown June 2018 Malaysia ... More >> Queen Elizabeth Hospital II Recruiting Kota Kinabalu, Malaysia, 88300 Contact: Liew Houng Bang, MD       hbliew22@gmail.com    Sarawak Genaral Hospital Heart Centre Recruiting Kota Samarahan, Malaysia, 94300 Contact: Ong Tiong Kiam, MD       ongtk@moh.gov.my    National Heart Institute Recruiting Kuala Lumpur, Malaysia, 50400 Contact: Rosli Mohd Ali, MD       rosli@ijn.com.my    University Malaya Recruiting Kuala Lumpur, Malaysia, 50603 Contact: Wan Azman Wan Ahmad, MD       wanazman@ummc.edu.my    Hospital Pulau Pinang Recruiting Penang, Malaysia, 10990 Contact: Muhamad Ali Sk Abdul Kader, MD       mdali_sheikh@hotmail.com Less <<
NCT02229864 Coronary Artery Disease ... More >> Coronary Artery Stenosis Coronary Disease Coronary Stenosis Less << Not Applicable Active, not recruiting October 2019 United States, Arizona ... More >> Scottsdale Healthcare Scottsdale, Arizona, United States, 85258 United States, Michigan Cardiac & Vascular Research Center of Northern Michigan Petoskey, Michigan, United States, 49770 Less <<
NCT01239368 - Terminated(Terminated due to i... More >>nsufficient accrual.) Less << - -
NCT00890253 Liver Transplantation ... More >> Chronic Renal Insufficiency Less << Phase 2 Unknown January 2013 Germany ... More >> University Medical Center Goettingen Recruiting Goettingen, Germany, 37099 Contact: Armin D Goralczyk, Dr.    +49 551 398490    agoralczyk@med.uni-goettingen.de    Contact: Aiman Obed, PD Dr.    +49 551 39 12296    aobed@chirurgie-goettingen.de    Principal Investigator: Aiman Obed, Prof. Dr.          Sub-Investigator: Armin D Goralczyk, MD Less <<
NCT00045370 Kidney Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00975819 Kaposiform Hemangioendotheliom... More >>as Tufted Angioma Capillary Venous Lymphatic Malformation Venous Lymphatic Malformation Microcystic Lymphatic Malformation Mucocutaneous Lymphangiomatosis and Thrombocytopenia Capillary Lymphatic Arterial Venous Malformations PTEN Overgrowth Syndrome With Vascular Anomaly Lymphangiectasia Syndromes Less << Phase 2 Active, not recruiting October 2019 United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT01034345 Liver Transplantation Phase 2 Unknown November 2011 Spain ... More >> Hospital Clinic Barcelona, University of Barcelona Recruiting Barcelona, Spain, 08036 Contact: Alberto Sanchez-Fueyo, MD    34-93-2275400 ext 2844    afueyo@clinic.ub.es Less <<
NCT02009332 Non-muscle Invasive Bladder Ca... More >>ncer (NMIBC) Less << Phase 1 Phase 2 Recruiting December 2020 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Ifeanyi Onyeji       ico2106@cumc.columbia.edu    Principal Investigator: James McKiernan, MD          United States, Tennessee Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Pamela Steele, RN BSN CCRC    615-343-2120    pamela.steele@vanderbilt.edu    Principal Investigator: Sam Chang, MD, FACS Less <<
NCT00766337 Age-Related Macular Degenerati... More >>on Choroidal Neovascularization Less << Phase 2 Terminated - United States, Arizona ... More >> Retinal Consultants of Arizona Phoenix, Arizona, United States, 85014 Less <<
NCT01492894 Kidney Graft Dysfunction Phase 4 Withdrawn(study terminated due... More >> to low enrollment) Less << - United States, Minnesota ... More >> University of Minnesota Departments of Medicine and Surgery Minneapolis, Minnesota, United States, 55455 Less <<
NCT01080261 Atherosclerosis ... More >> Coronary Artery Disease Less << Phase 3 Completed - Japan ... More >> Kokura Memorial Hospital Kitakyushu-shi, Fukuoka-ken, Japan Hoshi General Hospital Koriyama-shi, Fukushima-ken, Japan Hakodate Municipal Hospital Hakodate-shi, Hokkaido, Japan Hokkaido Social Insurance Hospital Sapporo-shi, Hokkaido, Japan Shonan Kamakura General Hospital Kamakura-shi, Kanagawa-ken, Japan Japan Labour Health and Welfare Organization Kanto Rosai Hospital Kawasaki-shi, Kanagawa-ken, Japan Saiseikai Yokohama-City Eastern Hospital Yokohama City, Kanagawa-ken, Japan Yokohama City University Hospital Yokohama, Kanagawa-ken, Japan Japan Labour Health and Welfare Organization Kumamoto Rosai Hospital Yatsushiro-shi, Kumamoto-ken, Japan Kyoto-Katsura Hospital Kyoto-shi, Kyoto-fu, Japan Kurashiki Central Hospital Kurashiki-shi, Okayama-ken, Japan Jichi Medical University Hospital Shimotsuke-shi, Tochigi-ken, Japan The Cardiovascular Institute Hospital Minato-ku, Tokyo-to, Japan Tokyo Women's Medical University Hospital Shinjuku-ku, Tokyo-to, Japan Toho University Ohashi Medical Center Meguro-ku, Tokyo-tu, Japan Less <<
NCT00223054 - Completed - Germany ... More >> University of Schleswig-Holstein, Campus Kiel, Department of Nephrology Kiel, Germany, 24105 Less <<
NCT02229864 - Active, not recruiting - -
NCT03214900 - Completed - -
NCT01217931 Kidney Cancer Phase 2 Active, not recruiting January 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01080261 - Completed - -
NCT01091740 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Dongsan Medical Center, Keimyung University College of Medicine Daegu, Korea, Republic of, 700-712 Division of Cardiology, Cardiovascular Hospital, Yonsei University Seoul, Korea, Republic of, 120-752 Less <<
NCT01500434 Coronary Artery Disease Phase 3 Completed - -
NCT01500434 - Completed - -
NCT02117596 Renal Transplant Not Applicable Completed - United States, Alabama ... More >> Pediatric Nephrology of Alabama Birmingham, Alabama, United States, 35205 United States, California UCLA Los Angeles, California, United States, 90095 Stanford University Stanford, California, United States, 94305 United States, Georgia Emory University Atlanta, Georgia, United States Less <<
NCT00621101 Pharmacokinetics ... More >> Drug Interactions Hypercholesterolemia Immunosuppression Less << Phase 1 Completed - Germany ... More >> Department of Clinical Pharmacology Greifswald, Germany, 17487 Less <<
NCT00504543 Kidney Transplantation Phase 2 Completed - -
NCT01595984 Kidney Failure Phase 3 Active, not recruiting August 2018 France ... More >> Nephrology department, Hospital University of Amiens Amiens, France, 80000 Nephrology Department, University Hospital of Montpellier Montpellier, France, 34285 Less <<
NCT00195481 Kidney Failure ... More >> Graft vs Host Disease Less << Phase 4 Completed - India ... More >> Bangalore, Karnataka, India, 566 006 Bangalore, Karnataka, India, 566 018 Saket, South Delhi, India Chennai, Tamil Nadu, India, 600 004 New Delhi, India Less <<
NCT00617084 Coronary Artery Disease Phase 4 Completed - Switzerland ... More >> Stiftung Inselspital, Department of Cardiology Bern, Switzerland, CH-3010 Less <<
NCT01086228 - Completed - Japan ... More >> Site Reference ID/Investigator# 104727 Aichi, Japan Site Reference ID/Investigator# 113428 Aichi, Japan Site Reference ID/Investigator# 115745 Aichi, Japan Site Reference ID/Investigator# 104424 Chiba, Japan Site Reference ID/Investigator# 113645 Chiba, Japan Site Reference ID/Investigator# 105015 Ehime, Japan Site Reference ID/Investigator# 105148 Fukuoka, Japan Site Reference ID/Investigator# 105177 Fukuoka, Japan Site Reference ID/Investigator# 104677 Gifu, Japan Site Reference ID/Investigator# 104365 Gunma, Japan Site Reference ID/Investigator# 105038 Hiroshima, Japan Site Reference ID/Investigator# 105043 Hiroshima, Japan Site Reference ID/Investigator# 104236 Hokkaido, Japan Site Reference ID/Investigator# 105963 Hyogo, Japan Site Reference ID/Investigator# 104326 Ibaraki, Japan Site Reference ID/Investigator# 104606 Ishikawa, Japan Site Reference ID/Investigator# 104607 Ishikawa, Japan Site Reference ID/Investigator# 104528 Kanagawa, Japan Site Reference ID/Investigator# 104536 Kanagawa, Japan Site Reference ID/Investigator#104563 Kanagawa, Japan Site Reference ID/Investigator# 104837 Kyoto, Japan Site Reference ID/Investigator# 104838 Kyoto, Japan Site Reference ID/Investigator# 104843 Kyoto, Japan Site Reference ID/Investigator# 104844 Kyoto, Japan Site Reference ID/Investigator# 104850 Kyoto, Japan Site Reference ID/Investigator# 104658 Nagano, Japan Site Reference ID/Investigator# 104990 Nara, Japan Site Reference ID/Investigator# 105027 Okayama, Japan Site Reference ID/Investigator# 105296 Okinawa, Japan Site Reference ID/Investigator# 104864 Osaka, Japan Site Reference ID/Investigator# 104898 Osaka, Japan Site Reference ID/Investigator# 104906 Osaka, Japan Site Reference ID/Investigator# 114863 Osaka, Japan Site Reference ID/Investigator# 104407 Saitama, Japan Site Reference ID/Investigator# 106044 Saitama, Japan Site Reference ID/Investigator# 104697 Shizuoka, Japan Site Reference ID/Investigator# 104356 Tochigi, Japan Site Reference ID/Investigator# 105092 Tokushima, Japan Site Reference ID/Investigator# 104448 Tokyo, Japan Site Reference ID/Investigator# 104454 Tokyo, Japan Site Reference ID/Investigator# 104473 Tokyo, Japan Site Reference ID/Investigator# 104497 Tokyo, Japan Site Reference ID/Investigator# 104510 Tokyo, Japan Site Reference ID/Investigator# 104514 Tokyo, Japan Site Reference ID/Investigator#104481 Tokyo, Japan Site Reference ID/Investigator # 104285 Yamagata, Japan Site Reference ID/Investigator# 104294 Yamagata, Japan Less <<
NCT00044720 Chronic Kidney Failure ... More >> Graft vs Host Disease Kidney Transplantation Less << Phase 4 Completed - -
NCT00768729 Kidney Failure, Chronic ... More >> Kidney Transplantation Immunosuppression Less << Phase 1 Completed - United States, California ... More >> Children's Hospital of Central California Madera, California, United States UCSF Children's Hospital San Francisco, California, United States United States, Massachusetts Children's Hospital, Boston Boston, Massachusetts, United States United States, Pennsylvania Children's Hospital, Philadelphia Philadelphia, Pennsylvania, United States United States, Washington Children's Hospital and Regional Medical Center, Seattle Seattle, Washington, United States Less <<
NCT01605721 Coronary Artery Disease Phase 4 Unknown April 2015 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Kyung-Woo Park, MD, PhD    82-2-2072-0244    kwparkmd@snu.ac.kr    Principal Investigator: Hyo-Soo Kim, MD, PhD Less <<
NCT01120379 - Completed - United States, California ... More >> Abbott Vascular Santa Clara, California, United States, 95054 Less <<
NCT01678937 - Completed - United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Less <<
NCT00617084 - Completed - -
NCT01967199 Coronary Restenosis Phase 4 Terminated - Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of, 138-736 Soon Chun Hyang University Hospital Bucheon Bucheon, Korea, Republic of Chungbuk National University Hospital Chungjoo, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of The Catholic University of Korea, Daejeon ST. Mary's Hospital Daejeon, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of National Health Insurance Service Ilsan Hospital Ilsan, Korea, Republic of Dong-A Medical Center Pusan, Korea, Republic of Seoul National University Boramae Medical Center Seoul, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT00971789 Cowden's Disease ... More >> Hamartoma Syndrome, Multiple Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01184885 - Completed - -
NCT01120379 - Completed - -
NCT00971789 - Completed - -
NCT01080859 - Completed - Finland ... More >> Satakunta Central Hospital Pori, Finland, 28500 Less <<
NCT01086228 - Completed - -
NCT00823212 Coronary Artery Disease Phase 3 Completed - -
NCT00823212 - Completed - -
NCT01184885 Lymphoid Malignancies (New or ... More >>Relapsed) Acute Lymphoblastic Leukemia Burkitt Lymphoma Lymphoblastic Lymphoma Mantle Cell Lymphoma Adult T-cell Leukemia/Lymphoma Less << Early Phase 1 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01178268 - Completed - -
NCT02954198 Immunosuppression Not Applicable Recruiting September 2019 United States, South Carolina ... More >> Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: David Taber, PharmD    843-792-4003 Less <<
NCT01182428 Coronary Artery Stenosis ... More >> Coronary Arteriosclerosis Coronary Artery Disease Coronary Artery Restenosis Total Coronary Occlusion Stent Thrombosis Vascular Disease Myocardial Ischemia Less << Phase 4 Completed - -
NCT01489761 Coronary Artery Disease Phase 4 Terminated - Korea, Republic of ... More >> Gangwon National Univ. Hospital Chuncheon, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of Kyungpook National university hospital Daegu, Korea, Republic of The Catholic University of Korea, Daejeon ST. Mary's Hospital Daejeon, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of National Health Insurance Service Ilsan Hospital Ilsan, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Kyunghee University Medical Center Seoul, Korea, Republic of The Catholic University of Korea, Yeouido St. Mary's Hospital Seoul, Korea, Republic of St.carollo Hospital Suncheon, Korea, Republic of Pusan National University Yangsan Hospital Yangsan, Korea, Republic of Less <<
NCT01182428 - Completed - -
NCT00478608 Renal Transplant Phase 3 Completed - Korea, Republic of ... More >> Deagu, Korea, Republic of, 700-712 Deagu, Korea, Republic of, 700-721 Pusan, Korea, Republic of, 614-735 Seoul, Korea, Republic of, 110-744 Seoul, Korea, Republic of, 120-752 Seoul, Korea, Republic of, 135-710 Seoul, Korea, Republic of, 137-701 Seoul, Korea, Republic of, 138-736 Suwon, Korea, Republic of, 443-721 Less <<
NCT01178268 Coronary Occlusion ... More >> Thrombosis (Stent Thrombosis) Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis Less << Phase 4 Completed - China ... More >> Fu Wai Hospital Beijing, China, 100037 Authorized Representative in China Guidant International Trading (Shanghai) Co., Ltd. Shanghai, China, 200122 Less <<
NCT00911976 Coronary Artery Bypass ... More >> Atherosclerosis Less << Phase 4 Completed - United States, Texas ... More >> VA North Texas Healthcare System Dallas, Texas, United States, 75216 Less <<
NCT00917163 Coronary Artery Disease Phase 4 Terminated(due to unavoidable ... More >>circumstances relating to logistic issues and regulatory processes in various countries causing unacceptable delays.) Less << - Brazil ... More >> Hospital Meridional Vitaria, Espirito Santo, Brazil, 29156-580 Centro de Cardiologia e Radiologia Intervencionista Goiania, Goiás., Brazil, 74823-470 Cardiovascular Diagnóstico Campo Grande, Mato Grosso do Sul, Brazil, 79002-250 Santa Casa de misericórdia de Juiz de fora Juiz de Fora, Minas Gerais, Brazil, 36025-040 Intistuto do Coracao do Triangulo Uberlandia, Minas Gerais, Brazil, 38400-299 Hospital Costantino Constantini Curitiba, Paraná, Brazil, 80320-320 Incor Hospital Brasília, Brazil, 70658-700 Instituto de Cardiologia Sao Paulo, Brazil, 01323-900 Hospital Bandeirantes Sao Paulo, Brazil, 01506-000 Incor Hospital Sao Paulo, Brazil, 04012-180 Instituto Dante Pazzanese Sao Paulo, Brazil, 04012-180 Hospital Albert Einstein Sao Paulo, Brazil, 05651-901 Hospital Santa Marcelina Sao Paulo, Brazil, 08270-070 India Escorts Heart Institute & Research Centre New Delhi, Delhi, India, 110 025 Max Devki Devi Heart and Vascular Institute New Delhi, Delhi, India, 110017 All India Institute of Medical Sciences New Delhi, Delhi, India, 110029 Life Care Institute Ahmedabad, Gujarat, India, 380014 Shri.Jayadeva Institute of Cardiology Bangalore, Karnataka, India, 560069 P.R.S Hospital Trivandrum, Kerala, India, 695002 Jaslok Hospital & Research Centre Mumbai, Maharashtra, India, 400 026 KEM Hospital Mumbai, Maharashtra, India, 400012 Ruby Hall Clinic Pune, Maharashtra, India, 411001 Madras Medical Mission Chennai, Tamil Nadu, India, 600037 Apollo Hospital Chennai, Tamilnadu, India, 600 006 Sanjay Gandhi Post Graduate Institute of Medical Sciences Lucknow, Uttar Pradesh, India, 226 014 Kailash Health Care Limited Noida, Uttar Pradesh, India, 201 301 B.M.Birla Heart Research Center Kolkata, West Bengal, India, 700 027 Saudi Arabia KAUH King Abdl Aziz University Hospital Jeddah, Saudi Arabia, 21589 Less <<
NCT01895049 Kidney Transplantation ... More >> Cytomegalovirus Less << Phase 4 Completed - Brazil ... More >> Hospital do Rim e Hipertensao São Paulo, Brazil, 04038-002 Less <<
NCT00478608 - Completed - -
NCT01473732 - Terminated(terminated after 2 ... More >>patients due to difficulty in enrollment) Less << - -
NCT00656643 Diabetic Macular Edema Phase 2 Completed - United States, Arizona ... More >> Retinal Consultants of Arizona Phoenix, Arizona, United States, 85014 Less <<
NCT02253108 Coronary Artery Disease ... More >> Angina Pectoris Myocardial Infarction Less << Not Applicable Active, not recruiting December 2025 Denmark ... More >> Aarhus University Hospital, Skejby Aarhus, Denmark, 8200 Odense University Hospital Odense, Denmark, 5000 Less <<
NCT01603004 - Recruiting May 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Nitya Raj, MD    646-888-4849       Contact: Kinh Gian Do, MD, PhD    212-639-8591       Principal Investigator: Nitya Raj, MD Less <<
NCT01473732 Chronic Allograft Injury ... More >> Calcineurin Inhibitor Toxicity Less << Not Applicable Terminated(terminated after 2 ... More >>patients due to difficulty in enrollment) Less << - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467 Less <<
NCT02854423 - Completed - -
NCT00496938 Coronary Artery Stenosis ... More >> Coronary Arteriosclerosis Coronary Artery Disease Coronary Artery Restenosis Total Coronary Occlusion Stent Thrombosis Vascular Disease Myocardial Ischemia Less << Phase 4 Completed - -
NCT03571438 Kidney Cancer Not Applicable Recruiting September 30, 2024 France ... More >> Grenoble Alps Hospital Recruiting Grenoble, France, 38043 Contact: Jean-Luc Descotes, PU-PH Less <<
NCT02577965 Acute Myocardial Infarction Phase 4 Completed - -
NCT00273871 Graft Rejection ... More >> Kidney Failure Kidney Transplantation Less << Phase 3 Completed - -
NCT01054313 Advanced Cancer Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00290069 Kidney Diseases ... More >> Graft Rejection Less << Phase 4 Unknown - Spain ... More >> Complejo Hospitalario Universitario de Santiago Not yet recruiting Santiago de Compostela, La Coruña, Spain, 15706 Contact: Rafael Romero, MD          Principal Investigator: Rafael Romero, MD          Hospital General Universitario Gregorio Marañón Not yet recruiting Madrid, Spain, 28007 Contact: Fernando Anaya, MD          Principal Investigator: Fernando Anaya, MD          Hospital Universitario Ramón y Cajal Not yet recruiting Madrid, Spain, 28034 Contact: Roberto Marcén, MD          Principal Investigator: Roberto Marcén, MD          Hospital Universitario 12 de Octubre Not yet recruiting Madrid, Spain, 28041 Contact: José L Morales, MD          Principal Investigator: José L Morales, MD          Hospital Universitario de Canarias Not yet recruiting Santa Cruz de Tenerife, Spain, 38320 Contact: Domingo Hernández, MD          Principal Investigator: Domingo Hernández, MD          Hospital Universitario Marqués de Valdecilla Not yet recruiting Santander, Spain, 39008 Contact: Juan C Ruiz San Millán, MD          Principal Investigator: Juan C Ruiz San Millán, MD          Hospital Universitario La Fe Not yet recruiting Valencia, Spain, 46009 Contact: Jaime Sánchez Plumed, MD          Principal Investigator: Jaime Sánchez Plumed, MD Less <<
NCT01266239 Ischemic Heart Disease Not Applicable Unknown July 2015 Japan ... More >> Kobe University Recruiting Kobe, Japan Contact: Toshiro Shinke, MD, PhD          Principal Investigator: Toshiro Shinke, MD, PhD          Sub-Investigator: Hiromasa Otake, MD, PhD          Hyogo Medical University Recruiting Nishinomiya, Japan Contact: Kenichi Fujii, MD, PhD          Principal Investigator: Kenichi Fujii, MD, PhD          Toyohashi Heart Center Recruiting Toyohashi, Japan Contact: Yoshihisa Kinoshita, MD    +81-532-37-3377    Ykinoshita@heart-center.or.jp    Principal Investigator: Yoshihisa Kinoshita, MD          Saiseikai Yokohama Eastern Hospital Recruiting Yokohama, Japan Contact: Masahiro Yamawaki, MD, PhD       m_yamawaki@tobu.saiseikai.or.jp    Principal Investigator: Masahiro Yamawaki, MD, PhD          New Yukuhashi hospital Recruiting Yukuhashi, Japan, 824-0026 Contact: Yoshinobu Murasato, MD, PhD    +81-930-24-8899    murasato@shinyukuhashihospital.or.jp    Principal Investigator: Yoshinobu Murasato, MD, PhD Less <<
NCT00598676 Coronary Heart Disease Phase 4 Completed - Germany ... More >> Medizinische Klinik, Klinikum rechts der Isar Muenchen, Germany, 81675 Deutsches Herzzentrum Muenchen Munich, Germany, 80636 Less <<
NCT00866879 Renal Transplant Rejection Phase 4 Active, not recruiting December 2018 United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Less <<
NCT01115933 Vascular Disease ... More >> Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis Less << Not Applicable Completed - Japan ... More >> Kokura Memorial Hospital Kita-kyushu, Fukuoka, Japan Hokkaido Social Insurance Hospital Cardiovascular Center Toyohira, Hokkaido, Japan Teikyo University Tokyo, Itabashi, Japan Tokai University Hospital Isehara, Kanagawa, Japan Shonan Kamakura General Hospital Kamakura, Kanagawa, Japan Saiseikai Yokohama City Eastern Hospital Yokohama, Kanagawa, Japan Kyoto University Hospital Sakyo-ku, Kyoto, Japan Sendai Kousei Hospital Sendai, Miyagi, Japan Nagoya Daini Red Cross Hospital Showa-ku, Nagoya, Japan Kurashiki Central Hospital Kurashiki, Okayama, Japan Sakurabashi Watanabe Hospital Kita-ku, Osaka, Japan Osaka University Hospital Suita, Osaka, Japan Tokushima Red Cross Hospital Komatsushima, Tokushima, Japan Kumamoto Central Hospital Kumamoto, Japan Less <<
NCT00812786 Heart Transplant Phase 4 Completed - France ... More >> CHU de Bordeaux Bordeaux, France CHU de Clermont-Ferrand Clermont-ferrand, France CHU de Lille Lille, France CHU de Limoges Limoges, France Hôpital Louis Pradel - CHU de Lyon Lyon, France CHU de Nantes Nantes, France Hôpital Européen Georges Pompidou Paris, France Hôpital Pitié-Salpêtrière Paris, France CHU de Rennes Rennes, France CHU de Rouen Rouen, France CHU de Strasbourg Strasbourg, France CHU de NANCY Vandoeuvre Les Nancy, France Less <<
NCT02208128 Renal Cell Carcinoma Not Applicable Unknown February 2018 Germany ... More >> Urological Department of the University Hospital Heidelberg Recruiting Heidelberg, Germany, 69120 Contact: Sascha Pahernik, PD Dr.    +49 6221 56 39689    sascha.pahernik@med.uni-heidelberg.de    Principal Investigator: Sascha Pahernik, PD Dr. Less <<
NCT02098876 Coronary Artery Disease Not Applicable Recruiting December 2018 United States, Georgia ... More >> Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Habib Samady, MD    404-712-7424    hsamady@emory.edu    Principal Investigator: Habib Samady, MD Less <<
NCT01267734 Coronary Heart Disease Phase 4 Unknown June 2015 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Kyung Woo Park, MD, PhD    82-2-2072-0244    kwparkmd@snu.ac.kr    Contact: Hyo-Soo Kim, MD, PhD    82-2-2072-2226    hyosoo@snu.ac.kr Less <<
NCT03125772 Type 2 Diabetes ... More >> Coronary Heart Disease Less << Not Applicable Completed - India ... More >> Fortis Escorts Heart Institute New Delhi, Delhi, India, 110025 Less <<
NCT01147237 Long Coronary Artery Disease Phase 4 Unknown December 2012 Japan ... More >> Japanese Red Cross Nagoya Daiichi Hospital Nagoya, Aichi, Japan Toyohashi Heart Center Toyohashi, Aichi, Japan, 4418530 Higashi Cardiovascular clinic Toyohashi, Aichi, Japan Hiraka General Hospital Yokote, Akita, Japan Kokura memorial hospital Kitakyushu, Fukuoka, Japan Hoshi General Hospital Koriyama, Fukushima, Japan Gunma Prefectural Cardiovascular Center Maebashi, Gunma, Japan Abashiri Kosei General Hospital Abashiri, Hokkaido, Japan Engaru-Kosei General Hospital Engaru, Hokkaido, Japan Hakodate Goryokaku Hospital Hakodate, Hokkaido, Japan Obihiro National Hospital Obihiro, Hokkaido, Japan Kinikyo Chuo Hospital Sapporo, Hokkaido, Japan Sapporo Orthopaedic Cardiovascular Hospital Sapporo, Hokkaido, Japan Shinko Kakogawa Hospital Kakogawa, Hyogo, Japan Daini Okamoto Hospital Uji, Kyoto, Japan Miyagi Cardiovascular ＆ Respiratory Center Kurihara, Miyagi, Japan Matsumoto Kyoritsu Hospital Matsumoto, Nagano, Japan Rinku General Medical Center Izumiotsu, Osaka, Japan Kasukabe Chuo General Hospital Kasukabe, Saitama, Japan Shuwa General Hospital Kasukabe, Saitama, Japan Kusatsu Heart Center Kusatsu, Shiga, Japan Ayase Heart Hospital Adachi, Tokyo, Japan Juntendo University Hospital Bunkyo, Tokyo, Japan Itabashi Chuo Medical Center Itabashi, Tokyo, Japan Tokyo-kita Social Insurance Hospital Kita, Tokyo, Japan Cardiovascular Institute Hospital Minato-ku, Tokyo, Japan, 1060032 JR Tokyo General Hospital Shibuya, Tokyo, Japan Tokyo Medical University Hospital Shinjuku, Tokyo, Japan Saiseikai Fukuoka General Hospital Fukuoka, Japan Sakurabashi Watanabe Hospital Osaka, Japan Tokyo Metropolitan Police Hospital Tokyo, Japan Less <<
NCT01115933 - Completed - -
NCT01632605 ADPKD Not Applicable Completed - Austria ... More >> Division of Nephrology and Dialysis, Department of Medicine III, Medical University Vienna Vienna, Austria, 1090 Less <<
NCT01313923 - Terminated(Lack of funding) - -
NCT01681381 Ischemic Heart Disease ... More >> Myocardial Ischemia Coronary Artery Lesions,Primary Coronary Disease Acute Coronary Syndrome Furcation Lesion of Coronary Artery Less << Not Applicable Unknown September 2018 China, Liaoning ... More >> The General Hospital of Shenyang Military Region Recruiting Shenyang, Liaoning, China, 86-110016 Contact: Han Yaling, Prof.    (86-024) 28851120    hanyaling@263.net    Principal Investigator: Han Yaling, Prof. Less <<
NCT01343498 Malignant Solid Tumour Phase 1 Completed - United States, Oklahoma ... More >> Oklahoma University Oklahoma City, Oklahoma, United States, 71304 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT03401216 Ischemic Heart Disease ... More >> Coronary Artery Disease Coronary Atherosclerosis Less << Not Applicable Recruiting April 30, 2019 Russian Federation ... More >> Academician E.N. Meshalkin national medical research center Recruiting Novosibirsk, Russian Federation, 630055 Contact: Evgeny Kretov, MD, PhD    +79137906533    sibvolna2005@yandex.ru    Principal Investigator: Evgeny Kretov, MD, PhD          Sub-Investigator: Aleksei Prokhorikhin, MD Less <<
NCT01313923 Pemphigus Early Phase 1 Terminated(Lack of funding) - United States, California ... More >> University of California, Irvine Irvine, California, United States, 92697 Less <<
NCT01347866 Advanced Cancer Phase 1 Terminated(Refer to Detailed D... More >>escription for documentaion of Termination Statement.) Less << - United States, California ... More >> Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095-6984 Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095 UCLA Medical Center Los Angeles, California, United States, 90095 UCLA Oncology Center Los Angeles, California, United States, 90095 Santa Monica - UCLA Medical Center and Orthopaedic Hospital Santa Monica, California, United States, 90404 UCLA Santa Monica Hematology Oncology Santa Monica, California, United States, 90404 United States, Colorado Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver (CTRC) Aurora, Colorado, United States, 80045 University of Colorado Hospital Anschutz Inpatient Pavilion Aurora, Colorado, United States, 80045 University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, South Carolina Medical University of South Carolina, Hollings Cancer Center Charleston, South Carolina, United States, 29425 Medical University of South Carolina Charleston, South Carolina, United States, 29425 MUSC, Investigational Drug Services Charleston, South Carolina, United States, 29425 MUSC Health East Cooper Mount Pleasant, South Carolina, United States, 29464 MUSC Specialty Care-North North Charleston, South Carolina, United States, 29406 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Italy Ospedale San Raffaele Milano, Italy, 20132 Spain Hospital General Vall d'Hebron Barcelona, Spain, 08035 Less <<
NCT01858077 Coronary Artery Disease ... More >> Myocardial Infarction Less << Not Applicable Active, not recruiting December 2020 Netherlands ... More >> AMC Amsterdam, Noord-Holland, Netherlands, 1105 AZ Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands Albert Schweitzer Hospital Dordrecht, Netherlands TerGooi Hospital Hilversum, Netherlands Medical Center Leeuwarden Leeuwarden, Netherlands Less <<
NCT00908466 Uveitis Inter... More >>mediate Uveitis Posterior Uveitis Panuveitis Less << Phase 1 Completed - United States, Maryland ... More >> Wilmer Eye Institute at Johns Hopkins University Baltimore, Maryland, United States, 21287 Less <<
NCT00908466 - Completed - -
NCT02280720 Acute Coronary Syndrome Phase 4 Completed - Finland ... More >> Kokkola Central Hospital Kokkola, Finland Heart Center, Kuopio University Hospital Kuopio, Finland Heart Center, Satakunta Central Hospital Pori, Finland, 28500 Heart Center, Turku University Hospital Turku, Finland Less <<
NCT01135225 Coronary Artery Disease Not Applicable Completed - Australia ... More >> The Prince Charles Hospital Chermside, Australia, QLD 4032 Monash Medical Centre Clayton, Australia, VIC 3168 St. Vincent's Hospital (Melbourne) Fitzroy, Australia, VIC 3065 Fremantle Hospital Fremantle, Australia, 6160 Belgium Academisch Ziekenhuis Middelheim Antwerpen, Belgium, 2020 Ziekenhuis Oost Limburg Genk, Belgium, 3600 UZ Gasthuisberg Leuven, Belgium, 3000 Centre Hospitalier Universitaire Sart Tilman Liège Liège, Belgium, 4000 Denmark Rigshospitalet Thoraxkirurgisk Klinik RT Copenhagen, Denmark, 2100 Skejby Sygehus Århus, Denmark, 8200 France Polyclinique Les Fleurs Ollioules, France, 83190 Hôpital Cochin Paris, France, 75014 Hôpital Rangueil Toulouse, France, 31059 Clinique Pasteur Toulouse, France, 31087 New Zealand Dunedin Hospital Dunedin, New Zealand, 9016 Middlemore Hospital Otahuhu, New Zealand, 1640 North Shore Hospital Takapuna, New Zealand, 0622 Poland Szpital Uniwersytecki im. dr. Antoniego Jurasza w Bydgoszczy Bydgoszcz, Poland, 85-094 Spain Hospital Clinic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital Universitario Virgen de la Arrixaca El Palmar, Spain, 30120 Hospital Clinico San Carlos Madrid, Spain, 28040 Hospital Universitario La Paz Madrid, Spain, 28046 Sweden Falu lasarett Falun, Sweden, 79182 Uppsala Akademiska Hospital Uppsala, Sweden, 756 52 United Kingdom Royal Victoria Hospital Belfast, United Kingdom, BT 12 6BA Papworth Hospital Cambridge, United Kingdom, CB3 8RE Golden Jubilee National Hospital Clydebank, United Kingdom, G81 4HX Liverpool Heart and Chest Hospital Liverpool, United Kingdom, L14 3PE John Radcliffe Hospital Oxford, United Kingdom, 0X3 9DU Less <<
NCT01347866 - Terminated(Refer to Detailed D... More >>escription for documentaion of Termination Statement.) Less << - -
NCT01703000 Atherosclerosis ... More >> Coronary Artery Disease Less << Not Applicable Completed - Australia, Western Australia ... More >> Fremantle Hospital Fremantle, Western Australia, Australia, 6160 New Zealand Mercy Angiography Unit, Ltd. Mercy Hospital Auckland, New Zealand, 1003 Auckland City Hospital Auckland, New Zealand, 1010 North Shore Hospital Auckland, New Zealand, 1030 Ascot Angiography Auckland, New Zealand, 1546 Christchurch Christchurch, New Zealand, 8140 Middlemore Hospital Otahuhu, New Zealand, 1640 Singapore National University Hospital Singapore Singapore, Singapore, 119228 National Heart Center Singapore Singapore, Singapore, 168752 Less <<
NCT02560012 Carcinoma, Renal Cell Phase 2 Terminated(Loss of laboratory ... More >>performing molecular analysis) Less << - United States, Texas ... More >> UTHealth Memorial Hermann Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01703000 - Completed - -
NCT01751906 Coronary Artery Disease ... More >> Coronary Artery Stenosis Coronary Disease Coronary Stenosis Less << Not Applicable Active, not recruiting April 2019 -
NCT01844284 Coronary Artery Disease ... More >> Myocardial Ischemia Less << Not Applicable Active, not recruiting May 2019 Japan ... More >> Abbott Vascular Japan Co., Ltd. Tokyo, Japan, 108-6304 Less <<
NCT02688881 Refractory Solid Tumors Phase 4 Recruiting December 2018 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 99999 Contact: Jeeyun Lee, MD    +82-10-9933-1779    jyun.lee@samsung.com    Sub-Investigator: Jeeyun Lee, Professor Less <<
NCT02173379 - Active, not recruiting - -
NCT02110069 Kaposiform Hemangioendotheliom... More >>a (KHE) Kasabach-Merritt Syndrome Tufted Angioma Less << Phase 2 Recruiting December 2026 United States, California ... More >> Lucille Packard Children's Hospital Stanford Recruiting Palo Alto, California, United States, 94304 Contact: Michael Jeng, MD    650-723-5535    mjeng@stanford.edu    United States, Georgia Emory Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Michael Briones, MD    401-785-1641    michael.briones@choa.org    United States, Maryland Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Clifford Takemoto    410-955-6132    ctakemot@jhmi.edu    United States, Massachusetts Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Denise Adams, MD    617-919-1761    denise.adams@childrens.harvard.edu    Contact: Yvonne Sheldon, RN, BSN    617-919-6299    yvonne.sheldon@childrens.harvard.edu    Principal Investigator: Denise Adams, MD          United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Adrienne M Hammill, MD, PhD    513-803-3184    adrienne.hammill@cchmc.org    United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77094 Contact: Ionela Iacobas, MD    832-824-4819    ixiacob@txch.org    United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Richard L Tower, MD       rtower@mcw.edu    Contact: Pam Boettcher    414-266-4858    pboettch@mcw.edu Less <<
NCT01979744 Coronary Artery Disease Phase 4 Unknown October 2017 Korea, Republic of ... More >> Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: Myeong-Ki Hong, MD    82-2-2228-8460    mkhong61@yuhs.ac Less <<
NCT01751906 - Active, not recruiting - -
NCT01190241 Advanced Solid Tumors ... More >> Inoperable Metastasis Less << Not Applicable Unknown - Netherlands ... More >> Medical Center Alkmaar Alkmaar, Netherlands, 1815 JD VU University Medical Center Amsterdam, Netherlands, 1081 HV Less <<
NCT02173379 Coronary Artery Disease ... More >> Coronary Artery Stenosis Coronary Disease Coronary Stenosis Less << Not Applicable Active, not recruiting April 2022 -
NCT00257387 Kidney Transplant Phase 1 Phase 2 Completed - -
NCT02316886 Coronary Artery Disease ... More >> Plaque, Atherosclerotic Less << Phase 4 Recruiting June 2019 -
NCT01256723 - Active, not recruiting May 2018 Japan ... More >> Non-profit organization Associations for Establishment of Evidence in Interventions Hamamatsu-cho, Tokyo, Japan, 105-0013 Less <<
NCT01920061 Neoplasm Phase 1 Recruiting January 2019 -
NCT00195468 Kidney Failure ... More >> Graft vs Host Disease Less << Phase 4 Completed - Brazil ... More >> Curitiba, PR, Brazil, 80730-150 Rio de Janeiro, RJ, Brazil, 21041-030 Rio de Janeiro, RJ, Brazil, 21941-590 Porto Alegre, RS, Brazil, 90020-090 Porto Alegre, RS, Brazil, 90035-903 Ribeirao Preto, RS, Brazil, 14048-900 Sao Jose do Rio Preto, SP, Brazil, 15015-200 Sao Paulo, SP, Brazil, 01323-001 Sao Paulo, SP, Brazil, 04038-002 Sao Paulo, SP, Brazil, 05403-000 Mexico Torreon, Coahuila, Mexico, 27000 Chihuahua, Mexico Mexico City DF, Mexico, 14000 Less <<
NCT01759719 - Unknown December 2015 Italy ... More >> Ospedale Maggiore della Carità Recruiting Novara, Piedmont, Italy, 28100 Contact: Alessandro Lupi, M.D.    0039 0321 3733236    lupialessandro1@tin.it    Principal Investigator: Alessandro Lupi, M.D.          Sub-Investigator: Andrea Rognoni, M.D. Less <<
NCT01972022 Coronary Artery Lesions Phase 4 Unknown September 2016 Italy ... More >> A.O. Ospedale Papa Giovanni XXIII Bergamo, Italy, 24127 Less <<
NCT01248494 Metastatic Breast Cancer Phase 1 Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States United States, Massachusetts Massachusetts General Hospital, Dana Farber Cancer Center Boston, Massachusetts, United States, 02114 United States, New York Columbia University Medical Center New York City, New York, United States United States, Tennessee Vanderbilt Cool Springs Nashville, Tennessee, United States, 37067 Vanderbilt Breast Center One Hundred Oaks Nashville, Tennessee, United States, 37204 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT02560012 - Terminated(Loss of laboratory ... More >>performing molecular analysis) Less << - -
NCT02057133 Breast Neoplasms Phase 1 Recruiting December 16, 2020 United States, Arkansas ... More >> Highlands Oncology Group Recruiting Fayetteville, Arkansas, United States, 72703 Contact    479-587-1700       Principal Investigator: Joseph T Beck          United States, California University of California - San Diego Recruiting La Jolla, California, United States, 92037-0845 Contact    858-246-4777       Principal Investigator: Teresa Helsten          United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact    617-632-5869       Principal Investigator: Sara M Tolaney          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905-0002 Contact    507-266-6264       Principal Investigator: Matthew P Goetz          United States, New York Columbia University College of Phys & Surgeons Completed New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact    646-888-5145       Principal Investigator: Komal Jhaveri          United States, North Carolina University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27514 Contact    919-843-7714       Principal Investigator: E. Claire Dees          United States, Ohio Peggy and Charles Stephenson Oklahoma Cancer Center Recruiting Oklahoma City, Ohio, United States, 73104 Contact    4052717770       Principal Investigator: Kathleen Moore          United States, Oregon Providence Cancer Center Oncology Hematology Care Recruiting Portland, Oregon, United States, 97213 Contact    506-216-8636       Principal Investigator: Alison Conlin          United States, Pennsylvania Univ of Pittsburgh Cancer Inst. (UPCI) Completed Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee Sarah Cannon Cancer Center Recruiting Nashville, Tennessee, United States, 37203 Contact    615-327-7212       Principal Investigator: SMO Sarah Cannon Research Inst.          Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact    615-329-7274       Principal Investigator: Howard A. Burris III          Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232-6307 Contact    615-936-3524       Principal Investigator: Brent N Rexer          United States, Texas Texas Oncology-Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States, 75246 Contact    214-370-1949       Principal Investigator: Carlos H Becerra          South Texas Accelerated Research Therapeutics, LLC Recruiting San Antonio, Texas, United States, 78229-3307 Contact    210-593-5250       Principal Investigator: Muralidhar Beeram          US Oncology Active, not recruiting The Woodlands, Texas, United States, 77380 Less <<
NCT02959918 Gout Chronic ... More >>Hyperuricemia Less << Phase 2 Active, not recruiting January 2019 United States, California ... More >> Anaheim Clinical Trials Anaheim, California, United States, 92801 Tri West Research Associates LLC El Cajon, California, United States, 92020 Irvine Center for Clinical Research Inc. Irvine, California, United States, 92614 United States, Florida Clinical Research of West Florida Clearwater, Florida, United States, 33765 Omega Research Consultants LLC DeBary, Florida, United States, 32713 Compass Research LLC Orlando, Florida, United States, 32806 United States, Hawaii East-West Medical Research Institute Honolulu, Hawaii, United States, 96814 United States, Idaho Advanced Clinical Research Boise, Idaho, United States, 83642 United States, Kentucky L-MARC Louisville, Kentucky, United States, 40213 United States, North Carolina Triad Clinical Trials LLC Greensboro, North Carolina, United States, 27410 United States, Ohio New Horizons Clinical Research Cincinnati, Ohio, United States, 45242 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 United States, Utah Advanced Clinical Research West Jordan, Utah, United States, 84088 Less <<
NCT02423954 Advanced Cancer ... More >> Pancreatic Cancer Renal Cell Cancer Non Small Cell Lung Cancer Colorectal Carcinoma Endometrial Uterine Less << Phase 1 Phase 2 Terminated(Investigator no lon... More >>ger at site to enroll patients or write up data) Less << - United States, Arizona ... More >> Cancer Treatment Center of America @ Western Regional Medical Center Goodyear, Arizona, United States, 85338 Less <<
NCT01397175 Coronary Artery Disease Not Applicable Active, not recruiting June 2019 Korea, Republic of ... More >> Wonju Christian Hospital Wonju, Gangwon, Korea, Republic of, 220-701 Chonnam National University Hospital Chuncheon, Korea, Republic of Daegu Catholic University Hospital Daegu, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of Suncheon St. Carollo Hospital Suncheon, Korea, Republic of Less <<
NCT00711490 - Completed - -
NCT00711490 Diabetic Retinopathy Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02049957 Breast Cancer Phase 2 Completed - -
NCT02450175 Neoplasm Not Applicable Unknown June 2016 United States, Maryland ... More >> SInai Hospital of Baltimore, Inc. Recruiting Baltimore, Maryland, United States, 21215 Contact: Judy Bosley, BSN, RN    410-601-6120    jbosley@lifebridgehealth.org    Contact: Paulette Ridgely, RN    410-601-6120    pridgely@lifebridgehealth.org    Principal Investigator: Kenneth Miller, MD Less <<
NCT01915420 - Unknown August 2017 Germany ... More >> Medical Care Center Prof. Mathey, Prof. Schofer GmbH Recruiting Hamburg, Germany, 22391 Contact: Detlef G Mathey, Prof. Dr.    +4940889009 ext 152    dgmathey@web.de    Sub-Investigator: Joachim Schofer, Prof. Dr.          Sub-Investigator: Carsten Schwencke, PD Dr. Less <<
NCT02076516 Coronary Artery Disease Phase 3 Unknown May 2015 Belgium ... More >> ZNA Middleheim Recruiting Antwerpen, Belgium, 2020 Contact: Stefan Verheye, MD       stefan.verheye@gmail.com    Principal Investigator: Stefan Verheye, MD          France Groupe Hospitalier Mutualiste de Grenoble Recruiting Grenoble, France, 38028 Contact: Benjamin Faurie, MD       faurieb@gmail.com    Principal Investigator: Benjamin Faurie, MD          Hospital Prive Jacques Cartier Recruiting Massy, France, 91300 Contact: Yves Louvard, MD       y.louvard@icps.fr    Principal Investigator: Yves Louvard          Spain Hospital Clínico San Carlos Recruiting Madrid, Spain, 28040 Contact: Sara Fernández, BSc/MSc       javier.escaned@salud.madrid.org    Principal Investigator: Javier Escaned          Turkey Bezmialem University Hospital Not yet recruiting Istanbul, Turkey, 34093 Contact: Omer Goktekin, Prof Dr       ogoktekin@ogu.edu.tr    Principal Investigator: Omer Goktekin, Prof Dr Less <<
NCT03736226 - Not yet recruiting September 2025 -
NCT02894255 Coronary Artery Disease Phase 4 Unknown - -
NCT01442636 Peripheral Arterial Disease Phase 2 Phase 3 Completed - Australia, New South Wales ... More >> Prince of Wales Private Hospital Randwick, New South Wales, Australia, 2031 Belgium Imelda Hospital Bonheiden, Antwerp, Belgium, 2820 Department Vascular Surgery, A.Z. Sint-Blasius Hospital Dendermonde, East-Flanders, Belgium, 9200 Germany Herz-zentrum Bad Krozingen Bad Krozingen, Germany, 79189 Herzzentrum Leipzig, Germany, 04289 St Fransiskus hospital Münster, Germany, 48145 Less <<
NCT02230254 Atherosclerosis Phase 3 Completed - -
NCT01991938 Non Hematologic Cancers ... More >> Metastatic Cancer Lymphoma Less << Phase 1 Terminated(Lack of recruitment... More >> and the company's decision to de-prioritize 5584 development) Less << - United States, Arizona ... More >> HonorHealth Research Institute Scottsdale, Arizona, United States, 85258 United States, California Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 United Kingdom The Royal Marsden Sutton, London, United Kingdom, SM2 5PT Less <<
NCT02264665 - Recruiting June 5, 2019 -
NCT03462498 Acute Coronary Syndrome ... More >> Acute Myocardial Infarction Coronary Artery Disease Percutaneous Coronary Intervention Platelet Aggregation Inhibitors Less << Phase 4 Recruiting March 31, 2026 Japan ... More >> Kyoto University Graduate School of Medicine Recruiting Kyoto, Japan, 606-8507 Contact: Takeshi Kimura, MD    +81-75-751-4254    taketaka@kuhp.kyoto-u.ac.jp    Contact: Hirotoshi Watanabe, MD    +81-75-751-4255    hwatanab@kuhp.kyoto-u.ac.jp    Principal Investigator: Takeshi Kimura, MD Less <<
NCT02064608 Prostate Cancer Phase 1 Completed - United Kingdom ... More >> Cambridge University Hospitals NHS Foundation Trust Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Less <<
NCT02494570 PEComa Phase 2 Recruiting September 2020 United States, California ... More >> Stanford University Medical Center Recruiting Palo Alto, California, United States, 94304 Contact: Marti Lohman    650-714-6582    mlohman@stanford.edu    Sarcoma Oncology Research Center Recruiting Santa Monica, California, United States, 90403 Contact: Victoria Chua    310-552-9999    vchua@sarcomaoncology.com    United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Sarcoma Research Nursing    617-632-5204       United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Rikki Leavitt    734-936-2712    leavitar@med.umich.edu    United States, Missouri Washington University School of Medicine - Siteman Cancer Center Recruiting Saint Louis, Missouri, United States, 63110 Contact: Ashley Bolden    314-747-8064    abolden@dom.wustl.edu    United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Tim Barz    646-888-1399    barzt@mskcc.org    United States, North Carolina Duke University Medical Center - Duke Cancer Center Recruiting Durham, North Carolina, United States, 27710 Contact: Colleen Piechocki    919-681-1883    Colleen.piechocki@duke.edu    United States, Texas University of Texas, MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Aaron Reckeweg    713-794-4274    asreckew@mdanderson.org    United States, Washington University of Washington - Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Roxanne Moore    206-288-6425    romoore@seattlecca.org Less <<
NCT03740100 HNSCC Phase 2 Not yet recruiting December 2020 -
NCT00514514 Kidney Transplantation Phase 3 Completed - Germany ... More >> Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Frankfurt am Main, Germany, 60596 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover Muenden, Germany, 34346 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Kaiserslautern, Germany, 67655 Novartis Investigative Site Koeln, Germany, 51109 Novartis Investigative Site Lubeck, Germany, 23538 Novartis Investigative Site Munchen, Germany, 81377 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Regensburg, Germany, 93053 Switzerland Novartis Investigative Site Bern, Switzerland, 3010 Less <<
NCT00317798 Drug/Agent Toxicity by Tissue/... More >>Organ Multiple Myeloma and Plasma Cell Neoplasm Less << Phase 1 Completed - United States, New York ... More >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT00252655 Kidney Transplantation Phase 4 Unknown - United States, Michigan ... More >> Detroit Medical Center, Harper University Hospital Detroit, Michigan, United States, 48201 Less <<
NCT00514514 - Completed - -
NCT02875951 - Unknown December 2017 Belgium ... More >> Katholieke Universiteit Leuven - Clinical Pharmacology and Pharmacotherapeutics Recruiting Leuven, Brabant, Belgium, 3000 Contact: Sandra De Coster, pharmacist    +3216377180    sandra.decoster@pharm.kuleuven.be    Contact: Veerle Foulon, professor    +3216323464    veerle.foulon@pharm.kuleuven.be    Sub-Investigator: Sandra De Coster          Principal Investigator: Veerle Foulon Less <<
NCT00923273 - Completed - -
NCT02605447 Coronary Artery Disease Phase 4 Active, not recruiting August 2019 -
NCT02466282 Coronary Artery Disease Not Applicable Completed - Korea, Republic of ... More >> Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine Seoul, Korea, Republic of, 120-752 Less <<
NCT00923273 Carcinoma, Non-Small-Cell Lung Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03451617 Percutaneous Coronary Interven... More >>tion Less << Not Applicable Recruiting October 5, 2020 Netherlands ... More >> University Medical Center Groningen Recruiting Groningen, Netherlands, 9700 RB Contact: Pim van der Harst, Prof. Dr.       p.van.der.harst@umcg.nl Less <<
NCT01420081 Endometrial Neoplasms Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02328781 Vertebrobasilar Insufficiency Phase 2 Unknown December 2016 China, Beijing ... More >> Beijing Tiantan Hospital Beijing, Beijing, China, 100010 Less <<
NCT02061397 Lymphangioleiomyomatosis ... More >> Tuberous Sclerosis Complex Less << Phase 1 Phase 2 Active, not recruiting May 2019 United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01420081 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01005706 - Completed - -
NCT01329237 Coronary Artery Disease Phase 4 Unknown - Switzerland ... More >> Hopital Cantonal HFR Recruiting Fribourg, Switzerland, 1708 Contact: Olivier Schafroth, RN    ++41-26-426-8507    schrafrotho@h-fr.ch    Principal Investigator: Mario Togni, MD Less <<
NCT00922129 Prostate Cancer Phase 2 Phase 3 Withdrawn(Study did not start ... More >>up as planned.) Less << January 2011 Canada, Ontario ... More >> McMaster Institute of Urology - St. Joseph's Healthcare Hamilton Hamilton, Ontario, Canada, L8N 4A6 Less <<
NCT01005706 Absence; Kidney Not Applicable Completed - United States, South Carolina ... More >> The Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT02599324 Renal Cell Carcinoma (RCC) ... More >> Urothelial Carcinoma Gastric Adenocarcinoma Colorectal Adenocarcinoma (CRC) Less << Phase 1 Phase 2 Recruiting June 2019 -
NCT02990312 Hiv Kidney Tr... More >>ansplant HIV Reservoir CCR5 Less << Phase 4 Recruiting July 2020 United States, Maryland ... More >> Institute of human virology Recruiting Baltimore, Maryland, United States, 21201 Contact: Jennifer Husson, MD    410-706-6973    Jhusson@ihv.umaryland.edu    Contact: Ilise Marrazzo    4107062564    IMarrazzo@ihv.umaryland.edu Less <<
NCT03185221 Coronary Artery Stenosis Phase 3 Active, not recruiting June 20, 2020 China, Beijing ... More >> Zhongshan Hospital Fudan University Beijing, Beijing, China, 100032 Less <<
NCT00993343 Graft-versus-host Disease ... More >> Survival Less << Phase 3 Completed - Sweden ... More >> Karolinska University Hospital Stockholm, Sweden, 14186 Less <<
NCT01938573 - Completed - -
NCT01202058 Atherosclerotic Coronary Arter... More >>y Disease Less << Phase 3 Terminated(The NEVO™ stent wil... More >>l not be commercialized. Cordis decided to close the study after 1 years. This decision took the absence of safety signals into account.) Less << - Netherlands ... More >> Erasmus MC - Thoraxcenter Rotterdam, Netherlands Spain Hospital Universitari Clinic de Barcelona Barcelona, Spain Switzerland Inselspital Bern, Switzerland Less <<
NCT00402415 Tumors Phase 1 Terminated - United States, Connecticut ... More >> Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT01184898 - Completed - -
NCT01938573 Recurrent Bladder Carcinoma ... More >> Stage II Bladder Cancer Stage III Bladder Cancer Stage IV Bladder Cancer Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01946529 - Active, not recruiting - -
NCT02711826 Kidney Transplant ... More >> Adult Living Donor Kidney Transplant Recipients Renal Transplant Living Kidney Donor Less << Phase 1 Phase 2 Recruiting October 1, 2021 United States, Alabama ... More >> University of Alabama, Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Jill Andringa    205-934-0035    jillrn@uab.edu    Principal Investigator: Rosyln Mannon, MD          United States, California University of California at San Francisco Recruiting San Francisco, California, United States, 94118 Contact: Erica Tavares    415-353-8380    erica.tavares@ucsf.edu    Principal Investigator: Flavio Vincenti, MD          United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Jennifer Mawby    734-936-4811    jlmawby@med.umich.edu    Principal Investigator: Abhijit Naik, MBBS          United States, Minnesota Mayo Clinic, Department of Surgery Not yet recruiting Rochester, Minnesota, United States, 55905 Contact: Nong Yowe Braaten    507-538-9617    Braaten.Nong@mayo.edu    Contact: Leah Majerus    507-255-3940    Majerus.Leah@mayo.edu    Principal Investigator: Mark Stegall, MD          United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Jennifer Czerr    216-444-3256    czerrj@ccf.org    Principal Investigator: Emilio Poggio, MD          United States, Pennsylvania University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Rita Johnson    412-383-8616    johnsonr1@upmc.edu    Principal Investigator: Rajil Mehta, MD Less <<
NCT01184898 AML Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00167947 Kidney Failure ... More >> Graft vs Host Disease Less << Phase 3 Completed - Italy ... More >> Roma, Lazio, Italy, 00144 Roma, Lazio, Italy, 00168 Palermo, Sicily, Italy, 90127 Bari, Italy, 70100 Bologna, Italy, 40138 Cagliari, Italy, 09125 Firenze, Italy, 50139 L'Aquila, Italy, 67100 Milano, Italy, 20162 Pisa, Italy, 56100 Sassari, Italy, 07100 Siena, Italy, 53100 Udine, Italy, 37100 Varese, Italy, 21100 Less <<
NCT01508663 Coronary Artery Disease Phase 4 Unknown - Korea, Republic of ... More >> Myeong-Ki, Hong Recruiting Seoul, Korea, Republic of Contact: Myeong-Ki Hong, MD.PhD    +82 2 2228 8458    mkhong61@yuhs.ac Less <<
NCT01946529 Desmoplastic Small Round Cell ... More >>Tumor Ewing Sarcoma of Bone or Soft Tissue Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Less << Phase 2 Active, not recruiting July 2026 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00306397 Kidney Transplantation Phase 4 Completed - Switzerland ... More >> University Hospital Basel, Clinic for Transplantation Immunology and Nephrology Basel, Switzerland, 4031 Less <<
NCT02688842 Coronary Heart Disease Not Applicable Active, not recruiting January 2020 China, Beijing ... More >> Fu Wai Hospital Peking, Beijing, China, 100037 Less <<
NCT02870140 Coronary Stenosis Not Applicable Active, not recruiting July 3, 2020 Bulgaria ... More >> Research Centre BG-004 Plovdiv, Bulgaria Research Centre BG-001 Sofia, Bulgaria Hungary Research Centre HU-002 Budapest, Hungary Research Centre HU-001 Szeged, Hungary Italy Research Centre IT-001 Milan, Italy Netherlands Research Centre NL-007 Amsterdam, Netherlands Research Centre NL-008 Breda, Netherlands Research Centre NL-009 Eindhoven, Netherlands Research Centre NL-002 Leeuwarden, Netherlands Research Centre NL-003 Rotterdam, Netherlands Poland Research Centre PL-002 Chrzanow, Poland Research Centre PL-005 Kędzierzyn- Koźle, Poland Research Centre NL-009 Warsaw, Poland Spain Research Centre ES-003 Barcelona, Spain Research Centre ES-005 Barcelona, Spain Research Centre ES-012 Madrid, Spain Research Centre ES-018 Vigo, Spain United Kingdom Research Centre GB-021 Belfast, United Kingdom Research Centre GB-002 Cardiff, United Kingdom Research Centre GB-010 Cottingham, United Kingdom Research Centre GB-022 London, United Kingdom Research Centre GB-013 Newcastle-Upon-Tyne, United Kingdom Research Centre GB-012 Stevenage, United Kingdom Less <<
NCT01197170 Solid Tumors ... More >>Advanced Cancer Less << Phase 1 Active, not recruiting September 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01266057 Advanced Cancers Phase 1 Active, not recruiting April 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00332397 Coronary Disease Phase 4 Completed - Germany ... More >> Deutsches Herzzentrum Muenchen Munich, Germany, 80636 First Medizinische Klinik, Klinikum rechts der Isar Munich, Germany, 81675 Less <<
NCT01640743 Kidney Transplantation Not Applicable Completed - Italy ... More >> Fondazione Policlinico "San Matteo" Pavia, Italy, 27100 Less <<
NCT02184416 - Recruiting July 20, 2019 -
NCT01394848 Stable Angina Phase 4 Terminated(Previous other stud... More >>y including EPC capture stent raised the issue of safety (significant high incidence of instent restenosis)) Less << - Korea, Republic of ... More >> Yonsei university Wonju College of Medicine Wonju, Gangwon-do, Korea, Republic of, 220-701 Less <<
NCT03454724 Coronary Artery Disease Not Applicable Not yet recruiting December 1, 2024 -
NCT02509468 Vascular Malformation Phase 2 Active, not recruiting March 2019 France ... More >> Service de dermatologie, CHU Angers Angers, France, 49933 Service de dermatologie, Hôpital du Bocage, CHU Dijon Dijon, France, 21079 Explorations Médecine Vasculaire Hôpital A. Michallon, CHU de Grenoble Grenoble, France, 38700 Service de radiologie Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon Lyon, France, 69000 Service de Dermatologie, vénéréologie et cancérologie cutanée, Hôpital La Timone APHM Marseille, France, 13000 Service de Dermatologie, Hôpital St Eloi, CHU Montpellier Montpellier, France, 34000 Service de Dermatologie, Hôpital Hôtel-Dieu, CHU Nantes Nantes, France, 44000 Service de dermatologie, CHU Nice Nice, France, 06202 Service de dermatologie, APHP Necker Paris, France, 75743 Service de Dermatologie, Hôpital Pontchaillou, CHU RENNES Rennes, France, 35000 Service de dermatologie, Hôpital Larrey, CHU Toulouse Toulouse, France, 31059 Consultations externes de Dermatologie, Hôpital Clocheville, CHU Tours Tours, France, 37000 Less <<
NCT02973204 - Recruiting October 2020 Denmark ... More >> Department of Hepatology and Gastroenterology Recruiting Aarhus, Aarhus C, Denmark, 8000 Contact: Stine Karlsen, MD, Phd Student    +4522793193    stinkarl@rm.dk    Contact: Jens Kelsen, Consultant, PhD    +4530562682    jenskels@rm.dk    Principal Investigator: Stine Karlsen, MD, Phd student Less <<
NCT02015728 Recurrent Childhood Brain Tumo... More >>r Less << Not Applicable Unknown December 2017 United States, Washington ... More >> Seattle Children's Seattle, Washington, United States, 98105 Less <<
NCT00731237 - Completed - -
NCT01633060 Metastatic Breast Cancer Phase 3 Completed - -
NCT00783796 - Completed - -
NCT01236378 - Completed - -
NCT00783796 Coronary Artery Disease ... More >> Atherosclerosis Myocardial Ischemia Less << Phase 3 Completed - -
NCT00485030 In-stent Restenosis Phase 4 Completed - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Korea, Republic of Choeng Ju St.Mary's Hospital Choeng Ju, Korea, Republic of Kangwon National University Hospital Chuncheon, Korea, Republic of Asan Medical Center GangNeung, Korea, Republic of DongGuk University Gyongju Hospital Gyongju, Korea, Republic of Chonbuk National University Hospital Jeonju, Korea, Republic of Kwangju Christian Hospital Kwangju, Korea, Republic of Inje University Pusan Paik Hospital Pusan, Korea, Republic of Hallym University Sacred Heart Hospital, PyeongChon, Korea, Republic of Hallym University Sacred Heart Hospital PyeongChon, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of, 138-736 Hangang Sacred Heart Hospital Seoul, Korea, Republic of Kyungsang University Hospital Seoul, Korea, Republic of Seoul Veterans Hospital Seoul, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT03721614 Coronary Artery Disease Not Applicable Not yet recruiting June 22, 2022 -
NCT01764607 - Terminated(Poor accrual) - -
NCT01236378 Transplant Rejection ... More >> Renal Transplantation Less << Phase 1 Completed - China ... More >> Pfizer Investigational Site Chongqing, China, 400038 Pfizer Investigational Site Shanghai, China, 200127 Less <<
NCT00086346 Liver Transplantation Phase 3 Terminated - -
NCT00047073 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT01166685 Coronary Artery Disease ... More >> Coronary Thrombosis Less << Phase 4 Completed - Austria ... More >> Universitätsklinikum Innsbruck, Austria, 6020 Denmark Gentofte Hospital Hellerup, Denmark, 2900 Germany Elisabethen Krankenhaus Essen, NRW, Germany, 45138 Switzerland Kantonsspital Aarau, AG, Switzerland, 5000 University Hospital Basel, BS, Switzerland, 4055 Kantonsspital St. Gallen, SG, Switzerland Cardiocentro Lugano, TI, Switzerland, 6903 Stadtspital Triemli Zürich, ZH, Switzerland, 8063 Less <<
NCT01764607 Squamous Cell Skin Carcinoma Phase 2 Terminated(Poor accrual) - United States, Florida ... More >> Shands at the University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT00086346 - Terminated - -
NCT03348670 Small Cell Lung Cancer Phase 3 Active, not recruiting May 28, 2020 United States, Maryland ... More >> Medicine Invention Design, Inc. (MIDI) - c/o - MIDINC Clinical Investigator Working Site North Bethesda, Maryland, United States, 20852 Less <<
NCT03365492 Coronary Artery Disease ... More >> Myocardial Infarction Less << Not Applicable Not yet recruiting June 30, 2018 Spain ... More >> Hospital Clinic de Barcelona Not yet recruiting Barcelona, Spain Contact: Manel Sabate, Dr. Less <<
NCT01088048 Indolent Non-Hodgkin's Lymphom... More >>a Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Less << Phase 1 Completed - United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, California UCLA Los Angeles, California, United States, 90024 Stanford Cancer Center Palo Alto, California, United States, 94304-5548 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 Weill Medical College of Cornell New York, New York, United States, 10021 United States, Oregon Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States, 97477 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Houston, Texas, United States, 77030 United States, Washington North Star Lodge Cancer Center Yakima, Washington, United States, 98902 Less <<
NCT01106534 Chronic Total Occlusion of Cor... More >>onary Artery Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis Less << Phase 4 Completed - -
NCT02137239 Kidney Transplantation Phase 2 Active, not recruiting November 6, 2019 -
NCT01106534 - Completed - -
NCT00993499 Carcinoma, Non-Small-Cell Lung Phase 1 Completed - Spain ... More >> 1200.70.34001 Boehringer Ingelheim Investigational Site Badalona (Barcelona), Spain 1200.70.34008 Boehringer Ingelheim Investigational Site Barcelona, Spain 1200.70.34009 Boehringer Ingelheim Investigational Site Barcelona, Spain 1200.70.34006 Boehringer Ingelheim Investigational Site Girona, Spain 1200.70.34007 Boehringer Ingelheim Investigational Site L'Hospitalet de Llobregat (Barcelona), Spain 1200.70.34005 Boehringer Ingelheim Investigational Site Majadahonda (Madrid), Spain 1200.70.34004 Boehringer Ingelheim Investigational Site Valencia, Spain 1200.70.34002 Boehringer Ingelheim Investigational Site Zaragoza, Spain Less <<
NCT03273023 - Recruiting December 31, 2023 China, Shandong ... More >> QiLu Hospital of ShanDong University Recruiting Qingdao, Shandong, China Contact: Beian YOU    18561811007    Dryoubeian@163.com    Contact: Sen ZHANG    18561811015    Profzhangsen@163.com Less <<
NCT00993499 - Completed - -
NCT00093080 Leiomyosarcoma ... More >> Liposarcoma Osteosarcoma Sarcoma, Soft Tissue Metastases Less << Phase 2 Completed - -
NCT00980460 Alpha Fetoprotein Increased ... More >> PRETEXT Stage 1 Hepatoblastoma PRETEXT Stage 2 Hepatoblastoma PRETEXT Stage 3 Hepatoblastoma PRETEXT Stage 4 Hepatoblastoma Less << Phase 3 Active, not recruiting December 31, 2018 -
NCT02446431 Solid Tumor Early Phase 1 Recruiting July 2029 United States, California ... More >> Miller Children's and Women's Hospital Long Beach Recruiting Long Beach, California, United States, 90806 Contact: Ted Zwerdling, MD    562-933-8600    tzwerdling@memorialcare.org    Contact: Devin Murphy, MSW    562-933-8601    dmurphy@memorialcare.org    Children's Hospital Orange County Recruiting Orange, California, United States, 92868 Contact: Elyssa Rubin, MD    714-509-4348    erubin@choc.org    Contact: Dorian Chan, RN,BSN,CCRC    714-509-7868    dchan@CHOC.ORG    Principal Investigator: Elyssa Rubin, MD Less <<
NCT03150914 LAM Lymphangi... More >>oleiomyomatosis Less << Phase 3 Recruiting June 6, 2023 United States, California ... More >> Stanford University Recruiting Palo Alto, California, United States, 94305 Contact: Stephen Ruoss, M.D.    650-723-6381    ruoss@stanford.edu    United States, Colorado National Jewish Hospital Recruiting Denver, Colorado, United States, 80206-2761 Contact: Gregory Downey, M.D.       downeyg@njhealth.org    United States, Georgia Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Srihari Veeraraghavan, MD    404-778-5736    veeraraghavan@emory.edu    United States, Illinois Loyola University Recruiting Chicago, Illinois, United States, 60153 Contact: Daniel Dilling, M.D.    708-216-4946    ddillin@lumc.edu    United States, Massachusetts Brigham and Woman's Hospital Recruiting Boston, Massachusetts, United States, 20892 Contact: Elizabeth P Henske, M.D.    857-307-0784    ehenske@bwh.harvard.edu    United States, Missouri Washington University St. Louis Recruiting Saint Louis, Missouri, United States, 63110 Contact: Adrian Shifren, M.D.    314-362-6904    ashifren@wustl.edu    United States, Ohio University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45174 Contact: Susan McMahan    513-558-4376    susan.mcmahan@uc.edu    Contact: Frank McCormack, M.D.    513-558-4831    frank.mccormack@uc.edu    Cleveland Clinic Foundation Recruiting Cleveland, Ohio, United States, 44195 Contact: Robert Kotloff, M.D.    216-444-4222    kotlofr@ccf.org    United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Maryl Kreider, M.D.    215-349-5488    KMaryElizabeth.Kreider@uphs.upenn.edu    United States, Tennessee Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232-2650 Contact: Lisa Young, M.D.    615-343-4761    lisa.young@Vanderbilt.Edu    United States, Washington Washington University Recruiting Seattle, Washington, United States, 98104 Contact: George Pappas, M.D.    206-320-6500    george.pappas@minorandjames.com Less <<
NCT02305485 Coronary Artery Disease Not Applicable Active, not recruiting June 2020 -
NCT02464397 Acute Coronary Syndrome Phase 4 Unknown August 2017 Belgium ... More >> Cardiovascular Center Aalst, OLV-Clinic, Aalst, Belgium Recruiting Aalst, Belgium Contact: Bernard de Bruyne, MD          Principal Investigator: Bernard de Bruyne, MD          Finland Heart Center, Satakunta Central Hospital Recruiting Pori, Finland, 28500 Contact: Pasi Karjalainen, MD, PhD    +358 2 627 7500    pasi.karjalainen@satshp.fi    Principal Investigator: Pasi Karjalainen, MD, Phd          Sub-Investigator: Jussi Mikkelsson, MD,PhD          Sub-Investigator: Tuomas Paana, MD Less <<
NCT01875835 Acute Myocardial Infarction Phase 4 Unknown May 2017 China, Heilongjiang ... More >> The Second Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China, 150081 Less <<
NCT01436123 Coronary Artery Disease ... More >> Atherosclerosis Less << Phase 1 Terminated(The study was termi... More >>nated under the political pressure of the Federal Security Service of the Russian Federation (FSB) and the Russian Society of Cardiology) Less << - Netherlands ... More >> De Haar Research Foundation Rotterdam, South Holland, Netherlands, 3071PR Russian Federation Ural Center of Modern Nanotechnologies, Institute of Natural Sciences, Ural Federal University Yekaterinburg, Sverdlovsk oblast, Russian Federation, 620000 Ural Institute of Cardiology Yekaterinburg, Sverdlovsk oblast, Russian Federation, 620144 Less <<
NCT03131999 Lymphangioleiomyomatosis Phase 1 Phase 2 Recruiting January 31, 2019 United States, New York ... More >> Columbia University Recruiting New York, New York, United States, 10032 Contact: Jeanine D'Armiento, MD, PhD    212-305-3745    jmd12@cumc.columbia.edu    Contact: Laura Fonseca    212-305-3745    lf2560@cumc.columbia.edu    United States, South Carolina Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Charlie Strange, MD    843-442-8061    strangec@musc.edu    Contact: Kimberly Brown, MS    843-792-6474    brownkl@musc.edu Less <<
NCT00927823 Cancer Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Los Angeles, California, United States, 90095-6984 Pfizer Investigational Site Los Angeles, California, United States, 90095 Pfizer Investigational Site Los Angeles, California, United States, 90404 Pfizer Investigational Site Santa Monica, California, United States, 90404 United States, Michigan Pfizer Investigational Site Detroit, Michigan, United States, 48201 United States, New York Pfizer Investigational Site Amherst, New York, United States, 14221 Pfizer Investigational Site Buffalo, New York, United States, 14263 Less <<
NCT02806947 Acute GVHD Phase 2 Active, not recruiting February 2020 -
NCT02638389 Vascular Malformations Phase 3 Recruiting October 2025 Belgium ... More >> Cliniques Universitaires Saint-Luc, Université Catholique de Louvain Bruxelles Recruiting Bruxelles, Région de Bruxelles-Capitale, Belgium, 1200 Contact: Laurence M Boon, MD, PhD    + 32-2-764 8020    laurence.boon@uclouvain.be    Contact: Emmanuel Seront, MD, PhD    + 32-2-764 1992    emmanuel.seront@uclouvain.be    France CHU Caen Recruiting Caen, Bretagne, France, 14000 Contact: Anne Dompmartin, MD, PhD       dompmartin-a@chu-caen.fr    Contact: Fabien Chaillot       chaillot-f@chu-caen.fr    Sub-Investigator: Annouk Bisdorff Bresson, MD          Principal Investigator: Isabelle Quere, MD, PhD          Principal Investigator: Philippe Orcel, MD, PhD          Principal Investigator: Marie-Antoinette Sevestre, MD, PhD          Principal Investigator: Anne Dompmartin, MD, PhD          Germany Universitätsklinikum Freiburg Not yet recruiting Freiburg, Germany, 79106 Contact: Jochen Roessler, MD, PhD       jochen.roessler@uniklinik-freiburg.de    Principal Investigator: Jochen Roessler, MD, PhD Less <<
NCT01294748 Coronary Artery Disease Phase 2 Completed - Belgium ... More >> Cardiovascular Center Aalst, Belgium Antwerp Hospital, ZNA Middelheim Antwerp, Belgium Brussels University Hospital Brussels, Belgium Ziekenhuis Oost-Limburg Genk, Belgium Virga Jesse Ziekenhuis Hasselt, Belgium KUL Cardiology Gasthuisberg Leuven, Belgium France Jacques Cartier Hospital Massy, France Claude Galien Hospital Quincy, France Clinique Pasteur Toulouse, France Netherlands OLV Amsterdam, Netherlands St. Antonius Ziekenhuis Nieuwegein, Netherlands TweeSteden Ziekenhuis Tilburg, Netherlands UMC Utrecht Utrecht, Netherlands Hospital Weezenlanden Zwolle, Netherlands New Zealand Auckland City Hospital Auckland, New Zealand Mercy Angiography Unit Auckland, New Zealand Christchurch Hospital Christchurch, New Zealand Dunedin Hospital Dunedin, New Zealand Wellington Hospital Wellington, New Zealand Sweden Sahlgrenska University Hospital Goteborg, Sweden Orebro University Hospital Orebro, Sweden United Kingdom Royal Sussex Hosp Brighton, United Kingdom Papworth Hospital Cambridge, United Kingdom Guy's & St. Thomas' London, United Kingdom Royal Brompton London, United Kingdom University Hospital South Manchester Manchester, United Kingdom Norfolk/Norwich UHosp Norwich, United Kingdom Southampton UHT Southampton, United Kingdom Less <<
NCT01106833 Chronic GVHD Phase 2 Phase 3 Completed - -
NCT00927823 - Completed - -
NCT01869114 Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) de Novo Myelodysplastic Syndromes Myelodysplastic Syndrome With Isolated Del(5q) Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Less << Phase 2 Recruiting January 2020 United States, New Jersey ... More >> Jefferson Health NJ Division (Kennedy Hospital) Not yet recruiting Sewell, New Jersey, United States, 08012 Contact: Trina Poretta, MD          United States, Pennsylvania Abington Hospital - Jefferson Health Not yet recruiting Abington, Pennsylvania, United States, 19001 Contact: Christian Fidler, MD          Sidney Kimmel Cancer Center at Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Neil Palmisiano, MD    215-955-5769       Principal Investigator: Neil Palmisiano, MD          Sub-Investigator: Neal Flomenberg, MD          Sub-Investigator: Matthew Carabasi, MD          Sub-Investigator: Mark Weiss, MD          Sub-Investigator: John Wagner, MD          Sub-Investigator: Joanne Filicko-O'Hara, MD          Sub-Investigator: S. Onder Alpdogan, MD          Sub-Investigator: Ubaldo Martinez Outschoorn, MD          Sub-Investigator: Manish Sharma, MD          Sub-Investigator: Thomas Klumpp, MD          Sub-Investigator: Sameh Gaballa, MD          Jefferson Health, Aria Hospital Not yet recruiting Philadelphia, Pennsylvania, United States, 19124 Contact: Moshe Chasky, MD          Jefferson Health, Methodist Hospital Not yet recruiting Philadelphia, Pennsylvania, United States, 19148 Contact: Margaret Kasner, MD Less <<
NCT03743675 Overweight and Obesity ... More >> Inflammation; Muscle Sedentary Lifestyle Less << Not Applicable Recruiting September 30, 2021 United States, Ohio ... More >> Miami University, Department of Kinesiology and Health, Phillips Hall Recruiting Oxford, Ohio, United States, 45056 Contact: Anita Sackenheim    513-529-2700    sackenac@miamioh.edu Less <<
NCT01106833 - Completed - -
NCT00672243 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT01294748 - Completed - -
NCT00374647 Primary Renal Allograft Phase 4 Completed - United States, Ohio ... More >> The Christ Hospital Cincinnati, Ohio, United States, 45267 University of Cincinnati Cincinnati, Ohio, United States, 45267 Less <<
NCT00672243 - Completed - -
NCT00743509 Osteosarcoma Phase 2 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT01809860 Healthy Subjects ... More >> Pharmacokinetics of Isavuconazole Pharmacokinetics of Sirolimus Less << Phase 1 Completed - United States, Texas ... More >> Covance Dallas, Texas, United States, 75247 Less <<
NCT00887211 Coronary Disease Not Applicable Unknown March 2010 China ... More >> Fuwai Hospital Recruiting Beijing, China, 100037 Contact: Runlin Gao       gaorunlin@263.net Less <<
NCT00414648 Lymphangioleiomyomatosis Phase 3 Unknown September 2011 United States, California ... More >> University of California Los Angeles Los Angeles, California, United States, 90024 United States, Colorado National Jewish Medical and Research Center Denver, Colorado, United States, 80206 United States, Florida University of Florida, Gainesville Gainesville, Florida, United States, 32611 United States, Maryland National Heart, Lung, and Blood Institute Bethesda, Maryland, United States, 20892 United States, Massachusetts Harvard's Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, Ohio University of Cincinnati Medical Center Cincinnati, Ohio, United States, 45267 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas University of Texas Health Center at Tyler Tyler, Texas, United States, 75708 Canada, Ontario Toronto General Hospital Toronto, Ontario, Canada, M5G 2N2 Japan National Kinki-Chou Hospital Sakai, Osaka, Japan, 591-8555 Niigata University Medical and Dental Hospital Niigata, Japan, 951-8520 Less <<
NCT02900716 Chronic Lymphocytic Leukemia ... More >> B-Cell Lymphoma Less << Phase 1 Recruiting - United States, Arizona ... More >> Mayo Clinic Recruiting Phoenix, Arizona, United States, 85054 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Allison Rosenthal, MD          United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States, 06510 Contact: Laura Leary, CCRC    203-737-8884    laura.leary@yale.edu    Principal Investigator: Scott Huntington, MD          United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States, 32224 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Han Tun, MD          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Offic    855-776-0015       Principal Investigator: Wei Ding, MD          United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Danielle Brander, MD    919-684-8964    Danielle.brander@duke.edu    Principal Investigator: Danielle Brander, MD          United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Kaitlin Kennard, RN       kaitlin.kennard@uphs.upenn.edu    Contact: Tanya Latorre, RN       Tanya.Latorre@uphs.upenn.edu    Principal Investigator: Stephen J Schuster, MD Less <<
NCT00743509 - Completed - -
NCT01687179 Lymphangioleiomyomatosis Phase 1 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02120 Less <<
NCT00319878 Anemia, Aplastic Phase 1 Phase 2 Unknown December 2009 United States, California ... More >> UCLA Center for Health Sciences Recruiting Los Angeles, California, United States, 90095 Contact: Ronald Paquette, MD    310-206-5755    paquette@ucla.edu    Principal Investigator: Ronald Paquette, MD          United States, Florida Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33606 Contact: Alan List, MD          Principal Investigator: Alan List, MD          Principal Investigator: Hussain Saba, MD          United States, Ohio Taussig Cancer Center, Cleveland Clinic Foundation Recruiting Cleveland, Ohio, United States, 44195 Contact: Jaroslaw P. Maciejewski, MD          Principal Investigator: Jaroslaw P. Maciejewski, MD          Principal Investigator: Mikkael Sekeres, MD          United States, Pennsylvania Penn State University Cancer Center Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Thomas Loughran, MD          Principal Investigator: Thomas Loughran, MD Less <<
NCT00895583 Graft Rejection ... More >> Kidney Transplant Renal Allograft Recipients Renal Transplant Less << Phase 4 Completed - -
NCT01003977 - Unknown September 2013 United States, District of Col... More >>umbia Washington Hospital Center Washington, District of Columbia, United States, 20010 Less <<
NCT01687179 - Completed - -
NCT03217669 Advanced Solid Tumor ... More >> Non-small Cell Lung Cancer (NSCLC) Less << Phase 1 Recruiting August 1, 2020 United States, Kansas ... More >> Clinical Research Center Recruiting Fairway, Kansas, United States, 66208 Contact: kerry hepler       ctnursenav@kumc.edu    Principal Investigator: Chao Huang          The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States, 66205 Contact: Kerry Hepler       ctnursenav@kumc.edu    Principal Investigator: Chao Huang, MD Less <<
NCT02013089 Gastrointestinal Cancers Not Applicable Unknown December 2017 China, Guangdong ... More >> Gastrointestinal Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanghong Deng, PhD    008613925106525    13925106525@163.com    Principal Investigator: Yanhong Deng, PhD Less <<
NCT00510393 Peripheral Vascular Disease ... More >> Critical Limb Ischemia Less << Phase 2 Completed - Belgium ... More >> Imelda Hospital Bonheiden, Belgium, 2820 AZ Sint-Blasius Dendermonde, Belgium, 9200 France Polyclinique Les Fleurs Ollioules, France, 83192 Germany Herz-zentrum Bad Krozingen Bad Krozingen, Germany, 79189 Herzzentrum Leipzig, Germany, 04289 Less <<
NCT03188068 Kaposiform Hemangioendotheliom... More >>a Kasabach Merritt Phenomenon Less << Phase 2 Recruiting January 1, 2020 China, Sichuan ... More >> West China Hospital of Sichuan University Recruiting Chengdu, Sichuan, China, 610041 Contact: Yi Ji, MD, PhD    +86 28 85423453    jijiyuanyuan@163.com    Contact: Siyuan Chen, MD, PhD    +86 28 85423460    siy_chen@163.com    Principal Investigator: Yi Ji, MD, PhD          Sub-Investigator: Bo Xiang, MD, PhD          Sub-Investigator: Zhicheng Xu, MD, PhD          Sub-Investigator: Fuyu Li, MD          Sub-Investigator: Xiaoping Jiang, MD          Sub-Investigator: Lin Zhong, MD          Sub-Investigator: Yuan Li, MD, PhD          Sub-Investigator: Siyuan Chen, MD, PhD          Sub-Investigator: Yanan Li, MD          Sub-Investigator: Chuan Wang, MD          Sub-Investigator: Qi Wang, MD          Sub-Investigator: Kaiying Yang, MD Less <<
NCT02241564 - Completed - Sweden ... More >> Department of Surgery, Section of Transplantation Surgery, Uppsala University Hospital Uppsala, Sweden, SE-75185 Less <<
NCT01369433 Solid Tumors Not Applicable Completed - -
NCT00141804 Kidney Transplantation Phase 3 Unknown - Germany ... More >> University Hospital Muenster Muenster, Germany, 48149 Less <<
NCT00600496 Breast Cancer ... More >> Breast Neoplasms Colon Cancer Colonic Cancer Colon Neoplasms Lung Cancer Melanoma Kidney Cancer Less << Phase 1 Active, not recruiting December 31, 2018 United States, Michigan ... More >> Research Site Detroit, Michigan, United States, 48201 United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Research Site Nashville, Tennessee, United States, 37203 United States, Texas Research Site Houston, Texas, United States, 77030 Less <<
NCT00895583 - Completed - -
NCT01293773 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Phase 4 Withdrawn - Italy ... More >> Azienda Policlinico-Universitaria di Modena Modena, Italy, 41100 Policlinico Casilino Rome, Italy, 00100 Less <<
NCT00098462 Lung Cancer Phase 1 Phase 2 Withdrawn(Withdrawn as study n... More >>ever opened) Less << - -
NCT00940381 Advanced Cancer Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00286624 Type 1 Diabetes Mellitus ... More >> Hypoglycemia Less << Phase 1 Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02675153 Crohn's Diseases Phase 4 Recruiting December 30, 2019 China, Jiangsu ... More >> Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210011 Contact: Faming Zhang, MD, PhD    086-25-58509883    fzhang@njmu.edu.cn Less <<
NCT00506948 Hematological Malignancies ... More >> Myelodysplastic Syndrome Leukemia Lymphoma Less << Phase 2 Terminated(Halted due to high ... More >>incidence of veno-oclusive disease of the liver.) Less << - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01659034 Coronary Artery Disease Phase 4 Completed - Japan ... More >> Department of Cardiovascular Medicine, Kyoto University Hospital Kyoto, Japan, 606-8507 Less <<
NCT00506948 - Terminated(Halted due to high ... More >>incidence of veno-oclusive disease of the liver.) Less << - -
NCT03730142 Advanced Cancer Phase 1 Enrolling by invitation October 25, 2019 China ... More >> Shanghai East Hospital Shanghai, China Less <<
NCT01066650 Coronary Artery Disease ... More >> Angina Pectoris Unstable Angina Pectoris Coronary Stenosis Coronary Restenosis Less << Phase 4 Completed - Netherlands ... More >> Medisch Spectrum Twnete Enschede, Overijssel, Netherlands, 7513ER Less <<
NCT01827384 Advanced Malignant Solid Neopl... More >>asm Less << Not Applicable Suspended(Scheduled Interim Mo... More >>nitoring) Less << - United States, Colorado ... More >> University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Kentucky University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States, 40536 United States, Maryland National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States, 20892 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00396721 Glomerulonephritis, IGA ... More >> Nephropathy, IGA IGA Nephropathy Less << Phase 2 Completed - Spain ... More >> Nephrology Department. Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Less <<
NCT01650545 Disorder Related to Lung Trans... More >>plantation Bronchiolitis Obliterans Decreased Immunologic Activity Chronic Rejection of Lung Transplant Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Less <<
NCT02487485 Depression Phase 2 Active, not recruiting August 2018 United States, Connecticut ... More >> Yale New Haven Hospital New Haven, Connecticut, United States, 06511 West Haven Veterans Affairs West Haven, Connecticut, United States, 06516 Less <<
NCT00548717 Graft-vs-Host Disease Phase 2 Terminated(First two patients ... More >>enrolled after trial reopened, developed grade III-IV acute GVHD and subsequently passed away.) Less << - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02619669 Breast Cancer Phase 1 Recruiting December 2019 United States, New Hampshire ... More >> Dartmouth Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Gary Schwartz, MD    800-639-6918    Cancer.Research.Nurse@Dartmouth.edu    Sub-Investigator: Todd Miller, Ph.D          Sub-Investigator: Mary Chamberlin, MD          Sub-Investigator: Peter Kaufman, MD          Sub-Investigator: Brad Arrick, MD Less <<
NCT00548717 - Terminated(First two patients ... More >>enrolled after trial reopened, developed grade III-IV acute GVHD and subsequently passed away.) Less << - -
NCT02968927 Tuberculosis Phase 2 Recruiting December 2020 South Africa ... More >> The Aurum Institute: Tembisa Clinical Research Centre Recruiting Tembisa, Gauteng, South Africa, 1736 Less <<
NCT01689987 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 1 Completed - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT00095329 Multiple Sclerosis (MS) - Rela... More >>psing-remitting Less << Phase 1 Phase 2 Terminated(Due to slow recruit... More >>ment.) Less << - United States, Massachusetts ... More >> Center for Neurological Diseases, Brigham and Women's Hospital, Harvard Medical School Boston, Massachusetts, United States, 02115 Less <<
NCT02071342 - Unknown September 2015 Italy ... More >> Division of interventional cardiology, Umberto I Hospital Recruiting Frosinone, Italy, 030100 Contact: Maurizio Menichelli, MD    +39 3382642317    menichelli747@yahoo.com    Sub-Investigator: Giancarlo Di Ruzza, MD          Sub-Investigator: Pasquale Mollo, MD          Sub-Investigator: Duino Boncompagni, MD          Sub-Investigator: Marco Cesario, MD          Sub-Investigator: Andrea Mazza, MD Less <<
NCT02043795 Critical Limb Ischemia Not Applicable Recruiting March 2018 Singapore ... More >> Changi General Hospital Recruiting Singapore, Singapore, 529889 Principal Investigator: Steven Kum, MD Less <<
NCT00368914 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT01650545 - Completed - -
NCT00126672 Nonmalignant Neoplasm Phase 2 Unknown - United States, California ... More >> Tuberous Sclerosis Clinic at Loma Linda University Medical Center Loma Linda, California, United States, 92350 United States, Connecticut Connecticut Children's Medical Center Hartford, Connecticut, United States, 06106 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York New York University Medical Center New York, New York, United States, 10016 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 Less <<
NCT02240810 - Completed - -
NCT00311623 Prostate Cancer Not Applicable Unknown - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0942 Less <<
NCT01003795 - Unknown October 2013 United States, District of Col... More >>umbia Washington Hospital Center Washington, District of Columbia, United States, 20010 Less <<
NCT01797315 Renal Transplant Patients at H... More >>igh-risk for Skin Cancer Less << Phase 4 Terminated(no adequate recruit... More >>ment) Less << - -
NCT01658007 Relapsed Lymphoblastic Leukemi... More >>a Recurrent Adult Lymphoblastic Lymphoma Refractory Acute Lymphoblastic Leukemia Refractory Lymphoblastic Lymphoma Less << Not Applicable Terminated(Slow Accrual) - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT03253913 Lymphangioleiomyomatosis Phase 2 Recruiting June 30, 2020 United States, Ohio ... More >> University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45267 Contact: Tammy Roads, CCRP    513-558-2148    roadst@ucmail.uc.edu    Principal Investigator: Nishant Gupta, MD Less <<
NCT02486068 Coronary Artery Lesion Not Applicable Active, not recruiting September 2024 -
NCT01675947 Geographic Atrophy Phase 2 Terminated(On May 30, 2014, st... More >>udy injections were discontinued at the request of the DSMC. No further recruitment will occur.) Less << February 2016 United States, California ... More >> Loma Linda University Loma Linda, California, United States, 92354 University of California, Davis Sacramento, California, United States, 95817 United States, Florida University of Florida HSC Jacksonville, Florida, United States, 32209 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Illinois University of Illinois Chicago, Illinois, United States, 60612 United States, Maryland Elman Retina Group Baltimore, Maryland, United States, 21237 United States, Michigan Vision Research Foundation Grand Rapids, Michigan, United States, 49546 United States, North Carolina Charlotte Eye Ear Nose & Throat Associates Charlotte, North Carolina, United States, 28210 United States, Pennsylvania Scheie Eye Institute, University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Palmetto Retina Center West Columbia, South Carolina, United States, 29169 United States, Tennessee Southeastern Retina Associates, P.C. Knoxville, Tennessee, United States, 37909 United States, Texas Texas Retina Associates Dallas, Texas, United States, 75231 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53705 Less <<
NCT00189202 End Stage Renal Disease ... More >> Kidney Transplantation Less << Phase 2 Phase 3 Completed - United States, Michigan ... More >> University of Michigan Health Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT00189202 - Completed - -
NCT00328770 Liver Carcinoma Phase 2 Phase 3 Completed - Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada, T6G 2B7 Less <<
NCT00068302 Leukemia Lymp... More >>homa Less << Phase 1 Terminated(Recruiting/enrollin... More >>g participants halted prematurely but potentially will resume) Less << - United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02018991 Late Acquired Stent Malapositi... More >>on Less << Phase 4 Completed - Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT03654040 Liver Transplant Phase 1 Phase 2 Not yet recruiting December 2025 United States, California ... More >> University of California, San Francisco Not yet recruiting San Francisco, California, United States, 94143 Principal Investigator: Sandy Feng, MD, PhD Less <<
NCT00401115 Diabetic Macular Edema ... More >> Diabetic Retinopathy Less << Phase 1 Completed - United States, Arizona ... More >> Retina Consultants of Arizona Phoenix, Arizona, United States, 85014 United States, Texas Texas Retina Associates Arlington, Texas, United States, 76012 Less <<
NCT00328770 - Completed - -
NCT03657004 - Recruiting May 1, 2019 Germany ... More >> University Hospital Giessen and Marburg Recruiting Giessen, Hessen, Germany, 35392 Contact: Stefan Kuhnert, MD    +4964198542351    stefan.kuhnert@innere.med.uni-giessen.de    Contact: Konstatin Mayer, MD    +4964198542351    konstatin.mayer@innere.med.uni.giessen.de    Principal Investigator: Konstantin Mayer, MD Less <<
NCT01223755 Autosomal Dominant Polycystic ... More >>Kidney Disease (ADPKD) Less << Phase 2 Phase 3 Terminated(safety and efficacy... More >> reason) Less << - Italy ... More >> Mario Negri Institute - Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Less <<
NCT03577431 Liver Transplant Phase 1 Phase 2 Not yet recruiting December 2025 United States, Massachusetts ... More >> Massachusetts General Hospital: Transplantation Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Kerry Crisali, RN, BSN    617-643-4087    KCRISALLI@mgh.harvard.edu    Contact: Margaret (Peg) Thomas    617-643-7555    mvthomas@mgh.harvard.edu    Principal Investigator: James F. Markmann, MD, PhD Less <<
NCT00766649 Age-Related Macular Degenerati... More >>on Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01595841 End Stage Renal Disease ... More >> Venous Stenosis Less << Phase 2 Recruiting December 2019 Canada, Ontario ... More >> London Health Sciences Centre Recruiting London, Ontario, Canada, N6A 5A5 Contact: Mary Jeanne Edgar    519-685-8500 ext 34755       Principal Investigator: Anthony Jevnikar, MSc MD          Canada, Saskatchewan Regina Qu'Appelle Health Region Withdrawn Regina, Saskatchewan, Canada, S4P 0W5 Less <<
NCT00766649 - Completed - -
NCT00859183 Coronary Restenosis Phase 4 Completed - Germany ... More >> Medizinische Klinik I, Garmisch-Partenkirchen Garmisch-Partenkirchen, Germany Deutsches Herzzentrum Munich, Germany, 80636 1. Medizinische Klinik, Klinikum rechts der Isar Munich, Germany, 81675 Less <<
NCT01581515 Coronary Artery Disease Phase 4 Unknown January 2014 Korea, Republic of ... More >> Severance Hospital Recruiting Seoul, Seodaemun-gu/Sinchon-dong, Korea, Republic of, 120-752 Contact: Shin-young Park, Staff    +82 2 2228 0453    smile@yuhs.ac    Principal Investigator: Myeong-Ki Hong, MD.PhD Less <<
NCT01680250 Polycystic Kidney Diseases Phase 2 Phase 3 Unknown August 2015 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Curie Ahn, MD, PhD    82-2-2072-2222    curie@snu.ac.kr Less <<
NCT01346085 Type 1 Diabetes Phase 1 Phase 2 Completed - Italy ... More >> IRCCS San Raffaele Scientific Institute Milan, Italy, 20132 Switzerland Universitè de Geneve Geneve, Switzerland, 1211 Less <<
NCT02123966 Chronic Graft-versus-Host-Dise... More >>ase Oral Mucosal Disease Due to Graft-versus-host Disease Less << Phase 2 Terminated(Due to slow accrual... More >>, study team has decided to end the study early.) Less << - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02123966 - Terminated(Due to slow accrual... More >>, study team has decided to end the study early.) Less << - -
NCT01331707 Acute Coronary Syndrome ... More >> Angina Pectoris Angina, Unstable Myocardial Infarction Coronary Artery Disease Coronary Stenosis Coronary Restenosis Less << Phase 4 Completed - Netherlands ... More >> Medisch Centrum Alkmaar Alkmaar, Netherlands Hospital Rijnstate Arnhem, Netherlands Scheper Hospital Emmen, Netherlands Thoraxcentrum Twente Enschede, Netherlands Less <<
NCT01445548 - Completed - -
NCT02596828 Pineoblastoma Phase 2 Recruiting April 2020 Germany ... More >> University Hospital of Regensburg Recruiting Regensburg, Germany, 93053 Contact: Selim Corbacioglu, MD    0043 (0)941 944 ext 2101    kinderonkologie@ukr.de    Contact: Susanne Ellinger    0043 (0)941 944 ext 2063    susanne.ellinger@ukr.de Less <<
NCT02177760 Severe Combined Immunodeficien... More >>cy Transplacental Maternal Engraftment Stem Cell Transplant Less << Phase 2 Withdrawn(Preliminary data sug... More >>gested a better approach available) Less << - United States, California ... More >> Benioff Children's Hospital at UCSF Medical Center San Francisco, California, United States, 94143 Less <<
NCT01517074 Scleritis Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01346085 - Completed - -
NCT02214706 Port-Wine Stain Not Applicable Terminated(Lack of efficacy / ... More >>adverse events) Less << - Netherlands ... More >> Erasmus MC Rotterdam, Zuid-Holland, Netherlands, 3015CA Less <<
NCT01517074 - Completed - -
NCT02513303 Complication of Renal Dialysis... More >> End Stage Renal Disease End Stage Kidney Disease ESRD Chronic Kidney Failure Complication of Hemodialysis Vascular Access Complication Arteriovenous Fistula Less << Phase 3 Recruiting December 2019 United States, Alabama ... More >> Nephrology Consultants, LLC Recruiting Huntsville, Alabama, United States, 35805 Contact: Rakesh Raghubanshi    201-266-8310    rakesh@vasculartx.com    United States, Arizona AKDHC Medical Research Service Recruiting Phoenix, Arizona, United States, 85012 Contact: Rakesh Raghubanshi    201-266-8310    rakesh@vasculartx.com    United States, California San Diego Institute of Medical Research Recruiting Escondido, California, United States, 92025 Contact: Rakesh Raghubanshi    201-266-8310    rakesh@vasculartx.com    United States, Pennsylvania Northeast Clinical Research Center Recruiting Bethlehem, Pennsylvania, United States, 18017 Contact: Rakesh Raghubanshi    201-266-8310    rakesh@vasculartx.com Less <<
NCT02524639 Hyperinsulinism Phase 1 Phase 2 Withdrawn(Due to strict inclus... More >>ion and exclusion criteria no subjects were enrolled) Less << - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00304954 Age-Related Macular Degenerati... More >>on Choroidal Neovascularization Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03095703 Adenomatous Polyposis Coli Phase 2 Recruiting March 1, 2019 Netherlands ... More >> Academic Medical Centre Recruiting Amsterdam, Noord-Holland, Netherlands, 1105AZ Contact: Evelien Dekker, MD, PhD       e.dekker@amc.uva.nl Less <<
NCT03350542 Coronary Artery Disease Phase 3 Recruiting May 2021 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Massoud Leesar, MD    205-934-7898    maleesar@uabmc.edu    Principal Investigator: Massoud Leesar, MD          United States, Minnesota Mercy Hospital Recruiting Coon Rapids, Minnesota, United States, 55433 Contact: Jeffrey Chambers, MD    763-427-9980    j.chambers@mhvi.com    Principal Investigator: Jeffrey Chambers, MD          HealthEast St. Joseph's Hospital Recruiting Saint Paul, Minnesota, United States, 55102 Contact: Mudassar Ahmed, MD    218-786-8364    mahmed@healtheast.org    Principal Investigator: Mudassar Ahmed, MD          United States, New York New York Presbyterian Hospital - Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Jeffrey Moses, MD    212-305-7060    jm2456@columbia.edu    Principal Investigator: Jeffrey Moses, MD          United States, North Carolina Rex Hospital Recruiting Raleigh, North Carolina, United States, 27607 Contact: Willis Wu, MD    919-787-5380    willis.wu@unchealth.unc.edu    Principal Investigator: Willis Wu, MD          United States, Ohio Lindner Center for Research and Education at Christ Hospital Recruiting Cincinnati, Ohio, United States, 45219 Contact: Robert Riley, MD    513-585-1777    robert.riley@thechristhospital.com    Principal Investigator: Robert Riley, MD          United States, Pennsylvania York Hospital Recruiting York, Pennsylvania, United States, 17403 Contact: William Nicholson, MD    717-851-2441    wjnichmd2@aol.com    Principal Investigator: William Nicholson, MD          United States, Texas Heart Hospital of Austin Recruiting Austin, Texas, United States, 78756 Contact: Roger Gammon, MD    512-206-3600    roger.gammon@hcahealthcare.com    Principal Investigator: Roger Gammon, MD          Baylor Heart & Vascular Hospital Recruiting Dallas, Texas, United States, 75226 Contact: Robert Stoler, MD    214-820-9903    rcstoler@gmail.com    Principal Investigator: Robert Stoler, MD          The Heart Hospital Baylor Plano Recruiting Plano, Texas, United States, 75024 Contact: Srinivasa Potluri, MD    469-800-6300    srinivasa.potluri@bswhealth.org    Principal Investigator: Srinivasa Potluri, MD          Latvia P. Stradins University Hospital Recruiting Riga, Latvia Contact: Andrejs Erglis, MD    371 67069379    a.a.erglis@stradini.lv    Principal Investigator: Andrejs Erglis, MD          New Zealand Auckland City Hospital Recruiting Auckland, New Zealand, 2025 Contact: Mark Webster, MD    64 9 307-4949    mwebster@adhb.govt.nz    Principal Investigator: Mark Webster, MD          North Shore Hospital Recruiting Takapuna, New Zealand, 0622 Contact: Seif El-Jack, MD    64 94868920    Seif.ElJack@waitematadhb.govt.nz    Principal Investigator: Seif El-Jack, MD          United Kingdom Royal Victoria Hospital Recruiting Belfast, United Kingdom, BT12 6BA Contact: Simon Walsh, MD    44 28 90263831    simon.walsh@belfasttrust.hscni.net    Principal Investigator: Simon Walsh, MD          Golden Jubilee National Hospital Recruiting Glasgow, United Kingdom, G81 4DY Contact: Keith Oldroyd, MD    44 141 951 5180    keith.oldroyd@nhs.net    Principal Investigator: Keith Oldroyd, MD          Freeman Hospital Recruiting Newcastle Upon Tyne, United Kingdom, NE7 7DN Contact: Azfar Zaman, MD    4419 259 6660    azfar.zaman@nuth.nhs.uk    Principal Investigator: Azfar Zaman, MD          John Radcliffe Hospital Recruiting Oxford, United Kingdom, OX3 9DU Contact: Adrian Banning, MD    441865228934    adrian.banning@ouh.nhs    Principal Investigator: Adrian Banning, MD Less <<
NCT00304954 - Completed - -
NCT01856101 Carcinoma Transitional Cell Phase 2 Terminated(Novartis decided to... More >> stop the marketing of BEZ235) Less << - Belgium ... More >> Clinique Saint-Pierre à Ottignies Ottignies, Brabant Wallon, Belgium, 1340 Epicura- RHMS Baudour Baudour, Hainaut, Belgium, 7331 Grand Hôpital de Charleroi Charleroi, Hainaut, Belgium, 6000 Hôpital de Jolimont Haine-Saint-Paul, Hainaut, Belgium, 7100 Centre Hospitalier Wallonie Picarde Tournai, Hainaut, Belgium, 7500 CHU de Liège site du Sart Tilman Liège 1, Liège, Belgium, 4000 Clinique du Sud Luxembourg Arlon, Luxembourg, Belgium, 6700 CHU de Mont-Godinne Yvoir, Namur, Belgium, 5530 Cliniques universitaires Saint-Luc Brussel, Belgium, 1200 Universitair Ziekenhuis Gent Gent, Belgium, 9000 Clinique et Maternité Ste Elisabeth Namur, Belgium, 5000 Luxembourg Centre Hospitalier de Luxembourg Luxembourg, Grand-Duché de Luxembourg, Luxembourg, 1210 Less <<
NCT03047980 Sturge-Weber Syndrome Phase 2 Phase 3 Recruiting September 1, 2019 United States, Maryland ... More >> Kennedy Krieger Institute Recruiting Baltimore, Maryland, United States, 21205 Contact: Alyssa M Day, B.A.    443-923-9569    DayAly@kennedykrieger.org    Contact: Kelly A Harmon, B.A.    443-923-9127    harmon@kennedykrieger.org    Principal Investigator: Anne M Comi, M.D.          United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Paula Mobberley-Schuman, M.S.    513-803-4862    hvmcresearch@cchmc.org    Principal Investigator: Adrienne M Hammill, M.D., PhD Less <<
NCT01135563 Solid Tumors ... More >>Central Nervous System Tumors Less << Phase 1 Completed - United States, California ... More >> Rady Children's Hospital-San Diego San Diego, California, United States, 92123 United States, Missouri SSM Cardinal Glennon Children's Medical Center St. Louis, Missouri, United States, 63104 United States, Vermont Fletcher Allen Health Care Burlington, Vermont, United States, 05401 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec CHU Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 Less <<
NCT03583307 Vascular Anomaly Not Applicable Recruiting December 31, 2021 China, Sichuan ... More >> West China Hospital of Sichuan University Recruiting Chengdu, Sichuan, China, 61004· Contact: Yi Ji, MD, PhD          Sub-Investigator: Bo Xiang, MD          Sub-Investigator: Lin Zhong, MD          Sub-Investigator: Zhicheng Xu, MD          Sub-Investigator: Kaiying Yang, MD          Sub-Investigator: Suhua Peng, MD          Sub-Investigator: Tong Qiu, MD          Sub-Investigator: Shiyi Dai, MD          Sub-Investigator: Xuepeng Zhang, MD          Sub-Investigator: Siyuan Chen, MD, PhD          Principal Investigator: Yi Ji, MD, PhD Less <<
NCT01843998 Cutaneous T-cell Lymphoma (CTC... More >>L) Less << Phase 2 Withdrawn December 2015 United States, Wisconsin ... More >> Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01445548 Age-Related Macular Degenerati... More >>on Geographic Atrophy Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01087983 Advanced Cancers Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01486095 True Coronary Bifurcation Lesi... More >>ons Less << Not Applicable Active, not recruiting December 2017 Belgium ... More >> ZOL Genk Genk, Belgium, 3600 UH Leuven Leuven, Belgium, 3000 Less <<
NCT02565901 Castration Levels of Testoster... More >>one Castration-Resistant Prostate Carcinoma Metastatic Prostate Carcinoma Prostate Carcinoma Metastatic in the Bone PSA Level Greater Than or Equal to Two PSA Progression Stage IV Prostate Cancer AJCC v7 Less << Phase 1 Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Robert B. Montgomery    206-598-0860    rbmontgo@uw.edu    Principal Investigator: Robert B. Montgomery Less <<
NCT02015832 - Active, not recruiting February 2021 Netherlands ... More >> Research Center NL007 Amsterdam, Noord Holland, Netherlands Research Center NL001 Rotterdam, Zuid-Holland, Netherlands Poland Research Center PL008 Bielsko-Biała, Poland Research Center PL012 Katowice, Poland Research Center PL010 Krakow, Poland Research Center PL004 Poznan, Poland Spain Research Center ES009 Santander, Cantabria, Spain Research Center ES001 Barcelona, Cataluna, Spain Research Center ES007 Madrid, Comunidad Autonoma de Madrid, Spain Research Center ES012 Madrid, Comunidad Autonoma de Madrid, Spain Research Center ES015 Madrid, Comunidad Autonoma de Madrid, Spain Research Center ES004 Vigo, Galicia, Spain Research Center ES016 Salamanca, Spain United Kingdom Research Center GB014 Belfast, County Antrim, United Kingdom Research Center GB019 Oxford, Oxfordshire, United Kingdom Research Center GB005 Brighton, United Kingdom Research Center GB020 Cambridge, United Kingdom Research Center GB015 Edinburgh, United Kingdom Research Center GB001 Liverpool, United Kingdom Research Center GB017 London, United Kingdom Research Center GB006 Manchester, United Kingdom Research Center GB013 Newcastle upon Tyne, United Kingdom Less <<
NCT01752894 Ischemic Heart Disease Not Applicable Unknown November 2017 Korea, Republic of ... More >> Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: MYEONG-KI HONG, MD    82-2-2228-8458    MKHONG61@yuhs.ac Less <<
NCT01522820 Anaplastic Astrocytoma ... More >> Anaplastic Oligoastrocytoma Anaplastic Oligodendroglioma Estrogen Receptor Negative Estrogen Receptor Positive Glioblastoma Hormone-Resistant Prostate Cancer Metastatic Prostate Carcinoma Metastatic Renal Cell Cancer Recurrent Adult Brain Neoplasm Recurrent Bladder Carcinoma Recurrent Breast Carcinoma Recurrent Colorectal Carcinoma Recurrent Esophageal Carcinoma Recurrent Gastric Carcinoma Recurrent Hepatocellular Carcinoma Recurrent Lung Carcinoma Recurrent Melanoma Recurrent Ovarian Carcinoma Recurrent Prostate Carcinoma Recurrent Renal Cell Carcinoma Recurrent Uterine Corpus Carcinoma Resectable Hepatocellular Carcinoma Sarcoma Stage IA Breast Cancer Stage IA Ovarian Cancer Stage IA Uterine Corpus Cancer Stage IB Breast Cancer Stage IB Ovarian Cancer Stage IB Uterine Corpus Cancer Stage IC Ovarian Cancer Stage II Uterine Corpus Cancer Stage IIA Breast Cancer Stage IIA Lung Carcinoma Stage IIA Ovarian Cancer Stage IIB Breast Cancer Stage IIB Esophageal Cancer Stage IIB Lung Carcinoma Stage IIB Ovarian Cancer Stage IIB Skin Melanoma Stage IIC Ovarian Cancer Stage IIC Skin Melanoma Stage IIIA Breast Cancer Stage IIIA Esophageal Cancer Stage IIIA Lung Carcinoma Stage IIIA Ovarian Cancer Stage IIIA Skin Melanoma Stage IIIA Uterine Corpus Cancer Stage IIIB Breast Cancer Stage IIIB Esophageal Cancer Stage IIIB Ovarian Cancer Stage IIIB Skin Melanoma Stage IIIB Uterine Corpus Cancer Stage IIIC Breast Cancer Stage IIIC Esophageal Cancer Stage IIIC Ovarian Cancer Stage IIIC Skin Melanoma Stage IIIC Uterine Corpus Cancer Stage IV Bladder Urothelial Carcinoma Stage IV Esophageal Cancer Stage IV Ovarian Cancer Stage IV Prostate Cancer Stage IV Skin Melanoma Stage IVA Uterine Corpus Cancer Stage IVB Uterine Corpus Cancer Less << Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT02890589 Acute Coronary Syndrome Not Applicable Recruiting July 2018 France ... More >> Didier CARRIE Recruiting Toulouse, France, 31500 Contact: Didier CARRIE, MD PhD    561323324 ext 33    carrie.d@chu-toulouse.fr Less <<
NCT00392951 Autoimmune Pancytopenia ... More >> Autoimmune Lymphoproliferative Syndrome (ALPS) Evans Syndrome Idiopathic Thrombocytopenic Purpura Anemia, Hemolytic, Autoimmune Autoimmune Neutropenia Lupus Erythematosus, Systemic Inflammatory Bowel Disease Rheumatoid Arthritis Less << Phase 1 Phase 2 Active, not recruiting February 2020 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02584647 Sarcoma Malig... More >>nant Peripheral Nerve Sheath Tumors Less << Phase 1 Phase 2 Recruiting October 2021 United States, Massachusetts ... More >> Early Drug Development Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Khahn Do, MD       Khanh_Do@DFCI.HARVARD.EDU    Principal Investigator: Khahn Do, MD          United States, Missouri Washington University in St. Louis Recruiting Saint Louis, Missouri, United States, 63110 Contact: Brian A Van Tine, MD    314-747-3096    bvantine@DOM.wustl.edu    Principal Investigator: Brian A Van Tine, MD          United States, New York Columbia University Recruiting New York, New York, United States, 10032 Contact: Gulam A Manji, MD    212-305-0592    gam2140@columbia.edu    Principal Investigator: Gulam Manji, MD Less <<
NCT02421016 Coronary Stenosis Not Applicable Unknown April 2017 Germany ... More >> Deutsches Herzzentrum München Recruiting Munich, Bavaria, Germany, 80636 Contact: Robert Byrne, MB BCh PhD    +49-89-1218- ext 4587    byrne@dhm.mhn.de    Contact: Salvatore Cassese, MD    +49-89-1218- ext 4578    cassese@dhm.mhn.de Less <<
NCT02389946 Coronary Artery Disease ... More >> Atherosclerosis, Coronary Myocardial Ischemia Ischemic Heart Disease Acute Coronary Syndrome Angina Pectoris Less << Not Applicable Active, not recruiting April 2021 -
NCT00693446 Pancreas Transplantation ... More >> Kidney Transplantation Less << Phase 4 Unknown April 2017 France ... More >> CHU de Nantes Nantes, France Less <<
NCT01453595 - Terminated(Given the number of... More >> toxicities seen and the difficulty with patient retention in the dose escalation portion, the sponsor decided to close the trial.) Less << - -
NCT01453595 Renal Cancer Phase 1 Phase 2 Terminated(Given the number of... More >> toxicities seen and the difficulty with patient retention in the dose escalation portion, the sponsor decided to close the trial.) Less << - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00406393 Leukemia, Myelocytic, Acute ... More >> Leukemia, Lymphocytic, Acute Leukemia, Myeloid, Chronic Myelodysplastic Syndromes Less << Phase 3 Completed - -
NCT00406393 - Completed - -
NCT00670423 Graft vs Host Disease ... More >> Peripheral Blood Stem Cell Transplantation Transplantation, Homologous Less << Phase 1 Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT01925027 Coronary Artery Disease Phase 4 Unknown November 2016 Belgium ... More >> UZ Virga Jesse Ziekenhuis Recruiting Hasselt, Belgium, B-3500 Contact: E Benit, Dr    0032 11 309 440    edouard.benit@virgajesse.be    Principal Investigator: E Benit, Dr          CHU Sart Tillman Recruiting Liège, Belgium, B-4000 Contact: V Legrand, Prof    0032 4 366 71 92    vlegrand@chu.ulg.ac.be    Principal Investigator: V Legrand, Prof          Netherlands Medisch Spectrum Twente Recruiting Enschede, Netherlands, 7511 Contact: C von Birgelen, Dr    0031 53 487 21 05    C.vonBirgelen@mst.nl    Principal Investigator: C von Birgelen, Dr          Medisch Centrum Leeuwarden Recruiting Leeuwarden, Netherlands, 8934 Contact: S Hofma, Dr    0031 58 286 66 66    S.H.Hofma@ZNB.NL    Principal Investigator: S Hofma, Dr          Erasmus Medical Centre Recruiting Rotterdam, Netherlands, 3015 Contact: R.J.M van Geuns, Dr    0031 10 703 33 48    r.vangeuns@erasmusmc.nl    Principal Investigator: R.J.M van Geuns, Dr Less <<
NCT00923845 Renal Cell Carcinoma ... More >> Graft-Versus-Host Disease Engraftment Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01363752 Kidney Transplantation Phase 4 Completed - -
NCT01339962 - Completed - Denmark ... More >> University of Copenhagen Herlev Hospital Herlev, Denmark, 2730 Less <<
NCT02638428 Relapsed Pediatric Solid Tumor... More >> Refractory Pediatric Solid Tumor Relapsed Pediatric AML Refractory Pediatric AML Less << Phase 2 Recruiting December 2023 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT02029001 Malignant Solid Neoplasms Phase 2 Recruiting October 2022 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO    +335 56 33 33 33    a.italiano@bordeaux.unicancer.fr    Principal Investigator: Antoine ITALIANO          Sub-Investigator: Delphine GARBAY          Sub-Investigator: Maud TOULMONDE          Sub-Investigator: Sophie COUSIN          Sub-Investigator: Sylvestre LE MOULEC          Sub-Investigator: Mathilde CABART          Sub-Investigator: Guilhem ROUBAUD          Centre Jean Perrin Not yet recruiting Clermont-Ferrand, France, 63011 Contact: Xavier DURANDO    04 73 27 81 31    xavier.durando@cjp.fr    Principal Investigator: Xavier DURANDO          Sub-Investigator: Pierre DALLOZ          Sub-Investigator: Anne-Françoise DILLIES-LEGRAIN          Sub-Investigator: Pascale DUBRAY-LONGERAS          Sub-Investigator: Hakim MAHAMMEDI          Sub-Investigator: Marie-Ange MOURET-REYNIER          Sub-Investigator: Isabelle VAN PRAAGH DOREAU          Institut Daniel Hollard Not yet recruiting Grenoble, France, 38028 Contact: Cécile LEYRONNAS    04 76 70 73 33    c.leyronnas@ghm-grenoble.fr    Principal Investigator: Cécile LEYRONNAS, MD          Sub-Investigator: Claire GARNIER-TIXIDRE, MD          Sub-Investigator: Laurence LANCRY-LECOMTE, MD          Sub-Investigator: Jérôme LONG, MD          Sub-Investigator: Christine REBISCHUNG, MD          Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Jean-Yves BLAY    +33478785126    jean-yves.blay@lyon.unicancer.fr    Principal Investigator: Jean-Yves BLAY, MD          Sub-Investigator: Virginie AVRILLON          Sub-Investigator: Thomas BACHELOT          Sub-Investigator: Christophe BERGERON          Sub-Investigator: Pierre BIRON          Sub-Investigator: Helen BOYLE          Sub-Investigator: Philippe CASSIER          Sub-Investigator: Patrick COMBEMALE          Sub-Investigator: Maria CHELGHOUM          Sub-Investigator: Françoise DESSEIGNE          Sub-Investigator: Cécile FAURE-CONTER          Sub-Investigator: Jérome FAYETTE          Sub-Investigator: Aude FLECHON          Sub-Investigator: Christelle DE LA FOUCHARDIERE          Sub-Investigator: Didier FRAPPAZ          Sub-Investigator: Pierre GUIBERT          Sub-Investigator: Pierre-Etienne HEUDEL          Sub-Investigator: Eve-Marie NEIDHARDT          Sub-Investigator: Maurice PEROL          Sub-Investigator: Isabelle RAY-COQUARD          Sub-Investigator: Paul REBATTU          Sub-Investigator: Pierre SAINTIGNY          Sub-Investigator: Catherine TERRET          Sub-Investigator: Olivier TREDAN          Sub-Investigator: Olivia BALLY          Sub-Investigator: Stéphane DEPIL          Sub-Investigator: Olfa DERBEL          Sub-Investigator: Nathalie MARQUES          Sub-Investigator: Philippe TOUSSAINT          Sub-Investigator: Mehdi BRAHMI          Sub-Investigator: Matthieu SARABI          Sub-Investigator: Alice BONNEVILLE-LEVARD          Sub-Investigator: Nadège CORRADINI          Sub-Investigator: Louis DOUBLET          Sub-Investigator: Armelle DUFRESNE          Sub-Investigator: Lauriane EBERST          Sub-Investigator: Sylvie NEGRIER          Sub-Investigator: Katell MICHAUX          Sub-Investigator: Anne-Sophie MICHALLET          Sub-Investigator: Guillaume MAURICEAU          Sub-Investigator: Juliette REURE          Sub-Investigator: Pauline ROCHEFORT          Hopital Edouard Herriot Not yet recruiting Lyon, France, 69437 Contact: Julien FORESTIER, MD    +33472119738    julien.forestier@chu-lyon.fr    Principal Investigator: Julien FORESTIER          Sub-Investigator: Catherine LOMBARD BOHAS          Sub-Investigator: Thomas WALTER          Sub-Investigator: Yann MOLIN          Sub-Investigator: Noura BEN SLAMA          Institut Paoli Calmettes Recruiting Marseille, France, 13273 Contact: François BERTUCCI    +334 91 22 35 37    bertuccif@ipc.unicancer.fr    Principal Investigator: François BERTUCCI          Sub-Investigator: Jean-Marc EXTRA          Sub-Investigator: Anthony GONCALVES          Sub-Investigator: Gwenaêlle GRAVIS-MESCAM          Sub-Investigator: Anne MADROSZYK-FLANDIN          Sub-Investigator: Jean-Luc RAOUL          Sub-Investigator: Delphine PERROT          Sub-Investigator: Magali PROVENSAL          Sub-Investigator: Carole TARPIN          Sub-Investigator: Frédéric VIRET          Sub-Investigator: Louis TASSY          Sub-Investigator: Maria Antonietta CAPPIELLO          Sub-Investigator: Slimane DERMECHE          Sub-Investigator: Simon LAUNAY          Sub-Investigator: Frederique ROUSSEAU          Sub-Investigator: Nicolas MEYER          Sub-Investigator: Loïc MOUREY          Sub-Investigator: Elisabeth MOYAL          Sub-Investigator: Roxana Maria RADUT          Sub-Investigator: Henri ROCHE          Sub-Investigator: Thibaud VALENTIN          Sub-Investigator: Sarah ZAHI          Institut Curie Recruiting Paris, France, 75248 Contact: Christophe LE TOURNEAU, MD    +33144324672    Christophe.letourneau@curie.fr    Principal Investigator: Christophe LE TOURNEAU, MD          Sub-Investigator: Philippe BEUZEBOC          Sub-Investigator: François-Clément BIDARD          Sub-Investigator: Bruno BUECHER          Sub-Investigator: Paul-Henri COTTU          Sub-Investigator: Catherine DANIEL          Sub-Investigator: Véronique DIERAS          Sub-Investigator: Valérie LAURENCE          Sub-Investigator: Alain LIVARTOWSKI          Sub-Investigator: Jean-Yves PIERGA          Sub-Investigator: Marie ALT          Sub-Investigator: Delphine LOIRAT          Sub-Investigator: Marie-Paule SABLIN          Sub-Investigator: Mustapha ZOUBIR          Sub-Investigator: Francesco RICCI          Sub-Investigator: Emanuela ROMANO          Sub-Investigator: Olivier COLLARD          Centre Hospitalier Lyon Sud Recruiting Pierre-Bénite, France, 69495 Contact: Benoit YOU, MD    +33478864319    benoit.you@chu-lyon.fr    Principal Investigator: Benoit YOU, MD          Sub-Investigator: Nathalie BONNIN          Sub-Investigator: Gilles FREYER          Sub-Investigator: Salima HAMIZI          Sub-Investigator: Sophie TARTAS          Sub-Investigator: Véronique TRILLET-LENOIR          Sub-Investigator: Marion CHAUVENET          Sub-Investigator: Denis MAILLET          Sub-Investigator: Julien PERON          Sub-Investigator: Claire FALANDRY          Sub-Investigator: Olivia LE SAUX          Institut de cancérologie LUCIEN NEUWIRTH Not yet recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Olivier COLLARD, MD    04 77 91 70 34    olivier.collard@icloire.fr    Principal Investigator: Olivier COLLARD, MD          Sub-Investigator: Claire BOSACKI, MD          Sub-Investigator: Pierre FOURNEL, MD          Sub-Investigator: Aline GUILLOT, MD          Sub-Investigator: Jean-Philippe JACQUIN, MD          Sub-Investigator: Thierry MURON, MD          Sub-Investigator: Léa SABAN-ROCHE, MD          Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Carlos-Alberto GOMEZ-ROCA    05 31 15 51 01    Gomez-roca.carlos@iuct-oncopole.fr    Principal Investigator: Carlos-Alberto GOMEZ-ROCA          Sub-Investigator: Christine CHEVREAU          Sub-Investigator: Ewa-Anna COTTURA          Sub-Investigator: Florence DALENC          Sub-Investigator: Jean-Pierre DELORD          Sub-Investigator: Marion DESLANDRES          Sub-Investigator: Cécile GANDY          Sub-Investigator: Laurence GLADIEFF          Sub-Investigator: Eleonora MAIO D'ESPOSITO          Sub-Investigator: Nicolas MEYER          Sub-Investigator: Loïc MOUREY          Sub-Investigator: Elisabeth MOYAL          Sub-Investigator: Henri ROCHE          Sub-Investigator: Thibaud VALENTIN          Sub-Investigator: Sarah ZAHI          Sub-Investigator: Roxana Maria RADUT Less <<
NCT01822015 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Untreated Adult Acute Myeloid Leukemia Less << Early Phase 1 Active, not recruiting June 2020 United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00518375 Kidney Transplantation Phase 4 Completed - -
NCT01305395 Cardiac Allograft Vasculopathy Not Applicable Withdrawn(Due in part, to redu... More >>ced transplant volume and enrollment has been difficult.) Less << - United States, Minnesota ... More >> Cardiology Division, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00891696 Sarcopenia Phase 1 Completed - United States, Texas ... More >> Department of Nutrition & Metabolism, University of Texas Medical Branch Galveston, Texas, United States, 77550 Less <<
NCT01802268 Kidney Transplant Phase 4 Completed - Brazil ... More >> Hospital University Evangélico de Curitiba, Curitiba, Parana, Brazil Curitiba, Paraná, Brazil Kidney & Pancreas Transplant Unit, Santa Casa de Misericordia, Porto Alegre, Brazil Porto Alegre, Rio Grande do Sul, Brazil Instituto de Urologia e Nefrologia & Medical School-FAMERP/HB-FUNFARME, São José do Rio Preto-SP, Brazil São Jose do Rio Preto, São Paulo, Brazil, 04038 Nephrology Service, Bonsucesso General Hospital. Rio de Janeiro, Brazil Rio de Janeiro, Brazil Nephrology Division, Hospital do Rim, Federal University of São Paulo, Brazil São Paulo, Brazil, 04038 Renal Transplant Service, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil. São Paulo, Brazil, 04038 Less <<
NCT00491517 Polycystic Kidney Phase 2 Completed - Italy ... More >> Hospital "Azienda Ospedaliera Ospedali Riuniti di Bergamo" Unit of Neprology and Dialysis Bergamo, Italy Less <<
NCT01791088 Unspecified Adult Solid Tumor,... More >> Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Active, not recruiting December 2018 United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT03135275 ST-elevation Myocardial Infarc... More >>tion Multivessel Coronary Disease Less << Not Applicable Recruiting December 2019 Switzerland ... More >> University Hospital Zürich, Cardiology Department Recruiting Zurich, Switzerland, 8091 Contact: Willibald Maier, MD       willibald.maier@usz.ch    Contact: Giulia Magnani, MD, PhD       giulia.magnani@usz.ch    Principal Investigator: Willibald Maier, MD Less <<
NCT00923845 - Completed - -
NCT00392951 - Active, not recruiting - -
NCT02753686 - Recruiting December 2, 2019 Canada, British Columbia ... More >> Novartis Investigative Site Recruiting Burnaby, British Columbia, Canada, V5G 2X6 Novartis Investigative Site Recruiting Richmond, British Columbia, Canada, V7C 5L9 Novartis Investigative Site Recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Canada, New Brunswick Novartis Investigative Site Recruiting Moncton, New Brunswick, Canada, E1C 8X3 Canada, Ontario Novartis Investigative Site Recruiting Cambridge, Ontario, Canada, N1R 3G2 Novartis Investigative Site Recruiting Kingston, Ontario, Canada, K7L 5P9 Novartis Investigative Site Recruiting Kitchener, Ontario, Canada, N2G 1G3 Novartis Investigative Site Recruiting Newmarket, Ontario, Canada, L3Y 2P9 Novartis Investigative Site Recruiting Ottowa, Ontario, Canada, K1H 8L6 Novartis Investigative Site Recruiting Sault Ste-Marie, Ontario, Canada, P6A 2C4 Novartis Investigative Site Recruiting Windsor, Ontario, Canada, N8W 2X3 Canada, Quebec Novartis Investigative Site Recruiting Greenfield Park, Quebec, Canada, J4V 2H1 Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3A 1A1 Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3T 1E2 Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H4J 1C5 Canada, Saskatchewan Novartis Investigative Site Recruiting Saskatoon, Saskatchewan, Canada, S7N 4H4 Canada Novartis Investigative Site Recruiting Quebec, Canada, G1S 4L8 Less <<
NCT01887704 Coronary Artery Disease Not Applicable Completed - China, Beijing ... More >> Xinguo Wang Beijing, Beijing, China, 100029 Less <<
NCT02891603 Graft Vs Host Disease ... More >> GVHD Less << Phase 1 Phase 2 Recruiting June 2020 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Principal Investigator: Joseph Pidala, M.D.          Sub-Investigator: Melissa Alsina, M.D.          Sub-Investigator: Marco Davila, M.D., Ph.D.          Sub-Investigator: Linda Kelley, Ph.D.          Sub-Investigator: Farhad Khimani, M.D.          Sub-Investigator: Frederick Locke, M.D.          Sub-Investigator: Asmita Mishra, M.D.          Sub-Investigator: Taiga Nishihori, M.D.          Sub-Investigator: Jose Ochoa-Bayona, M.D.          Sub-Investigator: Lia Perez, M.D.          Sub-Investigator: Hugo Fernandez, M.D, Less <<
NCT01923740 - Active, not recruiting - -
NCT00538772 - Withdrawn - Canada, British Columbia ... More >> BC Cancer Agency - Centre for Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BC Cancer Agency - Vancouver Vancouver, British Columbia, Canada, V5Z 4E6 BC Cancer Agency - Vancouver Island Victoria, British Columbia, Canada, V8R 6V5 Less <<
NCT01923740 Coronary Artery Disease ... More >> Coronary Artery Stenosis Coronary Disease Coronary Stenosis Less << Not Applicable Active, not recruiting July 2019 United States, California ... More >> Abbott Vascular Santa Clara, California, United States, 95054 Less <<
NCT00518271 Kidney Transplantation Phase 2 Completed - -
NCT02240407 Pompe Disease Phase 1 Recruiting June 2019 United States, Florida ... More >> Clinical and Translational Research Building (CTRB), University of Florida Recruiting Gainesville, Florida, United States, 32610 Contact: Samantha Norman, MPH, BS    352-273-8218    samantha.norman@peds.ufl.edu Less <<
NCT00519116 Kidney Transplantation Phase 4 Completed - -
NCT01134952 Hepatitis C Phase 4 Completed - Canada, Ontario ... More >> London Health Sciences Centre London, Ontario, Canada, N6A5A5 Less <<
NCT01958190 Liver Disease Phase 2 Phase 3 Recruiting October 2020 Netherlands ... More >> UMCG Recruiting Groningen, Netherlands, 9713 GZ Contact: Lyda Engelsman, RN       a.f.engelsman@umcg.nl    Sub-Investigator: Tim Schreuder, MD PhD          LUMC Recruiting Leiden, Netherlands, 2333 ZA Contact: Lida Beneken, RN       a.beneken_kolmer@lumc.nl    Principal Investigator: Bart van Hoek, MD PhD          Erasmus Medical Center Recruiting Rotterdam, Netherlands, 3015CE Contact: Herold J Metselaar, MD PhD          Principal Investigator: Herold J Metselaar, MD PhD Less <<
NCT00611286 Coronary Artery Disease Phase 4 Completed - Italy ... More >> Azienda Ospedaliera Universitaria di Ferrara Ferrara, Emilia Romagna, Italy, 44100 Less <<
NCT01134952 - Completed - -
NCT03239015 Rare Tumor Re... More >>fractory Tumor Less << Phase 2 Recruiting December 31, 2019 China, Shanghai ... More >> Shanghai Changzheng Hospital Recruiting Shanghai, Shanghai, China, 200003 Contact: Xiao-Dong Jiao, MD    +86-13817797639    pulava@139.com Less <<
NCT01521715 Locally Advanced and/or Metast... More >>atic Renal Cell Carcinoma Carcinoma, Renal Cell Clear-cell Metastatic Renal Cell Carcinoma Less << Phase 4 Completed - Germany ... More >> Urolog. Klinik im Waldkrankenhaus St. Marien, Friedrich-Alexander-Universität Erlangen, Germany, 91054 Universitätsklinikum Essen, Klinik f. Urologie Essen, Germany, 45122 Med. Klinik II, Johann-Wolfgang-Goethe-Universität Frankfurt, Germany, 60590 Medizinisches Versorgungszentrum (MVZ) Osthessen GmbH Fulda, Germany, 36043 Universitätsmedizin Greifswald Greifswald, Germany, 17475 Medizinische Hochschule Hannover Hannover, Germany, 30625 Ludwig-Maximilians-Universität (LMU) München, Klinikum Grosshadern München, Germany, 81377 Universitätsklinikum Münster Münster, Germany, 48149 Less <<
NCT02010021 Breast Cancer Not Applicable Completed - United States, New Hampshire ... More >> Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT01462006 Idiopathic Pulmonary Fibrosis ... More >> Diffuse Parenchymal Lung Disease Interstitial Lung Disease Less << Not Applicable Active, not recruiting June 2019 United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT02175706 Coronary Artery Disease ... More >> Angina Pectoris Unstable Angina Pectoris Acute Coronary Syndrome Coronary Stenosis Coronary Restenosis Less << Not Applicable Active, not recruiting June 2017 Netherlands ... More >> Medisch Centrum Alkmaar Alkmaar, Netherlands Ziekenhuis Rijnstate Arnhem, Netherlands Scheper Ziekenhuis Emmen, Netherlands Medisch Spectrum Twente Enschede, Netherlands Less <<
NCT01962896 Relapsed / Recurrent Germ Cell... More >> Tumors Less << Phase 2 Active, not recruiting January 2019 United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas UT Southwestern Medical Center/Children's Medical Center Dallas, Texas, United States, 75390 Less <<
NCT00275535 Kidney Diseases Phase 4 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00369382 - Completed - -
NCT02890160 Coronary Artery Disease Not Applicable Recruiting October 2023 China, Beijing ... More >> Fu Wai Hospital Recruiting Peking, Beijing, China, 100037 Contact: Bo Xu, MBBS    +86-10-88322562    bxu@citmd.com Less <<
NCT00079183 Graft Versus Host Disease Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00369382 Graft Rejection ... More >> Kidney Failure Less << Phase 4 Completed - United States, Florida ... More >> Pfizer Investigational Site Tampa, Florida, United States, 33606 United States, Minnesota Pfizer Investigational Site Rochester, Minnesota, United States, 55905 United States, New York Pfizer Investigational Site New York, New York, United States, 10027-6902 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19102 Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19104 Pfizer Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Pfizer Investigational Site Houston, Texas, United States, 77030 United States, Virginia Pfizer Investigational Site Norfolk, Virginia, United States, 23507 Australia, New South Wales Pfizer Investigational Site Darlinghurst, New South Wales, Australia, 2010 Austria Pfizer Investigational Site Vienna, Austria, A-1090 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H1T 1C8 Pfizer Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 Canada Pfizer Investigational Site Quebec, Canada, G1V 4G5 New Zealand Pfizer Investigational Site Epsom, Auckland, New Zealand, 1003 Pfizer Investigational Site Auckland, New Zealand Spain Pfizer Investigational Site L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Pfizer Investigational Site Santander, Cantabria, Spain, 39008 Pfizer Investigational Site Barcelona, Spain, 08036 Pfizer Investigational Site La Coru?a, Spain, 15001 Pfizer Investigational Site Madrid, Spain, 28035 Pfizer Investigational Site Sevilla, Spain, 41013 Pfizer Investigational Site Valencia, Spain, 46009 Switzerland Pfizer Investigational Site Bern, Switzerland, 3010 Less <<
NCT01758575 - Terminated - Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands, 1081HV Less <<
NCT00079183 - Completed - -
NCT02671318 Cytomegalovirus Infections Phase 4 Recruiting August 2020 Brazil ... More >> Hospital do Rim Recruiting São Paulo, Brazil, 04037-003 Contact: Geovana Basso, MD    +55 11 5087-8000    geovana_basso@hotmail.com Less <<
NCT01145079 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Severance Cardiovascular Hospital, Yonsei University College of Medicine Seoul, Korea, Republic of, 120-752 Less <<
NCT01331135 Ewing's Sarcoma ... More >> Osteosarcoma Astrocytoma Atypical Teratoid/Rhabdoid Tumor Ependymoma Germ Cell Tumor Glioma Medulloblastoma Rhabdoid Tumor Retinoblastoma Clear Cell Sarcoma Renal Cell Carcinoma Wilms Tumor Hepatoblastoma Neuroblastoma Rhabdomyosarcoma Less << Phase 1 Active, not recruiting April 2021 United States, Georgia ... More >> Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 Less <<
NCT00060645 Tumors Lympho... More >>ma Multiple Myeloma Less << Phase 1 Completed - United States, Texas ... More >> Cancer Therapy and Research Center, University of Texas Health Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00060632 Tumors Lympho... More >>ma Multiple Myeloma Less << Phase 1 Completed - -
NCT01265810 Oral Complaints ... More >> Renal Cell Carcinoma Hepatocellular Carcinoma Gastrointestinal Stromal Tumors Less << Phase 3 Completed - Netherlands ... More >> The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 CX Leiden University Medical Centre (LUMC) Leiden, Netherlands, 2300 RC Less <<
NCT00977691 Peripheral Blood Stem Cell Tra... More >>nsplantation Anemia, Sickle Cell Graft-Versus-Host Disease Sirolimus (Rapamune ) Alemtuzumab (Campath ) Less << Phase 1 Phase 2 Active, not recruiting August 1, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01460420 Hematologic Malignancies ... More >> Multiple Myeloma Less << Phase 1 Phase 2 Completed - Germany ... More >> Medizinische Klinik and Poliklinik II, University Hospital Würzburg,, Germany Italy S Giovanni Battista Hospital Torino, Italy Azienda Ospedaliera Universitaria di Udine Udine, Italy Spain Hospital Clinic i Provincial, Barcelona,, Spain Hospital Santa Creu I Sant Pau, Barcelona,, Spain Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Hospital Gregorio Marañón, Madrid, Spain Hospital Clinico Universitario Salamanca, Salamanca,, Spain Hospital Universitario Virgen del Rocío, Sevilla, Spain Sweden Karolinska University Hospital, Huddinge Stockholm, Sweden Less <<
NCT00928018 Non-hodgkin Lymphoma ... More >> Hodgkin Lymphoma Less << Phase 3 Completed - United States, Georgia ... More >> Emory University Hospital Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55454 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00040508 Focal Glomerulosclerosis Phase 2 Completed - United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 Less <<
NCT00928018 - Completed - -
NCT01365572 In-stent Arterial Restenosis Phase 4 Unknown March 2012 Korea, Republic of ... More >> Yousei Universty Healthcare System Recruiting Seoul, Korea, Republic of Contact: Yangsoo Jang, MD, PhD    +82-2228-8321 Less <<
NCT02071719 - Terminated October 2017 Netherlands ... More >> VU Medical Center Amsterdam, Noord Holland, Netherlands, 1081 HV Less <<
NCT01709136 Hypertension Phase 2 Phase 3 Terminated(Sirolimus usage dis... More >>continued since black box warning) Less << - -
NCT01709136 - Terminated(Sirolimus usage dis... More >>continued since black box warning) Less << - -
NCT00612274 Stem Cell Transplantation Early Phase 1 Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT00895791 Coronary Artery Stenosis Not Applicable Unknown December 2015 Belgium ... More >> UZ Leuven Cardiology Not yet recruiting Leuven, Belgium, 3000 Contact: Tom Adriaenssens, MD          Sub-Investigator: Christophe Dubois, MD          Principal Investigator: Tom Adriaenssens, MD          Sub-Investigator: Walter Desmet, MD, PhD Less <<
NCT01196819 Coronary Artery Disease Not Applicable Completed - China ... More >> Fuwai Hospital Beijing, China, 100037 Less <<
NCT01223027 - Completed - -
NCT00736970 Breast Cancer ... More >> Breast Neoplasms Less << Phase 2 Completed - -
NCT01196819 - Completed - -
NCT00931255 Kidney Transplant ... More >> Delayed Graft Function Less << Phase 4 Terminated(The trial was stopp... More >>ed because of slow recruitment.) Less << - United States, Maryland ... More >> University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Less <<
NCT01488253 Acute Leukemia in Remission ... More >> Myelodysplastic Syndromes Leukemia, Myeloid, Chronic-Phase Leukemia, Myeloid, Accelerated-Phase Less << Phase 2 Terminated(We could not receiv... More >>e the support from the national medical insurance owing to the changed policy of the government for clincal trials.) Less << - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Gyeonggi, Korea, Republic of, 420-767 Less <<
NCT03522298 Glioblastoma, Adult Phase 2 Recruiting December 30, 2020 United States, California ... More >> University of California Los Angeles - Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Emese Filka       efilka@mednet.ucla.edu    Principal Investigator: Timothy Cloughesy, MD          United States, Colorado University of Colorado Cancer Center Recruiting Aurora, Colorado, United States, 80045 Contact: Rachel Freedman       Rachel.Freedman@ucdenver.edu    Principal Investigator: Denise Damek, MD          United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Swati Samtani       Swati_Samtani@dfci.harvard.edu    Principal Investigator: Patrick Wen, MD          Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Edwin Nunez       Enunez2@mgh.harvard.edu    Principal Investigator: Elizabeth Gerstner, MD          United States, New Jersey John Theurer Cancer Center at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Lori Cappello    551-996-5098    Lori.Cappello@HackensackMeridian.org    Principal Investigator: Samual A Goldlust, MD          United States, Oklahoma University of Oklahoma Health Sciences Center (Stephenson Cancer Center) Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Julie Schreiner          Contact       Julie-Schreiner@ouhsc.edu    Principal Investigator: James Battiste, MD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Kathy Hunter    713-745-5769    kuhunter@mdanderson.org    Principal Investigator: John de Groot, MD Less <<
NCT00931255 - Terminated(The trial was stopp... More >>ed because of slow recruitment.) Less << - -
NCT01966159 Coronary Artery Disease Not Applicable Active, not recruiting December 2019 China ... More >> Beijing Affiliated Hospital of Armed Police Medical College Beijing, China Beijing Hospital of the Ministry of Health Beijing, China Cardiovascular Institute and Fu Wai Hospital Beijing, China Peking University First Hospital Beijing, China Daqing General Oil Field Hospital Daqing, China Guangdong Cardiovascular Institute of Guangdong Provincial Hospital Guangzhou, China Sir Run Run Shaw Hospital of Zhejiang University School of Medicine Hangzhou, China Shengjing Hospital of China Medical University Shengyang, China Shenyang Northern Hospital (The General Hospital of Shenyang Military Region) Shen, China, 110015 Logistics University of PAPF Affiliated Hospital Tianjing, China TEDA International Cardiovascular Hospital Tianjin, China Wuhan Asia Heart Hospital Wuhan, China First Affiliated Hospital of Medical College of Xi'an Jiaotong University Xi'an, China Xijing Hospital, Fourth Military Medical University Xi'an, China Less <<
NCT02730923 Endometrial Carcinoma ... More >> Metastatic Carcinoma Hormone Receptor Positive Tumor Less << Phase 1 Phase 2 Recruiting May 2019 France ... More >> ICO - Paul Papin Recruiting Angers, France Contact: Sophie ABADIE-LACOURTOISIE, MD    02 41 35 27 34    sophie.abadie-lacourtoisie@ico-unicancer.fr    Principal Investigator: Sophie ABADIE-LACOURTOISIE, MD          Sub-Investigator: Paule AUGEREAU, MD          Sub-Investigator: Elouen BOUGHALEM, MD          Institut Sainte Catherine Recruiting Avignon, France, 84918 Contact: Antoine ARNAUD, MD    0490276397 ext +33    a.arnaud@isc84.org    Principal Investigator: Antoine ARNAUD, MD          Sub-Investigator: Rania BOUSTANY-GRENIER, MD          Sub-Investigator: Yvelise GOUBELY, MD          Sub-Investigator: Julien GRENIER, MD          Sub-Investigator: Sylvie KIRSCHER, MD          Sub-Investigator: Gaëtan De RAGLAUDRE, MD          Hôpital Jean Minjoz Not yet recruiting Besançon, France, 25030 Contact: Elsa KALBACHER, MD    0381669382 ext +33    ekalbacher@chu-besancon.fr    Principal Investigator: Elsa KALBACHER, MD          Sub-Investigator: Fernando BAZAN, MD          Sub-Investigator: Martin DEMARCHI, MD          Sub-Investigator: Laura MANSI, MD          Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Anne FLOQUET, MD    05 56 33 33 33    a.floquet@bordeaux.unicancer.fr    Principal Investigator: Anne FLOQUET, MD          Sub-Investigator: Camille CHAKIBA-BRUGERE, MD          Centre Francois Baclesse Recruiting Caen, France Contact: Florence JOLY, MD    02 31 45 50 17    f.joly@baclesse.unicancer.fr    Principal Investigator: Florence JOLY, MD          Sub-Investigator: Pierre-Emmanuel BRACHET, MD          Sub-Investigator: Elodie COQUAN, MD          Sub-Investigator: Emeline MERIAUX, MD          Sub-Investigator: Laura MOISE, MD          Sub-Investigator: Carine SEGURA-DJEZZAR, MD          Sub-Investigator: Sandrine VIVIER, MD          GHM Institut Daniel Hollard Recruiting Grenoble, France, 38028 Contact: Laurence LANCRY-LECOMTE, MD    04 76 28 52 32    l.lancrylecomte@ghm-grenoble.fr    Sub-Investigator: Claire GARNIER-TIXIDRE, MD          Principal Investigator: Laurence LANCRY-LECOMTE, MD          Sub-Investigator: Cécile LEYRONNAS, MD          Sub-Investigator: Jérôme LONG, MD          Sub-Investigator: Christine REBISCHUNG, MD          Centre Oscar Lambret Recruiting Lille, France Contact: Anne LESOIN, MD    03 20 29 55 36    a-lesoin@o-lambret.fr    Principal Investigator: Anne LESOIN, MD          Sub-Investigator: Annick CHEVALIER-PLACE, MD          Centre Léon Bérard Recruiting Lyon, France Contact: Pierre-Etienne HEUDEL, MD          Principal Investigator: Pierre-Etienne HEUDEL          Sub-Investigator: Olivia BALLY          Sub-Investigator: Mehdi BRAHMI          Sub-Investigator: Isabelle RAY-COQUARD          Sub-Investigator: Olivier TREDAN          Sub-Investigator: Philippe TOUSSAINT          Institut régional du Cancer Montpellier (ICM) Recruiting Montpellier, France, 34298 Contact: Michel FABBRO, MD    04 67 61 30 63    michel.fabbro@icm.unicancer.fr    Principal Investigator: Michel FABBRO, MD          Sub-Investigator: Véronique D'HONDT, MD          Hcl - Chls Recruiting Pierre-benite, France Contact: Benoît YOU, MD    04 78 86 43 18    benoit.you@chu-lyon.fr    Principal Investigator: Benoît YOU, MD          Sub-Investigator: Nathalie BONNIN, MD          Sub-Investigator: Amandine BRUYAS, MD          Sub-Investigator: Gilles FREYER, MD          Sub-Investigator: Salima HAMIZI, MD          Sub-Investigator: Sophie TARTAS, MD          Sub-Investigator: Véronique TRILLET-LENOIR, MD          Sub-Investigator: Julien PERON, MD          Sub-Investigator: Claire FALANDRY, MD          ICO - René Gauducheau Recruiting Saint-Herblain, France Contact: Jean-Sébastien FRENEL, MD    02 40 67 99 00    jean-sebastien.frenel@ico.unicancer.fr    Principal Investigator: Jean-Sébastien FRENEL, MD          Sub-Investigator: Akila BENINE-DANDEC, MD          Sub-Investigator: Dominique BERTON-RIGAUD, MD          Sub-Investigator: Emmanuelle BOURBOULOUX, MD          Sub-Investigator: Carole GOURMELON, MD          Sub-Investigator: Marie ROBERT, MD          Sub-Investigator: Audrey ROLLOT-TADEC, MD          Sub-Investigator: Mathilde COLOMBIE, MD Less <<
NCT03047213 Metastatic Transitional Cell C... More >>arcinoma Metastatic Urothelial Carcinoma Recurrent Bladder Carcinoma Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 Stage IV Bladder Urothelial Carcinoma AJCC v7 TSC1 Gene Mutation TSC2 Gene Mutation Less << Phase 2 Recruiting - United States, California ... More >> Los Angeles County-USC Medical Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact    323-865-0451       Principal Investigator: David I. Quinn          USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact    323-865-0451       Principal Investigator: David I. Quinn          Keck Medical Center of USC Pasadena Recruiting Pasadena, California, United States, 91105 Contact: Site Public Contact    323-865-0451       Principal Investigator: David I. Quinn          University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact    916-734-3089       Principal Investigator: Primo N. Lara          United States, Connecticut Smilow Cancer Center/Yale-New Haven Hospital Recruiting New Haven, Connecticut, United States, 06510 Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu    Principal Investigator: Joseph W. Kim          Yale University Recruiting New Haven, Connecticut, United States, 06520 Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu    Principal Investigator: Joseph W. Kim          United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Site Public Contact    312-695-1301    cancer@northwestern.edu    Principal Investigator: Alicia K. Morgans          United States, Kansas University of Kansas Clinical Research Center Recruiting Fairway, Kansas, United States, 66205 Contact: Site Public Contact    913-945-7552    ctnursenav@kumc.edu    Principal Investigator: Rahul A. Parikh          United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Site Public Contact    410-955-8804    jhcccro@jhmi.edu    Principal Investigator: Noah M. Hahn          United States, Massachusetts Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Site Public Contact    877-726-5130       Principal Investigator: David J. Kwiatkowski          Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Site Public Contact    888-823-5923    ctsucontact@westat.com    Principal Investigator: David J. Kwiatkowski          Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Site Public Contact    617-667-9925       Principal Investigator: David J. Kwiatkowski          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Site Public Contact    877-442-3324       Principal Investigator: David J. Kwiatkowski          United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Site Public Contact    800-865-1125       Principal Investigator: Ajjai S. Alva          United States, Nebraska Nebraska Medicine-Bellevue Recruiting Bellevue, Nebraska, United States, 68123 Contact: Site Public Contact    402-559-6941    unmcrsa@unmc.edu    Principal Investigator: Benjamin A. Teply          Nebraska Medicine-Village Pointe Recruiting Omaha, Nebraska, United States, 68118 Contact: Site Public Contact    402-559-5600       Principal Investigator: Benjamin A. Teply          University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198 Contact: Site Public Contact    402-559-6941    unmcrsa@unmc.edu    Principal Investigator: Benjamin A. Teply          United States, North Carolina UNC Lineberger Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Site Public Contact    877-668-0683    cancerclinicaltrials@med.unc.edu    Principal Investigator: Matthew I. Milowsky          United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Site Public Contact    412-647-8073       Principal Investigator: Leonard J. Appleman          United States, Tennessee Vanderbilt University/Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Site Public Contact    800-811-8480       Principal Investigator: Nancy B. Davis          United States, Utah Huntsman Cancer Institute/University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Contact: Site Public Contact    888-424-2100    cancerinfo@hci.utah.edu    Principal Investigator: Sumati V. Gupta Less <<
NCT01223027 Metastatic Renal Cell Carcinom... More >>a Less << Phase 3 Completed - -
NCT01966159 - Active, not recruiting - -
NCT02821507 Conventional Chondrosarcoma ... More >> Myxoid Liposarcoma Mesenchymal Chondrosarcoma Dedifferentiated Chondrosarcoma Less << Phase 2 Recruiting June 2020 Netherlands ... More >> LUMC Recruiting Leiden, Netherlands, 2333ZA Contact: Hans Gelderblom, Prof       a.j.gelderblom@lumc.nl    Spain Hospital de Sant Pau Recruiting Barcelona, Spain Contact: A López Pousa          Hospital Val d'Hebron Recruiting Barcelona, Spain Contact: C Valverde          CIO Clara Campal Recruiting Madrid, Spain Contact: J Rodriguez          Hospital Universitario Virgen del Rocío Recruiting Sevilla, Spain Contact: J Martin Broto          Hospital Universitario y Politécnico de La Fe Recruiting Valencia, Spain Contact: R Diaz-Beveridge          Instituto Valenciano de Oncología Recruiting Valencia, Spain Contact: J Lavernia Less <<
NCT02517918 Solid Tumor O... More >>steosarcoma Less << Phase 1 Recruiting October 2019 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Maud Toulmonde, Doctor          Centre Léon Bérard Not yet recruiting Lyon, France, 69008 Contact: Jean-Yves BLAY, Professor          Institut Curie Not yet recruiting Paris Cedex 05, France, 75248 Contact: Sophie PIPERNO-NEUMANN, Doctor          Institut Gustave Roussy Not yet recruiting Villejuif Cedex, France, 94805 Contact: Julien DOMONT, Doctor Less <<
NCT00086125 Hematologic Malignancies ... More >> Leukemia Myelodysplastic Syndromes Myeloid Metaplasia Lymphoma Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Hospitals, Section of Hematology/Oncology Chicago, Illinois, United States, 60637 United States, Missouri Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place St. Louis, Missouri, United States, 63110 United States, New Jersey The Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York New York Presbyterian Hospital, Weill College of Cornell University New York, New York, United States, 10021 United States, North Carolina Morris Cancer Center - Duke University Medical Center, Adult Bone Marrow Transplant Clinic Durham, North Carolina, United States, 27705 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, Pennsylvania Jeane's Hospital of TUHS Philadelphia, Pennsylvania, United States, 19111 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01756118 Acute Lymphoblastic Leukemia ... More >> Leukemia, Myelocytic, Acute Chronic Myelogenous Leukemia With Crisis of Blast Cells Less << Phase 1 Active, not recruiting December 2017 Germany ... More >> Johann Wolfgang Goethe University Hospitals Frankfurt, Hessen, Germany, 60590 Less <<
NCT00122343 Endometrial Cancer Phase 2 Completed - -
NCT00781846 Solid Tumor Phase 1 Completed - -
NCT01242696 - Completed - -
NCT03363763 Angiofibroma of Face ... More >> Tuberous Sclerosis Less << Phase 2 Recruiting January 2019 United States, Massachusetts ... More >> Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Grace Bazin, BSN, BS    617-355-5230    Grace.Bazin@childrens.harvard.edu    Contact: Lindsay Swanson, MS    617-355-5111    Lindsay.Swanson@childrens.harvard.edu    Principal Investigator: Marilyn G. Liang, MD          United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Lorraine Greer, MSM    267-426-7032    greerl@email.chop.edu    Principal Investigator: Albert C. YAN, MD          Sub-Investigator: Katherine Taub, MD          United States, Tennessee LeBonheur Children's Hospital Recruiting Memphis, Tennessee, United States, 38103 Contact: Tracee Ridley- Pryor    901-287-5388    Tracee.Ridley-Pryor@lebonheur.org    Contact: Margaret Bissler    901-287-7467    margaret.bissler@lebonheur.org    Principal Investigator: James W. Wheless, MD          Sub-Investigator: Teresa Wright, MD Less <<
NCT01364844 Solid Tumor C... More >>olorectal Cancer Endometrial Cancer Less << Phase 1 Completed - United States, Michigan ... More >> Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Less <<
NCT02407054 Prostate Cancer Metastatic Phase 2 Active, not recruiting May 1, 2019 -
NCT01348022 - Completed - Korea, Republic of ... More >> Soon Chun Hyang University Hospital Bucheon Bucheon, Korea, Republic of Kangwon National University Hospital Chuncheon, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of Kyungpook National University Hospital Daegu, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of The Catholic University of Korea, Daejeon ST. Mary's Hospital Daejeon, Korea, Republic of Gangneung Asan Hospital Gangneung, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Kwangju Christian Hospital Kwangju, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of, 138-736 Korea University Anam Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University hospital Seoul, Korea, Republic of Severance Hospital Seoul, Korea, Republic of The Catholic University of Korea Seoul St. Mary's Hospital Seoul, Korea, Republic of Veterans Hospital Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Pusan National University Yangsan Hospital Yangsan, Korea, Republic of Less <<
NCT03716011 Coronary Artery Disease Not Applicable Not yet recruiting December 20, 2025 China, Beijing ... More >> JW Medical System Not yet recruiting Beijing, Beijing, China, 100029 Contact: Wei M Fu, Bachelor    +86 10 50981788    wei.fu@jwmsgrp.com    Contact: Hao M Lu, Ph.D    +86 10 50981788    haolu04@yahoo.com.cn    Principal Investigator: Junbo M Ge, Ph.D          Sub-Investigator: Lei M Ge, Ph.D          Sub-Investigator: Yong M Huo, Ph.D          Sub-Investigator: Jian an M Wang, Ph.D Less <<
NCT03486366 Epilepsy Not Applicable Recruiting March 30, 2020 Poland ... More >> Medical University of Warsaw Recruiting Warsaw, Poland, 05-091 Contact: Sergiusz Jóźwiak, Professor    +48 606 445 668    sergiusz.jozwiak@wum.edu.pl    Contact: Katarzyna Kotulska-Jóźwiak, Professor    +48 607 281 798    kotulska.jozwiak@gmail.com Less <<
NCT02372227 Relapsed Malignant Mesotheliom... More >>a Less << Phase 1 Terminated - United States, Illinois ... More >> The University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, New York Memorial Sloane Kettering Cancer Center New York, New York, United States, 10065 United Kingdom University of Leicester Leicester, United Kingdom The Institute of Cancer Research Sutton Surrey, United Kingdom Less <<
NCT00836927 Advanced Cancers Phase 2 Terminated - -
NCT00836927 - Terminated - -
NCT01201369 Coronary Artery Disease Not Applicable Completed - United Kingdom ... More >> Harefield Hospital Harefield, Middlesex, United Kingdom, UB96JH Less <<
NCT02987959 Soft-tissue Sarcoma Phase 2 Recruiting September 2019 United States, Pennsylvania ... More >> Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT03008148 Glioblastoma Phase 2 Phase 3 Not yet recruiting October 2023 Taiwan ... More >> Taipei Veterans General Hospital Not yet recruiting Taipei City, Taiwan, 11217 Principal Investigator: Yu-Ming Liu          Tri-Service General Hospital Not yet recruiting Taipei City, Taiwan, 11490 Principal Investigator: Hsin-I Ma Less <<
NCT01788150 Coronary Artery Disease Not Applicable Active, not recruiting May 2019 Belgium ... More >> OLV Ziekenhuis Aalst Aalst, Belgium Middelheim Ziekenhuis Antwerpen, Belgium ZOL Genk Genk, Belgium CHU Liège Liege, Belgium Czechia Všeobecná fakultní nemocnice Praha Prague, Czechia France Clinique Saint-Hilaire Rouen, France CHU de Toulouse Toulouse, France Clinique Pasteur Toulouse, France Germany Medizinisches Verzorgungszentrum Prof. Mathey, Prof. Schofer Hamburg, Germany University Medical Center Hamburg-Eppendorf Hamburg, Germany Netherlands OLVG Amsterdam Amsterdam, Netherlands Catharina Hospital Eindhoven Eindhoven, Netherlands Erasmus MC Rotterdam, Netherlands Maasstad Ziekenhuis Rotterdam, Netherlands University Medical Center Utrecht, Department of Cardiology Utrecht, Netherlands Sweden Skane University Hospital Malmo, Sweden Södersjukhuset Stockholm, Sweden Switzerland Inselspital Bern, Switzerland Less <<
NCT02062944 Acute Rejection of Liver Trans... More >>plant Effects of Immunosuppressant Therapy Less << Not Applicable Unknown March 2018 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Josh Levitsky, MD          Contact: Patrice Al-Saden, RN          Principal Investigator: Josh Levitsky, MD Less <<
NCT03507205 - Completed - Korea, Republic of ... More >> Wonju Severance Christian Hospital Wonju, Gangwon-do, Korea, Republic of Sejong General Hospital Bucheon, Gyeonggi-do, Korea, Republic of Seoul National University Hospital Seoul, Jongno-gu, Korea, Republic of, 03080 Hallym University Sacred Heart Hospital Anyang, Korea, Republic of Kosin University Gospel Hospital Busan, Korea, Republic of Dankook University Hospital Cheonan, Korea, Republic of Soon Chun Hyang University Hospital Cheonan Cheonan, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Gwangju Christian Hospital Gwangju, Korea, Republic of Kwangju Veterans Hospital Gwangju, Korea, Republic of Chonbuk National University Hospital Iksan, Korea, Republic of Wonkwang University Hospital Iksan, Korea, Republic of Inje University Ilsan Paik Hospital Ilsan, Korea, Republic of National Health Insurance Corporation Ilsan Hospital Ilsan, Korea, Republic of Inha University Hospital Inchon, Korea, Republic of Chungbuk National University Hospital Jeonju, Korea, Republic of Presbyterian Medical Center Jeonju, Korea, Republic of Gyeongsang National University Hospital Jinju, Korea, Republic of Inje University Pusan Paik Hospital Pusan, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of Bundang CHA Medical Center Seongnam, Korea, Republic of Seoul National University Bundang Hospital Seongnam, Korea, Republic of Ewha Womans University Medical Center Mokdong Hospital Seoul, Korea, Republic of Gangbuk Samsung Hospital Seoul, Korea, Republic of Gangnam Severance Hospital Seoul, Korea, Republic of Hallym University Kangdong Sacred Heart Hospital Seoul, Korea, Republic of Hanyang University Medical Center Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Kyung Hee University Hospital at Gangdong Seoul, Korea, Republic of Kyung Hee University Medical Center Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul Boramae Hospital Seoul, Korea, Republic of Soonchunhyang University Hospital Seoul, Korea, Republic of Yonsei University Medical Center Seoul, Korea, Republic of St. Carollo Hospital Suncheon, Korea, Republic of Uijeongbu St. Mary's Hospital Uijeongbu, Korea, Republic of Less <<
NCT03696355 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Recruiting June 2024 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tabatha E. Doyle, RN    901-595-2544    tabatha.doyle@stjude.org    Principal Investigator: Christopher Tinkle, MD, PhD          Principal Investigator: Amar Gajjar, MD Less <<
NCT00388362 Graft vs Host Disease Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00388362 - Completed - -
NCT02099162 - Unknown July 2018 Korea, Republic of ... More >> Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seodaemun-gu, Shinchondong Recruiting Seoul, Korea, Republic of, 120-752 Contact: Myeong ki Hong, MD, PhD    82-2-2228-8458 ext 88458    mkhong61@yuhs.ac Less <<
NCT02279758 Well-differentiated Neuroendoc... More >>rine Tumors Less << Phase 2 Unknown - Brazil ... More >> Instituto do Cancer do Estado de São Paulo Recruiting Sao Paulo, SP, Brazil, 01246-000 Contact: João Glasberg, MD    55 11 38932000    pesquisa.clinica@icesp.org.br Less <<
NCT01428973 Graft-Versus-Host Disease ... More >> Hematological Malignancies Less << Phase 2 Recruiting September 2020 Belgium ... More >> Ziekenhuis Netwerk Antwerpen (ZNA) Recruiting Antwerpen,, Antwerpen, Belgium, 2060 Contact: Pierre Zachee, MD; PhD    32-3-2177111    pierre.zachee@zna.be    University Hospital, Antwerp Recruiting Edegem, Antwerp, Belgium, 2650 Contact: Wilfried Schroyens, MD; PhD    32-03-2204111    wilfried.schroyens@uza.be    Jules Bordet Institute Recruiting Brussels, Brabant, Belgium, 1000 Contact: Philippe Lewalle, MD; PhD    32-02-5417208    plewalle@ulb.ac.be    Cliniques universitaires Saint-Luc- Université Catholique de Louvain Recruiting Brussels,, Brussels Region Capital, Belgium, 1200 Contact: Xavier Poiré, MD; PhD    32-02-7641880    xavier.poire@uclouvain.be    AZ VUB Jette Recruiting Brussels, Brussels Region Capital, Belgium, 1090 Contact: Rik Schots, MD; PhD    32-02-4763105    Rik.Schots@uzbrussel.be    Queen Fabiola Children's University Hospital Recruiting Brussels, Brussels, Region Capital, Belgium, 1020 Contact: Alice Fester, MD    32-02-4772678    afester@ulb.ac.be    University Hospital, Gasthuisberg Recruiting Leuven, Flamish Brabant, Belgium, 3000 Contact: Johan Maertens, MD    32-16-33 22 11    johan.maertens@uz.kuleuven.ac.be    UZ Gent Recruiting Gent, Flanders Ost, Belgium, 9000 Contact: Lucien Noens, MD; PhD    32-09-332 21 31    Lucien.Noens@Ugent.be    Contact: Tessa Kerre, MD; PhD    32-09-3323464    Tessa.Kerre@Ugent.be    Jolimont Hospital Haine Saint Paul Recruiting Haine St-Paul, Hainaut, Belgium, 7100 Contact: Nicole Straetmans, MD    32-64-233989    nicole.straetmans@scarlet.be    Cliniques Universitaires de Mont-Godinne Recruiting Yvoir, Namur, Belgium, 5530 Contact: Carlos Graux, MD; PhD    32-081-423831    carlos.graux@uclouvain.be    AZ Sint-Jan AV Recruiting Brugge, West Flanders, Belgium, 8000 Contact: Dominik Selleslag, MD    32-50-453060    dominik.selleslag@azbrugge.be    H.-Hart Hospital Roeselare-Menen Recruiting Roeselare, Western Flanders, Belgium, 8800 Contact: Dries Deeren, MD    32-51-237437    ddeeren@hhr.be    CHU Sart Tilman Recruiting Liège, Belgium, 4000 Principal Investigator: Frédéric Baron, MD; PhD          Sub-Investigator: Yves Beguin, MD; PhD          Sub-Investigator: Evelyne Willems, MD; PhD Less <<
NCT00160966 Polyomavirus Infections Phase 4 Completed - Germany ... More >> Department of Internal Medicine, University of Giessen Giessen, Germany, 35392 Less <<
NCT02071862 Solid Tumors ... More >>Triple-Negative Breast Cancer Non Small Cell Lung Cancer Renal Cell Carcinoma Mesothelioma Fumarate Hydratase (FH)-Deficient Tumors Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST) Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal Stromal Tumors Tumors Harboring Isocitrate Dehydrogenase-1 (IDH1) and IDH2 Mutations Tumors Harboring Amplifications in the cMyc Gene Less << Phase 1 Active, not recruiting September 2019 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94143 Stanford University Medical Center Stanford, California, United States, 94305 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Georgia Winship Cancer Institute of Emory School of Medicine Atlanta, Georgia, United States, 30322 United States, Maryland NIH - NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37203 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01927120 - Completed - -
NCT02187302 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Completed - -
NCT01721096 - Active, not recruiting December 2018 Japan ... More >> Abbott Vascular Japan Co., Ltd. Tokyo, Japan, 108-6304 Less <<
NCT00693251 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Korea, Republic of Busan Saint Mary's Hospital Busan, Korea, Republic of Cheongju Saint Mary's Hospital Cheongju, Korea, Republic of Kangwon University Hospital Chuncheon, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Kyungsang University Hospital Jinju, Korea, Republic of Hallym University Sacred Heart Hospital PyeongChon, Korea, Republic of Catholic University, Kangnam St. Mary's Hospital Seoul, Korea, Republic of Hallym University Sacred Heart Hospital Seoul, Korea, Republic of Korea Veterans Hospital Seoul, Korea, Republic of Aju University Hospital Suwon, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT01927120 Graft-Versus-Host-Disease Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00002790 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Less << Phase 1 Phase 2 Withdrawn - -
NCT00121784 Heart Transplantation Phase 4 Terminated(Poor recruitment) - -
NCT00694005 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Korea, Republic of Busan Saint Mary's Hospital Busan, Korea, Republic of Cheongju Saint Mary's Hospital Cheongju, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Kyungsang University Hospital Jinju, Korea, Republic of Hallym University Sacred Heart Hospital PyeongChon, Korea, Republic of Catholic University, Kangnam St. Mary's Hospital Seoul, Korea, Republic of Hallym University Sacred Heart Hospital Seoul, Korea, Republic of Aju University Hospital Suwon, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Kangwon University Hospital Wonju, Korea, Republic of Less <<
NCT01721096 - Active, not recruiting - -
NCT01499888 Sickle Cell Disease Phase 1 Phase 2 Recruiting May 2018 United States, Illinois ... More >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Lani Krauz, RN    312-413-0242    lignacio@uic.edu    Contact: Santosh Saraf, MD    312-996-2187    ssaraf@uic.edu    Principal Investigator: Damiano Rondelli, MD Less <<
NCT03114826 - Recruiting October 5, 2019 France ... More >> CHU Amiens Picardie Recruiting Amiens, Picardie, France, 80054 Contact: Sandra BODEAU, Dr    +33322087029    bodeau.sandra@chu-amiens.fr Less <<
NCT01414660 - Completed - France ... More >> Amiens University Hospital Amiens, France Caen University Hospital Caen, France Lille University Hospital Lille, France Reims University Hospital Reims, France Rouen University Hospital Rouen, France Less <<
NCT03631953 Meningioma Phase 1 Not yet recruiting January 1, 2022 France ... More >> Assistance Publique Hôpitaux de Marseille Not yet recruiting Marseille, France, 13354 Contact: Thomas GRAILLON, PH    491385545 ext +33    thomas.graillon@ap-hm.fr    Contact: Olivier CHINOT, PU-PH    491385545 ext +33    olivier.chinot@ap-hm.fr    Principal Investigator: Thomas GRAILLON, PH Less <<
NCT01446484 End-Stage Renal Disease ... More >> Kidney Failure Less << Phase 1 Phase 2 Unknown November 2014 Russian Federation ... More >> The Russian State Medical University Recruiting Moscow, Russian Federation, 117997 Contact: Svetlana N. Bykovskaia, M.D. Ph.D.    7-916-4362291    sbykovskaia@gmail.com    Contact: Anton A. Keskinov, Ph.D.    7-495-4341444    a.keskinov@mail.ru    Principal Investigator: Svetlana N. Bykovskaia, M.D. Ph.D.          Sub-Investigator: Anton A. Keskinov          Boris Petrovsky Scientific Center of Surgery Russian Academy of Medical Sciencies Recruiting Moscow, Russian Federation, 119991 Contact: Michael M. Kaabak, M.D. Ph.D.    7-499-2481344    kaabak@pochka.org    Contact: Nadezhda Babenko    7-499-2481344    babenko@pochka.org    Principal Investigator: Michael M. Kaabak, M.D. Ph.D.          Sub-Investigator: Nadezhda Babenko, Ph.D. Less <<
NCT03577093 - Recruiting December 2021 China ... More >> Xuanwu Hospital Recruiting Beijing, China Contact: Luo Yumin    01083198129    yumin111@ccmu.edu.cn Less <<
NCT03099499 Endometrial Cancer Phase 2 Recruiting October 1, 2020 United States, Pennsylvania ... More >> Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Gina Mantia-Smaldone, MD    215-214-1515    Gina.Mantia-Smaldone@fccc.edu Less <<
NCT01536054 Recurrent Fallopian Tube Cance... More >>r Recurrent Ovarian Epithelial Cancer Recurrent Primary Peritoneal Cavity Cancer Stage IIA Fallopian Tube Cancer Stage IIA Ovarian Epithelial Cancer Stage IIA Primary Peritoneal Cavity Cancer Stage IIB Fallopian Tube Cancer Stage IIB Ovarian Epithelial Cancer Stage IIB Primary Peritoneal Cavity Cancer Stage IIC Fallopian Tube Cancer Stage IIC Ovarian Epithelial Cancer Stage IIC Primary Peritoneal Cavity Cancer Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Epithelial Cancer Stage IIIA Primary Peritoneal Cavity Cancer Stage IIIB Fallopian Tube Cancer Stage IIIB Ovarian Epithelial Cancer Stage IIIB Primary Peritoneal Cavity Cancer Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Epithelial Cancer Stage IIIC Primary Peritoneal Cavity Cancer Stage IV Fallopian Tube Cancer Stage IV Ovarian Epithelial Cancer Stage IV Primary Peritoneal Cavity Cancer Less << Phase 1 Active, not recruiting January 1, 2019 United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT02849899 Disorder Related to Renal Tran... More >>splantation Diabetes Less << Phase 3 Not yet recruiting January 2020 -
NCT03764605 ADPKD Phase 3 Not yet recruiting January 30, 2022 Italy ... More >> AOUC "Policlinico" Bari, Italy, 70124 AOUConsorziale Policlinico Di Bari Not yet recruiting Bari, Italy, 70124 Contact: Loreto Gesualdo    +390805594040    trialnefrobari@gmail.com    Contact: Giovanni Piscopo    +393299664404    giopiscopo@gmail.com Less <<
NCT02813135 Children, Adolescents and Youn... More >>g Adults With Refractory or Recurrent Malignancies Less << Phase 1 Phase 2 Recruiting January 2022 France ... More >> Gustave Roussy Recruiting Villejuif, Val De Marne, France, 94805 Contact: Birgit Geoerger, MD    1 42 11 4661 ext +33    birgit.geoerger@gustaveroussy.fr    Contact: Xavier Paoletti, MD    1 42 11 6564 ext +33    xavier.paoletti@gustaveroussy.fr    Principal Investigator: Birgit Geoerger, MD          Germany University Children's Hospitalermany Not yet recruiting Heidelberg, Germany Contact: Olaf Witt, MD    6221 56 4555 ext +49    O.Witt@Dkfz-Heidelberg.de    Italy Fondazione IRCCS Istituto Nazionale dei Tumori Not yet recruiting Milan, Italy Contact: Michela Casanova, MD    02 23 90 25 94 ext +39    Michela.Casanova@istitutotumori.mi.it    Netherlands Erasmus MC, Sophia Children's Hospital Not yet recruiting Rotterdam, Netherlands Contact: Michel Zwaan, MD    10 703 6691 ext +31    c.m.zwaan@erasmusmc.nl    Spain Unidad de Oncología Pediátrica Hospital Niño Jesús Not yet recruiting Madrid, Spain, 28009 Contact: Francisco Bautista, MD    915 035 900 ext +43    franciscojose.bautista@salud.madrid.org    United Kingdom Pediatric and Adolescent Oncology The Royal Marsden Hospital Not yet recruiting Sutton, United Kingdom Contact: Lynley Marshall, MD    208 661 3678 ext +44    Lynley.Marshall@icr.ac.uk Less <<
NCT02688868 Coronary Heart Disease Not Applicable Recruiting December 2020 China, Beijing ... More >> Fu Wai Hospital Recruiting Peking, Beijing, China, 100037 Contact: Bo Xu, MBBS    +86-10-88322562    bxu@citmd.com Less <<
NCT02088931 Late Complication From Kidney ... More >>Transplant Less << Phase 1 Unknown December 2016 United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 Less <<
NCT02755844 Recurrent Endometrial Cancer Phase 1 Phase 2 Not yet recruiting November 2019 France ... More >> Centre Hospitalier Lyon Sud Not yet recruiting Pierre Benite, France, 69495 Contact: Benoit YOU          Contact: Marine DUPUIS          Principal Investigator: Benoit YOU, MD Less <<
NCT01205672 Endometrial Cancer Early Phase 1 Completed - United States, Texas ... More >> Lyndon B. Johnson General Hospital Houston, Texas, United States, 77026 University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02713763 Pancreatic Neuroendocrine Tumo... More >>ur Metastatic Less << Phase 2 Recruiting July 2019 Spain ... More >> Hospital Universitario Central de Asturias Recruiting Oviedo, Asturias, Spain, 33011 Contact: Paula Jiménez    +34 646662756    palucaji@hotmail.com    Principal Investigator: Paula Jiménez          Hospital Universitario Valle de Hebrón Active, not recruiting Barcelona, Spain, 08035 Hospital Reina Sofía Recruiting Córdoba, Spain, 14004 Contact: Raquel Serrano    +34 957011464    rsblanch@hotmail.com    Principal Investigator: Raquel Serrano          Hospital Universitario Donostia Active, not recruiting Donostia/San Sebastián, Spain, 20014 Hospital Ramón y Cajal Active, not recruiting Madrid, Spain, 28034 Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Rocío García Carbonero    34 91 390 83 39    rgcarbonero@gmail.com    Principal Investigator: Rocio Garcia Carbonero          Hospital General Universitario J.M. Morales Meseguer Active, not recruiting Murcia, Spain, 30008 Complejo Hospitalario Regional Virgen Del Rocío Recruiting Sevilla, Spain, 41013 Contact: Marta Benavent       martabenavent.v@gmail.com    Principal Investigator: Marta Benavent          Instituto Valenciano de Oncología Active, not recruiting Valencia, Spain, 46009 Less <<
NCT00934791 Polycystic Liver Disease Not Applicable Terminated(Terminated due to i... More >>nadequate enrollment) Less << - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01309022 - - - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 Less <<
NCT03217097 Neuroendocrine Tumors Phase 4 Not yet recruiting October 2021 France ... More >> Hôpital Sud - CHU Amiens Not yet recruiting Amiens, France, 80054 Contact: Vincent HAUTEFEUILLE, MD          Principal Investigator: Vincent HAUTEFEUILLE, MD          CHU d'Angers Not yet recruiting Angers, France, 49933 Contact: Sandrine LABOUREAU, MD          Principal Investigator: Sandrine LABOUREAU, MD          Hôpital Beaujon - APHP Not yet recruiting Clichy, France, 92118 Contact: Olivia HENTIC, MD          Principal Investigator: Olivia HENTIC, MD          Hôpital François Mitterrand - CHU Dijon Bourgogne Not yet recruiting Dijon, France, 21000 Contact: Côme LEPAGE, MD          Principal Investigator: Côme LEPAGE, MD          Hôpital André Michalon - CHU Grenoble Alpes Not yet recruiting La Tronche, France, 38700 Contact: Victoire GRANGER, MD          Principal Investigator: Victoire GRANGER, MD          Centre Oscar Lambret Not yet recruiting Lille, France, 59020 Contact: Eric DANSIN, MD          Principal Investigator: Eric DANSIN, MD          Hôpital Claude Hurriet - CHRU Lille Not yet recruiting Lille, France, 59037 Contact: Christine DO CAO, MD          Principal Investigator: Christine DO CAO, MD          Hôpital Edouard Herriot - Hospices Civils de Lyon Not yet recruiting Lyon, France, 69003 Contact: Thomas WALTER, MD          Principal Investigator: Catherine LOMBARD BOHAS, MD          Sub-Investigator: Thomas WALTER, MD          Hôpital Privé Jean Mermoz Not yet recruiting Lyon, France, 69008 Contact: Jérôme DESRAMES, MD          Principal Investigator: Jérôme DESRAMES, MD          Centre Léon Bérard Not yet recruiting Lyon, France, 69373 Contact: Matthieu SARABI, MD          Principal Investigator: Matthieu SARABI, MD          Institut Paoli Calmettes Not yet recruiting Marseille, France, 13009 Contact: Patricia NICCOLI, MD          Principal Investigator: Patricia NICCOLI, MD          Hôpital Saint Eloi - CHU Montpellier Not yet recruiting Montpellier, France, 34090 Contact: Eric ASSENAT, MD          Principal Investigator: Eric ASSENAT, MD          Hôpital Saint Louis - APHP Not yet recruiting Paris, France, 75010 Contact: Thomas APARICIO, MD          Principal Investigator: Thomas APARICIO, MD          Hôpital Cochin - APHP Not yet recruiting Paris, France, 75014 Contact: Romain CORIAT, MD          Principal Investigator: Romain CORIAT, MD          CH Annecy Genevois Not yet recruiting Pringy, France, 74374 Contact: Mathieu BACONNIER, MD          Principal Investigator: Mathieu BACONNIER, MD          Hôpital Robert Debré - CHU Reims Not yet recruiting Reims, France, 51092 Contact: Guillaume CADIOT, MD          Principal Investigator: Guillaume CADIOT, MD          Hôpital Nord - CHU Saint Etienne Not yet recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Nicolas WILLIET, MD          Principal Investigator: Nicolas WILLIET, MD          Institut de Cancérologie de la Loire Not yet recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Léa SABAN-ROCHE, MD          Principal Investigator: Léa SABAN-ROCHE, MD          Hôpital Rangueil - CHU Toulouse Not yet recruiting Toulouse, France, 31059 Contact: Rosine GUIMBAUD, MD          Principal Investigator: Rosine GUIMBAUD, MD          Hôpital Trousseau - CHU Tours Not yet recruiting Tours, France, 37044 Contact: Thierry LECOMTE, MD          Principal Investigator: Thierry LECOMTE, MD          Institut Gustave Roussy Not yet recruiting Villejuif, France, 94805 Contact: Eric BAUDIN, MD          Principal Investigator: Eric BAUDIN, MD Less <<
NCT01331967 Diabetic Stable Angina ... More >> Diabetic Unstable Angina Less << Phase 4 Completed - Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of, 136705 Less <<
NCT03118128 Acute Lymphoblastic Leukemia Not Applicable Completed - -
NCT03309007 PreDiabetes A... More >>ging Less << Phase 3 Recruiting July 31, 2018 United States, New Mexico ... More >> University of New Mexico Clincal & Translational Science Center Recruiting Albuquerque, New Mexico, United States, 87131 Contact: Mark R Burge, MD    505-272-4658    mburge@salud.unm.edu Less <<
NCT02104011 Renal Angiomyolipomas ... More >> Tuberous Sclerosis Less << Phase 2 Completed - France ... More >> Nephrology department Bordeaux, France Less <<
NCT00818792 Chronic Kidney Disease ... More >> Multivessel Coronary Artery Disease Less << Phase 2 Completed - Italy ... More >> European Hospital Rome, Italy, 00149 Azienda Ospedaliera Istituti Ospitalieri di Verona Verona, Italy, 37126 Less <<
NCT00788021 - Completed - United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT01850108 Sickle Cell Disease ... More >> Hemoglobinopathies Less << Not Applicable Recruiting November 2020 United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Clinical Trials Information Program    800-811-8480       Principal Investigator: Adetola A Kassim, MD Less <<
NCT03712761 - Active, not recruiting May 1, 2019 Canada, Ontario ... More >> Exercise Metabolism Research Laboratory, McMaster Univeristy Hamilton, Ontario, Canada, L8S 4K1 Less <<
NCT02038127 - Unknown December 2017 Korea, Republic of ... More >> Chuncheon Hallym University Hospital Not yet recruiting Chuncheon, Gangwon, Korea, Republic of Contact: Hyun Hee Choi, M.D.       jumdure@hanmail.net    Principal Investigator: Hyun Hee Choi, M.D.          Yonsei University Wonju Christian Hospital Recruiting Wonju, Gangwon, Korea, Republic of, 220768 Contact: Junghan Yoon, M.D., Ph.D.    +82-33-741-0906    jyoon@yonsei.ac.kr    Sub-Investigator: Young Jin Youn, M.D.          Principal Investigator: Junghan Yoon, M.D., Ph.D.          Sub-Investigator: Seung-Hwan Lee, M.D., Ph.D.          Sub-Investigator: Sung-Gyun Ahn, M.D., Ph.D.          Sub-Investigator: Jun-Won Lee, M.D., Ph.D.          Korea University Guro Hospital Recruiting Seoul, Korea, Republic of Contact: Cheol Ung Choi, M.D., Ph.D.       wmagpie@korea.com    Principal Investigator: Cheol Ung Choi, M.D., Ph.D. Less <<
NCT00704054 Solid Tumors Phase 1 Completed - -
NCT03664115 Lung Cancer Phase 2 Recruiting December 2, 2020 Egypt ... More >> oncology department Ain shams university Recruiting Cairo, Egypt, 11591 Contact: Amr sh Tawfik, MD          Contact: Asmaa WH Mohamed, Master    01003538597    drasmaa_wahid@hotmail.com Less <<
NCT00672204 Type 1 Diabetes Mellitus ... More >> Hypoglycemia Less << Phase 1 Phase 2 Terminated(Raptiva was withdra... More >>wn from the market) Less << - United States, Minnesota ... More >> Universtiy of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02928198 Myocardial Ischemia ... More >> Ischemia Coronary Disease Heart Diseases Cardiovascular Diseases Coronary Bifurcation Lesions Arterial Occlusive Lesions Infarction Myocardial Infarction Arteriosclerosis Less << Not Applicable Active, not recruiting March 2020 Netherlands ... More >> Academic Medical Center Amsterdam, Netherlands, 1105AZ Less <<
NCT03017521 Solid Tumor, Adult Phase 2 Recruiting December 2020 Korea, Republic of ... More >> Severance Hospital, Yonsei University Health System Recruiting Seoul, Korea, Republic of, 03722 Contact: Minkyu Jung Less <<
NCT01240460 Glioblastoma ... More >>Astrocytoma, Grade IV Less << Phase 1 Completed - United States, California ... More >> Investigational Site Number 840001 Los Angeles, California, United States, 90024 Investigational Site Number 840003 San Francisco, California, United States, 94143 United States, Massachusetts Investigational Site Number 840004 Boston, Massachusetts, United States, 02115 United States, New York Investigational Site Number 840002 New York, New York, United States, 10021 Less <<
NCT02013375 Sickle Cell Disease Phase 2 Active, not recruiting October 1, 2018 United States, Illinois ... More >> University of Illinois Cancer Center Chicago, Illinois, United States, 60612 Less <<
NCT00672204 - Terminated(Raptiva was withdra... More >>wn from the market) Less << - -
NCT00934791 - Terminated(Terminated due to i... More >>nadequate enrollment) Less << - -
NCT01856374 Multi-vessel Diseases, Angina Phase 4 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01857843 Acute Coronary Syndrome Phase 4 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01771458 Reccurent/Metastatic Solid Tum... More >>or Disease Less << Phase 2 Unknown December 2016 France ... More >> Centre régional de lutte contre le cancer de Bourgogne Georges François Leclerc Dijon, France, 21079 Centre Leon Berard Lyon, France, 69373 Institut Paoli Calmettes Marseille, France, 13009 Insitut Curie Paris, France, 75248 Institut Curie Hopital Rene Huguenin Saint-cloud, France, 92210 Institut de cancérologie de l'Ouest Centre René Gauducheau Saint-herblain, France, 44000 Institut Claudius Régaud Toulouse, France, 31052 Centre Alexis Vautrin Vandoeuvre Les Nancy, France, 54500 Less <<
NCT02588339 Graft Versus Host Disease ... More >> GVHD Less << Phase 2 Active, not recruiting December 2020 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02881697 - Active, not recruiting June 2019 -
NCT01737502 Extensive Stage Small Cell Lun... More >>g Carcinoma Lung Adenocarcinoma Recurrent Non-Small Cell Lung Carcinoma Recurrent Small Cell Lung Carcinoma Squamous Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Less << Phase 1 Phase 2 Recruiting November 2018 United States, Arizona ... More >> Mayo Clinic in Arizona Recruiting Scottsdale, Arizona, United States, 85259 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Helen J. Ross Less <<
NCT02312661 Epithelial Ovarian Cancer Phase 1 Completed - Netherlands ... More >> University Mecdical Center Groningen Groningen, Netherlands, 9713 GZ Less <<
NCT01543841 - Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01762033 Renal Cell Carcinoma Phase 2 Terminated - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33908 Florida Cancer Specialists Inverness, Florida, United States, 34453 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT02648269 Gout Phase 1 Completed - United States, Arkansas ... More >> Baptist Health Center for Clinical Research Little Rock, Arkansas, United States, 72205 United States, Florida Miami Research Associates Miami, Florida, United States, 33143 Orlando Clinical Research Center, Inc. Orlando, Florida, United States, 32809 United States, Maryland SNBL Clinical Pharmacology Center Inc. Baltimore, Maryland, United States, 21201 United States, Minnesota Davita Clinical Research Minneapolis, Minnesota, United States, 55404 United States, Pennsylvania Altoona Center for Clincal Research Duncansville, Pennsylvania, United States, 16635 Less <<
NCT03500848 Liver Transplantation Phase 2 Phase 3 Not yet recruiting May 31, 2023 China, Guangdong ... More >> Zhujiang Hospital of Southern Medical University Not yet recruiting Guangzhou, Guangdong, China, 510282 Contact: Peihua Cao, Ph.D    86-020-62783685    cphcc@smu.edu.cn    Principal Investigator: Kebo Zhong, M.D          Nanfang Hospital of Southern Medical University Not yet recruiting Guangzhou, Guangdong, China, 510515 Contact: Chongyang Duan, M.D    86-020-61649462    donyduang@126.com    Principal Investigator: Dinghua Yang, M.D          First Affiliated Hospital, Sun Yat-Sen University Guanzhou, Guangdong, China, 510080 Less <<
NCT01224288 Renal Cell Carcinoma Phase 3 Active, not recruiting January 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03218787 Coronary Artery Lesions Not Applicable Recruiting December 2020 -
NCT03158389 Glioblastoma, Adult Phase 1 Phase 2 Recruiting September 30, 2024 Germany ... More >> Charité Berlin, Neurosurgery Not yet recruiting Berlin, Germany Knappschaftskrankenhaus Bochum GmbH, Neurology Clinic Not yet recruiting Bochum, Germany University Hospital Bonn, Neurology Clinic Not yet recruiting Bonn, Germany University Hospital Cologne, Neurosurgery Not yet recruiting Cologne, Germany University Hospital Dresden, Neurosurgery Not yet recruiting Dresden, Germany University Hospital Essen, Neurology Clinic Not yet recruiting Essen, Germany University Hospital Frankfurt, Neurooncology Not yet recruiting Frankfurt am Main, Germany University Hospital Heidelberg, Neurology Clinic Recruiting Heidelberg, Germany University Hospital Saarland, Neurosurgery Not yet recruiting Homburg, Germany University Hospital Mainz, Neurosurgery Not yet recruiting Mainz, Germany University Hospital Mannheim, Neurology Clinic Not yet recruiting Mannheim, Germany University Hospital Regensburg, Neurology Clinic Not yet recruiting Regensburg, Germany University Hospital Tuebingen, Neurooncology Not yet recruiting Tübingen, Germany Less <<
NCT02833506 Recurrent Fallopian Tube Carci... More >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Stage IIA Fallopian Tube Cancer Stage IIA Ovarian Cancer Stage IIB Fallopian Tube Cancer Stage IIB Ovarian Cancer Stage IIC Fallopian Tube Cancer Stage IIC Ovarian Cancer Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Cancer Stage IIIA Primary Peritoneal Cancer Stage IIIB Fallopian Tube Cancer Stage IIIB Ovarian Cancer Stage IIIB Primary Peritoneal Cancer Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Cancer Stage IIIC Primary Peritoneal Cancer Stage IV Fallopian Tube Cancer Stage IV Ovarian Cancer Stage IV Primary Peritoneal Cancer Less << Phase 1 Withdrawn(production of adjuva... More >>nt to be used with vaccine was discontinued by sponsor) Less << August 15, 2019 United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT02913131 Prostate Cancer Phase 2 Recruiting April 2020 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94158 Contact: Rahul Aggarwal, MD    877-827-3222    cancertrials@ucsf.edu    Contact: Kamran Abri-Lavasani    877-827-3222    cancertrials@ucsf.edu Less <<
NCT03356769 Tuberous Sclerosis Complex ... More >> Aspirin Epilepsy Cognitive Decline Skin Lesions Less << Phase 2 Recruiting November 20, 2020 China, Beijing ... More >> Department of Neurology, Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100005 Contact: Qing Liu, MD, PhD    86-10-13366305331    drliuqing@126.com Less <<
NCT00120120 Radiculopathy Phase 2 Phase 3 Completed - -
NCT02099617 Stable Angina ... More >> Silent Myocardial Ischemia Acute Coronary Syndrome Less << Phase 4 Active, not recruiting June 2018 -
NCT00446264 Type 1 Diabetes ... More >> Hypoglycemia Metabolic Diseases Less << Phase 2 Completed - France ... More >> University Hospital of Lille Lille, France, 59037 Less <<
NCT02126527 Recurrent Non-small Cell Lung ... More >>Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Withdrawn(no participants enro... More >>lled) Less << - United States, Florida ... More >> Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 Less <<
NCT00446264 - Completed - -
NCT02850744 Glioblastoma Multiforme Phase 2 Terminated - Switzerland ... More >> University Hospital Zurich, Neurology Zurich, Switzerland, 8091 Less <<
NCT00006505 Diabetes Mellitus Type 1 Phase 2 Active, not recruiting June 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01017757 - Unknown November 2009 Italy ... More >> Department of Clinical Medicine Nephrology and Health Science, Parma University Hospital Parma, Italy, 43100 Less <<
NCT02058381 Pre-menopausal Breast Cancer ... More >> PI3K Pathway Inhibition Less << Phase 1 Completed - Hong Kong ... More >> Novartis Investigative Site Hong Kong, Hong Kong Korea, Republic of Novartis Investigative Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620 Novartis Investigative Site Gyeonggi-do, Korea, Korea, Republic of, 10408 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Republic of, 03722 Taiwan Novartis Investigative Site Kuei-Shan Chiang, Taoyuan/ Taiwan ROC, Taiwan, 33305 Novartis Investigative Site New Taipei City, TWN, Taiwan, 23561 Novartis Investigative Site Kaohsiung City, Taiwan, 83301 Novartis Investigative Site Taichung, Taiwan, 407 Novartis Investigative Site Taipei, Taiwan, 10002 Novartis Investigative Site Taipei, Taiwan, 10449 Novartis Investigative Site Taipei, Taiwan, 112 Thailand Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Chiang Mai, Thailand, 50200 Less <<
NCT01117142 - Recruiting - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00190099 Vessel Restenosis Phase 4 Completed - -
NCT01599351 Exposure to Ionizing Radiation Phase 4 Completed - Thailand ... More >> King Chulalongkorn Memorial Hospital Patumwan, Bangkok, Thailand, 10330 Less <<
NCT00916370 Myocardial Ischemia ... More >> Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis Less << Phase 3 Completed - -
NCT00023231 End-Stage Renal Disease Not Applicable Completed - United States, Maryland ... More >> Lauren Schenker Rockville, Maryland, United States, 20850 Less <<
NCT03319173 Mild Cognitive Impairment ... More >> Metabolic Syndrome Less << Not Applicable Recruiting May 15, 2018 United States, Minnesota ... More >> Bristlecone Health, Inc. Recruiting Maple Grove, Minnesota, United States, 55311 Contact: Julie A Gomer, Doctorate    763-913-4600    julie@bristleconefitness.com Less <<
NCT03355742 Bleeding Disorder ... More >> Stroke, Ischemic Stroke Hemorrhagic Hematological Disease Thrombocytopenia Coagulation Disorder Anemia Renal Insufficiency Coronary Artery Disease Less << Not Applicable Recruiting January 2020 -
NCT00916370 - Completed - -
NCT01177397 Multiple Myeloma ... More >> Diffuse Large B-Cell Lymphoma Glioblastoma Multiforme Hepatocellular Carcinoma Non-Small Cell Lung Cancer Neuroendocrine Tumors of Non-Pancreatic Origin Hormone Receptor-Positive Breast Cancer Less << Phase 1 Phase 2 Completed - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 UCLA Neuro-Oncology Program Los Angeles, California, United States, 90095 University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Minnesota Mayo Clinic Cancer Clinical Studies Unit Rochester, Minnesota, United States, 55905 United States, Montana Billings Clinic Billings, Montana, United States, 59102 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York NYU Cancer Institute - Bellevue Hospital New York, New York, United States, 10016 United States, Tennessee Sarah Cannon Research Institute Drug Development Unit Nashville, Tennessee, United States, 37203 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75201 France Institut Claudius Regaud Toulouse Cedex, France, 31052 Institut Gustave Roussy Faculte de Medecine Paris Sud Service de pneumologie Villejuif, France, 94800 Spain Hospital Universitario de Salamanca Salamanca, Spain, 37007 Hospital Universitario Virgen Del Rocio Sevilla, Spain, 41013 United Kingdom Sarah Cannon Research Institute UK London, United Kingdom, W1G 6AD UCL Cancer Institute London, United Kingdom, WC1E 6BT Less <<
NCT03487432 Calcified Coronary Artery Dise... More >>ase (Grade 3) Less << Not Applicable Recruiting June 2019 Germany ... More >> Deutsches Herzzentrum Muenchen Recruiting Muenchen, Germany Contact: Tobias Rheude, MD Less <<
NCT01308281 Coronary Artery Disease Not Applicable Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01855971 Fragile X Syndrome Not Applicable Completed - Spain ... More >> Parc de Salut MAR, Hospital del Mar Medical Research Institute-IMIM Barcelona, Spain, 08003 Less <<
NCT01545947 Carcinoma, Non-Small-Cell Lung... More >> Non-Small Cell Lung Cancer Less << Phase 1 Completed - United States, California ... More >> Cedars Sinai Medical Center, Inflammatory Bowel Disease Center Los Angeles, California, United States, 90048 University of California, San Francisco San Francisco, California, United States, 9411 United States, New York NYU School of Medicine New York, New York, United States, 10016 United States, South Carolina Cancer Center of the Carolinas Greenville, South Carolina, United States, 29605 United States, Tennessee Henry-Joyce Cancer Clinic Nashville, Tennessee, United States, 37232-5505 United States, Texas Mary Crowley Cancer Research Centers - Medical City Dallas, Texas, United States, 75201 The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Spain Vall d´Hebron University Hospital Barcelona, Spain, 08035 Hospital Virgen del RocíoServicio de Hematologia Sevilla, Spain, 41013 Less <<
NCT02330783 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Recruiting December 2018 China, Guangdong ... More >> Sun Yat-sen university cancer center Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Fangjian Zhou, MD    0086-20-87343088    zhoufj@sysucc.org.cn    Principal Investigator: Fangjian Zhou, MD          China Peking University First Hospital Recruiting Beijing, China, 100034 Contact: Zhisong He, MD    0086-10-83572211    wyj7074@sohu.com    Principal Investigator: Zhisong He, MD          Beijing Cancer Hospital Recruiting Beijing, China, 100142 Contact: Xinan Sheng, MD    0086-10-88196951    doctor_sheng@126.com    Principal Investigator: Jun Guo, MD,PHD          Sub-Investigator: Xinan Sheng, MD          Cancer Hospital, Fudan University Not yet recruiting Shanghai, China, 200032 Contact: Dingwei Ye, MD    0086-21-64175590    dwye@163.com    Principal Investigator: Dingwei Ye, MD Less <<
NCT01180218 - - - Korea, Republic of ... More >> Seung Woon Rha Seoul, Korea, Republic of Less <<
NCT03284255 Coronary Artery Disease ... More >> Antineoplastic Agents Less << Not Applicable Recruiting April 30, 2024 -
NCT01097434 Coronary Heart Disease Phase 4 Completed - Germany ... More >> Deutsches Herzzentrum Muenchen Munich, Germany, 80636 Less <<
NCT01370980 - Unknown September 2014 Switzerland ... More >> Policlinique Médicale Universitaire and Centre pluridisciplinaire d'oncologie, CHUV Recruiting Lausanne, Vaud, Switzerland, 1010 Contact: Bugnon Olivier    +41 21 314 48 48    Olivier.Bugnon@hospvd.ch    Contact: Schneider Marie-Paule    +41 21 314 48 46    Marie-Paule.Schneider@hospvd.ch Less <<
NCT02693535 Lymphoma, Non-Hodgkin ... More >> Multiple Myeloma Advanced Solid Tumors Less << Phase 2 Recruiting - -
NCT01068106 Coronary Heart Disease Phase 4 Unknown September 2013 Germany ... More >> Deutsches Herzzentrum Muenchen Munich, Germany, 80636 Klinikum rechts der Isar der Technischen Universitaet Muenchen Munich, Germany, 81675 Less <<
NCT00276744 Pancreatic Cancer Phase 2 Terminated(Because there was n... More >>o longer an active laboratory component to this study.) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00276744 - Terminated(Because there was n... More >>o longer an active laboratory component to this study.) Less << - -
NCT03685448 Renal Cell Carcinoma ... More >> Papillary Renal Cell Carcinoma Type 1 Papillary Renal Cell Carcinoma Type 2 Chromophobe Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma Xp11.2 Translocation-Related Renal Cell Carcinoma Less << Phase 2 Not yet recruiting January 30, 2024 Australia, New South Wales ... More >> Border Medical Oncology Research Unit / The Border Cancer Hospital Not yet recruiting Albury, New South Wales, Australia, 2460 Contact: Craig Underhill       cunderhill@bordermedonc.com.au    Contact: Jacqui McBurnie    +61 2 6064 1508    jacqui.mcburnie@bordermedonc.com.au    Macquarie University Hospital Not yet recruiting Macquarie Park, New South Wales, Australia, 2109 Contact: Howard Gurney       howard.gurney@mq.edu.au    Contact: Radhika Butala    +61 2 9812 3561    radhika.butala@mq.edu.au    Australia, South Australia Flinders Medical Centre Not yet recruiting Bedford Park, South Australia, Australia, 5042 Contact: Ganessan Kichenadasse       ganessan.kichenadasse@sa.gov.au    Contact: Alison Richards       Alison.richards@sa.gov.au    Adelaide Cancer Centre / Ashford Cancer Centre Research / Cancer Care SA Kurralta Park, South Australia, Australia, 5037 Australia, Victoria Box Hill Hospital - Eastern Health Not yet recruiting Box Hill, Victoria, Australia, 3128 Contact: Ian Davis       ian.davis@monash.edu    Contact: Lauren Mitchell    +61 3 9094 9544    lauren.mitchell@monash.edu Less <<
NCT03088280 Thymoglobulin Dose Phase 4 Recruiting June 2018 Brazil ... More >> Transplant ward of the Hospital do Fortaleza Recruiting Fortaleza, Ceará, Brazil, 60175-205 Contact: Tainá Freitas, MD PhD    55 85 31013306    taina.sandes@gmail.com    Contact: Ronaldo Esmeraldo, MD    55 85 31013306    ronaldo.esmeraldo@gmail.com Less <<
NCT03745053 Coronary Artery Disease Not Applicable Not yet recruiting January 1, 2021 Italy ... More >> IRCCS Policlinico S. Donato Not yet recruiting San Donato Milanese, Milano, Italy, 20097 Contact: Luca Testa, MD    00390252774987    luctes@gmail.com    Principal Investigator: Luca Testa, MD          Ospedale S. Raffaele Not yet recruiting Milano, MI, Italy, 20132 Contact: Alaide Chieffo, MD    00390226437362       Principal Investigator: Alaide Chieffo, MD          Spain Hospital Bellvitge Not yet recruiting Barcelona, Spain, 08025 Contact: Joan Antoni Gómez Hospital, MD          Principal Investigator: Joan Antoni Gómez Hospital, MD          Hospital de la Santa Creu i Sant Pau Not yet recruiting Barcelona, Spain, 08025 Contact: Antoni Serra, MD          Principal Investigator: Antoni Serra, MD          Hospital La Paz Not yet recruiting Madrid, Spain, 28046 Contact: José Raúl Moreno Gómez, MD       raulmorenog@hotmail.com    Principal Investigator: José Raúl Moreno Gómez, MD Less <<
NCT01677585 - Active, not recruiting May 2020 China ... More >> Second Affliated Hosptial Zhejiang University College of Medicine Hangzhou, China Less <<
NCT02142803 Adult Glioblastoma ... More >> Endometrial Clear Cell Adenocarcinoma Endometrial Serous Adenocarcinoma Ovarian Clear Cell Cystadenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mucinous Cystadenocarcinoma Ovarian Serous Cystadenocarcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Recurrent Uterine Corpus Carcinoma Solid Neoplasm Stage IIIA Fallopian Tube Cancer AJCC v7 Stage IIIA Ovarian Cancer AJCC v6 and v7 Stage IIIA Primary Peritoneal Cancer AJCC v7 Stage IIIB Fallopian Tube Cancer AJCC v7 Stage IIIB Ovarian Cancer AJCC v6 and v7 Stage IIIB Primary Peritoneal Cancer AJCC v7 Stage IIIC Fallopian Tube Cancer AJCC v7 Stage IIIC Ovarian Cancer AJCC v6 and v7 Stage IIIC Primary Peritoneal Cancer AJCC v7 Stage IV Fallopian Tube Cancer AJCC v6 and v7 Stage IV Ovarian Cancer AJCC v6 and v7 Stage IV Primary Peritoneal Cancer AJCC v7 Less << Phase 1 Active, not recruiting - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Massachusetts General Hospital Charlestown, Massachusetts, United States, 02129 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT03469856 Monotherapy After PCI Not Applicable Recruiting August 15, 2019 Brazil ... More >> Heart Institute - InCor Recruiting São Paulo, SP, Brazil, 05403-000 Contact: Expedito Ribeiro, MD PhD    +55 11 2661 5614    expribeiro@incor.usp.br    Contact: Patricia Pereira, RN    +55 11 26624030    patricia.pereira@incor.usp.br Less <<
NCT00743899 Coronary Artery Disease Not Applicable Unknown June 2016 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00240994 Kidney Failure, Chronic ... More >> Kidney Transplantation Immunosuppression Less << Phase 2 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143-0116 United States, Massachusetts Children's Hospital, Boston Boston, Massachusetts, United States, 02115 United States, Pennsylvania Children's Hospital, Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Washington Children's Hospital and Regional Medical Center, Seattle Seattle, Washington, United States, 98105 Less <<
NCT00240994 - Completed - -
NCT01116232 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Terminated(Lack of funding.) - United States, Michigan ... More >> Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT01116232 - Terminated(Lack of funding.) - -
NCT01977534 - Active, not recruiting November 2018 United Kingdom ... More >> Lister Hospital Stevenage, Hertfordshire, United Kingdom Basildon Hospital Basildon, United Kingdom Royal Victoria Hospital Belfast, United Kingdom Glan Clwyd District General Hospital Bodelwyddan, United Kingdom Royal Bournmouth Hospital Bournemouth, United Kingdom Sussex Cardiac Centre Brighton, United Kingdom Bristol Heart Institute Bristol, United Kingdom Papworth Hospital Cambridge, United Kingdom Royal Infirmary of Edinburgh Edinburgh, United Kingdom Frimley Park Hospital Frimley, United Kingdom Golden Jubilee National Hospital Glasgow, United Kingdom Leeds General Infirmary Leeds, United Kingdom Glenfield Hospital Leicester, United Kingdom Barts Heart Centre London, United Kingdom Kings College Hospital London, United Kingdom Northwick Park Hospital London, United Kingdom Royal Brompton Hospital London, United Kingdom Manchester Royal Infirmary Manchester, United Kingdom James Cook University Hospital Middlesbrough, United Kingdom The Freeman Hospital Newcastle, United Kingdom Norfolk & Norwich University Hospital Norwich, United Kingdom John Radcliffe Hospital Oxford, United Kingdom Queen Alexandra Hospital Portsmouth, United Kingdom Southampton General Hospital Southampton, United Kingdom Less <<
NCT00434811 Type 1 Diabetes Mellitus Phase 3 Completed - United States, California ... More >> University of Callifornia, San Francisco San Francisco, California, United States, 94143 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 University of Illinois, Chicago Chicago, Illinois, United States, 60612 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Canada, Alberta University of Alberta Edmonton, Alberta, Canada, T6G028 Less <<
NCT03061708 Stomach Neoplasms Phase 2 Active, not recruiting December 2019 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01372813 Advanced Clear Cell Renal Carc... More >>inoma Less << Phase 2 Terminated(Terminated for insu... More >>fficient accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02619760 Coronary Artery Disease Phase 4 Active, not recruiting December 2023 Japan ... More >> Division of Cardiology, Kyoto University Hospital Kyoto, Japan, 606-8507 Less <<
NCT01372813 - Terminated(Terminated for insu... More >>fficient accrual.) Less << - -
NCT01670175 Malignant Solid Tumor ... More >> Childhood Solid Tumor Less << Phase 1 Completed - United States, California ... More >> UCSF Benioff Children's Hospital San Francisco, California, United States, 94143 Less <<
NCT01337765 Unspecified Adult Solid Tumor,... More >> Protocol Specific Solid Tumor Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States, 02114 United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson PSC Houston, Texas, United States, 77030-4009 Australia, Victoria Novartis Investigative Site Parkville, Victoria, Australia, 3050 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Villejuif Cedex, France, 94805 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08035 Less <<
NCT03225417 Hematopoietic Stem Cell Transp... More >>lantation Multiple Myeloma Less << Phase 1 Phase 2 Recruiting May 27, 2023 Spain ... More >> ICO- Hospital Germans Trias i Pujol Not yet recruiting Badalona, Spain Contact: M. Christelle Ferra Coll, MD-PhD          Principal Investigator: M. Christelle Ferra Coll, MD-PhD          Hospital Clinic de Barcelona Not yet recruiting Barcelona, Spain Contact: Carmen Martínez, MD-Phd       CMARTI@clinic.cat    Principal Investigator: Carmen Martínez, MD-Phd          Hospital de la Santa Creu I Sant Pau Not yet recruiting Barcelona, Spain Contact: Jorge Sierra Gil, MD-Phd       jsierra@santpau.cat    Principal Investigator: Jorge Sierra Gil, MD-Phd          Hospital Universitario Vall D´Hebrón Not yet recruiting Barcelona, Spain Contact: David Valcarcel Ferreira, MD-Phd       dvalcarcel.vhebron@me.com    Principal Investigator: David Valcarcel Ferreira, MD-Phd          Hospital Clinico Universitario Salamanca Not yet recruiting Salamanca, Spain Contact: Lucía Lopez del Corral, MD-PhD       lucialopezcorral@usal.es    Principal Investigator: Lucía Lopez del Corral, MD-PhD          Hospital Universitario Virgen del Rocío Recruiting Sevilla, Spain, 41013 Contact: Jose-Antonio Perez-Simon, MD-PhD    0034955013260 ext 0034    josea.perez.simon.sspa@juntadeandalucia.es    Contact: Clara M. Rosso, MD    0034955013414 ext 0034    claram.rosso.sspa@juntadeandalucia.es    Hospital Clínico Universitario de Valencia Not yet recruiting Valencia, Spain Contact: Carlos Solano Vercet, MD-Phd       solano_car@gva.es    Principal Investigator: Carlos Solano Vercet, MD-Phd Less <<
NCT02574728 Cancer Phase 2 Recruiting June 2020 United States, Delaware ... More >> Nemours/Alfred I. duPont Hospital for Children Recruiting Wilmington, Delaware, United States, 19803 Contact: Debra Bertz, CTR, MBA    302-651-5757    debra.bertz@nemours.org    Principal Investigator: Andrew W Walter, MD          United States, Florida Nemour's Children's Specialty Care Jacksonville Recruiting Jacksonville, Florida, United States, 32207 Contact: Howard Katzenstein, MD    904-697-3985    Howard.Katzenstein@nemours.org    Principal Investigator: Howard Katzenstein, MD          United States, Georgia Children's Healthcare of Atlanta-Egleston Recruiting Atlanta, Georgia, United States, 30322 Contact: Kate Glasscox    404-785-0002    Katherine.GlasscoxSuggs@choa.org    Children's Healthcare of Atlanta, Scottish Rite Recruiting Atlanta, Georgia, United States, 30342 Contact: Kate Glasscox    404-785-0002    Katherine.GlasscoxSuggs@choa.org    Principal Investigator: Thomas Cash, MD          United States, Missouri Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 Contact: Amber Jenkins, MSc, CCRC    816-302-6891    amjenkins@cmh.edu    Principal Investigator: Jaszianne Tolbert, MD          United States, Virginia University of Virginia Health System Recruiting Charlottesville, Virginia, United States, 22908 Contact: Cindy Fischer, CCRC    434-243-0901    CRB3Y@hscmail.mcc.virginia.edu    Principal Investigator: William Petersen, MD Less <<
NCT01566747 Renal Cell Carcinoma Phase 2 Active, not recruiting September 2018 Ireland ... More >> Beaumont Hospital Dublin, Leinster, Ireland Mater Misericordiae University Hospital Dublin, Leinster, Ireland Mater Private Hospital Dublin, Leinster, Ireland Cork University Hospital Cork, Ireland The Adelaide & Meath Hospital Dublin incorporating the National Children's Hospital Dublin, Ireland Galway University Hospital Galway, Ireland Mid-Western Regional Hospital Limerick, Ireland Waterford Regional Hospital Waterford, Ireland Sweden Karolinska University Hospital Stockholm, Sweden Less <<
NCT00604357 End Stage Liver Disease ... More >> Impaired Renal Function Less << Phase 3 Completed - Germany ... More >> Regensburg University Medical Center, Department of Surgery Regensburg, Bavaria, Germany, 93053 Less <<
NCT00170053 Kidney Diseases Phase 1 Completed - United States, Florida ... More >> Mayo Clinic Jacksonville, Florida, United States, 32224 Less <<
NCT02179229 Renal Insufficiency, Chronic Not Applicable Unknown August 2015 Italy ... More >> Nutrition Unit of the Federico II University of Naples Recruiting Naples, Italy, 80131 Contact: Bruna Guida, MD    0039-081-7462102    bguida@unina.it    Contact: Rossella Trio, BSci       rostrio@unina.it    Principal Investigator: Bruna Guida, MD Less <<
NCT01817504 Renal Transplantation Not Applicable Recruiting November 2019 France ... More >> Service de Néphrologie, Médecine interne, Hémodialyse, Transplantation Rénale, Hôpital Sud Recruiting Amiens, France, 80054 Contact: Gabriel CHOUKROU, MD          Principal Investigator: Gabriel CHOUKROU, MD          Service de Néphrologie, Dialyse et Transplantation - Hôpital Jean Minjoz Recruiting Besançon, France, 25030 Contact: Didier DUCLOUX, MD          Principal Investigator: Didier DUCLOUX, MD          Service de Néphrologie - Hôpital de La Cavale blanche Recruiting Brest, France, 29609 Contact: Yannick LE MEUR, MD          Principal Investigator: Yannick LE MEUR, MD          Service de Néphrologie et Transplantation Rénale, CHU Gabriel Montpied Recruiting Clermont-Ferrand Cedex, France, 63000 Contact: Anne-Elisabeth HENG, MD          Principal Investigator: Anne-Elisabeth HENG, MD          Hôpitaux Civils de Colmar Recruiting Colmar, France, 68024 Contact: Alexandre KLEIN, MD          Principal Investigator: Alexandre KLEIN, MD          Service de Néphrologie -Dialyse-Transplantation, Hôpital Michallon Recruiting Grenoble Cedex, France, 38043 Contact: Paolo MALVEZZI, MD          Principal Investigator: Paolo MALVEZZI, MD          Centre Hospitalier de Haguenau Recruiting Haguenau, France, 67504 Contact: Marc KRIBS, MD          Principal Investigator: Marc KRIBS, MD          Centre Hospitalier départemental Vendée - Site de la Roche-sur-Yon Recruiting La Roche-sur-Yon, France, 85925 Contact: Grégoire COUVRAT-DESVERGNES, MD          Principal Investigator: Grégoire COUVRAT-DESVERGNES, MD          Service de Néphrologie - Hôpital Claude Huriez Recruiting Lille, France, 59000 Contact: Marc HAZZAN, MD          Principal Investigator: Marc HAZZAN, MD          Transplantation Department, Hôpital Edourad Herriot Recruiting Lyon, France, 69003 Contact: Emmanuel MORELON, MD    33 472 110 150 ext +33    emmanuel.morelon@chu-lyon.fr    Principal Investigator: Emmanuel MORELON, MD          Service de Néphrologie et Transplantation Rénale - Hôpital Lapeyronie Recruiting Montpellier, France, 34295 Contact: Valérie GARRIGUE, MD          Principal Investigator: Valérie GARRIGUE, MD          Institut de Transplantation, Urologie et Néphrologie - CHU Nantes Recruiting Nantes, France, 44093 Contact: Gilles BLANCHO, MD          Principal Investigator: Gilles BLANCHO, MD          Unité de Transplantation Rénale - Hôpital de l'Archet Recruiting Nice, France, 06202 Contact: Elisabeth CASSUTO, MD          Principal Investigator: Elisabeth CASSUTO, MD          Urgence Néphrologique et Transplantation Rénale - Hôpital Tenon Recruiting Paris, France, 75020 Contact: Alexandre HERTIG, MD          Principal Investigator: Alexandre HERTIG, MD          Service de Néphrologie, Centre Hospitalier Lyon Sud Recruiting Pierre Bénite, France, 69310 Contact: Solenne PELETTIER, MD          Principal Investigator: Solenne PELETTIER, MD          Service de Néphrologie-Dialyse, Centre Hospitalier d'Annecy Recruiting Pringy, France, 74374 Contact: Maizé DUCRET, MD          Principal Investigator: Maizé DUCRET, MD          Service de Néphrologie, Dialyse et Transplantation Rénale, Hôpital Nord Recruiting Saint-Etienne, France, 42055 Contact: Christophe MARIAT, MD          Principal Investigator: Christophe MARIAT, MD          Service de Néphrologie et Transplantation Rénale - Nouvel Hôpital Civil Recruiting Strasbourg, France, 67091 Contact: Bruno MOULIN, MD          Principal Investigator: Bruno MOULIN, MD          Département de Néphrologie et Transplantation d'Organes - Hôpîtal Rangueil Withdrawn Toulouse, France, 31059 Service de Néphrologie, Immunologie Clinique - CHU Bretonneau Recruiting Tours, France, 37044 Contact: Matthias BUCHLER, MD          Principal Investigator: Matthias BUCHLER, MD Less <<
NCT01181271 Diffuse, Large B-Cell, Lymphom... More >>a Lymphoma, Low-Grade T-Cell Lymphoma Mantle-Cell Lymphoma Hodgkin's Lymphoma Chronic Lymphocytic Leukemia Lymphoma, Small Lymphocytic Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01827254 - Completed - -
NCT02604420 - Completed - United States, New York ... More >> New York Presbyterian Hospital New York, New York, United States, 10021 Less <<
NCT01827254 - Completed - France ... More >> CHU de la Timone Marseille, Cedex 5, France, 13335 Hopital albert Michalon Grenoble, Cedex 9, France, 38043 Centre Paul Papin Angers, France, 49100 Hôpital Saint-André Bordeaux Cedex, France, 33075 Centre Catalan Urologie Andrologie Cabestany, France, 66330 Centre Oscar Lambret - Cancérologie Urologie Digestive Lille Cedex, France, 59020 clinique de la Louvière Lille Cedex, France, 59042 Hopital Dupuytren - Oncologie Medicale Limoges Cedex, France, 87042 Centre Leon Berard, Service d'Oncologie Medicale Lyon Cedex 08, France, 69373 Institut Paoli-Calmettes / Hôpital de jour Marseille Cedex 9, France, 13273 Cedex 9 Hopital Timone Adultes Marseille Cedex, France, 13385 Hopital Europeen Georges Pompidou Paris Cedex 15, France, 75908 Centre Eugene Marquis Rennes, France, 35042 CHU Charles Nicolle ROUEN Cedex, France, 76031 Departement d'Oncologie Medicale-Institut de Cancerologie de la Loire Saint Priest en Jarez Cedex, France, 42271 Centre Rene Gauducheau - Service Oncologie Medicale St Herblain Cedex, France, 44805 Institut Claudius Regaud Toulouse, France, 31000 Centre Alexis Vautrin Vandoeuvre les Nancy, France, 54511 Less <<
NCT01181271 - Completed - -
NCT00866684 Kidney Transplantation ... More >> Skin Cancer Less << Phase 4 Terminated(Insufficient patien... More >>t recruitment) Less << - Germany ... More >> Universitätsklinikum Erlangen, Hautklinik Erlangen, Bavaria, Germany, 91052 Universitätsklinikum Erlangen, Medizinische Klinik IV Erlangen, Bavaria, Germany, 91054 Klinikum der LMU München, Medizinische Poliklinik Innenstadt München, Bavaria, Germany, 80336 Klinikum der LMU München, Klinik und Poliklinik für Dermatologie München, Bavaria, Germany, 80337 Klinikum rechts der Isar, Klinik und Poliklinik für Dermatologie und Allergologie München, Bavaria, Germany, 80802 Klinikum rechts der Isar, II. Medizinische Klinik und Poliklinik München, Bavaria, Germany, 81675 Universität Regensburg, Dermatologie Regensburg, Bavaria, Germany, 93053 Universität Regensburg, Nephrologie Innere Medizin II Regensburg, Bavaria, Germany, 93053 Kliniken der Stadt Köln, Medizinische Klinik I Köln, North Rhine-Westphalia, Germany, 51109 Universitätsklinikum Münster, Klinik und Poliklinik für Hautkrankheiten Münster, North Rhine-Westphalia, Germany, 48149 Universitätsklinikum Münster, Med. Klinik und Poliklinik D Münster, North Rhine-Westphalia, Germany, 48149 HELIOS Klinikum Wuppertal, Zentrum für Dermatologie, Allergologie und Umweltmedizin Wuppertal, North Rhine-Westphalia, Germany, 42283 Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Venerologie und Allergologie Kiel, Schleswig-Holstein, Germany, 24105 Universitätsklinikum Schleswig-Holstein, Klinik für Nieren- und Hochdruckkrankheiten Kiel, Schleswig-Holstein, Germany, 24105 Charité Universitätsmedizin, Klinik für Dermatologie, Venerologie und Allergologie Berlin, Germany, 10117 Less <<
NCT00556933 End-stage Renal Disease Phase 4 Completed - United States, Nebraska ... More >> The Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT02870985 Coronary Artery Disease Phase 3 Recruiting - China, Beijing ... More >> Fuwai Hospital Recruiting Beijing, Beijing, China, 100032 Contact: Yuejin Yang    +86 13701151408 Less <<
NCT01062555 CNI Side Effects Phase 1 Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55414 Less <<
NCT01847261 Muscle Synthesis Not Applicable Unknown April 2014 United States, Texas ... More >> University of Texas Medical Branch Recruiting Galveston, Texas, United States, 77555 Principal Investigator: Blake Rasmussen, PhD Less <<
NCT00061568 Congenital Hemolytic Anemia ... More >> Sickle Cell Disease Less << Phase 1 Phase 2 Recruiting January 31, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00556933 - Completed - -
NCT03074305 Coronary Artery Disease ... More >> Coronary Restenosis Less << Not Applicable Active, not recruiting December 2020 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 06351 Less <<
NCT01443754 - Terminated(Lack of recruitment... More >>) Less << - Italy ... More >> Maria Cecilia Hospital Cotignola, Ravenna, Italy, 48010 Less <<
NCT02686619 Renal Transplantation Phase 3 Completed - France ... More >> Angers, France, 49933 Caen, France, 14033 Clermont-ferrand, France, 63000 La Tronche, France, 38700 Lille, France, 59037 Limoges, France, 87042 Lyon, France, 69437 Paris, France, 75018 Paris, France, 75475 Paris, France, 75743 Poitiers, France, 86021 Reims, France, 51092 Rennes, France, 35033 Rouen, France, 76031 Salouel, France, 80480 Strasbourg, France, 67091 Tours, France, 37044 Less <<
NCT02829008 Metastatic Breast Cancer Phase 2 Active, not recruiting April 2020 China, Beijing ... More >> Cancer Hospital, ChineseAMS Beijing, Beijing, China, 100021 Less <<
NCT01885689 Adult Acute Lymphoblastic Leuk... More >>emia in Remission Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Myeloid Leukemia in Remission Myelodysplastic Syndrome Secondary Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Therapy-Related Myelodysplastic Syndrome Less << Phase 2 Active, not recruiting December 2021 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT01318915 Renal Transplant Recipients Early Phase 1 Terminated(The stopping rule f... More >>or incidence of acute rejection was met.) Less << - United States, California ... More >> University of California San Francisco Medical Center San Francisco, California, United States, 94143 United States, Maryland University of Maryland Medical Center Baltimore, Maryland, United States, 21201 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York Rogosin Institute/New York Presbyterian-Cornell New York, New York, United States, 10021 United States, Pennsylvania Hospital at the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT02193971 Acute Coronary Syndrome Phase 4 Recruiting June 2020 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Kyung Woo Park, MD, PhD    82-2-2072-0244    kwparkmd@snu.ac.kr    Contact: Hyo-Soo Kim, MD, PhD    82-2-2072-2226    hyosoo@snu.ac.kr Less <<
NCT02583542 Triple-Negative Breast Cancer ... More >> Squamous Cell Lung Cancer Non-squamous Cell Lung Cancer With KRAS Mutations Non-squamous Cell Lung Cancer With Wild-type KRAS Less << Phase 1 Phase 2 Recruiting July 2019 United Kingdom ... More >> University Hospitals Birmingham NHS Foundation Trust Recruiting Birmingham, United Kingdom, B15 2TT Contact: Gary Middleton, Professor    +44 (0) 1213713573    Gary.Middleton@uhb.nhs.uk    Contact: Ceri Amstrong    +44 (0) 1214143795    c.j.armstrong@bham.ac.uk    Principal Investigator: Gary Middleton, Professor          Barts Health NHS Trust Recruiting London, United Kingdom, EC1M 6BQ Contact: Peter Schmid    +44 (0)20 7882 8498    p.schmid@qmul.ac.uk    Contact: Louise Lim       farahlouise.lim@bartshealth.nhs.uk    Principal Investigator: Peter Schmid          Sub-Investigator: Louise Lim          University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom, W1T 7HA Contact: Martin Forster, Dr    +44 (0) 2034475085    Martin.Forster@uclh.nhs.uk    Contact: Magda Rocha    +44 (0) 2034472921    Magda.PintoRocha@uclh.nhs.uk    Principal Investigator: Martin Forster, Dr          Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Contact: Yvonne Summers, Dr    +44 (0) 161 446 8016    yvonne.summers@christie.nhs.uk    Contact: Rachael Finney    +44 (0) 1619182318    rachael.finney@christie.nhs.uk    Principal Investigator: Yvonne Summers, Dr Less <<
NCT02053441 - Unknown September 2016 United Kingdom ... More >> University of Nottingham (Derby campus) Recruiting Derby, Derbyshire, United Kingdom, DE22 3NE Contact: Philip Atherton, PhD    0044 (0) 01332 724725    philip.atherton@nottingham.ac.uk    Contact: Syed SI Bukhari, MBBS    00447809239232    mzxsb@nottingham.ac.uk    Principal Investigator: Kenneth Smith, PhD Less <<
NCT03155620 Advanced Malignant Solid Neopl... More >>asm Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma Childhood Langerhans Cell Histiocytosis Histiocytic Sarcoma Juvenile Xanthogranuloma Malignant Glioma Recurrent Central Nervous System Neoplasm Recurrent Childhood Ependymoma Recurrent Childhood Malignant Germ Cell Tumor Recurrent Childhood Medulloblastoma Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Childhood Rhabdomyosarcoma Recurrent Childhood Soft Tissue Sarcoma Recurrent Ewing Sarcoma Recurrent Glioma Recurrent Hepatoblastoma Recurrent Langerhans Cell Histiocytosis Recurrent Malignant Solid Neoplasm Recurrent Neuroblastoma Recurrent Osteosarcoma Recurrent Peripheral Primitive Neuroectodermal Tumor Recurrent Rhabdoid Tumor Refractory Central Nervous System Neoplasm Refractory Childhood Malignant Germ Cell Tumor Refractory Ewing Sarcoma Refractory Glioma Refractory Hepatoblastoma Refractory Langerhans Cell Histiocytosis Refractory Malignant Solid Neoplasm Refractory Medulloblastoma Refractory Neuroblastoma Refractory Non-Hodgkin Lymphoma Refractory Osteosarcoma Refractory Peripheral Primitive Neuroectodermal Tumor Refractory Rhabdoid Tumor Refractory Rhabdomyosarcoma Rhabdoid Tumor Stage III Osteosarcoma AJCC v7 Stage III Soft Tissue Sarcoma AJCC v7 Stage IV Osteosarcoma AJCC v7 Stage IV Soft Tissue Sarcoma AJCC v7 Stage IVA Osteosarcoma AJCC v7 Stage IVB Osteosarcoma AJCC v7 Wilms Tumor Less << Phase 2 Recruiting September 30, 2027 -
NCT02226900 Multivessel Coronary Artery Di... More >>sease Less << Not Applicable Active, not recruiting - Brazil ... More >> InCor -Faculdade de Medicina da Universidade de São Paulo São Paulo, SP, Brazil, 05403000 Less <<
NCT01962740 Drug Eluting Stents (DES) ... More >> Percutaneous Coronary Intervention (PCI) Uncovered and Malapposed Stent Struts Optical Coherence Tomography (OCT) Less << Not Applicable Terminated(Lack of eligible pa... More >>tients) Less << - United States, Texas ... More >> VA North Texas Health Care System Dallas, Texas, United States, 75216 Less <<
NCT03436732 Mesothelioma Phase 1 Recruiting November 30, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02035865 - Unknown December 2016 Norway ... More >> Oslo University Hospital Oslo, Norway, 0424 Less <<
NCT00183248 Kidney Transplantation ... More >> Kidney Disease Kidney Failure Less << Phase 1 Phase 2 Completed - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 Less <<
NCT01318915 - Terminated(The stopping rule f... More >>or incidence of acute rejection was met.) Less << - -
NCT00183248 - Completed - -
NCT01574534 Coronary Heart Disease Not Applicable Recruiting October 2019 Austria ... More >> Medizinische Universität Graz Kardiologie Recruiting Graz, Austria, 8036 Contact: Robert Zweiker, Prof Dr          Germany Cardiology, Zentralklinik Bad Berka Recruiting Bad Berka, Germany, 99437 Contact: Marc-Alexander Ohlow, PD Dr          Unfallkrankenhaus Berlin, Dept. Internal Medicine Recruiting Berlin, Germany, 12683 Contact: Leonhard Bruch, MD          Charité Universitätsmedizin Berlin, Kardiologie Recruiting Berlin, Germany, 13353 Contact: Florian Krackhardt, MD          Immanuel Klinikum Bernau Herzzentrum Brandenburg Recruiting Bernau, Germany, 16321 Klinikum Westfalen GmbH Knappschaftskrankenhaus Recruiting Dortmund, Germany, 44309 Contact: Ahmed Farah, MD          Universitätsklinikum des Saarlandes - Kardiologie, Angiologie und internistische Intensivmedizin Recruiting Homburg/Saar, Germany Contact: Bruno Scheller, Prof Dr          University Hospital Jena Recruiting Jena, Germany, 07747 Contact: Sven Möbius-Winkler, PD Dr med          Herzzentrum Leipzig GmbH, Universitätsklinik Recruiting Leipzig, Germany, 04289 Contact: Norman Mangner, MD          Department of Internal Medicine/Cardiology, University Hospital Ulm Recruiting Ulm, Germany Contact: Jochen Wöhrle, Prof. Dr. med          Switzerland Cardiology, University Hospital Basel Recruiting Basel, Switzerland Contact: Raban V Jeger, Prof Dr          Cardiology Cantonal Hospital Baselland Liestal Recruiting Liestal, Switzerland, 4410 Contact: Gregor Leibundgut, MD    061 925 23 65    Gregor.Leibundgut@ksbl.ch    Luzerner Kantonsspital Recruiting Luzern, Switzerland, 6000 Contact: Florim Cuculi, PD Dr          Cardiology, Kantonsspital St. Gallen Recruiting St. Gallen, Switzerland Contact: Daniel Weilenmann, MD Less <<
NCT03502902 Idiopathic Pulmonary Fibrosis Phase 1 Recruiting March 4, 2019 United States, Florida ... More >> Covance Clinical Research Unit, Inc. Recruiting Daytona Beach, Florida, United States, 32117 Contact: Irene Mirkin, MD    608-443-1477 Less <<
NCT02362438 Giant Axonal Neuropathy ... More >> Gene Transfer Less << Phase 1 Recruiting April 1, 2030 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02972671 Coronary (Artery); Disease Not Applicable Active, not recruiting April 30, 2022 Japan ... More >> Iwaki Municipal Iwaki Kyoritsu Hospital Iwaki-shi, Fukushima, Japan Kansai Rosai Hospital Amagasaki-shi, Hyogo, Japan Tenyokai Central Hospital Kagoshima-shi, Kagoshima, Japan Kanto Rosai Hospital Kawasaki-shi, Kanagawa, Japan Sinkoga Hospital Kurume-shi, Kurume-shi, Fukuoka, Japan Omihachiman Community Medical Center Omihachiman-shi, Shiga, Japan, 523-0082 Toho Univ.Ohashi Medical Center Meguro-ku, Tokyo, Japan Cardiovascular Institute Hospital Minato-ku, Tokyo, Japan Saiseikai Yokohama Tobu Hospital Kanagawa, Yokohama, Japan Shonan Kamakura General Hospital Tokyo, Japan Less <<
NCT03297606 Lymphoma, Non-Hodgkin ... More >> Multiple Myeloma Advanced Solid Tumors Less << Phase 2 Recruiting September 2021 Canada, British Columbia ... More >> BCCA - Vancouver Cancer Centre Recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Contact: Daniel John Renouf    604 877-6000 ext 672357       Canada, Ontario London Regional Cancer Program Recruiting London, Ontario, Canada, N6A 5W9 Contact: Stephen Welch    519 685-8640       Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: John Hilton    613 737-7700 ext 70179       University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Lillian Siu    416 946-2911       Canada, Quebec The Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Cristiano Ferrario    514 398-8307 Less <<
NCT01328730 Coronary Artery Stenosis Phase 4 Withdrawn(the Cypher SES is no... More >>w withdrawing in China market) Less << June 2013 China, Shanghai ... More >> Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai, China, 200025 Less <<
NCT03541863 - Active, not recruiting December 20, 2018 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Shanghai, Shanghai, China, 200032 Less <<
NCT02178761 Erectile Dysfunction ... More >> Lower Urinary Tract Symptoms Peripheral Arterial Disease Less << Not Applicable Unknown June 2016 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei City, Taiwan, 10002 Contact: Tzung-Dau Wang, MD, PhD    +886-972651070    tdwang@ntu.edu.tw    Principal Investigator: Tzung-Dau Wang, MD, PhD          Principal Investigator: Wen-Jeng Lee, MD, PhD Less <<
NCT01537107 Acinar Cell Adenocarcinoma of ... More >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Suspended December 2018 United States, Arizona ... More >> Mayo Clinic Campus in Arizona Scottsdale, Arizona, United States United States, Florida Mayo Clinic Campus in Florida Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00473551 Leukemia Lymp... More >>homa Myeloma Less << Phase 1 Terminated(Terminated due to s... More >>low accrual.) Less << - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03504241 Kidney Transplantation ... More >> Renal Transplantation Renal Transplant Recipient Less << Phase 1 Recruiting August 2025 United States, North Carolina ... More >> Duke University Health System Recruiting Durham, North Carolina, United States, 27710 Contact: Sherri Swan-Nesbit    919-613-6472    sherri.swan@duke.edu    Contact: Stacy Gray    919-681-8730    stacy.gray@duke.edu    Principal Investigator: Allan Kirk, MD Less <<
NCT03768375 Cholangiocarcinoma of the Extr... More >>ahepatic Bile Duct Gallbladder Cancer Less << Phase 2 Recruiting December 30, 2021 China, Shanghai ... More >> Xinhua Hospital Recruiting Shanghai, Shanghai, China, 200092 Contact: Yingbin Liu, PHD    13918803900    laoniulyb@163.com    Principal Investigator: yingbin liu, PHD Less <<
NCT02423915 Leukemia Lymp... More >>homa Less << Phase 1 Phase 2 Active, not recruiting July 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00468442 Type 1 Diabetes Mellitus Phase 2 Terminated(Lack of efficacy) - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States Less <<
NCT03205046 DLBCL Richter... More >> Syndrome Less << Phase 1 Phase 2 Active, not recruiting December 2019 United States, California ... More >> UC San Diego Moores Cancer Center La Jolla, California, United States, 92093 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, Maryland National Institutes of Health Bethesda, Maryland, United States, 20892 United States, Minnesota The Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Nebraska The University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New Jersey John Theurer Cancer Center Hackensack, New Jersey, United States, 07601 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Texas Oncology Tyler, Texas, United States, 75702 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Swedish Health Services Seattle, Washington, United States, 98122 United Kingdom Barts Health NHS Trust London, United Kingdom, E1 1BB The Christine NHS Foundation Trust Manchester, United Kingdom, M20 4BX Nottingham University Hospitals NHS Trust Nottingham, United Kingdom, NG5 1PB Oxford University Hospitals NHS Trust Oxford, United Kingdom, 0X3 7LE Derriford Hospital Plymouth, United Kingdom, PL4 7QD The Royal Marsden Sutton, United Kingdom, SM2 5PT Less <<
NCT02723877 Metastatic Breast Cancer Phase 1 Phase 2 Completed - Spain ... More >> Hospital Universitarsi Vall d'Hebron Barcelona, Catalan, Spain, 08035 Insitut Català d´Oncologia Barcelona, Spain Fundación Instituto Valenciano de Oncología Valencia, Spain United Kingdom Barts Cancer Institute London, United Kingdom Churchill hospital Oxford, United Kingdom Less <<
NCT03750396 Breast Cancer ... More >> Recurrent Breast Cancer Stereotactic Body Radiotherapy Estrogen Receptor Positive Tumor Her2-negative Tumor Surgery Less << Phase 2 Recruiting July 31, 2025 Korea, Republic of ... More >> Gangnam Severance Hospital Recruiting Seoul, Korea, Republic of, 135720 Contact: Joon Jeong, M.D.,Ph.D.    82220193370    gsjjoon@yuhs.ac    Contact: Sung Gwe Ahn, M.D.    82220193370    asg2004@yuhs.ac Less <<
NCT03508219 Coronary Stenosis Not Applicable Recruiting August 2020 France ... More >> Research Centre FRA-001 Not yet recruiting Aix en Provence, France Research Centre FRA-004 Not yet recruiting Bron, France Research Centre FRA-003 Not yet recruiting Grenoble, France Research Centre FRA-002 Not yet recruiting Saint-Denis, France Italy Research Centre ITA-001 Not yet recruiting Naples, Italy Research Centre ITA-002 Not yet recruiting Ragusa, Italy Research Centre ITA-003 Not yet recruiting Syracuse, Italy Poland Research Centre PL-006 Not yet recruiting Katowice, Poland Research Centre PL-007 Not yet recruiting Krakow, Poland Research Centre PL-004 Not yet recruiting Olsztyn, Poland Research Centre PL-005 Not yet recruiting Poznan, Poland Research Centre PL-001 Recruiting Warsaw, Poland Research Centre PL-008 Not yet recruiting Warsaw, Poland Research Centre PL-002 Not yet recruiting Zabrze, Poland Research Centre PL-003 Not yet recruiting Zabrze, Poland Less <<
NCT02728700 Adult Hodgkin Lymphoma ... More >> Adult Myelodysplastic Syndrome Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Hodgkin Lymphoma Childhood Myelodysplastic Syndrome Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Myelofibrosis Primary Myelofibrosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Non-Hodgkin Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Non-Hodgkin Lymphoma Less << Phase 1 Terminated(Accrual factor) - United States, California ... More >> Stanford University, School of Medicine Palo Alto, California, United States, 94304 Less <<
NCT02484664 Lymphangioleiomyomatosis (LAM) Phase 2 Active, not recruiting June 2019 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02549586 Complication of Transplanted O... More >>rgan, Nos Less << Phase 2 Active, not recruiting January 2020 Canada, Ontario ... More >> The Ottawa Hopital Ottawa, Ontario, Canada, K1H 8L6 Multi-Organ Transplant Program, Toronto General Hospital Toronto, Ontario, Canada, M5G 2N2 Less <<
NCT02713581 - Recruiting January 3, 2020 France ... More >> CHRU de Montpellier - Hôpital Saint-Eloi Not yet recruiting Montpellier cedex 5, France, 34295 Principal Investigator: Isabelle Quéré, MD, PhD          Sub-Investigator: Jean-Philippe Galanaud, MD          CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Sylvie Bouvier, MD          Sub-Investigator: Jean-Christophe Gris, MD, PhD          Sub-Investigator: Géraldine Lavigne, MD          Sub-Investigator: Eva Nouvellon, MD          Sub-Investigator: Erick Mercier, MD Less <<
NCT01376310 Cancer Phase 2 Completed - -
NCT01238510 Coronary Artery Disease Phase 4 Completed - Japan ... More >> Edogawa Hospital Tokyo, Japan Saiseikai Yokohama City Eastern Hospital Yokohama, Japan, 230-8765 Less <<
NCT02939365 Transplantation Phase 4 Not yet recruiting June 2020 -
NCT01626170 - Completed - United States, California ... More >> Children's Oncology Group Monrovia, California, United States, 91006-3776 Less <<
NCT01733004 Hepatocellular Carcinoma Phase 1 Completed - United States, Georgia ... More >> Marietta, Georgia, United States United States, Massachusetts Boston, Massachusetts, United States United States, Michigan Detroit, Michigan, United States France Villejuif, France Less <<
NCT01713400 - Completed - -
NCT02385279 Coronary Stenosis Not Applicable Active, not recruiting December 2018 France ... More >> Research Center Corbeil Corbeil, France Research Center Nimes Nimes, France Research Center Poitiers Poitiers, France Germany Research Center Jena Jena, Germany Research Center Leipzig Leipzig, Germany Research Center Munster Munster, Germany Research Center Ulm Ulm, Germany Research Center Wiesbaden Wiesbaden, Germany Netherlands Research Center Amersfoort Amersfoort, Netherlands Research Center Amsterdam Amsterdam, Netherlands Tergooi Blaricum, Netherlands Research Center Emmen Emmen, Netherlands Research Center Leeuwarden Leeuwarden, Netherlands Research Center Nijmegen Nijmegen, Netherlands Research Center Venlo Venlo, Netherlands Poland Research Center Belchatow Belchatow, Poland Research Center Bielsko-Biala Bielsko-Biala, Poland Research center Chrzanow Chrzanow, Poland Research Center Tychy Tychy, Poland Research Center Zgierz Zgierz, Poland Less <<
NCT01713400 Graft vs. Host Disease Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01674803 Acute Coronary Syndrome ... More >> Angina Pectoris Angina, Unstable Myocardial Infarction Coronary Artery Disease Coronary Stenosis Coronary Restenosis Less << Not Applicable Active, not recruiting August 2019 Netherlands ... More >> Albert Schweitzer Ziekenhuis Dordrecht, Netherlands Less <<
NCT02188719 Liver Transplantation Phase 1 Recruiting January 2022 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Monique Koenigsberg    415-502-3016    Monique.Koenigsberg@ucsf.edu    Principal Investigator: Sandy Feng, MD, PhD          United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 55905 Contact: Patrice Al-Saden    312-503-1058    palsaden@northwestern.edu    Principal Investigator: Josh Levitsky, MD          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Julie Gecox Hanson, CCRP    507-293-6592    Gecox.Julie@mayo.edu    Principal Investigator: Timucin Taner, MD, PhD Less <<
NCT01398306 - Completed - Netherlands ... More >> University Medical Center Groningen Groningen, Netherlands, 9700RB Less <<
NCT01033500 Islets of Langerhans Transplan... More >>tation Diabetes Mellitus, Type 1 Kidney Transplantation Less << Not Applicable Withdrawn(Insufficient funding... More >>) Less << - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT02894697 Ischemic Heart Disease That Ar... More >>e Considered for Coronary Revascularization With Stent or Scaffold Implantation Less << Not Applicable Not yet recruiting August 2019 Korea, Republic of ... More >> Severance Cardiovascular Hospital, Yonsei University College of Medicine Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Myeong Ki Hong, MD, PhD    82-2-2228-8460    mkhong61@yuhs.ac Less <<
NCT01120028 Kidney Transplantation Phase 2 Phase 3 Active, not recruiting February 2019 United Kingdom ... More >> Oxford Radcliffe Hospitals NHS Trust Oxford, Oxon, United Kingdom, OX3 7LJ University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom Addenbrooke's Hospital NHS Trust Cambridge, United Kingdom University Hospital of Wales Cardiff, United Kingdom University Hospitals Coventry & Warwickshire Coventry, United Kingdom Royal Infirmary Edinburgh, United Kingdom Western Infirmary Glasgow, United Kingdom Hull and East Yorkshire Hospitals NHS Trust Hull, United Kingdom Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom Royal Liverpool and Broadgreen University Hospitals NHS Trust Liverpool, United Kingdom Bart's and the London NHS Trust London, United Kingdom Guy's and St Thomas's NHS Trust London, United Kingdom Kings College Hospital NHS Trust London, United Kingdom Royal Free Hampstead NHS Trust London, United Kingdom Central Manchester NHS Trust Manchester, United Kingdom Newcastle-upon-Tyne Hospitals NHS Trust Newcastle, United Kingdom Nottingham University Hospitals NHS Trust Nottingham, United Kingdom Plymouth Teaching Hospitals NHS Trust Plymouth, United Kingdom Portsmouth Hospitals NHS Trust Portsmouth, United Kingdom Sheffield Teaching Hospitals NHS Trust Sheffield, United Kingdom Less <<
NCT02303717 Coronary Artery Disease Not Applicable Not yet recruiting December 2020 -
NCT00346151 Renal Transplant Phase 2 Terminated(Stopping rule-acute... More >> rejection threshold-was met based on local biopsy results) Less << - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT00346151 - Terminated(Stopping rule-acute... More >> rejection threshold-was met based on local biopsy results) Less << - -
NCT01210911 Locally Advanced Pancreatic Ca... More >>ncer Metastatic Pancreatic Cancer Less << Phase 2 Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Netherlands, 1105AZ Less <<
NCT01383668 Recurrent Non-small Cell Lung ... More >>Cancer Squamous Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Withdrawn(lack of access to st... More >>udy drug) Less << - -
NCT01162551 Cancer Leukem... More >>ia Lymphoma Less << Phase 2 Completed - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02669511 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Completed - United States, California ... More >> UC Irvine - Medical Center Orange, California, United States, 92686 Kaiser Permanente-Sacramento Redwood Estates, California, United States, 94063 Kaiser Permanente-Sacramento Sacramento, California, United States, 95825 Germany University Hospital Freiburg General Medicine I Freiburg im Breisgau, Baden Würtenberg, Germany, 79106 Medizinische Klinik und Poliklinik III Munich, Bavaria, Germany, 81377 Charite Universitaetsmedizin Berlin Berlin, Germany Neurologische University Hospital Bochum Bochum, Germany, 44892 Klinik für Hämatologie, Onkologie und Palliativmedizin Stuttgart, Germany, 70174 Switzerland University Hospital Zurich, Neurology Zurich, Switzerland, 8091 Less <<
NCT03168776 Coronary Artery Disease Not Applicable Recruiting June 2023 -
NCT00166712 Kidney Transplant Failure and ... More >>Rejection Less << Phase 4 Terminated(Study stopped due t... More >>o lack of efficacy & funding.) Less << - United States, Illinois ... More >> Northwestern University/Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Less <<
NCT00166712 - Terminated(Study stopped due t... More >>o lack of efficacy & funding.) Less << - -
NCT03120000 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Withdrawn(Withdrawn) December 2019 France ... More >> Aix-Marseilles Université Marseille, France, 13305 Service de Neurology CHRU de Nancy Nancy, France, 54035 Hôpital Pitié-Sâlpétrier, Paris, France, 75013 Hématologie, Départment d'ongolgie médicale Saint-Herblain, France, 44800 Less <<
NCT00954512 Neoplasms Phase 1 Phase 2 Terminated(This study was term... More >>inated for business reasons.) Less << - -
NCT02019693 Papillary Renal Cell Carcinoma Phase 2 Recruiting January 1, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01690871 Malignant PEComa (Perivascular... More >> Epithelioid Cell Tumors) Less << Phase 2 Withdrawn January 2015 Spain ... More >> Novartis Investigative Site Barcelona, Cataluña, Spain, 08025 Less <<
NCT00498966 Kidney Cancer Phase 2 Completed - United States, Kentucky ... More >> Investigative Site Louisville, Kentucky, United States, 40202 United States, New Jersey Investigative Site Morristown, New Jersey, United States, 07962 United States, New York Investigative Site Armonk, New York, United States, 10504 Less <<
NCT00565773 Organ Transplantation Phase 2 Active, not recruiting August 2019 United States, Georgia ... More >> Emory University Hospital Atlanta, Georgia, United States, 30322 The Emory Clinic Atlanta, Georgia, United States, 30322 Less <<
NCT01687361 Neuromuscular Electrical Stimu... More >>lation Less << Not Applicable Completed - France ... More >> Assistance Publique Hopitaux de Marseille Marseille, France, 13354 Less <<
NCT03628859 - Not yet recruiting December 2023 France ... More >> Centre Leon Berard Not yet recruiting Lyon, France, 69008 Contact: BOYLE Ellen, MD    +33 4.26.55.67.52    helen.boyle@lyon.unicancer.fr Less <<
NCT03097601 - Active, not recruiting December 30, 2019 France ... More >> Centre Antoine LACASSAGNE Nice, France, 06189 Less <<
NCT02325505 - Recruiting August 2019 Brazil ... More >> InCor Heart Institute Recruiting Sao Paulo, Brazil, 05303900 Contact: Bruno G Baldi, MD    551126615695    bruno.guedes2@terra.com.br    InCor Heart Institute Recruiting Sao Paulo, Brazil, 05403900 Contact: Luciana Cassimiro, Coordinator    551126615109    luciana.cassimiro@incor.usp.br    Contact: Kátia Sansivieri, Coordinator    551126615109    katia@incor.usp.br    Principal Investigator: Carlos Roberto Ribeiro Carvalho, MD, PhD          Principal Investigator: Bruno G Baldi, MD          Sub-Investigator: Elieser Watanabe, MD          Sub-Investigator: Maria Luiza Manreza, MD          Sub-Investigator: José Roberto Colombo, MD          Sub-Investigator: Zilda Najjar, MD, PhD          Sub-Investigator: Luiz Fernando Onuchic, MD, PhD Less <<
NCT00954512 - Terminated(This study was term... More >>inated for business reasons.) Less << - -
NCT02503566 Disorder Related to Cardiac Tr... More >>ansplantation Less << Not Applicable Active, not recruiting June 1, 2019 Czechia ... More >> Helena Bedanova Brno, Czechia, 65691 Michal Pazdernik Prague, Czechia, 14021 Less <<
NCT00611910 Arteriosclerosis of Arterial C... More >>oronary Artery Bypass Graft Less << Phase 4 Completed - Germany ... More >> Herzzentrum Bad Krozingen Bad Krozingen, Germany Bad Segeberger Kliniken Bad Segeberg, Germany Medizinische Klinik, Klinikum rechts der Isar Muenchen, Germany, 81675 Deutsches Herzzentrum Muenchen Munich, Germany, 80636 Less <<
NCT02102893 - Enrolling by invitation February 2024 Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less <<
NCT02716363 Coronary Artery Disease Not Applicable Recruiting August 31, 2020 Korea, Republic of ... More >> Hyoen-Cheol Gwon, MD,PhD Recruiting Seoul, Korea, Republic of, 135-710 Contact: Hyoen-Cheol Gwon, MD,PhD    82-2-3410-3418    hcgwon@skku.edu Less <<
NCT00638794 - Completed - United States, Minnesota ... More >> Minneapolis Heart Institute Minneapolis, Minnesota, United States, 55407 United States, New York Columbia University Medical Center & New York Presbyterian New York, New York, United States, 10027 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28202 LeBauer Cardiovascular Research Greensboro, North Carolina, United States, 27401 FirstHealth Moore Regional Hospital Pinehurst, North Carolina, United States, 28374 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Pennsylvania Lehigh Valley Hospital and Health Network Allentown, Pennsylvania, United States, 18105 United States, Tennessee Wellmont Holston Valley Medical Center Kingsport, Tennessee, United States, 37660 Less <<
NCT00948883 - Completed - France ... More >> Hôpital Bicêtre - Assistance Publique-Hôpitaux de Paris Le Kremlin Bicetre Cedex, France, 94275 Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01316809 Glioblastoma Multiforme ... More >> Anaplastic Astrocytoma Anaplastic Oligodendroglioma Malignant Glioma Brainstem Glioma Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02566590 Muscular Atrophy Not Applicable Completed - United States, Utah ... More >> University of Utah Salt Lake City, Utah, United States, 84108 Less <<
NCT02773771 Muscle Atrophy Phase 2 Phase 3 Not yet recruiting January 2019 -
NCT00747851 - Recruiting December 2018 United States, Utah ... More >> University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Contact: Christian C Yost, M.D.    801-581-7052    christian.yost@hmbg.utah.edu    Principal Investigator: Christian C Yost, M.D. Less <<
NCT02561481 Autism Spectrum Disorder Phase 1 Phase 2 Active, not recruiting March 2019 United States, Massachusetts ... More >> University of Massachusetts Medical School Worcester, Massachusetts, United States, 01655 Less <<
NCT03166904 Solid Tumor Phase 2 Not yet recruiting December 2019 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT02583893 Recurrent Adult Acute Myeloid ... More >>Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Recruiting January 2021 United States, Pennsylvania ... More >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Neil Palmisiano, MD    215-955-8874       Contact: Clinical Trials Office    215-955-1661       Principal Investigator: Neil Palmisiano, MD          Sub-Investigator: Neal Flomenberg, MD          Sub-Investigator: Joanne Filicko-O'Hara, MD          Sub-Investigator: Manish Sharma, MD          Sub-Investigator: John Wagner, MD          Sub-Investigator: Matthew Carabasi, MD          Sub-Investigator: S. Onder Alpdogan, MD          Sub-Investigator: Mark Weiss, MD          Sub-Investigator: Ubaldo Martinez Outschoorn, MD          Sub-Investigator: Thomas Klumpp, MD          Sub-Investigator: Michael Ramirez, MD          Sub-Investigator: Sameh Gaballa, MD Less <<
NCT03082833 Cancer of Stomach Phase 2 Active, not recruiting February 2019 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 06351 Less <<
NCT00784979 - Completed - -
NCT01889992 Cardiac Hypertrophy ... More >> Immunosuppression Less << Phase 1 Unknown April 2016 United States, Nebraska ... More >> The Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198-2265 Contact: Trish Fischer, BSN    402-559-4479    pfischer@unmc.edu    Principal Investigator: Eugenia Raichlin, MD          Sub-Investigator: Brian Lowes, MD PhD Less <<
NCT01299207 - Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00784979 End Stage Renal Disease Phase 4 Completed - United States, Florida ... More >> LifeLink HealthCare Institute Tampa, Florida, United States, 33606 Less <<
NCT03208868 Cirrhosis, Liver Not Applicable Recruiting December 31, 2020 United States, Ohio ... More >> Cleveland Clinic Foundation Recruiting Cleveland, Ohio, United States, 44195 Contact: Annette Bellar, BS    216-636-5247    bellara@ccf.org    Contact: Revathi Penumatsa, MD    216-445-0688    penumar@ccf.org    Principal Investigator: Srinivasan Dasarathy, MD Less <<
NCT00369356 Coronary Artery Disease ... More >> Ischemic Heart Disease Atherosclerosis Less << Phase 2 Phase 3 Completed - Italy ... More >> Istituto Clinico Humanitas Milano, Italy, 20089 Ospedale Maggiore della Carità Novara, Italy, 28100 European Hospital Rome, Italy, 00149 Ospedale San Giovanni Bosco Torino, Italy, 10100 Università di Verona Verona, Italy, 37126 Less <<
NCT03456700 Ovarian Serous Tumor ... More >> Recurrent Ovarian Carcinoma Less << Phase 2 Recruiting March 15, 2023 United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clincial Trials Referral Office    855-776-0015       Principal Investigator: Aminah Jatoi Less <<
NCT00258596 Coronary Artery Disease ... More >> Coronary Disease Coronary Stenosis Less << Phase 3 Completed - Netherlands ... More >> Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1090HM St Antonius Hospital Nieuwegein, Netherlands, 3435CM Less <<
NCT00263263 Stable Angina ... More >> Unstable Angina Coronary Artery Disease Saphenous Vein Graft Disease Less << Phase 2 Completed - Belgium ... More >> Antwerp Cardiovascular Institute Middelheim Antwerp, Belgium, 2020 Less <<
NCT00275522 Kidney Transplant Phase 4 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00282217 Kidney Failure ... More >> Kidney Diseases Less << Phase 4 Completed - Spain ... More >> Albacete, Spain, 2006 Barcelona, Spain, 8035 Cadiz, Spain, 11009 Granada, Spain, 18014 L'Hospitalet de Llobregat, Spain, 8701 La Coruna, Spain, 15006 Madrid, Spain, 28034 Madrid, Spain, 28035 Madrid, Spain, 28040 Malaga, Spain, 29010 Oviedo, Spain, 33006 Sevilla, Spain, 41013 Zaragoza, Spain, 50009 Less <<
NCT00288210 Myocardial Infarction Phase 4 Unknown - Italy ... More >> Cardiologia Interventistica Ospedale San Camillo Roma, Italy, 00100 Less <<
NCT00378612 Coronary Occlusions Phase 3 Completed - United States, California ... More >> Green Hospital of Scripps Health La Jolla, California, United States, 92037 Scripps Memorial Hospital-La Jolla La Jolla, California, United States, 92037 United States, District of Columbia Washington Hospital Center Washington, District of Columbia, United States, 20010 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Brigham and Womens Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Michigan William Beaumont Hospital Royal Oak, Michigan, United States, 48073 United States, Missouri Saint Lukes Hospital Kansas City, Missouri, United States, 64111 United States, New York New York Presbyterian Medical New York, New York, United States, 10032 United States, North Carolina The Sanger Clinic PA Charlotte, North Carolina, United States, 28203 Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio North Ohio Heart Center Elyria, Ohio, United States, 44035 United States, Texas Heart Hospital of Austin Austin, Texas, United States, 78756 Canada, British Columbia Vancouver Hospital and Health Science Centre Vancouver, British Columbia, Canada, V5Z 1M9 Canada, Ontario Saint Michaels Hospital Toronto, Ontario, Canada, M5B 1W8 Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT00428454 Coronary Artery Disease ... More >> Coronary Disease Coronary Stenosis Less << Phase 3 Completed - Belgium ... More >> AZ Middelheim Antwerpen, Belgium, 2020 Netherlands Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1090HM AMC Amsterdam, Netherlands, 1105AZ Catharina Ziekenhuis Eindhoven, Netherlands, 5602ZA St Antonius Hospital Nieuwegein, Netherlands, 3435CM Less <<
NCT00433485 Neoplastic Syndrome ... More >> Non-melanomatous Skin Cancer Less << Phase 1 Completed - -
NCT00452517 Acute Coronary Syndrome Phase 4 Completed - Croatia ... More >> University hospital Zagreb Zagreb, Croatia, 10000 Less <<
NCT00352976 Fanconi Anemia Phase 2 Phase 3 Recruiting December 2018 United States, Minnesota ... More >> University of Minnesota Medical Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Margaret L MacMillan, M.D.    612-626-2778    macmi002@umn.edu Less <<
NCT00485004 In Stent Restenosis Phase 4 Completed - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Korea, Republic of Choeng Ju St.Mary's Hospital Choeng Ju, Korea, Republic of Kangwon National University Hospital Chuncheon, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Asan Medical Center GangNeung, Korea, Republic of DongGuk University Gyongju Hospital Gyongju, Korea, Republic of Chonbuk National University Hospital Jeonju, Korea, Republic of Kwangju Christian Hospital Kwangju, Korea, Republic of Inje University Pusan Paik Hospital Pusan, Korea, Republic of Hallym University Sacred Heart Hospital, PyeongChon, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of, 138-736 Hangang Sacred Heart Hospital Seoul, Korea, Republic of Kyungsang University Hospital Seoul, Korea, Republic of Seoul Veterans Hospital Seoul, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT00489164 Peripheral Vascular Diseases Phase 1 Phase 2 Terminated - United States, California ... More >> Foundation for Cardiovascular Medicine La Jolla, California, United States, 92037 United States, Florida Florida Hospital Orlando, Florida, United States, 32803 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Missouri St Luke's Hospital Kansas City, Missouri, United States, 64111 China Queen Mary Hospital Hong Kong, China India Batra Hospital & Research Centre New Delhi, Delhi, India, 110062 Apollo Hospital Chennai, Tamil Nadu, India, 600006 Jaslok Hospital & Research Centre Mumbai, India, 400 026 Escorts Heart Institute & Research Centre New Delhi, India, 110 025 Malaysia National Heart Institute Kuala Lumpur, Malaysia, 50400 Singapore National Heart Center Singapore, Singapore, 168752 Less <<
NCT00497172 Coronary Artery Disease Phase 4 Completed - Italy ... More >> Azienda USL Ravenna - Ospedale santa Maria delle Croci Ravenna, Italy, 48100 Less <<
NCT00552656 - Unknown August 2010 China, Shannxi ... More >> Department of Cardiology of Xijing Hospital, Fourth Military Medical University Xi'an, Shannxi, China, 710032 Less <<
NCT00495898 Coronary Artery Disease Phase 4 Completed - Germany ... More >> University of Essen Essen, Germany, 45147 Less <<
NCT00554125 Hepatocellular Carcinoma Phase 3 Unknown August 2013 China ... More >> Liver Cancer Institute and Zhongshan Hospital, Fudan University Recruiting Shanghai, China, 200032 Contact: Jian Zhou, MD    +86-21-64037181    jianzhou@zshospital.net Less <<
NCT00288535 Coronary Artery Disease Phase 4 Unknown - Germany ... More >> Herz-Zentrum Bad Krozingen Recruiting Bad Krozingen, Suedring 15, Germany, 79189 Contact: Miroslaw Ferenc, Dr.    0049 7633 4020    Miroslaw.Ferenc@herzzentrum.de    Contact: Franz-Josef Neumann, Prof. Dr.    0049 7633 4020    Franz-Josef.Neumann@herzzentrum.de Less <<
NCT00664963 Arterial Occlusive Diseases Phase 4 Completed - Germany ... More >> Herz-Zentrums Bad Krozingen Bad Krozingen, Germany, 79189 Universitäres Herzzentrum Hamburg Hamburg, Germany, 22527 University Hospital of Tübingen Tübingen, Germany, 72076 Less <<
NCT00715884 - Unknown - -
NCT00627900 Coronary Artery Disease Phase 4 Completed - Germany ... More >> Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie Berlin, Germany, 10098 Less <<
NCT00715884 Coronary Artery Disease ... More >> Coronary Atherosclerosis Less << Not Applicable Unknown September 2014 United States, District of Col... More >>umbia Washington Hospital Center Washington, District of Columbia, United States, 20010 Less <<
NCT00714623 - Completed - United States, California ... More >> Scripps Green Hospital/Scripps Clinic Torrey Pines La Jolla, California, United States, 92037 Less <<
NCT00781716 Myocardial Infarction ... More >> Coronary Artery Disease Less << Not Applicable Unknown May 2011 China, Beijing ... More >> Beijing Chaoyang Hospital Heart Center Not yet recruiting Beijing, Beijing, China, 10000 Contact: LeFeng Wang, MD    86-13601255020    CrestMI@gmail.com Less <<
NCT00811616 Coronary Artery Disease Not Applicable Completed - India ... More >> Max Heart and Vascular Institute New Delhi, India, 110017 Less <<
NCT00821080 Glioblastoma Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Instiute Boston, Massachusetts, United States, 02115 Less <<
NCT00997711 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Korea, Republic of Busan Saint Mary's Hospital Busan, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of NHIC Ilsan Hospital Ilsan, Korea, Republic of Gyeongsang Uniservity Hospital Jinju, Korea, Republic of Hallym University Sacred Heart Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Korea University Hospital Seoul, Korea, Republic of St.Mary's Catholic Medical Center Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT00967902 Coronary Artery Lesions Phase 2 Completed - Australia, New South Wales ... More >> John Hunter Hospital Newcastle, New South Wales, Australia, 2300 Less <<
NCT01024179 Coronary Artery Disease Phase 4 Unknown June 2011 China, Heilong jiang ... More >> The second Affiliated Hospital of Harbin Medical University Recruiting Harbin, Heilong jiang, China, 150081 Contact: Bo Yu, MD.PhD    86-0451-86605180    yubodr@163.com    Principal Investigator: Bo Yu, MD,PhD Less <<
NCT00876434 Anterior Uveitis Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01106378 - Terminated(Early termination o... More >>f patient enrollment based on business decision) Less << December 2011 Brazil ... More >> Instituto do Coracão do Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo, Brazil Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Switzerland Clinique La Tour Meyrin, Switzerland Less <<
NCT01186094 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Stcarollo Hospital Suncheon, Cheon-nam, Korea, Republic of Konyang University Hospital Daejeon, Chungnam, Korea, Republic of Soon Chun Hyang University Hospital Bucheon Bucheon, Gyeong-gi, Korea, Republic of Inje University Ilsan Paik Hospital Ilsan, Gyeong-gi, Korea, Republic of Wonju Christian Hospital Wonju, Kangwon, Korea, Republic of Yeungnam University Medical Center Daegu, Kyung-book, Korea, Republic of Busan Paik Hospital Busan, Korea, Republic of Dong-A University Medical Center Busan, Korea, Republic of Soonchunhyang University Cheonan Hospital Cheonan, Korea, Republic of Gangwon National University Hospital Chuncheon, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Kyung Hee University Medical Hospital Seoul, Korea, Republic of Less <<
NCT01186107 Coronary Artery Disease ... More >> Diabetes Less << Phase 4 Completed - Korea, Republic of ... More >> Hallym University Sacred Heart Hospital Anyang, Gyeong-gi, Korea, Republic of Soonchunhyang University Bucheon Hospital Bucheon, Korea, Republic of Soonchunhyang University Cheonan Hospital Cheonan, Korea, Republic of Kangwon University Hospital Chuncheon, Korea, Republic of Daejeon St Mary's Hospital Catholic University Daejeon, Korea, Republic of GangNeung Asan Hospital GangNeung, Korea, Republic of Chonbuk National University Hospital Jeonju, Korea, Republic of Pusan National University Yangsan Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Seoul Veterans Hospital Seoul, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT01121744 Coronary Artery Disease Not Applicable Completed - India ... More >> Life Care Institute of Medical Science & research Ahmedabad, Gujarat, India, 380014 Baroda Heart Institute & Research Center Baroda, Gujarat, India, 390007 Shree B. D. Mahavir Heart Institute Surat, Gujarat, India, 395001 Bankers Heart Institute Vadodara, Gujarat, India, 390015 Less <<
NCT01247428 Coronary Artery Disease Phase 2 Completed - Australia ... More >> St. Vincent's Hospital Melbourne Melbourne, Australia Belgium Onze-Lieve-Vrouwziekenhuis Aalst (OLV Hospital) Aalst, Belgium Ziekenhuis Oost-Limburg Genk, Belgium New Zealand Auckland City Hospital Auckland, New Zealand, 1032 Mercy Angiography Unit - Mercy Hospital Aukland, New Zealand, 1032 Less <<
NCT01280669 Uveitis Inter... More >>mediate Uveitis Posterior Uveitis Panuveitis Less << Phase 2 Recruiting December 2019 United States, California ... More >> Stanford University Recruiting Palo Alto, California, United States, 94303 Contact: Quan D Ngueyn, MD, MSc    650-724-4280    ndquan@stanford.edu    Contact: Lisa C Greer, MBA    6507259184    lgreer7@stanford.edu Less <<
NCT01274234 Coronary Restenosis ... More >> Coronary Thrombosis Less << Phase 1 Phase 2 Completed - Hong Kong ... More >> Division of Cardiology, Queen Mary Hospital, The University of Hong Kong Hong Kong, Hong Kong Less <<
NCT01368627 Coronary Artery Disease Phase 4 Completed - Brazil ... More >> CIAS- Unimed Vitória Vitória, Espírito Santo, Brazil, 29047-575 Centro de Cardiologia e Radiologia Goiânia, Goiás, Brazil, 74823-320 Hospital Luxemburgo Belo Horizonte, Minas Gerais, Brazil, 30380-090 Hospital Monte Sinai Juiz de Fora, Minas Gerais, Brazil, 36025-550 Hospital Vita Curitiba, Paraná, Brazil H.C.Unesp Botucatu, Sao Paulo, Brazil Hospital São Camilo São Paulo, Brazil, 05022-001 Less <<
NCT01226355 Coronary Artery Diseases Not Applicable Unknown November 2014 China ... More >> Fuwai Hospital, National Center for Cardiovascular Diseases Beijing, China, 100037 Less <<
NCT01260558 Coronary Heart Disease Phase 4 Unknown December 2012 Germany ... More >> Deutsches Herzzentrum Muenchen Recruiting Munich, Bavaria, Germany, 80636 Contact: Julinda Mehilli, MD    +49 89 12 18 ext 4582    mehilli@dhm.mhn.de    Contact: Klaus Tiroch, MD    +49 89 12 18 ext 4578    tiroch@dhm.mhn.de    Klinikum rechts der Isar Recruiting Munich, Bavaria, Germany, 81675 Contact: Steffen Massberg, MD    +49 89 12 18 ext 4025    massberg@dhm.mhn.de Less <<
NCT01507519 Coronary Artery Disease Not Applicable Completed - India ... More >> Life Care Institute of Medical Sciences & Research Ahmedabad, Gujarat, India, 380024 Less <<
NCT01375296 Coronary Artery Disease Phase 2 Phase 3 Unknown November 2011 China, Shanghai ... More >> ruijin hospital, Shanghai Jiao Tong University, School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: Ruiyan Zhang, MD    862164370045 ext 665215    zhangruiyan@263.net Less <<
NCT01247428 - Completed - -
NCT01220297 Hematologic Diseases ... More >> Acute-graft-versus-host Disease Leukemia Non-Hodgkin Lymphoma (NHL) Hodgkin Lymphoma Less << Phase 2 Terminated(Low accrual) - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01874002 - Active, not recruiting March 2019 Latvia ... More >> Pauls Stradins Clinical University Hospital Riga, Latvia, LV-1002 Luxembourg Centre Hospitalier de Luxembourg Luxembourg, Luxembourg Netherlands Academic Medical Center - University of Amsterdam Amsterdam, Netherlands, 1105AZ Ter Gooi Ziekenhuizen Blaricum, Netherlands Amphia Ziekenhuis Breda, Netherlands Radboud UMC Nijmegen, Netherlands Isala Klinieken Zwolle, Netherlands Spain Meixoeiro Hospital Vigo, Spain United Kingdom Craigavon Cardiac Centre Craigavon, United Kingdom Less <<
NCT01814059 Eosinophilic Gastroenteritis ... More >> Eosinophilic Esophagitis Less << Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01220297 - Terminated(Low accrual) - -
NCT02152007 Pachyonychia Congenita Phase 1 Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 Less <<
NCT02152007 - Completed - -
NCT02127138 Coronary Heart Disease Not Applicable Recruiting December 2019 China, Beijing ... More >> Beijing Anzhen Hospital Recruiting Beijing, Beijing, China, 100029 Contact: Qing Yang, MD,PHD    +86 13911711189    yq1963884@sina.com    Principal Investigator: Qing Yang, MD          Sub-Investigator: Lixia Yang, MD Less <<
NCT02183454 - Completed - Netherlands ... More >> Amphia Ziekenhuis Breda, Netherlands Less <<
NCT02195414 Coronary Artery Disease Phase 1 Active, not recruiting September 2019 China, Liaoning ... More >> The General Hospital of Shenyang Military Region Shenyang, Liaoning, China, 110015 China, Zhejiang Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China, 310016 Less <<
NCT01879358 Coronary Artery Disease ... More >> Ischemic Heart Disease Less << Not Applicable Active, not recruiting February 2019 Denmark ... More >> Odense University Hospital Odense, Denmark, 5000 Less <<
NCT02165007 Sickle Cell-thalassemia Diseas... More >>e Thalassemia Less << Phase 1 Recruiting April 2023 United States, District of Col... More >>umbia Childrens National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Less <<
NCT02251938 Non-Infectious Uveitis of the ... More >>Posterior Segment of the Eye Less << Phase 3 Completed - -
NCT02216058 Coronary Artery Disease Not Applicable Recruiting June 2020 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Yundai Chen, Dr.    010-55499209    cyundai@medmail.com.cn    Principal Investigator: Yundai Chen, Dr. Less <<
NCT02360709 - Recruiting April 2021 China, Beijing ... More >> Fuwai Hospital,National Center for Cardiovasular disease Recruiting Beijing, Beijing, China, 100044 Contact: Shubin Qiao, MD    +86 13701237893    qsbfw@sina.com Less <<
NCT02195414 - Active, not recruiting - -
NCT02360423 Coronary Artery Disease Phase 3 Recruiting April 2021 China, Beijing ... More >> Fuwai Hospital,National Center for Cardiovasular disease Recruiting Beijing, Beijing, China, 100044 Contact: Shubin Qiao, MD    +86 13701237893    qsbfw@sina.com Less <<
NCT02428296 PIK3CA-Related Overgrowth Spec... More >>trum (PROS) Growth Disorder Genetics Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02448524 Coronary Heart Disease Phase 3 Active, not recruiting November 2022 China, Hunan ... More >> The Third Xiangya Hospital of Central South University Changsha, Hunan, China China, Inner Mongolia The First Affiliated Hospital of Baotou University Baotou, Inner Mongolia, China Inner Mongolia People'S Hospital Hohhot, Inner Mongolia, China The First Affiliated Hospital of Inner Mongolia Medical University Hohhot, Inner Mongolia, China China, Jiangxi The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China China, Shaanxi The First Affiliated Hospital of Xi'An Jiaotong University Xi'an, Shaanxi, China China, Zhejiang Sir Run Run Shaw Hospital School of Medicine, Zhejiang University Hangzhou, Zhejiang, China China The General Hospital of Shenyang Military Region Area Of Shenyang, China Fu Wai Hospital, National Center for Cardiovascular Disease Beijing, China The First Hospital of Jilin University Changchun, China The Second Xiangya Hospital of Central South University Changsha, China The First Hospital of Lanzhou University Lanzhou, China Shanghai Ninth People's Hospital Shanghai, China West China Hospital, Sichuan University Sichuan, China The Second Hospital of Shanxi Medical University Taiyuan, China TEDA International Cardiovascular Hospital Tianjin, China Less <<
NCT02504307 Coronary Artery Disease Phase 4 Completed - Brazil ... More >> Instituto Nacional de Cardiologia Rio de Janeiro, RJ, Brazil Less <<
NCT02305472 Coronary Artery Disease Not Applicable Active, not recruiting September 2020 -
NCT02440789 HIV-1 Infection Phase 1 Phase 2 Completed - -
NCT02539966 Coronary Artery Disease Not Applicable Recruiting March 2023 Australia ... More >> The Prince Charles Hospital Active, not recruiting Chermside, Australia St Vincent's Hospital Sydney Active, not recruiting Darlinghurst, Australia Prince of Wales Hospital (Eastern Heart) Active, not recruiting Randwick, Australia Belgium Cardiovascular Center Aalst Active, not recruiting Aalst, Belgium Brazil Instituto Dante Pazzanese de Cardiologia Active, not recruiting Sao Paulo, Brazil Albert Einstein Hospital Active, not recruiting São Paulo, Brazil Denmark Aarhus University Hospital (Skejby) Active, not recruiting Aarhus, Denmark Rigshospitalet Active, not recruiting Copenhagen, Denmark Odense University Hospital Active, not recruiting Odense, Denmark France institut Hospitalier J.Cartier Active, not recruiting Massy, France La Pitié-Salpétrière Active, not recruiting Paris, France Clinique Pasteur Active, not recruiting Toulouse, France Hôpital Rangueil Active, not recruiting Toulouse, France Germany Am Urban Hospital, Berlin Active, not recruiting Berlin, Germany Friedrichshein Hospital, Berlin Recruiting Berlin, Germany Principal Investigator: Stephan Kische, Dr. med.          Klinikum Coburg Active, not recruiting Coburg, Germany St.- Johannes-Hospital Dortmund Recruiting Dortmund, Germany Principal Investigator: Joachim Weber-Albers, MD          Universitätsklinikum Erlangen Active, not recruiting Erlangen, Germany Elisabeth-Krankenhaus Essen Active, not recruiting Essen, Germany Universitätsklinikum Schleswig-Holstein Recruiting Kiel, Germany Principal Investigator: Norbert Frey, Prof. Dr. med.          Netherlands Academic Medical Center Amsterdam Active, not recruiting Amsterdam, Netherlands Onze Lieve Vrouwe Gasthuis Active, not recruiting Amsterdam, Netherlands Erasmus Medical Center Active, not recruiting Rotterdam, Netherlands University Medical Center Utrecht Active, not recruiting Utrecht, Netherlands Poland Krakowskie Centrum Kardiologii Inwazyjnej Active, not recruiting Krakow, Poland Szpital Uniwersytecki w Krakowie Active, not recruiting Krakow, Poland Szpital Kliniczny Przemienienia Panskiego UM w Poznaniu Active, not recruiting Poznan, Poland Oddział Kardiologii Inwazyjnej I Katedra Active, not recruiting Warszawa, Poland Less <<
NCT02443818 Segmental Overgrowth Disorders... More >> Due to PIK3CA Less << Phase 2 Completed - France ... More >> CHU d'Angers Angers, France, 49933 CHU de Bordeaux - GH Pellegrin Bordeaux, France, 33076 CHU de DIJON Dijon, France, 21079 Hôpital Jeanne de Flandre Lille, France, 59037 CHRU de Montpellier - Hôpital Saint-Eloi Montpellier, France, 34295 Hopitaux de Brabois Chu Nancy Nancy, France, 54511 Hôpital mère-enfant de Nantes Nantes, France, 44093 CHU Paris - Necker Paris, France, 75015 HCL Lyon - CH Lyon Sud Pierre-Bénite, France, 69495 Pôle Cardiovasculaire et Métabolique - Hôpital Larrey Toulouse, France, 31059 CHRU de Tours Tours, France, 37044 Less <<
NCT02542007 Coronary Arteriosclerosis Not Applicable Active, not recruiting July 2021 China, Heilongjiang ... More >> Daqing General Oilfield Hospital Daqing, Heilongjiang, China The First Affiliated Hospital of Harbin University Harbin, Heilongjiang, China The Secondary Affiliated Hospital of Harbin University Harbin, Heilongjiang, China China, Jiangsu Nanjing First Hospital Nanjing, Jiangsu, China China, Jilin China Japan Union Hospital of Jilin University Changchun, Jilin, China China, Liaoning The people Hospital of Liaoning Province Shenyang, Liaoning, China China, Shanxi The Secondary Affiliated Hospital of Shanxi Medical University Taiyuan, Shanxi, China China, Sichuan West China Hospital of Sichuan University Chengdu, Sichuan, China China, Yunnan Kunming General Hospital of Chengdu Military region Kunming, Yunnan, China China Beijing Chao Yang Hospital Beijing, China The Military General Hospital of Beijing PLA Beijing, China Bethune International Peace Hospital Shijiazhuang, China Tianjing Chest Hospital Tianjing, China TEDA International Cardiovascular Hospital Tianjin, China Tianjin Medical University General Hospital Tianjin, China The First Affiliated Hospital of the Fourth Military Medical University Xi'an, Shanxi, China Less <<
NCT02597283 Coronary Artery Disease Not Applicable Withdrawn(Funding issues) - -
NCT02449564 Solid Tumor Not Applicable Completed - Korea, Republic of ... More >> Samsung Medical center Seoul, Korea, Republic of, 135-710 Less <<
NCT02545985 Sirolimus-eluting Stainless St... More >>eel Coronary Stent Prolim? Less << Not Applicable Completed - -
NCT02634931 Tuberous Sclerosis ... More >> Angiofibroma Hypomelanotic Macule Plaque Less << Phase 3 Unknown February 2018 Japan ... More >> Graduate School of Medicine, Osaka University Suita, Osaka, Japan, 565-0871 Less <<
NCT02578069 Ischemic Stroke Not Applicable Recruiting December 2019 China ... More >> Beijing Tiantan Hospital Recruiting Beijing, China, 100050 Contact: Zhongrong Miao, M.D.    +861067098386    zhongrongm@163.com    Contact: Peijuan Ren, B.D    +861067098039 Less <<
NCT02635789 Tuberous Sclerosis ... More >> Angiofibroma Hypomelanotic Macule Plaque Less << Phase 3 Completed - Japan ... More >> Graduate School of Medicine, Osaka University Suita, Osaka, Japan, 565-0871 Less <<
NCT02659254 Coronary Artery Disease Not Applicable Active, not recruiting October 2021 China, Beijing ... More >> Fu Wai Hospital Peking, Beijing, China, 100037 Less <<
NCT02663323 Coronary Artery Disease Not Applicable Active, not recruiting July 5, 2020 Brazil ... More >> Instituto Dante Pazzanese de Cardiologia Sao Paulo, SP, Brazil, 04012-909 Indonesia Medistra Hospital Jakarta, Indonesia, 12950 Macedonia, The Former Yugoslav Republic of University Clinic of Cardiology Skopje, Macedonia, The Former Yugoslav Republic of, 1000 Malaysia Institut Jantung Negara Kuala Lumpur, Malaysia, 50400 Less <<
NCT02732899 - Completed - -
NCT02768116 Coronary Heart Disease Not Applicable Not yet recruiting June 2019 -
NCT02901353 - Recruiting December 1, 2020 Hungary ... More >> University of Semmelweis Recruiting Budapest, Europe, Hungary, 1085 Contact: Prof. Dr. Bela Merkely, MD, Ph.D, D.Sc       Merkely.Bela@kardio.sote.hu    University of Debrecen Recruiting Debrecen, Europe, Hungary, 4032 Contact: Dr. Szűk Tibor, Ph.D, MD       tszuk01@gmail.com    Jordan Jordan Hospital Recruiting Amman, Jordan Contact: Dr. Imad A Haddad, MD       alhaddad63@gmail.com    Malaysia University Malaya Medical Centre (UMMC) Recruiting Kuala Lumpur, Selangor, Malaysia, 59100 Contact: Dr. Ramesh Singh, MBBS, MRCP       ramesh@ummc.edu.my    Netherlands St. Antonius Hospital Recruiting Nieuwegein, Germany, Netherlands, 3435CM Contact: Dr. P. Agostoni Less <<
NCT02853994 - Unknown September 2018 -
NCT02941224 Patients With Peripheral Arter... More >>y Disease in the SFA or PA Less << Phase 1 Active, not recruiting June 2019 Germany ... More >> Universitäts-Herzzentrum Freiburg-Bad Krozingen Bad Krozingen, Baden Wuertemberg, Germany, 79189 Radiologische Gemeinschaftspraxis Ihre-Radiologen Franziskus - Krankenhaus Berlin Berlin, Germany, 10787 Vivantes Klinikum Neukölln Berlin, Germany, 12351 Evangelisches Krankenhaus Hubertus Berlin, Germany, 14129 Less <<
NCT02929030 - Recruiting January 2022 China, Shanxi ... More >> Xijing Hospital Recruiting Xi'an, Shanxi, China Contact: Chen Wang    15802929290 Less <<
NCT02978456 Coronary Disease ... More >> Coronary Stenoses Less << Not Applicable Recruiting June 30, 2020 Korea, Republic of ... More >> Korea University Anam Hospital Recruiting Anam, Korea, Republic of Contact: Soon-Jun Hong, MD    +8229205445    psyche94@hanmail.net    Hallym University Medical Center Recruiting Gyeonggi-do, Korea, Republic of Contact: Hyun-sook Kim, MD       hearthsk@hotmail.com    National Health Insurance Service Ilsan Hospital Recruiting Ilsan, Korea, Republic of Contact: Sung-Jin Oh, MD       osjwsa@naver.com    Gachon University Gil Medical Center Not yet recruiting Incheon, Korea, Republic of Contact: Woong-cheol Kang, MD       kangwch@gilhospital.com    Pusan National University Yangsan Hospital Recruiting Pusan, Korea, Republic of Contact: June-hong Kim, MD       junehongk@gmail.com    Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Cheol-whan Lee, MD    +82230103150    cheolwlee@amc.seoul.kr    Principal Investigator: Cheol-Whan Lee, MD          Gangnam Severance Christian Hospital Recruiting Seoul, Korea, Republic of Contact: Young-won Yoon, MD    +82220194378    drcliff@yuhs.ac    Principal Investigator: Young-won Yoon, MD          Kangbuk Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Jong-young Lee, MD       jyleeheart@naver.com    Principal Investigator: Jong-young Lee, MD          The Catholic Univ. of Korea Seoul St. Mary's hospital Recruiting Seoul, Korea, Republic of Contact: Ki-yook Chang, MD       kiyukchang@daum.ne    Principal Investigator: Ki-yook Chang, MD Less <<
NCT02732899 Exudative Age Related Macular ... More >>Degeneration Less << Phase 2 Completed - United States, Indiana ... More >> Raj K Maturi MD PC Indianapolis, Indiana, United States, 46290 Less <<
NCT02995096 - Active, not recruiting October 2018 -
NCT03016715 Epidermolysis Bullosa Simplex ... More >> Epidermolysis Bullosa Simplex Kobner Weber-Cockayne Syndrome Less << Phase 2 Recruiting - Australia, New South Wales ... More >> Premier Specialists Recruiting Sydney, New South Wales, Australia, 2217 Contact: Charmaine Peras    61 02 9598 5800    premierspecnurse@gmail.com    Principal Investigator: Dedee F Murrell, MD          Sub-Investigator: Charlotte E Gollins, MBChB          Sub-Investigator: Anes Yang          Sub-Investigator: Melissa Radjenovic Less <<
NCT02916485 Coronary Artery Disease Not Applicable Suspended(Awaiting National Ph... More >>armaceutical Pricing Authority (NPPA) review of ceiling prices for innovative products in India.) Less << September 2018 India ... More >> All India Institute of Medical Sciences Delhi, India, 110029 Less <<
NCT03085823 - Recruiting January 2020 Italy ... More >> Unita' Operativa di Cardiologia Recruiting Milano, Italy, 20121 Contact: Bernardo Cortese, MD       bcortese@gmail.com    Principal Investigator: Bernardo Cortese, MD Less <<
NCT02960997 Epidermolysis Bullosa Simplex ... More >> Epidermolysis Bullosa Simplex Kobner Weber-Cockayne Syndrome Less << Phase 2 Active, not recruiting December 13, 2020 United States, California ... More >> Stanford University Palo Alto, California, United States, 94304 Less <<
NCT03364764 Pure Red Cell Aplasia Phase 4 Recruiting February 2020 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Yali Y Du, master    +8618910575941    yali_crazy@126.com Less <<
NCT03263260 - Recruiting December 30, 2022 Brazil ... More >> União Brasileira de Educação e Assistência - Hospital São Lucas da PUC - RS Recruiting Porto Alegre, Rio Grande Do Sul, Brazil, 90.619-900 Contact: Paulo Caramori, Medicine       caramori@cardiarte.com.br    Principal Investigator: Paulo Caramori, Medicine Less <<
NCT03443999 - Recruiting February 2020 Netherlands ... More >> Amphia Ziekenhuis Recruiting Breda, North Brabant, Netherlands, 4818 CK Breda Catharina Ziekenhuis Recruiting Eindhoven, North Brabant, Netherlands, 5623 EJ Albert Schweitzer Ziekenhuis Recruiting Dordrecht, South Holland, Netherlands, Post bus 444 3300 AK Maasstad Ziekenhuis Recruiting Rotterdam, South Holland, Netherlands, 3079 DZ Less <<
NCT02683291 Disorder Related to Renal Tran... More >>splantation Cytomegalovirus Infections Less << Phase 4 Completed - -
NCT03600948 - Recruiting August 2020 Brazil ... More >> Moinhos de Vento Hospital Recruiting Porto Alegre, Brazil, 90560-030 Contact: Marco Weinstain, MD    +55 51 33143434    mvwainstein@uol.com.br    Hospital de Base Recruiting São José do Rio Preto, Brazil Contact: Marcios Santos, MD Less <<
NCT03216733 Coronary Heart Disease ... More >> Angina Pectoris Myocardial Infarction Less << Not Applicable Recruiting December 31, 2028 Denmark ... More >> Aalborg University Hospital, Department of Cardiology Recruiting Aalborg, Denmark, 9100 Contact: Svend E Jensen, MD       svend.eggert.jensen@rn.dk    Aarhus University Hospital, Skejby Recruiting Aarhus N, Denmark, 8200 Contact: Lars Jakobsen, MD    2280 7644    helbar@rm.dk    Contact: Evald H Christiansen, MD    6165 5176    evald.christiansen@dadlnet.dk    Rigshospitalet, Hjertecentret Not yet recruiting København, Denmark, 2100 Contact: Jens F Lassen, MD       jens.flensted.lassen@rh.regionh.dk    Contact: Thomas Engstrøm, MD       thomas.engstroem@rh.regionh.dk    Odense Unversity Hospital, Department of Cardiology Recruiting Odense C, Denmark, 5000 Contact: Lisette O Jensen, MD       okkels@dadlnet.dk Less <<
NCT03589976 Multiple System Atrophy Phase 2 Recruiting August 2021 United States, New York ... More >> New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Jose Martinez, MA    212-263-7225    Jose.Martinez4@nyulangone.org    Principal Investigator: Jose A Palma Carazo, MD Less <<
NCT03365869 Systemic Sclerosis Phase 2 Not yet recruiting June 30, 2019 -
NCT03634020 Coronary Artery Disease Not Applicable Not yet recruiting December 31, 2019 New Zealand ... More >> North Shore Hospital Auckland, New Zealand, 0622 Auckland City Hospital Auckland, New Zealand, 1023 Less <<
NCT03666208 End Stage Renal Failure on Dia... More >>lysis Arteriovenous Graft Occlusion Less << Phase 2 Active, not recruiting March 30, 2019 Singapore ... More >> Singapore General Hospital Renal Department Singapore, Singapore, 169608 Less <<
NCT03747328 Leigh Syndrome Phase 2 Not yet recruiting March 31, 2023 -
NCT03509142 Single Coronary Vessel Disease Not Applicable Recruiting April 30, 2023 China ... More >> Beijing Fuwai hospital Recruiting Peking, China, 100037 Principal Investigator: Runlin Gao, MD Less <<
NCT03716102 Acute Coronary Syndrome Not Applicable Recruiting July 15, 2021 United States, Arizona ... More >> Scottsdale Healthcare Not yet recruiting Scottsdale, Arizona, United States, 85258 Contact: Joanne Saczynski    480-225-3757    joanne.saczynski@honorhealth.com    Principal Investigator: David Rizik, MD          United States, Michigan Northern Michigan Hospital d.b.a McLaren Northern Michigan Recruiting Petoskey, Michigan, United States, 49770 Contact: Jennifer LaLonde       jlalonde@cvrcnm.com    Principal Investigator: Thomas Earl, MD Less <<
NCT03765944 Bioequivalence Study Phase 1 Not yet recruiting January 2019 Japan ... More >> Clinique Soigner Not yet recruiting Matsudo, Chiba, Japan, 270 -2231 Contact: Yutaka Kanamaru, Dr Less <<
NCT01888302 Hepatic Complication Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03600961 - Recruiting May 2020 Portugal ... More >> Hospital de Santa Cruz Recruiting Carnaxide, Portugal, 2799-134 Contact: Manuel Almeida, MD    +351936359285    Almeidams@sapo.pt Less <<
NCT03688191 Connective Tissue Diseases ... More >> Thrombocytopenia Less << Phase 4 Recruiting September 30, 2019 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100005 Contact: Chanyuan Wu, MD Less <<
NCT02430363 Glioblastoma Phase 1 Phase 2 Unknown June 2018 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Belgium UCL- Cliniques Universitaires Saint Luc Brussels, Belgium Germany St Johannes Hospital Duisburg, Germany, 47166 Italy Spedali Civili di Brescia Brescia, Italy IRCCS San Raffaele Milan, Italy Poland Lower-Silesian Oncology Centre Wroclaw, Lower-Silesian, Poland, 53413 Russian Federation Pavlov State Medical University St. Petersburg, Russian Federation, 197089 Spain Hospital Universitario Germans Trias I Pujol Barcelona,, Spain Switzerland Universitätsklinik für Frauenheilkunde Bern, Switzerland Ukraine Regional Cancer Center Dnepropetrovsk, Ukraine, 49000 National Institute of Cancer Kiev, Ukraine, 03035 United Kingdom Royal Victoria Hospital Belfast, Ulster, United Kingdom, BT12 6BA Less <<
NCT02142036 Metastatic Cancer Phase 2 Active, not recruiting January 2022 Norway ... More >> Akershus University Hospital Lillestrøm, Norway, 1478 The Norwegian Radium Hospital Oslo, Norway, 0379 Less <<
NCT00927992 - Completed - -
NCT00078689 Uveitis Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01651390 Coronary Artery Disease ... More >> Coronary Restenosis Less << Not Applicable Completed - Germany ... More >> Universitäts-Herzzentrum Freiburg-Bad Krozingen Bad Krozingen, Germany, 79189 Heart Center Segeberger Kliniken Bad Segeberg, Germany, 23795 Charité - Universitätsmedizin Berlin, Charité Centrum 11 für Herz-, Kreislauf- und Gefäßmedizin Berlin, Germany, 10117 Innere Medizin Kardiologie - Charité Centrum 11, Campus Benjamin Franklin Berlin, Germany, 12203 Kardiologie - Angiologie - Pneumologie, Klinikum Coburg Coburg, Germany, 96450 Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany, 45138 Medical Care Center Prof. Mathey, Prof. Schofer Hamburg, Germany, 22527 Kardiologie /Intern. Intensivmedizin, Johannes Wesling Klinikum Minden Minden, Germany, 32429 Klinikum Schwabing Munich, Germany, 80804 LMU - Klinikum der Universität München Munich, Germany, 81337 Klinikum Bogenhausen Munich, Germany, 81925 Universitätsklinikum Münster, Klinik für Kardiologie Münster, Germany, 48149 Innere Medizin III Kardiologie, Kliniken Villingen Villingen-Schwenningen, Germany, 78050 Latvia Cardiology, Pauls Stradins Clinical University Hospital Riga, Latvia, LV-1002 Less <<
NCT01244906 Hematologic Neoplasms Phase 2 Completed - United States, Georgia ... More >> Northside Hospital Atlanta, Georgia, United States, 30342 Less <<
NCT01244906 - Completed - -
NCT00977938 Coronary Artery Disease Phase 4 Completed - -
NCT00868829 Coronary Heart Disease Not Applicable Unknown March 2013 China, Shanghai ... More >> Zhongshan Hospital Recruiting Shanghai, Shanghai, China Contact: Caihong Wang       wch@ccheart.com.cn Less <<
NCT03242096 Coronary Restenosis Phase 2 Phase 3 Recruiting December 31, 2019 Germany ... More >> Clinical and Experimental Interventional Cardiology Recruiting Homburg, Saarland, Germany, 66421 Contact: Bruno Scheller, MD    +49 6841 1615927    bruno.scheller@uks.eu Less <<
NCT00977938 - Completed - -
NCT01093391 Coronary Artery Disease Phase 3 Completed - Brazil ... More >> Hospital Ibiapaba de Barbacena Barbacena, MG, Brazil, 36201-356 Instituto de Assistêcia Médica ao Servidor Publico Estadual São Paulo, SP, Brazil, 04029-000 Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da USP São Paulo, SP, Brazil, 05403-000 Hospital Santa Marcelina São Paulo, SP, Brazil, 08270-070 Less <<
NCT00957320 Acute Lymphoblastic Leukemia Phase 1 Withdrawn(no patients enrolled... More >>, decided not to pursue study) Less << - United States, Georgia ... More >> Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 Less <<
NCT00714883 Coronary Disease Phase 2 Terminated(The NEVO™ stent wil... More >>l not be commercialized. Cordis decided to close the study after 3 years. This decision took the absence of safety signals into account.) Less << - Germany ... More >> Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes Homburg/Saar, Germany Latvia P. Stradina Clinical - University Hospital Riga, Latvia Less <<
NCT03605927 Graft-versus-host-disease ... More >> GVHD GVHD, Acute Less << Phase 1 Phase 2 Not yet recruiting December 2023 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Not yet recruiting Tampa, Florida, United States, 33612 Contact: Brooke Carlton    813-745-3625    brooke.carlton@moffitt.org    Contact: Farhad Khimani, M.D.    813-745-1867    farhad.khimani@moffitt.org    Principal Investigator: Farhad Khimani, M.D. Less <<
NCT03667313 Coronary Restenosis Phase 3 Recruiting December 31, 2021 Czechia ... More >> Cardiovascular Department of University Hospital Recruiting Ostrava, Czechia, 70852 Contact: Leos Pleva, MD, PhD    733414740    leos.pleva@volny.cz Less <<
NCT01257373 - Unknown April 2013 China, Shannxi ... More >> Department of cardiology of Xijing Hospital, Fourth Military Medical University Recruiting Xi'an, Shannxi, China, 710032 Contact: Haichang Wang, MD,PhD    86-2984775183    wanghc@fmmu.edu.cn    Principal Investigator: Haichang Wang, MD,PhD          Sub-Investigator: Yan Li, MD,PhD          Sub-Investigator: Chengxiang Li, MD,PhD Less <<
NCT01373632 Coronary Artery Disease Phase 4 Unknown September 2013 China, Shanghai ... More >> Ruijin Hospital, Shanghai Jiaotong University School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: WeiFeng Shen, MD, PhD    86-21-64370045 ext 665215    rjshenweifeng@yahoo.com.cn    Contact: Xian Zhang, MD    86-21-64370045 ext 665215       Principal Investigator: WeiFeng Shen, MD, PhD          Sub-Investigator: Qi Zhang, MD, PhD Less <<
NCT03072485 Aging Phase 1 Recruiting December 31, 2017 United States, California ... More >> Stanford Dermatology Recruiting Redwood City, California, United States, 94603 Contact: Anne Chang, MD    650-721-7151    alschang@stanford.edu    Contact: Michaella Montana, BS    650 721 7159    mmontana@stanford.edu Less <<
NCT02027870 - Recruiting June 2019 China, Liaoning ... More >> Shenyang Northern Hospital Recruiting Shenyang, Liaoning, China, 110015 Contact: geng wang, PhD    +86 13309886393    wanggeng69@hotmail.com    Contact: he zhou    +86 13309888541    fengying_6@163.com    Sub-Investigator: Wang Geng, PhD Less <<
NCT02357342 Age-Related Macular Degenerati... More >>on Less << Phase 2 Completed - United States, Indiana ... More >> Raj K Maturi MD PC Indianapolis, Indiana, United States, 46290 Less <<
NCT02384837 - Completed - China ... More >> Cardiology Department, Chinese Armed Police Force Genral Hospital, Beijing China Beijing, China, 100039 Less <<
NCT02684032 Breast Cancer Phase 1 Recruiting October 10, 2019 -
NCT02551718 Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker    206-616-1589    pbecker@u.washington.edu    Principal Investigator: Pamela S. Becker Less <<
NCT03419572 - Recruiting January 5, 2021 -
NCT00790439 Diabetes Mellitus, Type I Phase 2 Withdrawn(Due to funding limit... More >>ations) Less << - -
NCT00634244 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Arizona Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Iowa Siouxland Hematology Oncology Associates Sioux City, Iowa, United States, 51101 United States, Maryland Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Ohio The Jewish Hospital Cincinnati, Ohio, United States, 45236 United States, Pennsylvania Geisinger Medical Center Danville, Pennsylvania, United States, 17822-2001 Geisinger Medical Center-Cancer Center Hazleton Hazleton, Pennsylvania, United States, 18201 Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Lewistown Hospital Lewistown, Pennsylvania, United States, 17044 Geisinger Medical Group State College, Pennsylvania, United States, 16801 Mount Nittany Medical Center State College, Pennsylvania, United States, 16803 Geisinger Wyoming Valley Wilkes-Barre, Pennsylvania, United States, 18711 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Israel Rambam Medical Center Haifa, Israel, 31096 Less <<
NCT00577278 Graft Versus Host Disease ... More >> Leukemia Lymphoma Less << Phase 2 Active, not recruiting March 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 Less <<
NCT00634244 - Completed - -
NCT01534143 - Terminated(Data was not collec... More >>ted, because funding was unavailable to continue study.) Less << - -
NCT00105001 Myelodysplastic/Myeloprolifera... More >>tive Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndrome Refractory Chronic Lymphocytic Leukemia Refractory Plasma Cell Myeloma Waldenstrom Macroglobulinemia Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Lymphoma Childhood Myelodysplastic Syndrome Stage II Contiguous Adult Burkitt Lymphoma Stage II Contiguous Adult Diffuse Large Cell Lymphoma Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma Stage II Adult Contiguous Immunoblastic Lymphoma Stage II Contiguous Adult Lymphoblastic Lymphoma Stage II Grade 1 Contiguous Follicular Lymphoma Stage II Grade 2 Contiguous Follicular Lymphoma Stage II Grade 3 Contiguous Follicular Lymphoma Stage II Contiguous Mantle Cell Lymphoma Stage II Non-Contiguous Adult Burkitt Lymphoma Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma Stage II Adult Non-Contiguous Immunoblastic Lymphoma Stage II Non-Contiguous Adult Lymphoblastic Lymphoma Stage II Grade 1 Non-Contiguous Follicular Lymphoma Stage II Grade 2 Non-Contiguous Follicular Lymphoma Stage II Grade 3 Non-Contiguous Follicular Lymphoma Stage II Non-Contiguous Mantle Cell Lymphoma Stage II Small Lymphocytic Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Burkitt Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Recurrent Childhood Hodgkin Lymphoma Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Secondary Myelodysplastic Syndrome Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Immunoblastic Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Childhood Anaplastic Large Cell Lymphoma Stage I Childhood Large Cell Lymphoma Stage I Childhood Lymphoblastic Lymphoma Stage I Childhood Burkitt Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Small Lymphocytic Lymphoma Stage II Childhood Anaplastic Large Cell Lymphoma Stage II Childhood Lymphoblastic Lymphoma Stage II Childhood Burkitt Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Immunoblastic Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Childhood Anaplastic Large Cell Lymphoma Stage III Childhood Large Cell Lymphoma Stage III Childhood Lymphoblastic Lymphoma Stage III Childhood Burkitt Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Childhood Anaplastic Large Cell Lymphoma Stage IV Childhood Large Cell Lymphoma Stage IV Childhood Lymphoblastic Lymphoma Stage IV Childhood Burkitt Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Less << Phase 2 Completed - United States, Colorado ... More >> Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States, 80218 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington Veterans Administration Center-Seattle Seattle, Washington, United States, 98108 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Denmark Rigshospitalet University Hospital Copenhagen, Denmark, 2100 Germany Medizinische Univ Klinik Koln Koln, Germany, 50924 Universitaet Leipzig Leipzig, Germany, D-04103 University of Tuebingen-Germany Tuebingen, Germany, D-72076 Less <<
NCT02357342 - Completed - -
NCT03246906 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Aggressive Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Diffuse Large B-Cell Lymphoma Hematopoietic Cell Transplantation Recipient Loss of Chromosome 17p Mantle Cell Lymphoma Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasm Prolymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Hodgkin Lymphoma Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Recurrent Waldenstrom Macroglobulinemia Less << Phase 2 Recruiting August 15, 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Masumi Ueda    206-667-4546    mueda@fredhutch.org    Principal Investigator: Masumi Ueda Less <<
NCT00679042 Type 1 Diabetes Mellitus Phase 3 Active, not recruiting July 2027 United States, Illinois ... More >> University of Illinois at Chicago Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT02673515 Excessive Diet Restriction Not Applicable Active, not recruiting June 2019 Austria ... More >> Dept. of Internal Medicine, Medical University of Graz Graz, Austria, 8036 Less <<
NCT00610012 - Active, not recruiting August 2020 Germany ... More >> iOMEDICO Freiburg, Germany Less <<
NCT03491371 Efficacy Toxi... More >>city Less << Not Applicable Completed - China ... More >> Musculoskeletal Tumor Center of Peking University People's Hospital Beijing, China, 100044 Peking University Shougang Hospital Beijing, China, 100144 Less <<
NCT00144677 Acute Myelogenous Leukemia ... More >> Graft Versus Host Disease Acute Lymphoblastic Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndromes Non-Hodgkin's Lymphoma Hodgkin's Disease Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Center Boston, Massachusetts, United States, 02115 Less <<
NCT03670966 Acute Lymphoblastic Leukemia i... More >>n Remission Acute Myeloid Leukemia in Remission Chronic Myelomonocytic Leukemia Myeloproliferative Neoplasm, Unclassifiable Less << Phase 1 Phase 2 Not yet recruiting September 1, 2024 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Not yet recruiting Seattle, Washington, United States, 98109 Contact: Phuong Vo          Principal Investigator: Phuong Vo Less <<
NCT00350181 Leukemia Lymp... More >>homa, Non-Hodgkin Blood and Marrow Transplant (BMT) Less << Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01534143 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 2 Terminated(Data was not collec... More >>ted, because funding was unavailable to continue study.) Less << - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00409461 Islet Transplantation ... More >> Type 1 Diabetes Less << Not Applicable Terminated - Belgium ... More >> Academisch Ziekenhuis and Diabetes Research Center – Brussels Free University-VUB Brussels, Belgium, 1090 Department of Endocrinology and Nephrology, UZ Gasthuisberg, Katholieke Universiteit Leuven –KUL Leuven, Belgium, 3000 Less <<
NCT00144703 Hematologic Malignancies ... More >> Myelogenous Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndrome Non-Hodgkin's Lymphoma Hodgkin's Disease Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00509431 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT00140543 Diabetes Mellitus, Type 1 ... More >> Diabetic Nephropathy Less << Phase 3 Unknown - Austria ... More >> Universitätsklinik Innsbruck, Austria, 6020 Belgium Cliniques Universitaires Saint Luc Brussels, Belgium, 1200 UZ Gent Gent, Belgium, 9000 UZ Gasthuisberg Leuven, Belgium, 3000 Czech Republic Institute for clinical and experimental medicine-IKEM Prague, Czech Republic, 14021 Germany Charite Campus Virchow Klinikum Berlin, Germany, 13353 Knappschaftskrankenhaus Bochum-Langendreer, Germany, 44892 Goethe University Frankfurt am Main, Germany, 60590 Chirurgische Universitätsklinik Freiburg, Germany, 79111 Klinikum Grosshadern-University of Munich Munich, Germany, 81366 Klinikum Innenstadt der Universität München Munich, Germany, 90336 Israel Tel Aviv Sourasky Medical Center Tel Aviv, Israel, 64239 Spain Hospital Clinico Barcelona, Spain, 08036 Switzerland Hôpital Cantonal de Geneve Geneva, Switzerland, 1211 Less <<
NCT00509613 Advanced Solid Tumor ... More >> Refractory to Standard Therapies Less << Phase 1 Completed - Netherlands ... More >> UMC St Radboud Nijmegen, Netherlands Less <<
NCT00834496 - Withdrawn - United States, Pennsylvania ... More >> THomas Jefferson University and Hospital Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00999258 Glomerular Filtration Rate ... More >> Chronic Allograft Nephropathy Less << Phase 4 Unknown June 2011 United States, Pennsylvania ... More >> Temple University Recruiting Philadelphia, Pennsylvania, United States, 19140 Contact: Serban Constantinescu, MD, PhD    217-707-9171    serban.constantinescu@tuhs.temple.edu    Principal Investigator: Serban Constantinescu, MD, PhD          Sub-Investigator: Patricio Silva, MD          Sub-Investigator: Nicole Sifontis, PharmD          Sub-Investigator: Iris Lee, MD          Sub-Investigator: John Daller, MD, PhD Less <<
NCT00382109 - Unknown - -
NCT00223028 Renal Transplantation Phase 4 Completed - -
NCT00235157 Renal Artery Stenosis Phase 2 Completed - France ... More >> Hopital Européen Georges Pompidou Paris, France, 75 015 Germany Universitätskliniken Köln Köln, Germany, 50931 Netherlands Erasmus MC Rotterdam Rotterdam, Netherlands, 3000 CA Less <<
NCT01021930 Coronary Heart Disease ... More >> Diabetes Mellitus Less << Phase 4 Unknown June 2011 China, Heilong jiang ... More >> The second Affiliated Hospital of Harbin Medical University Recruiting Harbin, Heilong jiang, China, 150081 Contact: Bo Yu, MD, PhD    86-0451-86605180    yubodr@163.com    Principal Investigator: Bo Yu, MD.PhD Less <<
NCT01126333 - Completed - United States, Maryland ... More >> University of Maryland Medicine, Division of Adult Nephrology Baltimore, Maryland, United States, 21201 Less <<
NCT01166724 Kidney Transplant Phase 3 Terminated(Collaborator stoppe... More >>d study) Less << - United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT00352950 Oncology Non-... More >>Small Cell Lung Cancer Less << Phase 1 Withdrawn - -
NCT02145559 Breast Neoplasms ... More >> Lung Neoplasms Cancer of Liver Lymphoma Cancer of Kidney Less << Phase 1 Active, not recruiting July 2019 United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01358266 Uveitis; Posterior, Disorder Phase 3 Completed - -
NCT02837003 - Recruiting March 2019 Japan ... More >> Teikyo University Hospital Recruiting Tokyo, Japan, 173-8606 Contact: Ken Kozuma, MD, PhD    +81-3-3964-1211    PXE00364@nifty.com Less <<
NCT03099356 Metastatic Thyroid Cancer Phase 2 Recruiting May 12, 2023 United States, Michigan ... More >> University of Michigan Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Francis P Worden, MD    734-936-0453    fworden@umich.edu    Contact: Cancer AnswerLine    1-800-865-1125    canceranswerline@umich.edu Less <<
NCT01777204 - Unknown January 2013 Brazil ... More >> Universidade Estadual de Ciências da Saúde de Alagoas Recruiting Maceio, Alagoas, Brazil, 57010382 Contact: Maria do Carmo B Teixeira, Dr    +558233156722    maruchaborges@hotmail.com    Contact: Luciana A Cora, Dr    +558233156728    luciana.cora@uncisal.edu.br    Principal Investigator: Maria do Carmo B Teixeira, Dr          Sub-Investigator: Luciana A Cora, Dr Less <<
NCT01842594 Sarcoma Phase 2 Terminated(Most patients compl... More >>eted only the primary objective (PET) and not went throught the secondary outcome (efficacy phase) of 8wks period.) Less << - Taiwan ... More >> Shin Kong Wu Ho-Su Memorial Hospital Taipei, Taiwan, 11101 Less <<
NCT01842594 - Terminated(Most patients compl... More >>eted only the primary objective (PET) and not went throught the secondary outcome (efficacy phase) of 8wks period.) Less << - -
NCT03616132 Single Coronary Vessel Disease Not Applicable Recruiting March 30, 2023 Malaysia ... More >> Institut Jantung Negara Not yet recruiting Kuala Lumpur, Negeri Selangor, Malaysia Principal Investigator: Jamauddin Bin Yahaya Shaiful Azmi          University Malaya Medical Centre Recruiting Kuala Lumpur, Negeri Selangor, Malaysia Principal Investigator: Azman Wan Ahmad Wan Less <<
NCT02329808 - Recruiting December 2018 Netherlands ... More >> Radboud University Medical Center Recruiting Nijmegen, Gelderland, Netherlands Contact: Roger Brüggemann, PharmD PhD       roger.bruggemann@radboudumc.nl    Contact: Lisa Martial, PharmD       lisa.martial@radboudumc.nl    Sub-Investigator: Maroeska Te Loo          Sub-Investigator: Michiel Schreuder          Sub-Investigator: Stefanie Henriet Less <<
NCT02133287 Ischemic Heart Disease ... More >> Myocardial Ischemia Coronary Disease Acute Coronary Syndrome Less << Not Applicable Recruiting August 2022 China, Beijing ... More >> Peking University First Hospital Recruiting Beijing, Beijing, China, 100034 Principal Investigator: Yong Huo, Prof. Less <<
NCT03214354 Sickle Cell Disease ... More >> Stem Cell Transplant Complications Red Blood Cell Disorder Pure Red Cell Aplasia Less << Phase 2 Recruiting July 2023 Canada, Alberta ... More >> Alberta Children's Hospital Recruiting Calgary, Alberta, Canada, T3B 6A8 Contact: Tony Truong, MD, MPH    403-955-7272    tony.truong@ahs.ca    Contact: Greg Guilcher, MD    403-955-7272       Principal Investigator: Tony Truong, MD, MPH          Sub-Investigator: Greg Guilcher, MD          Sub-Investigator: Victor Lewis, MD          Sub-Investigator: Michael Leaker, MD          Sub-Investigator: Aisha Bruce, MD          Sub-Investigator: Aru Narendran, MD, PhD Less <<
NCT03421756 Sickle Cell Disease Early Phase 1 Recruiting February 15, 2023 United States, Pennsylvania ... More >> UPMC Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Rita Johnson, RN    412-647-8571    rjohnson1@upmc.edu Less <<
NCT02645149 Melanoma Phase 4 Not yet recruiting August 2021 Australia, New South Wales ... More >> Royal Prince Alfred Hospital Not yet recruiting Camperdown, New South Wales, Australia, 2050 Contact: Maria Gonzalez    612 9911 7200    maria.gonzalez@melanoma.org.au    Principal Investigator: John Thompson          Westmead Hospital Westmead, New South Wales, Australia, 2145 Melanoma Institute Australia Not yet recruiting Wollstonecraft, New South Wales, Australia, 2065 Contact: Maria Gonzalez    +612 9911 7200    maria.gonzalez@melanoma.org.au    Contact: Alex Menzies    +612 9911 7200    info@melanoma.org.au    Sub-Investigator: Georgina Long          Principal Investigator: Alex Menzies Less <<
NCT00927992 - Completed - -
NCT00105001 - Completed - -
NCT00789308 Diabetes Mellitus, Type I Phase 2 Completed - Norway ... More >> University Hospital Rikshospitalet Oslo, Norway Sweden Karolinska University Hospital Stockholm, Sweden Uppsala University Hospital Uppsala, Sweden Less <<
NCT03587272 Sickle Cell Disease Phase 2 Recruiting November 2022 United States, District of Col... More >>umbia Children's National Health System Recruiting Washington, District of Columbia, United States, 20010 Contact: Fahmida Hoq, MBBS, MS    202-476-3634    fhoq@childrensnational.org Less <<
NCT00382109 B-cell Childhood Acute Lymphob... More >>lastic Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Graft Versus Host Disease L1 Childhood Acute Lymphoblastic Leukemia L2 Childhood Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Unknown - -
NCT00043979 Sarcoma Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00043979 - Completed - -
NCT01539291 Chronic Lymphocytic Leukemia Phase 3 Completed - -
NCT00305682 Myeloproliferative Disorders ... More >> Leukemia Lymphoma Myelodysplastic Syndromes Less << Phase 2 Active, not recruiting June 2019 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00602693 Leukemia Lymp... More >>homa Multiple Myeloma Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 1 Completed - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00489281 Sickle Cell Disease Phase 2 Active, not recruiting December 2018 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT01166724 - Terminated(Collaborator stoppe... More >>d study) Less << - -
NCT02867800 Sickle Cell Disease ... More >> Graft Versus Host Disease Less << Phase 1 Recruiting December 2019 United States, District of Col... More >>umbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Shahleen Ahmed, CRC    202-476-6850    szahmed@childrensnational.org    Principal Investigator: Allistair Abraham, MD          United States, Georgia Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Kelsey Rogowski, MPH    404-785-7749    Kelsey.Rogowski@choa.org    Principal Investigator: Ann Haight, MD          United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611 Contact: Nicole Fisher, CRC    312-227-4871    nfisher@luriechildrens.org    Principal Investigator: Sonali Chaudhury, MD          United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Danielle Dietzen, NP    212-305-8443    dad9025@nyp.org    Contact: Jean Sosna, RN MS    212-305-2050    js4403@cumc.columbia.edu    Principal Investigator: Monica Bhatia, MD          United States, North Carolina North Carolina Cancer Hospital Not yet recruiting Chapel Hill, North Carolina, United States, 27514 Contact: Juanita Cuffee    919-962-8733    cuffee@med.unc.edu    Principal Investigator: Kimberly Kasow, MD          United States, Ohio Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Mary Beth Scholz, RN    614-722-3654    Mary.Scholz@nationwidechildrens.org    Principal Investigator: Hemalatha Rangarajan, MD Less <<
NCT01625351 Ewing Sarcoma ... More >> Gastrointestinal Tumor Germ Cell Tumor Hepatic Tumor Lymphoma Wilms Tumor Rhabdoid Tumor Clear Cell Carcinoma Renal Cell Carcinoma Melanoma Neuroblastoma Rhabdomyosarcoma Non-rhabdomyosarcoma Less << Phase 1 Active, not recruiting August 19, 2019 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT03112603 Graft-versus-host Disease (GVH... More >>D) Less << Phase 3 Recruiting January 2022 -
NCT02790515 Acute Lymphoblastic Leukemia (... More >>ALL) Acute Myeloid Leukemia (AML) Myeloid Sarcoma Chronic Myeloid Leukemia (CML) Juvenile Myelomonocytic Leukemia (JMML) Myelodysplastic Syndrome (MDS) Non-Hodgkin Lymphoma (NHL) Less << Phase 2 Recruiting June 2020 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Brandon Triplett, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Brandon Triplett, MD Less <<
NCT02208583 Hormone Refractory Prostate Ca... More >>ncer Less << Not Applicable Unknown December 2016 China, Tianjin ... More >> Department of Interventional Oncology, Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Wang HaiTao, Ph.D    +86-18630955984    peterrock2000@126.com    Principal Investigator: Wang HaiTao, Ph.D Less <<
NCT01369082 - Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 University of Illinois Chicago, Illinois, United States, 60612 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02493 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00352547 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02836847 Cholangiocarcinoma of the Extr... More >>ahepatic Bile Duct Gallbladder Cancer Less << Phase 2 Recruiting December 2020 China, Shanghai ... More >> Xinhua Hospital Recruiting Shanghai, Shanghai, China, 200092 Contact: yingbin liu    13918803900    laoniulyb@163.com Less <<
NCT03018223 Non-Hodgkin's Lymphoma ... More >> Acute Leukemia in Remission Chronic Myeloid Leukemia Primary Myelofibrosis Chronic Myelomonocytic Leukemia Myelodysplastic Syndromes Hodgkin Lymphoma Multiple Myeloma Less << Phase 2 Active, not recruiting January 2021 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02722668 Acute Leukemia ... More >> Acute Myeloid Leukemia Acute Lymphoblastic Leukemia/Lymphoma Burkitt's Lymphoma Natural Killer Cell Malignancies Chronic Myelogenous Leukemia Myelodysplastic Syndrome Large-cell Lymphoma Hodgkin Lymphoma Multiple Myeloma Relapsed Chronic Lymphocytic Leukemia Relapsed Small Lymphocytic Lymphoma Marginal Zone B-cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-cell Lymphoma Prolymphocytic Leukemia Bone Marrow Failure Syndromes Myeloproliferative Neoplasms/Myelofibrosis Biphenotypic/Undifferentiated/Prolymphocytic Leukemias MRD Positive Leukemia Leukemia or MDS in Aplasia Relapsed T-Cell Lymphoma Relapsed Multiple Myeloma Plasma Cell Leukemia Less << Phase 2 Recruiting December 2029 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Claudio Brunstein, MD    612-625-3918    bruns072@umn.edu Less <<
NCT01636908 Cancer Advanc... More >>ed Solid Tumors Less << Not Applicable Active, not recruiting - Netherlands ... More >> VUMedical Center Amsterdam, Netherlands, 1081 HV Less <<
NCT02793544 Myelodysplastic Syndrome (MDS)... More >> Chronic Lymphocytic Leukemia (CLL) Chemotherapy-sensitive Lymphoma Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma Acute Myelogenous Leukemia (AML) Acute Biphenotypic Leukemia (ABL) Acute Undifferentiated Leukemia (AUL) Less << Phase 2 Recruiting December 2019 United States, Florida ... More >> Shands HealthCare & University of Florida Recruiting Gainesville, Florida, United States, 32610 Contact: Maxim Norkin, MD       Maxim.Norkin@medicine.ufl.edu    Contact: Meghan Vazquez       meghan.vazquez@medicine.ufl.edu    Principal Investigator: Maxim Norkin, MD          University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Antonio Jimenez, MD       amjimenez@miami.edu    Contact: Kirenia Correa       k.correa@med.miami.edu    Principal Investigator: Antonio Jimenez, MD          H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Farhad Khimani, MD       Farhad.Khimani@moffitt.org    Contact: Carmen Patton       Carmen.Patton@moffitt.org    Principal Investigator: Farhad Khimani, MD          United States, Maryland University of Maryland Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Nancy Hardy, MD       nhardy1@umm.edu    Contact: Sherri Bauman       sphilip1@umm.edu    Principal Investigator: Nancy Hardy, MD          The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Javier Bolanos Meade, MD       fbolano2@jhmi.edu    Contact: Leo Luznik, MD       luznile@jhmi.edu    Principal Investigator: Javier Bolanos Meade, MD          Principal Investigator: Leo Luznik, MD          United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Asif Alavi, MD       alavia@karmanos.org    Contact: Charlotte Brown       brownc@karmanos.org    Principal Investigator: Asif Alavi, MD          United States, New York Memorial Sloan Kettering Cancer Center - Adults Recruiting New York, New York, United States, 10065 Contact: Brian Shaffer, MD       shaffeb1@mskcc.org    Contact: Stephanie Chinapen       chinapes@mskcc.org    Principal Investigator: Brian Shaffer, MD          United States, North Carolina University of North Carolina Hospitals Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Katarzyna Jamieson, MD       katarzyna_jamieson@med.unc.edu    Contact: Mary Owen       mary_owen@med.unc.edu    Principal Investigator: Katarzyna Jamieson, MD          United States, Ohio Ohio State Medical Center, James Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Hannah Choe, MD          Contact: Nicole Szuminski       Nicole.Szuminski@osumc.edu    Principal Investigator: Hannah Choe, MD          United States, Virginia Virginia Commonwealth University Massey Cancer Center Bone Marrow Transplant Program Recruiting Richmond, Virginia, United States, 23298 Contact: John McCarty, MD       john.mccarty@vcuhealth.org    Contact: Kathy Candler       kcandler@mcvh-vcu.edu    Principal Investigator: John McCarty, MD          United States, Wisconsin Froedtert Memorial Lutheran Hospital Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Bronwen Shaw, MD, PhD       beshaw@mcw.edu    Contact: Sharon Yim       syim@mcw.edu    Principal Investigator: Bronwen Shaw, MD, PhD Less <<
NCT00050713 Membranous Glomerulonephritis ... More >> Lupus Membranous Nepropathy Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02776644 - Completed - -
NCT00188955 Kidney Transplantation Phase 4 Completed - Canada, Manitoba ... More >> Children's Hospital Winnipeg, Manitoba, Canada, R3A 1S1 Less <<
NCT02678143 Sickle Cell Disease Phase 1 Recruiting May 31, 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Mark A Schroeder, M.D.    314-454-8304    markschroeder@wustl.edu    Principal Investigator: Mark A Schroeder, M.D.          Sub-Investigator: Bader Alahmari, M.D.          Sub-Investigator: Morey Blinder, M.D.          Sub-Investigator: Allison King, M.D. Less <<
NCT00231257 In-Stent Restenosis Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT03193892 - Recruiting December 31, 2020 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Kai-Feng Xu, M.D.    86-10-69155039    xukf@pumch.cn    Contact: XinLun Tian, M.D.    86-10-69155039    xinlun_t@sina.com    Sub-Investigator: Xinlun Tian, M.D.          Principal Investigator: Kai-Feng Xu, M.D. Less <<
NCT00231244 Coronary Artery Disease Phase 3 Completed - United States, California ... More >> Scripps Clinic and Research LaJolla, California, United States, 92037 Less <<
NCT00232739 - Completed - -
NCT00232765 Coronary Artery Disease Phase 3 Completed - United States, New York ... More >> New York Presbyterian Hospital/Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00232752 Coronary Artery Disease Phase 3 Completed - United States, Massachusetts ... More >> Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00232856 Coronary Artery Disease Phase 4 Completed - Belgium ... More >> K.U. Leuven Leuven, Belgium, 3000 Germany Herz-zentrum Bad Krozingen Bad-Krozingen, Germany, 78189 Less <<
NCT00233714 Coronary Artery Disease Phase 1 Phase 2 Completed - Brazil ... More >> Institute Dante Pazzanese of Cardiology Sao Paolo, Brazil Less <<
NCT00204321 Renal Transplantation Phase 4 Completed - Germany ... More >> UKM Münster, NRW, Germany, 48149 Less <<
NCT00232791 Coronary Artery Disease Phase 2 Phase 3 Completed - United Kingdom ... More >> Cardiothoracic Center Liverpool Liverpool, United Kingdom, L14 3PE Less <<
NCT00233805 Coronary Artery Disease Phase 2 Completed - France ... More >> Dr Marie-Claude Morice Massy, France, F- 91300 Less <<
NCT00233792 Coronary Artery Disease Phase 1 Phase 2 Completed - Brazil ... More >> Instituto Dante Pazzanese of Cardiology Sao Paulo, Brazil, 04012-909 Less <<
NCT00232739 Coronary Artery Disease Phase 3 Completed - United States, New York ... More >> Lenox Hill Hospital New York, New York, United States, 10021 Less <<
NCT00235144 Coronary Artery Disease Phase 3 Completed - Germany ... More >> Herzkatheterlabor und Praxisklinik Hamburg, Germany Med. Klinik und Poliklinik Münster, Germany Less <<
NCT00254709 Kidney Failure ... More >> Graft Rejection Aged Less << Phase 4 Completed - -
NCT00234455 Coronary Artery Disease Phase 2 Completed - Italy ... More >> Centre Cuore Columbus Milano, Italy, I-20145 Less <<
NCT00233818 Coronary Artery Disease Phase 1 Phase 2 Completed - Netherlands ... More >> Erasmus Centrum Thoraxcentrum Rotterdam, Netherlands, NL- 3015 GD Less <<
NCT00233766 Coronary Artery Disease Phase 1 Phase 2 Completed - Brazil ... More >> Instituto Dante Pazzanese de Cardiologia Sao Paolo, Brazil Less <<
NCT00426517 Inherited Immune Deficiencies Early Phase 1 Recruiting January 8, 2026 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00589563 - Completed - -
NCT00074490 Lymphoma Leuk... More >>emia Myeloproliferative Disorders Multiple Myleoma Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States Less <<
NCT00078559 Kidney Transplantation ... More >> Kidney Disease Less << Phase 1 Phase 2 Completed - United States, Wisconsin ... More >> University of Wisconsin - Department of Medicine Madison, Wisconsin, United States, 53792-1735 Less <<
NCT01049633 - - - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00078559 - Completed - -
NCT00092222 Lymphoproliferative Disorder ... More >> HHV-8 Malignancy HIV Less << Phase 2 Recruiting October 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937 Less <<
NCT00133367 Multiple Myeloma ... More >> Non-Hodgkin's Lymphoma Hodgkin's Disease Myelogenous Leukemia Lymphoblastic Leukemia Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02601157 Stable Angina ... More >> Unstable Angina Non-ST Segment Elevation Myocardial Infarction Less << Phase 4 Recruiting - Korea, Republic of ... More >> Busan Paik Hospital Not yet recruiting Busan, Korea, Republic of Contact: Tae-Hyun Yang, M.D., PhD       yangthmd@naver.com    Kosin University Gospel Hospital Not yet recruiting Busan, Korea, Republic of Contact: Tae-Joon Cha, M.D., PhD       chatjn@gmail.com    SoonChunHyang University Cheonan Hospital Recruiting Cheonan, Korea, Republic of Contact: Seung Jin Lee, M.D., PhD       drlsj3@gmail.com    Chonnam National University Hospital Recruiting Gwangju, Korea, Republic of Contact: Myung-Ho Jeong, M.D., PhD       mhjeong@chonnam.ac.kr    Gwangju Christian Hospital Recruiting Gwangju, Korea, Republic of Contact: Seung Uk Lee, M.D., PhD       cardiosu@hanmail.net    Ewha Womans University Medical Center Mokdong Hospital Not yet recruiting Seoul, Korea, Republic of Contact: Wook Bum Pyun, MD. PhD.       pwb423@ewha.ac.kr    Hallym University Kangdong Sacred Heart Hospital Not yet recruiting Seoul, Korea, Republic of Contact: Kyu-Rock Han, MD. PhD.       krheart@hallym.or.kr    Kangnam Sacred Heart Hospital Not yet recruiting Seoul, Korea, Republic of Contact: Namho Lee, M.D., PhD       namholee@hallym.or.kr    Korea University Guro Hospital Recruiting Seoul, Korea, Republic of Contact: Jin Won Kim, M.D., PhD       kjwmm@korea.ac.kr    Kyung Hee University Hospital at Gangdong Not yet recruiting Seoul, Korea, Republic of Contact: Jin-Man Cho, M.D., PhD       aceri@medimail.co.kr    Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Hyo-Soo Kim, M.D., PhD    82-2-2072-2226    hyosoo@snu.ac.kr    Ajou University Hospital Recruiting Suwon, Korea, Republic of Contact: Myeong-Ho Yoon, M.D., PhD       yoonmh65@hanmail.net Less <<
NCT00589563 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Infection Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Precancerous Condition Secondary Myelofibrosis Small Intestine Cancer Less << Phase 2 Completed - United States, Arizona ... More >> Banner Good Samaritan Medical Center Phoenix, Arizona, United States, 85006 United States, California City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT01758107 Renal Transplant Phase 4 Unknown October 2015 Thailand ... More >> Chulalongkorn University Recruiting Bangkok, Thailand Contact: Natavudh Townamchai, MD    +66894904222    ntownamchai@gmail.com    Principal Investigator: Natavudh Townamchai, MD Less <<
NCT00434850 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, California ... More >> University of Californinia, San Francisco San Francisco, California, United States, 94143 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00261820 Graft Rejection ... More >> Kidney Failure Kidney Transplantation Less << Phase 4 Completed - -
NCT00455013 Disorder Related to Renal Tran... More >>splantation Less << Phase 2 Completed - United States, California ... More >> Ucsf San Francisco, California, United States, 94143 United States, Colorado Denver Nephrology, Pc Denver, Colorado, United States, 80218 University Of Colorado Health Sciences Center Denver, Colorado, United States, 80262 United States, Georgia Medical College Of Georgia Augusta, Georgia, United States, 30912 United States, Illinois Northwestern University Feinberg School Of Medicine Chicago, Illinois, United States, 60611 United States, Michigan Henry Ford Hospital Detriot, Michigan, United States, 48202 United States, New York Albany Medical College Albany, New York, United States, 12208 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28203 United States, Ohio University Of Cincinnati Cincinnati, Ohio, United States, 45267 Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Italy Local Institution Bologna, Italy, 40138 Local Institution Brescia, Italy, 25123 Local Institution Padova, Italy, 35128 Local Institution Roma, Italy, 00168 Spain Local Institution Barcelona, Spain, 08907 Local Institution Sevilla, Spain, 41013 Less <<
NCT00229515 Myocardial Infarction Phase 4 Unknown March 2012 Italy ... More >> Cattedra di Cardiologia, Azienda Ospedaliera Universitaria di Ferrara Ferrara, Italy, 44100 Less <<
NCT03121001 Sickle Cell Disease Phase 2 Recruiting October 28, 2026 United States, Illinois ... More >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Damiano Rondelli, MD    312-413-3547    drond@uic.edu Less <<
NCT01203722 Hematologic Malignancies Phase 1 Phase 2 Recruiting December 2023 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231-2410 Contact: Clinical Trials Office - Sidney Kimmel Comprehensive Cancer Ce    410-955-8804    jhcccro@jhmi.edu Less <<
NCT00455013 - Completed - -
NCT02821026 Type 1 Diabetes Phase 1 Phase 2 Active, not recruiting September 2018 Canada, Alberta ... More >> Clinical Islet Transplant Program Edmonton, Alberta, Canada, T6G2C8 Less <<
NCT02495727 Muscular Atrophy Not Applicable Completed - United Kingdom ... More >> University of Bath Bath, Avon, United Kingdom, BA2 7AY Less <<
NCT02711202 Kidney Transplantation Not Applicable Completed - -
NCT01588678 Advanced Solid Tumor ... More >> Lymphoma Less << Phase 1 Completed - United States, Texas ... More >> South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 Less <<
NCT02776202 Sickle Cell Disease Phase 2 Recruiting December 2019 Saudi Arabia ... More >> King Abdul Aziz Medical City for National Guard Recruiting Riyadh, Saudi Arabia Contact: Nagham RZ Sheblaq    009668011111 ext 53352    sheblaqn@ngha.med.sa    Contact    009668011111 ext 53352    sheblaqn@ngha.med.sa    Principal Investigator: Nagham RZ Sheblaq, BS.c Less <<
NCT01846130 Bed Rest Not Applicable Unknown - United States, Texas ... More >> Unversity of Texas Medical Branch Recruiting Galveston, Texas, United States, 77555 Principal Investigator: Douglas Paddon-Jones, Ph.D. Less <<
NCT01163357 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Less << Phase 1 Active, not recruiting September 2019 United States, California ... More >> City of Hope Duarte, California, United States, 91010 Less <<
NCT02445560 Aging Not Applicable Completed - United States, Florida ... More >> UF Food Science and Human Nutrition Department Gainesville, Florida, United States, 32611 UF/IFAS Extension Office Marion County Ocala, Florida, United States, 34470 Less <<
NCT00038948 Renal Transplantation Phase 3 Completed - -
NCT03500614 Blood Pressure ... More >> Lung Function Inflammation Oxidative Stress Less << Not Applicable Recruiting August 1, 2018 China ... More >> Department of Occupational & Environmental Health Sciences, School of Public Health, Peking University Recruiting Beijing, China, 100191 Contact: Yan Zhao    861082801522    zhaoyannash@163.com Less <<
NCT00038948 - Completed - -
NCT01363297 Acute Lymphocytic Leukemia Phase 2 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010-3000 Stanford Unversity Cancer Clinical Trials Office Palo Alto, California, United States, 94304 Stanford Unversity Hospital and Clinics, CTRU Palo Alto, California, United States, 94304 Stanford Cancer Institute Stanford, California, United States, 94305 Stanford University Hospital and Clinics Stanford, California, United States, 94305 United States, Illinois The University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Massachusetts Massachusetts General Hospital (MGH) Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital (BWH) Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Karmanos Cancer Institute at Farmington Hills Farmington Hills, Michigan, United States, 48334 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Texas The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less <<
NCT00452361 Kidney Transplantation Phase 4 Terminated - Taiwan ... More >> Select Cities, Taiwan Less <<
NCT01699360 Kidney Transplantation Phase 4 Unknown December 2013 China, Hunan ... More >> The third xiangya hospital, Central South University Recruiting Changsha, Hunan, China, 410013 Principal Investigator: Xi Luo, master Less <<
NCT00681213 Adult Primary Kidney Transplan... More >>tation Less << Phase 4 Completed - United States, Florida ... More >> University of Miami Division of Transplantation Miami, Florida, United States, 33136 Less <<
NCT01363297 - Completed - -
NCT01778309 Skeletal Muscle Damage ... More >> Skeletal Muscle Performance Intgracellular Signaling in Skeletal Muscle Inflammatory Status Less << Not Applicable Completed - Greece ... More >> Laboratory of Physical Education & Sport Performance Komotini, Thrace, Greece, 69100 Less <<
NCT02816411 Skeletal Muscle Damage ... More >> Exercise-induced Aseptic Inflammation Skeletal Muscle Performance Intracellular Signaling in Skeletal Muscle Proteasome Activation Less << Not Applicable Completed - Greece ... More >> Exercise Biochemistry Laboratory, School of Physical Education & Sports Sciences, University of Thessaly Karies, Trikala, Greece, 42100 Less <<
NCT03292861 Heart Transplantation Phase 2 Enrolling by invitation March 31, 2021 United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT00129961 Skin Neoplasms ... More >> Kidney Transplantation Less << Phase 4 Completed - -
NCT03348267 Skeletal Muscle Damage ... More >> Muscle Inflammation Muscle Recovery Soccer Performance Less << Not Applicable Completed - Greece ... More >> Exercise Biochemistry Laboratory, School of Physical Education & Sports Sciences, University of Thessaly Tríkala, Greece, 42100 Less <<
NCT01430585 Early Breast Cancer (Phase 2) ... More >> Advanced Breast Cancer (Phase 1b) Less << Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - Belgium ... More >> Pfizer Investigational Site Charleroi, Belgium, 6000 Italy Pfizer Investigational Site Milano, Italy, 20132 Spain Pfizer Investigational Site Barcelona, Spain, 08035 Sweden Pfizer Investigational Site Goteborg, Sweden, 413 45 Pfizer Investigational Site Stockholm, Sweden, 171 76 Less <<
NCT02092714 - Recruiting November 16, 2019 United States, Pennsylvania ... More >> Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111-2497 Contact: Paul F. Engstrom    215-728-2986    paul.engstrom@fccc.edu    Principal Investigator: Paul F. Engstrom Less <<
NCT01430585 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT03267160 - Active, not recruiting June 30, 2018 Taiwan ... More >> Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation Taipei, Taiwan, 23142 Less <<
NCT00005113 End-Stage Renal Disease ... More >> Kidney Transplantation Less << Phase 3 Terminated(Inability to meet t... More >>he accrual target of 213.) Less << - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT01925274 - Terminated(Enrollment to the s... More >>tudy was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.) Less << - -
NCT00166816 Transplantation ... More >> Kidney Transplantation Immunosuppression Less << Phase 4 Unknown - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT00166842 Transplantation ... More >> Kidney Transplantation Immunosuppression Less << Phase 4 Unknown - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT00493194 Kidney Failure, Chronic ... More >> Transplantation Immunosuppression Interstitial Fibrosis Less << Phase 4 Unknown July 2007 Belgium ... More >> University Hospital Antwerp Recruiting Edegem, Antwerp, Belgium, 9260 Contact: Jean-Louis Bosmans, M.D. Ph.D.    ..32/3/821 37 92    JeanLouis.Bosmans@ua.ac.be    Contact: Angelika Jurgens, Coordinator    ..32/3/821.34.68    Angelika.Jurgens@uza.be    Principal Investigator: Jean-Louis Bosmans, MD. Ph.D.          University Hospital Brussels Recruiting Brussels (Jette), Brabant, Belgium, 1090 Contact: Jacques Sennesael, M.D.    ..32/2/477.60.55    hemofsn@az.vub.ac.be    Contact: Katrien Van Bever, Study-nurse    ..32/2/477.60.55    Katrien.VanBever@az.vub.ac.be    Principal Investigator: Jacques Sennesael, M.D.          University Hospital Gent Recruiting Gent, Oost-Vlaanderen, Belgium, 9000 Contact: Patrick Peeters, M.D.    ..32/9/240.45.13    p.peeters@ugent.be    Contact: Cathy Vandermeulen, Study-Nurse    ..32/9/240.61.68    Cathy.Vandermeulen@uzgent.be    Principal Investigator: Patrick Peeters, M.D. Less <<
NCT01925274 Metastatic Colorectal Cancer Phase 2 Terminated(Enrollment to the s... More >>tudy was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.) Less << - United States, California ... More >> CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 Drug Management Only: UCLA West Medical Pharmacy, Att: Steven L Wong, Pharm D Los Angeles, California, United States, 90095-7349 Drug Management Only: UCLA West Medical Pharmacy Los Angeles, California, United States, 90095-7349 UCLA West Medical Pharmacy Los Angeles, California, United States, 90095-7349 Regulatory Management Only: TRIO-US Central Administration Los Angeles, California, United States, 90095 TRIO-US Central Administration (Regulatory Management only) Los Angeles, California, United States, 90095 TRIO_US Los Angeles, California, United States, 90095 West Valley Hematology/Oncology Med Group Northridge, California, United States, 91328 United States, Missouri Siteman Cancer Center - West County Creve Coeur, Missouri, United States, 63141 Barnes-Jewish Hospital Saint Louis, Missouri, United States, 63110 Drug Shipping Address: Washington University Infusion Center Pharmacy Saint Louis, Missouri, United States, 63110 Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Siteman Cancer Center - South County Saint Louis, Missouri, United States, 63129 Siteman Cancer Center - St Peters Saint Peters, Missouri, United States, 63376 United States, Nevada Regulatory Office: Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89014 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89052 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89074 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89128 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89148 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89169 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Washington Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States, 99336 Kadlec Medical Center Richland, Washington, United States, 99352 Outpatient Imaging Center Richland, Washington, United States, 99352 Spokane Valley Cancer Center Spokane Valley, Washington, United States, 99216 Medical Oncology Associates, PS Spokane, Washington, United States, 99208 Japan Aichi cancer center central hospital Nagoya, Aichi, Japan, 464-8681 National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 Korea, Republic of National Cancer Center Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Seoul National University Hospital / Department of Internal Medicine Seoul, Korea, Republic of, 110-744 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center Seoul, Korea, Republic of, 138-736 Spain Hospital General Universitario Gregorio Marañón Madrid, Spain, 28009 Less <<
NCT00137345 Kidney Transplant Phase 3 Terminated - -
NCT00282282 Graft Versus Host Disease ... More >> GVHD Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00282282 - Completed - -
NCT00129961 - Completed - -
NCT00321906 Delayed Graft Function ... More >> Acute Graft Rejection Less << Phase 4 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00606333 Coronary Atherosclerosis Not Applicable Terminated(The NEVO™ stent wil... More >>l not be commercialized. Cordis have decided to close the study after 3 years. This decision took the absence of safety signals into account.) Less << - Brazil ... More >> Instituto Dante Pazzanese de Cardiologia Sao Paulo, Brazil, 04012-909 New Zealand Mercy Angiography Unit Epsom, Auckland, New Zealand Less <<
NCT00311311 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00311311 Atherosclerosis ... More >> Kidney Failure Less << Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, New York ... More >> Pfizer Investigational Site Rochester, New York, United States, 14642 Canada, Alberta Pfizer Investigational Site Calgary, Alberta, Canada, T2N 2T9 Pfizer Investigational Site Edmonton, Alberta, Canada, T6G 2B7 Canada, Ontario Pfizer Investigational Site Hamilton, Ontario, Canada, L8N 4A6 Pfizer Investigational Site London, Ontario, Canada, N6A 5A5 Pfizer Investigational Site Toronto, Ontario, Canada, M5B 1W8 Pfizer Investigational Site Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H1T 2M4 Less <<
NCT01303965 Multiple Myeloma Phase 1 Phase 2 Terminated(Slow accrual) - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT01303965 - Terminated(Slow accrual) - -
NCT00452361 - Terminated - -
NCT01754389 Graft Versus Host Disease Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Insitute Boston, Massachusetts, United States, 02215 Less <<
NCT00566813 - Completed - -
NCT01038505 Living Donor Kidney Transplant... More >>s Patients Less << Phase 4 Withdrawn(Lost funding source) January 2013 -
NCT00321906 - Completed - -
NCT00305396 Kidney Transplantation Phase 4 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center/Nashville VA Nashville, Tennessee, United States, 37232 Less <<
NCT00566813 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Completed - United States, Illinois ... More >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 Less <<
NCT01453140 Graft Versus Host Disease Phase 1 Phase 2 Completed - United States, New Jersey ... More >> John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT01804634 Refractory and/or Relapsed Met... More >>astatic Solid Tumors Less << Phase 2 Recruiting December 2020 United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Heather Symons, MD, MHS    410-502-4997    hsymons2@jhmi.edu    Principal Investigator: Heather Symons, MD, MHS Less <<
NCT02554955 Heart Transplantation Phase 4 Completed - Spain ... More >> Barcelona, Spain, 08025 Barcelona, Spain, 08036 El Palmar Murcia, Spain, 30120 Hospitalet de Llobregat, Spain, 08907 La Coruna, Spain, 15006 Madrid, Spain, 28007 Madrid, Spain, 28035 Madrid, Spain, 28041 Oviedo, Spain, 33006 Pamplona, Spain, 31008 Santander, Spain, 39008 Sevilla, Spain, 41013 Valencia, Spain, 46009 Valladolid, Spain, 47005 Less <<
NCT01754389 - Completed - -
NCT02056691 Colorectal Cancer Not Applicable Completed - United Kingdom ... More >> The Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW Poole Hospital Poole, Dorset, United Kingdom, BH15 2JB Less <<
NCT02208791 Kidney Transplantation Phase 4 Unknown July 2017 Brazil ... More >> Hospital das Clinicas - Faculdade de Medicina da Universidade de São Paulo Recruiting Sao Paulo, Brazil, 05403-900 Contact: Elias David-Neto, PhD    55-11-2661-8089    elias.david.neto@attglobal.net    Contact: Nelson Z Galante, PhD    55-11-2661-8089    nelson.galante@hc.fm.usp.br    Principal Investigator: Elias David-Neto, PhD          Sub-Investigator: Nelson Z Galante, PhD Less <<
NCT03582878 Diabetes Mellitus, Type 1 Phase 4 Recruiting January 1, 2020 Czechia ... More >> Institute for Clinical and Experimental Medicine Recruiting Prague, Czechia, 14021 Contact: František Saudek, prof.    420261364107    frsa@ikem.cz    Contact: Peter Girman, M.D.    420 2 6136 8172    pegi@ikem.cz Less <<
NCT03353597 Aging Phase 1 Phase 2 Not yet recruiting December 15, 2022 United States, California ... More >> The Infusion Center & Clinic Not yet recruiting San Mateo, California, United States, 94401 Contact: Janeen Bc    650-348-6011       Contact: S Less <<
NCT00358657 Immunodeficiency Syndrome ... More >> Non-Cancer Diagnosis Severe Aplastic Anemia Less << Phase 2 Recruiting - United States, Tennessee ... More >> The Children's Hospital at TriStar Centennial Recruiting Nashville, Tennessee, United States, 37203 Contact: Haydar A. Frangoul    615-329-7339    Haydar.Frangoul@hcahealthcare.com    Principal Investigator: Haydar A. Frangoul          Vanderbilt University/Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: James Connelly    615-936-1762    james.a.connelly@vanderbilt.edu    Principal Investigator: James Connelly          United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Lauri M. Burroughs    206-667-2396    lburroug@fredhutch.org    Principal Investigator: Lauri M. Burroughs Less <<
NCT00825773 Ischemia Card... More >>iac Death Myocardial Infarction Less << Phase 4 Unknown April 2014 China ... More >> JW Medical Systems Recruiting Beijing, China, 100037 Contact: Yong zhi Yan, Post-graduate    +8613910074132    yongzhi.yan@jwmsgrp.com    Contact: Lei Ge, Prof    +8613816112695    ge.lei@zs-hospital.sh.cn    Principal Investigator: Junbo Ge, Prof Less <<
NCT03512756 Pancreatic Cancer Phase 2 Recruiting December 31, 2019 -
NCT02861040 Recurrent Adult Acute Lymphobl... More >>astic Leukemia Refractory Adult Acute Lymphoblastic Leukemia Less << Phase 1 Withdrawn - United States, California ... More >> Stanford University Palo Alto, California, United States, 94304 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21231 Less <<
NCT01251575 Adult Acute Lymphoblastic Leuk... More >>emia Adult Acute Myeloid Leukemia Adult Diffuse Large B-Cell Lymphoma Adult Myelodysplastic Syndrome Adult Non-Hodgkin Lymphoma Aggressive Non-Hodgkin Lymphoma Childhood Acute Lymphoblastic Leukemia Childhood Acute Myeloid Leukemia Childhood Diffuse Large B-Cell Lymphoma Childhood Myelodysplastic Syndrome Childhood Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia in Remission Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Hematopoietic and Lymphoid Cell Neoplasm Mantle Cell Lymphoma Plasma Cell Myeloma Prolymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia Refractory Chronic Lymphocytic Leukemia T-Cell Prolymphocytic Leukemia Waldenstrom Macroglobulinemia Recurrent Diffuse Large B-Cell Lymphoma Recurrent Hodgkin Lymphoma Less << Phase 2 Recruiting - United States, Colorado ... More >> Presbyterian - Saint Lukes Medical Center - Health One Recruiting Denver, Colorado, United States, 80218 Contact: Michael B. Maris    720-754-4800    Michael.Maris@healthonecares.com    Principal Investigator: Michael B. Maris          United States, Utah Huntsman Cancer Institute/University of Utah Completed Salt Lake City, Utah, United States, 84112 United States, Washington VA Puget Sound Health Care System Recruiting Seattle, Washington, United States, 98101 Contact: Thomas R. Chauncey    206-762-1010    thomas.chauncey@va.gov    Principal Investigator: Thomas R. Chauncey          Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Brenda M. Sandmaier    206-667-4961    bsandmai@fredhutch.org    Principal Investigator: Brenda M. Sandmaier          Denmark Rigshospitalet University Hospital Recruiting Copenhagen, Denmark, 2100 Contact: Niels Anderson    45 35 45 1134    niels.smedegaard.andersen@rh.regionh.dk    Principal Investigator: Niels Anderson Less <<
NCT01231412 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Aggressive Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Diffuse Large B-Cell Lymphoma Hematopoietic and Lymphoid Cell Neoplasm Indolent Non-Hodgkin Lymphoma Mantle Cell Lymphoma Myelodysplastic Syndrome Myeloproliferative Neoplasm Prolymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Plasma Cell Myeloma Refractory Chronic Lymphocytic Leukemia Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Hodgkin Lymphoma Small Lymphocytic Lymphoma T-Cell Chronic Lymphocytic Leukemia Waldenstrom Macroglobulinemia Less << Phase 3 Completed - United States, Colorado ... More >> University of Colorado Denver, Colorado, United States, 80217-3364 Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States, 80218 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Denmark Aarhus University Hospital Arhus, Denmark, 8200 Rigshospitalet University Hospital Copenhagen, Denmark, 2100 Germany Medizinische Univ Klinik Koln Koln, Germany, 50924 Universitaet Leipzig Leipzig, Germany, D-04103 University of Tuebingen-Germany Tuebingen, Germany, D-72076 Less <<
NCT03308747 Inflammaging ... More >>Sarcopenia Less << Not Applicable Completed - Greece ... More >> Exercise Biochemistry Laboratory, School of Physical Education & Sports Sciences, University of Thessaly Tríkala, Greece, 42100 Less <<
NCT00995059 Multiple Myeloma ... More >> Refractory Multiple Myeloma Less << Phase 1 Phase 2 Withdrawn - -
NCT02528877 Acute Myeloid Leukemia in Remi... More >>ssion Primary Myelofibrosis Primary Myelofibrosis, Prefibrotic Stage Secondary Acute Myeloid Leukemia Secondary Myelofibrosis Less << Phase 1 Withdrawn(The study design was... More >> revised so a new protocol will be opened.) Less << - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT01922167 Frail Elderly Not Applicable Active, not recruiting August 2018 Canada, Quebec ... More >> Institut Universitaire de Gériatrie de Montréal Montreal, Quebec, Canada, H3W 1W5 Royal Victoria Hospital - Glen Site Montreal, Quebec, Canada, H4A 3J1 Less <<
NCT01445106 Solid Tumors Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02917096 Primary Myelofibrosis ... More >> Secondary Myelofibrosis Less << Not Applicable Recruiting October 2019 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Haris Ali    626-256-4673       Principal Investigator: Haris Ali Less <<
NCT00089037 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00133237 Coronary Disease Phase 4 Completed - Germany ... More >> Deutsches Herzzentrum Munich, Germany, 80636 First Medizinische Klinik, Klinikum rechts der Isar Munich, Germany, 81675 Less <<
NCT03531281 Hematopoietic and Lymphoid Cel... More >>l Neoplasm Hematopoietic Cell Transplantation Recipient Less << Phase 1 Withdrawn(Administratively wit... More >>hdrawn) Less << December 30, 2022 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00146575 Coronary Disease Phase 4 Completed - Germany ... More >> Deutsches Herzzentrum Muenchen Munich, Germany, 80636 Deutsches Herzzentrum Munich, Germany, 80636 Less <<
NCT01231412 - Completed - -
NCT00233779 Coronary Artery Disease Phase 2 Completed - Brazil ... More >> Instituto Dante Pazzanese de Cardiologia Sao Paolo, Brazil Less <<
NCT00130546 Coronary Artery Disease Phase 3 Completed - Germany ... More >> Albert-Ludwig University Clinic Freiburg, Baden-Württemberg, Germany, 79116 Less <<
NCT03128034 Acute Lymphoblastic Leukemia i... More >>n Remission Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission CD45-Positive Neoplastic Cells Present Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome With Excess Blasts Recurrent Adult Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Recruiting April 19, 2026 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Brenda M. Sandmaier    206-667-4961    bsandmai@fredhutch.org    Principal Investigator: Brenda M. Sandmaier Less <<
NCT03048825 ST Elevation Myocardial Infarc... More >>tion Less << Phase 3 Recruiting December 30, 2021 Canada, Ontario ... More >> Hamilton General Hospital Recruiting Hamilton, Ontario, Canada, L8L2X2 Contact: CLEAR Investigator    9055274322    clear@phri.ca Less <<
NCT00297661 Coronary Heart Disease Phase 4 Completed - Switzerland ... More >> University Hospital Bern Bern, Switzerland, 3010 Less <<
NCT00422565 Myocardial Infarction Phase 4 Terminated(The recruitment rat... More >>e was much slower than expected.) Less << - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Asan Medical Center GangNeung, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of NHIC Ilsan Hospital Ilsan, Korea, Republic of Pusan Natioanal University Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of, 138-732 Korea University Hospital Seoul, Korea, Republic of St. Mary's Catholic Medical Center Seoul, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Yonsei University Wonju Christian Hospital Wonju, Korea, Republic of Less <<
NCT00146614 Graft Versus Host Disease ... More >> Hematologic Malignancies Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00418067 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of Kyungpook National University Hospital Daegu, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Asan Medical Center GangNeung, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of NHIC Ilsan Hospital Ilsan, Korea, Republic of Chonbuk National University Hospital Jeonju, Korea, Republic of Pusan Natioanal University Hospital Pusan, Korea, Republic of Hallym University Sacred Heart Hospital PyeongChon, Korea, Republic of Seoul National University Bundang Hospital Seongnam, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of, 138-736 Korea University Hospital Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of St.Mary's Catholic Medical Center Seoul, Korea, Republic of Yonsei University Medical Center Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Yonsei University Wonju Christian Hospital Wonju, Korea, Republic of Less <<
NCT00507793 Kidney Transplantation Phase 4 Completed - -
NCT00235092 Coronary Artery Disease Phase 4 Completed - France ... More >> Institut Hospitalier Jacques Cartier Massy, France Less <<
NCT00076570 Kidney Transplantation Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00076570 - Completed - -
NCT00598715 Coronary Artery Disease Phase 4 Completed - Germany ... More >> Deutsches Herzzentrum Muenchen Munich, Germany, 80636 1. Medizinische Klinik, Klinikum rechts der Isar Munich, Germany, 81675 Less <<
NCT00693030 Coronary Artery Disease Phase 4 Unknown December 2008 Italy ... More >> Cardiovascular Department Ospedali Riuniti di Bergamo Recruiting Bergamo, Italy, 24100 Contact: Giulio Guagliumi, MD    39-03-526-6455    guagliumig@interfree.it    Contact: Giuseppe Musumeci, MD    39-03-526-6455    giuseppe.musumeci@gmail.it    Principal Investigator: Giulio Guagliumi, MD Less <<
NCT00798954 Ischemic Heart Disease ... More >> Restenosis Less << Phase 4 Completed - Japan ... More >> Higashi Cardiovascular Clinic Toyohashi, Aichi, Japan, 4400836 Vulnerable Plaque Society Toyohashi, Aichi, Japan, 4400850 Toyohashi Heart Center Toyohashi, Aichi, Japan, 4418530 Teikyo University Chiba Medical Center Ichihara, Chiba, Japan, 2990111 Southen Tohoku Research Institute Koriyama, Fukushima, Japan, 9638563 Gunma Cardiovascular Center Maebashi, Gunma, Japan, 3710004 Kihara Junkanki Hospital Asahikawa, Hokkaido, Japan Chitose City Hospital Chitose, Hokkaido, Japan, 0668550 Hokkaido University Hospital Sapporo, Hokkaido, Japan, 0608648 Shinko Kagogwa Hospital Kakogawa, Hyogo, Japan, 6750115 Sanda City Hospital Sanda, Hyogo, Japan, 6691321 Rinku General Medical Center Izumisano, Osaka, Japan, 5980048 Matsubara Tokushukai Hospital Matsubara, Osaka, Japan, 5800032 Cardiovascular Institute Hospital Minato-ku, Tokyou, Japan, 1060032 Tokyo Metropolitan Police Hospital Chiyoda, Tokyo, Japan, 1028161 Itabashi Chuo Medical Center Itabashi, Tokyo, Japan, 1740051 Tokyo Medical University Hospital Shinjuku, Tokyo, Japan, 1600023 Less <<
NCT00006178 - Completed - -
NCT00166829 Kidney Transplantation Phase 4 Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Meng-Kun Tsai, MD, PhD    886-2-23123456 ext 5622    mark9@ha.mc.ntu.edu.tw    Contact: Fe-Lin L Wu, PhD    886-2-23123456 ext 8389    flwu@ha.mc.ntu.edu.tw    Principal Investigator: Meng-Kun Tsai, MD, PhD Less <<
NCT00195429 Kidney Failure ... More >> Graft vs Host Disease Less << Phase 4 Completed - Brazil ... More >> Sao Paulo, Brazil Less <<
NCT00195429 - Completed - -
NCT00266123 Graft Rejection ... More >> Kidney Failure Kidney Transplant Less << Phase 4 Completed - -
NCT01233167 Coronary Artery Disease Not Applicable Unknown May 2013 -
NCT00006178 Kidney Failure Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01495247 Inoperable Locally Advanced Br... More >>east Cancer Metastatic Breast Cancer (MBC) Less << Phase 1 Phase 2 Completed - France ... More >> Novartis Investigative Site Dijon Cedex, France, 21034 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Spain Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Less <<
NCT01023919 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Phase 4 Unknown June 2011 China, Heilong jiang ... More >> The second Affiliated Hospital of Harbin Medical University Recruiting Harbin, Heilong jiang, China, 150081 Contact: Bo Yu, MD,PhD    86-0451-86605180    yubodr@163.com    Principal Investigator: Bo Yu, MD, PhD Less <<
NCT01473095 Solid Tumor M... More >>alignant Lymphoma Tumor Less << Phase 1 Completed - United States, Alabama ... More >> Birmingham, Alabama, United States, 35294 United States, Arizona Scottsdale, Arizona, United States, 85258 United States, Florida Miami, Florida, United States, 33136 United States, Georgia Atlanta, Georgia, United States, 30322 Atlanta, Georgia, United States, 30341 United States, Indiana Lafayette, Indiana, United States, 47905 United States, Texas San Antonio, Texas, United States, 78229 Less <<
NCT00752362 Coronary Restenosis Phase 4 Completed - Brazil ... More >> Hospital Universitário Walter Cantídio Fortaleza, Ceará, Brazil, 60430-370 Hospital Meridional Intercath Vitória, Espirito Santo, Brazil, 29156-580 Hospital Universitário Cassiano Antonio de Moraes Vitória -, Espírito Santo, Brazil, 29042-755 Hospital Biocor Belo Horizonte, Minas Gerais, Brazil, 34000-000 Hospital Natal Center Natal, Rio Grande do Norte, Brazil, 59054-630 Hospital São Lucas da PUCRS Porto Alegre, Rio Grande do Sul, Brazil, 90610-000 Rede D'Or de Hospitais Rio de Janeiro, Brazil, 20941-150 Hospital São Paulo - UNIFESP São Paulo, Brazil, 04024-002 Hospital São Camilo São Paulo, Brazil, 05022-001 Instituto do Coração - InCor São Paulo, Brazil, 05403-900 Hospital Santa Marcelina São Paulo, Brazil, 08270-070 Less <<
NCT00428064 Renal Transplantation Phase 3 Completed - -
NCT00062712 Kidney Transplantation Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02756572 Blasts 10 Percent or More of B... More >>one Marrow Nucleated Cells Chronic Myelomonocytic Leukemia-2 High Grade Malignant Neoplasm Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts-2 Myeloid Neoplasm Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Mary-Elizabeth M. Percival    206-606-1320    mperciva@seattlecca.org    Principal Investigator: Mary-Elizabeth M. Percival Less <<
NCT00792948 - Active, not recruiting - -
NCT00513474 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114-2617 Less <<
NCT00792948 Acute Lymphoblastic Leukemia ... More >> Adult Acute Lymphoblastic Leukemia in Remission Adult B Acute Lymphoblastic Leukemia Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Adult L1 Acute Lymphoblastic Leukemia Adult L2 Acute Lymphoblastic Leukemia Adult T Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Active, not recruiting September 24, 2019 -
NCT00513474 - Completed - -
NCT00023244 End-Stage Renal Disease Phase 2 Terminated(Effective August 13... More >>, 2004 Unanticipated high incidence of post-transplant lymphoproliferative disorder) Less << - -
NCT00118742 - Completed - -
NCT00118742 Liver Transplantation Phase 4 Completed - -
NCT00195273 Graft vs Host Disease ... More >> Kidney Transplantation Less << Phase 3 Completed - Norway ... More >> Oslo, Norway, N-0027 Sweden Gothenburg, Sweden, SE-413 45 Uppsala, Sweden, SE-751 85 Less <<
NCT00195273 - Completed - -
NCT05773326 High Grade Glioma|Glioma|Gliom... More >>a, Malignant|Glioblastoma Less << EARLY_PHASE1 RECRUITING 2026-04-30 St. Joseph's Hospital and Medi... More >>cal Center, Phoenix, Arizona, 85013, United States Less <<
NCT01460979 Genital Diseases, Female|Ovari... More >>an Diseases|Ovarian Neoplasms|Endometrial Neoplasms Less << PHASE2 COMPLETED 2025-11-15 Universit?tsklinikum Ulm, Ulm,... More >> Baden-Württemberg, 89075, Germany|Universit?t Erlangen-Nürnberg, Erlangen, Bayern, 91054, Germany|Klinikum rechts der Isar der Technischen Universit?t, München, Bayern, 81675, Germany|Klinikum der J. W. Goethe-Universit?t, Frankfurt am Main, Hessen, 60590, Germany|Universit?tsklinikum Gie?en-Marburg, Standort Marburg, Marburg, Hessen, 35043, Germany|Klinikum Offenbach, Offenbach, Hessen, 63069, Germany|Universit?tsklinikum Greifswald der Ernst-Moritz-Arndt-Universit?t, Greifswald, Mecklenburg Vorpommern, 17475, Germany|Klinikum G?ttingen, Georg-August-Universit?t, G?ttingen, Niedersachsen, 37075, Germany|Gyn?kologisch-onkologische Praxis, Hannover, Niedersachsen, 30177, Germany|Medizinische Hochschule Hannover, Hannover, Niedersachsen, 30625, Germany|Universit?tsklinikum Essen, Essen, Nordrhein-Westfalen, 45122, Germany|Kliniken Essen Mitte, Evang. Huyssens Stiftung/Knappschaft GmbH, Essen, Nordrhein-Westfalen, 45136, Germany|St?dt. Klinikum Solingen gGmbH, Solingen, Nordrhein-Westfalen, 42653, Germany|Universit?tsklinikum Carl Gustav Carus, Dresden, Sachsen, 01307, Germany|Universit?tsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Schleswig-Holstein, 24105, Germany|Charité, Campus Virchow Klinikum, Berlin, 13353, Germany|GYNAEKOLOGICUM Bremen, Bremen, 28211, Germany|Universit?tsklinikum Hamburg-Eppendorf, Hamburg, 20251, Germany Less <<
NCT01111448 Myelodysplastic Syndrome PHASE2 TERMINATED 2025-06-14 Klinikum Chemnitz Klinik für I... More >>nnere Medizin III, Chemnitz, 09113, Germany|Universit?tsklinikum C. G. Carus der TU Dresden, Dresden, 01307, Germany|Universit?tsklinikum Düsseldorf Klinik für H?matologie, Onkologie und Klin. Immunologie, Düsseldorf, 40225, Germany|Universit?tsmedizin G?ttingen Georg-August-Universit?t Abteilung H?matologie und Onkologie, Goettingen, 37075, Germany|Universit?tsklinikum Leipzig A?R, Leipzig, 04103, Germany|Forschungsgesellschaft mbH, Leipzig, 04289, Germany|Klinikum Mannheim GmbH III. Medizinische Universit?tsklinik -SP H?matologie/Onkologie, Mannheim, 68167, Germany Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

0.97mL

0.19mL

0.10mL

4.85mL

0.97mL

0.49mL

9.71mL

1.94mL

0.97mL

References

[1]2018:5896786. doi: 10.1155/2018/5896786.

[2]Wu L. Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts. Cancer Res. 2005 Apr 1;65(7):2825-31. doi: 10.1158/0008-5472.CAN-04-3137.

[3]Agostini D. New Insights into the Role of Exercise in Inhibiting mTOR Signaling in Triple-Negative Breast Cancer. Oxid Med Cell Longev. 2018 Sep 30;2018:5896786. doi: 10.1155/2018/5896786.

[4]33(14):1551-6. doi: 10.1200/JCO.2014.56.2082. Epub 2014 Dec 8.

[5]Geoerger B. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy. Cancer Res. 2001 Feb 15;61(4):1527-32.

 

Historical Records

Categories

Inhibitors/Agonists
PI3K/AKT/mTOR
mTOR

Tags: Temsirolimus | CCI-779 | CCI779 | CCI 779 | mTOR | Autophagy | Apoptosis | Bacterial | Mammalian target of Rapamycin | 162635-04-3